Citrus Sinensis ID: 018816
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.871 | 0.423 | 0.343 | 6e-40 | |
| Q9LSV3 | 433 | Putative wall-associated | no | no | 0.865 | 0.699 | 0.331 | 3e-39 | |
| O64798 | 389 | Inactive serine/threonine | no | no | 0.891 | 0.802 | 0.330 | 7e-39 | |
| Q9S9M1 | 731 | Wall-associated receptor | no | no | 0.88 | 0.421 | 0.345 | 1e-38 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.891 | 0.422 | 0.319 | 5e-38 | |
| Q39191 | 735 | Wall-associated receptor | no | no | 0.882 | 0.420 | 0.319 | 7e-38 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.862 | 0.413 | 0.327 | 9e-38 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.88 | 0.421 | 0.343 | 1e-37 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.882 | 0.421 | 0.310 | 2e-37 | |
| O80795 | 372 | Probable inactive recepto | no | no | 0.891 | 0.838 | 0.307 | 2e-37 |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 165 bits (417), Expect = 6e-40, Method: Compositional matrix adjust.
Identities = 111/323 (34%), Positives = 178/323 (55%), Gaps = 18/323 (5%)
Query: 27 RNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRG 86
RNG + L++ + G N + FSS DL+ A + ++ I +G + Y G L D G
Sbjct: 355 RNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQGGQGTV-YKGMLED-G 412
Query: 87 PILVMKYRKSVRYAS-ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLA 145
I+ +K K+++ + E N I+ SQ+NH++++K++GCCLE E+P LVYE L
Sbjct: 413 MIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLF 472
Query: 146 DRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205
D L+ P + P+ RL +A E A+A++YL P+ R+++ NIL E++ AK
Sbjct: 473 DHLHNPSEDF--PMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAK 530
Query: 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265
+ DF +S+S+ TH+ + G++ + PEYL + ++ K+DVYSFG LL+ LLTG
Sbjct: 531 VSDFGISRSVAIDDTHL-TTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEK 589
Query: 266 IGHLSR---LATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAF 322
L R + G+ F R ++ + +D I C R E++ A +LA
Sbjct: 590 PVSLLRRQEVRMLGAYFLEAMRNDRL-----HEILDARI--KEECDR--EEVLAVAKLAR 640
Query: 323 KCLSHSAEDRPTMIDVAKKLRQM 345
+CLS ++E RPTM DV +L +M
Sbjct: 641 RCLSLNSEHRPTMRDVFIELDRM 663
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (411), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 106/320 (33%), Positives = 166/320 (51%), Gaps = 17/320 (5%)
Query: 29 GQIFLEKLIASFDGKRN-PIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGP 87
G + +E+L S G N + F+ ED+K A N Y + I + + + +Y G L D
Sbjct: 76 GGMLIERL--SGAGSSNIDFKIFTEEDMKEATNGYDVSRI-LGQGGQWTVYKGILPDNSI 132
Query: 88 ILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADR 147
+ + K R E+ N ++ SQ+NH++++KL+GCCLE E+P LVYE +L D
Sbjct: 133 VAIKKTRLGDNNQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITGGSLFDH 192
Query: 148 LYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207
L+G + + L HRL++A+E A A+AYL G P++ R+I+ NIL E AK+
Sbjct: 193 LHGSM--FVSSLTWEHRLEIAIEVAGAIAYLHSGASIPIIHRDIKTENILLDENLTAKVA 250
Query: 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIG 267
DF SK P K + + G+L + PEY TT NEK+DVYSFG +L+ L++G+
Sbjct: 251 DFGASKLKPMDKEQL-TTMVQGTLGYLDPEYYTTWLLNEKSDVYSFGVVLMELISGQKAL 309
Query: 268 HLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAY--VELAFKCL 325
R T V F+ + + +I D +E + + + +A +C
Sbjct: 310 CFERPETS------KHLVSYFVLATKENRLHEII--DDQVLNEENQREIHEAARVAVECT 361
Query: 326 SHSAEDRPTMIDVAKKLRQM 345
E+RP MI+VA +L +
Sbjct: 362 RLKGEERPRMIEVAAELETL 381
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O64798|Y1747_ARATH Inactive serine/threonine-protein kinase At1g67470 OS=Arabidopsis thaliana GN=At1g67470 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (408), Expect = 7e-39, Method: Compositional matrix adjust.
Identities = 116/351 (33%), Positives = 183/351 (52%), Gaps = 39/351 (11%)
Query: 4 WLRKFKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYS 63
W RK KK S+ E G L+ LI DGK NPI+ FS+++++ A NN+
Sbjct: 3 WWRKKKKPKSEIASE---------RGAKLLKDLIECCDGKSNPIKFFSADEIRKATNNFG 53
Query: 64 MRNITIDEIE---GYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSI 119
+ N+ + E+ Y Y G + ILV K Y + F +I +S ++ HK+
Sbjct: 54 VSNL-VSELSHDFDYKWYSGKNENHDMILVRKAFSQSVYYKDTFFRDIAVSSMVSGHKNF 112
Query: 120 LKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLR 179
LKLIG CLE E P +VY + + L++ +P R+K+A + A A+AYL
Sbjct: 113 LKLIGYCLEFEEPVMVYHGV-------KKHYHLESSEQPW--KRRMKIAEDIATALAYLH 163
Query: 180 FGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYL 239
FP+P V+R + NIL E+ AKL DFS SIPEG+T ++ G++++ P YL
Sbjct: 164 TAFPRPFVYRCLSLTNILLDEDGVAKLMDFSFCVSIPEGETFVQVDYIAGTVDYLKPNYL 223
Query: 240 TTGYYNEKTDVYSFGKLLLVLLTGRTI-GHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298
G +E+TDV++ G + +LL G I + R S F ++++ D
Sbjct: 224 KHGVVSEETDVFAVGHSMQMLLMGEKIFDRIMRRPFPTSKFMEEPKMDEI--------AD 275
Query: 299 PVIVGDRSCFRKEE--KLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347
P + G+ S +EE +++A++ L+ +C H E PTM++VAK+L+ + R
Sbjct: 276 PEM-GEIS---EEELCQMKAFLLLSLRCTGHVGE-VPTMVEVAKELKSIQR 321
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 160 bits (406), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 111/321 (34%), Positives = 178/321 (55%), Gaps = 13/321 (4%)
Query: 27 RNGQIFL-EKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDR 85
RNG + L ++L + DG + R FSSE+LK A +N+S++ + +G + Y G + D
Sbjct: 396 RNGGLLLKQQLTTTNDGNVDMSRLFSSEELKKATDNFSVKRVLGKGSQGTV-YKGMMVD- 453
Query: 86 GPILVMKYRKSVRYAS-ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144
G I+ +K K V E+ N I+ SQ+NH++I+KLIGCCLE E+P LVYE +
Sbjct: 454 GKIIAVKRSKVVDEDKLEKFINEIILLSQINHRNIVKLIGCCLETEVPILVYEYIPNGDM 513
Query: 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA 204
RL+ + + RL++A+E A A+ Y+ P+ R+I+ NIL E+Y A
Sbjct: 514 FKRLHDESDDY--AMTWEVRLRIAIEIAGALTYMHSAASFPIYHRDIKTTNILLDEKYGA 571
Query: 205 KLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
K+ DF S+S+ +TH+ A G+ + PEY + Y +K+DVYSFG +L+ L+TG
Sbjct: 572 KVSDFGTSRSVTIDQTHLTTMVA-GTFGYMDPEYFLSSQYTDKSDVYSFGVVLVELITGE 630
Query: 265 TIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKC 324
LSR+ + T +E ++ N ++I + + + S K ++L A +LA KC
Sbjct: 631 K--PLSRIRSEEGRGLATHFLEA-MKENRVIDIIDIRIKEES---KLDQLMAVAKLARKC 684
Query: 325 LSHSAEDRPTMIDVAKKLRQM 345
LS RP M + + +L ++
Sbjct: 685 LSRKGIKRPNMREASLELERI 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (400), Expect = 5e-38, Method: Compositional matrix adjust.
Identities = 103/322 (31%), Positives = 160/322 (49%), Gaps = 10/322 (3%)
Query: 27 RNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRG 86
+NG L + ++ ++ F+ E +K A + Y I +G + Y G L D
Sbjct: 375 QNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDGYDENRILGQGGQGTV-YKGILPDNS 433
Query: 87 PILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD 146
+ + K R E+ N ++ SQ+NH++++KL+GCCLE E+P LVYE TL D
Sbjct: 434 IVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFD 493
Query: 147 RLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206
L+G + L HRL++A+E A +AYL P++ R+I+ NIL E AK+
Sbjct: 494 HLHGSM--FDSSLTWEHRLRMAVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKV 551
Query: 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTI 266
DF S+ IP K + A+ G+L + PEY TG NEK+DVYSFG +L+ LL+G+
Sbjct: 552 ADFGASRLIPMDKEDL-ATMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKA 610
Query: 267 GHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLS 326
R T V F + + +I G + ++Q +A +C
Sbjct: 611 LCFERPQTS------KHIVSYFASATKENRLHEIIDGQVMNENNQREIQKAARIAVECTR 664
Query: 327 HSAEDRPTMIDVAKKLRQMYRT 348
+ E+RP M +VA +L + T
Sbjct: 665 LTGEERPGMKEVAAELEALRVT 686
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 7e-38, Method: Compositional matrix adjust.
Identities = 102/319 (31%), Positives = 160/319 (50%), Gaps = 10/319 (3%)
Query: 27 RNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRG 86
+NG L + ++ ++ F+ + +K A N Y+ I +G + Y G L D
Sbjct: 374 QNGGGMLTQRLSGAGPSNVDVKIFTEDGMKKATNGYAESRILGQGGQGTV-YKGILPDNS 432
Query: 87 PILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD 146
+ + K R E+ N ++ SQ+NH++++KL+GCCLE E+P LVYE TL D
Sbjct: 433 IVAIKKARLGDSSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFD 492
Query: 147 RLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206
L+G + L HRLK+A+E A +AYL P++ R+I+ NIL AK+
Sbjct: 493 HLHGSMID--SSLTWEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDVNLTAKV 550
Query: 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTI 266
DF S+ IP K ++ + G+L + PEY TG NEK+DVYSFG +L+ LL+G+
Sbjct: 551 ADFGASRLIPMDKEELE-TMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKA 609
Query: 267 GHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLS 326
R + V F + +D +I G+ +++Q +A +C
Sbjct: 610 LCFKRPQSS------KHLVSYFATATKENRLDEIIGGEVMNEDNLKEIQEAARIAAECTR 663
Query: 327 HSAEDRPTMIDVAKKLRQM 345
E+RP M +VA KL +
Sbjct: 664 LMGEERPRMKEVAAKLEAL 682
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 157 bits (398), Expect = 9e-38, Method: Compositional matrix adjust.
Identities = 106/324 (32%), Positives = 176/324 (54%), Gaps = 22/324 (6%)
Query: 27 RNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRG 86
RNG + L++ + + DG + FSS +L+ A +N+S+ + +G + Y L D G
Sbjct: 393 RNGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDNFSIDRVLGQGGQGTV-YKRMLVD-G 450
Query: 87 PILVMKYRKSVRYAS-ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLA 145
I+ +K K V E N IV SQ+NH++I+KL+GCCLE E+P LVYE L
Sbjct: 451 SIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLF 510
Query: 146 DRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205
RL+ ++ + RL++A+E A A++Y+ P+ R+I+ NIL E+Y AK
Sbjct: 511 KRLHDEYDDYM--MTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAK 568
Query: 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265
+ DF S+S+ +TH+ A G+ + PEY + Y K+DVYSFG +L+ L+TG
Sbjct: 569 ISDFGTSRSVATDQTHLTTLVA-GTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEK 627
Query: 266 IGHLSRL----ATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELA 321
+SR+ G + +F+ + ++ N ++I + + D S +++ A +LA
Sbjct: 628 --PMSRVRSEEGIGLATYFL-----EAMKENRAVDIIDIRIKDES-----KQVMAVAKLA 675
Query: 322 FKCLSHSAEDRPTMIDVAKKLRQM 345
+CL+ RP M +V+ KL ++
Sbjct: 676 RRCLNRKGNKRPNMREVSIKLERI 699
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (396), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 110/320 (34%), Positives = 177/320 (55%), Gaps = 12/320 (3%)
Query: 27 RNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRG 86
RNG + L++ + + DG + FSS++L+ A +N+S+ + +G + Y G L D G
Sbjct: 394 RNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTV-YKGMLVD-G 451
Query: 87 PILVMKYRKSVRYAS-ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLA 145
I+ +K K V E N IV SQ+NH++I+KL+GCCLE E+P LVYE L
Sbjct: 452 SIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLF 511
Query: 146 DRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205
RL+ + + RL++A+E A A+ Y+ P+ R+I+ NIL E+Y AK
Sbjct: 512 KRLHDESDDYT--MTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAK 569
Query: 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265
+ DF S+S+ +TH+ A G+ + PEY + Y K+DVYSFG +L+ L+TG
Sbjct: 570 VSDFGTSRSVTLDQTHLTTLVA-GTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEK 628
Query: 266 IGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCL 325
LSR+ + T +E ++ N ++I + + D S K E++ A +LA KCL
Sbjct: 629 --PLSRVRSEEGRGLATHFLEA-MKENRVIDIIDIRIKDES---KLEQVMAVAKLARKCL 682
Query: 326 SHSAEDRPTMIDVAKKLRQM 345
+ ++RP M +V+ +L ++
Sbjct: 683 NRKGKNRPNMKEVSNELERI 702
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (395), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 99/319 (31%), Positives = 161/319 (50%), Gaps = 10/319 (3%)
Query: 27 RNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRG 86
+NG L + ++ ++ F+ E +K A + Y+ I +G + Y G L+D
Sbjct: 373 QNGGGMLIQRLSGAGPSNVDVKIFTEEGMKEATDGYNESRILGQGGQGTV-YKGILQDNS 431
Query: 87 PILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD 146
+ + K R R E+ N ++ SQ+NH++++KL+GCCLE E+P LVYE TL D
Sbjct: 432 IVAIKKARLGDRSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFD 491
Query: 147 RLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206
L+G + L HRL++A+E A +AYL P++ R+++ NIL E AK+
Sbjct: 492 HLHGSM--FDSSLTWEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKV 549
Query: 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTI 266
DF S+ IP + + + G+L + PEY TG NEK+DVYSFG +L+ LL+G
Sbjct: 550 ADFGASRLIPMDQEQL-TTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKA 608
Query: 267 GHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLS 326
R + V F+ + + +I G + ++Q +A +C
Sbjct: 609 LCFERPQSS------KHLVSYFVSAMKENRLHEIIDGQVMNEYNQREIQESARIAVECTR 662
Query: 327 HSAEDRPTMIDVAKKLRQM 345
E+RP+M +VA +L +
Sbjct: 663 IMGEERPSMKEVAAELEAL 681
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O80795|Y1652_ARATH Probable inactive receptor-like protein kinase At1g65250 OS=Arabidopsis thaliana GN=At1g65250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (395), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 115/374 (30%), Positives = 186/374 (49%), Gaps = 62/374 (16%)
Query: 4 WLRKFKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYS 63
WLRK KK SD E G LE+LI DGK NPI+ FS++++ A N++S
Sbjct: 3 WLRKKKKPKSDIASE---------RGAKLLEELIECCDGKSNPIKFFSADEILKATNDFS 53
Query: 64 MRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYAS----ERCFNNIVFASQMN-HKS 118
N + + Y G + IL+ +K V + S +R +I +S ++ HK+
Sbjct: 54 DSNFVLRLEVPFKWYSGKNENHPMILI---KKDVGWWSGLRVDRLCRDIAVSSMVSGHKN 110
Query: 119 ILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYL 178
+KL+GCCLE + P +VY + + L+ +P R+K+A + A A+AYL
Sbjct: 111 FMKLVGCCLELDYPVMVYHSV-------KKHYKLEISEQPW--KKRMKIAEDIATALAYL 161
Query: 179 RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEY 238
FP+P V+R + WNIL E+ AKL DFS SIPEG+T ++ +G + A Y
Sbjct: 162 HTAFPRPFVYRILSHWNILLDEDGVAKLTDFSHCVSIPEGETFVRVDRDVGLYSYFADNY 221
Query: 239 LTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI- 297
+ +G ++KTDV++FG + GH RL G +F R E+ +G+ ++
Sbjct: 222 VRSGLVSDKTDVFAFGIFM---------GH--RLLLGYEYYFEHYRGEEEESEDGFDSLM 270
Query: 298 ---------------------DPVIVGDRSCFRKEEKLQ--AYVELAFKCLSHSAEDRPT 334
D ++ ++E+ Q A+++L+ +C S E+ PT
Sbjct: 271 KRHARNLLSTLKEDRPMEEIADSKMIEKMGQISEQERCQMKAFLKLSLRCTGPS-EEVPT 329
Query: 335 MIDVAKKLRQMYRT 348
M++VAK+L ++ R+
Sbjct: 330 MVEVAKELNKIQRS 343
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | ||||||
| 255582635 | 331 | receptor protein kinase, putative [Ricin | 0.922 | 0.975 | 0.485 | 3e-78 | |
| 224123144 | 344 | predicted protein [Populus trichocarpa] | 0.957 | 0.973 | 0.461 | 2e-76 | |
| 255542662 | 330 | serine-threonine protein kinase, plant-t | 0.905 | 0.960 | 0.452 | 3e-69 | |
| 255542658 | 356 | serine-threonine protein kinase, plant-t | 0.908 | 0.893 | 0.428 | 1e-63 | |
| 255542656 | 331 | serine-threonine protein kinase, plant-t | 0.882 | 0.933 | 0.423 | 6e-59 | |
| 255542676 | 247 | serine-threonine protein kinase, plant-t | 0.651 | 0.923 | 0.495 | 8e-49 | |
| 42566015 | 359 | putative protein kinase [Arabidopsis tha | 0.94 | 0.916 | 0.370 | 5e-48 | |
| 4678275 | 356 | putative protein [Arabidopsis thaliana] | 0.94 | 0.924 | 0.370 | 5e-48 | |
| 297817102 | 359 | hypothetical protein ARALYDRAFT_907243 [ | 0.934 | 0.910 | 0.376 | 1e-46 | |
| 297740943 | 321 | unnamed protein product [Vitis vinifera] | 0.874 | 0.953 | 0.364 | 1e-46 |
| >gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 298 bits (762), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 165/340 (48%), Positives = 229/340 (67%), Gaps = 17/340 (5%)
Query: 9 KKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNIT 68
KK+ S+R +L NG++ LEKLIAS DG+ NPIR FS+++L A ++Y R I
Sbjct: 4 KKAESER--------ISLMNGRMLLEKLIASCDGRCNPIRIFSADELSRATDDYDPRKI- 54
Query: 69 IDEIEGYILYMGFLRDRGPILVMKYR-KSVRYASERCFNNIVFASQMN-HKSILKLIGCC 126
I + GY LY G L +R I V K++ KS +Y + C+N+I+FA+QM+ HK+ LKL+GCC
Sbjct: 55 ITQDSGYKLYNGLLHER-TISVKKFKDKSEQY--KYCYNDIMFATQMSKHKNFLKLLGCC 111
Query: 127 LEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPV 186
LE ++P LV+EP Y TLA RLYGP +T +PLL HRLK+A+E ANAV+YL F +P+
Sbjct: 112 LETQIPVLVFEPIEYGTLAGRLYGPNKTLYQPLLWRHRLKIAVEIANAVSYLHTAFSRPI 171
Query: 187 VFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNE 246
VFRNI+P NI E + AKL DFSL+ SIPEG++H+K A G+ APEY T +NE
Sbjct: 172 VFRNIKPLNIFLDECHVAKLSDFSLAVSIPEGESHVKDMLA-GAWGLIAPEYAKTSCFNE 230
Query: 247 KTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG-YMNIDPVIVGDR 305
DVY+FG LL+LLTG+ + R G + D V+KFI + Y +D +I+G+
Sbjct: 231 SQDVYNFGVFLLMLLTGQKVVDSYR-PQAGEELGLVDHVKKFIADDRFYETVDSIILGEG 289
Query: 306 SCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
S K+++LQA+ L+F+C+S + EDRP MIDVAK+LR++
Sbjct: 290 SLPEKDQQLQAFTLLSFRCISEADEDRPMMIDVAKELRKI 329
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 292 bits (747), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 162/351 (46%), Positives = 227/351 (64%), Gaps = 16/351 (4%)
Query: 2 SCWLRKFKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINN 61
+CW + KK KE T ++NG LEKL+ DGK N IRSFS+ +LK A NN
Sbjct: 3 TCW--ETKKDKKVNKE-----TAFIKNGSKLLEKLVDICDGKCNSIRSFSATELKKATNN 55
Query: 62 YSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSIL 120
Y + I + GY LY GFL+ R P+ V K++ E CFN+IV+AS+M+ HKS +
Sbjct: 56 YDPQKILTGD-SGYKLYKGFLQGR-PVSVKKFKDDDE-QYEYCFNDIVYASKMSVHKSFM 112
Query: 121 KLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRF 180
KL+GCCLEA +P LV+E G TL+D L+G + +PLL R K+AM+ ANAVA+L
Sbjct: 113 KLLGCCLEARIPILVFEYVGDWTLSDFLWGSEEARCQPLLWIPRSKIAMDMANAVAFLHA 172
Query: 181 GFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT 240
F +P+VFRNI+P NIL + + AKL DFS+S SIP+G++H++ S A G+ APEYLT
Sbjct: 173 AFSKPIVFRNIKPLNILLDDNHEAKLSDFSISISIPKGESHVRDSVA-GATGLIAPEYLT 231
Query: 241 TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN-IDP 299
TG +NEK DV++FG LLVLL+G+ + SR + D V+K I + + ID
Sbjct: 232 TGNFNEKQDVFNFGVFLLVLLSGQMVVDFSRPE---KEILLQDHVKKCIEDDRFNKVIDS 288
Query: 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTSV 350
I+ + + KE++LQAY L+ +C+S AEDRPTMIDV+K+LR++Y +++
Sbjct: 289 TIIAEGTWPGKEQQLQAYTALSLRCISELAEDRPTMIDVSKELRKIYWSAI 339
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 268 bits (685), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 148/327 (45%), Positives = 212/327 (64%), Gaps = 10/327 (3%)
Query: 26 LRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYI-LYMGFLRD 84
L NG LEK +A +G+ NPIR+FSSE+L+ A NY+ + + +++GY LY GFL+D
Sbjct: 8 LINGSKLLEKSVAFCNGRCNPIRNFSSEELEKATRNYNEKQVL--KLDGYFELYKGFLQD 65
Query: 85 RGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAGYCT 143
R P++V K+ + + N IV+AS M+ H + +KL+GCCLE P LV+E A T
Sbjct: 66 R-PVIVKKFLEV--GVEQLAINEIVYASAMSVHINSIKLLGCCLETPSPILVFESAKEKT 122
Query: 144 LADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203
LADR+ H EP+ RLK+ + AN V Y+ FP+P+V RNI+ NIL E+Y
Sbjct: 123 LADRIIDRNDDHFEPVKWKLRLKIVADIANVVVYIHTAFPRPIVHRNIKASNILLDEDYV 182
Query: 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
AKL DFSL SIPEGK+ ++ A G++ A E L TGY+NEK+DVYSFG +LLV+LTG
Sbjct: 183 AKLSDFSLCVSIPEGKSRVRDIMA-GTMGLIASESLATGYFNEKSDVYSFGVVLLVVLTG 241
Query: 264 RTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN-IDPVIVGDRSCFRKEEKLQAYVELAF 322
+ SR T G F + + V+K I + G+ +DP+IV + + RK ++L+ + +LA
Sbjct: 242 QRSFDFSRTET-GEQFLLVNHVKKHIETGGFKEMVDPIIVAEEAGNRKGQELEDFRDLAL 300
Query: 323 KCLSHSAEDRPTMIDVAKKLRQMYRTS 349
+C+ SAE+RPTMI+VAK+LR +Y +S
Sbjct: 301 RCIHDSAEERPTMIEVAKQLRHIYLSS 327
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 249 bits (637), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 148/345 (42%), Positives = 210/345 (60%), Gaps = 27/345 (7%)
Query: 23 TTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFL 82
T +RNG I LEK IA +G+ NPIR FS ++L+TA N+YS N+ I E + LY GFL
Sbjct: 14 TALMRNGGILLEKSIAFNNGRGNPIRWFSVDELQTATNSYSQNNV-IYEGGWHTLYKGFL 72
Query: 83 RDRGPILVMKYRKSVRYASERC--FNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPA 139
RDR P++V +YR ++ ER N+IVFAS+M+ HK++LKL+GCCLE+E+P LV+E A
Sbjct: 73 RDR-PVIVKRYRNNIH---ERVCPINDIVFASEMSRHKNVLKLLGCCLESEIPILVFEYA 128
Query: 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ 199
L D +Y PLL RLK+A++ AN +AYL P+PVV R+I NI
Sbjct: 129 EKGKLQDYIYKTDSASFRPLLWKSRLKIAVDAANVIAYLHTACPRPVVHRDITLSNIWLD 188
Query: 200 EEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLV 259
E+Y AK+ DF++S SI EG+THI+ +G+ +AAPEY+ +G +NEK DV+SFG LLLV
Sbjct: 189 EDYVAKVTDFTVSMSILEGETHIE-DFVLGTCGYAAPEYVRSGIFNEKIDVFSFGVLLLV 247
Query: 260 LLT---------------GRTIGHLSRLATGGSNFFITDRVEKFI---RSNGYMNIDPVI 301
LLT R + L + +++E F+ R + IDP+I
Sbjct: 248 LLTDQKPFQGNWENILKDARFDEIIGSLIVEKGLWSEKEQLETFLTRTRQKLDLTIDPII 307
Query: 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346
V + KE++L+A++ L +C+ E+RP + DVAK+LR Y
Sbjct: 308 VEEGPWPEKEQQLKAFLMLGVQCIDPDEENRPEITDVAKQLRHFY 352
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 234 bits (596), Expect = 6e-59, Method: Compositional matrix adjust.
Identities = 138/326 (42%), Positives = 204/326 (62%), Gaps = 17/326 (5%)
Query: 26 LRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYI-LYMGFLRD 84
+RNG+ LEK +A +G+ NP+R FS ++L+ A N+YS N+ I+G LY G +RD
Sbjct: 15 MRNGRSLLEKSVALNNGRGNPVRCFSVKELQNATNSYSQHNVFY--IDGTCRLYKGLIRD 72
Query: 85 RGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAGYCT 143
R P++V KY ++ SE ++IV AS+M+ H+++LKL+GCCLE+E+P V+E A T
Sbjct: 73 R-PVIVKKY--DYKHPSEDPVSDIVIASEMSVHRNVLKLLGCCLESEIPIPVFEYAEKGT 129
Query: 144 LADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203
L D + LL RLK+A++ A+ +AYL FP+P+V R+I +IL E+ A
Sbjct: 130 LEDYV------QKTALLWKDRLKIAVDVASVIAYLHTAFPRPIVHRDISLASILLDEDCA 183
Query: 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
AK+ FSLS SIPEG+THI+ A G++ + APEY +NEK DVYSFG +LLVLLTG
Sbjct: 184 AKVTGFSLSISIPEGETHIEDEVA-GTIGYVAPEYFMKRMFNEKIDVYSFGVVLLVLLTG 242
Query: 264 RTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN-IDPVIVGDRSCFRKEEKLQAYVELAF 322
G + R T + + VE I++ + IDP I+ + KE++L++++ LA
Sbjct: 243 H--GPILRSPTTNESHALVVFVEAKIKNERFNEIIDPAILEEGPWPEKEQQLKSFLTLAM 300
Query: 323 KCLSHSAEDRPTMIDVAKKLRQMYRT 348
+C EDRP + DVAK+LR +Y +
Sbjct: 301 QCTRKDEEDRPEITDVAKQLRHIYHS 326
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542676|ref|XP_002512401.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548362|gb|EEF49853.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 200 bits (509), Expect = 8e-49, Method: Compositional matrix adjust.
Identities = 120/242 (49%), Positives = 163/242 (67%), Gaps = 14/242 (5%)
Query: 26 LRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDR 85
+RNG I LEK IA +G+ NPIR FS E+L+TA N+YS N+ I E + Y GFLR+R
Sbjct: 9 MRNGGILLEKSIAFNNGRGNPIRCFSVEELQTATNSYSQNNV-IYEGGWHTHYKGFLRER 67
Query: 86 GPILVMKYRKSVRYASERC--FNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAGYC 142
P++V +YR ++ ER N+IVFAS+M+ HK++LKL+GCCLE+E+P LV+E A
Sbjct: 68 -PVIVKRYRTNIH---ERVCPINDIVFASEMSRHKNVLKLLGCCLESEIPILVFEYAEKG 123
Query: 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY 202
L D +Y + RLK+A++ AN +AYL FP+PVV R+I N+ E+
Sbjct: 124 NLHDYIY-----KTDSASFRRRLKIAVDAANVIAYLHTAFPRPVVHRHITLSNVWLDEDS 178
Query: 203 AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
AK+ DFSLS SIPEG+THI+ +G+ +AAPEY +G +NEK DV+SFG LLLVLLT
Sbjct: 179 VAKVTDFSLSMSIPEGETHIE-DFVMGTCGYAAPEYARSGIFNEKIDVFSFGVLLLVLLT 237
Query: 263 GR 264
G+
Sbjct: 238 GQ 239
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42566015|ref|NP_191331.2| putative protein kinase [Arabidopsis thaliana] gi|119360045|gb|ABL66751.1| At3g57720 [Arabidopsis thaliana] gi|332646169|gb|AEE79690.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 197 bits (502), Expect = 5e-48, Method: Compositional matrix adjust.
Identities = 129/348 (37%), Positives = 197/348 (56%), Gaps = 19/348 (5%)
Query: 5 LRKFKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSM 64
L K K+ D +EE+ L NG IFL++LIA +GK PIR+FSS+ + A +N+
Sbjct: 17 LEKRKEKEKDIQEEKWF----LDNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNFGS 72
Query: 65 RNITIDEIEGYILYMGFLRDRGPILVMKYR--KSVRYASERCFNNIVFASQM-NHKSILK 121
E Y+ Y G + DR ++ ++ K +Y +N IV +++M NH + LK
Sbjct: 73 SCFVTAE-GFYVWYKGIIEDRS-YMIKRFSEYKVTQYRVAEVYNEIVLSARMSNHNNFLK 130
Query: 122 LIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLL--THRLKVAMETANAVAYLR 179
LIG CLE +P LV+E A + L R G + + E ++L + RLK+ E ANAV YL
Sbjct: 131 LIGFCLEFSLPVLVFEYAEHGVLNHR--GGVIVNGEEVILPLSLRLKIGKEIANAVTYLH 188
Query: 180 FGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYL 239
FP+ ++ R+I+P N+ E + KL DFS+S ++PEGK+ I+ G++ + P Y
Sbjct: 189 MAFPKILIHRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYLDPVYY 248
Query: 240 TTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN--I 297
TT E TDVYSFG L+V+LTG+ L+ ++ G I V+ F NG ++ I
Sbjct: 249 TTKMVTEYTDVYSFGVFLMVILTGKPA--LASTSSDGDYKHIASYVKGF-HENGQLDGVI 305
Query: 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
DP ++ D + +K ++A V LA +C E+RP MI +AK+L+Q+
Sbjct: 306 DPKVMEDITSAQKVH-VEACVVLALRCCELRDENRPKMIQIAKELKQI 352
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4678275|emb|CAB41183.1| putative protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 197 bits (502), Expect = 5e-48, Method: Compositional matrix adjust.
Identities = 129/348 (37%), Positives = 197/348 (56%), Gaps = 19/348 (5%)
Query: 5 LRKFKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSM 64
L K K+ D +EE+ L NG IFL++LIA +GK PIR+FSS+ + A +N+
Sbjct: 14 LEKRKEKEKDIQEEKWF----LDNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNFGS 69
Query: 65 RNITIDEIEGYILYMGFLRDRGPILVMKYR--KSVRYASERCFNNIVFASQM-NHKSILK 121
E Y+ Y G + DR ++ ++ K +Y +N IV +++M NH + LK
Sbjct: 70 SCFVTAE-GFYVWYKGIIEDRS-YMIKRFSEYKVTQYRVAEVYNEIVLSARMSNHNNFLK 127
Query: 122 LIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLL--THRLKVAMETANAVAYLR 179
LIG CLE +P LV+E A + L R G + + E ++L + RLK+ E ANAV YL
Sbjct: 128 LIGFCLEFSLPVLVFEYAEHGVLNHR--GGVIVNGEEVILPLSLRLKIGKEIANAVTYLH 185
Query: 180 FGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYL 239
FP+ ++ R+I+P N+ E + KL DFS+S ++PEGK+ I+ G++ + P Y
Sbjct: 186 MAFPKILIHRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYLDPVYY 245
Query: 240 TTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN--I 297
TT E TDVYSFG L+V+LTG+ L+ ++ G I V+ F NG ++ I
Sbjct: 246 TTKMVTEYTDVYSFGVFLMVILTGKPA--LASTSSDGDYKHIASYVKGF-HENGQLDGVI 302
Query: 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
DP ++ D + +K ++A V LA +C E+RP MI +AK+L+Q+
Sbjct: 303 DPKVMEDITSAQKVH-VEACVVLALRCCELRDENRPKMIQIAKELKQI 349
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297817102|ref|XP_002876434.1| hypothetical protein ARALYDRAFT_907243 [Arabidopsis lyrata subsp. lyrata] gi|297322272|gb|EFH52693.1| hypothetical protein ARALYDRAFT_907243 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 193 bits (491), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 130/345 (37%), Positives = 191/345 (55%), Gaps = 18/345 (5%)
Query: 11 SSSDRKEEETVCTTT---LRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNI 67
SS RKE+E L NG IFL++LIA +GK PIRSFSS+ + A +N+
Sbjct: 16 SSEKRKEKEKDIQEERCFLENGSIFLKELIADCNGKSIPIRSFSSDQILKATSNFGSSCF 75
Query: 68 TIDEIEGYILYMGFLRDRGPILVMKYR--KSVRYASERCFNNIVFASQM-NHKSILKLIG 124
E Y+ Y G + DR ++ K+ K Y +N IV +++M NH + LKL+G
Sbjct: 76 VTAE-GFYVWYKGIIEDRS-YMIKKFSEYKVTHYRVAEVYNEIVLSARMSNHNNFLKLVG 133
Query: 125 CCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEP--LLLTHRLKVAMETANAVAYLRFGF 182
CLE +P LV+E A + L R G + + E L L+ RLK+ E ANAV YL F
Sbjct: 134 FCLEFCLPVLVFEYAEHGVLNHR--GGVMVNGEEYILPLSLRLKIGKEIANAVTYLHMAF 191
Query: 183 PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG 242
P+ ++ R+I P N+ + + AKL DFS+S +IPEGK+ I+ G++ + P Y TT
Sbjct: 192 PKILIHRHINPRNVFLDKSWTAKLSDFSISINIPEGKSRIEVECVQGTIGYLDPVYYTTK 251
Query: 243 YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN--IDPV 300
E TDVYSFG L+V+LTG+ L+ ++ G I V+ F NG ++ ID
Sbjct: 252 MVTEYTDVYSFGVFLMVILTGKPA--LASTSSDGDYKHIAGYVKGF-HENGQLDGIIDSK 308
Query: 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
++ D + +K ++A V L +C E+RP MI +AK+L+Q+
Sbjct: 309 VMKDITSAQK-VLVEACVVLGLRCCELRDENRPKMIQIAKELKQI 352
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740943|emb|CBI31255.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 193 bits (490), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 121/332 (36%), Positives = 189/332 (56%), Gaps = 26/332 (7%)
Query: 24 TTLRNGQIFLEKLIASFDGKR-NPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFL 82
+ L+NG + L++ I+ F+GK NPIRSF ++L+ A ++Y+ I ++ I Y G L
Sbjct: 5 SMLKNGSLLLKERISYFNGKYFNPIRSFCMKELQNATDDYNTGLIFDHDVGNCIWYKGSL 64
Query: 83 RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAGY 141
R + R + E N IV ASQM+ HK+ LKL+GCCLE +P LVYE
Sbjct: 65 EGR----TISVRTNFYEGVEMAINEIVIASQMSAHKNALKLLGCCLETRIPILVYEFPSG 120
Query: 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201
+L DR++ P PL RL++A + AN +AYL FP+ ++ +I+P + ++
Sbjct: 121 GSLIDRIFSPPN----PLSWKSRLRIAYDIANVIAYLHIAFPRSIIHTDIKPSSFFLDQD 176
Query: 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLL 261
AAKL DFSLS ++PEG+ H++ G+ + APE L +G Y EK DV+SFG LLL LL
Sbjct: 177 CAAKLSDFSLSITLPEGEMHVEDEIR-GTFGYLAPETLISGVYTEKNDVFSFGILLLELL 235
Query: 262 TGR---TIGHLSRLATGGSNFFITDRVEKFIRS---NGYMNIDPVIVGDRSCFRKEEKLQ 315
G+ +I H R + I D + F+ + NG +DP+I+ +E + Q
Sbjct: 236 IGKRAHSIMHEERAS-------IQDYAQSFVNTYDINGI--VDPIILAQPRGIHEELQFQ 286
Query: 316 AYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347
A +LA +C ++RPT+++ AK++R++ +
Sbjct: 287 AIFDLAMRCSMKDMDERPTIVNAAKEVRRIQK 318
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 350 | ||||||
| TAIR|locus:2076681 | 359 | AT3G57720 [Arabidopsis thalian | 0.94 | 0.916 | 0.376 | 1.5e-49 | |
| TAIR|locus:2076586 | 351 | AT3G57710 [Arabidopsis thalian | 0.94 | 0.937 | 0.350 | 6.9e-47 | |
| TAIR|locus:2076671 | 355 | AT3G57730 [Arabidopsis thalian | 0.957 | 0.943 | 0.343 | 3.8e-46 | |
| TAIR|locus:2076596 | 340 | AT3G57700 [Arabidopsis thalian | 0.937 | 0.964 | 0.356 | 7.1e-45 | |
| TAIR|locus:2076646 | 334 | AT3G57750 [Arabidopsis thalian | 0.9 | 0.943 | 0.371 | 1.7e-43 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.882 | 0.423 | 0.349 | 7e-41 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.928 | 0.451 | 0.337 | 1.4e-39 | |
| TAIR|locus:2094468 | 433 | AT3G25490 [Arabidopsis thalian | 0.934 | 0.755 | 0.310 | 1.8e-39 | |
| TAIR|locus:2079959 | 351 | AT3G52530 [Arabidopsis thalian | 0.897 | 0.894 | 0.357 | 6.1e-39 | |
| TAIR|locus:2008818 | 389 | AT1G67470 [Arabidopsis thalian | 0.888 | 0.799 | 0.335 | 1.3e-38 |
| TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 516 (186.7 bits), Expect = 1.5e-49, P = 1.5e-49
Identities = 131/348 (37%), Positives = 197/348 (56%)
Query: 5 LRKFKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSM 64
L K K+ D +EE+ L NG IFL++LIA +GK PIR+FSS+ + A +N+
Sbjct: 17 LEKRKEKEKDIQEEKWF----LDNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNFGS 72
Query: 65 RNITIDEIEG-YILYMGFLRDRGPILVMKYR--KSVRYASERCFNNIVFASQM-NHKSIL 120
EG Y+ Y G + DR ++ ++ K +Y +N IV +++M NH + L
Sbjct: 73 SCFVT--AEGFYVWYKGIIEDRS-YMIKRFSEYKVTQYRVAEVYNEIVLSARMSNHNNFL 129
Query: 121 KLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLL-LTHRLKVAMETANAVAYLR 179
KLIG CLE +P LV+E A + L R G + E +L L+ RLK+ E ANAV YL
Sbjct: 130 KLIGFCLEFSLPVLVFEYAEHGVLNHR-GGVIVNGEEVILPLSLRLKIGKEIANAVTYLH 188
Query: 180 FGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYL 239
FP+ ++ R+I+P N+ E + KL DFS+S ++PEGK+ I+ G++ + P Y
Sbjct: 189 MAFPKILIHRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYLDPVYY 248
Query: 240 TTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN--I 297
TT E TDVYSFG L+V+LTG+ L+ ++ G I V+ F NG ++ I
Sbjct: 249 TTKMVTEYTDVYSFGVFLMVILTGKPA--LASTSSDGDYKHIASYVKGF-HENGQLDGVI 305
Query: 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
DP ++ D + +K ++A V LA +C E+RP MI +AK+L+Q+
Sbjct: 306 DPKVMEDITSAQKVH-VEACVVLALRCCELRDENRPKMIQIAKELKQI 352
|
|
| TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 491 (177.9 bits), Expect = 6.9e-47, P = 6.9e-47
Identities = 121/345 (35%), Positives = 194/345 (56%)
Query: 9 KKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNIT 68
K S RKE++ L NG IFL +L+A +GK PIRSFS E + A NN+
Sbjct: 7 KSGSGTRKEKDKAKRWFLDNGSIFLRELVADCNGKSIPIRSFSPEQILKATNNFDSSCFV 66
Query: 69 IDEIEGYILYMGFLRDRGPILVMKYRKSV----RYASERCFNNIVFASQM-NHKSILKLI 123
++ Y Y G + DR ++ ++ + R+ + +N+IV +++M NH + L+L+
Sbjct: 67 SQDVY-YKWYRGEIEDRS-YMIKRFSEDEITGKRHRVKEVYNDIVLSARMSNHSNFLQLL 124
Query: 124 GCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLL-LTHRLKVAMETANAVAYLRFGF 182
GCCLE P LV+E A + + R G + E LL + RLK+ E ANAV YL F
Sbjct: 125 GCCLEFPFPVLVFEFAEHGAMNQR-GGVIVNGEESLLPWSVRLKIGKEIANAVTYLHTAF 183
Query: 183 PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG 242
P+ ++ R+++P ++ + + AKL D S S S+PEGK+ I+A +G+ + P Y T
Sbjct: 184 PKIIIHRDVKPMHVFLDKNWTAKLSDLSFSISLPEGKSRIEAEWVLGTFGYIDPLYHKTC 243
Query: 243 YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN--IDPV 300
+ E TDVYSFG LLV++TG+ + ++ G ++ + + + NG ++ IDP
Sbjct: 244 FVTEYTDVYSFGICLLVIITGKPA--IMTISDGDLQGILS--LVRELCENGKLDEVIDPR 299
Query: 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
++ D + ++ + ++A V LA +C EDRP MI VAK+L+Q+
Sbjct: 300 LMKDITSGQRLQ-VEACVVLALRCCKERDEDRPKMIQVAKELKQI 343
|
|
| TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 484 (175.4 bits), Expect = 3.8e-46, P = 3.8e-46
Identities = 123/358 (34%), Positives = 199/358 (55%)
Query: 1 MSCWLRKFK---KSSSDRKEEETVCTTT--LRNGQIFLEKLIASFDGKRNPIRSFSSEDL 55
M ++K K ++ S +K+E+++ L NG IFL++LI +GK PIRSF+S +
Sbjct: 1 MESMVKKLKQNLRTGSWKKKEKSMKKERWFLENGSIFLKELIVDCNGKSIPIRSFTSSQI 60
Query: 56 KTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYR--KSVRYASERCFNNIVFASQ 113
+ A N+ + +E YI Y G + DR ++ ++ K Y + +IV +++
Sbjct: 61 RKATKNFDLSCFVAEE-GFYIWYKGVIEDRS-YMIKRFSEYKVTDYRVSEVYKDIVLSAR 118
Query: 114 M-NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLL--THRLKVAME 170
M NH + LKL+GCCLE P LV+E A + L R G + + E LL + RLK+ E
Sbjct: 119 MSNHNNFLKLLGCCLEFPFPVLVFEFAEHGVLNYR--GGITVNGEESLLPLSLRLKIGKE 176
Query: 171 TANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
ANA+AYL FP+ +++R+++P ++ + AKL D S S S+ EGK+ I+A +G+
Sbjct: 177 IANALAYLHMAFPKIIIYRDVKPLHVFLDNNWTAKLSDLSFSISLEEGKSQIEAEDVLGT 236
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR-VEKFI 289
+ P Y T E TDVYSFG L+V++TG +S TG + + K +
Sbjct: 237 YGYLDPLYFATRIVTEYTDVYSFGVFLMVVITG-----ISVYFTGSDGYPVGILGYMKGL 291
Query: 290 RSNGYMN--IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
NG +N + P+I+ + + ++ + ++A V LA +C EDRP MI VAK+L+++
Sbjct: 292 AENGKLNEIVYPMIMKEMTSAQRLQ-VEACVLLALRCCEERVEDRPKMIQVAKELKRI 348
|
|
| TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 7.1e-45, P = 7.1e-45
Identities = 124/348 (35%), Positives = 195/348 (56%)
Query: 5 LRKFKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSM 64
LR F+K +KEEE +NG + LE+LIA+ G NPIR+FSS+ + A N++
Sbjct: 2 LRLFRKKKKQKKEEEI---NLQKNGSLLLEELIATSGGIYNPIRTFSSDQILQATNHFDW 58
Query: 65 RNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLI 123
N I E + ++ Y G + +R P+L+ K++ + ++ + +I +S M+ HK++LKL+
Sbjct: 59 -NYVISE-DRFVWYKGMIENR-PVLIKKFQDCSVFDADNFYRDIAVSSLMSSHKNVLKLL 115
Query: 124 GCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP 183
GCCLE P LV E + L G P + RL++A E A+AVAYL FP
Sbjct: 116 GCCLEFPRPVLVCEYPEHGALNCIRCGKEGVRSFPWNV--RLRIAKEIADAVAYLHTEFP 173
Query: 184 QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY 243
+ ++ R+++ NI E ++AKL FSLS +PEG+T + S + P+Y TG
Sbjct: 174 RTIIHRDLKLANIFLDENWSAKLSSFSLSIVLPEGETGVNDMVCRTS-SYIEPDYFNTGL 232
Query: 244 YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN--IDPVI 301
E D+YS G ++L++LTG++ + S +A + V KF+ G + IDP I
Sbjct: 233 VTENVDIYSLGIIMLIILTGKS-EYNSEVAVYLP--VLPVYVGKFLE-RGLLTELIDPSI 288
Query: 302 VGDRSC-FRKEEKLQ--AYVELAFKCLS-HSAEDRPTMIDVAKKLRQM 345
+ S K +LQ A++ELAF+C+ E+ P MIDVAK+L+++
Sbjct: 289 LDSTSDDIPKHSRLQMEAFIELAFRCVRFRPGENVPRMIDVAKELKKI 336
|
|
| TAIR|locus:2076646 AT3G57750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 459 (166.6 bits), Expect = 1.7e-43, P = 1.7e-43
Identities = 123/331 (37%), Positives = 187/331 (56%)
Query: 26 LRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDR 85
L+NG I LE+LIASFDGK NPIR FSS+ + A +N+S I I +I Y G + +R
Sbjct: 13 LKNGGILLEELIASFDGKTNPIRCFSSDQILKATDNFSESRI-ISSWGYFIWYKGVIEER 71
Query: 86 GPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAGYCTL 144
+ + K+ + + +I +SQM+ HK+ LKLIGCCLE ++PALV E + L
Sbjct: 72 -QVSIKKWSSQNLSSFTEAYRDISVSSQMSGHKNALKLIGCCLEFDLPALVCEYTEHGPL 130
Query: 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA 204
+R G + P + RLK+A E A++V YL FP+ +V RNI P NI E + A
Sbjct: 131 -NRDGGLSSGVVLPWKV--RLKIAKEIASSVTYLHTAFPETIVHRNINPTNIFIDENWTA 187
Query: 205 KLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
KL DF +IPEG+ +++ G + F P+Y T EK D+YSFG ++LVLL+GR
Sbjct: 188 KLSDFWFCVAIPEGELYVEDDVK-GVIGFVDPDYYWTMKVTEKVDIYSFGVVMLVLLSGR 246
Query: 265 T-IGHLSRLATGGSNFFITDRVEK--F--IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVE 319
+ + A N +++ +EK F I N D + GD + +++A++
Sbjct: 247 AAVFNGPDEAPMSLNDHVSEVMEKGEFDEIVDKEIWN-D--LGGDDDLVLRRSQVKAFLR 303
Query: 320 LAFKCLSHSAEDRPT-MIDVAKKLRQMYRTS 349
LA +C+ + ED + M++VAK+L+ + + S
Sbjct: 304 LALRCVRYKKEDPVSGMLEVAKELKLIEKLS 334
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 440 (159.9 bits), Expect = 7.0e-41, P = 7.0e-41
Identities = 114/326 (34%), Positives = 182/326 (55%)
Query: 27 RNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRG 86
RNG + L++ + + DG + FSS++L+ A +N+S+ + +G + Y G L D G
Sbjct: 394 RNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTV-YKGMLVD-G 451
Query: 87 PILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLA 145
I+ +K K V E N IV SQ+NH++I+KL+GCCLE E+P LVYE Y
Sbjct: 452 SIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYE---YIPNG 508
Query: 146 DRLYGPLQTHLEPLLLTH--RLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203
D L+ L + +T RL++A+E A A+ Y+ P+ R+I+ NIL E+Y
Sbjct: 509 D-LFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYR 567
Query: 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
AK+ DF S+S+ +TH+ A G+ + PEY + Y K+DVYSFG +L+ L+TG
Sbjct: 568 AKVSDFGTSRSVTLDQTHLTTLVA-GTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITG 626
Query: 264 RTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFK 323
LSR+ + T +E ++ N ++I + + D S K E++ A +LA K
Sbjct: 627 EK--PLSRVRSEEGRGLATHFLEA-MKENRVIDIIDIRIKDES---KLEQVMAVAKLARK 680
Query: 324 CLSHSAEDRPTMIDVAKKLRQMYRTS 349
CL+ ++RP M +V+ +L ++ R+S
Sbjct: 681 CLNRKGKNRPNMKEVSNELERI-RSS 705
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 428 (155.7 bits), Expect = 1.4e-39, P = 1.4e-39
Identities = 117/347 (33%), Positives = 189/347 (54%)
Query: 4 WLRKFKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYS 63
WL K++ RK + RNG + L++ + G N + FSS DL+ A + ++
Sbjct: 334 WL--LCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFN 391
Query: 64 MRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYAS-ERCFNNIVFASQMNHKSILKL 122
I +G + Y G L D G I+ +K K+++ + E N I+ SQ+NH++++K+
Sbjct: 392 ASRILGQGGQGTV-YKGMLED-GMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKI 449
Query: 123 IGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF 182
+GCCLE E+P LVYE L D L+ P + P+ RL +A E A+A++YL
Sbjct: 450 LGCCLETEVPILVYEFIPNRNLFDHLHNPSEDF--PMSWEVRLCIACEVADALSYLHSAV 507
Query: 183 PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI-GSLEFAAPEYLTT 241
P+ R+++ NIL E++ AK+ DF +S+S+ TH+ +T + G++ + PEYL +
Sbjct: 508 SIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHL--TTIVQGTIGYVDPEYLQS 565
Query: 242 GYYNEKTDVYSFGKLLLVLLTG-RTIGHLSRLATG--GSNFFITDRVEKFIRSNGYMNID 298
++ K+DVYSFG LL+ LLTG + + L R G+ F R ++ + +D
Sbjct: 566 NHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRL-----HEILD 620
Query: 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
I C R+E + A +LA +CLS ++E RPTM DV +L +M
Sbjct: 621 ARI--KEECDREE--VLAVAKLARRCLSLNSEHRPTMRDVFIELDRM 663
|
|
| TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 421 (153.3 bits), Expect = 1.8e-39, P = 1.8e-39
Identities = 107/345 (31%), Positives = 176/345 (51%)
Query: 4 WLRKFKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRN-PIRSFSSEDLKTAINNY 62
+++ +K D K + + G + +E+L + G N + F+ ED+K A N Y
Sbjct: 52 YIKNIRKHQKDTKIQRQLFFEK-NGGGMLIERLSGA--GSSNIDFKIFTEEDMKEATNGY 108
Query: 63 SMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKL 122
+ I + + + +Y G L D + + K R E+ N ++ SQ+NH++++KL
Sbjct: 109 DVSRI-LGQGGQWTVYKGILPDNSIVAIKKTRLGDNNQVEQFINEVLVLSQINHRNVVKL 167
Query: 123 IGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF 182
+GCCLE E+P LVYE +L D L+G + + L HRL++A+E A A+AYL G
Sbjct: 168 LGCCLETEVPLLVYEFITGGSLFDHLHGSM--FVSSLTWEHRLEIAIEVAGAIAYLHSGA 225
Query: 183 PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG 242
P++ R+I+ NIL E AK+ DF SK P K + G+L + PEY TT
Sbjct: 226 SIPIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQLTTMVQ-GTLGYLDPEYYTTW 284
Query: 243 YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGS--NFFITDRVEKFIRSNGYMNIDPV 300
NEK+DVYSFG +L+ L++G+ R T ++F+ E + ID
Sbjct: 285 LLNEKSDVYSFGVVLMELISGQKALCFERPETSKHLVSYFVLATKENRLHEI----IDDQ 340
Query: 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
++ + + + ++ +A +C E+RP MI+VA +L +
Sbjct: 341 VLNEEN----QREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381
|
|
| TAIR|locus:2079959 AT3G52530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 416 (151.5 bits), Expect = 6.1e-39, P = 6.1e-39
Identities = 123/344 (35%), Positives = 181/344 (52%)
Query: 8 FKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNI 67
FK S RK + +NG + E+LIA DGK NPIR FSS+ + A NN+ +I
Sbjct: 5 FKTESETRKHSD-------KNGSLLHEELIACSDGKYNPIRMFSSDQILKATNNFDADHI 57
Query: 68 TIDEIEGYILYMGFLRDRGPILVMKYRKS-VRYAS-ERCFNNIVFASQMN-HKSILKLIG 124
+ +I Y G + +R +L+ K+ V ++S E + +I S M+ HK++LKL+G
Sbjct: 58 IAKD--RFIWYKGTIEERR-VLIKKWEGDYVLFSSPENVYRDIAVLSMMSSHKNVLKLLG 114
Query: 125 CCLEAEMPALVYEPAGYCTLADRLYGPLQTH-LE--PLLLTHRLKVAMETANAVAYLRFG 181
CC+E P LV C LA++ GPL+ ++ PL + RLK+ + ANAVAYL
Sbjct: 115 CCVEFYKPVLV------CELAEK--GPLKLEDMDGTPLPWSARLKIGKDIANAVAYLHTA 166
Query: 182 FPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT 241
FP+ ++ R++ P NI E+ AKL F L SIPEG++ + + + PEY T
Sbjct: 167 FPRVIINRDVRPQNIFLDEDGTAKLSSFCLRISIPEGESSVYDDKVVYGVS-VDPEYNGT 225
Query: 242 GYYNEKTDVYSFGKLLLVLLTGRT-IGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300
G +EK DVYSFG +L LL G + LS + G F E+ Y+ ID
Sbjct: 226 GLVSEKFDVYSFGVTMLFLLGGELGLTWLSAII-GEFGFPFPGCGEELADQFMYV-IDSN 283
Query: 301 IVGDRSCFRKEEKLQAYVELAFKCLSH-SAEDRPTMIDVAKKLR 343
I S +++ + LA +C+ +D TMIDVAK+L+
Sbjct: 284 IWNGES-EASAVQVETFFGLALRCIRFWPGQDVLTMIDVAKELK 326
|
|
| TAIR|locus:2008818 AT1G67470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 413 (150.4 bits), Expect = 1.3e-38, P = 1.3e-38
Identities = 118/352 (33%), Positives = 187/352 (53%)
Query: 4 WLRKFKKSSSDRKEEETVCTTTLRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYS 63
W RK KK S+ E G L+ LI DGK NPI+ FS+++++ A NN+
Sbjct: 3 WWRKKKKPKSEIASER---------GAKLLKDLIECCDGKSNPIKFFSADEIRKATNNFG 53
Query: 64 MRNITIDEIE---GYILYMGFLRDRGPILVMK-YRKSVRYASERCFNNIVFASQMN-HKS 118
+ N+ + E+ Y Y G + ILV K + +SV Y + F +I +S ++ HK+
Sbjct: 54 VSNL-VSELSHDFDYKWYSGKNENHDMILVRKAFSQSVYY-KDTFFRDIAVSSMVSGHKN 111
Query: 119 ILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYL 178
LKLIG CLE E P +VY + + L++ +P R+K+A + A A+AYL
Sbjct: 112 FLKLIGYCLEFEEPVMVYHGV-------KKHYHLESSEQPW--KRRMKIAEDIATALAYL 162
Query: 179 RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEY 238
FP+P V+R + NIL E+ AKL DFS SIPEG+T ++ G++++ P Y
Sbjct: 163 HTAFPRPFVYRCLSLTNILLDEDGVAKLMDFSFCVSIPEGETFVQVDYIAGTVDYLKPNY 222
Query: 239 LTTGYYNEKTDVYSFGKLLLVLLTGRTI-GHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297
L G +E+TDV++ G + +LL G I + R S F ++++
Sbjct: 223 LKHGVVSEETDVFAVGHSMQMLLMGEKIFDRIMRRPFPTSKFMEEPKMDEIA-------- 274
Query: 298 DPVIVGDRSCFRKEE--KLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347
DP + G+ S +EE +++A++ L+ +C H E PTM++VAK+L+ + R
Sbjct: 275 DPEM-GEIS---EEELCQMKAFLLLSLRCTGHVGEV-PTMVEVAKELKSIQR 321
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XIII000087 | hypothetical protein (344 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 350 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-16 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-16 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-16 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-14 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-10 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-07 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-07 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-06 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-06 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-06 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-04 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-04 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-04 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-04 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.001 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.001 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 0.001 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.001 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 0.001 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.001 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.002 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 0.002 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.002 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.003 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.003 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.003 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 0.003 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.003 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.003 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 0.004 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 4e-21
Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 13/187 (6%)
Query: 78 YMGFLRDRGPILVMKY--RKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135
Y+ + G + +K ++ E I ++NH +I+KL G + LV
Sbjct: 10 YLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLV 69
Query: 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWN 195
E +L D L+ + L L++ ++ + YL ++ R+++P N
Sbjct: 70 MEYCEGGSLKDL----LKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPEN 122
Query: 196 ILFQEEYA-AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT-TGYYNEKTDVYSF 253
IL + KL DF LSK + K+ T +G+ + APE L GYY+EK+D++S
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSL 180
Query: 254 GKLLLVL 260
G +L L
Sbjct: 181 GVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-17
Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 50/247 (20%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL------------EPL 159
++ H ++++L+G C E E LV E Y G L +L L
Sbjct: 51 KKLGHPNVVRLLGVCTEEEPLYLVLE---YME-----GGDLLDYLRKSRPVFPSPEKSTL 102
Query: 160 LLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219
L L A++ A + YL + V R++ N L E+ K+ DF LS+ + +
Sbjct: 103 SLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159
Query: 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF 279
+ K + + + APE L G + K+DV+SFG VLL + T G+
Sbjct: 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFG----VLLW--------EIFTLGATP 207
Query: 280 FI---TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI 336
+ + V +++R + P D +L EL C EDRPT
Sbjct: 208 YPGLSNEEVLEYLRKGYRLPK-PEYCPD--------ELY---ELMLSCWQLDPEDRPTFS 255
Query: 337 DVAKKLR 343
++ ++L
Sbjct: 256 ELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 57/235 (24%), Positives = 103/235 (43%), Gaps = 37/235 (15%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRL-YGPLQTHLEPLLLTHRLKVAME 170
+++H +++KL+G C E E +V E Y D L Y L+ + L L+ L A++
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVME---YMEGGDLLSY--LRKNRPKLSLSDLLSFALQ 110
Query: 171 TANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
A + YL + + R++ N L E K+ DF LS+ + + + K +
Sbjct: 111 IARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-P 166
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF--ITD-RVEK 287
+ + APE L G + K+DV+SFG VLL + T G + +++ V +
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFG----VLLW--------EIFTLGEQPYPGMSNEEVLE 214
Query: 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342
++++ + P +L +C + EDRPT ++ + L
Sbjct: 215 YLKNGYRLPQ-P-----------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (193), Expect = 1e-16
Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 9/147 (6%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD-RLYGPLQTHLEPLLLTHRLKVAME 170
+++H +I++L+G C + E +V E Y D + L+ H E L L L++A++
Sbjct: 56 KKLSHPNIVRLLGVCTQGEPLYIVTE---YMPGGDLLDF--LRKHGEKLTLKDLLQMALQ 110
Query: 171 TANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
A + YL + V R++ N L E K+ DF LS+ I E + K
Sbjct: 111 IAKGMEYLES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+++ APE L G + K+DV+SFG LL
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 54/239 (22%), Positives = 93/239 (38%), Gaps = 44/239 (18%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL---EPLLLTHRLKVA 168
+++H +I+KL+G C E E +V E Y G L +L P L+ ++
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVME---YMP-----GGDLLDYLRKNRPKELSLSDLLS 107
Query: 169 MET--ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
A + YL + + R++ N L E K+ DF LS+ + + K
Sbjct: 108 FALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKG 163
Query: 227 AIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFI---TD 283
+ + APE L G + K+DV+SFG VLL + T G +
Sbjct: 164 GKLPIRWMAPESLKEGKFTSKSDVWSFG----VLLW--------EIFTLGEEPYPGMSNA 211
Query: 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342
V ++++ + + +L +C + EDRPT ++ + L
Sbjct: 212 EVLEYLKKGYRL------------PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 18/178 (10%)
Query: 90 VMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC---TLAD 146
V+K + E+ N I + H +I+K G L+ + +V E +C +L D
Sbjct: 32 VIKLESKEKK--EKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME---FCSGGSLKD 86
Query: 147 RLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206
L++ + L + V E + YL ++ R+I+ NIL + KL
Sbjct: 87 ----LLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKL 139
Query: 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
DF LS + + K +T +G+ + APE + Y+ K D++S G + L G+
Sbjct: 140 IDFGLSAQLSDTK---ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 4e-15
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
++ H +I++L + + LV E L D L L +
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL-----KKRGRLSEDEARFYLRQI 106
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+A+ YL + +V R+++P NIL E+ KL DF L++ + G+ K +T +G+
Sbjct: 107 LSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTP 160
Query: 232 EFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265
E+ APE L Y + D++S G +L LLTG+
Sbjct: 161 EYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 73.6 bits (179), Expect = 2e-14
Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 23/234 (9%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANA 174
+ +I+KL + LV E +L D L + PL + L + + +A
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG--PLSESEALFILAQILSA 113
Query: 175 VAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLSKSIPEGKTH----IKASTAIG 229
+ YL + ++ R+I+P NIL + KL DF L+K +P+ + ST++G
Sbjct: 114 LEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 230 SLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE 286
+ + APE L Y + +D++S G L LLTG N T +
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE------KNSSATSQTL 224
Query: 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340
K I P + S E +A +L K L+ ++R +
Sbjct: 225 KIILELPT----PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 17/156 (10%)
Query: 114 MNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRL--YGPLQTHLEPLLLTHRLKVAMET 171
++H +I++LI + + LV E L D L GPL K+A++
Sbjct: 55 LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSED-------EAKKIALQI 107
Query: 172 ANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
+ YL G ++ R+++P NIL E K+ DF L+K + + + +T +G+
Sbjct: 108 LRGLEYLHSNG----IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGT 161
Query: 231 LEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRT 265
+ APE L G Y K DV+S G +L LLTG+
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKP 197
|
Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 59/254 (23%), Positives = 101/254 (39%), Gaps = 47/254 (18%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTL-----ADRLYGP--------------LQ 153
Q+NH ++KL G C + L+ E A Y +L R GP
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 154 THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213
L + + A + + + YL +V R++ N+L E K+ DF LS+
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLA 273
+ E +++K S +++ A E L Y ++DV+SFG LL ++T
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----------- 224
Query: 274 TGGSNF--FITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAED 331
GG+ + +R+ +++ M R E + L C +
Sbjct: 225 LGGNPYPGIAPERLFNLLKTGYRME------------RPENCSEEMYNLMLTCWKQEPDK 272
Query: 332 RPTMIDVAKKLRQM 345
RPT D++K+L +M
Sbjct: 273 RPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 60/234 (25%), Positives = 102/234 (43%), Gaps = 36/234 (15%)
Query: 114 MNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETAN 173
++H+++++L G L + +V E A +L DRL + L L++ A++ AN
Sbjct: 53 LDHENLIRLYGVVLTHPL-MMVTELAPLGSLLDRLR---KDALGHFLISTLCDYAVQIAN 108
Query: 174 AVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
+ YL RF + R++ NIL + K+ DF L +++P+ + H
Sbjct: 109 GMRYLESKRF------IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV-MEEHLK 161
Query: 231 LEFA--APEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288
+ FA APE L T ++ +DV+ FG L + T G GS I +++K
Sbjct: 162 VPFAWCAPESLRTRTFSHASDVWMFGVTLWEMF---TYGEEPWAGLSGSQ--ILKKIDK- 215
Query: 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342
G+R R E Q + +C +H+ DRPT + + L
Sbjct: 216 -------------EGER-LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 64/246 (26%), Positives = 105/246 (42%), Gaps = 49/246 (19%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLE--PLLLTHRLKV-A 168
+Q++H I++LIG C E LV E A GPL +L+ + LK A
Sbjct: 51 AQLDHPCIVRLIGVCK-GEPLMLVMELAPL--------GPLLKYLKKRREIPVSDLKELA 101
Query: 169 METANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
+ A +AYL F V R++ N+L + AK+ DF +S+++ G + +A+
Sbjct: 102 HQVAMGMAYLESKHF------VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155
Query: 226 TAIGS--LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT--GRTIGHLSRLATGGSNFFI 281
TA G L++ APE + G ++ K+DV+S+G L + + G + G+
Sbjct: 156 TA-GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-----GAE--- 206
Query: 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341
V + S + R EE Q + C + EDRPT ++
Sbjct: 207 ---VIAMLESGERLP------------RPEECPQEIYSIMLSCWKYRPEDRPTFSELEST 251
Query: 342 LRQMYR 347
R+
Sbjct: 252 FRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 77/315 (24%), Positives = 128/315 (40%), Gaps = 39/315 (12%)
Query: 40 FDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRY 99
FD K + +S + D+ +++ N+ +G Y G G V+K V
Sbjct: 675 FDSKVS--KSITINDILSSLKE---ENVISRGKKG-ASYKGKSIKNGMQFVVKEINDVNS 728
Query: 100 ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPL 159
++ ++ H +I+KLIG C + L++E L++ L L
Sbjct: 729 IPSSEIADM---GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------L 777
Query: 160 LLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219
R K+A+ A A+ +L VV N+ P I+ + L SL +
Sbjct: 778 SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836
Query: 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF 279
+S + APE T EK+D+Y FG +L+ LLTG+ + + F
Sbjct: 837 KCFISSA------YVAPETRETKDITEKSDIYGFGLILIELLTGK--------SPADAEF 882
Query: 280 FITDRVEKFIR---SNGYMN--IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT 334
+ + ++ R S+ +++ IDP I GD S + E + + LA C + RP
Sbjct: 883 GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE--IVEVMNLALHCTATDPTARPC 940
Query: 335 MIDVAKKLRQMYRTS 349
DV K L R+S
Sbjct: 941 ANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 19/152 (12%)
Query: 110 FASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAM 169
+ + H ++++L+G L+ +V E +L D L + + L +L A+
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVIT---LAQQLGFAL 109
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK----SIPEGKTHIKAS 225
+ + YL + V R++ N+L E+ AK+ DF L+K GK +K
Sbjct: 110 DVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK-- 164
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ APE L ++ K+DV+SFG LL
Sbjct: 165 -------WTAPEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 114 MNHKSILKLIGCCLEAEMPA--LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
++H++I+K G C + + L+ E +L R Y LQ H + + L L + +
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDY--LQRHRDQINLKRLLLFSSQI 118
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+ YL Q + R++ NIL + E K+ DF L+K +PE K + S
Sbjct: 119 CKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 232 EF-AAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
F APE L T ++ +DV+SFG L L T
Sbjct: 176 IFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 50/191 (26%), Positives = 91/191 (47%), Gaps = 27/191 (14%)
Query: 77 LYMGFLRDRGPILVMKYRK------SVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130
++ G L+D+ P+ V ++ +++ SE Q +H +I+KLIG C + +
Sbjct: 11 VFKGTLKDKTPVAVKTCKEDLPQELKIKFLSE-----ARILKQYDHPNIVKLIGVCTQRQ 65
Query: 131 MPALVYE--PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVF 188
+V E P G L+ + L +K A++ A +AYL + +
Sbjct: 66 PIYIVMELVPGG------DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIH 116
Query: 189 RNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL--EFAAPEYLTTGYYNE 246
R++ N L E K+ DF +S+ +G I +S+ + + ++ APE L G Y+
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDG---IYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 247 KTDVYSFGKLL 257
++DV+S+G LL
Sbjct: 174 ESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 7e-10
Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 19/195 (9%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASE--RCFNN-IVFASQMNHKSILKLIGCCLEAE--MP 132
Y+ +D G ++ +K + + E I S + H +I++ G + E
Sbjct: 17 YLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTL 76
Query: 133 ALVYEPAGYCTLADRL--YGPLQTHLEPLLLTHRLKVAMETANAVAYL-RFGFPQPVVFR 189
+ E +L+ L +G L EP++ R K + +AYL G +V R
Sbjct: 77 NIFLEYVSGGSLSSLLKKFGKLP---EPVI---R-KYTRQILEGLAYLHSNG----IVHR 125
Query: 190 NIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTD 249
+I+ NIL + KL DF +K + + +T + G+ + APE + Y D
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAAD 185
Query: 250 VYSFGKLLLVLLTGR 264
++S G ++ + TG+
Sbjct: 186 IWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (139), Expect = 2e-09
Identities = 27/80 (33%), Positives = 45/80 (56%), Gaps = 2/80 (2%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+++R+++P NIL + KL DF L+K + + + +T G+ E+ APE L Y
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYG 171
Query: 246 EKTDVYSFGKLLLVLLTGRT 265
+ D +S G LL +LTG+
Sbjct: 172 KAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 49/165 (29%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYE--PAG----YCTLA--DRLYGPLQTHLEPLLLTH 163
S NH +I+KL+G CL E ++ E G Y A +R PL L L
Sbjct: 54 SNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL------LTLKE 107
Query: 164 RLKVAMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEE-YAA----KLFDFSLSKSIPE 217
L + ++ A YL + F + R++ N L E+ Y A K+ DF L++ I +
Sbjct: 108 LLDICLDVAKGCVYLEQMHF----IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK 163
Query: 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+ K + + + APE L G + ++DV+SFG L+ +LT
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 49/244 (20%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEP---------LLLTH 163
Q+++ I+++IG C EAE LV E A GPL L+ L H
Sbjct: 52 QLDNPYIVRMIGIC-EAESWMLVMELAEL--------GPLNKFLQKNKHVTEKNITELVH 102
Query: 164 RLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK 223
++ + M+ YL V R++ N+L ++ AK+ DF LSK++ + + K
Sbjct: 103 QVSMGMK------YLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153
Query: 224 A-STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282
A + +++ APE + ++ K+DV+SFG L + + G G+
Sbjct: 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVL---MWEAFSYGQKPYKGMKGNE---- 206
Query: 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342
V + I S M C + +L C ++ ++RP V +L
Sbjct: 207 --VTQMIESGERMECPQ------RCPPE------MYDLMKLCWTYGVDERPGFAVVELRL 252
Query: 343 RQMY 346
R Y
Sbjct: 253 RNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 116 HKSILKLIGCCLEAEMPALVYEPAGYCTLADRL-----------YGPLQTHLEPLLLTHR 164
HK+I+ L+G C + +V E A + L D L + E L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 165 LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224
+ A + A + +L + + R++ N+L E++ K+ DF L++ I + K
Sbjct: 135 VSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+ +++ APE L Y ++DV+SFG LL + T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 43/192 (22%), Positives = 85/192 (44%), Gaps = 24/192 (12%)
Query: 158 PLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217
P L +++A E A+ +AYL + V R++ N + ++ K+ DF +++ I E
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGS 277
+ K + + + APE L G + +D++SFG +L ++ LA
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW---------EITSLAEQPY 222
Query: 278 NFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMID 337
++V KF+ GY++ P +C E++ + + C + + RPT ++
Sbjct: 223 QGLSNEQVLKFVMDGGYLD-QP-----DNC---PERVTDLMRM---CWQFNPKMRPTFLE 270
Query: 338 VAKKLRQMYRTS 349
+ L+ S
Sbjct: 271 IVNLLKDDLHPS 282
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 25/175 (14%)
Query: 114 MNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL-----EPLLLTHRLKVA 168
+ HK ++ L C E ++ E L ++ G L L + L + + +A
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITE------LMEK--GSLLAFLRSPEGQVLPVASLIDMA 110
Query: 169 METANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
+ A +AYL Q + R++ NIL E+ K+ DF L++ I E ++ + I
Sbjct: 111 CQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKI 166
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-------GRTIGHLSRLATGG 276
++ APE + G ++ K+DV+SFG LL + T G + T G
Sbjct: 167 -PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 36/154 (23%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 109 VFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVA 168
V AS ++H +++L+G CL +++ L+ + L D + + ++ L L
Sbjct: 62 VMAS-VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNH-KDNIGSQYL---LNWC 115
Query: 169 METANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
++ A ++YL + +V R++ N+L + K+ DF L+K + + A
Sbjct: 116 VQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+++ A E + Y K+DV+S+G + L+T
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 45/179 (25%), Positives = 80/179 (44%), Gaps = 19/179 (10%)
Query: 100 ASERCFNNIVFASQM-----NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRL------ 148
A+E+ ++++ +M HK+I+ L+G C + ++ E A L + L
Sbjct: 62 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 121
Query: 149 -----YGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203
Y P Q E L + A + A + YL + + R++ N+L E+
Sbjct: 122 GMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNV 178
Query: 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
K+ DF L++ I + K + +++ APE L Y ++DV+SFG LL + T
Sbjct: 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 32/82 (39%), Positives = 47/82 (57%), Gaps = 6/82 (7%)
Query: 184 QPVVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEG-KTHIKASTAIGSLEFAAPEYLTT 241
Q +++R+++P NIL + KL DF L K SI EG TH T G++E+ APE L
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH----TFCGTIEYMAPEILMR 174
Query: 242 GYYNEKTDVYSFGKLLLVLLTG 263
+ + D +S G L+ +LTG
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 57/237 (24%), Positives = 95/237 (40%), Gaps = 31/237 (13%)
Query: 112 SQMNHKSILKLIGCCLEA--EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAM 169
S+ NH++I++LIG E L G R P L + L A
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 170 ETANAVAYLR-FGFPQPVVFRNIEPWNILFQEEYA---AKLFDFSLSKSIPEGKTHIKAS 225
+ A YL F + R+I N L + AK+ DF +++ I + K
Sbjct: 124 DVAKGCKYLEENHF----IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV 285
A+ +++ PE G + KTDV+SFG LL + ++G++ G +N V
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF---SLGYMPY--PGRTN----QEV 230
Query: 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342
+F+ G + DP + C ++ C H+ EDRP + +++
Sbjct: 231 MEFVTGGGRL--DP----PKGCPGPVYRIMT------DCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 40/243 (16%)
Query: 110 FASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQ--THLEPLLLTHRLKV 167
Q+++ I+++IG C EAE LV E A L L G T + L H++ +
Sbjct: 48 IMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM 106
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
M+ YL + V R++ N+L ++ AK+ DF LSK++ ++ KA +A
Sbjct: 107 GMK------YLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157
Query: 228 IGS--LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF--FITD 283
G L++ APE + ++ ++DV+S+G I + G +
Sbjct: 158 -GKWPLKWYAPECINFRKFSSRSDVWSYG-----------ITMWEAFSYGQKPYKKMKGP 205
Query: 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343
V FI ++ C L C + EDRP V +++R
Sbjct: 206 EVMSFIEQGKRLDCPA------EC------PPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
Query: 344 QMY 346
Y
Sbjct: 254 TYY 256
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYE--PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAME 170
Q +H +I+KLIG C++ + +V E P G L L+ L + L+++++
Sbjct: 48 QYDHPNIVKLIGVCVQKQPIYIVMELVPGG------SLLTFLRKKKNRLTVKKLLQMSLD 101
Query: 171 TANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
A + YL + + R++ N L E K+ DF +S+ G +
Sbjct: 102 AAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+++ APE L G Y ++DV+S+G LL
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILL 185
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 32/79 (40%), Positives = 48/79 (60%), Gaps = 4/79 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
+++R+++P NIL EE KL DF LSK SI K KA + G++E+ APE + +
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCGTVEYMAPEVVNRRGH 175
Query: 245 NEKTDVYSFGKLLLVLLTG 263
+ D +SFG L+ +LTG
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 47/146 (32%), Positives = 70/146 (47%), Gaps = 17/146 (11%)
Query: 113 QMNHKSILKLIGCCLEAEMPA-LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
Q +H I+KLIG E P +V E A L R Y LQ + L L + + +
Sbjct: 63 QFDHPHIVKLIGVI--TENPVWIVMELAPLGEL--RSY--LQVNKYSLDLASLILYSYQL 116
Query: 172 ANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
+ A+AYL RF V R+I N+L KL DF LS+ + E +++ KAS
Sbjct: 117 STALAYLESKRF------VHRDIAARNVLVSSPDCVKLGDFGLSRYL-EDESYYKASKGK 169
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFG 254
+++ APE + + +DV+ FG
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFG 195
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 13/148 (8%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLE---PLLLTHRLKVAM 169
Q +H +I++LIG C + + +V E G T L P L L +
Sbjct: 49 QYSHPNIVRLIGVCTQKQPIYIVMELVQG--------GDFLTFLRTEGPRLKVKELIQMV 100
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
E NA A + + + + R++ N L E+ K+ DF +S+ +G
Sbjct: 101 E--NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+++ APE L G Y+ ++DV+SFG LL
Sbjct: 159 PVKWTAPEALNYGRYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 38/145 (26%), Positives = 74/145 (51%), Gaps = 7/145 (4%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
++ H ++++L+G C ++ E Y L D L + + ++L L +A + +
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQIS 114
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
+A+ YL + + R++ N L E + K+ DF LS+ + G T+ + A ++
Sbjct: 115 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIK 170
Query: 233 FAAPEYLTTGYYNEKTDVYSFGKLL 257
+ APE L ++ K+DV++FG LL
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLL 195
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPA--LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRL 165
I ++ H++I++ +G L+A+ L Y P G YG + E L+
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE---ETLVRN--- 110
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
+ + YL + ++ R+I+ NIL + K+ DF +SK + K +
Sbjct: 111 -FVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166
Query: 226 TAIGSLE----FAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
A SL+ + APE + Y K D++S G L++ +LTG+
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 106 NNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRL 165
N IV S + H +I+ ++ + E A TL D++ + L +
Sbjct: 48 NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEM 102
Query: 166 KVAM--ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK 223
+ + +AV+Y+ ++ R+I+ NI + KL DF +SK + +
Sbjct: 103 VLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM-- 157
Query: 224 ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
A T +G+ + +PE YN K+D+++ G +L LLT
Sbjct: 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 16/154 (10%)
Query: 114 MNHKSILKLIGCCLEAEMPALV----YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAM 169
+ H++I+K GCC E L Y P G +L D Y P L L L A
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLG--SLRD--YLPKHK----LNLAQLLLFAQ 114
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ +AYL Q + R++ N+L + K+ DF L+K++PEG + +
Sbjct: 115 QICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 230 SLEF-AAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
S F A E L ++ +DV+SFG L LLT
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 12/147 (8%)
Query: 112 SQMNHKSILKLIGCCLEAEMPA-LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAME 170
+Q+ H ++++L+G +E + +V E +L D L ++ L L LK +++
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLD 110
Query: 171 TANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
A+ YL V R++ N+L E+ AK+ DF L+K + T
Sbjct: 111 VCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLP 162
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+++ APE L ++ K+DV+SFG LL
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 6/102 (5%)
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG--KTHIKASTA 227
E + YL + R+I+ NIL E+ + K+ DF +S S+ +G +T T
Sbjct: 110 EVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 228 IGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGH 268
+G+ + APE + + Y+ K D++SFG + L TG
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 114 MNHKSILKLIGCCLEAEMPALVYE--PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
+ H +I++ +G CL+ ++ E P G + +GPL EP+ K +
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPL---PEPVFC----KYTKQI 111
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+ VAYL VV R+I+ N++ KL DF ++ + H S + S+
Sbjct: 112 LDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 232 E----FAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ APE + Y K+D++S G + + TG+
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 41/179 (22%), Positives = 77/179 (43%), Gaps = 19/179 (10%)
Query: 100 ASERCFNNIVFASQM-----NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRL------ 148
A+E+ +++V +M HK+I+ L+G C + ++ E A L + L
Sbjct: 59 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 118
Query: 149 -----YGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203
Y + E + + + A + YL Q + R++ N+L E
Sbjct: 119 GMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNV 175
Query: 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
K+ DF L++ + + K + +++ APE L Y ++DV+SFG L+ + T
Sbjct: 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 39/189 (20%), Positives = 81/189 (42%), Gaps = 24/189 (12%)
Query: 156 LEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215
P L +++A E A+ +AYL V R++ N + E++ K+ DF +++ I
Sbjct: 113 QAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 169
Query: 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG 275
E + K + + + +PE L G + +DV+SFG +L + T LA
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQ 220
Query: 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335
++V +F+ G ++ + + EL C ++ + RP+
Sbjct: 221 PYQGMSNEQVLRFVMEGGLLD------------KPDNCPDMLFELMRMCWQYNPKMRPSF 268
Query: 336 IDVAKKLRQ 344
+++ +++
Sbjct: 269 LEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 23/153 (15%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC--TLADRLYGPLQTHLEPLLLTHRL 165
+ F Q+ H + ++ GC L+ LV E YC + +D L + H +PL +
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLKEHTAWLVME---YCLGSASDLL----EVHKKPL---QEV 121
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF-SLSKSIPEGKTHIKA 224
++A T A+ L + ++ R+I+ NIL E KL DF S SKS P A
Sbjct: 122 EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------A 174
Query: 225 STAIGSLEFAAPEYLTT---GYYNEKTDVYSFG 254
++ +G+ + APE + G Y+ K DV+S G
Sbjct: 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 4e-07
Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 17/154 (11%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLL---------LTHR- 164
+H +I+ L+G C L E A + L D L +P L+ +
Sbjct: 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 165 -LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK 223
L A + A + YL + + R++ NIL E Y AK+ DF LS+ + ++K
Sbjct: 114 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVK 167
Query: 224 ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ + + A E L Y +DV+S+G LL
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 201
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 2/80 (2%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
V+ R+++P NI KL DF L+K + A T +G+ + +PE L Y+
Sbjct: 131 VLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPEQLNHMSYD 188
Query: 246 EKTDVYSFGKLLLVLLTGRT 265
EK+D++S G L+ L
Sbjct: 189 EKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD-----RLYGPLQTHLEPLLLTHRLK 166
+++HK++++L+G C EAE ++ E Y L D R L+P L+ + K
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILE---YTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 167 VAMETA-----NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221
VA+ T + ++ RF V R++ N L + K+ SLSK +
Sbjct: 120 VALCTQIALGMDHLSNARF------VHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEY 172
Query: 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
K A+ L + APE + ++ K+DV+SFG L+ + T
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+++R+++P N+L KL DF +K + G+ K T G+ E+ APE + Y+
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 246 EKTDVYSFGKLLLVLLTGR 264
D +S G LL LLTGR
Sbjct: 171 FSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 41/158 (25%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 116 HKSILKLIGCCLEAEMPALVYEPAGYCTL-----ADRLYGP------LQTHLEPLLLTHR 164
HK+I+ L+G C + ++ E A L A R GP + E L
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 165 LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224
+ A + A + YL + + R++ N+L E+ K+ DF L++ + + + K
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
S +++ APE L Y ++DV+SFG L+ + T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 31/223 (13%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
++ H+ +++L E E +V E +L D L G + +L L + +A + A
Sbjct: 57 KLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLR---LPQLVDMAAQIA 112
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+ +AY+ R + V R++ NIL E K+ DF L++ I E + A +
Sbjct: 113 SGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPI 167
Query: 232 EFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291
++ APE G + K+DV+SFG LL L T + + G N + D+VE+
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVER---- 218
Query: 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT 334
GY P E ++ +L +C E+RPT
Sbjct: 219 -GYRMPCP-----------PECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 17/154 (11%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLL---------LTHR- 164
+H +I+ L+G C + E A Y L D L +P LT +
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 165 -LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK 223
L+ A + A + YL + + R++ N+L E A+K+ DF LS+ + ++K
Sbjct: 121 LLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRG---EEVYVK 174
Query: 224 ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ + + A E L Y K+DV+SFG LL
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLL 208
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 37/156 (23%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL----------ADRLYGPLQTHLEPLLL 161
+ H++I+K G C E + P +V+E + L A L P L L
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM-GELTL 121
Query: 162 THRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221
+ L++A++ A+ + YL Q V R++ N L + K+ DF +S+ + +
Sbjct: 122 SQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ + + PE + + ++DV+SFG +L
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVL 214
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 36/159 (22%), Positives = 66/159 (41%), Gaps = 13/159 (8%)
Query: 114 MNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD--RLYGPLQTHLE--------PLLLTH 163
+ H+ I++ G C E +V+E + L R +GP L L L
Sbjct: 64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123
Query: 164 RLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK 223
L +A + A+ + YL V R++ N L + K+ DF +S+ I +
Sbjct: 124 MLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
Query: 224 ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+ + + PE + + ++D++SFG +L + T
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 8e-07
Identities = 38/148 (25%), Positives = 73/148 (49%), Gaps = 16/148 (10%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD--RLYGPLQTHLEPLLLTHRLKVAM 169
++++HK++++L+G L + +V E L + R G + LL + ++
Sbjct: 54 TKLHHKNLVRLLGVILHNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQLL-----QFSL 107
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ A + YL + +V R++ NIL E+ AK+ DF L++ G +
Sbjct: 108 DVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKL 159
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+++ APE L ++ K+DV+S+G LL
Sbjct: 160 PVKWTAPEALKHKKFSSKSDVWSYGVLL 187
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 27/66 (40%), Positives = 37/66 (56%), Gaps = 2/66 (3%)
Query: 189 RNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKT 248
R+I+ NIL EE AKL DF +S + T K +T IG+ + APE + YN K
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180
Query: 249 DVYSFG 254
D++S G
Sbjct: 181 DIWSLG 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 28/119 (23%), Positives = 48/119 (40%), Gaps = 8/119 (6%)
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
E A+ YL + ++ R+I+P NIL E+ + DF+++ + ++ G
Sbjct: 108 EIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSG 161
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTI--GHLSRLATGGSNFFITDRVE 286
+ + APE L Y+ D +S G L G+ GH + T V
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL 220
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 37/158 (23%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYC---TLADRL--YGPLQTHLEPLLLTHRLK 166
+ H +I+K IG ++ ++ E Y +L + +GP L + + L+
Sbjct: 54 KNLKHPNIVKYIGSIETSDSLYIILE---YAENGSLRQIIKKFGPFPESLVAVYVYQVLQ 110
Query: 167 VAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
+AYL Q V+ R+I+ NIL ++ KL DF ++ + ++
Sbjct: 111 -------GLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDAS 158
Query: 227 AIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+G+ + APE + + +D++S G ++ LLTG
Sbjct: 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 37/144 (25%), Positives = 66/144 (45%), Gaps = 8/144 (5%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRL-KVAMETAN 173
NH++I+ L+G C ++ E YC D L L+ E L L + + A
Sbjct: 97 NHENIVNLLGACTIGGPILVITE---YCCYGD-LLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 174 AVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEF 233
+A+L + + R++ N+L K+ DF L++ I ++ A +++
Sbjct: 153 GMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209
Query: 234 AAPEYLTTGYYNEKTDVYSFGKLL 257
APE + Y ++DV+S+G LL
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 37/185 (20%), Positives = 73/185 (39%), Gaps = 11/185 (5%)
Query: 83 RDRGPILVMK---YRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139
+ + MK K R E + ++++ I++ L+ +V E A
Sbjct: 22 KADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81
Query: 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ 199
L L PL + ++ +A+L + ++ R+I+ N+
Sbjct: 82 ENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLD 135
Query: 200 EEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLV 259
K+ D ++K + A+T +G+ + +PE YNEK+DV++ G +L
Sbjct: 136 AYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193
Query: 260 LLTGR 264
TG+
Sbjct: 194 CCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 8/122 (6%)
Query: 150 GPLQTHLEPLLLTHRLKVAMET---ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206
G L H++ H+ + T A + L+F + +V+R+++ NIL + K+
Sbjct: 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKI 137
Query: 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTI 266
DF + K G K T G+ ++ APE L YN D +SFG LL +L G++
Sbjct: 138 ADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
Query: 267 GH 268
H
Sbjct: 196 FH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 29/99 (29%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
KV++ +AYLR ++ R+++P NIL KL DF +S + + A+
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----AN 160
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ +G+ + +PE L +Y+ ++D++S G L+ L GR
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 3/101 (2%)
Query: 157 EPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216
EPL L + + + A + +L + + R++ NIL E K+ DF L++ I
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ +++ A L++ APE + Y ++DV+SFG LL
Sbjct: 225 KDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLL 265
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 29/103 (28%), Positives = 50/103 (48%), Gaps = 9/103 (8%)
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
K+ + A+ YL+ V+ R+++P NIL KL DF +S + + K +++
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 226 TAIGSLEFAAPEYLT----TGYYNEKTDVYSFGKLLLVLLTGR 264
G + APE + Y+ + DV+S G L+ L TG+
Sbjct: 176 ---GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS--IPEGKTHIKAS 225
A E A+A+ YL +++R+++P NIL + L DF L K PE T S
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT----S 154
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
T G+ E+ APE L Y+ D + G +L +L G
Sbjct: 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 21/150 (14%)
Query: 110 FASQMNHKSILKLIGCCLEAEMPALVYEPAGYC--TLADRLYGPLQTHLEPLLLTHRLKV 167
F Q+ H + ++ GC L LV E YC + +D L + H +PL +++
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTAWLVME---YCLGSASDIL----EVHKKPL---QEVEI 117
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
A A+ L + + R+I+ NIL E KL DF S S+ A++
Sbjct: 118 AAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG-SASLVS-----PANSF 171
Query: 228 IGSLEFAAPEYLTT---GYYNEKTDVYSFG 254
+G+ + APE + G Y+ K DV+S G
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 33/122 (27%), Positives = 54/122 (44%), Gaps = 21/122 (17%)
Query: 147 RLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206
+ GP+ + K+A+ + YL ++ R+I+P NIL KL
Sbjct: 95 KKGGPIPVEILG-------KIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKL 145
Query: 207 FDFSLS----KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
DF +S SI A T +G+ + +PE + G Y K+DV+S G ++ L
Sbjct: 146 CDFGVSGELINSI--------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197
Query: 263 GR 264
G+
Sbjct: 198 GK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 50/154 (32%), Positives = 70/154 (45%), Gaps = 10/154 (6%)
Query: 112 SQMNHKSILKLIGCCLEAEMPA--LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAM 169
+ H +I+K G C A LV E Y +L D L Q H E L L A
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL----QKHRERLDHRKLLLYAS 115
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ + YL + V R++ NIL + E K+ DF L+K +P+ K + K
Sbjct: 116 QICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172
Query: 230 SLEF-AAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
S F APE LT ++ +DV+SFG +L L T
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY-- 243
+++R+I+ NIL E L DF LSK + +A + G++E+ APE + G
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGG 184
Query: 244 YNEKTDVYSFGKLLLVLLTG 263
+++ D +S G L LLTG
Sbjct: 185 HDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 2/97 (2%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
A + L+F + +++R+++ N+L ++ K+ DF + K G+ KAST G+
Sbjct: 103 AEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTP 160
Query: 232 EFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGH 268
++ APE L YNE D +SFG LL +L G++ H
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 3e-06
Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 20/170 (11%)
Query: 102 ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLL 161
E N + ++NH +I+K E +V E Y G L ++
Sbjct: 44 EDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME---YAD-----GGDLSQKIKKQKK 95
Query: 162 THR-------LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214
+ L ++ A+ YL + ++ R+I+P NI KL DF +SK
Sbjct: 96 EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152
Query: 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ T A T +G+ + +PE YN K+D++S G +L L T +
Sbjct: 153 LSS--TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 61/265 (23%), Positives = 102/265 (38%), Gaps = 39/265 (14%)
Query: 91 MKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLE-AEMPALVYEPAGYCTLADRLY 149
MK R E + V + +H ++++LIG CL+ E P+ L +
Sbjct: 34 MKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY---PSPVVILPFMKH 90
Query: 150 GPLQTHL-------EPLLLTHRLKVAMET--ANAVAYLRFGFPQPVVFRNIEPWNILFQE 200
G L + L P L ++ V T A+ + YL + + R++ N + E
Sbjct: 91 GDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNE 147
Query: 201 EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVL 260
+ DF LSK I G + + A +++ A E L Y K+DV+SFG + +
Sbjct: 148 NMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207
Query: 261 LT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVE 319
T G+T G N I D ++R + P + L
Sbjct: 208 ATRGQTP------YPGVENSEIYD----YLRQGNRLKQPP------------DCLDGLYS 245
Query: 320 LAFKCLSHSAEDRPTMIDVAKKLRQ 344
L C + +DRP+ + +L +
Sbjct: 246 LMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 46/243 (18%)
Query: 111 ASQM---NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYG--PLQTHLEPLLLTHRL 165
AS M N +++L+G + +V E L L P + L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 166 KV---AMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219
K A E A+ +AYL +F V R++ N + E+ K+ DF +++ I E
Sbjct: 120 KFIQMAAEIADGMAYLAAKKF------VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
Query: 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT----G 275
+ K + + + APE L G + K+DV+SFG +L + T LA G
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------LAEQPYQG 224
Query: 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335
SN + V KF+ G+++ E +EL C ++ + RPT
Sbjct: 225 LSN----EEVLKFVIDGGHLD------------LPENCPDKLLELMRMCWQYNPKMRPTF 268
Query: 336 IDV 338
+++
Sbjct: 269 LEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 116 HKSILKLIGCCLEAEMPALVYEPAGYCTLADRL-----------YGPLQTHLEPLLLTHR 164
HK+I+ L+G C + ++ E A L + L + + E L
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 165 LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224
+ A + A + YL Q + R++ N+L E+ K+ DF L++ + + K
Sbjct: 137 VSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+ +++ APE L Y ++DV+SFG LL + T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 5e-06
Identities = 21/79 (26%), Positives = 42/79 (53%), Gaps = 2/79 (2%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
++ R+I+P N+L + K+ DF +SK + + +T +G++ + +PE + Y+
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGESYS 178
Query: 246 EKTDVYSFGKLLLVLLTGR 264
D++S G LL G+
Sbjct: 179 YAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 39/157 (24%), Positives = 67/157 (42%), Gaps = 9/157 (5%)
Query: 114 MNHKSILKLIG---CCLEAEMPALVYEPAGYCTLADRLYG-PLQTHLEPLLLTHRLKVAM 169
+N + +L L+ C M + P C + D + G L HL + ++
Sbjct: 42 LNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF 101
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ L + VV+R+++P NIL E ++ D L+ + K H ++G
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVG 157
Query: 230 SLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRT 265
+ + APE L G Y+ D +S G +L LL G +
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 11/101 (10%)
Query: 170 ETANAVAYLR-FGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK------SIPEGKTHI 222
E A+ YL G ++ R+++P NIL KL DF LSK I
Sbjct: 101 EIVLALEYLHSNG----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156
Query: 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+ +G+ ++ APE + +++ D +S G +L L G
Sbjct: 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 29/99 (29%), Positives = 47/99 (47%), Gaps = 7/99 (7%)
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
K+A ++YL + ++ R+I+P NIL + KL DF +S + A
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS----LAG 161
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
T G+ + APE + Y+ +DV+S G LL + R
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 22/166 (13%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPALVYE--PAGYCTLADRL---YGPLQTHLEPLLLT 162
I S + H++I++ +G E + E P G +L+ L +GPL+ + E
Sbjct: 56 IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG--SLSALLRSKWGPLKDN-EQ---- 108
Query: 163 HRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA--KLFDFSLSKSIPEGKT 220
+ T + L++ +V R+I+ N+L Y+ K+ DF SK +
Sbjct: 109 ---TIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRL--AGI 162
Query: 221 HIKASTAIGSLEFAAPEYLTTGY--YNEKTDVYSFGKLLLVLLTGR 264
+ T G+L++ APE + G Y D++S G ++ + TG+
Sbjct: 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 42/175 (24%), Positives = 80/175 (45%), Gaps = 26/175 (14%)
Query: 101 SERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLL 160
++R + + M H++++ L+ V+ PA + +Y L THL
Sbjct: 60 AKRTYRELRLLKHMKHENVIGLLD----------VFTPARSLEEFNDVY--LVTHLMGAD 107
Query: 161 LTHRLKVAMETANAVAYL--------RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212
L + +K T + V +L ++ ++ R+++P N+ E+ K+ DF L+
Sbjct: 108 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167
Query: 213 KSIPEGKTHIKASTAIGSLEFAAPE-YLTTGYYNEKTDVYSFGKLLLVLLTGRTI 266
+ + T A+ + APE L +YN+ D++S G ++ LLTGRT+
Sbjct: 168 RHTDDEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 217
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 37/159 (23%), Positives = 68/159 (42%), Gaps = 11/159 (6%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD--RLYGP---LQTHLEP---LLLTH 163
+ + H+ I+K G C+E + +V+E + L R +GP L L +
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 164 RLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK 223
L +A + A + YL Q V R++ N L E K+ DF +S+ + +
Sbjct: 122 MLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 224 ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+ + + PE + + ++DV+S G +L + T
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
E A+ Y+ V+ R+I+ NIL KL DF ++ + + + K ST +G
Sbjct: 109 EVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVG 163
Query: 230 SLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTG 263
+ + APE +T G YY+ K D++S G + + TG
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 40/153 (26%), Positives = 64/153 (41%), Gaps = 17/153 (11%)
Query: 116 HKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLL-LTHR---------- 164
H +I+ L+G C L E A + L D L +P + +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 165 LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224
L A + A + YL + + R++ NIL E Y AK+ DF LS+ + ++K
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKK 180
Query: 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ + + A E L Y +DV+S+G LL
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 8/153 (5%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
++ H +++L C E +V E Y +L + L G L+ L + +A + A
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK---LPQLIDMAAQVA 113
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
+ +AYL Q + R++ N+L E K+ DF L++ I E + ++
Sbjct: 114 SGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF-PIK 169
Query: 233 FAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GR 264
+ APE ++ K+DV+SFG LL ++T GR
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 44/132 (33%), Positives = 60/132 (45%), Gaps = 20/132 (15%)
Query: 145 ADRLY--------GPLQTHL--EPLLLTHRLKV-AMETANAVAYLRFGFPQPVVFRNIEP 193
AD+LY G L HL E L R + A E A+A+ YL +V+R+++P
Sbjct: 68 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKP 124
Query: 194 WNILFQEEYAAKLFDFSLSKS--IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVY 251
NIL + L DF L K G T ST G+ E+ APE L Y+ D +
Sbjct: 125 ENILLDSQGHIVLTDFGLCKENIEHNGTT----STFCGTPEYLAPEVLHKQPYDRTVDWW 180
Query: 252 SFGKLLLVLLTG 263
G +L +L G
Sbjct: 181 CLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 34/145 (23%), Positives = 68/145 (46%), Gaps = 8/145 (5%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
+++H +++L G C E LV+E + L+D L + L + ++
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVC 110
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
+AYL V+ R++ N L E K+ DF +++ + + + T ++
Sbjct: 111 EGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVK 166
Query: 233 FAAPEYLTTGYYNEKTDVYSFGKLL 257
+++PE + Y+ K+DV+SFG L+
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLM 191
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 38/163 (23%), Positives = 70/163 (42%), Gaps = 16/163 (9%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD--RLYGP----------LQTHLEPL 159
+ + H+ I+K G C + + +V+E + L R +GP Q E L
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-L 120
Query: 160 LLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219
L+ L +A + A+ + YL Q V R++ N L K+ DF +S+ +
Sbjct: 121 GLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+ + + + PE + + ++DV+SFG +L + T
Sbjct: 178 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 28/121 (23%), Positives = 54/121 (44%), Gaps = 3/121 (2%)
Query: 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196
E + + + + L L + + + A + +L + + R++ NI
Sbjct: 154 EEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNI 210
Query: 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKL 256
L E K+ DF L++ I + +++ A L++ APE + Y ++DV+SFG L
Sbjct: 211 LLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 270
Query: 257 L 257
L
Sbjct: 271 L 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 22/121 (18%), Positives = 51/121 (42%), Gaps = 24/121 (19%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK------------------SIPEGKTHIKASTA 227
++ R+++P NIL ++ K+ DF +K K + ++
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 228 IGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287
+G+ E+ +PE L + +D+++ G ++ +LTG+ G + + ++ K
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR------GSNEYLTFQKILK 236
Query: 288 F 288
Sbjct: 237 L 237
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 48/189 (25%), Positives = 85/189 (44%), Gaps = 24/189 (12%)
Query: 74 GYILYMGFLRDRGPILVMKYRKSVRYASER---CFNNIVFASQMNHKSILKLIGCCLEAE 130
G + + +R+ + + K S + ++E+ + F ++ H + ++ GC L
Sbjct: 29 GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88
Query: 131 MPALVYEPAGYC--TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVF 188
LV E YC + +D L + H +PL +++A T A+ L + ++
Sbjct: 89 TAWLVME---YCLGSASDLL----EVHKKPL---QEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 189 RNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT---GYYN 245
R+++ NIL E KL DF S SI A+ +G+ + APE + G Y+
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFG-SASIMA-----PANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 246 EKTDVYSFG 254
K DV+S G
Sbjct: 193 GKVDVWSLG 201
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY-Y 244
VV+R+++P NIL E ++ D L+ + K H ++G+ + APE L G Y
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAY 173
Query: 245 NEKTDVYSFGKLLLVLLTGRT 265
+ D +S G +L LL G +
Sbjct: 174 DSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
++ H +++L C E E +V E +L D L L L + +A + A
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKL---RLPQLVDMAAQIA 113
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
+AYL + + R++ NIL E K+ DF L++ I + + + ++
Sbjct: 114 EGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF-PIK 169
Query: 233 FAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRT 265
+ APE G + K+DV+SFG LL ++T GR
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 27/99 (27%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
KV++ + YLR ++ R+++P NIL KL DF +S + + A+
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----AN 160
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ +G+ + +PE L +Y+ ++D++S G L+ + GR
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 22/80 (27%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+V+R+++P N+L + ++ D L+ + GK IK G+ + APE L Y+
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-IKGR--AGTPGYMAPEVLQGEVYD 172
Query: 246 EKTDVYSFGKLLLVLLTGRT 265
D ++ G L ++ GR+
Sbjct: 173 FSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 22/196 (11%)
Query: 78 YMGFLRDRGPILVMK------YRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131
Y G D G +K ++ + A ++ I S++ H +I++ +G E +
Sbjct: 17 YEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76
Query: 132 PALVYE--PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFR 189
+ E P G +LA +L + EP+ + + T + L + + V R
Sbjct: 77 LYIFLELVPGG--SLA-KLLKKYGSFPEPV-------IRLYTRQILLGLEYLHDRNTVHR 126
Query: 190 NIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYL-TTGYYNEKT 248
+I+ NIL KL DF ++K + E A + GS + APE + G Y
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 249 DVYSFGKLLLVLLTGR 264
D++S G +L + TG+
Sbjct: 184 DIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 23/153 (15%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC--TLADRLYGPLQTHLEPLLLTHRL 165
+ F ++ H + ++ GC L LV E YC + +D L + H +PL +
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVME---YCLGSASDLL----EVHKKPL---QEV 125
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF-SLSKSIPEGKTHIKA 224
++A T A+ L + ++ R+I+ NIL E KL DF S S + P A
Sbjct: 126 EIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------A 178
Query: 225 STAIGSLEFAAPEYLTT---GYYNEKTDVYSFG 254
++ +G+ + APE + G Y+ K DV+S G
Sbjct: 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 23/71 (32%), Positives = 40/71 (56%)
Query: 187 VFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNE 246
+ R++ NIL E K+ DF L++ I + +++ +A L++ APE + Y
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 247 KTDVYSFGKLL 257
++DV+SFG LL
Sbjct: 256 QSDVWSFGVLL 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 4/87 (4%)
Query: 178 LRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI-PEGKTHIKASTAIGSLEFAAP 236
L F V+ R+I+ NIL + + KL DF I PE K ST +G+ + AP
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAP 184
Query: 237 EYLTTGYYNEKTDVYSFGKLLLVLLTG 263
E +T Y K D++S G + + ++ G
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 12/176 (6%)
Query: 88 ILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADR 147
I M+ RK + E N I+ H +I+ L + +V E +L D
Sbjct: 49 IKKMRLRKQNK---ELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI 105
Query: 148 LYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207
+ EP + V E + YL Q V+ R+I+ NIL ++ + KL
Sbjct: 106 ITQNFVRMNEPQIAY----VCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLA 158
Query: 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
DF + + K K ++ +G+ + APE + Y K D++S G + + + G
Sbjct: 159 DFGFAAQL--TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 26/86 (30%), Positives = 44/86 (51%), Gaps = 2/86 (2%)
Query: 178 LRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPE 237
L F V+ R+I+ N+L + + KL DF I ++ K ST +G+ + APE
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPE 185
Query: 238 YLTTGYYNEKTDVYSFGKLLLVLLTG 263
+T Y K D++S G + + ++ G
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 46/160 (28%), Positives = 68/160 (42%), Gaps = 28/160 (17%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPL---LLTHRLKVA--M 169
+H ++L L+G CL +E LV P Y D P L+ L+VA M
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLP--YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGM 111
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI-------PEGKTHI 222
E YL + V R++ N + E + K+ DF L++ I T
Sbjct: 112 E------YLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162
Query: 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
K +++ A E L T + K+DV+SFG LL L+T
Sbjct: 163 KLP-----VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 24/80 (30%), Positives = 46/80 (57%), Gaps = 3/80 (3%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+V+R+++P NIL + ++ D L+ +PEG+T IK +G++ + APE + Y
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGR--VGTVGYMAPEVVKNERYT 179
Query: 246 EKTDVYSFGKLLLVLLTGRT 265
D ++ G LL ++ G++
Sbjct: 180 FSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 35/167 (20%), Positives = 70/167 (41%), Gaps = 20/167 (11%)
Query: 105 FNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRL--------------YG 150
S + H +I+ L+G C + + +++E + L + L
Sbjct: 56 RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 151 PLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210
+++ L+ H +A++ A + YL V R++ N L E K+ DF
Sbjct: 116 TVKSSLDCSDFLH---IAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFG 169
Query: 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
LS+ I + S ++ + + PE + G + ++D++SFG +L
Sbjct: 170 LSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 29/97 (29%), Positives = 50/97 (51%), Gaps = 2/97 (2%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
A V L+F + +++R+++ N++ + K+ DF + K G +AST G+
Sbjct: 103 AEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTFCGTP 160
Query: 232 EFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGH 268
++ APE L Y D +SFG LL +L G++ H
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 47/193 (24%), Positives = 88/193 (45%), Gaps = 28/193 (14%)
Query: 86 GPILVMKYRKSVRYASERCF--NNIVFASQMNH----KSILKLIGCCLEAEMPALVYEPA 139
G + + K++ + Y + +C I+ Q+ H KSIL +E P +V
Sbjct: 32 GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSIL------MELSHPFIVNMMC 85
Query: 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVA-------YLRFGF--PQPVVFRN 190
+ +R+Y L+ + L TH L+ A N VA L F + + +++R+
Sbjct: 86 SFQD-ENRVYFLLEFVVGGELFTH-LRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRD 143
Query: 191 IEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDV 250
++P N+L + K+ DF +K +P+ + T G+ E+ APE + + + + D
Sbjct: 144 LKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEVIQSKGHGKAVDW 198
Query: 251 YSFGKLLLVLLTG 263
++ G LL + G
Sbjct: 199 WTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 34/108 (31%), Positives = 56/108 (51%), Gaps = 7/108 (6%)
Query: 159 LLLTHRLKVAMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217
L L + +A + A+ +AY+ R + + R++ NIL + K+ DF L++ I E
Sbjct: 99 LKLPQLVDMAAQIADGMAYIERMNY----IHRDLRAANILVGDNLVCKIADFGLARLI-E 153
Query: 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GR 264
+ A +++ APE G + K+DV+SFG LL L+T GR
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 187 VFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNE 246
+ R+I+ N+L E+ KL DF ++ + + T IK +T +G+ + APE + Y+
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAYDS 180
Query: 247 KTDVYSFGKLLLVLLTG 263
K D++S G + L G
Sbjct: 181 KADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 44/131 (33%), Positives = 61/131 (46%), Gaps = 18/131 (13%)
Query: 145 ADRLY--------GPLQTHL--EPLLLTHRLKV-AMETANAVAYLRFGFPQPVVFRNIEP 193
AD+LY G L HL E R + A E A+A+ YL +++R+++P
Sbjct: 68 ADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKP 124
Query: 194 WNILFQEEYAAKLFDFSLSKSIPEGKTHIKA-STAIGSLEFAAPEYLTTGYYNEKTDVYS 252
NIL + L DF L K EG H K ST G+ E+ APE L Y+ D +
Sbjct: 125 ENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181
Query: 253 FGKLLLVLLTG 263
G +L +L G
Sbjct: 182 LGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 4/87 (4%)
Query: 178 LRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI-PEGKTHIKASTAIGSLEFAAP 236
L F V+ R+I+ NIL + + KL DF I PE K ST +G+ + AP
Sbjct: 128 LDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAP 184
Query: 237 EYLTTGYYNEKTDVYSFGKLLLVLLTG 263
E +T Y K D++S G + + ++ G
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 22/78 (28%), Positives = 44/78 (56%), Gaps = 4/78 (5%)
Query: 186 VVFRNIEPWNILF-QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
++ R+++ NIL + + K+ DF +SK + + KA T +G+ + +PE Y
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGKPY 178
Query: 245 NEKTDVYSFGKLLLVLLT 262
N+K+D+++ G +L L +
Sbjct: 179 NQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 100 ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRL-YGPLQTHLEP 158
A + C I Q+NH +++K + +E +V E A L+ + Y Q L P
Sbjct: 45 ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP 104
Query: 159 LLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218
K ++ +AV ++ + V+ R+I+P N+ KL D L +
Sbjct: 105 ERTV--WKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
Query: 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
T A + +G+ + +PE + YN K+D++S G LL
Sbjct: 160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 6/99 (6%)
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
K+A+ + YL ++ R+++P NIL KL DF +S + + A
Sbjct: 104 KIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL----VNSLAK 157
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
T +G+ + APE + Y+ K+D++S G L+ L TGR
Sbjct: 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 20/154 (12%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL---------EPLLLTH 163
+H +++KLIG C EA +L P L +G L + L E L L
Sbjct: 57 DFDHPNVMKLIGVCFEAS--SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114
Query: 164 RLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220
LK ++ A + YL F + R++ N + +E+ + DF LSK I G
Sbjct: 115 LLKFMVDIALGMEYLSNRNF------IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168
Query: 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFG 254
+ + A +++ A E L Y K+DV++FG
Sbjct: 169 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 13/157 (8%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY-GPLQTHLEPLLLTHRLK 166
I SQ + I + G L+ ++ E G + D L GPL+ T+
Sbjct: 53 ITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEE-------TYIAT 105
Query: 167 VAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
+ E + YL + + R+I+ N+L E+ KL DF ++ + + T IK +T
Sbjct: 106 ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNT 160
Query: 227 AIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+G+ + APE + Y+ K D++S G + L G
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 165 LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224
+ +A + A +A++ + + R++ NIL E K+ DF L++ I E +
Sbjct: 105 IDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLI-EDNEYTAR 160
Query: 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GR 264
A +++ APE + G + K+DV+SFG LL ++T GR
Sbjct: 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 4/94 (4%)
Query: 171 TANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS-IPEGKTHIKASTAIG 229
A + L F + +++R+++ N+L E KL DF + K I GKT ST G
Sbjct: 102 AAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TSTFCG 158
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+ ++ APE L Y D ++ G LL +L G
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 34/116 (29%), Positives = 55/116 (47%), Gaps = 3/116 (2%)
Query: 150 GPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209
G L THL +V + + V L +++R+I+ NIL L DF
Sbjct: 90 GELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 149
Query: 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY--YNEKTDVYSFGKLLLVLLTG 263
LSK E + +A + G++E+ AP+ + G +++ D +S G L+ LLTG
Sbjct: 150 GLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 5/99 (5%)
Query: 171 TANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
TA V L ++ R+++P N+L + KL DF + E ++ TA+G+
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGT 206
Query: 231 LEFAAPEYLTT----GYYNEKTDVYSFGKLLLVLLTGRT 265
++ +PE L + GYY + D +S G L +L G T
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 29/104 (27%), Positives = 53/104 (50%), Gaps = 4/104 (3%)
Query: 159 LLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218
+LL + + + A +AY+ + + R++ N+L E K+ DF L++ I E
Sbjct: 100 VLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI-ED 155
Query: 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+ A +++ APE + G + K+DV+SFG LL ++T
Sbjct: 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 40/168 (23%), Positives = 71/168 (42%), Gaps = 27/168 (16%)
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
+ + A +A++ + + R++ NIL K+ DF L++ I E + A
Sbjct: 108 SAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGA 163
Query: 228 IGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVE 286
+++ APE + G + K+DV+SFG LL+ ++T GR G SN + +E
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEVIRALE 217
Query: 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT 334
+ R R E + + +C + E+RPT
Sbjct: 218 RGYRMP----------------RPENCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 20/163 (12%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD--RLYGPLQTHLE------------ 157
++ +H +I+KL+G C + L++E Y L + R P
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 158 ---PLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214
PL T +L +A + A +AYL + V R++ N L E K+ DF LS++
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
I + + + + PE + Y ++DV+++G +L
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 34/150 (22%), Positives = 69/150 (46%), Gaps = 10/150 (6%)
Query: 114 MNHKSILKLIGCCLEAEMPALV-YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
++H I++L+G C A + + P G +L D + + L+P L L ++ A
Sbjct: 66 LDHAYIVRLLGICPGASLQLVTQLSPLG--SLLDHVRQH-RDSLDPQRL---LNWCVQIA 119
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
+ YL +V RN+ NIL + + ++ DF ++ + S ++
Sbjct: 120 KGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 233 FAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+ A E + G Y ++DV+S+G + +++
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 4/88 (4%)
Query: 178 LRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH-IKASTAIGSLEFAAP 236
L+F + +++R+++ N+L E K+ DF + K EG + ST G+ ++ AP
Sbjct: 109 LQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAP 165
Query: 237 EYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
E L+ Y D ++ G LL +L G+
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 29/87 (33%), Positives = 44/87 (50%), Gaps = 4/87 (4%)
Query: 178 LRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI-PEGKTHIKASTAIGSLEFAAP 236
L F V+ R+I+ NIL + + KL DF I PE K ST +G+ + AP
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAP 185
Query: 237 EYLTTGYYNEKTDVYSFGKLLLVLLTG 263
E +T Y K D++S G + + ++ G
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
A E A+A+ YL +V+R+++P NIL + L DF L K EG +T
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTT 155
Query: 228 I-GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
G+ E+ APE + Y+ D + G +L +L G
Sbjct: 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 31/223 (13%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
+++H ++++L G C + +V E L + L + L L + +
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDVC 110
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
A+ YL GF + R++ N L E+ K+ DF L++ + + + + + +
Sbjct: 111 EAMEYLESNGF----IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPV 165
Query: 232 EFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291
++A PE ++ K+DV+SFG L+ + + + + SN + + V S
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-----SNSEVVESV-----S 215
Query: 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT 334
GY P + + Y + + C EDRP
Sbjct: 216 AGYRLYRP-----KLAPTE-----VY-TIMYSCWHEKPEDRPA 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 36/162 (22%), Positives = 64/162 (39%), Gaps = 19/162 (11%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYC---TLADRLYGPLQTHLEPLLLTHRLKVA 168
+ H +++K G + E + E YC TL + L + + +
Sbjct: 54 ELLKHPNLVKYYGVEVHREKVYIFME---YCSGGTLEELLEH---GRILDEHVIRVYTLQ 107
Query: 169 METANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT--HIKAST 226
+ +AYL +V R+I+P NI KL DF + + T + +
Sbjct: 108 L--LEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162
Query: 227 AIGSLEFAAPEYLTTGYYNEK---TDVYSFGKLLLVLLTGRT 265
G+ + APE +T G D++S G ++L + TG+
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 22/80 (27%), Positives = 43/80 (53%), Gaps = 3/80 (3%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+V+R+++P NIL + ++ D L+ IPEG+T +G++ + APE + Y
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYT 179
Query: 246 EKTDVYSFGKLLLVLLTGRT 265
D + G L+ ++ G++
Sbjct: 180 FSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 24/82 (29%), Positives = 39/82 (47%), Gaps = 4/82 (4%)
Query: 184 QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY 243
Q ++ R+++ NIL K+ D +SK + A T IG+ + APE
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRP 177
Query: 244 YNEKTDVYSFGKLLLVLLTGRT 265
Y+ K+D++S G LL + T
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 114 MNHKSILKLIGCCLE-AEMPALVYEPAGYCTLADRL----YGPLQTHLEPLLLTHRL-KV 167
++H++IL ++ C+E E P ++Y + L L G L T +L +
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA--LSTQQLVHM 122
Query: 168 AMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
A++ A ++YL + G V+ ++I N + EE K+ D +LS+ + H
Sbjct: 123 AIQIACGMSYLHKRG----VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178
Query: 227 AIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+++ A E L Y+ +DV+SFG LL L+T
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 40/159 (25%), Positives = 67/159 (42%), Gaps = 8/159 (5%)
Query: 100 ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRL-YGPLQTHLEP 158
A C I Q+NH +++K +E +V E A L+ + + Q L P
Sbjct: 45 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 104
Query: 159 LLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218
+ V + +A L + V+ R+I+P N+ KL D L +
Sbjct: 105 EKTVWKYFVQLCSA-----LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
Query: 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
T A + +G+ + +PE + YN K+D++S G LL
Sbjct: 160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 25/168 (14%)
Query: 112 SQMNHKSILKLI--GCCLEAEMPALVYEPAGYCTLADRLY--GPLQTHLEPLLLTHRLKV 167
+++ H +I+ L+ G + A V+E TL + L G L P T RL +
Sbjct: 33 ARLYHPNIVALLDSGEAPPGLLFA-VFEYVPGRTLREVLAADGAL-----PAGETGRLML 86
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKLFDFSLSKSIPEGKTHIKA 224
+ A A A+ Q +V R+++P NI+ + AK+ DF + +P G
Sbjct: 87 QVLDALACAH-----NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLP-GVRDADV 140
Query: 225 STA------IGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTI 266
+T +G+ + APE L +D+Y++G + L LTG+ +
Sbjct: 141 ATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 28/79 (35%), Positives = 40/79 (50%), Gaps = 4/79 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI-KASTAIGSLEFAAPEYLTTGYY 244
+V+R+++ N+L E K+ DF L K EG + ST G+ EF APE LT Y
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPEVLTETSY 178
Query: 245 NEKTDVYSFGKLLLVLLTG 263
D + G L+ +L G
Sbjct: 179 TRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 106 NNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC---TLADRLYGPLQTHLEPLLLT 162
I + H +I+ G L + +V E YC +L D +Y + L L +
Sbjct: 49 QEISMLKECRHPNIVAYFGSYLRRDKLWIVME---YCGGGSLQD-IYQVTRGPLSELQIA 104
Query: 163 HRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222
+ V ET +AYL + R+I+ NIL E+ KL DF +S + T
Sbjct: 105 Y---VCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIA 156
Query: 223 KASTAIGSLEFAAPEYL---TTGYYNEKTDVYSFG 254
K + IG+ + APE G Y+ K D+++ G
Sbjct: 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 14/152 (9%)
Query: 116 HKSILKLIGCCLEAEMPA----LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
H++I+K G C E + + P+G L L + + L +LK A++
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSG------SLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+ YL G Q V R++ N+L + E+ K+ DF L+K+I K + + S
Sbjct: 119 CKGMDYL--GSRQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP 175
Query: 232 EF-AAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
F APE L + +DV+SFG L LLT
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 20/165 (12%)
Query: 100 ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPL 159
A + C I Q++H +++K + +E +V E LAD G L ++
Sbjct: 45 ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE------LADA--GDLSRMIKHF 96
Query: 160 LLTHRL-------KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212
RL K ++ +A+ ++ + ++ R+I+P N+ KL D L
Sbjct: 97 KKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLG 153
Query: 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ KT A + +G+ + +PE + YN K+D++S G LL
Sbjct: 154 RFFSS-KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 14/155 (9%)
Query: 114 MNHKSILKLIGCCLEAEMPA--LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
++H +I++ +G E + L Y P G R YG + L L+
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE----- 119
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+AYL + ++ R+++ N+L + K+ DF +SK + + + + GS+
Sbjct: 120 --GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 232 EFAAPEYLTTGY--YNEKTDVYSFGKLLLVLLTGR 264
+ APE + + Y+ K D++S G ++L + GR
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 34/108 (31%), Positives = 56/108 (51%), Gaps = 7/108 (6%)
Query: 159 LLLTHRLKVAMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217
L L + + +A + A +AY+ R + + R++ NIL + K+ DF L++ I E
Sbjct: 99 LKLPNLVDMAAQVAAGMAYIERMNY----IHRDLRSANILVGDGLVCKIADFGLARLI-E 153
Query: 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GR 264
+ A +++ APE G + K+DV+SFG LL L+T GR
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 5/106 (4%)
Query: 158 PLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217
PL T + E + YL + + R+I+ N+L E KL DF ++ + +
Sbjct: 97 PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153
Query: 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
T IK +T +G+ + APE + Y+ K D++S G + L G
Sbjct: 154 --TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 24/76 (31%), Positives = 38/76 (50%)
Query: 187 VFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNE 246
V R++ N+L E K+ DF L++ I +I + L++ APE + Y
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 247 KTDVYSFGKLLLVLLT 262
+DV+SFG LL + T
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 27/100 (27%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK-A 224
K+++ + YLR ++ R+++P NIL KL DF +S G+ A
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMA 155
Query: 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
++ +G+ + +PE L +Y ++D++S G L+ + GR
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
A E A+ YL + +V+R+++P NIL +E KL DF +K K + T
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTL 158
Query: 228 IGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
G+ E+ APE + + +N+ D ++ G L+ +L G
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 23/80 (28%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
V+R+++P NIL + ++ D L+ IPEG++ I+ +G++ + APE L Y
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGR--VGTVGYMAPEVLNNQRYT 179
Query: 246 EKTDVYSFGKLLLVLLTGRT 265
D + G L+ ++ G++
Sbjct: 180 LSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 27/80 (33%), Positives = 42/80 (52%), Gaps = 2/80 (2%)
Query: 184 QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY 243
+ + R+I+ NIL EE KL DF +S + T K +T +G+ + APE +
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 244 YNEKTDVYSFGKLLLVLLTG 263
Y+EK D++S G + L G
Sbjct: 175 YDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 3/93 (3%)
Query: 165 LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224
L +A++ A + YL F V +++ NIL E+ K+ D LS+ I +
Sbjct: 127 LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
++ + + PE + G ++ +D++SFG +L
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 28/217 (12%)
Query: 54 DLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMK---YRKSVRYASERCFNNIVF 110
D +T ++N+ I I E I+ + ++ G ++ +K RK R E FN +V
Sbjct: 17 DPRTYLDNF----IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR--RELLFNEVVI 70
Query: 111 ASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAME 170
H++++++ L + +V E L D + TH + ++A
Sbjct: 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-----IVTHTR----MNEEQIAAV 121
Query: 171 TANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF----SLSKSIPEGKTHIKAST 226
+ L Q V+ R+I+ +IL + KL DF +SK +P K+
Sbjct: 122 CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS------ 175
Query: 227 AIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+G+ + APE ++ Y + D++S G +++ ++ G
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 13/160 (8%)
Query: 106 NNIVFASQMNHKSILKLIGCCLEAEMPALV--YEPAGYCTLADRLYGPLQTHLEPLLLTH 163
I + H+ I++ GC + E ++ Y P G + YG L +
Sbjct: 53 CEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR----- 107
Query: 164 RLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK 223
K + V YL +V R+I+ NIL KL DF SK + +
Sbjct: 108 --KYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT 162
Query: 224 A-STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+ G+ + +PE ++ Y K DV+S G ++ +LT
Sbjct: 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 28/78 (35%), Positives = 41/78 (52%), Gaps = 2/78 (2%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
V++R+++P NIL + L DF L K K K +T G+ E+ APE L Y
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 246 EKTDVYSFGKLLLVLLTG 263
+ D ++ G LL +LTG
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 53/252 (21%), Positives = 96/252 (38%), Gaps = 52/252 (20%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYE------------------PAGYCTLADRLYGPLQ 153
S++ +I++L+G C++ + ++ E A L
Sbjct: 74 SRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLP 133
Query: 154 THLEPLLLTHRLKVAMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212
LL VA++ A+ + YL F V R++ N L E K+ DF +S
Sbjct: 134 AISYSSLLH----VALQIASGMKYLSSLNF----VHRDLATRNCLVGENLTIKIADFGMS 185
Query: 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL---LVLLTGRTIGHL 269
+++ G + A+ + + A E + G + +DV++FG L L+L + G L
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 270 SRLATGGSNFFITDRVEKFIRSNG---YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLS 326
++ + + +F R G Y+ FR Q EL +C S
Sbjct: 246 -------TDEQVIENAGEFFRDQGRQVYL------------FRPPPCPQGLYELMLQCWS 286
Query: 327 HSAEDRPTMIDV 338
+RP+ D+
Sbjct: 287 RDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 7/84 (8%)
Query: 187 VFRNIEPWNILFQEEYAAKLFDF-SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT---- 241
+ R+++P N+L + KL DF + K EG ++ TA+G+ ++ +PE L +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM--VRCDTAVGTPDYISPEVLKSQGGD 221
Query: 242 GYYNEKTDVYSFGKLLLVLLTGRT 265
GYY + D +S G L +L G T
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 16/106 (15%)
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS----KSIPEGKTH 221
K+A+ T A+ YL+ ++ R+++P NIL KL DF +S SI KT
Sbjct: 111 KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--AKTR 166
Query: 222 IKASTAIGSLEFAAPEYLTTGY---YNEKTDVYSFGKLLLVLLTGR 264
G + APE + Y+ ++DV+S G L + TG+
Sbjct: 167 -----DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 3/80 (3%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+V+R+++P N+L ++ +L D L+ + +GKT + + G+ + APE L Y+
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA---GTNGYMAPEILKEEPYS 172
Query: 246 EKTDVYSFGKLLLVLLTGRT 265
D ++ G + ++ GRT
Sbjct: 173 YPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 15/174 (8%)
Query: 102 ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL----- 156
E + +H +++KLIG L + + P L +G L T L
Sbjct: 46 EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL--PIPMVILPFMKHGDLHTFLLMSRI 103
Query: 157 --EPLLLTHR--LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212
EP L + ++ ++ A+ + YL + + R++ N + E + DF LS
Sbjct: 104 GEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLS 160
Query: 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRT 265
K I G + + + +++ A E L Y +DV++FG + ++T G+T
Sbjct: 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 26/77 (33%), Positives = 38/77 (49%), Gaps = 5/77 (6%)
Query: 187 VFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNE 246
+ R+++P N L KL DF LSK I A++ +GS ++ APE L Y+
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDF 177
Query: 247 KTDVYSFGKLLLVLLTG 263
D +S G +L L G
Sbjct: 178 TVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 34/137 (24%), Positives = 60/137 (43%), Gaps = 18/137 (13%)
Query: 136 YEPAG-YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPW 194
Y+P G +L +R + L L +A+ + + + Y V R+I+P
Sbjct: 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAE-LVLAIHSVHQMGY---------VHRDIKPE 131
Query: 195 NILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT------GYYNEKT 248
N+L KL DF + + K + + +G+ ++ APE LTT G Y +
Sbjct: 132 NVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVEC 190
Query: 249 DVYSFGKLLLVLLTGRT 265
D +S G + ++ GR+
Sbjct: 191 DWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 9e-04
Identities = 22/72 (30%), Positives = 42/72 (58%), Gaps = 3/72 (4%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+V R++ P NI+ E+ + DF L+K + + K ++ +G++ ++ PE + Y
Sbjct: 135 IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCPEIVKNEPYG 191
Query: 246 EKTDVYSFGKLL 257
EK DV++FG +L
Sbjct: 192 EKADVWAFGCIL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 27/79 (34%), Positives = 42/79 (53%), Gaps = 2/79 (2%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYL-TTGYY 244
+V+R+I+ NIL E L DF LSK + + + G++E+ APE + G +
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGH 184
Query: 245 NEKTDVYSFGKLLLVLLTG 263
+ D +S G L+ LLTG
Sbjct: 185 GKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 30/124 (24%), Positives = 51/124 (41%), Gaps = 32/124 (25%)
Query: 170 ETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK--------- 219
E A+ + + GF + R+I+P NIL + KL DF L K + + K
Sbjct: 109 ELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 220 ------------------THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLL 261
++A++ +G+ ++ APE L Y + D +S G +L +L
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 262 TGRT 265
G
Sbjct: 225 YGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS-IPEGKTHIKASTAIGS 230
A V+ L + + VV+R+I+ N++ ++ K+ DF L K I +G T T G+
Sbjct: 102 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGT 158
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
E+ APE L Y D + G ++ ++ GR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 14/92 (15%)
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI--PEGKTHIKASTA 227
ET +AYL V+ R+I+ NIL + KL DF +S + G+ + T
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN----TF 173
Query: 228 IGSLEFAAPEYLT-----TGYYNEKTDVYSFG 254
IG+ + APE + Y+ ++DV+S G
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 26/99 (26%), Positives = 48/99 (48%), Gaps = 7/99 (7%)
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
++A+ + YL + ++ R+++P N+L KL DF +S + + A
Sbjct: 99 RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAK 151
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
T +G+ + APE ++ Y +DV+S G + L GR
Sbjct: 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 27/180 (15%)
Query: 91 MKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYG 150
M RK R E FN +V +H++++ + L + +V E L D
Sbjct: 55 MDLRKQQR--RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD---- 108
Query: 151 PLQTHL---EPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207
+ TH E + T V + A++YL Q V+ R+I+ +IL + KL
Sbjct: 109 -IVTHTRMNEEQIAT----VCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLS 160
Query: 208 DF----SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
DF +SK +P+ K+ +G+ + APE ++ Y + D++S G +++ ++ G
Sbjct: 161 DFGFCAQVSKEVPKRKS------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 33/171 (19%), Positives = 75/171 (43%), Gaps = 18/171 (10%)
Query: 101 SERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLL 160
++R + +V +NHK+I+ L+ V+ P +Y ++ L
Sbjct: 64 AKRAYRELVLLKCVNHKNIISLLN----------VFTPQKSLEEFQDVYLVMELMDANLC 113
Query: 161 LTHRLKVAMETANAVAY-----LRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215
+++ E + + Y ++ ++ R+++P NI+ + + K+ DF L+++
Sbjct: 114 QVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART- 172
Query: 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTI 266
T+ + + + + APE + Y E D++S G ++ L+ G I
Sbjct: 173 --ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVI 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 54/251 (21%), Positives = 103/251 (41%), Gaps = 37/251 (14%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLL------- 160
I S++ + +I++L+G C+ + ++ E Y D Q +E
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITE---YMENGDLNQFLSQREIESTFTHANNIP 124
Query: 161 ---LTHRLKVAMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216
+ + L +A++ A+ + YL F V R++ N L Y K+ DF +S+++
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNF----VHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG 276
G + A+ + + A E + G + +DV++FG L + T S L
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL---- 236
Query: 277 SNFFITDRVEKFIRSNG---YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP 333
S+ + + +F R+ G Y++ P+ +L +C S +DRP
Sbjct: 237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPS------------PVFKLMMRCWSRDIKDRP 284
Query: 334 TMIDVAKKLRQ 344
T + LR+
Sbjct: 285 TFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 27/92 (29%), Positives = 40/92 (43%), Gaps = 7/92 (7%)
Query: 178 LRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPE 237
L F V+ R+++ NIL + KL DF +S T K T IG+ + APE
Sbjct: 116 LNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYWMAPE 173
Query: 238 YLTT-----GYYNEKTDVYSFGKLLLVLLTGR 264
+ Y+ K D++S G L+ L
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 23/82 (28%), Positives = 46/82 (56%), Gaps = 3/82 (3%)
Query: 184 QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY 243
+ +V+R+++P NIL + ++ D L+ IPEG+T I+ +G++ + APE +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGR--VGTVGYMAPEVVKNER 177
Query: 244 YNEKTDVYSFGKLLLVLLTGRT 265
Y D + G L+ ++ G++
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 25/79 (31%), Positives = 38/79 (48%), Gaps = 3/79 (3%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPE-YLTTGYY 244
+V+R+++P NIL L DF LSK + +T G+ E+ APE L Y
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 245 NEKTDVYSFGKLLLVLLTG 263
+ D +S G L+ + G
Sbjct: 175 TKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 7/96 (7%)
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA-STAI 228
E +A+ YL G +V+R+++ N++ ++ K+ DF L K EG T T
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFC 156
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
G+ E+ APE L Y D + G ++ ++ GR
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 26/77 (33%), Positives = 37/77 (48%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
++ R+I+ NIL KL DF SK + T G+ + APE Y+
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 246 EKTDVYSFGKLLLVLLT 262
+K D++S G LL LLT
Sbjct: 224 KKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 4/94 (4%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGS 230
A L F V++R+++ NIL E KL DF + K I G T +T G+
Sbjct: 103 AEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TTTFCGT 159
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
++ APE L Y D ++ G L+ ++ G+
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS-IPEGKTHIKASTAI 228
E +A+ YL + VV+R+++ N++ ++ K+ DF L K I +G T T
Sbjct: 103 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFC 157
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
G+ E+ APE L Y D + G ++ ++ GR
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 23/179 (12%)
Query: 90 VMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY 149
+M RK R E FN +V H++++++ L E ++ E L D +
Sbjct: 53 MMDLRKQQR--RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS 110
Query: 150 GPLQTHL-EPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208
QT L E + T V A+ YL Q V+ R+I+ +IL + KL D
Sbjct: 111 ---QTRLNEEQIAT----VCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSD 160
Query: 209 F----SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
F +SK +P K + +G+ + APE ++ Y + D++S G +++ ++ G
Sbjct: 161 FGFCAQISKDVP------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 34/128 (26%), Positives = 58/128 (45%), Gaps = 12/128 (9%)
Query: 146 DRLY--------GPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
DRLY G L H++ + A L F + +++R+++ N++
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM 133
Query: 198 FQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKL 256
E K+ DF + K +I GKT T G+ ++ APE + Y + D ++FG L
Sbjct: 134 LDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 190
Query: 257 LLVLLTGR 264
L +L G+
Sbjct: 191 LYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 23/158 (14%)
Query: 114 MNHKSILKLIGCCLEAEMPALV----YEPAGYCTLADRL--YGPLQTHLEPLLLTHRLKV 167
+ H I++ GC + E L Y P G ++ D+L YG L ++ +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGG--SIKDQLKAYGALTENVTR-------RY 111
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE---GKTHIKA 224
+ V+YL +V R+I+ NIL KL DF SK I T IK+
Sbjct: 112 TRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168
Query: 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
T G+ + +PE ++ Y K DV+S ++ +LT
Sbjct: 169 VT--GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 26/84 (30%), Positives = 42/84 (50%), Gaps = 6/84 (7%)
Query: 187 VFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT----- 241
V R+I+P NIL +L DF + E T +++S A+G+ ++ +PE L
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGK 182
Query: 242 GYYNEKTDVYSFGKLLLVLLTGRT 265
G Y + D +S G + +L G T
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 37/158 (23%), Positives = 67/158 (42%), Gaps = 11/158 (6%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKV 167
I ++NH +I+KL+ LV+E + D LY ++ L +
Sbjct: 49 IKLLKELNHPNIIKLLDVFRHKGDLYLVFE---FM-DTD-LYKLIKDRQRGLPESLIKSY 103
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
+ +A+ ++ R+++P N+L E KL DF L++S G +
Sbjct: 104 LYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHY 158
Query: 228 IGSLEFAAPEYL-TTGYYNEKTDVYSFGKLLLVLLTGR 264
+ + + APE L Y+ D++S G + LL+ R
Sbjct: 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 22/81 (27%), Positives = 43/81 (53%), Gaps = 1/81 (1%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+V R+I+P N+L KL DF ++++ EG ++ + + + + +PE L Y
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANYTEYVATRWYRSPELLLGAPYG 179
Query: 246 EKTDVYSFGKLLLVLLTGRTI 266
+ D++S G +L L G+ +
Sbjct: 180 KAVDMWSVGCILGELSDGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.27 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.1 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.91 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.72 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.64 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.58 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.55 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.54 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.49 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.45 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.32 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.23 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.07 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.06 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.97 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.96 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.9 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.74 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.73 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.69 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.42 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.42 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.36 | |
| PLN02236 | 344 | choline kinase | 97.34 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.3 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.17 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.1 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.09 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.03 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.0 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.79 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.7 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.68 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.58 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.24 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.2 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.09 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.95 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.91 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.42 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.02 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-58 Score=419.33 Aligned_cols=289 Identities=36% Similarity=0.580 Sum_probs=250.0
Q ss_pred CcccccHHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeee
Q 018816 46 PIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGC 125 (350)
Q Consensus 46 ~~~~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 125 (350)
+.+.|++.||..+|++|+..++| |+|+||.||+|...++..||||++.........+|.+|+.++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~i-g~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLI-GEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcce-ecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 67889999999999999999999 99999999999998888999998877643314559999999999999999999999
Q ss_pred eecCC-cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCce
Q 018816 126 CLEAE-MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA 204 (350)
Q Consensus 126 ~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 204 (350)
|.+.+ ..+||+||+++|+|.++++..... +++|..+++||.++|+||+|||..+..+|+||||||+|||||+++.+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99999 499999999999999999876422 78999999999999999999998877889999999999999999999
Q ss_pred eEcccCCCccCCC-CCcccccccc-ccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 205 KLFDFSLSKSIPE-GKTHIKASTA-IGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 205 kl~Dfg~~~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
||+|||+|+..+. ... ..+. .||.+|+|||+...+..+.++|||||||+++||+||+++.+.... .....+.
T Consensus 217 KlsDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~---~~~~~l~ 290 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP---RGELSLV 290 (361)
T ss_pred EccCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC---cccccHH
Confidence 9999999976654 221 1111 599999999999999999999999999999999999998876542 2234488
Q ss_pred HHHHHHHHhcC-CCccCcccc-CCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 283 DRVEKFIRSNG-YMNIDPVIV-GDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 283 ~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.|+++.+.++. .+.+||.+. +.... ......+..++..|++.+|.+||+|.+|++.|+.+..
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88888888876 788999987 33321 1467779999999999999999999999999977653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=374.33 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=210.2
Q ss_pred ccccccCCCceEEEEEEECCCceEEEEEecccchh--hHHHHHHHHHHHHhcCCCCccceeeeeecCC-cCeEEeecCCC
Q 018816 65 RNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRY--ASERCFNNIVFASQMNHKSILKLIGCCLEAE-MPALVYEPAGY 141 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~ 141 (350)
...+ |+|+||+||+|.+.+...||||++...... ..+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||+++
T Consensus 46 ~~~i-G~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 46 EEVL-GSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhc-ccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3457 999999999999988856999999875432 2568999999999999999999999999988 79999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-eEeeccccCceEeCCCC-ceeEcccCCCccCCCCC
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP-VVFRNIEPWNILFQEEY-AAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 219 (350)
|+|.++++.... ..+++..++.++.|||.||.||| +.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~~~---~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 125 GSLSVLLHKKRK---RKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999977411 68999999999999999999999 888 99999999999999997 99999999998765432
Q ss_pred ccccccccccCCCCCCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 220 THIKASTAIGSLEFAAPEYLT--TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.......||+.|||||++. ...|+.++||||||+++|||+||..||..... ...+...+..+....+
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---------~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---------VQVASAVVVGGLRPPI 267 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---------HHHHHHHHhcCCCCCC
Confidence 1223356999999999999 56899999999999999999999999986543 1112222222222221
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.. .+++.+..|+..||+.||+.||++.+++..|+.+..
T Consensus 268 p~------------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 268 PK------------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred Cc------------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 11 355789999999999999999999999999998865
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=361.57 Aligned_cols=251 Identities=17% Similarity=0.199 Sum_probs=206.4
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-cCeEEeec
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE-MPALVYEP 138 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 138 (350)
......| |+|..|+||++.+ .++..+|+|.+... .+...+++.+|+++++..+||+||.++|.|.... ..+++|||
T Consensus 81 le~~~~l-G~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 81 LERLGVL-GSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred hhhhhhc-ccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3445677 9999999999999 56667788888443 3455678999999999999999999999999988 49999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
|++|||.+++... +.+++...-+++.+|++||.|||. .++||||||||+|||++..|.+||+|||.+..+.+.
T Consensus 160 MDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999998654 579999999999999999999993 389999999999999999999999999999877554
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... ........+...+....
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~----~~~~~~~Ll~~Iv~~pp----- 299 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP----PYLDIFELLCAIVDEPP----- 299 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC----CCCCHHHHHHHHhcCCC-----
Confidence 34567799999999999999999999999999999999999999875411 11122222222221111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
|.+ ....+++++.+|+..||+.||.+|||+.++++
T Consensus 300 P~l-------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 PRL-------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCC-------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 11146789999999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=366.78 Aligned_cols=252 Identities=20% Similarity=0.231 Sum_probs=210.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh-------hHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY-------ASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
.+.|...+.| |+|+||.|-+|.. ++++.||||.+++.... ....+.+|+++|++|+|||||++++++..++
T Consensus 171 ~d~yii~~~L-GsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 171 NDYYIISKTL-GSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred cceeEeeeee-cCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3455666777 9999999999999 78889999999765321 1233569999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC---CceeEc
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE---YAAKLF 207 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~ 207 (350)
..|+||||++||+|.+.+-.. +.+.+.....++.|++.|+.||| ++||+||||||+|||++.+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEec
Confidence 999999999999999999765 56778888999999999999999 9999999999999999877 789999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY---YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 284 (350)
|||+|+..+... .+.+.||||.|.|||++.+.. +..+.|+||+||++|-+++|.+||...... ..
T Consensus 322 DFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~---------~s 389 (475)
T KOG0615|consen 322 DFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD---------PS 389 (475)
T ss_pred ccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC---------cc
Confidence 999999886544 366788999999999998764 345889999999999999999999865321 11
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+.+.++.+....+.+ ...+++..+|+.+||..||++|||+.|+|+
T Consensus 390 l~eQI~~G~y~f~p~~w---------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 LKEQILKGRYAFGPLQW---------DRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHHhcCcccccChhh---------hhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 34445555544433333 367889999999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-51 Score=374.61 Aligned_cols=247 Identities=19% Similarity=0.237 Sum_probs=212.7
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS---VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
..|...+.| |+|||+.||.+++ ..+..||+|.+.+. .....+.+.+||++.++|+|||||+++++|++.++.|+|
T Consensus 18 ~~Y~~g~~L-GkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFL-GKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeee-ccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 568888888 9999999999999 88889999998763 235567899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
+|+|+.++|..++... .++++.++..+..||+.||.||| +++|+|||||..|+|++++.++||+|||+|...
T Consensus 97 LELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeee
Confidence 9999999999998744 68999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.... ....+.+|||.|.|||++....++..+||||+||++|.|+.|+|||..... .+.. ..+....+.
T Consensus 169 e~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v---------kety-~~Ik~~~Y~ 236 (592)
T KOG0575|consen 169 EYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV---------KETY-NKIKLNEYS 236 (592)
T ss_pred cCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH---------HHHH-HHHHhcCcc
Confidence 6432 245677899999999999999999999999999999999999999985421 1111 122222211
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. | ...+.+..+||.++|+.||.+|||+++|+.
T Consensus 237 ~--P-----------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 M--P-----------SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred c--c-----------cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 1 245567899999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-53 Score=352.34 Aligned_cols=259 Identities=20% Similarity=0.220 Sum_probs=210.6
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceee-eeecCCc-CeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIG-CCLEAEM-PAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~l 134 (350)
.+|.+...| |.|.||+||++.. .++..||.|.+.-. +.........|+.+|++|+|||||++++ .+.+++. ++|
T Consensus 19 ~~y~Il~~I-G~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKI-GRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHH-cCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 356666777 9999999999999 78889999998643 3355677889999999999999999999 4555554 999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEeeccccCceEeCCCCceeEcccCCC
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP--VVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
|||+|++|+|.+.+.....++ ..+++..+++++.|++.||.++|+.. .+ |+||||||.||+|+.+|.+||+|||++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999997644333 57999999999999999999999421 44 999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
+.+.+... ...+.+|||.||+||.+...+|+++|||||+||++|||+.-++||..... ..+.+.+.++
T Consensus 176 r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~----------~~L~~KI~qg 243 (375)
T KOG0591|consen 176 RFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL----------LSLCKKIEQG 243 (375)
T ss_pred hHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH----------HHHHHHHHcC
Confidence 98866443 24566799999999999999999999999999999999999999985421 1122233332
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
+.++.+.+..+..+..|+..|+..||+.||+...++..++.
T Consensus 244 -----------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 -----------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 22222234778899999999999999999996655555543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-51 Score=359.07 Aligned_cols=201 Identities=22% Similarity=0.340 Sum_probs=182.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
..+|.....| |.|+||+||+|++ +++..||||.+.+. .....+.+..|+.+|+.++|||||++++++.+++.++||
T Consensus 9 ~~~y~~~~~i-G~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREI-GSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhc-cCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 4677778888 9999999999999 66779999999776 456677889999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC------CceeEccc
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE------YAAKLFDF 209 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~------~~~kl~Df 209 (350)
||||.||+|.++++.. +.+++..+..++.|||.||++|| +++||||||||.||||+.+ -.+||+||
T Consensus 88 MEyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 9999999999999875 57999999999999999999999 9999999999999999875 56899999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSR 271 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 271 (350)
|+|+...++. ...+.+|++.|||||++....|+.|+|+||+|+++|++++|++||+...
T Consensus 160 GfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 160 GFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred chhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9999887544 3556779999999999999999999999999999999999999998543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-51 Score=371.28 Aligned_cols=254 Identities=24% Similarity=0.314 Sum_probs=213.5
Q ss_pred cccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCc
Q 018816 64 MRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCT 143 (350)
Q Consensus 64 ~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s 143 (350)
..+.| |+|.||.||.|.+++...||+|.+.... ...+.|.+|+.+|++|+|+|||+++|+|..+..++||||||+.|+
T Consensus 210 l~~~L-G~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 210 LIREL-GSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHh-cCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 34567 9999999999999888899999998763 345778899999999999999999999999899999999999999
Q ss_pred hhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcccc
Q 018816 144 LADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK 223 (350)
Q Consensus 144 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 223 (350)
|.++|..... ..+...+.+.++.|||.|++||+ ++++|||||.++|||++++..+||+|||+|+.........
T Consensus 288 Ll~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~- 360 (468)
T KOG0197|consen 288 LLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA- 360 (468)
T ss_pred HHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceee-
Confidence 9999986322 67899999999999999999999 9999999999999999999999999999999554433322
Q ss_pred ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcccc
Q 018816 224 ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIV 302 (350)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
.....-+..|.|||.+..+.||.+||||||||+||||+| |+.||..... ..+...+.++.. ...
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------~ev~~~le~GyR-lp~---- 425 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------EEVLELLERGYR-LPR---- 425 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------HHHHHHHhccCc-CCC----
Confidence 222225778999999999999999999999999999999 8888764332 223333433321 111
Q ss_pred CCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 303 GDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 303 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
|..+++.+.+++..||+.+|++|||++.+...|+++..+
T Consensus 426 -------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 426 -------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 236788999999999999999999999999999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=338.04 Aligned_cols=243 Identities=20% Similarity=0.175 Sum_probs=204.6
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
..++|...++| |+|+||.||.++. +.++-+|+|.+.+..- ...+....|..+|.+++||.||.++..|++...+|
T Consensus 23 ~~~dF~~lkvi-GkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVI-GKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred Chhheeeeeee-eccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 35789999999 9999999999999 5666889999877532 34566889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+|+||+.||.|...|.+. +.+++..+..++.+|+.||.||| +++||||||||+|||||.+|+++|+|||+|+
T Consensus 102 lVld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred EEEeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccch
Confidence 999999999999999764 67999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
..-.... .+.+.+||+.|||||++.+..|+.++|+||||+++|||++|.+||..... ..+..+.... .
T Consensus 174 ~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---------~~~~~~I~~~-k 241 (357)
T KOG0598|consen 174 EDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---------KKMYDKILKG-K 241 (357)
T ss_pred hcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---------HHHHHHHhcC-c
Confidence 6543322 35567899999999999999999999999999999999999999985432 2222222221 1
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP 333 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 333 (350)
....+ .-.+.+..+++...|+.||++|.
T Consensus 242 ~~~~p------------~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LPLPP------------GYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCCC------------ccCCHHHHHHHHHHhccCHHHhc
Confidence 11111 12456789999999999999995
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=368.74 Aligned_cols=264 Identities=20% Similarity=0.299 Sum_probs=221.3
Q ss_pred cCcccccccccCCCceEEEEEEE------CCCceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
.+....+.| |+|+||.||+|.. ++...||||.+++.... ...+|.+|+.+++.++|||||+++|+|.+++..
T Consensus 486 ~~i~~~~eL-GegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEEL-GEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhh-cCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344556678 9999999999997 23458999999887654 788999999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCC-----C----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 133 ALVYEPAGYCTLADRLYGPLQT-----H----LEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~-----~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
++|+|||..|+|.++|...... . ..+++..+.+.||.|||.|+.||- ++.+|||||..+|+||+++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence 9999999999999999642110 1 234899999999999999999999 999999999999999999999
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 282 (350)
|||+|||+++.....+.+.......-+++|||||.+..++||.+||||||||+|||+++ |+.|+.....
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---------- 711 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---------- 711 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----------
Confidence 99999999998877665544333335789999999999999999999999999999998 9999875432
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
+.+...+.++.. .- .++.++.++.+|+..||+.+|++||++.||-.+|+..-..+
T Consensus 712 ~EVIe~i~~g~l-L~-----------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 712 QEVIECIRAGQL-LS-----------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHHHcCCc-cc-----------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 234444444332 11 12478899999999999999999999999999999986554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=349.47 Aligned_cols=247 Identities=20% Similarity=0.273 Sum_probs=213.4
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
.|.....| |+|+.|.||.+.. ..+..||||++........+-+.+|+.+|+..+|+|||.+++.|...+.+|.||||+
T Consensus 274 ~y~~~~ki-gqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 274 KYTDFKKI-GQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhcchhhh-ccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 34455566 9999999999999 677799999998887676777899999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
+||+|.+.+.. ..+++.++..|+.++++||+||| .++|+|||||.+|||++.+|.+||+|||+|..+....
T Consensus 353 ~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999865 35899999999999999999999 9999999999999999999999999999998876544
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC-CCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG-YMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 298 (350)
. ...+.+|||.|||||++....|.++.||||||++++||+-|.+||-...+. .+...+...+ ..+-.
T Consensus 424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl----------rAlyLIa~ng~P~lk~ 491 (550)
T KOG0578|consen 424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----------RALYLIATNGTPKLKN 491 (550)
T ss_pred C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH----------HHHHHHhhcCCCCcCC
Confidence 3 456778999999999999999999999999999999999999999854331 2222333333 22222
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+ +..+..+.+|+.+||+.||++||++.|||+
T Consensus 492 ~-----------~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 492 P-----------EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred c-----------cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 2 366789999999999999999999999997
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=335.61 Aligned_cols=255 Identities=22% Similarity=0.248 Sum_probs=201.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCC--cCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE--MPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 136 (350)
.++...+.| |+|+||.||++.. +++...|||..........+.+.+|+.+|.+++|||||+++|...... .+++.|
T Consensus 17 ~~~~~~~~l-G~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLL-GRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccc-cCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345566777 9999999999999 447789999986653333677899999999999999999999855554 599999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-CCceeEcccCCCccC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-EYAAKLFDFSLSKSI 215 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 215 (350)
||+++|+|.+++.+.. ..+++..+..+..||+.||.||| +++|+||||||+|||++. ++.+||+|||+++..
T Consensus 96 Ey~~~GsL~~~~~~~g----~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYG----GKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 9999999999997642 26999999999999999999999 999999999999999999 799999999998876
Q ss_pred CC-CCccccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 216 PE-GKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 216 ~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.. ...........||+.|||||++..+. ...++|||||||++.||+||++||... ..............
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--------~~~~~~~~~ig~~~- 239 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--------FEEAEALLLIGRED- 239 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--------cchHHHHHHHhccC-
Confidence 53 11112233456999999999999643 335999999999999999999998742 01111111111111
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
..|.+ +...+.+..+++..|++.+|++||||.++|..-
T Consensus 240 ---~~P~i--------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 ---SLPEI--------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ---CCCCC--------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11211 124567899999999999999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=324.37 Aligned_cols=265 Identities=18% Similarity=0.207 Sum_probs=203.7
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.|+...++ |+|+||.||+++. +.|.-||||++..+.. .-.+..++|++.|++|+|+|+|.++.+|.....++||+|
T Consensus 3 kYE~Lgkv-GEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 3 KYEKLGKV-GEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred HHhhhhcc-ccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45566677 9999999999999 5667899999976543 334668899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
||+..-|. -+.... ..++...+.+++.|++.|+.|+| +++++||||||+||||+.+|.+||+|||+|+.+..
T Consensus 82 ~~dhTvL~-eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDHTVLH-ELERYP----NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecchHHHH-HHHhcc----CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99764444 443332 56889999999999999999999 99999999999999999999999999999998864
Q ss_pred CCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcch-HHHHH-------HHH
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF-ITDRV-------EKF 288 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~-------~~~ 288 (350)
+.. ..+..+.|..|.|||.+.+ .+|...+||||+||++.||++|.+.|.+.++.+ ... +...+ .+.
T Consensus 154 pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD---QLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 154 PGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID---QLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred Ccc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHH---HHHHHHHHHcccCHHHHHH
Confidence 332 3445568999999999988 579999999999999999999999998765531 111 11111 111
Q ss_pred HHhcC--CCccCccccCCCCc--cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRSNG--YMNIDPVIVGDRSC--FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~~~--~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+..+. ....-|......+. .. ...+..+.+|+..||+.||++|++.++++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22211 11111111111110 01 144557899999999999999999999985
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=349.25 Aligned_cols=267 Identities=19% Similarity=0.275 Sum_probs=215.4
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
++.+.-.+.+.....| |+|.||+||+|.+.+ .||||.++... +...+.|.+|+..+++-+|.||+-+.|+|..+.
T Consensus 385 ~~WeIp~~ev~l~~rI-GsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERI-GSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhcccee-ccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4444444555666777 999999999999976 69999997654 355678999999999999999999999998887
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
. .||+.+|+|-+|+.+++... ..+.+...+.|+.||++|+.||| .++|||||||..||++.+++.|||+|||
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred e-eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccc
Confidence 7 99999999999999998764 57899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
++.....-..........|...|||||++.. .+|++.+||||||+++|||++|..||...... . ..
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--q--Ii------- 602 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--Q--II------- 602 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--h--eE-------
Confidence 9865543333333445558899999999975 47999999999999999999999999832210 0 00
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
+.- +...+.+++.... ..+++++.+|+..||..++++||.+.+|+..|+.+..+
T Consensus 603 -fmV-GrG~l~pd~s~~~-----s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 603 -FMV-GRGYLMPDLSKIR-----SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -EEe-cccccCccchhhh-----ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 000 1111112221111 26788999999999999999999999999999988763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=329.61 Aligned_cols=263 Identities=17% Similarity=0.180 Sum_probs=210.8
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
..++|....+| |.|..++||+|+. ..+..||||+++-.. ..+.+.+.+|+..|+.++||||++++..|..+..+|+|
T Consensus 24 n~~~YeL~e~I-G~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVI-GVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEE-eccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 34788888998 9999999999999 556799999986543 24468899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|.||.+||+.+.+..... ..+.+..+..|++++++||.||| .+|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 103 mpfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ehhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999999865433 45889999999999999999999 999999999999999999999999999987555
Q ss_pred CCCCccc-cc-cccccCCCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 216 PEGKTHI-KA-STAIGSLEFAAPEYLTTG--YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 216 ~~~~~~~-~~-~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
....... .. .+.+||++|||||++..+ .|+.|+||||||++..||.+|..||...++. ..+...+.+
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---------kvLl~tLqn 247 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---------KVLLLTLQN 247 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---------HHHHHHhcC
Confidence 4333221 12 566799999999996543 5999999999999999999999999866542 111122222
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. ...+ .+...........+.+.+++..||+.||.+|||+.++++
T Consensus 248 ~p-p~~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 248 DP-PTLL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CC-CCcc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11 1111 111111111255678999999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=340.64 Aligned_cols=265 Identities=17% Similarity=0.312 Sum_probs=206.7
Q ss_pred hcCcccccccccCCCceEEEEEEE------CCCceEEEEEecccch-hhHHHHHHHHHHHHhc-CCCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSVR-YASERCFNNIVFASQM-NHKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 130 (350)
.++|...+.| |+|+||.||+|.+ ..+..||+|.+..... .....+.+|+.++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~l-G~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVL-GHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEe-ccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3578888888 9999999999975 2234799999865432 3346788999999999 8999999999887644
Q ss_pred -cCeEEeecCCCCchhhhhhCCCCC-------------------------------------------------------
Q 018816 131 -MPALVYEPAGYCTLADRLYGPLQT------------------------------------------------------- 154 (350)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~------------------------------------------------------- 154 (350)
..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 688999999999999998643110
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCC
Q 018816 155 --HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232 (350)
Q Consensus 155 --~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 232 (350)
...++++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0134788899999999999999999 99999999999999999999999999999986543332222333446788
Q ss_pred CCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchH
Q 018816 233 FAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKE 311 (350)
Q Consensus 233 y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (350)
|+|||++.+..++.++|||||||++|||++ |..||..... ..........+..... + .
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~---------~~~~~~~~~~~~~~~~-~-----------~ 300 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---------NEEFCQRLKDGTRMRA-P-----------E 300 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc---------cHHHHHHHhcCCCCCC-C-----------C
Confidence 999999998899999999999999999997 9999874321 0111122222111100 0 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 312 EKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 312 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..+..+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus 301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3346789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=338.79 Aligned_cols=262 Identities=16% Similarity=0.201 Sum_probs=207.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHH--HHHHHHHHHhcC-CCCccceeeeeecCC-cCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASER--CFNNIVFASQMN-HKSILKLIGCCLEAE-MPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~ 133 (350)
.++|...+.| |.|.||.||+|+. .++..||||++...-.. .++ -.+|++.|++|+ |||||++.+++.+.+ .++
T Consensus 9 m~RY~~i~kl-GDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKL-GDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHh-cCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3567777888 9999999999999 66779999999776432 333 358999999998 999999999999888 999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+|||||+ .+|++++.++. ..+++..+..|+.||++||+|+| .+|+.|||+||+|||+..+..+||+|||+|+
T Consensus 87 fVfE~Md-~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeHHhhh-hhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccc
Confidence 9999995 79999997763 68999999999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.+.+... .+..+.|..|.|||++.. +.|+.+.|+||+||+++|+.+-++.|.+.... .....+...+...
T Consensus 159 ev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~------Dqi~KIc~VLGtP 229 (538)
T KOG0661|consen 159 EVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI------DQIYKICEVLGTP 229 (538)
T ss_pred ccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH------HHHHHHHHHhCCC
Confidence 8876554 445568999999998875 56999999999999999999999999876542 1111111111111
Q ss_pred CCC-------------ccCccccCCC-CccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYM-------------NIDPVIVGDR-SCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~-------------~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... ..-|...+.. ....+ .++.++.+|+.+|+++||.+||||.++++
T Consensus 230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred ccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 100 0011111111 11111 46788999999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=340.08 Aligned_cols=253 Identities=21% Similarity=0.212 Sum_probs=210.5
Q ss_pred HHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhc-CCCCccceeeeeecCC
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQM-NHKSILKLIGCCLEAE 130 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 130 (350)
.+..+||...++| |.|+|++|++|+. ..++.+|||++.+.-- ...+-+..|-.+|.+| .||.|++|+..|.+..
T Consensus 69 kk~~~DF~Fg~~l-GeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKIL-GEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred cCChhhcchhhee-ccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 4556789999999 9999999999999 6777999999876532 2223466888899999 7999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
.+|+|+||+++|+|.++|.+. +.+++.....++.+|+.||+||| +.|||||||||+|||||.++++||+|||
T Consensus 148 sLYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecc
Confidence 999999999999999999764 78999999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCcc---------cc--ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcc
Q 018816 211 LSKSIPEGKTH---------IK--ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF 279 (350)
Q Consensus 211 ~~~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~ 279 (350)
.|+.+...... .. ....+||..|.+||++..+..+..+|+|+|||++|+|+.|.+||..... .
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------y 293 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------Y 293 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------H
Confidence 99888643221 11 1457899999999999999999999999999999999999999986543 1
Q ss_pred hHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 280 FITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+-. .+... +-.+. ..+++.+.+|+.+.|..||++|+|+.+|-+
T Consensus 294 liFq----kI~~l-----~y~fp--------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 294 LIFQ----KIQAL-----DYEFP--------EGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHH----HHHHh-----cccCC--------CCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1111 11111 11111 134567899999999999999999988765
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=328.96 Aligned_cols=261 Identities=18% Similarity=0.273 Sum_probs=207.3
Q ss_pred CCcccccHHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhh---HHHHHHHHHHHHhcCCCCccc
Q 018816 45 NPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYA---SERCFNNIVFASQMNHKSILK 121 (350)
Q Consensus 45 ~~~~~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~ 121 (350)
..++.++.+++.. .....+ |+|++|.||+|.+.+ ..||+|.+....... .+.+.+|+.+|.+++||||++
T Consensus 10 ~~~~~i~~~~i~~-----~~~~~i-~~g~~~~v~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 82 (283)
T PHA02988 10 NDIKCIESDDIDK-----YTSVLI-KENDQNSIYKGIFNN-KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82 (283)
T ss_pred CcceecCHHHcCC-----CCCeEE-eeCCceEEEEEEECC-EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEE
Confidence 4456677777732 222345 999999999999954 599999987653322 466789999999999999999
Q ss_pred eeeeeec----CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCce
Q 018816 122 LIGCCLE----AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNI 196 (350)
Q Consensus 122 ~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Ni 196 (350)
+++++.+ ....++||||+++|+|.+++... ..+++...+.++.+++.||.||| . .+++||||||+||
T Consensus 83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~ni 154 (283)
T PHA02988 83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSF 154 (283)
T ss_pred EeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhE
Confidence 9999876 34688999999999999999654 46889999999999999999999 6 4889999999999
Q ss_pred EeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCcccC
Q 018816 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT--GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT 274 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 274 (350)
+++.++.+||+|||++....... ....++..|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 155 ll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-- 227 (283)
T PHA02988 155 LVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-- 227 (283)
T ss_pred EECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--
Confidence 99999999999999987653322 23348899999999976 6799999999999999999999999974321
Q ss_pred CCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 275 GGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
...............++ ..++..+.+|+.+||+.||++|||+.+|++.|+.++
T Consensus 228 -------~~~~~~i~~~~~~~~~~------------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 228 -------KEIYDLIINKNNSLKLP------------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -------HHHHHHHHhcCCCCCCC------------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111111111111111 134567999999999999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=332.12 Aligned_cols=261 Identities=18% Similarity=0.146 Sum_probs=207.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecC--CcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEA--EMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 133 (350)
.+.|.....| |+|.||.||+|++ .++..||+|++.... .....-..+||.||++|+||||+++.+...+. ..+|
T Consensus 116 ~~~feki~kI-GeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKI-GEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHh-cCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3567777888 9999999999999 777899999987654 23344567999999999999999999998876 6899
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
||+|||+ .+|..++.... -.++..++..++.|++.||+|+| .++|+|||||.+|||||++|.+||+|||+|+
T Consensus 195 lVFeYMd-hDL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 195 LVFEYMD-HDLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred EEEeccc-chhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEecccccee
Confidence 9999996 58888886532 47999999999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
++....... .+..+-|..|.|||.+.+. .|+.+.|+||.|||+.||+.|++++...... .....+.+.....
T Consensus 267 ~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv------eQl~kIfklcGSP 339 (560)
T KOG0600|consen 267 FYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV------EQLHKIFKLCGSP 339 (560)
T ss_pred eccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH------HHHHHHHHHhCCC
Confidence 876554332 4455689999999999886 5999999999999999999999999865432 2222222222111
Q ss_pred CC-----------CccC------ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GY-----------MNID------PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~-----------~~~~------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. ..+. ..+.+.+ ..++....+|+..+|..||.+|.|+.++|.
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~-----~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRETF-----KDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHHh-----ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 10 0000 0111111 244667889999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=335.55 Aligned_cols=250 Identities=23% Similarity=0.227 Sum_probs=207.6
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc----ch-hhHHHHHHHHHHHHhcC-CCCccceeeeeecC
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS----VR-YASERCFNNIVFASQMN-HKSILKLIGCCLEA 129 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 129 (350)
...+.|...+.| |+|+||.|++|.+ ..+..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++...
T Consensus 14 ~~~g~y~~~~~l-G~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 14 LSIGKYELGRTL-GSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred cccCceeeeeee-cCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 455788888888 9999999999998 66689999976553 11 23455678999999998 99999999999999
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-CceeEcc
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKLFD 208 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~D 208 (350)
...++||||+.+|+|.+++... +++.+..+..++.|+++|++|+| +++|+||||||+|||++.+ +++||+|
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~D 164 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSD 164 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEec
Confidence 9999999999999999999773 67889999999999999999999 9999999999999999999 9999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY-YN-EKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
||++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+.... .....
T Consensus 165 FG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---------~~l~~ 233 (370)
T KOG0583|consen 165 FGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---------PNLYR 233 (370)
T ss_pred cccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---------HHHHH
Confidence 99998874 1122355677999999999999977 86 899999999999999999999986332 12222
Q ss_pred HHHHhcCCCccCccccCCCCccchHHH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEK-LQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+ +..+...... .. +.++..|+.+||..||..|+|+.+++.
T Consensus 234 k-i~~~~~~~p~-------------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 234 K-IRKGEFKIPS-------------YLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred H-HhcCCccCCC-------------CcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 2 2222211111 22 567899999999999999999999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=334.50 Aligned_cols=249 Identities=16% Similarity=0.153 Sum_probs=200.3
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
...++|....+| |+|+||.||+++. ..|.-+|+|++.+..- ...+.+..|-.+|...++|+||+++..|++.+.+
T Consensus 138 ~~~~DFe~Lk~I-gkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 138 LSLDDFELLKVI-GKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred CCcccchhheee-ccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 356889999998 9999999999999 5555778888887643 3345577899999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
||||||++||++..+|... ..+++..+..++.+++.|+.-|| +.|+|||||||+|+|||..|++||+|||+|
T Consensus 217 YLiMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred EEEEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeecccccc
Confidence 9999999999999999765 68999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCC---------------------Cccc------------------------cccccccCCCCCCccccccCCCCcc
Q 018816 213 KSIPEG---------------------KTHI------------------------KASTAIGSLEFAAPEYLTTGYYNEK 247 (350)
Q Consensus 213 ~~~~~~---------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~ 247 (350)
...... .... .....+|||.|+|||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 533210 0000 0012469999999999999999999
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHcccc
Q 018816 248 TDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSH 327 (350)
Q Consensus 248 ~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 327 (350)
+|+||||||+|||+.|.+||....+. ...++.......-...+. ...+.+..+||.+|+.
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~---------~T~rkI~nwr~~l~fP~~----------~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQ---------ETYRKIVNWRETLKFPEE----------VDLSDEAKDLITRLLC- 428 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHHhhhccCCCc----------CcccHHHHHHHHHHhc-
Confidence 99999999999999999999865431 112222221110000000 1344788999999999
Q ss_pred CCCCCCC
Q 018816 328 SAEDRPT 334 (350)
Q Consensus 328 ~P~~RPt 334 (350)
||++|.-
T Consensus 429 d~~~RLG 435 (550)
T KOG0605|consen 429 DPENRLG 435 (550)
T ss_pred CHHHhcC
Confidence 9999975
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=342.37 Aligned_cols=268 Identities=24% Similarity=0.320 Sum_probs=216.7
Q ss_pred cccHHHHHHHhcCcccccccccCCCceEEEEEEEC--CC---ceEEEEEecc---cchhhHHHHHHHHHHHHhcCCCCcc
Q 018816 49 SFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLR--DR---GPILVMKYRK---SVRYASERCFNNIVFASQMNHKSIL 120 (350)
Q Consensus 49 ~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~--~~---~~vaik~~~~---~~~~~~~~~~~E~~~l~~l~h~niv 120 (350)
++.-..++-..++......| |+|+||.||+|++. ++ ..||+|.... .......++++|+.+|++++|||||
T Consensus 146 PI~r~~Wel~H~~v~l~kkL-GeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 146 PIPRQKWELSHSDIELGKKL-GEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred cccccccEEeccCcccccee-ecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 34444444555666667888 99999999999993 22 2389998874 3356678899999999999999999
Q ss_pred ceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC
Q 018816 121 KLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE 200 (350)
Q Consensus 121 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 200 (350)
+++|++....++++|||+|.||+|.++|.... ..++..+++.++.+.|.||+||| +++++||||..+|+|++.
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSK 297 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecC
Confidence 99999999999999999999999999997753 36999999999999999999999 999999999999999999
Q ss_pred CCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcc
Q 018816 201 EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNF 279 (350)
Q Consensus 201 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~ 279 (350)
++.+||+|||+++...... .......-+..|+|||.+..+.|++++|||||||++||+++ |..||.....
T Consensus 298 ~~~vKISDFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------- 368 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------- 368 (474)
T ss_pred CCeEEeCccccccCCccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-------
Confidence 9999999999987653111 11112235789999999999999999999999999999999 7888875432
Q ss_pred hHHHHHHHHHHhcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 280 FITDRVEKFIRSNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 280 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..+...+.... .....+ ..+..+..++.+||..+|++||||.++.+.|+.+...
T Consensus 369 ---~~v~~kI~~~~~r~~~~~------------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 369 ---YEVKAKIVKNGYRMPIPS------------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred ---HHHHHHHHhcCccCCCCC------------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 23334442222 222111 3456788999999999999999999999999998754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=306.01 Aligned_cols=263 Identities=16% Similarity=0.136 Sum_probs=206.6
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh--hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY--ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.|...+++ |+|.||.||+|++ ..++.||||++...... -.....+|++.|+.++|+||+.++++|.....+.||+|
T Consensus 3 rY~~~~~l-GEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKL-GEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhh-cCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46667788 9999999999999 78889999999765322 13457899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|++ .+|+..+.+.. ..++..++..++.++++|++||| .+.|+||||||.|+|++++|.+||+|||+|+.+.+
T Consensus 82 fm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 996 69999997654 57899999999999999999999 99999999999999999999999999999999877
Q ss_pred CCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC--
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY-- 294 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 294 (350)
........ +-|..|.|||.+.+. .|+...|+||.||++.||+-|.+.|.+..+. .........+.....
T Consensus 154 p~~~~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi------dQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 154 PNRIQTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI------DQLSKIFRALGTPTPDQ 225 (318)
T ss_pred CCcccccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH------HHHHHHHHHcCCCCccc
Confidence 65443332 579999999998876 5999999999999999999999988765442 111111111111000
Q ss_pred ----------CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 295 ----------MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 295 ----------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
..+............ ...+.+..+|+.+||..||.+|+|+.++++.
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CccccccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000000000000011 1456677999999999999999999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=335.68 Aligned_cols=246 Identities=21% Similarity=0.260 Sum_probs=204.6
Q ss_pred cCcccccccccCCCceEEEEEEECC-CceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD-RGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~-~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|...+.| |+|.||+||||+.+. ...||+|.+.+... ...+.+.+|++|++.++|||||.++++|++..++++|+
T Consensus 2 e~yhv~e~i-G~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMI-GEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHh-cCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 456666677 999999999999954 45677787766543 34567899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+.| +|..++... +.+++..+..++.+++.||.||| +.+|+|||+||.|||++.++.+|++|||+|+.+.
T Consensus 81 e~a~g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred hhhhh-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcc
Confidence 99975 999999765 68999999999999999999999 9999999999999999999999999999999876
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.+.. ......|||.|||||.+.+.+|+..+|+||+||++||+++|++||.... +...+.....
T Consensus 152 ~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---------i~~Lv~~I~~------ 214 (808)
T KOG0597|consen 152 TNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---------ITQLVKSILK------ 214 (808)
T ss_pred cCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---------HHHHHHHHhc------
Confidence 5432 2334459999999999999999999999999999999999999997432 1111111111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
||.. ++...+..+.+|+...|..||..|.|..+++.
T Consensus 215 -d~v~-------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 215 -DPVK-------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CCCC-------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1111 11256678999999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=313.71 Aligned_cols=236 Identities=19% Similarity=0.156 Sum_probs=200.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|+....| |.|+||.|.+++. .++.-+|+|.+.+..- ...+...+|..+|+.++||.++++++.|.+.+.+++|
T Consensus 44 ~dfe~~~tl-GtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTL-GTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeee-ccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 467777888 9999999999999 5566889999876532 3445677999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||++||.|..++++. ++++...+..++.+|+.||+||| +.+|++|||||+|||+|++|.+||+|||+|+..
T Consensus 123 meyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EeccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999775 68999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... +.+.||||.|+|||+++...|+.++|.|||||++|||+.|.+||....+ .....+.+.. ...
T Consensus 195 ~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---------~~iY~KI~~~-~v~ 259 (355)
T KOG0616|consen 195 SGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---------IQIYEKILEG-KVK 259 (355)
T ss_pred cCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------HHHHHHHHhC-ccc
Confidence 442 4567799999999999999999999999999999999999999986543 1112222221 111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCC
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDR 332 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 332 (350)
- |..++.++.+|+...|+.|-.+|
T Consensus 260 --f-----------P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 --F-----------PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --C-----------CcccCHHHHHHHHHHHhhhhHhh
Confidence 0 12455678999999999999888
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=328.13 Aligned_cols=266 Identities=19% Similarity=0.253 Sum_probs=203.6
Q ss_pred cCcccccccccCCCceEEEEEEECC-----------------CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccc
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD-----------------RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILK 121 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~-----------------~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 121 (350)
++|...+.| |+|+||.||++.+++ +..||+|.+.... ......+.+|+.++.+++||||++
T Consensus 5 ~~~~~~~~l-g~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKL-GEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEe-cccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 567778888 999999999998632 2269999987643 334567899999999999999999
Q ss_pred eeeeeecCCcCeEEeecCCCCchhhhhhCCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeE
Q 018816 122 LIGCCLEAEMPALVYEPAGYCTLADRLYGPLQ--------------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVV 187 (350)
Q Consensus 122 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 187 (350)
+++++.+.+..++||||+++++|.+++..... .....+++.....++.||+.||.||| +.+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence 99999999999999999999999998854211 01134788899999999999999999 99999
Q ss_pred eeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh--CCC
Q 018816 188 FRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT--GRT 265 (350)
Q Consensus 188 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~ 265 (350)
|+||||+|||++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999976644333222333446789999999988899999999999999999987 455
Q ss_pred CCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 266 IGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
||..... ..................... .. ..++..+.+|+.+||+.||++|||+.+|.+.|++
T Consensus 241 p~~~~~~------~~~~~~~~~~~~~~~~~~~~~----~~-----~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD------EQVIENAGEFFRDQGRQVYLF----RP-----PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH------HHHHHHHHHHhhhcccccccc----CC-----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6653321 111222222222111111000 00 1345678999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=364.65 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=215.2
Q ss_pred CcccccccccCCCceEEEEEEE--CCCc----eEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL--RDRG----PILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~--~~~~----~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
+......| |+|+||.||.|.. .++. .||+|.+.... .....+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 693 ~v~l~~~l-G~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVL-GKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeee-ccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 33445667 9999999999998 2332 39999997764 456778999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQT--HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
|++|||++|+|..+|++.... ....++..+.+.++.|||+|+.||+ .+++|||||..+|+||+....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999875221 1257999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
|+.+.............-+..|||||.+..+.||.++|||||||++||++| |..||...+. ..+...+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n----------~~v~~~~~ 918 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN----------FEVLLDVL 918 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----------HHHHHHHH
Confidence 996655544433333235678999999999999999999999999999999 8888875432 12222222
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.++ .+++ +..+++.+.+++.+||+.+|++||++..|++++..+...
T Consensus 919 ~gg--RL~~----------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 919 EGG--RLDP----------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred hCC--ccCC----------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 222 1221 137788999999999999999999999999999988654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=331.35 Aligned_cols=247 Identities=20% Similarity=0.248 Sum_probs=207.7
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.|+....| |+|.||.||+|.+ ..++.||+|.+.-.. ....+++.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 14 ~~~~~~~I-grGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELI-GRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhc-cccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45555667 9999999999999 667788999986553 35567899999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
|.||++.+.+... ..+.+..+.-++++++.||.||| ..+.+|||||+.|||+..+|.+||+|||.+......
T Consensus 93 ~~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred hcCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999998654 34578888889999999999999 999999999999999999999999999999877554
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ...+.+||+.|||||++....|+.++||||||++.+||++|.+|+...++.. ... .+ .....
T Consensus 165 ~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---vlf-------lI----pk~~P 228 (467)
T KOG0201|consen 165 VK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---VLF-------LI----PKSAP 228 (467)
T ss_pred hh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---EEE-------ec----cCCCC
Confidence 33 2367779999999999998899999999999999999999999998766521 000 11 11122
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
|.+.+ .+++.+.+|+..||..||+.||||.++++
T Consensus 229 P~L~~--------~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDG--------DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred Ccccc--------ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22322 45567999999999999999999999987
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=339.74 Aligned_cols=241 Identities=20% Similarity=0.266 Sum_probs=204.2
Q ss_pred ccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 63 SMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 63 ~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
+..+.| |+|+.|-||+|++.+. .||||+++.-. ..+|+-|++|+||||+.+.|+|.....+|||||||+.|
T Consensus 127 sELeWl-GSGaQGAVF~Grl~ne-tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWL-GSGAQGAVFLGRLHNE-TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhh-ccCcccceeeeeccCc-eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 455778 9999999999999887 99999986432 24789999999999999999999999999999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
-|...|... .+++......|..+||.|+.||| .+.|||||||.-||||+.+..|||+|||-++......
T Consensus 198 qL~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--- 266 (904)
T KOG4721|consen 198 QLYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--- 266 (904)
T ss_pred cHHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh---
Confidence 999999765 57889999999999999999999 9999999999999999999999999999998765543
Q ss_pred cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcccc
Q 018816 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIV 302 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
.....+||..|||||++.+.+.+.|+|||||||+||||+||..||.+.... .++--.-.
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---------------------AIIwGVGs 325 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---------------------AIIWGVGS 325 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---------------------eeEEeccC
Confidence 244566999999999999999999999999999999999999998754321 01100001
Q ss_pred CCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 303 GDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 303 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
.......+..+++-+.-|+.+||+..|..||++.+++..|.=
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 111112234778899999999999999999999999998863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=334.22 Aligned_cols=262 Identities=19% Similarity=0.253 Sum_probs=205.0
Q ss_pred hcCcccccccccCCCceEEEEEEE------CCCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 130 (350)
.++|...+.| |+|+||.||+|++ ..+..||+|.+.... ....+.+.+|+.++..+ +||||++++++|.+.+
T Consensus 34 ~~~~~~~~~L-G~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTL-GAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhhee-cCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 3468888888 9999999999974 334589999986543 23456788999999999 8999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCC--------------------------------------------------------
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQT-------------------------------------------------------- 154 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~-------------------------------------------------------- 154 (350)
..++||||+++|+|.+++......
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 999999999999999998643210
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCc
Q 018816 155 --------------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220 (350)
Q Consensus 155 --------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 220 (350)
....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 0124788899999999999999999 99999999999999999999999999999976644332
Q ss_pred cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
........++..|+|||++.+..++.++|||||||++|||++ |..||..... .....+.+..+.... .+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---------~~~~~~~~~~~~~~~-~~ 339 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---------DSKFYKMIKEGYRML-SP 339 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---------hHHHHHHHHhCccCC-CC
Confidence 222222335678999999999999999999999999999998 8888764321 111122222221111 11
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus 340 -----------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 -----------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 02245789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=320.24 Aligned_cols=264 Identities=18% Similarity=0.248 Sum_probs=211.0
Q ss_pred cCcccccccccCCCceEEEEEEEC------CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++|...+.| |+|+||.||++... ++..+|+|.+..........+.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~l-g~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKREL-GEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeecccc-CCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 567788888 99999999999852 23468889887665556678999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCcee
Q 018816 134 LVYEPAGYCTLADRLYGPLQ--------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 205 (350)
+||||+++++|.+++..... .....+++..++.++.|++.||.||| +.+++||||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence 99999999999999864311 11235899999999999999999999 99999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHH
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 284 (350)
|+|||.+................+++.|+|||++.+..++.++|+|||||++|+|++ |.+||..... ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----------~~ 230 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----------NE 230 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------HH
Confidence 999999876543332222223335778999999998889999999999999999998 8888764321 11
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
....+..+...... ...+..+.+|+.+||+.||.+|||+.+|++.|+++...+
T Consensus 231 ~~~~i~~~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 231 VIECITQGRVLQRP------------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HHHHHHcCCcCCCC------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 11222222111110 023457899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=321.31 Aligned_cols=250 Identities=16% Similarity=0.189 Sum_probs=200.0
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
|...+.| |+|+||.||++.. .++..||+|.+..... .....+.+|+.++++++|+||+.+++++.+++..++|||
T Consensus 2 f~~~~~l-g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVL-GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEE-ecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 6667778 9999999999998 6777999999865422 223457799999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999999988754321 36889999999999999999999 99999999999999999999999999999876543
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ................ .
T Consensus 155 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~-~ 224 (285)
T cd05631 155 GET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER------VKREEVDRRVKEDQEE-Y 224 (285)
T ss_pred CCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc------hhHHHHHHHhhccccc-C
Confidence 221 22345899999999999999999999999999999999999999754321 1111111111111100 0
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 340 (350)
. ...+..+.+|+.+||+.||++||+ +.++++
T Consensus 225 ~------------~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 S------------EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred C------------ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0 134567889999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=316.38 Aligned_cols=256 Identities=16% Similarity=0.197 Sum_probs=204.1
Q ss_pred hcCcccccccccCCCceEEEEEEEC----CCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR----DRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~----~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.++|...+.| |+|+||.||+|.++ .+..||+|.+..... .....+.+|+.++.+++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~i-g~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERIL-GTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeee-cccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 3567888888 99999999999872 345889999876532 33467889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.++++|||.+.
T Consensus 83 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999986532 46899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
....... .......++..|+|||++.+..++.++|||||||++||+++ |..||..... . .....+...
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---------~-~~~~~~~~~ 224 (266)
T cd05064 156 EDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---------Q-DVIKAVEDG 224 (266)
T ss_pred cccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---------H-HHHHHHHCC
Confidence 5422211 11112235678999999999999999999999999999875 9999864321 1 111122211
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
..... +..++..+.+++.+||+.+|++|||+.+|++.|.++
T Consensus 225 ~~~~~------------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 FRLPA------------PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCC------------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11100 014456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=318.36 Aligned_cols=260 Identities=20% Similarity=0.285 Sum_probs=207.4
Q ss_pred cCcccccccccCCCceEEEEEEECCC------ceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDR------GPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~------~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
++|...+.| |+|+||.||+|..... ..|++|.+.... ......+.+|+.++.+++||||+++++++.+....
T Consensus 5 ~~~~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEEL-GEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcc-cCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 466777888 9999999999998332 478999886543 23456788999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTH-----------LEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 201 (350)
+++|||+++++|.+++....... ...+++..++.++.|++.||.||| +.+++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence 99999999999999986532111 145788999999999999999999 9999999999999999999
Q ss_pred CceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcch
Q 018816 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFF 280 (350)
Q Consensus 202 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~ 280 (350)
+.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-------- 232 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-------- 232 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 9999999999876544332222333446889999999988899999999999999999998 9999874321
Q ss_pred HHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 281 ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
......+........ +..++.++.+|+.+||+.||++||++.+|++.|+.+
T Consensus 233 --~~~~~~i~~~~~~~~------------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 233 --QEVIEMIRSRQLLPC------------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred --HHHHHHHHcCCcCCC------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 112222222211110 124567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=335.40 Aligned_cols=263 Identities=19% Similarity=0.280 Sum_probs=206.0
Q ss_pred hcCcccccccccCCCceEEEEEEE------CCCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 130 (350)
.++|...+.| |+|+||.||+|++ .++..||+|.+.... ....+.+.+|+.+++.+ +|+||++++++|.+.+
T Consensus 37 ~~~~~~~~~L-G~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTL-GAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehhee-cCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3578888888 9999999999985 223479999987543 23456688999999999 8999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCC---------------------------------------------------------
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQ--------------------------------------------------------- 153 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~--------------------------------------------------------- 153 (350)
..++||||+++|+|.+++.....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999998853210
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcccccc
Q 018816 154 --------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225 (350)
Q Consensus 154 --------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 225 (350)
....++++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 00124788899999999999999999 9999999999999999999999999999987654433222222
Q ss_pred ccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
...++..|+|||++.+..++.++|||||||++|+|++ |+.||...... .......... .....+.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---------~~~~~~~~~~-~~~~~~~---- 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---------SKFYKMVKRG-YQMSRPD---- 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---------HHHHHHHHcc-cCccCCC----
Confidence 3335678999999988899999999999999999997 99998743210 1111122111 1111110
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
..+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 339 -------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 -------FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 22467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=327.16 Aligned_cols=253 Identities=19% Similarity=0.155 Sum_probs=203.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|.....| |+|+||.||+|.+ .++..||+|.+..... .....+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~i-g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQV-GQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEE-eecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 467888888 9999999999999 4567999999875422 2345688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 80 MEYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999999999998653 46889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+......
T Consensus 152 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----------~~~~~~i~~~~~~ 216 (333)
T cd05600 152 VT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP----------NETWENLKYWKET 216 (333)
T ss_pred cc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH----------HHHHHHHHhcccc
Confidence 43 22344589999999999988999999999999999999999999874322 0111111111111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...+...... ...+.++.+|+.+||..+|.+||++.++++.
T Consensus 217 ~~~~~~~~~~-----~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 217 LQRPVYDDPR-----FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCCCCCccc-----cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1111111000 1345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.15 Aligned_cols=258 Identities=17% Similarity=0.285 Sum_probs=205.0
Q ss_pred cCcccccccccCCCceEEEEEEEC-CCc----eEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-DRG----PILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-~~~----~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.+|+..+.| |+|+||.||+|++. ++. .||+|.+.... .....++.+|+.+++.++||||++++++|... ..+
T Consensus 7 ~~f~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeee-ecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 568888888 99999999999973 332 38999986543 34456788999999999999999999998765 578
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+++||+++|+|.+++.... ..+++...+.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccc
Confidence 9999999999999987542 45889999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...............++..|+|||++.+..++.++|||||||++|||++ |..||..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----------~~~~~~~~~~ 227 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----------SEISSILEKG 227 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----------HHHHHHHhCC
Confidence 7654333222222334678999999999999999999999999999998 9999864321 1112222221
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
......+ .++..+.+++.+||+.+|++|||+.+++..|.++.+.
T Consensus 228 ~~~~~~~------------~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 228 ERLPQPP------------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCCC------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 1111111 2345688999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=321.44 Aligned_cols=245 Identities=18% Similarity=0.127 Sum_probs=200.4
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTV-GTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeee-ecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 367788888 9999999999999 4677899999865321 2345688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 80 MEYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999999998654 46889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .. ....+......
T Consensus 152 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---------~~-~~~~i~~~~~~ 216 (291)
T cd05612 152 RDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---------FG-IYEKILAGKLE 216 (291)
T ss_pred cCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HH-HHHHHHhCCcC
Confidence 332 1234589999999999988899999999999999999999999874321 11 11111111111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAKK 341 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~~ 341 (350)
+. ...+..+.+|+.+||+.||.+||+ +.++++.
T Consensus 217 -~~------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 -FP------------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CC------------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00 123457889999999999999995 8887753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=316.69 Aligned_cols=264 Identities=17% Similarity=0.234 Sum_probs=210.7
Q ss_pred cCcccccccccCCCceEEEEEEEC------CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.+|...+.| |+|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~l-g~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKREL-GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeee-cccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 456777788 99999999999862 33468888887665555677899999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY 202 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 202 (350)
+||||+++++|.+++..... .....+++..++.++.||+.||.||| +++++|+||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence 99999999999999864321 11135889999999999999999999 99999999999999999999
Q ss_pred ceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchH
Q 018816 203 AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFI 281 (350)
Q Consensus 203 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~ 281 (350)
.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------- 231 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------- 231 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------
Confidence 999999999976644332222333446788999999998899999999999999999998 9999864322
Q ss_pred HHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
................ ...+..+.+++.+||+.+|++|||+.+|++.|+++...+
T Consensus 232 -~~~~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 232 -TEVIECITQGRVLERP------------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred -HHHHHHHhCCCCCCCC------------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 1111222221111100 133467899999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=332.63 Aligned_cols=247 Identities=19% Similarity=0.201 Sum_probs=209.4
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
+-|.....| |.|+.|.|-+|++ .+|+.+|||.+.+... .....+.+|+.+|+-+.|||+++++++|++..++|+|
T Consensus 12 GpwkLgkTL-G~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTL-GKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccc-cCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 345566778 9999999999999 7888899999876522 2345688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
.||+++|.|++++... +++++.++.+++.||+.|+.|+| ..+||||||||+|+|||.++++||+|||+|..-
T Consensus 91 lEyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred EEecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence 9999999999999765 78999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYN-EKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..+.. ..+.||+|.|.|||++.+.+|. .++||||.|||||.|++|+.||++... ..+...+..+.+
T Consensus 163 ~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----------r~LLlKV~~G~f 229 (786)
T KOG0588|consen 163 VPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----------RVLLLKVQRGVF 229 (786)
T ss_pred cCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----------HHHHHHHHcCcc
Confidence 54443 4566799999999999999875 899999999999999999999985431 112222333333
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
... ...+.++.+|+.+||..||+.|.|++||++.
T Consensus 230 ~MP-------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 EMP-------------SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCC-------------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 322 1456788999999999999999999999874
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=315.58 Aligned_cols=259 Identities=18% Similarity=0.290 Sum_probs=206.2
Q ss_pred cCcccccccccCCCceEEEEEEECC------CceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD------RGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~------~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
++|...+.| |+|+||.||+|...+ ...||+|.+...... ..+.+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~l-g~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKREL-GEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhc-cccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 457777788 999999999998733 358999998765433 457899999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 133 ALVYEPAGYCTLADRLYGPL---------QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
++||||+++++|.+++.... ......+++..+..++.|++.|+.||| +.+++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence 99999999999999986431 111245789999999999999999999 999999999999999999999
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 282 (350)
++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---------- 230 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---------- 230 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH----------
Confidence 99999999876543322222223336788999999999999999999999999999998 9999864322
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
......+..+...... ...+..+.+++.+||+.||++|||+.||++.|++
T Consensus 231 ~~~~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 231 EEVIECITQGRLLQRP------------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHHHHcCCcCCCC------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111122211111111 1344678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=311.49 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=205.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.+|...+.| |+|++|.||+|.+ +.+..|++|.+.... .....+.+|+.++++++||||+++++++...+..+++|||
T Consensus 6 ~~~~~~~~i-g~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeec-CCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 457777888 9999999999999 556689999876543 3456788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 84 MTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999865321 46889999999999999999999 999999999999999999999999999998776443
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ............
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----------~~~~~~~~~~~~--- 223 (263)
T cd05052 158 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------SQVYELLEKGYR--- 223 (263)
T ss_pred eee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----------HHHHHHHHCCCC---
Confidence 221 1112224668999999998899999999999999999998 8888763221 111122221111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
+.. +...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 224 -~~~--------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 -MER--------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCC--------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 000 013456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=324.81 Aligned_cols=240 Identities=16% Similarity=0.123 Sum_probs=195.5
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
.| |+|+||.||++.. .++..||+|.+.... ......+.+|+.++.+++||||+++++++.+.+..++||||++++
T Consensus 2 ~l-G~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 2 LL-GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred ee-eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 45 9999999999998 567789999987542 233456778999999999999999999999999999999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 150 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-- 150 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--
Confidence 999988653 56899999999999999999999 99999999999999999999999999999875422211
Q ss_pred cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcccc
Q 018816 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIV 302 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ............. +.
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----------~~~~~~~~~~~~~-~p---- 215 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------EKLFELILMEEIR-FP---- 215 (323)
T ss_pred cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH----------HHHHHHHHcCCCC-CC----
Confidence 22344599999999999988999999999999999999999999874321 1111111111110 00
Q ss_pred CCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 303 GDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 303 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
...+..+.+|+.+||+.||++|| ++.++++
T Consensus 216 --------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 --------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 13456789999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=320.97 Aligned_cols=197 Identities=18% Similarity=0.219 Sum_probs=172.3
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |+|+||.||++.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISEL-GAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEee-cCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 678888888 9999999999999 456677888876542 2345678999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ-PVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|+++++|.+++... ..+++..+..++.|++.||.||| +. +|+|+||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999998654 46889999999999999999999 65 69999999999999999999999999987653
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHL 269 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 269 (350)
... .....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 321 2234589999999999988999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.31 Aligned_cols=253 Identities=17% Similarity=0.156 Sum_probs=203.4
Q ss_pred CcccccccccCCCceEEEEEEE-CC-CceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RD-RGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~-~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.|...+.| |+|++|.||++.. .+ +..||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 68 ~y~~~~~l-g~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLV-GRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEE-EeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 37778888 9999999999998 33 557888877555545556778899999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++|+|.+++....... .++++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 147 ~~gg~L~~~l~~~~~~~-~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEH-LPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCHHHHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999875432111 46889999999999999999999 999999999999999999999999999999876543
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.........+||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........ .+......
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---------~~~~~~~~-~~~~~~~~ 292 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---------REIMQQVL-YGKYDPFP 292 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHH-hCCCCCCC
Confidence 322223445699999999999998999999999999999999999999864321 11111111 11111100
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+..+.+++.+||+.||++||++.+++.
T Consensus 293 ------------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 ------------CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------------ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 133467899999999999999999999875
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=325.84 Aligned_cols=245 Identities=16% Similarity=0.149 Sum_probs=200.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|++ .++..||+|.+..... ...+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 17 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETL-GTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEE-EecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3678888888 9999999999999 5667899999865421 234568899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 96 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred EEcCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 99999999999998653 46889999999999999999999 99999999999999999999999999999986
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+.....
T Consensus 168 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----------~~~~~~i~~~~~ 232 (329)
T PTZ00263 168 VPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----------FRIYEKILAGRL 232 (329)
T ss_pred cCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----------HHHHHHHhcCCc
Confidence 54322 234589999999999998899999999999999999999999874321 011111111111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 340 (350)
. + | ...+..+.+|+.+||+.||.+||+ +.+++.
T Consensus 233 ~-~-p-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 K-F-P-----------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred C-C-C-----------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 0 1 023356889999999999999997 677764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=310.45 Aligned_cols=251 Identities=18% Similarity=0.265 Sum_probs=201.8
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
++|...+.| |+|+||.||++.++++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~l-g~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKEL-GSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEe-cCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 457777788 9999999999999777789999876443 33467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++|+|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 82 ENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 9999999986532 35889999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||..... .... ..+..+.. ...
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---------~~~~-~~i~~~~~-~~~ 222 (256)
T cd05114 155 YT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---------YEVV-EMISRGFR-LYR 222 (256)
T ss_pred ee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---------HHHH-HHHHCCCC-CCC
Confidence 21 1122235678999999988889999999999999999999 8888864321 1111 11111111 111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
+. ..+..+.+++.+||+.+|++|||+.++++.|
T Consensus 223 ~~-----------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PK-----------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CC-----------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11 2235789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=311.38 Aligned_cols=255 Identities=20% Similarity=0.295 Sum_probs=206.2
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
++|...+.| |+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 6 ~~~~~~~~l-g~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKL-GAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeec-CCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 567888888 9999999999999777789999876543 34567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 84 AKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999865322 46888999999999999999999 8999999999999999999999999999998764432
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ......++..|+|||++....++.++|||||||++|+|++ |..||..... ......+......
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----------~~~~~~~~~~~~~--- 223 (261)
T cd05072 158 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----------SDVMSALQRGYRM--- 223 (261)
T ss_pred ee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----------HHHHHHHHcCCCC---
Confidence 21 1122235678999999988889999999999999999998 8998864321 1111112111110
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
+.. ...+..+.+++.+||+.+|++|||++++++.|+++
T Consensus 224 ~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRM---------ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCC---------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 100 13346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=316.72 Aligned_cols=249 Identities=30% Similarity=0.408 Sum_probs=194.7
Q ss_pred ccccccCCCceEEEEEEEC-----CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 65 RNITIDEIEGYILYMGFLR-----DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~~-----~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.+.| |.|.||.||+|.+. .+..|+||.+.... ....+.+.+|+..+++++||||++++|++...+..++||||
T Consensus 4 ~~~i-g~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQI-GEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEE-EEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEE-ccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3456 99999999999996 24489999996543 34478899999999999999999999999988889999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++|+|.+++..... ..+++..+..|+.||+.||.||| +.+++|+||+++||+++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp -TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc---ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999976522 56899999999999999999999 899999999999999999999999999999877433
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
..............|+|||.+....++.++||||||+++||+++ |+.|+..... .... ..+.+......
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---------~~~~-~~~~~~~~~~~ 226 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---------EEII-EKLKQGQRLPI 226 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---------HHHH-HHHHTTEETTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---------cccc-cccccccccee
Confidence 33333334447788999999999999999999999999999999 6788764321 1122 22222221111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
.+ .++..+.+++.+||+.+|++|||+.+|++.|
T Consensus 227 ~~------------~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PD------------NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BT------------TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc------------chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 3456789999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=317.08 Aligned_cols=271 Identities=15% Similarity=0.151 Sum_probs=200.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|...+.| |+|+||.||++++ .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~l-g~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVV-GEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEe-cccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 367888888 9999999999999 456689999986542 233466889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||++++++..+.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 80 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 80 EYVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred ecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999987776554322 46889999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCC------CcchHHHHHHHHHH
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG------SNFFITDRVEKFIR 290 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~ 290 (350)
..... ......|++.|+|||++.+..++.++|+|||||++|||++|++||......... ..............
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 152 EGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 33221 122345899999999999888999999999999999999999999754321000 00000000000001
Q ss_pred hcC-CCccCccccCCCCc--cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 SNG-YMNIDPVIVGDRSC--FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ~~~-~~~~~~~~~~~~~~--~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... .....+........ ......+..+.+|+.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00000110000000 000124567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=299.67 Aligned_cols=253 Identities=18% Similarity=0.204 Sum_probs=215.8
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--------hhHHHHHHHHHHHHhc-CCCCccceeeee
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--------YASERCFNNIVFASQM-NHKSILKLIGCC 126 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 126 (350)
...+.|...+++ |.|..+.|-++.+ .+++.+|+|++..... .-.+.-.+|+.||+++ .||+|+.+.+++
T Consensus 14 ~fy~~y~pkeil-grgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 14 GFYAKYEPKEIL-GRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hHHhhcChHHHh-cccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 345677888888 9999999999988 6777999999865321 1234456899999999 599999999999
Q ss_pred ecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeE
Q 018816 127 LEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206 (350)
Q Consensus 127 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 206 (350)
+.+...++|+|.|+.|.|+|++... -.+++.....|+.|+..|+.||| ..+||||||||+|||++++.++||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEE
Confidence 9999999999999999999999765 57899999999999999999999 999999999999999999999999
Q ss_pred cccCCCccCCCCCccccccccccCCCCCCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcch
Q 018816 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT------GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF 280 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~ 280 (350)
+|||+++.+..+.. ....+|||+|+|||.+.. ..|+...|+||+||++|.|+.|.+||--.
T Consensus 165 sDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---------- 231 (411)
T KOG0599|consen 165 SDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---------- 231 (411)
T ss_pred eccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----------
Confidence 99999999876653 455679999999998853 35889999999999999999999998622
Q ss_pred HHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 281 ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
-+..+...+..+.+..-.|.+ .+.+....+|+.+||+.||.+|.|++|+|+
T Consensus 232 kQmlMLR~ImeGkyqF~speW---------adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 232 KQMLMLRMIMEGKYQFRSPEW---------ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHHHHHhcccccCCcch---------hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 233445566667777777766 366778999999999999999999999987
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=294.51 Aligned_cols=249 Identities=20% Similarity=0.192 Sum_probs=209.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|+..+.| |+|.||.||.|+. ++.--||+|.+.+..- .-..++.+|++|-+.|+||||++++++|.+....||
T Consensus 21 l~dfeigr~L-gkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPL-GKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccc-cCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3578889999 9999999999999 5666889999877532 234678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
++||.+.|++...|+.... ..++......+..|+|.||.|+| .++++||||||+|+|++..+.+|++|||-+..
T Consensus 100 ilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999999985432 56888999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.+. ....+.+||..|++||...+..++...|+|++|++.||++.|.+||..... ...-+-+.+ .
T Consensus 174 ~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~----------~etYkrI~k--~ 237 (281)
T KOG0580|consen 174 APS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH----------SETYKRIRK--V 237 (281)
T ss_pred cCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh----------HHHHHHHHH--c
Confidence 542 235677899999999999999999999999999999999999999985431 111112221 2
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...+| ...+..+.++|.+|+..+|.+|.+..+++..
T Consensus 238 ~~~~p-----------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 DLKFP-----------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccCC-----------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 22222 1455678999999999999999999999863
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=312.14 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=210.4
Q ss_pred HhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
...+|...+.| |.|+||.||+|...++..+++|.+..........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~~y~~~~~i-g~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKL-GSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhh-ccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 44677888888 99999999999997788999999877665556788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||.+.....
T Consensus 83 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 83 LMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred ecccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 9999999999975432 46899999999999999999999 99999999999999999999999999999977643
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... .....++..|+|||++.+..++.++|+||||+++|+|++ |..||..... ..... ........
T Consensus 157 ~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---------~~~~~-~~~~~~~~- 223 (261)
T cd05148 157 DVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---------HEVYD-QITAGYRM- 223 (261)
T ss_pred cccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---------HHHHH-HHHhCCcC-
Confidence 3221 123336778999999988899999999999999999998 8888864321 11111 11111110
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
..+ ..+++.+.+++.+||+.||++|||+.++++.|+.+
T Consensus 224 ~~~-----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCP-----------AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCC-----------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 000 13456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=309.56 Aligned_cols=257 Identities=17% Similarity=0.236 Sum_probs=206.6
Q ss_pred hcCcccccccccCCCceEEEEEEECC----CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRD----RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~----~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.++|+..+.| |+|+||.||+|.+.. ...||+|.+.... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 3 ~~~~~~~~~l-g~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVI-GGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEe-cCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 3578888888 999999999999832 3478999886543 234567889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.
T Consensus 82 iv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 82 IITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 9999999999999986532 46899999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----------~~~~~~~~~~ 224 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----------QDVIKAVEDG 224 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----------HHHHHHHHcC
Confidence 7752222212222335678999999998899999999999999999998 9988754321 1111222211
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
... +.. ...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 225 ~~~---~~~---------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRL---PPP---------MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCC---CCC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 100 13346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=314.78 Aligned_cols=246 Identities=22% Similarity=0.237 Sum_probs=210.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
..|...+.| |+|.||.|-++.. ..++.||||.+.++.. ++.-.+.+|++||+.|+||||+.++.+|++.+.+.||
T Consensus 53 HRyE~~etL-GkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 53 HRYEITETL-GKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hHHHHHHHh-cCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 467777788 9999999999998 7888999999987643 3344578999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||..+|.|++++... +.+++.++.++++||++|+.|+| .++++|||||.+|||+|.|+++||+|||++..+
T Consensus 132 MEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999775 68999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCccccccccccCCCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYN-EKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..... ..+.+|++.|.+||.+.+.+|. +..|.|||||+||.|+.|..||+.... ..+...+.++.+
T Consensus 204 ~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----------k~lvrQIs~GaY 270 (668)
T KOG0611|consen 204 ADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----------KRLVRQISRGAY 270 (668)
T ss_pred ccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----------HHHHHHhhcccc
Confidence 65554 4567899999999999998875 889999999999999999999985432 223333443332
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.. | ..+....-||++||..||++|.|+.+|...
T Consensus 271 rE--P------------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 271 RE--P------------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cC--C------------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11 1 223456789999999999999999999764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=311.60 Aligned_cols=259 Identities=18% Similarity=0.262 Sum_probs=203.1
Q ss_pred cCcccccccccCCCceEEEEEEEC-CCc----eEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-DRG----PILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-~~~----~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++|...+.| |+|+||.||+|.+. ++. .|++|.+.... .....++..|+..+++++||||+++++++. +...+
T Consensus 7 ~~~~~~~~l-g~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLL-GSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceecccc-CccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 356667788 99999999999983 333 37777775432 233456778888999999999999999875 45678
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+++||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||.++
T Consensus 85 ~i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 9999999999999996532 46899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...............++..|+|||++.++.++.++|||||||++||+++ |..||..... ......+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----------~~~~~~~~~~ 227 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----------HEVPDLLEKG 227 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----------HHHHHHHHCC
Confidence 6644332222233446788999999998899999999999999999998 9999864321 1122223222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
... ..+. .++..+.+++.+||..+|++|||+.++++.|..+.+.+
T Consensus 228 ~~~-~~~~-----------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 228 ERL-AQPQ-----------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CcC-CCCC-----------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 211 1111 22346788999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=308.73 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=206.3
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...+.| |+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~l-g~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKL-GAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEe-cccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4568888888 9999999999999777789999986543 3356788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++..... ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 83 MKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ccCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999865421 46899999999999999999999 999999999999999999999999999999876532
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.... ......+..|+|||++.+..++.++|+||||+++|+|++ |+.||..... ......+........
T Consensus 157 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----------~~~~~~~~~~~~~~~ 225 (261)
T cd05068 157 IYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----------AEVLQQVDQGYRMPC 225 (261)
T ss_pred cccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----------HHHHHHHHcCCCCCC
Confidence 2111 111123457999999998899999999999999999999 8988864321 111122221111000
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
. ...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~------------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 226 P------------PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred C------------CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 13446789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=321.01 Aligned_cols=239 Identities=21% Similarity=0.156 Sum_probs=193.4
Q ss_pred ccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 69 IDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 69 ig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
||+|+||.||++.. .++..||+|.+.... ......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 49999999999999 556689999986532 23445678899999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 224 (350)
.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||+++....... ..
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~ 150 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KT 150 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cc
Confidence 9998653 46899999999999999999999 99999999999999999999999999999875432221 22
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... .... +.
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---------~~~~~~~~~-~~~~-~~------ 213 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---------NEMYRKILQ-EPLR-FP------ 213 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---------HHHHHHHHc-CCCC-CC------
Confidence 344589999999999998999999999999999999999999874321 111111111 1110 00
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPT---MIDVAK 340 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~evl~ 340 (350)
...+..+.+++.+||+.||++||+ +.+++.
T Consensus 214 ------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 ------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 134467899999999999999985 566654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=330.77 Aligned_cols=264 Identities=18% Similarity=0.274 Sum_probs=207.0
Q ss_pred hcCcccccccccCCCceEEEEEEECC------CceEEEEEecccch-hhHHHHHHHHHHHHhcC-CCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRD------RGPILVMKYRKSVR-YASERCFNNIVFASQMN-HKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~------~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 130 (350)
.+.|...+.| |+|+||.||+|++.. ...||+|++..... ...+.+.+|+.++.++. ||||++++++|.+..
T Consensus 36 ~~~~~~~~~L-G~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRIL-GSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhhee-cCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4577778888 999999999998721 23699999865432 34567899999999996 999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCC--------------------------------------------------------
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQT-------------------------------------------------------- 154 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~-------------------------------------------------------- 154 (350)
..++||||+++|+|.+++......
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999988643110
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC
Q 018816 155 -----------------------------------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ 199 (350)
Q Consensus 155 -----------------------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~ 199 (350)
....+++..+..++.||+.||.||| +.+|+|+||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence 0124788889999999999999999 99999999999999999
Q ss_pred CCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCc
Q 018816 200 EEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSN 278 (350)
Q Consensus 200 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~ 278 (350)
.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~------ 345 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV------ 345 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch------
Confidence 999999999999876544332222333346788999999998899999999999999999997 8888764321
Q ss_pred chHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 279 FFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
................ +...+..+.+++.+||+.+|++|||+.+|.+.|+++.+
T Consensus 346 ---~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 346 ---DSTFYNKIKSGYRMAK------------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---hHHHHHHHhcCCCCCC------------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0111111111111100 01445679999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=306.81 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=196.6
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
.| |+|+||.||+|++ .+++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 2 ~l-g~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RI-GRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred cc-CcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 45 9999999999999 567789999876443 34456789999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 224 (350)
.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||.+............
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99986432 45889999999999999999999 999999999999999999999999999998765432211111
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVG 303 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (350)
.....+..|+|||.+.++.++.++|+||||+++|+|++ |..||..... ...............
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----------~~~~~~~~~~~~~~~------ 217 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----------QQTREAIEQGVRLPC------ 217 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----------HHHHHHHHcCCCCCC------
Confidence 11123457999999998899999999999999999998 8888753221 111122211111110
Q ss_pred CCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 304 DRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 304 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 218 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 218 ------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 01335678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=338.15 Aligned_cols=260 Identities=18% Similarity=0.169 Sum_probs=210.5
Q ss_pred hcCcccccccccCCCceEEEEEEECCC-ceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeee-eec------C
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDR-GPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGC-CLE------A 129 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~-~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~------~ 129 (350)
..+..+.++| .+|||+.||++.+..+ ..+|+|++...+....+.+.+||.+|++|+ |+|||.+++. ... .
T Consensus 36 ~~~v~V~~vL-AEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVL-AEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEE-ccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3566778888 9999999999999444 899999998877788889999999999997 9999999993 221 1
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
-+.+|+||||.||+|-|++..... ..|++.++++|+.++++|+.+||.. ..+|||||||.+||||+.++..|||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 367899999999999999976554 4599999999999999999999965 567999999999999999999999999
Q ss_pred CCCccCCCCCc-ccc------ccccccCCCCCCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcc
Q 018816 210 SLSKSIPEGKT-HIK------ASTAIGSLEFAAPEYL---TTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF 279 (350)
Q Consensus 210 g~~~~~~~~~~-~~~------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~ 279 (350)
|.+........ ... .-...-|+.|.|||++ .+...+.|+|||||||+||-|+....||+.....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------ 264 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------ 264 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence 99864432221 100 1122368999999976 4567899999999999999999999999865321
Q ss_pred hHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 280 FITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.+ +.+.+........+..+.+||..||+.||++||++-+|+..+.+|...
T Consensus 265 ---------------aI----lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 ---------------AI----LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---------------eE----EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 11 112222112136788999999999999999999999999999988654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=310.01 Aligned_cols=268 Identities=16% Similarity=0.190 Sum_probs=207.5
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEec--ccchhhHHHHHHHHHHHHhcCCCCccceeeeeec-----
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYR--KSVRYASERCFNNIVFASQMNHKSILKLIGCCLE----- 128 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 128 (350)
.....|...+.| |+|+||.|..+.+ .++..||||++. -......++..+|+++|+.++|+||+.+++.+..
T Consensus 19 ~i~~~y~~~~~i-G~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPI-GRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccc-cCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344556656677 9999999999999 677899999997 3445667889999999999999999999998865
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
-+..|+|+|+| ..+|...+... ..++......++.|++.||.|+| +.+++||||||.|+|++.+..+||+|
T Consensus 98 f~DvYiV~elM-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecc
Confidence 34789999999 57899988764 45999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccC---------CCCc
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT---------GGSN 278 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~~~ 278 (350)
||+|+...........+..+.|..|.|||.+.. ..|+.+.||||+|||+.||++|++.|.+..... +...
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 999998754322222455668999999998865 469999999999999999999999998654320 0000
Q ss_pred ch-----HHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 279 FF-----ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 279 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. ....+++.+.+.....- ..+....+ ...+...+|+.+||..||.+|+|++|.++
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~-----~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPK-----QPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCC-----CCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 11123333333221100 00111111 34467889999999999999999999886
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.26 Aligned_cols=263 Identities=23% Similarity=0.312 Sum_probs=206.3
Q ss_pred CcccccccccCCCceEEEEEEEC------CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 61 NYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
+|...+.| |+|+||.||+|+.. ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~l-g~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTL-GEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred Cccccccc-cCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 35667778 99999999999872 22367777776543 233467889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccC
Q 018816 134 LVYEPAGYCTLADRLYGPLQ-------------------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPW 194 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 194 (350)
+++||+++++|.+++..... .....+++..++.++.|++.||.||| +.+++|+||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhh
Confidence 99999999999998864211 01135889999999999999999999 999999999999
Q ss_pred ceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCccc
Q 018816 195 NILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLA 273 (350)
Q Consensus 195 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~ 273 (350)
||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++++|++ |..||....+
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~- 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP- 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 99999999999999999876543332222233335778999999988889999999999999999998 9988864321
Q ss_pred CCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 274 TGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
..+............ + ...+..+.+++.+||+.+|++||++.++++.|+++...+
T Consensus 236 ---------~~~~~~~~~~~~~~~-~-----------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~~ 290 (290)
T cd05045 236 ---------ERLFNLLKTGYRMER-P-----------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290 (290)
T ss_pred ---------HHHHHHHhCCCCCCC-C-----------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhcC
Confidence 122222222111100 0 134467899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=336.28 Aligned_cols=262 Identities=19% Similarity=0.176 Sum_probs=208.1
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecC
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEA 129 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 129 (350)
.+.....++|...+.| |+|+||+||++.. .++..||+|.+... .......+.+|+.++..++|+||+++.+.+...
T Consensus 25 ~~~~~~~~rY~i~~~L-G~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 25 ATAKEQAKKYWISRVL-GSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred ccccccCCCEEEEEEE-ecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 4455566899999998 9999999999998 66779999998654 234456788999999999999999998876543
Q ss_pred C--------cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC
Q 018816 130 E--------MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201 (350)
Q Consensus 130 ~--------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 201 (350)
. ..++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.+
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSN 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCC
Confidence 2 367999999999999998653221 246899999999999999999999 9999999999999999999
Q ss_pred CceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchH
Q 018816 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFI 281 (350)
Q Consensus 202 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~ 281 (350)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------- 250 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--------- 250 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---------
Confidence 99999999999876543322233455699999999999999999999999999999999999999874321
Q ss_pred HHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...+.... ......+. ...++.+.+++.+||+.||++||++.+++..
T Consensus 251 ~~~~~~~~-~~~~~~~~------------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 EEVMHKTL-AGRYDPLP------------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHh-cCCCCCCC------------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111111 11111111 1345679999999999999999999999863
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=326.26 Aligned_cols=251 Identities=21% Similarity=0.215 Sum_probs=211.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc-CeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEM-PALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv 135 (350)
++|...+.+ |+|+||.+++.++ .+...+++|++.-.. ....+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 4 ~~Ye~~~~i-G~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQV-GRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhc-CccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 456677778 9999999999999 566699999986543 3445568899999999999999999999999888 9999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|+||+||++.+.+..... ..+++..+..|+.|++.|+.||| .++|+|||||+.||+++.++.|+|+|||+|+..
T Consensus 83 m~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred EeecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence 999999999999976542 56899999999999999999999 999999999999999999999999999999998
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.+... ...+.+||+.|++||.+.+.+|+.++|||||||++|||++-+++|..... ...+.+... .
T Consensus 157 ~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---------~~Li~ki~~----~ 221 (426)
T KOG0589|consen 157 NPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---------SELILKINR----G 221 (426)
T ss_pred CCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---------HHHHHHHhh----c
Confidence 76542 34566799999999999999999999999999999999999999985432 111222211 1
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
..+|.. ...+.++..++..||+.+|+.||++.+++..
T Consensus 222 ~~~Plp---------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLP---------SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCC---------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122221 2556789999999999999999999999975
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=320.01 Aligned_cols=240 Identities=17% Similarity=0.123 Sum_probs=194.5
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
.| |+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 2 ~l-G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 2 LL-GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred ee-eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 45 9999999999998 567799999987642 233456778999999999999999999999999999999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
+|..++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 150 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-- 150 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--
Confidence 999888653 46899999999999999999999 99999999999999999999999999999875322211
Q ss_pred cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcccc
Q 018816 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIV 302 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... .. ........... +.
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---------~~-~~~~~~~~~~~-~p---- 215 (323)
T cd05595 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------ER-LFELILMEEIR-FP---- 215 (323)
T ss_pred ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---------HH-HHHHHhcCCCC-CC----
Confidence 12334589999999999988999999999999999999999999874321 01 11111111110 00
Q ss_pred CCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 303 GDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 303 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
...++.+.+++.+||+.||++|| ++.++++
T Consensus 216 --------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 --------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 13446788999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=311.35 Aligned_cols=261 Identities=18% Similarity=0.301 Sum_probs=204.5
Q ss_pred HhcCcccccccccCCCceEEEEEEEC------CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
.+++|+..+.| |+|+||.||+|.+. .+..||+|++.... .....++.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~i-g~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSREL-GQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeee-ccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 46788999998 99999999999863 23479999886432 234456889999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCcee
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQT-----HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 205 (350)
..++||||+++++|.+++...... ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence 999999999999999998642110 0134678889999999999999999 89999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHH
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 284 (350)
|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----------~~ 229 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----------EQ 229 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----------HH
Confidence 999999876544333222223346788999999998889999999999999999999 6788764321 11
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
.............. ...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 230 ~~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 230 VLRFVMEGGLLDKP------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHHHcCCcCCCC------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11122221111110 1334678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=322.68 Aligned_cols=245 Identities=18% Similarity=0.171 Sum_probs=200.0
Q ss_pred hcCcccccccccCCCceEEEEEEECC--CceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRD--RGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~--~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.++|.....| |+|+||.||+|.+.+ +..||+|.+.... ....+.+.+|+.++..++||||+++++++.+.+..+
T Consensus 29 ~~~y~~~~~i-g~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTL-GTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEE-eecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4578888888 999999999998733 3579999986542 233456889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 108 lv~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 999999999999998654 46889999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..||..... . .....+....
T Consensus 180 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~----~~~~~i~~~~ 244 (340)
T PTZ00426 180 VVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------L----LIYQKILEGI 244 (340)
T ss_pred ecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------H----HHHHHHhcCC
Confidence 65432 2234589999999999988899999999999999999999999975322 0 1111111111
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
. .+.+ ..+..+.+++.+||+.||++|+ +++++++
T Consensus 245 ~-~~p~------------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 I-YFPK------------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred C-CCCC------------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1 1111 2345688999999999999995 8888876
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=307.27 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=198.7
Q ss_pred ccccccccCCCceEEEEEEECCCc---eEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecC------Cc
Q 018816 63 SMRNITIDEIEGYILYMGFLRDRG---PILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEA------EM 131 (350)
Q Consensus 63 ~~~~~lig~G~~g~V~~~~~~~~~---~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 131 (350)
.....| |+|+||.||+|.+.++. .||+|.+... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~i~~~i-g~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTL-GEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred cccccc-CcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 345667 99999999999984433 5888887543 234456788999999999999999999987532 25
Q ss_pred CeEEeecCCCCchhhhhhCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 132 PALVYEPAGYCTLADRLYGPL-QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
.+++|||+++|+|.+++.... ......+++.....++.|++.||.||| +++|+||||||+|||++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999998874321 112245889999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
++................+++.|+|||+..+..++.++||||||+++|||++ |..||..... ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----------~~~~~~~ 227 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----------SEIYDYL 227 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----------HHHHHHH
Confidence 9987654332222223336778999999998889999999999999999999 7888764221 1122222
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
..+...... ...+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 228 ~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 RQGNRLKQP------------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCCCCC------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222111111 13345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=314.56 Aligned_cols=264 Identities=15% Similarity=0.156 Sum_probs=197.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |.|+||.||+|.. .++..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKL-GEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEE-ecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 568888888 9999999999998 5667899998864432 234567799999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|++ ++|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 997 48988885432 35789999999999999999999 99999999999999999999999999999876533
Q ss_pred CCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC---
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG--- 293 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 293 (350)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...... ..............
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 156 PTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK------EELHLIFRLLGTPTEET 227 (288)
T ss_pred CCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCChHH
Confidence 221 1223357999999998875 46899999999999999999999998754321 11111111100000
Q ss_pred ----------CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 ----------YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....+..............+.++.+|+.+||+.||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00001110000000000023457889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=321.72 Aligned_cols=264 Identities=18% Similarity=0.314 Sum_probs=205.6
Q ss_pred cCcccccccccCCCceEEEEEEEC------CCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecC-C
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEA-E 130 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~ 130 (350)
++|...+.| |+|+||.||+|... .++.||+|++.... ....+.+.+|+.++.++ +|+||++++++|... .
T Consensus 7 ~~~~i~~~l-G~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPL-GRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhccc-ccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 467788888 99999999999752 23579999986542 23345678899999999 799999999988654 5
Q ss_pred cCeEEeecCCCCchhhhhhCCCCC--------------------------------------------------------
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQT-------------------------------------------------------- 154 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~-------------------------------------------------------- 154 (350)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999988542110
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCC
Q 018816 155 HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFA 234 (350)
Q Consensus 155 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 234 (350)
....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0126889999999999999999999 9999999999999999999999999999998764433222233444678899
Q ss_pred CccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHH
Q 018816 235 APEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEK 313 (350)
Q Consensus 235 aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (350)
|||++.+..++.++|||||||++|||++ |..||..... ................ + ...
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~~~~~-~-----------~~~ 301 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---------DEEFCRRLKEGTRMRA-P-----------EYA 301 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc---------cHHHHHHHhccCCCCC-C-----------ccC
Confidence 9999999999999999999999999998 9999864221 0111122222111111 0 133
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 314 LQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 314 ~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
+.++.+++.+||+.+|++||++.+|++.|+++.+.
T Consensus 302 ~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 302 TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 46789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.16 Aligned_cols=252 Identities=15% Similarity=0.265 Sum_probs=202.1
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
++|.....| |+|++|.||+|...++..+|+|.+.... ...+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~l-g~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKEL-GTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEe-cCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 456677778 9999999999998777689999886543 33467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++.... ..+++..++.++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||.++......
T Consensus 82 ~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 82 SNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 9999999986532 36889999999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... .....++..|+|||++.+..++.++|||||||++|+|++ |..||..... .. ............ .
T Consensus 155 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---------~~-~~~~~~~~~~~~-~ 222 (256)
T cd05113 155 YTS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---------SE-TVEKVSQGLRLY-R 222 (256)
T ss_pred eee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---------HH-HHHHHhcCCCCC-C
Confidence 211 112225678999999988889999999999999999998 8988764321 11 111222111110 0
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
+ ...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 223 ~-----------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 P-----------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C-----------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1 023467899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=307.20 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=208.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS---VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+|+. .++..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 2 ~~~~i~~~l-~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKI-GRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeee-ccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 578888888 9999999999998 56779999987542 223445688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
+||+++++|.+++...... ...++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999999999888532111 145788999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .... ....+......
T Consensus 157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-------~~~~-~~~~~~~~~~~ 226 (267)
T cd08228 157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLFS-LCQKIEQCDYP 226 (267)
T ss_pred cchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-------cHHH-HHHHHhcCCCC
Confidence 43321 12233488899999999888899999999999999999999999864321 1111 11112111111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
+. .....+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 227 ---~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 ---PL--------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---CC--------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 10 11245577999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=319.27 Aligned_cols=241 Identities=15% Similarity=0.119 Sum_probs=195.4
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
.| |+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 2 ~l-G~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 2 LL-GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred ee-eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 45 9999999999998 567799999987542 233456789999999999999999999999999999999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 150 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-- 150 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--
Confidence 999888653 46899999999999999999999 99999999999999999999999999999875432211
Q ss_pred cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcccc
Q 018816 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIV 302 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .. ....+..... .+.
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---------~~-~~~~~~~~~~-~~p---- 215 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------EK-LFELILMEDI-KFP---- 215 (328)
T ss_pred ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---------HH-HHHHhccCCc-cCC----
Confidence 12334589999999999988999999999999999999999999874321 01 1111111110 000
Q ss_pred CCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 018816 303 GDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAKK 341 (350)
Q Consensus 303 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 341 (350)
...+..+.+|+.+||+.||++|| ++.++++.
T Consensus 216 --------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 --------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 13346788999999999999997 89988763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.13 Aligned_cols=198 Identities=17% Similarity=0.214 Sum_probs=171.4
Q ss_pred hcCcccccccccCCCceEEEEEEEC-CCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|+..+.| |+|+||.||++.+. ++..+|+|.+... .....+.+.+|+.++++++||||++++++|.+++..++||
T Consensus 4 ~~~y~~~~~l-g~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISEL-GAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccc-cCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3678888888 99999999999994 5557777776543 2234567889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ-PVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
||+++++|.+++... ..+++.....++.+++.||.||| +. +++|+||||+|||++.++.+||+|||++...
T Consensus 83 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 83 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999998653 46888999999999999999999 64 7999999999999999999999999998755
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHL 269 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 269 (350)
.... .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 155 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3221 2234589999999999988899999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=325.25 Aligned_cols=252 Identities=16% Similarity=0.128 Sum_probs=199.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+++. .++..||+|.+.... ......+.+|+.++..++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVI-GRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEE-EecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 468888888 9999999999999 567789999987542 23345677899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++...
T Consensus 80 ~E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 80 MEYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred ECCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999998653 46899999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCccc------------------------------------cccccccCCCCCCccccccCCCCccchhHHHHHHHHH
Q 018816 216 PEGKTHI------------------------------------KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLV 259 (350)
Q Consensus 216 ~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 259 (350)
....... .....+||+.|+|||++.+..++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 3211000 0112358999999999998899999999999999999
Q ss_pred HHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC---HH
Q 018816 260 LLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT---MI 336 (350)
Q Consensus 260 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~ 336 (350)
|++|..||..... ......... .......+. . ...++.+.+|+.+|+. +|.+|++ +.
T Consensus 232 l~~G~~Pf~~~~~---------~~~~~~i~~-~~~~~~~~~---~------~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 232 MLVGYPPFCSDNP---------QETYRKIIN-WKETLQFPD---E------VPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred hhcCCCCCCCCCH---------HHHHHHHHc-CCCccCCCC---C------CCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 9999999975432 111111111 111110010 0 0234578899999997 8999998 88
Q ss_pred HHHH
Q 018816 337 DVAK 340 (350)
Q Consensus 337 evl~ 340 (350)
+++.
T Consensus 292 ~ll~ 295 (364)
T cd05599 292 EIKS 295 (364)
T ss_pred HHhc
Confidence 8876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=308.33 Aligned_cols=259 Identities=17% Similarity=0.259 Sum_probs=204.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCc----eEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRG----PILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~----~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++|...+.| |+|+||+||+|.+ .++. .||+|.+.... ......+.+|+.++..++||||+.+++++.. ...+
T Consensus 7 ~~~~~~~~l-g~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVL-GSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeec-CCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 567777888 9999999999997 3443 37899886543 3445678899999999999999999999875 4578
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+++||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+++|+||||+|||+++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 9999999999999986532 46899999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...............+++.|+|||...+..++.++|||||||++|||++ |..||..... ......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----------~~~~~~~~~~ 227 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----------REIPDLLEKG 227 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----------HHHHHHHHCC
Confidence 7643322211222235678999999988899999999999999999998 8888764321 1112222222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
...... ...+..+.+++.+||+.||+.||++.++++.|+++...+
T Consensus 228 ~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 ERLPQP------------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CcCCCC------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111111 133467899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=341.59 Aligned_cols=274 Identities=17% Similarity=0.238 Sum_probs=223.0
Q ss_pred CCcccccHHHHHHHhcCc---------ccccccccCCCceEEEEEEEC----CCceEEEEEecccc-hhhHHHHHHHHHH
Q 018816 45 NPIRSFSSEDLKTAINNY---------SMRNITIDEIEGYILYMGFLR----DRGPILVMKYRKSV-RYASERCFNNIVF 110 (350)
Q Consensus 45 ~~~~~~~~~~l~~~~~~f---------~~~~~lig~G~~g~V~~~~~~----~~~~vaik~~~~~~-~~~~~~~~~E~~~ 110 (350)
.-+.+++++|--.+...| .++++| |.|.||+|++|+++ ....||||.++... ...+.+|..|+.|
T Consensus 605 ~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VI-GaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsI 683 (996)
T KOG0196|consen 605 TYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVI-GAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASI 683 (996)
T ss_pred eecCCccccCccHHHHHhhhhcChhheEEEEEE-ecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhh
Confidence 334567777654444333 455666 99999999999992 33489999998764 4567789999999
Q ss_pred HHhcCCCCccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeec
Q 018816 111 ASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRN 190 (350)
Q Consensus 111 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 190 (350)
|.+++||||+++-|+.......+||+|||++|+|..+|+... +.+++.+...++++||.|+.||- +.++||||
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLs---dm~YVHRD 756 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRD 756 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHh---hcCchhhh
Confidence 999999999999999999999999999999999999997654 56999999999999999999999 99999999
Q ss_pred cccCceEeCCCCceeEcccCCCccCCCCCccccccccc--cCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCC
Q 018816 191 IEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI--GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIG 267 (350)
Q Consensus 191 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~ 267 (350)
|..+|||++.+..+|++|||+++.+..+.. ...++.. -+.+|.|||.+...+||.+|||||||++|||.++ |..||
T Consensus 757 LAARNILVNsnLvCKVsDFGLSRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 757 LAARNILVNSNLVCKVSDFGLSRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred hhhhheeeccceEEEeccccceeecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 999999999999999999999997754431 1122221 2578999999999999999999999999999887 88886
Q ss_pred CCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 268 HLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
=+... ..+.+.++.+- ..+.+.+++..+.+|+..||+.|-++||++.+|+..|.++.+
T Consensus 836 WdmSN----------QdVIkaIe~gy------------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 836 WDMSN----------QDVIKAIEQGY------------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred cccch----------HHHHHHHHhcc------------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 54321 12233333221 111224889999999999999999999999999999999987
Q ss_pred cC
Q 018816 348 TS 349 (350)
Q Consensus 348 ~~ 349 (350)
.+
T Consensus 894 nP 895 (996)
T KOG0196|consen 894 NP 895 (996)
T ss_pred Cc
Confidence 64
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.63 Aligned_cols=264 Identities=20% Similarity=0.260 Sum_probs=207.8
Q ss_pred HHhcCcccccccccCCCceEEEEEEECC------CceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeec
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFLRD------RGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLE 128 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~~~------~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 128 (350)
...++|+..+.| |+|+||.||++...+ ...+|+|.+.... .....++.+|+.++.++ +|+||+++++++.+
T Consensus 9 ~~~~~~~~~~~i-g~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 9 LPRDRLTLGKPL-GEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred cCHhHeEEeeEe-cccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 345678888888 999999999999732 2478888886532 23345688999999999 79999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceE
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 197 (350)
++..+++|||+++++|.+++..... .....+++..++.++.|++.||.||| +.+|+|+||||+||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence 9999999999999999999864210 12256899999999999999999999 999999999999999
Q ss_pred eCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCC
Q 018816 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGG 276 (350)
Q Consensus 198 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~ 276 (350)
++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---- 240 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---- 240 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----
Confidence 99999999999999987654332222222335678999999988889999999999999999998 8888764321
Q ss_pred CcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
....+........... ...+..+.+|+.+||+.+|++|||+.++++.|+++.
T Consensus 241 ------~~~~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 ------EELFKLLKEGYRMEKP------------QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HHHHHHHHcCCcCCCC------------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1112222221111000 133467889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=329.02 Aligned_cols=243 Identities=18% Similarity=0.188 Sum_probs=203.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 132 (350)
.-++|....+| |+|.||.|+++.. .++..+|||.+.+.. .++.+..+.|-.|+... +||.++.++.+|++.+++
T Consensus 366 ~l~~F~~l~vL-GkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 366 TLDDFRLLAVL-GRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred cccceEEEEEe-ccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34788999999 9999999999999 555688999988764 35567788898888877 599999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+.||++..+++. ..+++..+..++..|+.||.||| +++|||||||.+|||||.+|++||+|||++
T Consensus 445 ~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccc
Confidence 999999999996665543 57999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
+..... ...+.+.+|||.|+|||++.+..|+.++|+|||||++|||+.|..||......
T Consensus 516 Ke~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------------------- 574 (694)
T KOG0694|consen 516 KEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------------------- 574 (694)
T ss_pred cccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------
Confidence 875422 23577889999999999999999999999999999999999999999854321
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 335 (350)
+.+|..+..+... +.-++.+..+++.++|..+|++|.-+
T Consensus 575 --e~FdsI~~d~~~y--P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 --EVFDSIVNDEVRY--PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --HHHHHHhcCCCCC--CCcccHHHHHHHHHHhccCcccccCC
Confidence 1111111111111 12566789999999999999999755
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=323.27 Aligned_cols=262 Identities=16% Similarity=0.126 Sum_probs=197.0
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
++|...+.| |+|+||.||++.+ ..+..||+|... ...+.+|+.++++++||||+++++++......++|+|+
T Consensus 92 ~~y~~~~~l-g~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETF-TPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEE-cCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 579999998 9999999999999 666788998643 23467899999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+. ++|..++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 165 ~~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 165 YK-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred CC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 95 7888887543 46889999999999999999999 999999999999999999999999999998754322
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCc--chHHHH------------
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN--FFITDR------------ 284 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~--~~~~~~------------ 284 (350)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..|+.......+... ..+...
T Consensus 236 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 NA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred cc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 11 112334599999999999988999999999999999999999988764322111100 000000
Q ss_pred ------HHHHH-HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 285 ------VEKFI-RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 285 ------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....+ .........+... .........+.++.+|+.+||+.||++|||+.|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSR--PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCC--CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 0000000000000 000001134668999999999999999999999985
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=323.76 Aligned_cols=266 Identities=21% Similarity=0.284 Sum_probs=220.1
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
++++-...+....+.| |.|.||.||.|.| +-.-.||||.+..+. ...++|..|+.+|+.+.|||+|+++|+|.....
T Consensus 260 DkWEmeRtdItMkhKL-GGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeecc-CCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4455555677788899 9999999999999 555589999987654 557899999999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
+|||+|||..|+|.++|..... ..++.-..+.++.||++|+.||. .+++|||||..+|+|+.++..+|++|||+
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred eEEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999987544 45777888999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
++.+....... .....-++.|.|||-+..+.|+.++|||+|||+|||+.| |-.||..... ..+..+++
T Consensus 412 sRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------SqVY~LLE 480 (1157)
T KOG4278|consen 412 SRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------SQVYGLLE 480 (1157)
T ss_pred hhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------HHHHHHHh
Confidence 99886544322 222224678999999999999999999999999999988 7777764321 12233333
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
++-.. . .++.|++.+.+|+++||+++|++||++.|+-+.|+.|..++
T Consensus 481 kgyRM------~------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 481 KGYRM------D------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred ccccc------c------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 32211 1 12367889999999999999999999999999999997654
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=292.05 Aligned_cols=262 Identities=17% Similarity=0.160 Sum_probs=210.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----c
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE-----M 131 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 131 (350)
..++|.+...| |.|||+-||++.. .+++.+|+|++......+.+..++|++..++++|||++++++++..+. .
T Consensus 19 n~~Ryri~~~L-geGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLL-GEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeee-cCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45688888999 9999999999997 777799999998777778889999999999999999999999976544 5
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEeeccccCceEeCCCCceeEccc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP--VVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
.||+++|...|||.+.+....... ..+++.+.+.|+.+|++||.+|| ... ++||||||+|||++..+.++++||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEec
Confidence 899999999999999986543222 46999999999999999999999 555 999999999999999999999999
Q ss_pred CCCccCCCCCc-------cccccccccCCCCCCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcc
Q 018816 210 SLSKSIPEGKT-------HIKASTAIGSLEFAAPEYLTTG---YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF 279 (350)
Q Consensus 210 g~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~ 279 (350)
|.++...-.-. .+.......|..|.|||.+.-. ..+.++|||||||++|+|+.|..||+..
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~--------- 244 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI--------- 244 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------
Confidence 99876532110 0111223478999999988643 4789999999999999999999998732
Q ss_pred hHHHHHHHHHHhcC---CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 280 FITDRVEKFIRSNG---YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 280 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
+..++ .....+.+.-. +....++.+.+++.+||+.||.+||++.+++..++++.
T Consensus 245 ---------~~~GgSlaLAv~n~q~s~P----~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 245 ---------YQQGGSLALAVQNAQISIP----NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------hhcCCeEEEeeeccccccC----CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11221 22222222211 11246788999999999999999999999999998764
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=305.07 Aligned_cols=251 Identities=17% Similarity=0.270 Sum_probs=200.6
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
.+|+..+.| |+|+||.||+|.++++..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~l-g~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKEL-GSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhh-ccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 346677788 9999999999999777789999886543 23456889999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 82 ANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 9999999986532 36889999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... . ......... ....
T Consensus 155 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------~-~~~~~~~~~-~~~~ 222 (256)
T cd05059 155 YTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---------E-VVESVSAGY-RLYR 222 (256)
T ss_pred ccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---------H-HHHHHHcCC-cCCC
Confidence 111 111124567999999998899999999999999999999 78888643221 1 111111111 0000
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
+ ...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 223 ~-----------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 P-----------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred C-----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1 13456799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=308.62 Aligned_cols=259 Identities=18% Similarity=0.255 Sum_probs=203.4
Q ss_pred cCcccccccccCCCceEEEEEEE-----CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-----RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-----~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.+|+..+.| |+|+||.||+|.. ..+..|++|.+.... ......+.+|+.++++++||||+++++++..+...+
T Consensus 5 ~~~~~~~~l-g~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEEL-GECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeec-cccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 456777888 9999999999985 244589999986533 234467889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQ------------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 201 (350)
+||||+++++|.+++..... .....+++...+.++.|++.||.||| +++++|+||||+||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence 99999999999999853210 00135788999999999999999999 9999999999999999999
Q ss_pred CceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcch
Q 018816 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFF 280 (350)
Q Consensus 202 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~ 280 (350)
+.+||+|||++................++..|+|||++.+..++.++|+|||||++|||++ |..||.....
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------- 232 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------- 232 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 9999999999976644332222333346778999999988889999999999999999998 8888764321
Q ss_pred HHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 281 ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
................ ..++..+.+++.+||+.||++||++.+|++.|+.
T Consensus 233 --~~~~~~~~~~~~~~~~------------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 --QEVIEMVRKRQLLPCS------------EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHHHHHHcCCcCCCC------------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111222211111100 1334678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=320.04 Aligned_cols=264 Identities=17% Similarity=0.224 Sum_probs=194.4
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----cC
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAE-----MP 132 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 132 (350)
.|...+.| |+|+||.||+|+. .++..||+|++.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 1 ry~i~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVI-GKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEE-eecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 36677788 9999999999998 567799999986432 233456889999999999999999999876432 47
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||++ ++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 80 ~lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 80 YVVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccc
Confidence 99999995 6898888643 46899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCcc-ccccccccCCCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCcccC---------CCCcch
Q 018816 213 KSIPEGKTH-IKASTAIGSLEFAAPEYLTT--GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT---------GGSNFF 280 (350)
Q Consensus 213 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~~~~~ 280 (350)
+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||....... +.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 151 RVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 765322211 11233458999999999876 578999999999999999999999986533210 000000
Q ss_pred HHHHH-----HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 281 ITDRV-----EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 281 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....+ ........ ........... ...+..+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~i~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 231 TISRVRNEKARRYLSSMR-KKQPVPFSQKF-----PNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHhhhhhHHHHHHhhc-ccCCCchHHhc-----CCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 00000000 00000000000 023456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=319.59 Aligned_cols=248 Identities=16% Similarity=0.189 Sum_probs=192.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |+|+||.||+|.+ .++..||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 74 ~~~~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRI-GSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhc-cCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 344556677 9999999999998 5677999999865432 345678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+. .......+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 153 ~~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 153 FMDGGSLEGT---------HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred cCCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 9999998653 23456778899999999999999 99999999999999999999999999999876543
Q ss_pred CCccccccccccCCCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTG-----YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
... ......||..|+|||++... ..+.++|||||||++|||++|+.||...... ........ ....
T Consensus 221 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~~~~~~~-~~~~ 291 (353)
T PLN00034 221 TMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLMCA-ICMS 291 (353)
T ss_pred ccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHH-Hhcc
Confidence 221 12334589999999987532 2456899999999999999999998733211 11111111 1000
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...... ...+.++.+|+.+||+.||++|||+.++++.
T Consensus 292 ~~~~~~------------~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 QPPEAP------------ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCC------------CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 1345679999999999999999999999874
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=321.83 Aligned_cols=261 Identities=18% Similarity=0.237 Sum_probs=214.7
Q ss_pred cccccccCCCceEEEEEEECCCceEEEEEecccchhh-HHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 64 MRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYA-SERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 64 ~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
..+.| |+|.||+|.++...+...||+|+++...... .++|..|+++|.+|+||||++++|+|..++.+++|+||+++|
T Consensus 542 ~~eki-GeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 542 FKEKI-GEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred hhhhh-cCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 44567 9999999999999887899999998876544 588999999999999999999999999999999999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
+|.+++..... ..+.....+.|+.||+.|++||. +.++|||||.+.|+|++.++++||+|||.++.+..+....
T Consensus 621 DLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 621 DLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred cHHHHHHhccC---cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999976532 22455566789999999999999 9999999999999999999999999999999887777666
Q ss_pred cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT--GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....+-+++|||||.+..++||.+||+|+||+++||+++ ...||...... ...+-...++....
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e------~vven~~~~~~~~~------- 761 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE------QVVENAGEFFRDQG------- 761 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH------HHHHhhhhhcCCCC-------
Confidence 5556667899999999999999999999999999999876 67887755431 11111222222211
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
....... +..++..+.+++..||..+-++|||+++|...|++..
T Consensus 762 -~~~~l~~-P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 762 -RQVVLSR-PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -cceeccC-CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1111111 1267789999999999999999999999999998753
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=303.71 Aligned_cols=261 Identities=18% Similarity=0.258 Sum_probs=209.0
Q ss_pred cCcccccccccCCCceEEEEEEEC-CCceEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKS---VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|+..+.| |+|++|.||+|... ++..||+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~l-g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKI-GKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred Cceeeeeee-ccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 578888888 99999999999994 7779999987532 223456788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++...... ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 9999999999988643211 145889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
...... .....+++.|+|||.+.+..++.++|+|||||++|+|++|..||..... ....... ....+.
T Consensus 157 ~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~-~~~~~~-- 224 (267)
T cd08224 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLYSLCK-KIEKCD-- 224 (267)
T ss_pred cCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-------cHHHHHh-hhhcCC--
Confidence 432211 2233488899999999888899999999999999999999999864321 1111111 111111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
..+. .....+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 225 -~~~~--------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 -YPPL--------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCC--------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1110 01144567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=320.41 Aligned_cols=253 Identities=14% Similarity=0.107 Sum_probs=196.1
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|+..+.| |+|+||+||++.. .++..||+|.+..... .....+.+|+.++.+++||||+++++.+.+....++|
T Consensus 1 ~~y~~~~~L-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVI-GRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEE-EeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 468888888 9999999999998 5567999999865432 2345678899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 80 MEFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EcCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999998653 56899999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCcc---------------------------------ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh
Q 018816 216 PEGKTH---------------------------------IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262 (350)
Q Consensus 216 ~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 262 (350)
...... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 321100 00123469999999999999899999999999999999999
Q ss_pred CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc-cCccccCCCCccchHHHHHHHHHHHHHccc--cCCCCCCCHHHHH
Q 018816 263 GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN-IDPVIVGDRSCFRKEEKLQAYVELAFKCLS--HSAEDRPTMIDVA 339 (350)
Q Consensus 263 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~~P~~RPt~~evl 339 (350)
|..||..... .... ..+....... +.+.. ..++++.+++.+++. .++..||++.+|+
T Consensus 232 G~~Pf~~~~~---------~~~~-~~i~~~~~~~~~p~~~----------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~ 291 (363)
T cd05628 232 GYPPFCSETP---------QETY-KKVMNWKETLIFPPEV----------PISEKAKDLILRFCCEWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCCCCCCCH---------HHHH-HHHHcCcCcccCCCcC----------CCCHHHHHHHHHHcCChhhcCCCCCHHHHh
Confidence 9999974321 1111 1111111111 11111 223466777777543 2334568999998
Q ss_pred HH
Q 018816 340 KK 341 (350)
Q Consensus 340 ~~ 341 (350)
+.
T Consensus 292 ~h 293 (363)
T cd05628 292 TN 293 (363)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.96 Aligned_cols=252 Identities=17% Similarity=0.133 Sum_probs=196.1
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.|...+.| |+|+||.||+|+. .++..||+|++.... ......+.+|+.++.+++||||+++++++.+.+.+++||
T Consensus 2 ~f~~~~~L-G~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTL-GIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEE-eecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 57777888 9999999999999 666789999986542 233456889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 81 DYIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 999999999998653 46889999999999999999999 9999999999999999999999999999975431
Q ss_pred CCCc---------------------------------------------cccccccccCCCCCCccccccCCCCccchhH
Q 018816 217 EGKT---------------------------------------------HIKASTAIGSLEFAAPEYLTTGYYNEKTDVY 251 (350)
Q Consensus 217 ~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 251 (350)
.... .......+||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 1000 0001234699999999999988899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHH--ccccCC
Q 018816 252 SFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFK--CLSHSA 329 (350)
Q Consensus 252 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~~P 329 (350)
||||++|||++|..||...... ..............+.+. ...+.++.+|+.+ |+..+|
T Consensus 233 SlG~il~elltG~~Pf~~~~~~---------~~~~~i~~~~~~~~~~~~----------~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPT---------ETQLKVINWENTLHIPPQ----------VKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHH---------HHHHHHHccccccCCCCC----------CCCCHHHHHHHHHHccCcccc
Confidence 9999999999999999753220 111111110110001100 0234567888887 555666
Q ss_pred CCCCCHHHHHH
Q 018816 330 EDRPTMIDVAK 340 (350)
Q Consensus 330 ~~RPt~~evl~ 340 (350)
..||++.+++.
T Consensus 294 ~~R~~~~~~l~ 304 (381)
T cd05626 294 LGRNGADDIKA 304 (381)
T ss_pred cCCCCHHHHhc
Confidence 67999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=311.83 Aligned_cols=266 Identities=15% Similarity=0.132 Sum_probs=197.7
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||.||+|.. .++..||+|.+..... .....+.+|+.+++.++||||+++++++.++...++||
T Consensus 4 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKL-GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeE-EecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3678888888 9999999999999 4677899999865432 22345778999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||++ ++|.+++.... ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 83 EYVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred ECCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9995 67877775432 46888999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC-
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY- 294 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 294 (350)
.... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ................
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 155 VPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-----QDQLERIFLVLGTPNED 227 (303)
T ss_pred CCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-----HHHHHHHHHHhCCCChh
Confidence 2221 1233458999999999865 45889999999999999999999999754321 0011111110000000
Q ss_pred --------CccCccccCCCCccc------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 --------MNIDPVIVGDRSCFR------KEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 --------~~~~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....+.......... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000000 0012356889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=302.72 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=195.9
Q ss_pred cCCCceEEEEEEEC---CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCchh
Q 018816 70 DEIEGYILYMGFLR---DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLA 145 (350)
Q Consensus 70 g~G~~g~V~~~~~~---~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 145 (350)
|+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++|.
T Consensus 4 g~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~ 82 (257)
T cd05115 4 GSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLN 82 (257)
T ss_pred CCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHH
Confidence 99999999999873 34468999886553 234567889999999999999999999885 45789999999999999
Q ss_pred hhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcccc-c
Q 018816 146 DRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK-A 224 (350)
Q Consensus 146 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~ 224 (350)
+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++........... .
T Consensus 83 ~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 83 KFLSGKK----DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9986432 46899999999999999999999 99999999999999999999999999999876543322111 1
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVG 303 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (350)
....++..|+|||++.+..++.++|||||||++|++++ |..||..... ..+...+..+.....++
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~~---- 221 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----------PEVMSFIEQGKRLDCPA---- 221 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----------HHHHHHHHCCCCCCCCC----
Confidence 11224578999999988889999999999999999996 9999874432 11222222222111111
Q ss_pred CCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 304 DRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 304 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
.++.++.+++.+||+.+|++||++.+|.+.|+.++
T Consensus 222 --------~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 222 --------ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred --------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 34567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=304.91 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=207.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|++|.||++.. .++..+++|.+.... .....++.+|+.+++.++||||+++++++.+++..+++
T Consensus 2 ~~y~~~~~i-g~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKI-GRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhh-cccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 457777778 9999999999998 677799999876432 23446788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++...... ...+++..++.++.+|+.||.||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999988642211 146899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
...... .....++..|+|||++.+..++.++|+||||+++|+|++|..||..... .... ....+.....
T Consensus 157 ~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~-~~~~~~~~~~- 225 (267)
T cd08229 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLYS-LCKKIEQCDY- 225 (267)
T ss_pred ccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-------hHHH-HhhhhhcCCC-
Confidence 433221 2233488999999999888899999999999999999999999863221 1111 1111111111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
+.. .....+..+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 226 ---~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 ---PPL-------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---CCC-------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111 01145678999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=303.60 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=203.4
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
++|...+.| |+|+||.||+|.+.++..||+|++.... ...+.+.+|+.++++++||||+++++++.+ ...++||||+
T Consensus 6 ~~~~~~~~l-g~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKL-GQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HHeeEeeec-CCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 568888888 9999999999999776789999987543 234678899999999999999999998754 5689999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 83 SKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999965321 35789999999999999999999 9999999999999999999999999999987664333
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... .....++..|+|||+..+..++.++|+||||+++|+|++ |..||..... ...............
T Consensus 157 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----------~~~~~~~~~~~~~~~- 224 (262)
T cd05071 157 YTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQVERGYRMPC- 224 (262)
T ss_pred ccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----------HHHHHHHhcCCCCCC-
Confidence 211 122336778999999988889999999999999999999 7878764321 111111111110000
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
....+..+.+++.+||+.+|++|||+.++++.|++.+
T Consensus 225 -----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 -----------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -----------ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 0145577899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=324.06 Aligned_cols=254 Identities=17% Similarity=0.156 Sum_probs=201.3
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
..++|...+.| |+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 41 ~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVI-GRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CHHHcEEEEEE-eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45788888998 9999999999999 566789999986532 123345778999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++|+|.+++.. ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 120 lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 99999999999998854 35788889999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCccccccccccCCCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTG----YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||..... ........
T Consensus 191 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---------~~~~~~i~ 260 (370)
T cd05596 191 KMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---------VGTYSKIM 260 (370)
T ss_pred eccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---------HHHHHHHH
Confidence 65432211 12344599999999998653 478999999999999999999999974322 11111111
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAED--RPTMIDVAKK 341 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~ 341 (350)
. .......+. . ...+..+.+|+.+||+.+|.+ |||+.+++..
T Consensus 261 ~-~~~~~~~~~---~------~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 261 D-HKNSLTFPD---D------IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred c-CCCcCCCCC---c------CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1 111111110 0 034567899999999999987 9999999763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=322.39 Aligned_cols=253 Identities=19% Similarity=0.186 Sum_probs=203.4
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+|.. .++..||+|.+..... .....+.+|+.++..++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVI-GRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEE-EeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 467888888 9999999999999 4677999999875432 3345688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 9999999999998654 46899999999999999999999 899999999999999999999999999998766
Q ss_pred CCCC---------------------------ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 018816 216 PEGK---------------------------THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGH 268 (350)
Q Consensus 216 ~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 268 (350)
.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 4432 0011234458999999999999999999999999999999999999987
Q ss_pred CCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 018816 269 LSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-MIDVAKK 341 (350)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~evl~~ 341 (350)
.... ...............+.. . ...++.+.+|+.+||+ ||.+||+ +.++++.
T Consensus 232 ~~~~---------~~~~~~i~~~~~~~~~p~-~---------~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 232 SDTL---------QETYNKIINWKESLRFPP-D---------PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCH---------HHHHHHHhccCCcccCCC-C---------CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 5432 111111111001000000 0 0235678999999998 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=302.21 Aligned_cols=248 Identities=21% Similarity=0.272 Sum_probs=197.1
Q ss_pred ccccCCCceEEEEEEE---CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL---RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~---~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|.+ .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 2 ~l-g~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 EL-GSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cC-CCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 35 9999999999975 456689999876443 234567889999999999999999999885 4567999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|.+++... ..+++..+..++.|++.||.||| +++++|+||||.||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 80 GPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999998643 46889999999999999999999 999999999999999999999999999999776543322
Q ss_pred c-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 222 I-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 222 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
. ......++..|+|||.+....++.++|+|||||++|||++ |..||..... ......+.........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----------~~~~~~i~~~~~~~~~- 220 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----------NEVTQMIESGERMECP- 220 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHHCCCCCCCC-
Confidence 1 1122234678999999988889999999999999999998 9999864321 1112222222211111
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
...+..+.+++.+||+.||++||++.+|.+.|++.+
T Consensus 221 -----------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 221 -----------QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred -----------CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 134467889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=307.93 Aligned_cols=259 Identities=17% Similarity=0.245 Sum_probs=204.4
Q ss_pred cCcccccccccCCCceEEEEEEE------CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.+|.....| |+|+||.||++.. .++..+++|.+..........+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWEL-GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred Hhceecccc-CCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 456667788 9999999999974 234578888887666566678999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQ----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
++|||+++++|.+++..... .....+++..++.++.|++.||.||| +.+++|+||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence 99999999999999864321 11135789999999999999999999 999999999999999999999
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 282 (350)
++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |.+||..... .
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------~ 231 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---------T 231 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---------H
Confidence 99999999876543332222223335788999999998899999999999999999998 8888864322 1
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
... .......... .+ ..++..+.+++.+||+.||++||++.+|++.|++
T Consensus 232 ~~~-~~~~~~~~~~-~~-----------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 232 EAI-ECITQGRELE-RP-----------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHH-HHHHcCccCC-CC-----------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111 1111111111 01 1334678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=306.58 Aligned_cols=260 Identities=21% Similarity=0.296 Sum_probs=203.1
Q ss_pred hcCcccccccccCCCceEEEEEEECC------CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRD------RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~------~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
+++|...+.| |+|++|.||+|.+.+ ...|++|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus 5 ~~~~~~~~~l-g~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRAL-GHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeEC-CCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4678888888 999999999999943 4578888876443 3345678999999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC---ceeE
Q 018816 132 PALVYEPAGYCTLADRLYGPLQ--THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY---AAKL 206 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl 206 (350)
.++||||+++++|.+++..... .....+++..++.++.||+.||.||| +.+++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865321 11135899999999999999999999 89999999999999998754 5899
Q ss_pred cccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHH
Q 018816 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||..... . ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---------~-~~ 230 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---------Q-EV 230 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------H-HH
Confidence 99999987643222111222224568999999998899999999999999999997 8888864321 1 11
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
...+......... ...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 231 ~~~~~~~~~~~~~------------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 231 MEFVTGGGRLDPP------------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHHHHcCCcCCCC------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1222211111100 1334678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=308.63 Aligned_cols=258 Identities=16% Similarity=0.240 Sum_probs=202.6
Q ss_pred CcccccccccCCCceEEEEEEECC------CceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 61 NYSMRNITIDEIEGYILYMGFLRD------RGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~~------~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
+|...+.| |+|+||.||+|...+ +..||+|.+..... ...+.+.+|+.++.+++||||+++++++.+....+
T Consensus 6 ~~~~~~~l-g~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 6 TVRFMEEL-GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHh-CCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45556677 999999999998732 35899999875533 33466889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY 202 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 202 (350)
+++||+++++|.+++..... .....+++..+..++.|++.||.||| +.+++||||||+||+++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence 99999999999999853210 01135788899999999999999999 99999999999999999999
Q ss_pred ceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchH
Q 018816 203 AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFI 281 (350)
Q Consensus 203 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~ 281 (350)
.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.....
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------- 232 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------- 232 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence 999999999876644332222233346789999999988889999999999999999998 7778763221
Q ss_pred HHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
. .....+......... ..++..+.+|+.+||+.+|++||++.+|+..|+.
T Consensus 233 ~-~~~~~i~~~~~~~~~------------~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 Q-DVIEMIRNRQVLPCP------------DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-HHHHHHHcCCcCCCC------------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 112222222211110 1445678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=303.76 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=200.8
Q ss_pred cccccccccCCCceEEEEEEEC-C---CceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc----
Q 018816 62 YSMRNITIDEIEGYILYMGFLR-D---RGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEM---- 131 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~-~---~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 131 (350)
|...+.| |+|+||.||+|... + ...||+|++.... ....+.+.+|+..++.++||||+++++++.+...
T Consensus 1 ~~~~~~l-g~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKIL-GEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred Ccccccc-CcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 3456677 99999999999983 2 2579999986542 2345678999999999999999999998876554
Q ss_pred --CeEEeecCCCCchhhhhhCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 132 --PALVYEPAGYCTLADRLYGPL-QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 132 --~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
.++++||+++++|..++.... ......+++.....++.|++.||.||| +.+++|+||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECC
Confidence 799999999999999885432 111246899999999999999999999 89999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... . ....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---------~-~~~~ 226 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---------H-EIYD 226 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---------H-HHHH
Confidence 999886644332222222335678999999988889999999999999999999 8888764321 1 1112
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
.......... +...+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 227 ~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 YLRHGNRLKQ------------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHcCCCCCC------------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2221111110 013456799999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=305.50 Aligned_cols=265 Identities=20% Similarity=0.293 Sum_probs=209.2
Q ss_pred HhcCcccccccccCCCceEEEEEEECC-----CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeec-CC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRD-----RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLE-AE 130 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~-----~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 130 (350)
..++|...++| |+|+||.||+|.+.+ +..|++|.+.... ....+.+.+|+.++++++||||+++++++.. +.
T Consensus 4 ~~~~~~~~~~i-~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 4 SRDRVTLSDLL-QEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred chhheEEeeee-cccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34678888888 999999999999854 5688888876543 3445678899999999999999999998776 56
Q ss_pred cCeEEeecCCCCchhhhhhCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQT---HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
..++++||+++++|.+++...... ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence 889999999999999998653211 1135889999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||..... . ...
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~----~~~ 229 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------F----EMA 229 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------H----HHH
Confidence 9999986644332222223336778999999988889999999999999999999 9999864321 1 112
Q ss_pred HHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..+.... ....+ ..+++.+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 230 ~~~~~~~-~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 230 AYLKDGY-RLAQP-----------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHHHcCC-CCCCC-----------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 2222211 10000 13346789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=309.88 Aligned_cols=265 Identities=18% Similarity=0.268 Sum_probs=208.3
Q ss_pred HhcCcccccccccCCCceEEEEEEE--------CCCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeee
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL--------RDRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCL 127 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~--------~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 127 (350)
..++|.....| |+|+||.||+++. .++..||+|.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 13 SRDKLTLGKPL-GEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred cHHHeeeccee-eccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34677888888 9999999999975 123368899886542 34456788999999999 8999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCce
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQT-----------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 196 (350)
.....++||||+++++|.+++...... ....+++..+..++.||+.||.||| +++++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence 999999999999999999998653210 1135788899999999999999999 99999999999999
Q ss_pred EeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCC
Q 018816 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATG 275 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~ 275 (350)
+++.++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 999999999999999987654333222233346778999999988889999999999999999998 7777653221
Q ss_pred CCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
......+........ + ..++..+.+|+.+||+.+|++|||+.+|++.|+++...
T Consensus 246 -------~~~~~~~~~~~~~~~-~-----------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 -------EELFKLLKEGHRMDK-P-----------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -------HHHHHHHHcCCcCCC-C-----------CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 112222222111100 0 13456789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=307.13 Aligned_cols=260 Identities=21% Similarity=0.320 Sum_probs=206.1
Q ss_pred hcCcccccccccCCCceEEEEEEECC------CceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRD------RGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~------~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
.++|...+.| |+|+||.||+|...+ +..||+|.+..... .....+.+|+.++..++||||+++++++.++..
T Consensus 5 ~~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIREL-GQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEe-cCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3577888888 999999999999843 24799999865532 334568899999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeE
Q 018816 132 PALVYEPAGYCTLADRLYGPLQT-----HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 206 (350)
.++||||+++++|.+++...... ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEE
Confidence 99999999999999998643211 1135788999999999999999999 999999999999999999999999
Q ss_pred cccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHH
Q 018816 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||..... ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----------~~~ 230 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----------EEV 230 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH----------HHH
Confidence 99999876644332222333446789999999988889999999999999999998 8888763221 112
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
.+........... ...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 231 ~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 231 LKFVIDGGHLDLP------------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHHhcCCCCCCC------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 2222222111111 1235678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=309.33 Aligned_cols=259 Identities=20% Similarity=0.276 Sum_probs=205.7
Q ss_pred hcCcccccccccCCCceEEEEEEE------CCCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 130 (350)
.++|...+.| |+|+||.||++.. ..+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus 34 ~~~~~~~~~i-g~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTL-GAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEccee-eccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3578888888 9999999999985 223478999886543 23356788999999999 7999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++||||+++++|.+++..... ..+++.++..++.+++.||.||| +++++|+||||+||+++.++.++++|||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCc
Confidence 99999999999999999865321 34899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
++................++..|+|||++.+..++.++|||||||++|+|++ |..||..... ........
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~---------~~~~~~~~ 257 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV---------DSKFYKLI 257 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc---------hHHHHHHH
Confidence 9876644332212223346788999999998899999999999999999998 9998864321 11111122
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
....... .+ ...+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 258 ~~~~~~~-~~-----------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGYRMA-QP-----------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCCcCC-CC-----------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111100 00 12345799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=308.74 Aligned_cols=251 Identities=16% Similarity=0.174 Sum_probs=200.1
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
+|...+.| |+|+||.||++.. .++..||+|.+..... .....+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVL-GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEE-ecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 46677788 9999999999998 5677999999865422 22345778999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||++....
T Consensus 80 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 80 TLMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred eccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999988754321 46899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... .....|++.|+|||++.+..++.++||||+||++|+|++|..||..... ......+...+......
T Consensus 154 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~- 223 (285)
T cd05605 154 EGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE------KVKREEVERRVKEDQEE- 223 (285)
T ss_pred CCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch------hhHHHHHHHHhhhcccc-
Confidence 3221 2234589999999999988899999999999999999999999975322 11111111111111100
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
. +...+..+.+|+.+||+.||++|| ++.+++.
T Consensus 224 ~------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 224 Y------------SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred c------------CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0 013456789999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=314.63 Aligned_cols=244 Identities=19% Similarity=0.192 Sum_probs=193.0
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHH---HhcCCCCccceeeeeecCCcCeE
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFA---SQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~l 134 (350)
|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++ +.++||||+++++++.+.+..++
T Consensus 1 y~i~~~l-g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVL-GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEE-eecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 4556677 9999999999998 567799999987542 22345566776655 46679999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|...+.. ..+++..+..++.||+.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 80 v~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 80 VMEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 9999999999988754 46899999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...... ......|++.|+|||++.+..++.++|||||||++|+|++|..||..... ..... .+.....
T Consensus 151 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---------~~~~~-~i~~~~~ 218 (324)
T cd05589 151 GMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---------EEVFD-SIVNDEV 218 (324)
T ss_pred CCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---------HHHHH-HHHhCCC
Confidence 432221 23345689999999999988999999999999999999999999874321 11111 1111111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
. . + ...+..+.+++.+||+.||++|| ++.++++
T Consensus 219 ~-~-p-----------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 R-Y-P-----------RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred C-C-C-----------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 0 0 13346788999999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=301.00 Aligned_cols=262 Identities=16% Similarity=0.159 Sum_probs=204.3
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhh--HHHHHHHHHHHHhcCCCCccceeeeeec--CCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYA--SERCFNNIVFASQMNHKSILKLIGCCLE--AEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 132 (350)
..++|...+.| ++|.||.||+|++ +++.-||+|+++...... --...+||.+|.+++|||||.+-.+... -+.+
T Consensus 74 sv~efe~lnrI-~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRI-EEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhc-ccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 34567777888 9999999999999 667789999987653211 1235699999999999999999988764 3479
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
|+|||||+ .+|...+..-. .++...++..+..|++.|++||| .+.|+||||||+|+|+++.|.+||+|||+|
T Consensus 153 y~VMe~~E-hDLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eeeHHHHH-hhHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchh
Confidence 99999996 68998887653 57999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
+.++.... ..+..+-|..|.|||.+.+. .|+++.|+||+|||+.||+++++.|..... ....+...+.+..
T Consensus 225 R~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE------~dQl~~If~llGt 296 (419)
T KOG0663|consen 225 REYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE------IDQLDKIFKLLGT 296 (419)
T ss_pred hhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch------HHHHHHHHHHhCC
Confidence 98876532 23445579999999999886 499999999999999999999999875443 2222222222222
Q ss_pred cCCCccCcc-------------------ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 292 NGYMNIDPV-------------------IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~-------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... .+-|. +...+.. ...++.-.+|+...|.+||.+|.|+++.|+
T Consensus 297 Pte-~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~---~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 297 PSE-AIWPGYSELPAVKKMTFSEHPYNNLRKKFGA---LSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred Ccc-ccCCCccccchhhccccCCCCchhhhhhccc---cccchhHHHHHHHHhccCccccccHHHhhc
Confidence 111 11111 0111111 124577889999999999999999999875
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=319.60 Aligned_cols=252 Identities=17% Similarity=0.153 Sum_probs=201.0
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||++.. .++..||+|.+..... ...+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLV-GRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEE-EeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 468888888 9999999999999 5677899999876432 2345678899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 80 MEYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred ECCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999999986542 46899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCccccccccccCCCCCCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLT------TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||..... ........
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---------~~~~~~i~ 222 (330)
T cd05601 153 TANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---------AKTYNNIM 222 (330)
T ss_pred CCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---------HHHHHHHH
Confidence 443322 223345899999999986 45678999999999999999999999974332 11111111
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
........ +. . ...+..+.+|+.+||+ +|++|||+.+++.
T Consensus 223 ~~~~~~~~-~~---~------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 223 NFQRFLKF-PE---D------PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCCccCC-CC---C------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11110000 10 0 0234678899999998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=315.38 Aligned_cols=249 Identities=17% Similarity=0.166 Sum_probs=195.3
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
+| |+|+||.||++.+ .++..||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 2 ~l-G~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 2 VI-GRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred eE-eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 45 9999999999999 566789999987542 23345677899999998 699999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
|+|.+++... ..+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 9999888643 57899999999999999999999 99999999999999999999999999999875322111
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||......... ...........+...... +.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~p--- 225 (329)
T cd05588 152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP-DQNTEDYLFQVILEKQIR-IP--- 225 (329)
T ss_pred -ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc-cccchHHHHHHHHcCCCC-CC---
Confidence 223446899999999999989999999999999999999999999743321100 111122222222221111 10
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT------MIDVAK 340 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt------~~evl~ 340 (350)
...+..+.+++.+||+.||++||| +.++++
T Consensus 226 ---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 ---------RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 123457889999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=309.25 Aligned_cols=266 Identities=19% Similarity=0.268 Sum_probs=202.0
Q ss_pred cCcccccccccCCCceEEEEEEECCC---------------ceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCcccee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDR---------------GPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLI 123 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~---------------~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~ 123 (350)
++|...+.| |+|+||.||++...+. ..||+|.+... .......+.+|+.++++++||||++++
T Consensus 5 ~~~~~~~~l-g~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKL-GEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhcc-CCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 467778888 9999999999987332 24889988654 233456789999999999999999999
Q ss_pred eeeecCCcCeEEeecCCCCchhhhhhCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCce
Q 018816 124 GCCLEAEMPALVYEPAGYCTLADRLYGPLQ-------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196 (350)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 196 (350)
+++...+..++||||+++++|.+++..... .....+++..++.++.|++.||.||| +.+++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence 999999999999999999999999854311 11124788999999999999999999 99999999999999
Q ss_pred EeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCcccC
Q 018816 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT--GRTIGHLSRLAT 274 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~p~~~~~~~~ 274 (350)
+++.++.+||+|||++................++..|+|||++.++.++.++|+|||||++|+|++ |..||.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-- 238 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-- 238 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence 999999999999999876543322222223335778999999988899999999999999999998 5556553221
Q ss_pred CCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 275 GGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
..................... . + ...+..+.+|+.+||+.+|++|||+.+|++.|++
T Consensus 239 ----~~~~~~~~~~~~~~~~~~~~~----~-~----~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 ----EQVIENTGEFFRNQGRQIYLS----Q-T----PLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ----HHHHHHHHHhhhhccccccCC----C-C----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111111111100000 0 0 0234679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=308.90 Aligned_cols=266 Identities=20% Similarity=0.241 Sum_probs=205.0
Q ss_pred cCcccccccccCCCceEEEEEEECC-----------------CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccc
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD-----------------RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILK 121 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~-----------------~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 121 (350)
++|...+.| |+|+||.||++...+ ...||+|.+.... ....+.+.+|+.++.+++||||++
T Consensus 5 ~~~~~~~~l-g~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKL-GEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccc-cCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 567788888 999999999998733 2357899887553 344667889999999999999999
Q ss_pred eeeeeecCCcCeEEeecCCCCchhhhhhCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCc
Q 018816 122 LIGCCLEAEMPALVYEPAGYCTLADRLYGPLQT------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWN 195 (350)
Q Consensus 122 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 195 (350)
+++++..++..+++|||+++++|.+++...... ....+++..++.++.|++.||.||| +.+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 999999999999999999999999998654311 1136899999999999999999999 9999999999999
Q ss_pred eEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCccc
Q 018816 196 ILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT--GRTIGHLSRLA 273 (350)
Q Consensus 196 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~p~~~~~~~ 273 (350)
|+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876544332222334446788999999988889999999999999999998 5666653221
Q ss_pred CCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 274 TGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
....................+. +...+.++.+++.+||+.||++|||+.+|++.|++
T Consensus 240 -----~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 -----QQVIENAGHFFRDDGRQIYLPR---------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -----HHHHHHHHhccccccccccCCC---------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111111111111110000 01334679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.54 Aligned_cols=240 Identities=16% Similarity=0.126 Sum_probs=194.0
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
.| |+|+||.||++.. .++..||+|.+.... ......+.+|+.++..++||||+++++++.+.+..++||||++++
T Consensus 2 ~l-G~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 2 LL-GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred ee-eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 45 9999999999998 567799999987542 233456778999999999999999999999999999999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
+|..++... ..+++..+..++.||+.||.||| + .+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 151 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 151 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence 999888653 46899999999999999999999 7 7999999999999999999999999999875432211
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+...... +.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----------~~~~~~i~~~~~~-~p--- 216 (325)
T cd05594 152 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------EKLFELILMEEIR-FP--- 216 (325)
T ss_pred -ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----------HHHHHHHhcCCCC-CC---
Confidence 12234589999999999988999999999999999999999999864321 1111111111111 00
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
...++.+.+|+.+||+.||++|+ ++.++++
T Consensus 217 ---------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 ---------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ---------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 12346789999999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=301.22 Aligned_cols=250 Identities=18% Similarity=0.236 Sum_probs=203.6
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|+..+.| |+|++|.||+|.. .++..|++|.+... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~~~~~~~l-~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKI-GKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEe-cCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 46777788 9999999999999 56778999988643 23456678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++..... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 80 YAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred eCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 9999999999875322 46889999999999999999999 99999999999999999999999999999886654
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.... .....+++.|+|||++.+..++.++|+||||+++++|++|+.||..... ..............+
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~~~~~ 221 (256)
T cd08529 154 NTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----------GALILKIIRGVFPPV 221 (256)
T ss_pred ccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----------HHHHHHHHcCCCCCC
Confidence 3221 2234588999999999998899999999999999999999999874321 111111111111111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
. ...+..+.+++.+||+.+|++||++.++++.
T Consensus 222 ~------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 S------------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred c------------cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1 1344678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=305.42 Aligned_cols=266 Identities=22% Similarity=0.278 Sum_probs=203.1
Q ss_pred cCcccccccccCCCceEEEEEEE-----CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeec--CCcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-----RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLE--AEMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 132 (350)
++|.....| |+|+||.||++.. .++..||+|++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQL-GKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeec-cCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 467777788 9999999999984 3566899999877666666789999999999999999999998754 3468
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 99999999999999986532 45889999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCcccc-ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccC----CC--CcchHHHHH
Q 018816 213 KSIPEGKTHIK-ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT----GG--SNFFITDRV 285 (350)
Q Consensus 213 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~--~~~~~~~~~ 285 (350)
........... .....++..|+|||++.+..++.++|+|||||++|||++|..++....... +. .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 87654332111 111223456999999988889999999999999999999887654321100 00 000011111
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
.......... + .+...+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 236 ~~~~~~~~~~---~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRL---P---------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcC---C---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1111111100 0 0113456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=311.92 Aligned_cols=255 Identities=21% Similarity=0.222 Sum_probs=200.1
Q ss_pred HHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh--------------hHHHHHHHHHHHHhcCCCCcc
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY--------------ASERCFNNIVFASQMNHKSIL 120 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv 120 (350)
.+..+.|.....| |+|.||.|-+|+. .++..||||.+.+.... ..+...+||.+|+++.|||||
T Consensus 93 ~k~lNqy~l~~ei-G~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 93 RKQLNQYELIKEI-GSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred ceehhheehhhhh-cCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3456788888898 9999999999999 77779999998764321 235788999999999999999
Q ss_pred ceeeeeecCC--cCeEEeecCCCCchhhhhhCCCCCCCCC-CCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceE
Q 018816 121 KLIGCCLEAE--MPALVYEPAGYCTLADRLYGPLQTHLEP-LLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197 (350)
Q Consensus 121 ~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 197 (350)
+++.+..+.. .+|||+|||..|.+...=.. .+ +++.++.+++.+++.||.||| .++||||||||+|+|
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d------~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD------KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLL 242 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCC------cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheE
Confidence 9999988654 89999999998887543222 34 899999999999999999999 999999999999999
Q ss_pred eCCCCceeEcccCCCccCCCCCcc---ccccccccCCCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCC
Q 018816 198 FQEEYAAKLFDFSLSKSIPEGKTH---IKASTAIGSLEFAAPEYLTTGY----YNEKTDVYSFGKLLLVLLTGRTIGHLS 270 (350)
Q Consensus 198 l~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~tg~~p~~~~ 270 (350)
|+.+|++||+|||.+..+..+... ......+|||.|+|||.+.++. -+.+.||||+||+||-|+.|+.||...
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 999999999999999877433211 1122356999999999998743 357899999999999999999999743
Q ss_pred cccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 271 RLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.. .....+.+.. ...-|.. .+..+.+.+||.++|..||+.|.+..+|...
T Consensus 323 ~~---------~~l~~KIvn~---pL~fP~~---------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 323 FE---------LELFDKIVND---PLEFPEN---------PEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred hH---------HHHHHHHhcC---cccCCCc---------ccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 21 1111111111 1111110 1456789999999999999999999988654
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.96 Aligned_cols=246 Identities=21% Similarity=0.316 Sum_probs=197.8
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCchh
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLA 145 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 145 (350)
+| |+|+||.||+|...++..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 2 ~i-g~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LL-GKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred cc-CCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 45 99999999999988788999999876532 33456889999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcccccc
Q 018816 146 DRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225 (350)
Q Consensus 146 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 225 (350)
+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSG 152 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCC
Confidence 9886432 45789999999999999999999 999999999999999999999999999998754332221 112
Q ss_pred ccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
...+++.|+|||++.+..++.++||||||+++|++++ |..||..... ................
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~------ 216 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN----------QQAREQVEKGYRMSCP------ 216 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----------HHHHHHHHcCCCCCCC------
Confidence 2234678999999998889999999999999999998 8989864321 1111112211111000
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 217 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 ------QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 134567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=302.95 Aligned_cols=257 Identities=18% Similarity=0.246 Sum_probs=204.3
Q ss_pred hcCcccccccccCCCceEEEEEEEC-CCc---eEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR-DRG---PILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~-~~~---~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.++|+..+.| |+|+||.||+|... +++ .+++|.+.... ....+.+.+|+.++++++||||+++.+++.+.+..+
T Consensus 4 ~~~~~~~~~l-g~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVI-GAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEe-cCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 4577888888 99999999999984 332 68888886542 344567889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 83 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 83 IITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred EEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccce
Confidence 9999999999999986532 46899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCcccc-ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 214 SIPEGKTHIK-ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 214 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
.......... ......++.|+|||++.+..++.++|||||||++||+++ |..||..... ......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----------~~~~~~i~~ 225 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----------HEVMKAIND 225 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----------HHHHHHHhc
Confidence 6543222111 111123457999999988889999999999999999997 9999864321 111222221
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
.. ..+. ....+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 ~~---~~~~---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GF---RLPA---------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC---CCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 0010 013456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=308.11 Aligned_cols=266 Identities=17% Similarity=0.248 Sum_probs=203.3
Q ss_pred cCcccccccccCCCceEEEEEEEC-----------------CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccc
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-----------------DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILK 121 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-----------------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 121 (350)
++|+..+.| |+|+||.||++... +...||+|.+.... ......+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~l-g~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKL-GEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeec-cCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 467888888 99999999998642 23368888886542 344567899999999999999999
Q ss_pred eeeeeecCCcCeEEeecCCCCchhhhhhCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCc
Q 018816 122 LIGCCLEAEMPALVYEPAGYCTLADRLYGPLQT------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWN 195 (350)
Q Consensus 122 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 195 (350)
+++++.+++..++||||+++++|.+++...... ....+++..+..++.|++.||.||| +.+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence 999999999999999999999999998653211 1134778899999999999999999 9999999999999
Q ss_pred eEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCccc
Q 018816 196 ILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT--GRTIGHLSRLA 273 (350)
Q Consensus 196 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t--g~~p~~~~~~~ 273 (350)
|+++.++.++|+|||++................+++.|++||+..++.++.++|+|||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD- 239 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence 9999999999999999876543322222222335678999999888889999999999999999998 6677753322
Q ss_pred CCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 274 TGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
....................+.. ..++..+.+|+.+||+.||++|||+.+|++.|++
T Consensus 240 -----~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 -----EQVIENTGEFFRDQGRQVYLPKP---------ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -----HHHHHHHHHHHhhccccccCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111122111111111110 1344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=322.31 Aligned_cols=253 Identities=16% Similarity=0.109 Sum_probs=197.1
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||++.. .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.++...++|
T Consensus 1 ~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVI-GKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEE-eecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 467888888 9999999999998 667799999986542 23345678899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 80 MEFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999998653 56889999999999999999999 999999999999999999999999999998633
Q ss_pred CCCCc------------cc---------------------------------cccccccCCCCCCccccccCCCCccchh
Q 018816 216 PEGKT------------HI---------------------------------KASTAIGSLEFAAPEYLTTGYYNEKTDV 250 (350)
Q Consensus 216 ~~~~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 250 (350)
..... .. .....+||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 21000 00 0012358999999999998899999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCC
Q 018816 251 YSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAE 330 (350)
Q Consensus 251 wslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~ 330 (350)
|||||++|||++|.+||..... .......... .....-|. . ...+.++.+|+.+||. +|.
T Consensus 232 wSlGvil~elltG~~Pf~~~~~---------~~~~~~i~~~-~~~~~~p~---~------~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENS---------HETYRKIINW-RETLYFPD---D------IHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCH---------HHHHHHHHcc-CCccCCCC---C------CCCCHHHHHHHHHHhc-CHh
Confidence 9999999999999999964321 1111111111 10000010 0 0234678899999998 676
Q ss_pred CC---CCHHHHHHH
Q 018816 331 DR---PTMIDVAKK 341 (350)
Q Consensus 331 ~R---Pt~~evl~~ 341 (350)
+| +|+.+++..
T Consensus 292 ~r~~r~~~~~~l~h 305 (377)
T cd05629 292 NRLGRGGAHEIKSH 305 (377)
T ss_pred hcCCCCCHHHHhcC
Confidence 65 599998863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=309.77 Aligned_cols=264 Identities=19% Similarity=0.254 Sum_probs=206.5
Q ss_pred hcCcccccccccCCCceEEEEEEEC--------CCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR--------DRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLE 128 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~--------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 128 (350)
.++|...+.| |+|+||.||++... ....+|+|.+.... .....++.+|+.++..+ +||||+++++++..
T Consensus 17 ~~~~~i~~~l-g~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPL-GEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeee-ccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3578888888 99999999999862 12369999887542 23456788999999999 79999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceE
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQT-----------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 197 (350)
.+..++||||+++++|.+++...... ....+++..++.++.|++.||.||| +.+++|+||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheE
Confidence 99999999999999999999653210 1135889999999999999999999 999999999999999
Q ss_pred eCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCC
Q 018816 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGG 276 (350)
Q Consensus 198 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~ 276 (350)
++.++.++|+|||.+................+++.|+|||++.+..++.++|+|||||++|+|++ |..||.....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---- 248 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 248 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence 99999999999999876543222111222224578999999988889999999999999999998 7888753221
Q ss_pred CcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..+............. ...+.++.+|+.+||+.+|++|||+.+|++.|+++...
T Consensus 249 ------~~~~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 ------EELFKLLKEGHRMDKP------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ------HHHHHHHHcCCCCCCC------------CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1112222221111000 13456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=306.50 Aligned_cols=245 Identities=15% Similarity=0.155 Sum_probs=192.4
Q ss_pred ccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 69 IDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 69 ig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
||+|+||.||++.. .++..||+|.+..... .....+..|+.++.+++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 49999999999998 5677999999864321 2234456799999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 224 (350)
.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~ 151 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---I 151 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---e
Confidence 988754321 45889999999999999999999 99999999999999999999999999999876643322 2
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
....|++.|+|||++.+..++.++|+|||||++|+|++|..||...... ........... ...... .
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-----~~~~~~~~~~~----~~~~~~----~ 218 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-----VAKEELKRRTL----EDEVKF----E 218 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-----hhHHHHHHHhh----cccccc----c
Confidence 2334899999999999888999999999999999999999998643210 01011111111 000000 0
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....+.++.+|+.+||+.||++||++.|+++
T Consensus 219 -----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 219 -----HQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred -----cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 0134567899999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=306.81 Aligned_cols=260 Identities=20% Similarity=0.268 Sum_probs=204.6
Q ss_pred hcCcccccccccCCCceEEEEEEEC------CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
.++|.....| |+|+||.||++... ++..||+|.+.... ......+.+|+.++++++||||+++++++.++..
T Consensus 4 ~~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDI-GQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccc-cccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4678888888 99999999999873 45689999886543 2345678899999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQ-----------------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPW 194 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~-----------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 194 (350)
.++||||+++++|.+++..... .....+++..++.++.|++.||.||| +.+++|+||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence 9999999999999999864211 11134788899999999999999999 999999999999
Q ss_pred ceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCccc
Q 018816 195 NILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLA 273 (350)
Q Consensus 195 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~ 273 (350)
||+++.++.++|+|||.+.................+..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~- 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH- 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999876543322222222335678999999988899999999999999999997 8778753221
Q ss_pred CCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 274 TGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
.. ....+......... ...+.++.+|+.+||+.+|++|||+.|+++.|++
T Consensus 239 --------~~-~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 --------EE-VIYYVRDGNVLSCP------------DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --------HH-HHHHHhcCCCCCCC------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 11122211111000 1334679999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=314.63 Aligned_cols=244 Identities=17% Similarity=0.159 Sum_probs=191.3
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||++.. .++..||+|.+.... ......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 2 ~l-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 2 VI-GRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred ee-eeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 45 9999999999999 556689999987542 23345677899888877 799999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|..++... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 9999888543 46899999999999999999999 99999999999999999999999999999875322211
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...........+...... +.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~~~~~~~~~~~i~~~~~~-~p--- 225 (329)
T cd05618 152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-DQNTEDYLFQVILEKQIR-IP--- 225 (329)
T ss_pred -ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc-ccccHHHHHHHHhcCCCC-CC---
Confidence 123445899999999999999999999999999999999999999643221111 111122222222221111 11
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 335 (350)
...+..+.+++.+||+.||++||++
T Consensus 226 ---------~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 ---------RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---------CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1334578899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=301.00 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=205.4
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...+.| |+|++|.||+|...+ +.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~~~~~~~~i-g~g~~g~v~~~~~~~-~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATI-GKGEFGDVMLGDYRG-QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeee-ecCCCceEEEEEecC-cEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 3567778888 999999999999875 4899999976643 567789999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 82 MAKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred cCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 999999999865421 36899999999999999999999 999999999999999999999999999998876332
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. ....+..|+|||++.++.++.++|+||||+++|++++ |..||..... ...............
T Consensus 156 ~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------~~~~~~~~~~~~~~~ 220 (256)
T cd05039 156 QD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----------KDVVPHVEKGYRMEA 220 (256)
T ss_pred cc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----------HHHHHHHhcCCCCCC
Confidence 21 2225678999999988889999999999999999997 9988763321 111222221111100
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
+ ...++.+.+++.+||..+|++|||+.++++.|+++
T Consensus 221 -~-----------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 221 -P-----------EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -c-----------cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0 13356789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=305.50 Aligned_cols=254 Identities=19% Similarity=0.181 Sum_probs=201.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
++|.....| |+|+||.||+|+. .++..||+|.+..........+.+|+.++.+++||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~l-g~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRV-GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhhee-ecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 468888888 9999999999998 56678999988755444456688999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++......
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 88 CGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999988643 46889999999999999999999 999999999999999999999999999998765432
Q ss_pred CccccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......+++.|+|||.+. ...++.++|+|||||++|||++|..|+....... .. ..... ..
T Consensus 160 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~---------~~-~~~~~--~~ 225 (267)
T cd06646 160 IA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---------AL-FLMSK--SN 225 (267)
T ss_pred cc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh---------hh-eeeec--CC
Confidence 11 122334888999999874 3457889999999999999999999986432110 00 00000 00
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
...+.+... ...+..+.+++.+||+.+|++|||++++++.|
T Consensus 226 ~~~~~~~~~------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 FQPPKLKDK------TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCccc------cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 011111110 13456899999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=308.52 Aligned_cols=260 Identities=16% Similarity=0.198 Sum_probs=193.4
Q ss_pred cCcccccccccCCCceEEEEEEE-C-CCceEEEEEecccch--hhHHHHHHHHHHHHhc---CCCCccceeeeee-----
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-R-DRGPILVMKYRKSVR--YASERCFNNIVFASQM---NHKSILKLIGCCL----- 127 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~-~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~----- 127 (350)
++|...+.| |+|+||.||+|.+ . ++..||+|.+..... .....+.+|+.++..+ +||||++++++|.
T Consensus 1 ~~Y~~~~~l-g~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEe-ccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 357778888 9999999999998 3 456789998864322 2234566788777766 6999999999885
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
.....++||||++ ++|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEc
Confidence 2346899999996 689988865322 45889999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|.+||...... . ....
T Consensus 153 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~------~---~~~~ 220 (290)
T cd07862 153 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------D---QLGK 220 (290)
T ss_pred cccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH------H---HHHH
Confidence 999987654321 223445899999999998889999999999999999999999999754321 1 1111
Q ss_pred HHHhcC---CC-----------ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNG---YM-----------NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~---~~-----------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...... .. .+.+.......... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 221 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHhCCCChhhchhhhcccchhccCCCCCCHHHHc-cCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 111100 00 00000000000000 124467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=301.84 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=201.4
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
++|...+.| |+|++|.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++. ....+++|||+
T Consensus 6 ~~~~~~~~i-g~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKL-GNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred HHhhhhhee-ccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 466777788 99999999999987777899999876432 3467899999999999999999999875 45689999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++..... ..+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 83 SKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999865321 45889999999999999999999 8999999999999999999999999999997654332
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... .....++..|+|||++.+..++.++|+||||+++|+|++ |..||..... .. ....+........
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---------~~-~~~~~~~~~~~~~- 224 (260)
T cd05070 157 YTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------RE-VLEQVERGYRMPC- 224 (260)
T ss_pred ccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---------HH-HHHHHHcCCCCCC-
Confidence 211 112225678999999988889999999999999999999 8888864321 11 1111211111000
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
+...+..+.+|+.+||..+|++|||+.++.+.|++
T Consensus 225 -----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 -----------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----------CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=307.89 Aligned_cols=262 Identities=21% Similarity=0.248 Sum_probs=199.6
Q ss_pred ccccccccCCCceEEEEEEE-----CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecC--CcCeE
Q 018816 63 SMRNITIDEIEGYILYMGFL-----RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEA--EMPAL 134 (350)
Q Consensus 63 ~~~~~lig~G~~g~V~~~~~-----~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 134 (350)
.....| |+|+||.||++.. .++..||+|.+.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 7 ~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 7 KKIRVL-GEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred eeceec-ccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 566777 9999999988653 456689999986543 23456788999999999999999999988754 35789
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 86 v~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999999864 35899999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCCcccc-ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCC-----CcchHHHHHHHH
Q 018816 215 IPEGKTHIK-ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-----SNFFITDRVEKF 288 (350)
Q Consensus 215 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~~~ 288 (350)
......... .....++..|+|||.+.+..++.++||||||+++|+|++|..|+......... ............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 654322111 12223566799999998888999999999999999999999997643211000 000000000000
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
.. ....... +...+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 237 ~~--------~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LE--------RGMRLPC----PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hh--------cCCCCCC----CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00 0000000 1134568999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=306.42 Aligned_cols=247 Identities=14% Similarity=0.136 Sum_probs=194.4
Q ss_pred ccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 69 IDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 69 ig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
||+|+||+||++.+ .++..||+|++..... ...+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 49999999999998 5667999999865422 2235677899999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 224 (350)
.+++..... ....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~ 154 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KT 154 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cc
Confidence 988754221 1146899999999999999999999 99999999999999999999999999999876544322 12
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...... .. ........ ......
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-----~~-~~~~~~~~-------~~~~~~-- 219 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-----VE-NKELKQRI-------LNDSVT-- 219 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc-----hh-HHHHHHhh-------cccCCC--
Confidence 2345899999999999999999999999999999999999998743211 00 00001100 000000
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
.+...+..+.+++.+||+.||++|| |++++++
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 220 ----YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ----CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 0013456789999999999999999 7777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=322.83 Aligned_cols=264 Identities=20% Similarity=0.278 Sum_probs=205.9
Q ss_pred HhcCcccccccccCCCceEEEEEEEC------CCceEEEEEecccch-hhHHHHHHHHHHHHhcC-CCCccceeeeeecC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSVR-YASERCFNNIVFASQMN-HKSILKLIGCCLEA 129 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 129 (350)
..++|...+.| |+|+||.||+|++. .+..||+|++..... ...+.+.+|+.++.++. ||||++++++|...
T Consensus 35 ~~~~~~~~~~l-G~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 35 PRDNLVLGRTL-GSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred cHHHeehhhhc-cCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34566777788 99999999999863 335899999975432 33456889999999997 99999999999999
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCC-------------------------------------------------------
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQT------------------------------------------------------- 154 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~------------------------------------------------------- 154 (350)
...++||||+++|+|.+++......
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999999999998643210
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCce
Q 018816 155 --------------------------------------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196 (350)
Q Consensus 155 --------------------------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 196 (350)
....+++...+.++.||+.||.||| +.+++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceE
Confidence 0124677888999999999999999 99999999999999
Q ss_pred EeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCC
Q 018816 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATG 275 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~ 275 (350)
|++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--- 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--- 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc---
Confidence 999999999999999976543322222223346788999999998889999999999999999998 8888764321
Q ss_pred CCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
.......+..+. ....+ ...+..+.+|+.+||+.+|++||++.+|++.|+++.
T Consensus 348 ------~~~~~~~~~~~~-~~~~p-----------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 ------NEQFYNAIKRGY-RMAKP-----------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ------hHHHHHHHHcCC-CCCCC-----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111111121111 11011 133467999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=306.98 Aligned_cols=260 Identities=19% Similarity=0.241 Sum_probs=202.2
Q ss_pred cCcccccccccCCCceEEEEEEECC-Cc--eEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD-RG--PILVMKYRKS-VRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~-~~--~vaik~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 134 (350)
++|+....| |+|+||.||+|...+ +. .+++|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVI-GEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeee-cCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 467888888 999999999999843 32 4688877642 234456788999999999 79999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 135 VYEPAGYCTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
++||+++++|.+++..... .....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCe
Confidence 9999999999999864321 01135889999999999999999999 999999999999999999999
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 282 (350)
+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 158 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---------~ 225 (297)
T cd05089 158 SKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---------A 225 (297)
T ss_pred EEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------H
Confidence 9999999986432111 1111223567999999988889999999999999999997 9999864321 1
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
... ....... .+... ..++..+.+|+.+||+.+|.+|||+.++++.|+++...
T Consensus 226 ~~~-~~~~~~~----~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 226 ELY-EKLPQGY----RMEKP--------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHH-HHHhcCC----CCCCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 1111111 00000 13446789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=313.82 Aligned_cols=235 Identities=20% Similarity=0.179 Sum_probs=189.7
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|.. .++..||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 2 ~l-g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 2 VL-GKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred ee-eeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 45 9999999999999 456689999986542 23345677888888877 699999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 9999988654 46889999999999999999999 99999999999999999999999999999875422211
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .. ....+..... ..+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---------~~-~~~~i~~~~~--~~~-- 216 (320)
T cd05590 152 -TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---------DD-LFEAILNDEV--VYP-- 216 (320)
T ss_pred -cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---------HH-HHHHHhcCCC--CCC--
Confidence 12344589999999999988999999999999999999999999974321 11 1111111111 011
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 335 (350)
...+..+.+++.+||+.||++||++
T Consensus 217 ---------~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 ---------TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ---------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1234578899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=300.56 Aligned_cols=255 Identities=17% Similarity=0.152 Sum_probs=192.9
Q ss_pred ccccCCCceEEEEEEECC---CceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 67 ITIDEIEGYILYMGFLRD---RGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~---~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
.| |+|+||.||+|...+ ...+++|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~l-g~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EI-GNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cc-cccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35 999999999998743 34689998865432 33457889999999999999999999999999999999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
+|.+++...........++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986532211235677788899999999999999 9999999999999999999999999999987554332222
Q ss_pred cccccccCCCCCCccccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 223 KASTAIGSLEFAAPEYLTTG-------YYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
......++..|+|||++... .++.++|+||||+++|||++ |..||..... . ............
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------~---~~~~~~~~~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD------E---QVLTYTVREQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh------H---HHHHHHhhcccC
Confidence 22334477889999988642 35789999999999999996 9999864321 0 111111111112
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
...++.+.. ..++.+.+++..|| .+|++|||+.+|++.|.
T Consensus 229 ~~~~~~~~~--------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKL--------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCC--------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222222211 23356888999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=308.99 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=201.8
Q ss_pred hcCcccccccccCCCceEEEEEEEC-CCc--eEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR-DRG--PILVMKYRKS-VRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~-~~~--~vaik~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 133 (350)
.++|+..+.| |+|+||.||+|.+. ++. .+++|.+... .......+.+|+.++.++ +||||+++++++.+.+..+
T Consensus 6 ~~~~~~~~~l-g~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVI-GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeee-cCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 3577888888 99999999999983 333 4577776543 234456788999999999 8999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY 202 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 202 (350)
+||||+++++|.+++..... .....+++..++.++.|++.||.||| +.+++||||||+|||++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCC
Confidence 99999999999999864321 11135789999999999999999999 99999999999999999999
Q ss_pred ceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchH
Q 018816 203 AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFI 281 (350)
Q Consensus 203 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~ 281 (350)
.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------- 229 (303)
T cd05088 162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------- 229 (303)
T ss_pred cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---------
Confidence 99999999986432111 1112224678999999988889999999999999999998 9999864321
Q ss_pred HHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
... ........ . ... +...+..+.+|+.+||+.+|++||++.+++..|+++..
T Consensus 230 ~~~-~~~~~~~~-~---~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 230 AEL-YEKLPQGY-R---LEK--------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHH-HHHHhcCC-c---CCC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011 11111110 0 000 01234578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=313.17 Aligned_cols=240 Identities=20% Similarity=0.174 Sum_probs=192.9
Q ss_pred ccccCCCceEEEEEEE----CCCceEEEEEecccch----hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 67 ITIDEIEGYILYMGFL----RDRGPILVMKYRKSVR----YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~----~~~~~vaik~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.| |+|+||.||++.. ..+..||+|.+..... .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 3 ~l-g~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 3 VL-GKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ee-eecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 45 9999999999986 3566899999865421 2234577899999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++... ..+.+..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999988653 46788889999999999999999 999999999999999999999999999998754322
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .... .+.
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---------~~~~~~~~-~~~~-~~~ 220 (323)
T cd05584 154 GT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---------KKTIDKIL-KGKL-NLP 220 (323)
T ss_pred CC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---------HHHHHHHH-cCCC-CCC
Confidence 21 12334589999999999988899999999999999999999999874321 11111111 1111 111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
+ ..+..+.+++.+||+.+|++|| ++.+++.
T Consensus 221 ~------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 P------------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C------------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 2345788999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=311.83 Aligned_cols=239 Identities=19% Similarity=0.170 Sum_probs=189.6
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|.. .++..||+|.+.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 2 ~l-G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 2 VL-GKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred ee-eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 45 9999999999999 556689999987542 12334556677777654 899999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 9999988653 46899999999999999999999 9999999999999999999999999999987543322
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
.......||+.|+|||++.+..++.++|||||||++|||++|..||..... .... ..+.... ..+.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---------~~~~-~~i~~~~-~~~~--- 216 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---------DELF-DSILNDR-PHFP--- 216 (316)
T ss_pred CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---------HHHH-HHHHcCC-CCCC---
Confidence 123344589999999999988999999999999999999999999874321 1111 1111111 1111
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI-DVA 339 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl 339 (350)
...+..+.+++.+||+.||++||++. +++
T Consensus 217 ---------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 ---------RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ---------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12345788999999999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=319.64 Aligned_cols=256 Identities=17% Similarity=0.179 Sum_probs=200.3
Q ss_pred HHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
....++|...+.| |+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 39 ~~~~~~y~~~~~l-G~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 39 QMKAEDYDVVKVI-GRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred CCCHHHCeEEEEE-EecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3445789999998 9999999999999 556688999886432 1234457789999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++|+|.+++.. ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 9999999999999999854 35788999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTG----YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
+......... ......||+.|+|||++.+. .++.++|+|||||++|+|++|..||..... ......
T Consensus 189 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---------~~~~~~ 258 (370)
T cd05621 189 CMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---------VGTYSK 258 (370)
T ss_pred ceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---------HHHHHH
Confidence 9876432221 22345699999999998754 378999999999999999999999974321 111122
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAED--RPTMIDVAKK 341 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~ 341 (350)
.........+.. . ...+..+.+++..||+.+|.+ |||+.++++.
T Consensus 259 i~~~~~~~~~p~----~------~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 259 IMDHKNSLNFPE----D------VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHhCCcccCCCC----c------ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 221111111110 0 134567889999999865543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.37 Aligned_cols=256 Identities=16% Similarity=0.205 Sum_probs=202.2
Q ss_pred cCcccccccccCCCceEEEEEEEC-CC---ceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-DR---GPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-~~---~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
++|...+.| |+|+||.||+|.+. ++ ..||+|.+... .......+..|+.++++++||||+++++++.++...++
T Consensus 4 ~~~~~~~~l-g~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVI-GAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEe-cCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 456777888 99999999999983 33 25999998654 23445679999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++.... +.+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccc
Confidence 999999999999986532 46889999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCccccc-ccc--ccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 215 IPEGKTHIKA-STA--IGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 215 ~~~~~~~~~~-~~~--~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
.......... ... ..+..|+|||++.+..++.++|||||||++||+++ |..||..... . .....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~------~----~~~~~i~ 225 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------Q----DVINAIE 225 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH------H----HHHHHHH
Confidence 5432221111 111 12457999999998899999999999999999886 9998864321 1 1111221
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
....... +.+++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 226 ~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QDYRLPP------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCcCCC------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110000 013456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=313.26 Aligned_cols=240 Identities=17% Similarity=0.157 Sum_probs=192.7
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
+| |+|+||.||+|+. .++..||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 2 ~l-G~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 2 VL-GKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred cc-ccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 45 9999999999999 456689999987542 23345677889998876 799999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 9999888653 46889999999999999999999 99999999999999999999999999999875432221
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...... +.... ...|
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---------~~~~~~-i~~~~--~~~p-- 216 (321)
T cd05591 152 -TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---------DDLFES-ILHDD--VLYP-- 216 (321)
T ss_pred -cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---------HHHHHH-HHcCC--CCCC--
Confidence 12344589999999999988999999999999999999999999974432 111111 11111 1011
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-------TMIDVAK 340 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-------t~~evl~ 340 (350)
...+.++.+++.+||+.||++|| ++.++++
T Consensus 217 ---------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 ---------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 02345788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.00 Aligned_cols=264 Identities=19% Similarity=0.298 Sum_probs=205.6
Q ss_pred HhcCcccccccccCCCceEEEEEEEC------CCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
..++|+....| |+|+||.||+|..+ .+..||+|.+..... .....+.+|+.++++++||||+++++++.++.
T Consensus 4 ~~~~~~i~~~l-g~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLREL-GQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeee-cCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678888898 99999999999763 234789998764432 33456789999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCcee
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQ-----THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 205 (350)
..++||||+++|+|.+++..... ......++..+..++.|++.||.||| +++++|+||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999964211 11134577888999999999999999 99999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHH
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 284 (350)
|+|||+++...............++..|+|||.+.++.++.++|+|||||++|||++ |..||..... ..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----------~~ 229 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----------EQ 229 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----------HH
Confidence 999999876543332222223335778999999998899999999999999999998 6778753221 11
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.............. ...+..+.+++.+||+.+|++|||+.++++.|++...
T Consensus 230 ~~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 230 VLKFVMDGGYLDQP------------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHHHHHcCCCCCCC------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 11222211111100 1334679999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=306.49 Aligned_cols=261 Identities=18% Similarity=0.182 Sum_probs=198.8
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----cCeE
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE-----MPAL 134 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 134 (350)
.|...+++ |.|+||.||+|.. .++..||||+...+.. ---+|+.+|+.++|||||++.-+|.... ...+
T Consensus 25 ~~~~~~li-G~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLI-GSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEE-eecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 45566777 9999999999999 5567999999876643 1237999999999999999998887432 4568
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-CceeEcccCCCc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKLFDFSLSK 213 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~ 213 (350)
||||+| .+|.+.+....... ..++.-.+.-+..||.+||.||| ..+||||||||.|+|+|.+ |.+||+|||.|+
T Consensus 100 VleymP-~tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 100 VLEYMP-ETLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHhch-HHHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 999997 59998886421111 56888888999999999999999 8999999999999999976 899999999999
Q ss_pred cCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
....+... .....|..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+.. .......+.+...
T Consensus 175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~------dQL~eIik~lG~P 245 (364)
T KOG0658|consen 175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV------DQLVEIIKVLGTP 245 (364)
T ss_pred eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH------HHHHHHHHHhCCC
Confidence 88665543 344478999999999875 5999999999999999999999999864321 1111111111111
Q ss_pred --------C---CCccCccccCCCCc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 --------G---YMNIDPVIVGDRSC-FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 --------~---~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. .....|.+...... ......+++..+|+.++|+++|.+|.++.+++.
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1 12222333333211 112255678999999999999999999999885
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=299.60 Aligned_cols=253 Identities=21% Similarity=0.244 Sum_probs=201.2
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
++|.....| |+|++|.||+|.+.++..||+|.+.... ...+.+.+|+.++++++|||++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~i-g~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKL-GQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeee-cCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 456777788 9999999999999777789999876543 23467889999999999999999999875 45689999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++..... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 83 GKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999965321 35789999999999999999999 9999999999999999999999999999997654332
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ......++..|+|||+..+..++.++|+||||+++|+|++ |..||..... ...............
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----------~~~~~~~~~~~~~~~- 224 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----------REVLEQVERGYRMPC- 224 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHHcCCCCCC-
Confidence 21 1112235678999999988889999999999999999999 8888864321 111111211111100
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus 225 -----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 -----------PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----------CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=318.45 Aligned_cols=251 Identities=22% Similarity=0.287 Sum_probs=209.6
Q ss_pred ccccccCCCceEEEEEEEC---CC--ceEEEEEecc-cchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 65 RNITIDEIEGYILYMGFLR---DR--GPILVMKYRK-SVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~~---~~--~~vaik~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.+.| |.|.||.||+|+.. .+ -.||||.... .+....+.|+.|..+|++++|||||+++|+|.+. ..+||||.
T Consensus 394 ~r~i-G~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL 471 (974)
T KOG4257|consen 394 KRLI-GEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL 471 (974)
T ss_pred HHhh-cCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence 3455 99999999999982 22 3788999876 4556688899999999999999999999999664 57999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
++.|.|..++..+. ..++......++.||+.||.||| +.++|||||..+|||+.+...+||+|||+++.+...
T Consensus 472 ~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 472 APLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred ccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999997654 57889999999999999999999 999999999999999999999999999999988665
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
...... ...-++.|||||-+....|+.+||||-|||.+||+++ |..||...... ..+
T Consensus 545 ~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------------DVI 602 (974)
T KOG4257|consen 545 AYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------------DVI 602 (974)
T ss_pred chhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------------ceE
Confidence 544333 3336789999999999999999999999999999977 99999854321 111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
-..-+|...+.. ..|++.+..|+.+||.++|.+||++.++...|.+++.
T Consensus 603 ~~iEnGeRlP~P-~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GHIENGERLPCP-PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEecCCCCCCCC-CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 111222222222 3788999999999999999999999999999998875
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=312.93 Aligned_cols=241 Identities=16% Similarity=0.157 Sum_probs=192.6
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCC-CccceeeeeecCCcCeEE
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHK-SILKLIGCCLEAEMPALV 135 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv 135 (350)
+|...+.| |+|+||.||+|.. .++..||+|.+.... ....+.+..|+.++..++|+ +|+.+++++.+.+..++|
T Consensus 1 ~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVL-GKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEE-eeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 46777888 9999999999999 455689999987542 23445678899999999765 588899999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 80 MEYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999999988653 46889999999999999999999 999999999999999999999999999998653
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+......
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----------~~~~~~i~~~~~~ 219 (324)
T cd05587 152 IFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----------DELFQSIMEHNVS 219 (324)
T ss_pred CCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----------HHHHHHHHcCCCC
Confidence 22111 12344589999999999999999999999999999999999999874321 1111111111110
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 335 (350)
+. ...+..+.+++.+||+.||++||+.
T Consensus 220 -~~------------~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 -YP------------KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CC------------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 1234578899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=314.29 Aligned_cols=251 Identities=18% Similarity=0.153 Sum_probs=197.1
Q ss_pred CcccccccccCCCceEEEEEEE----CCCceEEEEEecccch----hhHHHHHHHHHHHHhc-CCCCccceeeeeecCCc
Q 018816 61 NYSMRNITIDEIEGYILYMGFL----RDRGPILVMKYRKSVR----YASERCFNNIVFASQM-NHKSILKLIGCCLEAEM 131 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~----~~~~~vaik~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 131 (350)
+|...+.| |+|+||.||++.. .++..||+|.+..... ...+.+.+|+.++.++ +||||+.+++++.+.+.
T Consensus 1 ~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVL-GTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEE-eecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 46777888 9999999999987 3566899999865321 2345677899999999 49999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcC
Confidence 99999999999999998653 46889999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
++........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... .........+.
T Consensus 152 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~~~~~~~ 224 (332)
T cd05614 152 SKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER------NTQSEVSRRIL 224 (332)
T ss_pred CccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC------CCHHHHHHHHh
Confidence 8765332221 12234589999999998865 4789999999999999999999999743221 11111111111
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
. .++.+. ...+..+.+++.+||+.||++|| ++.++++
T Consensus 225 ~-----~~~~~~--------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 K-----CDPPFP--------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred c-----CCCCCC--------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 111111 12345788999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=312.02 Aligned_cols=240 Identities=18% Similarity=0.168 Sum_probs=193.6
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|.+ .++..||+|.+.... ......+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 2 ~l-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 2 VL-GKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred ee-eeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 45 9999999999999 456689999987642 23345677899999888 699999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|.+++... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 9999888653 46899999999999999999999 99999999999999999999999999999865322211
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|..||..... ......+..... .+ +
T Consensus 152 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~----------~~~~~~i~~~~~-~~-~-- 216 (318)
T cd05570 152 -TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----------DELFQSILEDEV-RY-P-- 216 (318)
T ss_pred -cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH----------HHHHHHHHcCCC-CC-C--
Confidence 12334589999999999999999999999999999999999999874321 111111111111 00 0
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM-----IDVAK 340 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~ 340 (350)
...+..+.+|+.+||+.||++|||+ .++++
T Consensus 217 ---------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 ---------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1334678999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=300.33 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=203.3
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...++| |+|+||.||+|..+++..||+|.+.... .....+.+|+.++++++||||+++++++ ..+..+++|||
T Consensus 5 ~~~~~~~~~i-g~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKL-GAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred hHHceeeeee-ccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 3567778888 9999999999999888899999987543 2346788999999999999999999986 45678999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 82 MENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999998865322 46889999999999999999999 999999999999999999999999999998766432
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ......++..|+|||++.+..++.++||||||+++|++++ |..||..... ... ...+......
T Consensus 156 ~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------~~~-~~~~~~~~~~-- 222 (260)
T cd05067 156 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---------PEV-IQNLERGYRM-- 222 (260)
T ss_pred Ccc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---------HHH-HHHHHcCCCC--
Confidence 221 1122235778999999988889999999999999999999 9999864321 111 1111111110
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
+ .. ...+.++.+++.+||..+|++|||+++++..|++
T Consensus 223 -~-~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 -P-RP--------DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -C-CC--------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0 00 1234679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=320.77 Aligned_cols=251 Identities=16% Similarity=0.093 Sum_probs=194.8
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.|...+.| |+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++.+.+++..++||
T Consensus 2 ~f~~~~~L-G~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTL-GIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEE-EeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 57778888 9999999999999 566689999987543 233456889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 81 DYIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 999999999998653 46888999999999999999999 9999999999999999999999999999975321
Q ss_pred CCCc---------------------------------------------cccccccccCCCCCCccccccCCCCccchhH
Q 018816 217 EGKT---------------------------------------------HIKASTAIGSLEFAAPEYLTTGYYNEKTDVY 251 (350)
Q Consensus 217 ~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 251 (350)
.... .......+||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 1000 0001234589999999999988999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCC
Q 018816 252 SFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAED 331 (350)
Q Consensus 252 slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~ 331 (350)
||||++|||++|++||...... ......... ......|.. ...++++.+++.+|+ .+|++
T Consensus 233 SlGvil~elltG~~Pf~~~~~~---------~~~~~i~~~-~~~~~~p~~---------~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPL---------ETQMKVINW-QTSLHIPPQ---------AKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHH---------HHHHHHHcc-CCCcCCCCc---------ccCCHHHHHHHHHHc-cCHhH
Confidence 9999999999999999753321 111111110 111100100 123456778887776 49999
Q ss_pred CCC---HHHHHH
Q 018816 332 RPT---MIDVAK 340 (350)
Q Consensus 332 RPt---~~evl~ 340 (350)
|++ +.+++.
T Consensus 293 R~~~~~~~ei~~ 304 (382)
T cd05625 293 RLGKNGADEIKA 304 (382)
T ss_pred cCCCCCHHHHhc
Confidence 997 887765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=300.19 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=205.8
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...+.| |+|++|.||+|..+++..|++|.+.... ...+++.+|+.++++++||||+++++++.+....++||||
T Consensus 5 ~~~~~i~~~i-g~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKL-GAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeee-ccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4678888888 9999999999999777789999987543 3356789999999999999999999999998999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++..... ..+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 83 MSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred cCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999965422 46899999999999999999999 999999999999999999999999999998766532
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.... ......+..|+|||.+.+..++.++|+||||+++|++++ |+.||..... .... ...........
T Consensus 157 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---------~~~~-~~~~~~~~~~~ 225 (261)
T cd05034 157 EYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---------REVL-EQVERGYRMPR 225 (261)
T ss_pred hhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHH-HHHHcCCCCCC
Confidence 2111 112224678999999998889999999999999999998 8998853321 1111 11111111000
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
+ ...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 226 -~-----------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 -P-----------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -C-----------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 1234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=299.92 Aligned_cols=255 Identities=17% Similarity=0.168 Sum_probs=191.4
Q ss_pred ccccCCCceEEEEEEECC---CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 67 ITIDEIEGYILYMGFLRD---RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~---~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
.| |+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 2 ~l-g~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EI-GNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cC-CccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 35 999999999997632 3367888765432 233456889999999999999999999999999999999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
+|.+++...........++.....++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997643222234567888999999999999999 9999999999999999999999999999986543322221
Q ss_pred cccccccCCCCCCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 223 KASTAIGSLEFAAPEYLTT-------GYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||..... .............
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---------~~~~~~~~~~~~~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---------EQVLKQVVREQDI 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---------HHHHHHHhhccCc
Confidence 2233336778999998743 356889999999999999999 7777764321 1112222222222
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
....+.+. ...+..+.+++..|| .||++|||+.+|++.|.
T Consensus 229 ~~~~~~~~--------~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLD--------LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCccc--------ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22222221 134466788999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=300.55 Aligned_cols=257 Identities=21% Similarity=0.264 Sum_probs=204.4
Q ss_pred cCcccccccccCCCceEEEEEEECC----CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD----RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~----~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
++|.....| |+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 6 ~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCI-GEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeee-CCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 457777888 999999999999733 2368889887654 3456689999999999999999999998875 55789
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++.... ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999996532 35899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
........ .....++..|+|||.+....++.++||||||+++||+++ |..||..... .... ..+....
T Consensus 157 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---------~~~~-~~~~~~~ 225 (270)
T cd05056 157 LEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---------NDVI-GRIENGE 225 (270)
T ss_pred ccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---------HHHH-HHHHcCC
Confidence 64432221 122234568999999988889999999999999999986 9999864321 1111 1122111
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..... ..++..+.+++.+||..+|++|||+.++++.|+++..+
T Consensus 226 ~~~~~------------~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 RLPMP------------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred cCCCC------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11100 13456799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=301.61 Aligned_cols=259 Identities=19% Similarity=0.276 Sum_probs=205.4
Q ss_pred cCcccccccccCCCceEEEEEEECC-Cc----eEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD-RG----PILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~-~~----~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.+|...+.| |+|+||.||+|.+++ +. .||+|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~i-g~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVL-GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEccee-cCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 456667788 999999999999833 32 58888876553 3345678899999999999999999999987 7889
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||.+.
T Consensus 85 ~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 9999999999999986542 45899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...............++..|+|||.+....++.++|+||||+++||+++ |..||..... ......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----------~~~~~~~~~~ 227 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----------VEIPDLLEKG 227 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----------HHHHHHHhCC
Confidence 7654332222222224678999999988889999999999999999998 9999874321 1122222221
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
......+ .++..+.+++.+||..+|++|||+.++++.|.++.+.+
T Consensus 228 ~~~~~~~------------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 228 ERLPQPP------------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred CCCCCCC------------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 1111110 23356889999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=309.98 Aligned_cols=239 Identities=21% Similarity=0.191 Sum_probs=190.6
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|.+ .++..||+|.+.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 2 ~l-G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 2 ML-GKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred ee-eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 45 9999999999999 556689999987642 22345566788888764 899999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 9999998653 46889999999999999999999 99999999999999999999999999999875322211
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.... ..+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----------~~~~~~i~~~~-~~~~--- 216 (316)
T cd05619 152 -KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----------EELFQSIRMDN-PCYP--- 216 (316)
T ss_pred -ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----------HHHHHHHHhCC-CCCC---
Confidence 12334589999999999988999999999999999999999999874321 11111121111 1111
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI-DVA 339 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl 339 (350)
...+..+.+++.+||+.||++||++. +++
T Consensus 217 ---------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 ---------RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ---------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 12345688999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=310.42 Aligned_cols=239 Identities=19% Similarity=0.174 Sum_probs=190.6
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|.+ .++..||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 2 ~l-g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 2 VL-GKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred ee-eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 45 9999999999999 456689999987642 12345567788888765 899999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|.+++... ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.++|+|||++........
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-
Confidence 9999988653 46889999999999999999999 99999999999999999999999999999874322111
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.... +..
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~----------~~~~~~~~~~~-----~~~ 215 (316)
T cd05620 152 -RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE----------DELFESIRVDT-----PHY 215 (316)
T ss_pred -ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----------HHHHHHHHhCC-----CCC
Confidence 22345589999999999999999999999999999999999999974321 11111111111 111
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI-DVA 339 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl 339 (350)
. ...+.++.+++.+||+.||++||++. +++
T Consensus 216 ~--------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 P--------RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C--------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 02345788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=298.14 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=197.3
Q ss_pred ccccCCCceEEEEEEE-CCC---ceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDR---GPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~---~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|++ ..+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 2 ~i-g~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 2 EL-GHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred cc-CccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 45 9999999999987 222 5899999876543 34567889999999999999999999876 4568999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|.+++... ..+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||.+.........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999654 36889999999999999999999 899999999999999999999999999998766443322
Q ss_pred cc-ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 222 IK-ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 222 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.. .....++..|+|||.+.+..++.++||||||+++|++++ |..||..... ......+....... .+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----------~~~~~~~~~~~~~~-~~ 220 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----------AEVIAMLESGERLP-RP 220 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----------HHHHHHHHcCCcCC-CC
Confidence 11 112224568999999988889999999999999999998 9999864321 11122222211110 00
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
...+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 221 -----------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 -----------EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 134467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=306.94 Aligned_cols=262 Identities=19% Similarity=0.256 Sum_probs=204.6
Q ss_pred cCcccccccccCCCceEEEEEEEC--------CCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR--------DRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEA 129 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~--------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 129 (350)
++|...+.| |+|+||.||++... ....||+|.+.... ......+.+|+.++.++ +||||+++++++.+.
T Consensus 12 ~~~~~~~~l-g~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPL-GEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeee-cCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 567778888 99999999999752 23468888876542 23456788999999999 699999999999998
Q ss_pred CcCeEEeecCCCCchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 198 (350)
...+++|||+++++|.+++..... .....+++..+..++.|++.||.||| +.+++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 999999999999999999865321 01135889999999999999999999 9999999999999999
Q ss_pred CCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCC
Q 018816 199 QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGS 277 (350)
Q Consensus 199 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~ 277 (350)
+.++.+||+|||.++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 9999999999999986643322211222224567999999988889999999999999999999 8888754321
Q ss_pred cchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 278 NFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
................ ..++.++.+++.+||+.+|++|||+.++++.|+++..
T Consensus 243 -----~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 -----EELFKLLREGHRMDKP------------SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -----HHHHHHHHcCCCCCCC------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111222211110000 1334578899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=299.16 Aligned_cols=252 Identities=18% Similarity=0.191 Sum_probs=201.6
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-----hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-----YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++|...+.| |+|++|.||++.. .++..|++|.+..... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 2 ~~~~~~~~l-g~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLL-GQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred Cccccccee-cCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 578888888 9999999999998 5677999998764321 22356889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+|+||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred EEEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 999999999999988653 46889999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCcccc-ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIK-ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.......... .....++..|+|||++.+..++.++||||||+++|+|++|+.||..... ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~~~~~ 223 (263)
T cd06625 153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---------MAAIFKIATQP 223 (263)
T ss_pred eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---------HHHHHHHhccC
Confidence 6543221111 1233478899999999998899999999999999999999999864321 01111111110
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.. +.+. ...+..+.+++.+||..+|++|||+.++++.
T Consensus 224 ~~----~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TN----PQLP--------SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CC----CCCC--------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11 1111 1345678999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=298.74 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=199.2
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeee-cCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCL-EAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~ 138 (350)
.+|...+.| |+|+||.||++...+. .|++|.+... ...+.+.+|+.++++++|+|++++++++. +++..+++|||
T Consensus 6 ~~~~~~~~l-g~g~~~~v~~~~~~~~-~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTI-GKGEFGDVMLGDYRGN-KVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeee-cccCCCeEEEEEEcCC-cEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 467777888 9999999999988754 8999988654 23467889999999999999999999764 55678999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 82 MAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999865321 35889999999999999999999 999999999999999999999999999998754332
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
. ....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... . .....+........
T Consensus 156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---------~-~~~~~~~~~~~~~~ 220 (256)
T cd05082 156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------K-DVVPRVEKGYKMDA 220 (256)
T ss_pred C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---------H-HHHHHHhcCCCCCC
Confidence 2 12235678999999988889999999999999999997 8888763211 1 11111221111110
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
. ..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 221 ~------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 221 P------------DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred C------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0 13456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=302.02 Aligned_cols=250 Identities=17% Similarity=0.260 Sum_probs=197.3
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
+|...+.| |+|+||.||+|.+ .++..||+|.+... .......+.+|+.++.+++||||+++++++...+..++||||
T Consensus 2 ~~~~~~~l-g~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEIL-GHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeee-ccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 56667778 9999999999998 66678999988654 233456788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|..+ ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 81 MDGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CCCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999998654 24678889999999999999999 999999999999999999999999999998765432
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
. .....++..|+|||++.+..++.++|+||||+++|+|++|..||......... .............. .
T Consensus 149 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~----~ 217 (279)
T cd06619 149 I----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS---LMPLQLLQCIVDED----P 217 (279)
T ss_pred c----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc---cchHHHHHHHhccC----C
Confidence 2 22345899999999999889999999999999999999999998653221000 00111111111111 1
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
+.+.. ...+.++.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~-------~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 PVLPV-------GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCC-------CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11100 1234578999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=296.61 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=199.2
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCchh
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLA 145 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 145 (350)
.| |.|++|.||++.+.++..|++|.+...... ....+.+|+.++++++||||+++++++.+....++||||+++++|.
T Consensus 2 ~l-g~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 2 KI-GKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred cc-ccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 45 999999999999966889999988765433 5567899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcccccc
Q 018816 146 DRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225 (350)
Q Consensus 146 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 225 (350)
+++.... ..+++.....++.+++.||.||| +++++|+||+|+||+++.++.++|+|||.+.............
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9986532 45789999999999999999999 9999999999999999999999999999987654322221212
Q ss_pred ccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
....+..|+|||.+.++.++.++|+||||+++|+|++ |..||..... ......+.... ....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----------~~~~~~~~~~~-~~~~------ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----------QQTRERIESGY-RMPA------ 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----------HHHHHHHhcCC-CCCC------
Confidence 2234667999999988899999999999999999999 7887754321 11111121111 0000
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 217 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 -----PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -----CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0144568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=320.96 Aligned_cols=253 Identities=16% Similarity=0.083 Sum_probs=196.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||++.. .++..||+|.+..... .....+.+|+.++.+++||||+++++.+.+++.+++|
T Consensus 1 ~~y~~~~~l-G~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTI-GIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEE-EeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 367888888 9999999999998 5667999999865422 2345678999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++... ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|..+
T Consensus 80 ~E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 80 MDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999999998653 46788899999999999999999 999999999999999999999999999997533
Q ss_pred CCCCc-----------------------------------------cccccccccCCCCCCccccccCCCCccchhHHHH
Q 018816 216 PEGKT-----------------------------------------HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFG 254 (350)
Q Consensus 216 ~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 254 (350)
..... .......+||+.|+|||++.+..++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 11000 0001134699999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-
Q 018816 255 KLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP- 333 (350)
Q Consensus 255 ~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP- 333 (350)
|++|||++|+.||...... ...... .........+.. ...+..+.+++.+|+ .+|.+|+
T Consensus 232 vilyell~G~~Pf~~~~~~---------~~~~~i-~~~~~~~~~~~~---------~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 232 VILYEMLVGQPPFLADTPA---------ETQLKV-INWETTLHIPSQ---------AKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred ceeeehhhCCCCCCCCCHH---------HHHHHH-hccCccccCCCC---------CCCCHHHHHHHHHHh-cCHhhcCC
Confidence 9999999999999754321 111111 110101000100 123456778888876 4999999
Q ss_pred --CHHHHHHH
Q 018816 334 --TMIDVAKK 341 (350)
Q Consensus 334 --t~~evl~~ 341 (350)
|+.+++..
T Consensus 292 ~~t~~ell~h 301 (376)
T cd05598 292 KNGADEIKAH 301 (376)
T ss_pred CCCHHHHhCC
Confidence 88988753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=299.40 Aligned_cols=256 Identities=17% Similarity=0.226 Sum_probs=203.4
Q ss_pred cCcccccccccCCCceEEEEEEEC-CC---ceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-DR---GPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-~~---~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
++|...+.| |+|+||.||+|.+. ++ ..+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVI-GAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeee-cccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 567778888 99999999999873 22 268898886542 2345678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+..
T Consensus 83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999986532 46889999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCcccc-ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 215 IPEGKTHIK-ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 215 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
......... .....++..|+|||++.+..++.++|+||||+++|++++ |..||..... . .....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~------~----~~~~~~~~~ 225 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN------Q----DVIKAIEEG 225 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH------H----HHHHHHhCC
Confidence 644322111 111223568999999998889999999999999999886 9999864321 0 111111111
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
. .. +.. ...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 226 ~-~~--~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 Y-RL--PAP---------MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C-cC--CCC---------CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1 00 100 13346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=297.76 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=202.9
Q ss_pred ccccCCCceEEEEEEECC----CceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFLRD----RGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~----~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|.... +..|++|.+...... ..+.+.+|+..+..++|+||+++++++.+....++||||+++
T Consensus 2 ~i-g~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 2 KL-GEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred cc-ccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 45 999999999999943 669999998765433 367788999999999999999999999999999999999999
Q ss_pred CchhhhhhCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 142 CTLADRLYGPLQT----HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 142 ~sL~~~l~~~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
++|.+++...... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998764211 0156899999999999999999999 99999999999999999999999999999987765
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
...........+++.|+|||.+....++.++||||||+++|+|++ |..||..... ..............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------~~~~~~~~~~~~~~ 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----------EEVLEYLRKGYRLP 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----------HHHHHHHHcCCCCC
Confidence 432222334447889999999988889999999999999999999 5888875421 11122222111110
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
.+ ...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 228 -~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 -KP-----------EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CC-----------ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00 134568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=302.85 Aligned_cols=256 Identities=19% Similarity=0.235 Sum_probs=201.9
Q ss_pred HHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 55 LKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 55 l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++.+++++.....| |+|+||.||+|.+ .++..|++|.+........+.+.+|+.++++++|+||+++++++..++..+
T Consensus 3 ~~~~~~~~~~~~~l-g~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVL-GKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEE-ecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 44566777777777 9999999999998 566689999987765556678999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-CCceeEcccC
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPL--LLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-EYAAKLFDFS 210 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg 210 (350)
+|+||+++++|.+++.... ..+ +...+..++.||+.||.||| +.+|+|+||||+||+++. ++.++|+|||
T Consensus 82 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecch
Confidence 9999999999999987532 234 78888999999999999999 999999999999999986 6789999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY--YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
.+........ ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...... ... ....
T Consensus 155 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~------~~~--~~~~ 224 (268)
T cd06624 155 TSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP------QAA--MFKV 224 (268)
T ss_pred hheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh------hhh--Hhhh
Confidence 9876533221 122234789999999987654 789999999999999999999998643210 000 0000
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. ....+.+ +....+.+.+++.+||+.+|++|||+.+++.
T Consensus 225 ---~~-~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 225 ---GM-FKIHPEI--------PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---hh-hccCCCC--------CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 0001111 1134567899999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=313.48 Aligned_cols=236 Identities=19% Similarity=0.170 Sum_probs=188.0
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHH-HHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIV-FASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|.+ .++..||+|.+..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 2 ~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 2 VI-GKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred ee-eeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 45 9999999999999 5677999999865422 22344555555 56789999999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|..++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK- 151 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-
Confidence 9999988653 46889999999999999999999 99999999999999999999999999999875422211
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........ ... ..+.+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---------~~~~~~i~-~~~-~~~~~-- 217 (323)
T cd05575 152 -TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---------AEMYDNIL-NKP-LRLKP-- 217 (323)
T ss_pred -ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---------HHHHHHHH-cCC-CCCCC--
Confidence 22344589999999999998999999999999999999999999874321 11111111 111 11111
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI 336 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 336 (350)
..+..+.+++.+||+.||++||++.
T Consensus 218 ----------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 ----------NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----------CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2346788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=300.73 Aligned_cols=252 Identities=19% Similarity=0.172 Sum_probs=202.0
Q ss_pred cCcccccccccCCCceEEEEEEECC-CceEEEEEecccchh---hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD-RGPILVMKYRKSVRY---ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~-~~~vaik~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
+.|.....| |.|.-|+||++.+.+ +..+|+|.+.+..-. ...+...|-+||+.++||.++.+|+.++.+...|++
T Consensus 77 ~~f~llk~L-G~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRL-GCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHc-CCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 345566778 999999999999944 468999999876433 234567899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
||||+||+|..+.+.... +.+++..+..++.+|+-||+||| -.|||+|||||+||||-++|++-|+||.++...
T Consensus 156 meyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred EecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 999999999998876544 67999999999999999999999 999999999999999999999999999987433
Q ss_pred CCC--------------------------------C-c---------------------cccccccccCCCCCCcccccc
Q 018816 216 PEG--------------------------------K-T---------------------HIKASTAIGSLEFAAPEYLTT 241 (350)
Q Consensus 216 ~~~--------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~ 241 (350)
... . . .......+||..|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 210 0 0 001223569999999999999
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHH
Q 018816 242 GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELA 321 (350)
Q Consensus 242 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 321 (350)
...+.++|+|+|||++|||+.|..||...... ..+.+.+.+.. .+.+. ...+..+.+||
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---------~Tl~NIv~~~l------~Fp~~------~~vs~~akDLI 368 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------ETLRNIVGQPL------KFPEE------PEVSSAAKDLI 368 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---------hhHHHHhcCCC------cCCCC------CcchhHHHHHH
Confidence 99999999999999999999999999865431 11122222111 11111 14567899999
Q ss_pred HHccccCCCCCCC----HHHHH
Q 018816 322 FKCLSHSAEDRPT----MIDVA 339 (350)
Q Consensus 322 ~~cl~~~P~~RPt----~~evl 339 (350)
++.|..||++|.- +.||-
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred HHHhccChhhhhccccchHHhh
Confidence 9999999999987 66654
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.07 Aligned_cols=249 Identities=19% Similarity=0.251 Sum_probs=202.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.+|...+.| |+|++|.||+|.. .++..|++|.+........+.+.+|+.+++.++||||+++++.+.++...++||||
T Consensus 20 ~~y~~~~~l-g~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEe-cCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 567777888 9999999999998 56779999998766555567788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++.. ..+++.++..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred cCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999999854 35789999999999999999999 999999999999999999999999999998765432
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...... ......... ..
T Consensus 170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---------~~~~~~~~~-~~---- 233 (296)
T cd06654 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---------RALYLIATN-GT---- 233 (296)
T ss_pred cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---------HhHHHHhcC-CC----
Confidence 21 122335889999999998888999999999999999999999998643210 011111111 11
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+.. +...+..+.+++.+||..+|++|||+.+++.
T Consensus 234 ~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQN------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCC------ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 00100 1144567899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.95 Aligned_cols=241 Identities=15% Similarity=0.143 Sum_probs=193.0
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEE
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 135 (350)
+|.....| |+|+||.||+|.. .++..||+|.+..... ...+.+..|..++..+ .|++|+.+++++.+.+..++|
T Consensus 1 df~~~~~l-g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVL-GKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEE-eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 47777888 9999999999999 4566899999875422 2334567788888877 589999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 80 MEYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EcCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999999988653 46889999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+......
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---------~~-~~~~i~~~~~~ 219 (323)
T cd05616 152 MWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------DE-LFQSIMEHNVA 219 (323)
T ss_pred CCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---------HH-HHHHHHhCCCC
Confidence 32211 12344589999999999999999999999999999999999999974321 11 11111111110
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 335 (350)
+. ...+.++.+++.+||+.+|++|++.
T Consensus 220 -~p------------~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 -YP------------KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CC------------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 1334678999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=317.12 Aligned_cols=265 Identities=17% Similarity=0.206 Sum_probs=197.6
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----cC
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE-----MP 132 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 132 (350)
+|+..+.| |+|+||.||++.+ .++..||+|++... .....+++.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPI-GYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCccccee-eeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 46777888 9999999999998 67779999998643 2234567889999999999999999999998776 78
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+. ++|.+.+... ..+++..+..++.||+.||.||| +.+++||||||+|||++.++.+||+|||++
T Consensus 80 ~lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccce
Confidence 99999996 6788777543 46899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccC---------CCCcchH-
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT---------GGSNFFI- 281 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~~~~~~- 281 (350)
......... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||....... +......
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 151 RVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred eecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 765432221 12233478999999998874 47999999999999999999999997543210 0000000
Q ss_pred ---HHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 282 ---TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 282 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.......+...... .+....... .....++++.+|+.+||+.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 230 RSACEGARAHILRGPHK--PPSLPVLYT--LSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHhhHHHHHHHHhCCCC--CCchHHhcc--cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00011111111100 000000000 00123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=298.95 Aligned_cols=252 Identities=19% Similarity=0.249 Sum_probs=195.8
Q ss_pred ccccCCCceEEEEEEECC-Cc--eEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFLRD-RG--PILVMKYRKS-VRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~-~~--~vaik~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
+| |+|+||.||+|.+.+ +. .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 2 ~l-g~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VI-GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cC-CCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 45 999999999999843 33 4678877643 234456788999999999 799999999999999999999999999
Q ss_pred CchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 142 CTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 142 ~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
++|.+++..... .....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 999999864321 11135789999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
++...... ........+..|+|||++....++.++|+|||||++|||++ |..||..... ... ....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---------~~~-~~~~ 224 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------AEL-YEKL 224 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---------HHH-HHHH
Confidence 98532211 11112224567999999988889999999999999999997 9999864321 111 1111
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.... ..+ . +...+..+.+++.+||+.+|.+|||+.+++..|+++..
T Consensus 225 ~~~~--~~~--~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 225 PQGY--RLE--K--------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred hCCC--CCC--C--------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 1110 000 0 01234578899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=293.48 Aligned_cols=251 Identities=18% Similarity=0.210 Sum_probs=207.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++.|+..++| |+|.|+.||++.. ..+..+|+|.++.. ...+.+++.+|+.|-+.|+||||+++.+.+.+....++|
T Consensus 10 ~d~y~l~e~i-gkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEEL-GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHH-ccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3566777788 9999999999998 66778888887543 234567899999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCceeEcccCCC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKLFDFSLS 212 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~ 212 (350)
+|++.|++|..-|-.. .-+++..+-+...||+.+|.|+| .++|||||+||+|+++.+ ...+||+|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999997766433 35788889999999999999999 999999999999999954 455899999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.....+. .....+|||+|||||++...+|+..+|||+.||++|-|+.|.+||.... ...+...+..+
T Consensus 161 i~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~----------~~rlye~I~~g 227 (355)
T KOG0033|consen 161 IEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----------QHRLYEQIKAG 227 (355)
T ss_pred EEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc----------HHHHHHHHhcc
Confidence 8876332 3455669999999999999999999999999999999999999997532 22333444444
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+..-.|.+. ..+++..+|+++||..||++|.|+.|.|.
T Consensus 228 ~yd~~~~~w~---------~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 228 AYDYPSPEWD---------TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccCCCCcccC---------cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 4444333331 45678899999999999999999999875
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=305.35 Aligned_cols=259 Identities=15% Similarity=0.205 Sum_probs=199.6
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |+|+||.||++.+ .++..+|+|.+.... ......+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 1 ~~~~~~~~l-g~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGEL-GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeec-cCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 468888888 9999999999998 455567777775442 2344668899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|+++++|.+++... ..+++..+..++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 y~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 80 HMDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred ccCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 99999999998654 46889999999999999999999 6 589999999999999999999999999986553
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
... .....++..|+|||++.+..++.++|+||||+++|+|++|..||...... . ....+.......
T Consensus 152 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~------~----~~~~~~~~~~~~ 217 (308)
T cd06615 152 DSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK------E----LEAMFGRPVSEG 217 (308)
T ss_pred ccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh------h----HHHhhcCccccc
Confidence 221 22345889999999998888999999999999999999999998643211 0 000000000000
Q ss_pred c-------------------------CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 297 I-------------------------DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 297 ~-------------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
. +.......+.......+.++.+++.+||+.+|++|||+.+|+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000000000001245679999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=310.90 Aligned_cols=252 Identities=21% Similarity=0.221 Sum_probs=210.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh---hHHHHHHHHHHHHhcC-CCCccceeeeeecCCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY---ASERCFNNIVFASQMN-HKSILKLIGCCLEAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 132 (350)
....|...+.| |.|.||.||+++. .++..+|+|.+.+.... ..+.+.+|+.+|++++ |||||.+.+.+++....
T Consensus 33 ~~~~Y~l~~~l-G~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 33 IKEKYELGREL-GRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred ccccEEehhhh-CCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567777788 9999999999999 45889999999776442 3468999999999998 99999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC----CceeEcc
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE----YAAKLFD 208 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~D 208 (350)
++|||++.||.|.+.+... .+++..+..++.|++.++.||| +.+++||||||+|+|+... +.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999654 2899999999999999999999 9999999999999999643 5799999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...... .....
T Consensus 183 FGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~----------~~~~~ 249 (382)
T KOG0032|consen 183 FGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF----------EIFLA 249 (382)
T ss_pred CCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh----------HHHHH
Confidence 999998766 22355667999999999999999999999999999999999999999854321 01112
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
+..+.....++.+ +..+..+.+++..|+..||..|+|+.++++.
T Consensus 250 i~~~~~~f~~~~w---------~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 250 ILRGDFDFTSEPW---------DDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHcCCCCCCCCCc---------cccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 3333332222222 2557789999999999999999999999974
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=296.97 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=193.1
Q ss_pred ccccCCCceEEEEEEEC----CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeee-cCCcCeEEeecCC
Q 018816 67 ITIDEIEGYILYMGFLR----DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCL-EAEMPALVYEPAG 140 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~----~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 140 (350)
.| |+|+||.||+|.+. +...||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 2 ~l-g~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 2 VI-GKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred cc-cccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 45 99999999999872 23478999885432 344567889999999999999999999876 4556899999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCc
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 220 (350)
+++|.+++.... ...++.....++.|++.||.||| +.+++|+||||+|||++.++.+||+|||++........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999986532 34677888999999999999999 99999999999999999999999999999876543221
Q ss_pred c--ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 221 H--IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG-RTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 221 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
. .......++..|+|||.+.+..++.++|||||||++|||++| .+||..... . .. ............
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~---~~-~~~~~~~~~~~~ 223 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------F---DI-TVYLLQGRRLLQ 223 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------H---HH-HHHHhcCCCCCC
Confidence 1 111122357789999999888899999999999999999995 455542211 1 11 111111111000
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
+ ...+..+.+++.+||+.+|++||++.+|++.|+++..
T Consensus 224 -~-----------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 -P-----------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -C-----------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 1234678999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=323.40 Aligned_cols=244 Identities=20% Similarity=0.274 Sum_probs=203.3
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCchh
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLA 145 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 145 (350)
+| |+|.||+||-|++ .+...+|||-+.........-+..|+.+.++|+|.|||+++|.|.+++.+-|.||-++||||.
T Consensus 582 VL-GKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VL-GKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred Ee-ecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 45 9999999999999 555688999997776666677899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-CCceeEcccCCCccCCCCCccc
Q 018816 146 DRLYGPLQTHLEPL--LLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-EYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 146 ~~l~~~~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
+++.... +++ .+...-.+..||+.||.||| .+.|||||||-+|||++. .|.+||+|||-++....-..
T Consensus 661 sLLrskW----GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-- 731 (1226)
T KOG4279|consen 661 SLLRSKW----GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-- 731 (1226)
T ss_pred HHHHhcc----CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence 9997543 667 78888899999999999999 999999999999999974 78999999999987754333
Q ss_pred cccccccCCCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 223 KASTAIGSLEFAAPEYLTTGY--YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.+.+..||..|||||++..++ |..++|||||||++.||.||++||...... ..+ .++-+-+. ..|.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---------qAA--MFkVGmyK-vHP~ 799 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---------QAA--MFKVGMYK-VHPP 799 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---------hHh--hhhhccee-cCCC
Confidence 355667999999999998764 899999999999999999999999865331 000 01111111 1121
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
-+++.+.+...++.+|+.+||.+||++.+++.
T Consensus 800 --------iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 --------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --------CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 13578889999999999999999999999985
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=313.67 Aligned_cols=264 Identities=16% Similarity=0.274 Sum_probs=203.4
Q ss_pred cCcccccccccCCCceEEEEEEE------CCCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecC-C
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEA-E 130 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~ 130 (350)
++|...+.| |+|+||.||+|.+ .++..||+|.+.... ......+.+|+.++.++ +||||+++++++... .
T Consensus 7 ~~~~~~~~l-G~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPL-GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccc-cCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 467888888 9999999999974 345689999987543 23345688999999999 689999999988654 4
Q ss_pred cCeEEeecCCCCchhhhhhCCCCC--------------------------------------------------------
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQT-------------------------------------------------------- 154 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~-------------------------------------------------------- 154 (350)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998642110
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccc
Q 018816 155 ------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228 (350)
Q Consensus 155 ------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 228 (350)
....+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0023678888999999999999999 9999999999999999999999999999987654332222222333
Q ss_pred cCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCc
Q 018816 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSC 307 (350)
Q Consensus 229 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (350)
+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ............... .+.
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---------~~~~~~~~~~~~~~~-~~~------- 305 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---------DEEFCRRLKEGTRMR-APD------- 305 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc---------cHHHHHHHhccCCCC-CCC-------
Confidence 5678999999988889999999999999999997 8888764321 011111121111110 010
Q ss_pred cchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 308 FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 308 ~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..++.+.+++..||+.+|++|||+.+|++.|+.+.+.
T Consensus 306 ----~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 306 ----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1235689999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=301.49 Aligned_cols=265 Identities=19% Similarity=0.193 Sum_probs=202.5
Q ss_pred cCcccccccccCCCceEEEEEEE-----CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecC--Cc
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-----RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEA--EM 131 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-----~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 131 (350)
..|...+.| |+|+||.||++.. .++..||+|.+.... ......+.+|+.++++++||||+++.+++.+. ..
T Consensus 4 ~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceec-CCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345666777 9999999999984 345689999986543 33456788999999999999999999998875 57
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcc
Confidence 899999999999999986432 35899999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccC------CCCcchHHHH
Q 018816 212 SKSIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT------GGSNFFITDR 284 (350)
Q Consensus 212 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~~~~~~~ 284 (350)
+.......... ......++..|+|||++.+..++.++|||||||++|+|+++..|........ ...... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 234 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT-VTR 234 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccccc-HHH
Confidence 88664432211 1223446778999999988889999999999999999999877643211100 000001 111
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
.......+..... +..++..+.+|+.+||+.+|++|||+.++++.|+++
T Consensus 235 ~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEEGKRLPR------------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHcCccCCC------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111111000 013456899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=309.78 Aligned_cols=242 Identities=17% Similarity=0.144 Sum_probs=191.5
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++.++ +||||+.+++++.+.+..++||||+++
T Consensus 2 ~l-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 2 VI-GRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred ee-eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 45 9999999999999 566689999987542 23345678899999888 599999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|..++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 9999888643 46899999999999999999999 99999999999999999999999999999875322111
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ................... +.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~-~p--- 223 (327)
T cd05617 152 -TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN---PDMNTEDYLFQVILEKPIR-IP--- 223 (327)
T ss_pred -ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC---cccccHHHHHHHHHhCCCC-CC---
Confidence 123455899999999999999999999999999999999999999643221 1111122222222221111 11
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 335 (350)
...+..+.+++.+||+.||++||++
T Consensus 224 ---------~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 ---------RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ---------CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1234568899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=313.47 Aligned_cols=269 Identities=18% Similarity=0.217 Sum_probs=197.7
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC----
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE---- 130 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 130 (350)
..++|...+.| |+|+||.||++.+ ..+..||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPI-GSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEe-ecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45789988998 9999999999998 56779999998643 2234567889999999999999999999986543
Q ss_pred --cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 131 --MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 131 --~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
..++||||+++ +|.+.+. ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEec
Confidence 46999999964 6666553 34788889999999999999999 99999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccC---------CCCcc
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT---------GGSNF 279 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~~~~ 279 (350)
||++....... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||....... +....
T Consensus 167 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 167 FGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred CCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 99987543222 1223458999999999999899999999999999999999999997543210 00000
Q ss_pred hHHH----HHHHHHHhcC-CCcc-----CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 280 FITD----RVEKFIRSNG-YMNI-----DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 280 ~~~~----~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.... .......... .... .+.+............++.+.+|+.+||+.||++|||+.|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 1111111111 0000 00000000000001234678999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=304.63 Aligned_cols=257 Identities=18% Similarity=0.283 Sum_probs=201.3
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCc----eEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRG----PILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~----~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++|...+.| |+|+||.||+|.+ .++. .||+|.+..... ....++.+|+.+++.++||||++++++|... ..+
T Consensus 7 ~~~~~~~~l-g~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVL-GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceecccc-ccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456667777 9999999999998 3333 468888765432 3344688999999999999999999998754 467
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+++||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccc
Confidence 9999999999999986532 46889999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...............++..|+|||++.+..++.++|||||||++|||++ |..||.... .......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~----------~~~~~~~~~~~ 227 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP----------TREIPDLLEKG 227 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC----------HHHHHHHHHCC
Confidence 7654332222223335778999999988889999999999999999997 888876321 11122222222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
..... + ..++..+.+++..||..+|++||++.++++.|+++.+
T Consensus 228 ~~~~~-~-----------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 228 ERLPQ-P-----------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCC-C-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11110 0 0234578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=315.96 Aligned_cols=260 Identities=17% Similarity=0.157 Sum_probs=201.8
Q ss_pred HHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeee
Q 018816 52 SEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCL 127 (350)
Q Consensus 52 ~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 127 (350)
..++....++|...+.| |+|+||.||++.+ .++..||+|.+.... ......+.+|+.+++.++||||+++++.+.
T Consensus 35 ~~~~~~~~~~y~i~~~l-G~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 35 IRDLRMKAEDYEVVKVI-GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HhhcCcchhhcEEEEEE-eecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34455566899999999 9999999999999 556688899886432 123455778999999999999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
+++..++||||+++|+|.+++.. ..++...+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~ 184 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLA 184 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999998854 35788889999999999999999 9999999999999999999999999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG----YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|..||..... ..
T Consensus 185 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------~~ 254 (371)
T cd05622 185 DFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---------VG 254 (371)
T ss_pred eCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---------HH
Confidence 99999866432221 22345699999999998753 378999999999999999999999974321 11
Q ss_pred HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 018816 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAED--RPTMIDVAKK 341 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~ 341 (350)
........ .....-+.. ...+..+.+++..||..++.+ ||++.++++.
T Consensus 255 ~~~~i~~~-~~~~~~~~~---------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 255 TYSKIMNH-KNSLTFPDD---------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHHcC-CCcccCCCc---------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11222111 111000100 134567889999999844433 7899988874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=295.00 Aligned_cols=268 Identities=16% Similarity=0.158 Sum_probs=201.6
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh--hHHHHHHHHHHHHhcCCCC-ccceeeeeecCC-----
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY--ASERCFNNIVFASQMNHKS-ILKLIGCCLEAE----- 130 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~----- 130 (350)
..|...++| |+|+||+||+|+. .++..||+|++.-.... .-....+|+.+++.|+|+| |+.+++++.+.+
T Consensus 11 ~~~~~~ekl-GeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKL-GEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHh-CCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345555667 9999999999999 66679999998765432 2345679999999999999 999999998877
Q ss_pred -cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 131 -MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
.+++|+||++ -+|..++....... ..++...+..++.||+.||+||| +++|+||||||.||||+++|.+||+||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeecc
Confidence 7899999995 69999987643211 24666889999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
|+|+...-+.. .....++|..|.|||++.+. .|+...||||+|||++||+++++.|..... ..........
T Consensus 165 GlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se------~~ql~~If~~ 236 (323)
T KOG0594|consen 165 GLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE------IDQLFRIFRL 236 (323)
T ss_pred chHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH------HHHHHHHHHH
Confidence 99986653322 23445689999999999987 699999999999999999999999886543 2222222222
Q ss_pred HHhcCCCcc-----CccccCCCCccc-h----HH---HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 289 IRSNGYMNI-----DPVIVGDRSCFR-K----EE---KLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 289 ~~~~~~~~~-----~~~~~~~~~~~~-~----~~---~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
+........ -+.....+.... + .. ......+++.+||+++|.+|.|+..++..
T Consensus 237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 221110000 011110000000 0 01 11378899999999999999999999875
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=300.15 Aligned_cols=252 Identities=18% Similarity=0.175 Sum_probs=199.4
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
++|...+.| |+|+||.||+|+. .++..||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~l-g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRI-GSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHh-CCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 466777778 9999999999998 56778999988665444456688999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++... +.+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 88 CGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999988643 56899999999999999999999 899999999999999999999999999998765332
Q ss_pred CccccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
. .......|+..|+|||++. ...++.++|+|||||++|+|++|..||...... ....... ...
T Consensus 160 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~---------~~~~~~~-~~~-- 225 (267)
T cd06645 160 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---------RALFLMT-KSN-- 225 (267)
T ss_pred c--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch---------hhHHhhh-ccC--
Confidence 1 1223345899999999874 456889999999999999999999998643221 0001110 001
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+..... ...+..+.+++.+||+.+|++|||+.+|++
T Consensus 226 ~~~~~~~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 226 FQPPKLKDK------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCCccccc------CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 001111100 023456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=296.60 Aligned_cols=255 Identities=19% Similarity=0.268 Sum_probs=203.7
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...+.| |+|+||.||++...++..+++|.+.... ...+.+.+|+.++++++|+||+++++++.+ ...+++|||
T Consensus 5 ~~~~~~~~~l-g~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKL-GAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEe-cCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 3567888888 9999999999998777789999876543 345678899999999999999999999887 778999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++..... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||.+......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 82 MAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred CCCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999865321 45788999999999999999999 899999999999999999999999999998765433
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ......++..|+|||++....++.++|+|||||++|++++ |..||..... ......+......
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----------~~~~~~~~~~~~~-- 222 (260)
T cd05073 156 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----------PEVIRALERGYRM-- 222 (260)
T ss_pred Ccc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----------HHHHHHHhCCCCC--
Confidence 221 1122235678999999988889999999999999999998 8888864321 0111111111100
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
+. ....+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 223 -~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 -PR---------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -CC---------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 00 013446789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=297.40 Aligned_cols=252 Identities=20% Similarity=0.339 Sum_probs=201.3
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
.+|+....| |+|+||.||++.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~i-g~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEI-GSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeee-cCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 456777788 9999999999998766789999886543 23457889999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++.... ..+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 82 EHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 9999999986532 45789999999999999999999 8999999999999999999999999999987654322
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ......++..|+|||++.++.++.++|+||||+++|||++ |..||..... .......... .....
T Consensus 155 ~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----------~~~~~~~~~~-~~~~~ 222 (256)
T cd05112 155 YT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----------SEVVETINAG-FRLYK 222 (256)
T ss_pred cc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----------HHHHHHHhCC-CCCCC
Confidence 11 1112225678999999998889999999999999999998 8998864321 1111111111 11111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
+. ..+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus 223 ~~-----------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 PR-----------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CC-----------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11 22467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=304.67 Aligned_cols=249 Identities=19% Similarity=0.253 Sum_probs=203.0
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
++|...+.| |+|++|.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 19 ~~y~~~~~l-g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKI-GQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhceeeeee-ccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 677888888 9999999999998 67779999998765555567788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 98 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999854 35788999999999999999999 999999999999999999999999999998765433
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... .....+++.|+|||.+.+..++.++|+|||||++|++++|..||....... .... ......
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~---------~~~~-~~~~~~---- 232 (297)
T cd06656 169 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---------ALYL-IATNGT---- 232 (297)
T ss_pred ccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch---------heee-eccCCC----
Confidence 211 223348889999999998889999999999999999999999986432210 0000 000000
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+... .+...+..+.+++.+||+.+|++|||+.+|++
T Consensus 233 ~~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PELQ------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCC------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01244567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=323.12 Aligned_cols=264 Identities=17% Similarity=0.187 Sum_probs=191.3
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecC-------
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEA------- 129 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 129 (350)
...+|...+.| |+|+||.||+|.. ..+..||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~L-G~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNII-GNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEE-EeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 34679999998 9999999999999 566799999986542 2244799999999999999998876432
Q ss_pred -CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-ceeEc
Q 018816 130 -EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLF 207 (350)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~ 207 (350)
..+++||||++ ++|.+++...... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence 24678999997 4776666432111 156899999999999999999999 99999999999999999665 69999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|.+||...... .......
T Consensus 214 DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~------~~~~~i~ 284 (440)
T PTZ00036 214 DFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV------DQLVRII 284 (440)
T ss_pred ccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHH
Confidence 9999986643322 2234589999999998764 6899999999999999999999999754321 1000010
Q ss_pred HHHHhc----------CCC-ccCcccc-CCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 287 KFIRSN----------GYM-NIDPVIV-GDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 287 ~~~~~~----------~~~-~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...... ... ..-+... .......+...+.++.+|+.+||+.||.+|||+.++++
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000 000 0000000 00000001123467899999999999999999999985
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=311.52 Aligned_cols=240 Identities=19% Similarity=0.175 Sum_probs=188.6
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHH-HHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIV-FASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||++.+ .++..||+|.+..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 2 ~l-g~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 2 VI-GKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred ee-eeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 45 9999999999999 4566899999865421 22234444544 56788999999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|.+++... ..+....+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 9999988653 46788889999999999999999 99999999999999999999999999999875432211
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ......... .. ....+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~i~~-~~-~~~~~-- 217 (325)
T cd05602 152 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---------AEMYDNILN-KP-LQLKP-- 217 (325)
T ss_pred -CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---------HHHHHHHHh-CC-cCCCC--
Confidence 23344599999999999999999999999999999999999999974322 111111111 11 11111
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..+..+.+++.+||+.||.+||++.+.+.
T Consensus 218 ----------~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 ----------NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ----------CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 33467899999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=296.89 Aligned_cols=250 Identities=17% Similarity=0.171 Sum_probs=201.5
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
+|...+.| |+|+||.||++.. .++..+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+.+.++++|||
T Consensus 1 ~y~~~~~l-g~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVV-GEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEe-eccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 46677788 9999999999999 56778999988543 234456788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++..... ..++......++.|++.||.||| +.+++|+||+|+||+++.++.++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999998854321 45789999999999999999999 999999999999999999999999999998765432
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ......+++.|+|||++.+..++.++|+||||+++|+|++|..||..... ...... +..+....+.
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---------~~~~~~-~~~~~~~~~~ 221 (255)
T cd08219 154 GA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---------KNLILK-VCQGSYKPLP 221 (255)
T ss_pred cc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---------HHHHHH-HhcCCCCCCC
Confidence 22 12234588999999999888899999999999999999999999874321 111111 1111111111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...+..+.+++.+||+.||++|||+.+|+.+
T Consensus 222 ------------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 ------------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=294.63 Aligned_cols=254 Identities=16% Similarity=0.137 Sum_probs=190.8
Q ss_pred ccccCCCceEEEEEEECCCc---eEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 67 ITIDEIEGYILYMGFLRDRG---PILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~---~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
.| |+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.|.+....++||||++++
T Consensus 2 ~l-g~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EI-GNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cC-CCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 35 99999999999863332 45666665433 234567999999999999999999999999999999999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
+|.+++...... ....+......++.||+.||.||| +.+++|+||||+|||++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999998753211 135677788899999999999999 8999999999999999999999999999876432222111
Q ss_pred cccccccCCCCCCcccccc-------CCCCccchhHHHHHHHHHHHhC-CCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 223 KASTAIGSLEFAAPEYLTT-------GYYNEKTDVYSFGKLLLVLLTG-RTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
......++..|+|||++.. ..++.++|||||||++|||+++ ..||..... .............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---------~~~~~~~~~~~~~ 227 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---------REVLNHVIKDQQV 227 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHhhccc
Confidence 2233457889999998753 2457899999999999999974 666653221 2222233333333
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
...++.+.. ...+.+.+++..|| .+|++||++.+|++.|.
T Consensus 228 ~~~~~~~~~--------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLEL--------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCC--------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333443322 23356788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=315.77 Aligned_cols=252 Identities=15% Similarity=0.140 Sum_probs=196.1
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||++.. .++..||+|.+.... ......+.+|+.++.+++||||+++++.+.+.+..++|
T Consensus 1 ~~f~~~~~l-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVI-GRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEE-eeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467788888 9999999999999 566789999986542 23345678899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++... ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++...
T Consensus 80 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 80 MEFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999998653 46899999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCcc---------------------------------ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh
Q 018816 216 PEGKTH---------------------------------IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262 (350)
Q Consensus 216 ~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 262 (350)
...... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 321100 00113469999999999999999999999999999999999
Q ss_pred CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 018816 263 GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT---MIDVA 339 (350)
Q Consensus 263 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~evl 339 (350)
|..||..... ...............+.+.. ..+.++.+|+.+|+. ||.+|++ +.+++
T Consensus 232 G~~Pf~~~~~---------~~~~~~i~~~~~~~~~p~~~----------~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 232 GYPPFCSETP---------QETYRKVMNWKETLVFPPEV----------PISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCCCCCCH---------HHHHHHHHcCCCceecCCCC----------CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 9999975432 11111111100111111110 234567888888774 9999985 56665
Q ss_pred H
Q 018816 340 K 340 (350)
Q Consensus 340 ~ 340 (350)
.
T Consensus 292 ~ 292 (360)
T cd05627 292 S 292 (360)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=302.49 Aligned_cols=250 Identities=16% Similarity=0.191 Sum_probs=198.3
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
|+..+.| |+|+||.||++.. .++..||+|.+..... .....+.+|+.++++++|+||+.+++.+.+.+..++|||
T Consensus 2 f~~~~~i-g~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVL-GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEe-ecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 5666777 9999999999999 5667999999865421 223457789999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 9999999998854321 35889999999999999999999 99999999999999999999999999999876543
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...... ...............
T Consensus 155 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~------~~~~~~~~~~~~~~~--- 222 (285)
T cd05630 155 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK------IKREEVERLVKEVQE--- 222 (285)
T ss_pred Ccc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc------chHHHHHhhhhhhhh---
Confidence 221 12335899999999999889999999999999999999999999753210 001111111111000
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 340 (350)
... ...+..+.+|+.+||+.||++||| +.++++
T Consensus 223 --~~~--------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 --EYS--------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --hcC--------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 133456889999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=311.36 Aligned_cols=237 Identities=20% Similarity=0.138 Sum_probs=191.3
Q ss_pred ccccCCCceEEEEEEE----CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCC
Q 018816 67 ITIDEIEGYILYMGFL----RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAG 140 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~----~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 140 (350)
.| |+|+||.||++.. .++..||+|.+..... .....+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 3 ~l-g~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 3 VL-GQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ee-eeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 46 9999999999986 3567899999875432 234557789999999999999999999999999999999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCc
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 220 (350)
+++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 99999998653 46899999999999999999999 99999999999999999999999999999876543221
Q ss_pred cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .... ..+...... +.
T Consensus 154 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---------~~~~-~~i~~~~~~-~p-- 218 (318)
T cd05582 154 --KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---------KETM-TMILKAKLG-MP-- 218 (318)
T ss_pred --ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---------HHHH-HHHHcCCCC-CC--
Confidence 12334589999999999988899999999999999999999999874321 1111 111111110 00
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHH
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMID 337 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 337 (350)
...+..+.+|+.+||+.||++||++.+
T Consensus 219 ----------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 ----------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 133467889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=334.50 Aligned_cols=264 Identities=17% Similarity=0.199 Sum_probs=205.4
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+|.+ .++..||+|++.... ....+++.+|+.++++++||||+++++++.+++..++|
T Consensus 2 grYeIi~~L-GkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLI-GKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEE-ecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 578888888 9999999999999 567799999986532 23356789999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 136 YEPAGYCTLADRLYGPLQ------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
|||+++++|.+++..... ......++..++.++.||+.||.||| +.+|+||||||+||+++.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEec
Confidence 999999999998864211 01134667788999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCc----------------cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCccc
Q 018816 210 SLSKSIPEGKT----------------HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLA 273 (350)
Q Consensus 210 g~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 273 (350)
|++........ .......+||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99976521110 00112346999999999999999999999999999999999999998642210
Q ss_pred CCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhh
Q 018816 274 TGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-TMIDVAKKLRQMYR 347 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~~~ 347 (350)
.. ... ....++.-... ....+..+.+++.+||+.||++|| +++++++.|+...+
T Consensus 238 ------ki-------~~~--~~i~~P~~~~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 ------KI-------SYR--DVILSPIEVAP-----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ------hh-------hhh--hhccChhhccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 000 00001100000 013456788999999999999996 67888888887755
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=315.82 Aligned_cols=262 Identities=19% Similarity=0.222 Sum_probs=198.9
Q ss_pred hcCcccccccccCCCceEEEEEEEC---CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR---DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
...|.....| |.|+||.||++... .+..|++|.+... ....+|+.++++++||||+++++++......++|
T Consensus 91 ~~~y~i~~~L-g~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSL-TPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEee-cCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3568888998 99999999999863 3457888887643 2356899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
||++. ++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++...
T Consensus 165 ~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred ehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 99995 6888888432 57899999999999999999999 999999999999999999999999999999766
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC-
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY- 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 294 (350)
.............||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.......+.
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~l~~i~~~~~~~ 309 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS------SSSQLRSIIRCMQVH 309 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC------cHHHHHHHHHHhccC
Confidence 54433223334569999999999999999999999999999999999999987543311 00111111110000
Q ss_pred -Ccc---------------CccccCCCC---ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 295 -MNI---------------DPVIVGDRS---CFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 295 -~~~---------------~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
... ......... .......+.++.+++.+||+.||++|||+.+++..
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 310 PLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 000000000 00001234578899999999999999999999863
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=299.00 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=197.7
Q ss_pred ccccCCCceEEEEEEECCC-------ceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 67 ITIDEIEGYILYMGFLRDR-------GPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~-------~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.| |+|+||.||+|+..+. ..+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 2 ~l-g~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FL-GSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred cc-ccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 35 9999999999998432 368888876543 23456788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-----ceeEcccCC
Q 018816 139 AGYCTLADRLYGPLQT--HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-----AAKLFDFSL 211 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~ 211 (350)
+++++|.+++...... ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998653211 1134788999999999999999999 89999999999999999887 899999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+................++..|+|||++.++.++.++|||||||++|+|++ |..||..... .. ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---------~~-~~~~~~ 227 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---------QE-VLQHVT 227 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---------HH-HHHHHh
Confidence 876543332222223346788999999999999999999999999999998 9998863321 11 111111
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
....... +...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 228 ~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 228 AGGRLQK------------PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cCCccCC------------cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1110000 01445678999999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=295.57 Aligned_cols=238 Identities=22% Similarity=0.294 Sum_probs=187.9
Q ss_pred ccccCCCceEEEEEEECCC-------------ceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 67 ITIDEIEGYILYMGFLRDR-------------GPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~-------------~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.| |+|+||.||+|+..+. ..|++|.+..........+.+|+.++..++||||+++++++.+....+
T Consensus 2 ~l-g~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 2 HL-GRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred cc-ccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 35 9999999999986322 258888877655555567889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc-------eeE
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA-------AKL 206 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-------~kl 206 (350)
+||||+++++|..++.... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++. +++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999998876432 46899999999999999999999 999999999999999987664 899
Q ss_pred cccCCCccCCCCCccccccccccCCCCCCccccc-cCCCCccchhHHHHHHHHHHH-hCCCCCCCCcccCCCCcchHHHH
Q 018816 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT-TGYYNEKTDVYSFGKLLLVLL-TGRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~-tg~~p~~~~~~~~~~~~~~~~~~ 284 (350)
+|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+...... .
T Consensus 154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----------~ 217 (262)
T cd05077 154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA----------E 217 (262)
T ss_pred CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh----------H
Confidence 999988654322 2234788999999887 456899999999999999998 577776532210 0
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
..... ........ .....+.+|+.+||+.||++||++.+|++.|
T Consensus 218 ~~~~~-~~~~~~~~-------------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 KERFY-EGQCMLVT-------------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHH-hcCccCCC-------------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11111 11111111 2235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=302.44 Aligned_cols=249 Identities=18% Similarity=0.261 Sum_probs=203.3
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.+|+....| |.|++|.||+|.. .++..|++|.+........+.+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 19 ~~y~~~~~l-g~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKI-GQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEE-ecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 457888888 9999999999998 66779999998765555567788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|..++.. ..+++.++..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 98 LAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred cCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999998854 35889999999999999999999 999999999999999999999999999998765433
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...... .... .........
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---------~~~~-~~~~~~~~~-- 234 (296)
T cd06655 169 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---------RALY-LIATNGTPE-- 234 (296)
T ss_pred ccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHH-HHHhcCCcc--
Confidence 221 22334888999999999888999999999999999999999998743220 1111 111111111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+... ...+..+.+++.+||..||++|||+.+++.
T Consensus 235 --~~~~------~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 --LQNP------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --cCCc------ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1000 134567889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=318.15 Aligned_cols=265 Identities=15% Similarity=0.147 Sum_probs=197.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
...|.....| |+|+||.||++.+ ..+..||+|.... ..+.+|+.++++++|+||+++++++......++|||
T Consensus 168 ~~gy~i~~~L-g~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRAL-TPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEE-ccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3468888888 9999999999999 5566899986432 235689999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
++. ++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.++|+|||+++....
T Consensus 241 ~~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 241 KYR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred ccC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 995 78888875432 46899999999999999999999 99999999999999999999999999999976543
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC--C
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY--M 295 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 295 (350)
...........||+.|+|||++.+..++.++|||||||++|||++|..|+........... ....+...+..... .
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~--~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRP--YDAQILRIIRQAQVHVD 390 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCC--cHHHHHHHHHhhccccc
Confidence 3222122234599999999999999999999999999999999998876544322111111 11111111111110 0
Q ss_pred cc--------------------CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 296 NI--------------------DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 296 ~~--------------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.+ .+........ ........+.+|+.+||+.||.+|||+.|+|+.
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWT-RYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchh-hhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0000000000 000223468899999999999999999999874
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=299.84 Aligned_cols=249 Identities=18% Similarity=0.186 Sum_probs=196.6
Q ss_pred cccccccccCCCceEEEEEEEC-CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCC
Q 018816 62 YSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAG 140 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 140 (350)
|+....| |+|+||.||+|... ++..+++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus 7 ~~i~~~l-g~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGEL-GDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhc-ccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3445667 99999999999994 455778888866555556778899999999999999999999999999999999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCc
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 220 (350)
+++|..++.... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 86 GGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 999998875432 46899999999999999999999 99999999999999999999999999999876533221
Q ss_pred cccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 221 HIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
......+++.|+|||++. +..++.++|+|||||++|+|++|.+||..... ..............
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---------~~~~~~~~~~~~~~ 227 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---------MRVLLKIAKSEPPT 227 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---------HHHHHHHhhcCCCC
Confidence 123345889999999884 34578899999999999999999999864321 11111111111111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+ ...+..+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~~-----------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 LAQP-----------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCCc-----------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 134567899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=346.23 Aligned_cols=272 Identities=25% Similarity=0.311 Sum_probs=211.8
Q ss_pred cccHHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeee
Q 018816 49 SFSSEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCL 127 (350)
Q Consensus 49 ~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 127 (350)
.++.+++. ..|...++| |+|+||.||+|.. .++..||+|++...... ...|+..+++++|||||+++++|.
T Consensus 682 ~~~~~~~~---~~~~~~~~i-g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~ 753 (968)
T PLN00113 682 SITINDIL---SSLKEENVI-SRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCR 753 (968)
T ss_pred hhhHHHHH---hhCCcccEE-ccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEE
Confidence 35555543 457777788 9999999999998 67779999998654321 234688999999999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
+.+..++||||+++|+|.+++. .++|..+..++.|++.||+|||+.++.+|+||||||+||+++.++.+++.
T Consensus 754 ~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~ 825 (968)
T PLN00113 754 SEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR 825 (968)
T ss_pred cCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence 9999999999999999999983 47899999999999999999997667799999999999999999888775
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
||.+..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||+.... .......+...
T Consensus 826 -~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~----~~~~~~~~~~~ 894 (968)
T PLN00113 826 -LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG----VHGSIVEWARY 894 (968)
T ss_pred -ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC----CCCcHHHHHHH
Confidence 555433211 1122488999999999999999999999999999999999999853221 12233444433
Q ss_pred HHHhcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 288 FIRSNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 288 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
...... ...+|+.+...... +.....++.+++.+||+.||++||||.+|++.|+++.+++
T Consensus 895 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 895 CYSDCHLDMWIDPSIRGDVSV--NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred hcCccchhheeCccccCCCCc--cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 332222 23345554333221 1255667899999999999999999999999999997743
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=300.52 Aligned_cols=250 Identities=15% Similarity=0.162 Sum_probs=197.4
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
|...+.| |+|+||+||+|.+ .++..||+|.+..... .....+.+|+.++++++|+||+.+.+.+.+++..++|||
T Consensus 2 ~~~~~~l-g~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVL-GKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEE-ecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 5556677 9999999999999 5677899999865421 223457789999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred eccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 9999999988864321 46899999999999999999999 99999999999999999999999999999876533
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... .....|+..|+|||++.+..++.++|+|||||++|+|++|..||..... ..........+.... ...
T Consensus 155 ~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~------~~~~~~~~~~~~~~~-~~~ 224 (285)
T cd05632 155 GES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE------KVKREEVDRRVLETE-EVY 224 (285)
T ss_pred CCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhhhccc-ccc
Confidence 221 2234589999999999988999999999999999999999999874322 111111111111111 010
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 340 (350)
. ...+..+.+|+..||+.||++||+ +.+++.
T Consensus 225 ~------------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 S------------AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred C------------ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0 133457889999999999999999 667766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=300.75 Aligned_cols=238 Identities=21% Similarity=0.238 Sum_probs=186.9
Q ss_pred ccccCCCceEEEEEEECC-------------------------CceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccc
Q 018816 67 ITIDEIEGYILYMGFLRD-------------------------RGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILK 121 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~-------------------------~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 121 (350)
.| |+|+||.||+|.... ...|++|.+..........+.+|+.++++++||||++
T Consensus 2 ~l-G~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HL-GQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred Cc-CcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence 35 999999999998621 1258888887655455567889999999999999999
Q ss_pred eeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC
Q 018816 122 LIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201 (350)
Q Consensus 122 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 201 (350)
++++|.+....++||||+++++|..++.... ..+++..++.++.||+.||.||| +++|+||||||+||+++..
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence 9999999999999999999999999886432 46889999999999999999999 9999999999999999764
Q ss_pred C-------ceeEcccCCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHH-hCCCCCCCCcc
Q 018816 202 Y-------AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLL-TGRTIGHLSRL 272 (350)
Q Consensus 202 ~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~-tg~~p~~~~~~ 272 (350)
+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|..||.....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3 3799999987644221 12237788999998876 46899999999999999995 68888764321
Q ss_pred cCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 273 ATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
. . ......... .. + . .....+.+++.+||+.+|++|||+.+|++.|
T Consensus 228 ~------~----~~~~~~~~~-~~--~---~--------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 S------E----KERFYEKKH-RL--P---E--------PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H------H----HHHHHHhcc-CC--C---C--------CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 0 1 111111110 00 0 0 1224688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=299.50 Aligned_cols=266 Identities=20% Similarity=0.237 Sum_probs=204.9
Q ss_pred CcccccccccCCCceEEEEEEEC-----CCceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeec--CCcC
Q 018816 61 NYSMRNITIDEIEGYILYMGFLR-----DRGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLE--AEMP 132 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~-----~~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 132 (350)
+|...+.| |+|+||.||++.+. .+..||+|.+...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~i-g~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 5 HLKFIKQL-GEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hchhheee-ccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45566777 99999999999973 3568999998765443 46779999999999999999999999887 5588
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
+++|||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 99999999999999996542 35899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCC-----CcchHHHHHH
Q 018816 213 KSIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-----SNFFITDRVE 286 (350)
Q Consensus 213 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-----~~~~~~~~~~ 286 (350)
.......... ......++..|+|||.+.+..++.++|+||||++++||++|..|+......... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 8765332211 111223566799999998888999999999999999999999987643211000 0000111111
Q ss_pred HHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
........... +..++.++.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 237 ~~~~~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 237 ELLKEGERLPR------------PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHcCCcCCC------------CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11111110000 0134467999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=306.78 Aligned_cols=241 Identities=14% Similarity=0.149 Sum_probs=192.6
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEE
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 135 (350)
+|+..+.| |+|+||.||++.. .++..||+|.+.... ....+.+..|..++..+. |++|+.+++++.+.+..++|
T Consensus 1 ~f~~~~~l-g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVL-GKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEE-EecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 46667788 9999999999998 567789999987542 233456778899998886 57788899999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 80 MEYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEecccccccc
Confidence 9999999999988653 46899999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..... .+......
T Consensus 152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---------~~~~~-~i~~~~~~ 219 (323)
T cd05615 152 MVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---------DELFQ-SIMEHNVS 219 (323)
T ss_pred CCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---------HHHHH-HHHhCCCC
Confidence 32221 12334589999999999988999999999999999999999999874321 11111 11111111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 335 (350)
. | ...+..+.+++.+||+.+|++|++.
T Consensus 220 ~--p-----------~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 Y--P-----------KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C--C-----------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 0 1334578899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=311.39 Aligned_cols=239 Identities=17% Similarity=0.158 Sum_probs=189.0
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHH-HHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIV-FASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||++.. .++..||+|.+..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 2 ~l-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 2 VI-GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred ce-eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 45 9999999999998 5677999999865421 23345556655 46778999999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|..++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 9999888643 56899999999999999999999 99999999999999999999999999999875422211
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......... . ...+.+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---------~~~~~~~~~-~-~~~~~~-- 217 (325)
T cd05604 152 -TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---------AEMYDNILH-K-PLVLRP-- 217 (325)
T ss_pred -CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---------HHHHHHHHc-C-CccCCC--
Confidence 22344589999999999999999999999999999999999999874321 111111111 1 111111
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVA 339 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 339 (350)
..+..+.+++.+||+.+|.+||++.+.+
T Consensus 218 ----------~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 ----------GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ----------CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 2345688999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=295.57 Aligned_cols=249 Identities=21% Similarity=0.263 Sum_probs=202.6
Q ss_pred cCcccccccccCCCceEEEEEEEC-CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
++|+....| |+|++|.||+|... ++..|++|.+..... .+.+.+|+.++++++||||+++++++.+....++++||
T Consensus 3 ~~y~~~~~i-~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKL-GEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhh-cCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 567888888 99999999999994 467899999866532 67899999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 80 CGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999986432 56899999999999999999999 999999999999999999999999999998876443
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ......++..|+|||++.+..++.++||||||+++|+|++|+.||...... .. .........
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~---------~~-~~~~~~~~~---- 216 (256)
T cd06612 153 MA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM---------RA-IFMIPNKPP---- 216 (256)
T ss_pred cc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh---------hh-hhhhccCCC----
Confidence 21 122334788999999998888999999999999999999999998743221 00 000000000
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+.. +...+..+.+++.+||+.+|++|||+.+|+.
T Consensus 217 ~~~~~------~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 PTLSD------PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCc------hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00000 1134567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=294.85 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=198.7
Q ss_pred ccccCCCceEEEEEEECC--Cc--eEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFLRD--RG--PILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~--~~--~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|++|.||+|.+.+ +. .||+|.+..... ...+.+.+|+.++++++||||+++++++.+ ...++||||+++
T Consensus 2 ~i-g~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 2 KL-GDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred cC-CccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 45 999999999999832 22 589999877655 556789999999999999999999999988 889999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|.+++..... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 999999876421 36899999999999999999999 999999999999999999999999999999876543221
Q ss_pred c-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 222 I-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 222 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
. ......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ..... ...........+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~-~~~~~~~~~~~~ 223 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---------SQILK-KIDKEGERLERP 223 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---------HHHHH-HHHhcCCcCCCC
Confidence 1 1223346789999999998899999999999999999998 9999864321 11111 111111110000
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 224 -----------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 -----------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 134567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=306.53 Aligned_cols=262 Identities=19% Similarity=0.258 Sum_probs=204.8
Q ss_pred cCcccccccccCCCceEEEEEEEC--------CCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR--------DRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEA 129 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~--------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 129 (350)
.+|...+.| |+|+||.||++... ....||+|.+.... ....+.+.+|+.++.++ +||||++++++|...
T Consensus 12 ~~~~i~~~i-g~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPL-GEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeeccee-ccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 467778888 99999999999862 12268899876542 23456788999999999 799999999999999
Q ss_pred CcCeEEeecCCCCchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 198 (350)
+..++++||+++++|.+++..... .....+++..++.++.|++.||.||| .++++|+||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence 999999999999999999864321 01135788999999999999999999 9999999999999999
Q ss_pred CCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCC
Q 018816 199 QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGS 277 (350)
Q Consensus 199 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~ 277 (350)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 242 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 242 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 9999999999999876544322222222334578999999998899999999999999999998 7888754321
Q ss_pred cchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 278 NFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.. ....+......... ...+..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 243 ----~~-~~~~~~~~~~~~~~------------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 ----EE-LFKLLKEGHRMDKP------------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----HH-HHHHHHcCCCCCCC------------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 11122211111100 1334678899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=298.56 Aligned_cols=248 Identities=20% Similarity=0.242 Sum_probs=208.3
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCC
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAG 140 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 140 (350)
|+....| |+|+||.||++.+ ..|..||||++... .+..++..|+.++.+.+.|++|++||.+.....+++|||||.
T Consensus 35 FDi~~KL-GEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKL-GEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHh-cCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 5556678 9999999999999 56667788887655 446789999999999999999999999999999999999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCc
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 220 (350)
.|++.+.++.++ .++++.++..++...+.||+||| ...-+|||||..|||++.+|++||+|||.+-.+...
T Consensus 112 AGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-- 182 (502)
T KOG0574|consen 112 AGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-- 182 (502)
T ss_pred CCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhh--
Confidence 999999987654 68999999999999999999999 888999999999999999999999999999766432
Q ss_pred cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....+..|||.|||||++..-.|+.++||||||++..||..|++||..-++..... .+. ....|.
T Consensus 183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------MIP----T~PPPT 248 (502)
T KOG0574|consen 183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------MIP----TKPPPT 248 (502)
T ss_pred HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------ecc----CCCCCC
Confidence 223556779999999999999999999999999999999999999998766531110 000 001111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
+ ..++..+.++.+++.+||-.+|++|.|+..+++.
T Consensus 249 F------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 F------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred C------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1 1235778899999999999999999999998863
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=304.85 Aligned_cols=264 Identities=17% Similarity=0.174 Sum_probs=197.0
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |+|+||.||+|+. .++..||+|.+..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKL-GEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEe-cccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 567788888 9999999999998 4566899999864432 233467789999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++ +|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 9974 8888775432 35789999999999999999999 99999999999999999999999999999876433
Q ss_pred CCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH----------
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE---------- 286 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 286 (350)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...... .......
T Consensus 157 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~------~~~~~~~~~~~~~~~~~ 228 (309)
T cd07872 157 PTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE------DELHLIFRLLGTPTEET 228 (309)
T ss_pred Ccc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCCHHH
Confidence 221 1223347899999998865 46899999999999999999999999754321 0000000
Q ss_pred -HHHHhcC-CCcc-CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 287 -KFIRSNG-YMNI-DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 287 -~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+.... .... .+..............+.++.+|+.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 0000 0000000000000134567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=299.58 Aligned_cols=252 Identities=19% Similarity=0.178 Sum_probs=202.3
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
++|...+.| |.|++|.||+|.. .++..||+|.+........+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 5 ~~~~i~~~l-~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 5 DIWEIIGEL-GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hHHHHHHHh-cCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457777788 9999999999998 56678999998766556667889999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+......
T Consensus 84 ~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 84 CDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred cCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999886532 46899999999999999999999 999999999999999999999999999988655332
Q ss_pred CccccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.. ......+++.|+|||++. ...++.++|+||||+++|+|++|..||..... ...... +....
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---------~~~~~~-~~~~~ 224 (280)
T cd06611 157 LQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---------MRVLLK-ILKSE 224 (280)
T ss_pred cc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---------HHHHHH-HhcCC
Confidence 21 122345889999999875 34577899999999999999999999874321 111111 11111
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...+.. +...+..+.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 PPTLDQ----------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCcCC----------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111110 01344678899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=294.25 Aligned_cols=253 Identities=21% Similarity=0.231 Sum_probs=203.7
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
++|.....| |+|++|.||+|.. .++..+++|.+........+.+.+|+.++++++||||+++++++.+....+++|||
T Consensus 3 ~~~~~~~~l-~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRI-GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEe-cCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 567788888 9999999999999 55668999998766555667889999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 82 CGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999886532 46889999999999999999999 999999999999999999999999999998765432
Q ss_pred CccccccccccCCCCCCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTG---YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... .... ........
T Consensus 155 ~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---------~~~~-~~~~~~~~ 222 (262)
T cd06613 155 IA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---------RALF-LISKSNFP 222 (262)
T ss_pred hh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---------HHHH-HHHhccCC
Confidence 21 12234578899999998776 7899999999999999999999998743321 0001 11111100
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+.+.. ....+..+.+++.+||+.+|++|||+.+|+.
T Consensus 223 --~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 --PPKLKD------KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --Cccccc------hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111110 1245678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=302.35 Aligned_cols=199 Identities=17% Similarity=0.191 Sum_probs=159.8
Q ss_pred cccccCCCceEEEEEEEC---CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeec--CCcCeEEeecCC
Q 018816 66 NITIDEIEGYILYMGFLR---DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLE--AEMPALVYEPAG 140 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 140 (350)
..| |+|+||+||+|... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||++
T Consensus 7 ~~l-G~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 7 CKV-GRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccc-ccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 456 99999999999974 45689999986542 23457789999999999999999998864 456789999995
Q ss_pred CCchhhhhhCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe----CCCCceeEcccCCC
Q 018816 141 YCTLADRLYGPLQ----THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF----QEEYAAKLFDFSLS 212 (350)
Q Consensus 141 ~~sL~~~l~~~~~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~ 212 (350)
++|.+++..... .....++...+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 588877643211 11135889999999999999999999 9999999999999999 45678999999999
Q ss_pred ccCCCCCcc-ccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 018816 213 KSIPEGKTH-IKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSR 271 (350)
Q Consensus 213 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~ 271 (350)
......... .......+|+.|+|||++.+. .++.++||||+||++|+|++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876433211 122344589999999998774 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=307.67 Aligned_cols=236 Identities=20% Similarity=0.191 Sum_probs=186.4
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHH-HHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIV-FASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
+| |+|+||.||+|++ .++..||+|.+..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 2 ~l-g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 2 VI-GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred ee-eeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 45 9999999999999 5667899999865421 22344555554 67889999999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|...+... ..++...+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE- 151 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-
Confidence 9999888643 46888999999999999999999 99999999999999999999999999999875322211
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ........ ... ..+.+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~i~-~~~-~~~~~-- 217 (321)
T cd05603 152 -TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---------SQMYDNIL-HKP-LQLPG-- 217 (321)
T ss_pred -ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---------HHHHHHHh-cCC-CCCCC--
Confidence 22344589999999999988899999999999999999999999874321 11111111 111 01110
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI 336 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 336 (350)
..+..+.+++.+||+.||.+||++.
T Consensus 218 ----------~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 ----------GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ----------CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2345788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=298.29 Aligned_cols=251 Identities=16% Similarity=0.140 Sum_probs=199.6
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
+.|...+.| |.|+||.||+|.. .++..|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 12 ~~y~i~~~l-g~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGEL-GDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhhee-cCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 456777788 9999999999999 55678899998776656677888999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|..++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 91 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 91 CPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred CCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999988775432 46889999999999999999999 999999999999999999999999999988654322
Q ss_pred CccccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.. ......+++.|+|||++. ...++.++|+|||||++|+|++|.+||..... ............
T Consensus 164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---------~~~~~~~~~~~~ 232 (292)
T cd06644 164 LQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---------MRVLLKIAKSEP 232 (292)
T ss_pred cc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---------HHHHHHHhcCCC
Confidence 11 122334788999999885 34578899999999999999999999864321 111111111100
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..... +...+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTLSQ-----------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccCCC-----------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11000 0134457889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=299.07 Aligned_cols=248 Identities=23% Similarity=0.255 Sum_probs=201.7
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|+....| |.|++|.||+|.+ .++..|++|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 1 ~~y~~~~~l-g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECI-GKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred Chhhhhhhh-cCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 356777788 9999999999999 566789999886543 3345678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 80 YCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999999864 36889999999999999999999 99999999999999999999999999999977654
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||..... ......+.....
T Consensus 151 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----------~~~~~~~~~~~~--- 215 (274)
T cd06609 151 TMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----------MRVLFLIPKNNP--- 215 (274)
T ss_pred ccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch----------HHHHHHhhhcCC---
Confidence 321 12334578899999999988899999999999999999999999864321 011111111111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+... ..+..+.+++.+||+.+|++|||+.+++.
T Consensus 216 -~~~~~~-------~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 -PSLEGN-------KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -CCCccc-------ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111100 14467889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=294.54 Aligned_cols=248 Identities=19% Similarity=0.251 Sum_probs=197.7
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccchh---------hHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY---------ASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
|.....| |+|++|.||+|.. .++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 2 ~~~~~~i-g~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 2 WIKGALI-GSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred cccccee-ecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4556677 9999999999998 56678999988643221 22567899999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCC
Confidence 99999999999999999653 46889999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCccc----cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 212 SKSIPEGKTHI----KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 212 ~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
++......... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||..... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~ 223 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---------LQAIFK 223 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---------HHHHHH
Confidence 87665321111 11223478899999999988899999999999999999999999874321 011111
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ... ..+.+. ...+..+.+++.+||+.||++||++.+|++
T Consensus 224 ~-~~~----~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 I-GEN----ASPEIP--------SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred H-hcc----CCCcCC--------cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1 111 111111 134567899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=292.66 Aligned_cols=251 Identities=20% Similarity=0.218 Sum_probs=204.0
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|+..+.| |.|+||.||.+.. .++..+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~i-g~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVL-GKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEe-cccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 46777888 9999999999998 66778999987643 23445678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 80 YANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred ecCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 9999999999865421 46889999999999999999999 89999999999999999999999999999876644
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||..... ....... ..+.....
T Consensus 154 ~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---------~~~~~~~-~~~~~~~~ 221 (256)
T cd08221 154 EYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---------LNLVVKI-VQGNYTPV 221 (256)
T ss_pred ccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---------HHHHHHH-HcCCCCCC
Confidence 332 22334589999999999888899999999999999999999999864321 1111111 11111111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
. ...+..+.+++.+||+.+|++|||+.++++.+
T Consensus 222 ~------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 V------------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred c------------cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1 13456789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=297.90 Aligned_cols=252 Identities=26% Similarity=0.315 Sum_probs=198.0
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhH--HHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYAS--ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
|...+.| |+|+||+||++.. .++..||+|.+........ ....+|+.++.+++||||+++++++.+....++||||
T Consensus 1 y~~~~~l-g~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKL-GSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEE-EEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEE-EeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 4456677 9999999999999 5555899999987654332 2345699999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++... ..+++..+..++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~- 150 (260)
T PF00069_consen 80 CPGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE- 150 (260)
T ss_dssp ETTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-
T ss_pred ccccccccccccc-----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 9999999999722 57899999999999999999999 89999999999999999999999999999876411
Q ss_pred CccccccccccCCCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.........++..|+|||++. +..++.++|+||||+++|+|++|..||..... .............. ..
T Consensus 151 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~------~~~~~~~~~~~~~~---~~ 220 (260)
T PF00069_consen 151 -NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS------DDQLEIIEKILKRP---LP 220 (260)
T ss_dssp -TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH------HHHHHHHHHHHHTH---HH
T ss_pred -cccccccccccccccccccccccccccccccccccccccccccccccccccccc------hhhhhhhhhccccc---cc
Confidence 112233445899999999998 78899999999999999999999999885411 01111111111100 00
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+.... ......+.+++.+||+.||++|||+.++++
T Consensus 221 ~~~~~~-------~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 221 SSSQQS-------REKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHTTSH-------TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccc-------chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 011368999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=298.34 Aligned_cols=245 Identities=22% Similarity=0.258 Sum_probs=197.7
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
|+..+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 6 y~~~~~l-~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERI-GKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHh-cCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4445567 9999999999998 556688998876432 344567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++.. ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 85 GGGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999998853 46889999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
. ......++..|+|||++.+..++.++|+|||||++|||++|..|+...... . ......... .+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~----~~~~~~~~~----~~ 219 (277)
T cd06642 156 I--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM------R----VLFLIPKNS----PP 219 (277)
T ss_pred h--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh------h----HHhhhhcCC----CC
Confidence 1 122334788999999999888999999999999999999999998643211 0 001111111 11
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+. ...+..+.+++.+||+.+|++|||+.+++.
T Consensus 220 ~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 TLE--------GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCC--------cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111 134567899999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=306.38 Aligned_cols=255 Identities=16% Similarity=0.129 Sum_probs=196.6
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||++.. .++..||+|.+.... ....+.+.+|+.++..++|+||+.+++++.+++..++|
T Consensus 1 ~~y~~~~~l-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVI-GRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEE-EecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 467888888 9999999999998 567799999986532 12345588899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 99999999999986421 46889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCccccccccccCCCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTT-----GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
...... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||..... .........
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~---------~~~~~~i~~ 222 (331)
T cd05597 153 LADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---------VETYGKIMN 222 (331)
T ss_pred CCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH---------HHHHHHHHc
Confidence 432221 1223458999999999863 4578899999999999999999999874321 111111211
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAE--DRPTMIDVAKK 341 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~--~RPt~~evl~~ 341 (350)
......+.+.. ...+..+.+++.+||..+++ .||++.+++..
T Consensus 223 ~~~~~~~~~~~---------~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 223 HKEHFQFPPDV---------TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCcccCCCcc---------CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11111111110 02456788999998865443 37899988864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=312.27 Aligned_cols=244 Identities=22% Similarity=0.283 Sum_probs=202.1
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
|+..+.| |.|+||-||-+++ .+...||||++.-... ..+.++..|+..|.+++|||+|.+-|+|......|||||
T Consensus 28 f~dLrEI-GHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHh-cCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4444556 9999999999999 6777899999876543 446779999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|| -||-.|++.-.. .++.+-.+..|+.+.++||.||| +.+.||||||..|||++..|.|||+|||.|....+
T Consensus 107 YC-lGSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HH-hccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 99 578888775332 67889999999999999999999 99999999999999999999999999999877643
Q ss_pred CCccccccccccCCCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..+.+|||.|||||++.. +.|+.++||||||++..||.-.++|..+..-. -+.=.+..+.
T Consensus 179 ------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM----------SALYHIAQNe- 241 (948)
T KOG0577|consen 179 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------SALYHIAQNE- 241 (948)
T ss_pred ------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH----------HHHHHHHhcC-
Confidence 345679999999999864 67999999999999999999999998755421 1111122211
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.|.+..+ +.+..+..|+..||+.-|.+|||.+++++.
T Consensus 242 ---sPtLqs~-------eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 ---SPTLQSN-------EWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---CCCCCCc-------hhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2223222 677899999999999999999999998863
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=300.83 Aligned_cols=266 Identities=18% Similarity=0.209 Sum_probs=205.4
Q ss_pred cccHHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeee
Q 018816 49 SFSSEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCC 126 (350)
Q Consensus 49 ~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 126 (350)
.+.++++....++|.....| |+|+||.||++.. .++..+|+|.+.... .....+.+|+.++.++ +||||+++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~~~l-g~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETI-GKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred eEEeecCCCcccceeeeeee-ccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 35667777888999999998 9999999999999 556688898875532 2245678899999999 699999999987
Q ss_pred e-----cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC
Q 018816 127 L-----EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201 (350)
Q Consensus 127 ~-----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 201 (350)
. +++..++||||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCC
Confidence 4 345789999999999999987532211 146889999999999999999999 9999999999999999999
Q ss_pred CceeEcccCCCccCCCCCccccccccccCCCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCC
Q 018816 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-----GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG 276 (350)
Q Consensus 202 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 276 (350)
+.++|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|..|+......
T Consensus 161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--- 235 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--- 235 (286)
T ss_pred CCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---
Confidence 9999999999876543221 1233458999999998753 44789999999999999999999998754321
Q ss_pred CcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
...............++ ...+..+.+++.+||+.||++|||+.+|++.+
T Consensus 236 ------~~~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 236 ------RALFKIPRNPPPTLHQP-----------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ------HHHhhccccCCCcccCC-----------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00001000000011111 12345789999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=298.05 Aligned_cols=253 Identities=19% Similarity=0.227 Sum_probs=197.4
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecC-----
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEA----- 129 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----- 129 (350)
.+++.|+..+.| |+|+||.||+|.. .++..||+|.+.... .....+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~l-g~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELV-GNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHhe-eecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 355678888888 9999999999998 556688888886543 3346788999999998 699999999998753
Q ss_pred -CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 130 -EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
...+++|||+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEcc
Confidence 357899999999999999875321 46889999999999999999999 89999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
||++........ ......|++.|+|||++. +..++.++|+|||||++|||++|..||...... .
T Consensus 155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---------~ 223 (272)
T cd06637 155 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---------R 223 (272)
T ss_pred CCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---------H
Confidence 999876533211 223445889999999986 335888999999999999999999998643221 0
Q ss_pred HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ......... +.... ...+..+.+|+.+||+.+|.+|||+.++++
T Consensus 224 ~-~~~~~~~~~----~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 224 A-LFLIPRNPA----PRLKS-------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred H-HHHHhcCCC----CCCCC-------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 011111110 00000 133467899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=295.64 Aligned_cols=238 Identities=20% Similarity=0.267 Sum_probs=188.0
Q ss_pred ccccCCCceEEEEEEECC-C-------ceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 67 ITIDEIEGYILYMGFLRD-R-------GPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~-~-------~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.| |+|+||.||+|.... + ..|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 2 ~l-g~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 2 SL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CC-CcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 45 999999999998832 2 24888887665545567788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc--------eeEcccC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA--------AKLFDFS 210 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg 210 (350)
+++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999986542 35889999999999999999999 999999999999999987765 5999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCC-CCCCCCcccCCCCcchHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGR-TIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
.+...... ....+++.|+|||++.+. .++.++||||||+++|+|++|. .|+..... . . ....
T Consensus 154 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------~---~-~~~~ 217 (258)
T cd05078 154 ISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------Q---K-KLQF 217 (258)
T ss_pred cccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------H---H-HHHH
Confidence 88654321 223478899999999874 5799999999999999999995 44442211 0 0 0111
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
... ... +.+ ....++.+|+.+||+.+|++|||+.++++.|
T Consensus 218 ~~~-~~~-~~~------------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 218 YED-RHQ-LPA------------PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHc-ccc-CCC------------CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 111 111 000 2235689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=312.30 Aligned_cols=197 Identities=19% Similarity=0.201 Sum_probs=171.2
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-C-----CCccceeeeeecCCcCe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-H-----KSILKLIGCCLEAEMPA 133 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~ 133 (350)
.|.+.++| |+|+||.|-+|.+ +++..||||.++... .-..+...|+.+|..|+ | -|+|+++++|...+++|
T Consensus 187 rY~V~e~L-GkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVL-GKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEe-cccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 46677888 9999999999999 667899999997764 33456678999999997 4 37999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC--CceeEcccCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE--YAAKLFDFSL 211 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~ 211 (350)
||+|.+ ..+|.+++..+. ...++...+..++.||+.||.+|| ..+|||+||||+||||... ..+||+|||.
T Consensus 265 iVfELL-~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeehhh-hhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 999999 579999997653 367999999999999999999999 9999999999999999653 4799999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSR 271 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 271 (350)
|+....... +.+-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+..
T Consensus 338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 998654332 4457889999999999999999999999999999999998887654
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=296.36 Aligned_cols=251 Identities=16% Similarity=0.212 Sum_probs=198.3
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
+|+..+.| |+|+||.||++.. ..+..||+|.+... .......+.+|+.++.+++||||+++++.+...+..++||||
T Consensus 2 ~~~~~~~i-g~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDEL-GKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhh-cccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 56667788 9999999999999 46779999988653 223456788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
+++++|..++..... ...+++..+..++.+++.||.||| . .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 81 MDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred cCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 999999988865321 146899999999999999999999 5 5899999999999999999999999999876533
Q ss_pred CCccccccccccCCCCCCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGY------YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
.. .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||..... ........... .
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~-~ 224 (286)
T cd06622 156 SL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY------ANIFAQLSAIV-D 224 (286)
T ss_pred Cc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch------hhHHHHHHHHh-h
Confidence 22 22334788999999986543 58899999999999999999999864321 11111111111 1
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....+. ...+.++.+++.+||+.+|++||++.+++.
T Consensus 225 ~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 225 GDPPTLP------------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred cCCCCCC------------cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111111 145677899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=298.78 Aligned_cols=262 Identities=16% Similarity=0.157 Sum_probs=191.3
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhc---CCCCccceeeeeecC-----
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQM---NHKSILKLIGCCLEA----- 129 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~----- 129 (350)
.|.....| |+|+||.||+|.+ .++..||+|.+..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 1 ~y~~~~~l-g~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEE-eecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 36677778 9999999999999 5667899998865321 1223456677777665 699999999988643
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
...++||||++ ++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+||
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcc
Confidence 35799999997 588888865321 35899999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
|++........ .....+|..|+|||++.+..++.++|||||||++|+|++|.+||...... ..........
T Consensus 153 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~------~~~~~~~~~~ 223 (288)
T cd07863 153 GLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA------DQLGKIFDLI 223 (288)
T ss_pred CccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH------HHHHHHHHHh
Confidence 99876543221 22344889999999999889999999999999999999999998643221 1111111111
Q ss_pred HhcC-----------CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 290 RSNG-----------YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 290 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... .....+.......... ...+..+.+++.+||+.||++|||+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 224 GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCCChhhCcccccccccccCCCCCCchHHhC-cCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000000000000000 134567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.59 Aligned_cols=247 Identities=22% Similarity=0.334 Sum_probs=197.4
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
++|...+.| |+|+||.||+|...+ ..||+|.+.... ..+.+.+|+.++++++||||+++++++... ..++||||+
T Consensus 6 ~~~~~~~~l-g~g~~g~v~~~~~~~-~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEII-GEGEFGAVLQGEYTG-QKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeee-ccCCCCceEecccCC-CceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 467778888 999999999998654 489999986542 345788999999999999999999998654 579999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 81 SKGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 99999999865321 35789999999999999999999 9999999999999999999999999999987543221
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.....+..|+|||.+.++.++.++|+||||+++|+|++ |..||..... ............ .+
T Consensus 155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----------~~~~~~~~~~~~--~~ 217 (254)
T cd05083 155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----------KEVKECVEKGYR--ME 217 (254)
T ss_pred -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----------HHHHHHHhCCCC--CC
Confidence 11224578999999988899999999999999999998 8998864321 111222222111 11
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
+ +...+..+.+++.+||+.+|++||++.+|+..|++
T Consensus 218 ~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 P----------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred C----------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1 01345678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=308.79 Aligned_cols=270 Identities=15% Similarity=0.187 Sum_probs=198.3
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC---
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAE--- 130 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 130 (350)
...++|...+.| |+|+||.||++.+ ..+..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPI-GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEe-eecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 345789988998 9999999999998 566799999986532 234567889999999999999999999886433
Q ss_pred ---cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 131 ---MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEe
Confidence 46999999964 6766663 34788889999999999999999 9999999999999999999999999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCC---------CCc
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG---------GSN 278 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---------~~~ 278 (350)
|||+++....... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...
T Consensus 162 Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 162 DFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred eCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999976543221 2334589999999999988999999999999999999999999975432100 000
Q ss_pred ch----HHHHHHHHHHhcC-CC-ccCcc-ccCCC---CccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 279 FF----ITDRVEKFIRSNG-YM-NIDPV-IVGDR---SCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 279 ~~----~~~~~~~~~~~~~-~~-~~~~~-~~~~~---~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.. ............. .. ...+. ..... ...........+.+|+.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 0001111111111 00 00000 00000 000001234678999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=299.25 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=202.3
Q ss_pred cCcccccccccCCCceEEEEEEEC------CCceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
++|.....| |+|+||.||+|+.+ +...|++|.+...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTL-GRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred Hhceeeeee-cccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 567777888 99999999999973 2347888887654333 456799999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTH----LEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
++||||+++++|.+++....... ...+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999986542110 125899999999999999999999 99999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .. ...
T Consensus 161 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---------~~-~~~ 229 (275)
T cd05046 161 LSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---------EE-VLN 229 (275)
T ss_pred cccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---------HH-HHH
Confidence 9998654322211 1223346778999999988889999999999999999999 7778753221 11 111
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
...........+ ...+..+.+++.+||+.+|++|||+.+++..|.+
T Consensus 230 ~~~~~~~~~~~~-----------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 230 RLQAGKLELPVP-----------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HHHcCCcCCCCC-----------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111111111000 1344679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.85 Aligned_cols=244 Identities=18% Similarity=0.233 Sum_probs=197.6
Q ss_pred cccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 66 NITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
..| |+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus 28 ~~l-g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKI-GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hcc-cCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456 9999999999998 56679999998665555567788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 224 (350)
.+++.. ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 107 ~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 175 (292)
T cd06658 107 TDIVTH------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR 175 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence 998854 35789999999999999999999 89999999999999999999999999999876533221 12
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
....++..|+|||.+.+..++.++|+||||+++|||++|..||..... .. ... .+... ..+.+...
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~---~~~-~~~~~----~~~~~~~~ 241 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------LQ---AMR-RIRDN----LPPRVKDS 241 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HH---HHH-HHHhc----CCCccccc
Confidence 234588999999999888899999999999999999999999874321 11 111 11111 11111111
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...+..+.+++.+||..||++|||+.++++.
T Consensus 242 ------~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 ------HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ------cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1334578899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=308.60 Aligned_cols=240 Identities=17% Similarity=0.093 Sum_probs=187.6
Q ss_pred ccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhc---CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 69 IDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQM---NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 69 ig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
||+|+||+||+|+. .++..||+|.+..... ........|..++.++ .||||+.+++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 49999999999999 5677999999865422 2223455677777665 699999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 9999888653 56899999999999999999999 99999999999999999999999999999875432221
Q ss_pred ccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 222 IKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ......+.........
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----------~~~~~~i~~~~~~~~~-- 218 (330)
T cd05586 152 -TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----------QQMYRNIAFGKVRFPK-- 218 (330)
T ss_pred -CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH----------HHHHHHHHcCCCCCCC--
Confidence 12344589999999998765 489999999999999999999999874321 1111222211111100
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP----TMIDVAK 340 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP----t~~evl~ 340 (350)
...++.+.+++.+||+.||++|| ++.++++
T Consensus 219 ----------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 ----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ----------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12346788999999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=307.73 Aligned_cols=268 Identities=15% Similarity=0.201 Sum_probs=197.1
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecC-----
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEA----- 129 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 129 (350)
..++|...+.| |+|+||.||++.+ ..+..||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPI-GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEe-ecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45789999998 9999999999998 566789999986532 23456788999999999999999999987643
Q ss_pred -CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 130 -EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
...++||||++ ++|.+.+. ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEe
Confidence 35799999996 47777663 34788899999999999999999 99999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCC---------CCcc
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG---------GSNF 279 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---------~~~~ 279 (350)
||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....
T Consensus 170 fG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 170 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred CCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99997654322 12234589999999999999999999999999999999999999975432100 0000
Q ss_pred hHHH----HHHHHHHhcC-CCc-----cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 280 FITD----RVEKFIRSNG-YMN-----IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 280 ~~~~----~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... .......... ... ..+.................+.+|+.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 0011111110 000 00000000000000123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=297.14 Aligned_cols=257 Identities=18% Similarity=0.241 Sum_probs=202.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |+|+||+||++.. .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 5 ~~~~~~~~i-g~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDL-GAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHc-CCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 456667778 9999999999998 566688888875543 2345678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|+++++|.+++... +.+++.....++.+++.||.||| + .+++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 84 FMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred cCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999988653 46899999999999999999999 5 589999999999999999999999999886542
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCC--CcchHHHHHHHHHHhcCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG--SNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 294 (350)
... .....|+..|+|||++.+..++.++|+|||||++|++++|..||......... ....+...........
T Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 229 (284)
T cd06620 156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-- 229 (284)
T ss_pred hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--
Confidence 221 22345899999999998888999999999999999999999999854321100 0011111111111110
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.+.+. ....+..+.+|+.+||+.||++|||+.++++.
T Consensus 230 ---~~~~~-------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 ---PPRLP-------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ---CCCCC-------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 01110 11355679999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=302.68 Aligned_cols=269 Identities=12% Similarity=0.114 Sum_probs=194.3
Q ss_pred cccccCC--CceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCC
Q 018816 66 NITIDEI--EGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAG 140 (350)
Q Consensus 66 ~~lig~G--~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 140 (350)
.+| |+| +|++||++.. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 4 ~~i-g~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 4 TVI-GRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhc-cccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 455 999 6789999999 677789999986542 2334567789999999999999999999999999999999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCc
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 220 (350)
+++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++++||+.+........
T Consensus 83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999854321 35889999999999999999999 99999999999999999999999999986543321111
Q ss_pred c-----ccccccccCCCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH-------
Q 018816 221 H-----IKASTAIGSLEFAAPEYLTT--GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE------- 286 (350)
Q Consensus 221 ~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 286 (350)
. .......++..|+|||++.+ ..++.++|||||||++|||++|..||....... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~ 231 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-----MLLEKLNGTVPCLL 231 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-----HHHHHhcCCccccc
Confidence 0 01122346778999999976 358999999999999999999999997532210 0000000
Q ss_pred -------HHHH-hcCCCccCc-------------cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHH
Q 018816 287 -------KFIR-SNGYMNIDP-------------VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK--KLR 343 (350)
Q Consensus 287 -------~~~~-~~~~~~~~~-------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~ 343 (350)
.... .......+. ..............+..+.+|+.+||+.||++|||+.+|++ .++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 0000 000000000 00000000011134568999999999999999999999987 354
Q ss_pred Hhh
Q 018816 344 QMY 346 (350)
Q Consensus 344 ~~~ 346 (350)
++.
T Consensus 312 ~~~ 314 (327)
T cd08227 312 QIK 314 (327)
T ss_pred hcc
Confidence 443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=294.21 Aligned_cols=247 Identities=21% Similarity=0.251 Sum_probs=200.4
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.|+..+.| |+|+||.||+|.+ .++..||+|.+.... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 5 ~y~~~~~l-g~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERI-GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhc-ccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45556677 9999999999998 456789999876442 34456788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++.. .+++......++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999998854 45788999999999999999999 999999999999999999999999999998766433
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ......++..|+|||++.+..++.++|+|||||++|||++|..|+...... ...........
T Consensus 155 ~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----------~~~~~~~~~~~---- 218 (277)
T cd06640 155 QI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----------RVLFLIPKNNP---- 218 (277)
T ss_pred cc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----------hHhhhhhcCCC----
Confidence 21 122334788999999998888999999999999999999999998643221 00011111101
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
+. .....+..+.+++.+||+.+|++||++.+++..
T Consensus 219 ~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PT--------LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CC--------CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11 112566789999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=306.60 Aligned_cols=261 Identities=15% Similarity=0.184 Sum_probs=194.3
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecC-----
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEA----- 129 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 129 (350)
..++|.....| |+|+||.||+|.+ .++..||+|++..... .....+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPV-GSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheec-ccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678888888 9999999999998 5667899999865422 2345677999999999999999999987643
Q ss_pred -CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 130 -EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcC
Confidence 3568999988 7899887743 46899999999999999999999 99999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ........
T Consensus 162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~ 230 (343)
T cd07878 162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI------DQLKRIME 230 (343)
T ss_pred CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHH
Confidence 9998765432 223458999999999877 46899999999999999999999998643211 00000000
Q ss_pred HHHhcCCCc-----------cCccccCCCCcc---chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMN-----------IDPVIVGDRSCF---RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~-----------~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......... ....+....... ......+.+.+|+.+||+.||++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 231 VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000000000000 00012345789999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=294.28 Aligned_cols=250 Identities=17% Similarity=0.199 Sum_probs=194.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-----hhhHHHHHHHHHHHHhcCCCCccceeeeeec--CCc
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-----RYASERCFNNIVFASQMNHKSILKLIGCCLE--AEM 131 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 131 (350)
.+|...+.| |+|+||.||+|.. ..+..|++|++.... ......+.+|+.++++++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~l-g~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLL-GQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCcccccee-cCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCE
Confidence 478888888 9999999999998 567799999875432 1234568899999999999999999998875 356
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++++||+++++|.+++... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~ 152 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA 152 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCC
Confidence 78999999999999998653 45789999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCcc-ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 212 SKSIPEGKTH-IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 212 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+......... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||..... ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---------~~~~~~~~- 222 (266)
T cd06651 153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---------MAAIFKIA- 222 (266)
T ss_pred ccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---------HHHHHHHh-
Confidence 8765332111 111223478899999999988899999999999999999999999874321 11111111
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....+.+ +....+.+.+++ .||..+|++||++++|+.
T Consensus 223 ---~~~~~~~~--------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 ---TQPTNPQL--------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---cCCCCCCC--------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111111 113345677777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=291.32 Aligned_cols=250 Identities=18% Similarity=0.264 Sum_probs=198.2
Q ss_pred cccccccccCCCceEEEEEEECCCceEEEEEecccc------hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 62 YSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSV------RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
|.....| |+|+||.||+|...++..+|+|.+.... ......+.+|+.++++++|+||+++++++.+.+..+++
T Consensus 2 ~~~~~~i-g~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 2 WTKGEVL-GKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ccccceE-eccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 5566777 9999999999998777789999876432 12235688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
+||+++++|.+++... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999998653 46789999999999999999999 899999999999999999999999999998754
Q ss_pred CCCCc----cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 216 PEGKT----HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 216 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... ........++..|+|||++.+..++.++|+|||||++|+|++|..||...... ... . ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~-~-~~~~ 222 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--------AAM-F-YIGA 222 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--------HHH-H-Hhhh
Confidence 32111 11122344889999999999888999999999999999999999998643210 000 0 0111
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....+.+. ...+..+.+++.+||+.+|++|||+.+++.
T Consensus 223 --~~~~~~~~~--------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 --HRGLMPRLP--------DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --ccCCCCCCC--------CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 101111111 134567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=300.41 Aligned_cols=264 Identities=17% Similarity=0.176 Sum_probs=197.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |.|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~l-g~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKL-GEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEe-ccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 567888888 9999999999998 456689999986442 2234567789999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|++ ++|.+++.... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 997 58888886532 45789999999999999999999 99999999999999999999999999999875432
Q ss_pred CCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH-------
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI------- 289 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 289 (350)
... ......+++.|+|||++.+. .++.++|||||||++|+|++|++||...... ..........
T Consensus 157 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~------~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 157 PTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE------EQLHFIFRILGTPTEET 228 (301)
T ss_pred CCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHcCCCChhh
Confidence 221 11223478899999988654 5789999999999999999999998754321 0000000000
Q ss_pred -----HhcCCCc-cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 290 -----RSNGYMN-IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 290 -----~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....... ..+..............++.+.+|+.+||+.||.+|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 00110000000000134567899999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=290.20 Aligned_cols=249 Identities=17% Similarity=0.194 Sum_probs=198.9
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeec-CCcCeEEe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLE-AEMPALVY 136 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 136 (350)
+|...+.| |.|++|.||++.. .++..||+|++.... ....+.+.+|+.++++++|+|++++++.+.. +..++++|
T Consensus 1 ~y~~~~~l-g~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVV-GKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEe-cCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 46777888 9999999999998 556689999986532 2345568899999999999999999998764 44678999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++..... ..+++.++..++.+++.|+.+|| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 e~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~ 153 (257)
T cd08223 80 GFCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE 153 (257)
T ss_pred cccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence 99999999999865321 46899999999999999999999 9999999999999999999999999999987664
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ......+++.|+|||++.+..++.++|+||||+++++|++|+.||..... ........ .+....
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---------~~~~~~~~-~~~~~~ 221 (257)
T cd08223 154 NQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---------NSLVYRII-EGKLPP 221 (257)
T ss_pred ccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---------HHHHHHHH-hcCCCC
Confidence 3221 22334588999999999988999999999999999999999999863221 11111111 111111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. +...++.+.+++.+||+.+|++|||+.++++
T Consensus 222 ~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 M------------PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred C------------ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 0145568999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=291.98 Aligned_cols=258 Identities=18% Similarity=0.275 Sum_probs=198.2
Q ss_pred cccccccccCCCceEEEEEEEC----CCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----
Q 018816 62 YSMRNITIDEIEGYILYMGFLR----DRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE----- 130 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~----~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 130 (350)
|...+.| |+|+||.||+|.+. .+..||+|.+... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~i-g~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRML-GKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred Ccchhcc-cCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 4455667 99999999999872 3468999988654 2334567889999999999999999999886532
Q ss_pred -cCeEEeecCCCCchhhhhhCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 131 -MPALVYEPAGYCTLADRLYGPL-QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
..++++||+++++|.+++.... ......+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECc
Confidence 2478899999999998875321 111235788999999999999999999 89999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
||.++...............+++.|++||.+....++.++|||||||++|+|++ |.+||..... . ....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---------~-~~~~ 226 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---------S-EIYN 226 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---------H-HHHH
Confidence 999886644332222223335678999999988889999999999999999999 8888763321 1 1111
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
.+......... ...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 227 ~~~~~~~~~~~------------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YLIKGNRLKQP------------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHcCCcCCCC------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 12111111101 03346799999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=291.94 Aligned_cols=253 Identities=16% Similarity=0.193 Sum_probs=197.7
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccch----------hhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR----------YASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
|...+.| |+|++|.||+|.. .++..||+|.+..... ...+.+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~l-g~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 3 WVKGELI-GKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred eeeccee-cccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4556677 9999999999998 5677899998753211 11345778999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998654 46889999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY--YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
++................++..|+|||++.... ++.++|+||||+++|++++|..||..... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---------~~~~~~~ 224 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---------IAAMFKL 224 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---------HHHHHHh
Confidence 987654322222223344888999999987654 88999999999999999999999863221 1111111
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
........+.+... ...+..+.+++.+||+.+|++|||+.+|++
T Consensus 225 ~~~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 225 GNKRSAPPIPPDVS--------MNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hccccCCcCCcccc--------ccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11111111111110 134578999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=305.37 Aligned_cols=254 Identities=16% Similarity=0.123 Sum_probs=196.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+++. .++..||+|.+.... ......+.+|+.++..++|+||+.+++++.+.+..++|
T Consensus 1 d~y~i~~~l-G~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVI-GRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEE-eeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 468888888 9999999999999 566689999886532 12334577899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EeCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999999996532 46889999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCccccccccccCCCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTT-----GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
...... ......||+.|+|||++.+ +.++.++|+|||||++|+|++|+.||..... .........
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---------~~~~~~i~~ 222 (331)
T cd05624 153 NQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL---------VETYGKIMN 222 (331)
T ss_pred cCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH---------HHHHHHHHc
Confidence 443221 1223459999999999875 4678999999999999999999999974321 111111111
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAED--RPTMIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~ 340 (350)
......+.+.+ ...+..+.+++.+||..++.+ |+++.++++
T Consensus 223 ~~~~~~~p~~~---------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 223 HEERFQFPSHI---------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCCcccCCCcc---------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 11111111111 134567889999999876544 467888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=291.60 Aligned_cols=253 Identities=16% Similarity=0.197 Sum_probs=200.2
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc------hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV------RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
+|+....| |+|++|.||+|.. .++..||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 1 ~~~~~~~l-g~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQL-GTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred Ccccccee-cCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEE
Confidence 46677788 9999999999998 667799999986432 123467889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-ceeEcccCCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLS 212 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~ 212 (350)
+|+||+++++|.+++... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.+
T Consensus 80 ~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred EEEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 999999999999998653 46889999999999999999999 99999999999999998776 5999999998
Q ss_pred ccCCCCCccc--cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 213 KSIPEGKTHI--KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 213 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
.......... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...... ...........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~ 225 (268)
T cd06630 152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS------NHLALIFKIAS 225 (268)
T ss_pred cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc------chHHHHHHHhc
Confidence 7665432111 122345788999999998888999999999999999999999998643210 11111111100
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...... .+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 226 ~~~~~~------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ATTAPS------------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred cCCCCC------------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000111 11245678999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=297.48 Aligned_cols=263 Identities=19% Similarity=0.209 Sum_probs=204.6
Q ss_pred ccHHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeee
Q 018816 50 FSSEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCL 127 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 127 (350)
++..++...+++|.....| |+|+||.||++.. .++..+|+|.+.... .....+.+|+.++.++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l-~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETI-GKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEe-ecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 5556777788999999999 9999999999999 566788999886542 2245677899999999 7999999999987
Q ss_pred cC-----CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC
Q 018816 128 EA-----EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY 202 (350)
Q Consensus 128 ~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 202 (350)
.. +..++||||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCC
Confidence 54 3589999999999999988542111 146889999999999999999999 89999999999999999999
Q ss_pred ceeEcccCCCccCCCCCccccccccccCCCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCC
Q 018816 203 AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-----YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGS 277 (350)
Q Consensus 203 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 277 (350)
.+||+|||++......... .....++..|+|||++... .++.++|+|||||++|+|++|+.||.....
T Consensus 166 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~----- 238 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP----- 238 (291)
T ss_pred CEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----
Confidence 9999999998765432211 2233488999999988653 368999999999999999999999874322
Q ss_pred cchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 278 NFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
................++ ......+.+++.+||+.+|++||++.++++
T Consensus 239 ----~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 239 ----VKTLFKIPRNPPPTLLHP-----------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ----HHHHHHHhcCCCCCCCcc-----------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111111111111111 134457999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=306.56 Aligned_cols=265 Identities=17% Similarity=0.205 Sum_probs=192.6
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
...+|...+.| |+|+||.||+|.. ..+..||+|..... ....|+.++++++||||+++++++.+....++||
T Consensus 64 ~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTL-TPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhcCcEEEEEe-cCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34679999998 9999999999999 45557888875432 2356899999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|++. ++|.+++.... ..+++..+..++.||+.||.||| ..+|+||||||+|||++.++.+||+|||++....
T Consensus 137 e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 68888875432 56899999999999999999999 9999999999999999999999999999987533
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCc-chHHHHHHHHHHhcC--
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN-FFITDRVEKFIRSNG-- 293 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~-- 293 (350)
... ......||+.|+|||++.+..++.++|||||||++|||+++..|+....+...... ......+...+....
T Consensus 209 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 209 VAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred cCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 221 12234589999999999999999999999999999999986655433221100000 000111111111100
Q ss_pred CCccC--cc----------------ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNID--PV----------------IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~--~~----------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+. +. .............+..+.+|+.+||+.||++|||+.||++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00000 00 0000000000123445678999999999999999999986
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=300.14 Aligned_cols=198 Identities=17% Similarity=0.195 Sum_probs=159.0
Q ss_pred cccccCCCceEEEEEEEC---CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeec--CCcCeEEeecCC
Q 018816 66 NITIDEIEGYILYMGFLR---DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLE--AEMPALVYEPAG 140 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 140 (350)
..| |+|+||.||+|+.. .+..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||++
T Consensus 7 ~~l-G~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKV-GRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEe-ccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 456 99999999999974 34589999886542 23457789999999999999999998854 457899999986
Q ss_pred CCchhhhhhCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe----CCCCceeEcccCCC
Q 018816 141 YCTLADRLYGPL----QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF----QEEYAAKLFDFSLS 212 (350)
Q Consensus 141 ~~sL~~~l~~~~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~ 212 (350)
++|.+++.... ......+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57777764211 111235888999999999999999999 9999999999999999 56678999999999
Q ss_pred ccCCCCCcc-ccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 018816 213 KSIPEGKTH-IKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLS 270 (350)
Q Consensus 213 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~ 270 (350)
+........ .......+|+.|+|||++.+. .++.++|||||||++|||++|.+||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876443221 112334589999999998764 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=299.17 Aligned_cols=244 Identities=18% Similarity=0.224 Sum_probs=197.0
Q ss_pred cccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 66 NITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
..| |+|+||.||++.. .++..||+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus 27 ~~i-g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKI-GEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhc-CCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 346 9999999999998 56779999998665445566788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 224 (350)
..++.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 106 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 174 (297)
T cd06659 106 TDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR 174 (297)
T ss_pred HHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence 987743 45889999999999999999999 99999999999999999999999999999875543221 12
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
....++..|+|||++.+..++.++|+|||||++|||++|..||..... . ... ..+....... ....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~---~~~-~~~~~~~~~~----~~~~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP------V---QAM-KRLRDSPPPK----LKNA 240 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------H---HHH-HHHhccCCCC----cccc
Confidence 234588999999999988899999999999999999999999874321 1 111 1111111000 0000
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...+..+.+++.+||+.+|++||++.++++.
T Consensus 241 ------~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 ------HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ------CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1234568899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.50 Aligned_cols=249 Identities=18% Similarity=0.196 Sum_probs=201.6
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|+..+.| |+|+||.||++.. .++..|++|.+... .....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l-g~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKI-GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEe-ccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 36777888 9999999999999 56778999998643 23345678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++..... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 80 YCEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred cCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999998864321 35789999999999999999999 89999999999999999999999999999876543
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ......+++.|+|||++.+..++.++|+|||||++++|++|..||..... .......... .....
T Consensus 154 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---------~~~~~~~~~~-~~~~~ 221 (256)
T cd08218 154 TVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---------KNLVLKIIRG-SYPPV 221 (256)
T ss_pred chh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---------HHHHHHHhcC-CCCCC
Confidence 221 12233478899999999888899999999999999999999999864321 1122222111 11100
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+...+..+.+++.+||+.+|++||++.+|++
T Consensus 222 ------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 ------------SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ------------cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0134567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=301.27 Aligned_cols=247 Identities=20% Similarity=0.241 Sum_probs=208.1
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
+-|+.++.| |+|.|+.|-++++ -.|..||||.+.+..- .....+++|+..|+-++|||||++|.+..+...+|||+
T Consensus 18 GLYDLekTl-G~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTL-GRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhh-cCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 456666778 9999999999999 6677999999977532 34567899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe-CCCCceeEcccCCCccC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF-QEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~~ 215 (350)
|.-++|+|++||.+.. ..+.+..+.+++.||+.|+.|+| +..+|||||||+||.+ ..-|-|||+|||++..+
T Consensus 97 ELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999997654 56889999999999999999999 8999999999999876 56689999999999887
Q ss_pred CCCCccccccccccCCCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYN-EKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.++. ...+.+|+..|-|||++.+..|. ++.||||||||||.|++|++||....+.+ .. -
T Consensus 170 ~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE------TL-----------T 229 (864)
T KOG4717|consen 170 QPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE------TL-----------T 229 (864)
T ss_pred CCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh------hh-----------h
Confidence 6554 35667799999999999999886 78999999999999999999998665420 00 1
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.++|-.. ..+...+.++.+||..||..||.+|.+.++|..
T Consensus 230 mImDCKY------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 230 MIMDCKY------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hhhcccc------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1112111 112478899999999999999999999999875
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=296.28 Aligned_cols=262 Identities=17% Similarity=0.187 Sum_probs=195.8
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|...+.| |+|++|.||+|+. .++..||+|++.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l-~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKI-GEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEe-cccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 46677788 9999999999999 567799999986432 2234568899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|++ ++|.+++..... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 80 FLS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred cCC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 997 688888754322 146889999999999999999999 99999999999999999999999999999876543
Q ss_pred CCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC---
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG--- 293 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 293 (350)
... ......+++.|+|||++.+. .++.++|+|||||++|+|++|++||...... ...........
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~---------~~~~~~~~~~~~~~ 222 (285)
T cd07861 154 PVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI---------DQLFRIFRILGTPT 222 (285)
T ss_pred Ccc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---------HHHHHHHHHhCCCC
Confidence 221 12223478899999988754 4789999999999999999999998743221 00000000000
Q ss_pred ------------CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 ------------YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....+..............+.++.+++.+||+.||++|||+.+|+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 223 EDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000000124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=295.44 Aligned_cols=254 Identities=18% Similarity=0.267 Sum_probs=199.5
Q ss_pred CcccccccccCCCceEEEEEEECC--CceEEEEEecccc----------hhhHHHHHHHHHHHHh-cCCCCccceeeeee
Q 018816 61 NYSMRNITIDEIEGYILYMGFLRD--RGPILVMKYRKSV----------RYASERCFNNIVFASQ-MNHKSILKLIGCCL 127 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~~--~~~vaik~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~ 127 (350)
+|+....| |+|+||.||+|.+.. +..+|+|.+.... .....++.+|+.++.+ ++||||+++++++.
T Consensus 1 ~y~~~~~i-g~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 1 EYAVLEHL-GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred Cchhhhhh-cCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 46667778 999999999999944 6689999875321 2234557788888875 79999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCCceeE
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEYAAKL 206 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~~~kl 206 (350)
+++..+++|||+++++|.+++...... ...+++..++.++.|++.||.||| + .+++|+||+|+||+++.++.++|
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEE
Confidence 999999999999999999987432111 146889999999999999999999 6 67999999999999999999999
Q ss_pred cccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH
Q 018816 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|.+||..... .....
T Consensus 156 ~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---------~~~~~ 223 (269)
T cd08528 156 TDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---------LSLAT 223 (269)
T ss_pred ecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---------HHHHH
Confidence 9999987654432 22344588999999999988899999999999999999999999864321 11111
Q ss_pred HHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
.+...... +... ...+..+.+++.+||+.||++||++.+|.++++
T Consensus 224 -~~~~~~~~---~~~~--------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 224 -KIVEAVYE---PLPE--------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -HHhhccCC---cCCc--------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111111 1100 123467899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=303.64 Aligned_cols=255 Identities=16% Similarity=0.121 Sum_probs=196.1
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||++.. ..+..+|+|.+.+.. ......+.+|+.++..++|+||+.+++++.+.+..++|
T Consensus 1 ~~y~~~~~l-G~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVI-GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEE-EeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 367888888 9999999999999 455578899886432 12234577899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 80 ~ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 80 MDYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EeccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 99999999999996532 46889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCccccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .........
T Consensus 153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~---------~~~~~~i~~ 222 (332)
T cd05623 153 MEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL---------VETYGKIMN 222 (332)
T ss_pred ccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH---------HHHHHHHhC
Confidence 332221 123345999999999986 34688999999999999999999999974321 111111111
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAED--RPTMIDVAKK 341 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~~ 341 (350)
......+.... ...+..+.+|+.+|+..+++. |+++.++++.
T Consensus 223 ~~~~~~~p~~~---------~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 223 HKERFQFPAQV---------TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCccccCCCcc---------ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11101011100 134567889999988765544 6889988764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=328.39 Aligned_cols=257 Identities=18% Similarity=0.215 Sum_probs=196.9
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeec--CCc
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLE--AEM 131 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 131 (350)
...++|.....| |+|+||+||++.+ ..+..||+|.+... .......+..|+.++.+|+|||||+++++|.+ ...
T Consensus 10 ~~l~~YeIl~kL-G~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKI-GNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEE-ecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 445789999998 9999999999999 55557788877543 22345678899999999999999999998864 356
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC----CCCeEeeccccCceEeCC-------
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF----PQPVVFRNIEPWNILFQE------- 200 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~dlkp~Nill~~------- 200 (350)
+++||||+++++|.++|...... ...+++..++.|+.||+.||.|||... ..+|+|+||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 89999999999999998653211 146899999999999999999999321 146999999999999964
Q ss_pred ----------CCceeEcccCCCccCCCCCccccccccccCCCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 018816 201 ----------EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT--GYYNEKTDVYSFGKLLLVLLTGRTIGH 268 (350)
Q Consensus 201 ----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~ 268 (350)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 34589999999976543221 233458999999999864 458899999999999999999999997
Q ss_pred CCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 269 LSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... .. .+...+.... .+.. ...+..+.+|+..||+.+|.+||++.+++.
T Consensus 245 ~~~~--------~~-qli~~lk~~p------~lpi-------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANN--------FS-QLISELKRGP------DLPI-------KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCc--------HH-HHHHHHhcCC------CCCc-------CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 4322 11 1111111111 0000 023467899999999999999999999984
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=289.17 Aligned_cols=246 Identities=22% Similarity=0.205 Sum_probs=198.7
Q ss_pred cccccccccCCCceEEEEEEEC-CCceEEEEEecccc-----hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 62 YSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSV-----RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
|...+.| |+|++|.||+|... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.++...+++
T Consensus 2 ~~~~~~i-g~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELL-GSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred cccccee-eecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5566777 99999999999994 77799999876543 22446788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
+||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999998653 45889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCccccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||..... .............
T Consensus 153 ~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---------~~~~~~~~~~~~~ 220 (258)
T cd06632 153 VEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---------VAAVFKIGRSKEL 220 (258)
T ss_pred cccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---------HHHHHHHHhcccC
Confidence 4332 123344889999999987776 89999999999999999999999874321 1111111110111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..+. ...+..+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~------------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PPIP------------DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcC------------CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1111 133467889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=297.73 Aligned_cols=256 Identities=18% Similarity=0.113 Sum_probs=199.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||++.. ..+..|++|.+..... .....+.+|+.+++.++||||+++++.+.+++..++|
T Consensus 1 ~~y~~~~~l-~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLI-SNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEe-ecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 467788888 9999999999999 5566899998865532 3345688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.++..
T Consensus 80 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 80 MEYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999998653 46889999999999999999999 999999999999999999999999999988642
Q ss_pred CCCCc-------------cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 216 PEGKT-------------HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 216 ~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
..... ........++..|+|||.+.+..++.++|+|||||++|||++|..||..... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---------~ 222 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---------E 222 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------H
Confidence 11100 0011123478899999999888899999999999999999999999864321 1
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
... ........ ..+... ...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 223 ~~~-~~~~~~~~--~~~~~~--------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 ELF-GQVISDDI--EWPEGD--------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHH-HHHHhccc--CCCCcc--------ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111 11111110 011100 0234678999999999999999996555555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=292.26 Aligned_cols=250 Identities=18% Similarity=0.199 Sum_probs=196.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-----hhhHHHHHHHHHHHHhcCCCCccceeeeeecC--Cc
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-----RYASERCFNNIVFASQMNHKSILKLIGCCLEA--EM 131 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 131 (350)
.+|...+.| |+|+||.||+|.. .++..|++|.+.... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l-~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLL-GQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEE-ecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 468888888 9999999999998 557799999875321 12345788999999999999999999988764 46
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
++++|||+++++|.+++... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~ 152 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGA 152 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcc
Confidence 78999999999999998643 45788899999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCcc-ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 212 SKSIPEGKTH-IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 212 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+......... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||..... .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---------~~~~~~~~~ 223 (265)
T cd06652 153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---------MAAIFKIAT 223 (265)
T ss_pred ccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---------HHHHHHHhc
Confidence 8765332111 112233488899999999888899999999999999999999999864321 011111110
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....+.. +......+.+++.+||. +|+.||++++|++
T Consensus 224 ----~~~~~~~--------~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 ----QPTNPVL--------PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----CCCCCCC--------chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011111 12455678899999995 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=288.52 Aligned_cols=250 Identities=25% Similarity=0.361 Sum_probs=199.4
Q ss_pred ccccccccCCCceEEEEEEECC-----CceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 63 SMRNITIDEIEGYILYMGFLRD-----RGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 63 ~~~~~lig~G~~g~V~~~~~~~-----~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
...+.| |.|+||.||++...+ ...||+|.+...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 2 ~~~~~l-g~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKL-GEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred ccccee-ccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 345667 999999999999943 368999998665433 5678899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 99999999999865321 12899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
........ ...+++.|+|||.+.+..++.++|+||||+++++|++ |.+||..... .............
T Consensus 155 ~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----------~~~~~~~~~~~~~ 223 (258)
T smart00219 155 DDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----------EEVLEYLKKGYRL 223 (258)
T ss_pred cccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHhcCCCC
Confidence 54322211 2226789999999988889999999999999999998 7787764211 1111122211111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
.. + ...+.++.+++.+||..+|++|||+.++++.|
T Consensus 224 ~~-~-----------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PK-P-----------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC-C-----------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 10 0 13456799999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=289.07 Aligned_cols=236 Identities=22% Similarity=0.281 Sum_probs=187.2
Q ss_pred ccccCCCceEEEEEEECCCc-----------eEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 67 ITIDEIEGYILYMGFLRDRG-----------PILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~-----------~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
.| |+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 2 ~l-g~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 2 HL-GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred cc-cccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 45 99999999999995443 4777776554333 6778899999999999999999999988 778999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-------ceeEcc
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-------AAKLFD 208 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-------~~kl~D 208 (350)
|||+++++|.+++.... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999986542 26889999999999999999999 99999999999999999887 799999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccC--CCCccchhHHHHHHHHHHHhC-CCCCCCCcccCCCCcchHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG--YYNEKTDVYSFGKLLLVLLTG-RTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
||++..... .....++..|+|||++.+. .++.++|+||||+++|+|++| ..|+...... . .
T Consensus 152 fg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---------~-~ 215 (259)
T cd05037 152 PGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---------E-K 215 (259)
T ss_pred CCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---------h-H
Confidence 999876543 1123367789999998876 789999999999999999994 6666533210 0 0
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
...+.... .... .....+.+++.+||..+|.+|||+.+|++.|
T Consensus 216 ~~~~~~~~-~~~~-------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 216 ERFYQDQH-RLPM-------------PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHhcCC-CCCC-------------CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11111100 0000 1115788999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=296.69 Aligned_cols=260 Identities=18% Similarity=0.228 Sum_probs=203.1
Q ss_pred ccHHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeee
Q 018816 50 FSSEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCL 127 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 127 (350)
.+..++....+.|+....| |.|+||.||+|.+ .++..||+|.+.... .....+..|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~l-g~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVV-GNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheee-ccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 4667777778899999998 9999999999999 566688888875543 3345688899999998 6999999999985
Q ss_pred c------CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC
Q 018816 128 E------AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201 (350)
Q Consensus 128 ~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 201 (350)
. ....+++|||+++++|.+++..... ..+++..+..++.||+.||.||| +.+++|+||+|+||+++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~ 157 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence 3 4578999999999999998865322 45788889999999999999999 9999999999999999999
Q ss_pred CceeEcccCCCccCCCCCccccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCC
Q 018816 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG 276 (350)
Q Consensus 202 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 276 (350)
+.++|+|||++........ ......|++.|+|||.+. ...++.++|+|||||++|+|++|..||......
T Consensus 158 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--- 232 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM--- 232 (282)
T ss_pred CCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH---
Confidence 9999999999875532211 123345889999999876 345788999999999999999999998643221
Q ss_pred CcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..... ...... +... ....+..+.+|+.+||+.||.+|||+.+|++
T Consensus 233 ------~~~~~-~~~~~~----~~~~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 233 ------RALFL-IPRNPP----PKLK-------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------hhhhh-HhhCCC----CCCc-------ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 111000 1010 0134567999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=291.85 Aligned_cols=252 Identities=17% Similarity=0.210 Sum_probs=201.5
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
+|+..+.| |+|++|.||++.+ .++..|++|.+.... ......+.+|+.++++++||||+++++.+...+..++++||
T Consensus 2 ~~~~~~~i-g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGEL-GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHh-cCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 56667778 9999999999999 466789999886653 34456788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
+++++|.+++.... ..++......++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999986542 46889999999999999999999 8 9999999999999999999999999999866532
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .............. ..
T Consensus 154 ~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~-~~--- 221 (265)
T cd06605 154 SLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP----PDGIFELLQYIVNE-PP--- 221 (265)
T ss_pred HHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc----cccHHHHHHHHhcC-CC---
Confidence 211 1145888999999999889999999999999999999999998754210 01111111111111 10
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+ .....+..+.+++.+||..+|++|||+.+++.
T Consensus 222 -~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 -PRL-------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -CCC-------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111 00125567999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=311.23 Aligned_cols=249 Identities=21% Similarity=0.295 Sum_probs=204.6
Q ss_pred cccccCCCceEEEEEEEC--CC--ceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCC
Q 018816 66 NITIDEIEGYILYMGFLR--DR--GPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAG 140 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~--~~--~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 140 (350)
+.| |+|.||.|++|.|. ++ -.||||.+...... ...+|.+|+.+|.+|+|+|+|++||+..+ ....+|||+++
T Consensus 116 e~L-G~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 116 ELL-GEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHh-cCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 456 99999999999992 22 27899999877543 67889999999999999999999999988 77899999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCc
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 220 (350)
.|||.+.|++... ..+.....-.++.|||.|+.||. ++++|||||..+|+|+-..-.+||+|||+.+.++....
T Consensus 194 lGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999987432 56788888999999999999999 99999999999999999999999999999998877665
Q ss_pred ccccc-ccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 221 HIKAS-TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 221 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
..... ..--.+.|+|||.+....|+.++|+|+|||++|||+| |..||..... ..+ .+.+..+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------~qI----L~~iD~~------ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------IQI----LKNIDAG------ 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------HHH----HHhcccc------
Confidence 54322 2224668999999999999999999999999999999 7788875543 111 1111111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
+....+..+++++.+++..||..+|++|||+..|.+.+-.
T Consensus 332 ------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 332 ------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 1111223788999999999999999999999999755443
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=293.75 Aligned_cols=264 Identities=17% Similarity=0.191 Sum_probs=198.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|+....| |+|++|.||+|.+ .++..||+|++..... ...+.+.+|+.++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~l-~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKI-GEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred Cceeeeeee-cccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 357777888 9999999999999 4677999998865422 23356789999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|..++... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++....
T Consensus 80 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 80 EYCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred eccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecC
Confidence 999998888776443 46899999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH------
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI------ 289 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 289 (350)
.... ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||...... ..........
T Consensus 152 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 152 GPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV------DQLYLIRKTLGDLIPR 223 (286)
T ss_pred CCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCChH
Confidence 4321 1122347889999999876 45889999999999999999999998754321 0000000000
Q ss_pred -----HhcC-C-CccCccccCCCCc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 290 -----RSNG-Y-MNIDPVIVGDRSC-FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 290 -----~~~~-~-~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... . ....+........ ......+..+.+|+.+||+.+|++|||+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 0 0000000000000 000123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=289.65 Aligned_cols=258 Identities=19% Similarity=0.236 Sum_probs=204.4
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|+..+.| |.|++|+||+|.. .++..+++|.+.... ......+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 1 ~~y~~~~~l-g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVI-GVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred Ccceeeeee-cCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 467888888 9999999999998 566689999886542 2345678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
++++++|.+++..... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999999865321 135889999999999999999999 99999999999999999999999999999876654
Q ss_pred CCccc--cccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 218 GKTHI--KASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 218 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..... ......++..|+|||++... .++.++|+|||||++|+|++|..||...... ......... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---------~~~~~~~~~-~~ 224 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---------KVLMLTLQN-DP 224 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---------hhHHHHhcC-CC
Confidence 43321 22334588999999998877 7899999999999999999999998754321 111111111 11
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....... . ....+..+.+++.+||+.||++|||+.+|+.
T Consensus 225 ~~~~~~~----~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGA----D---YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCcc----c---cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111100 0 0145578899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=295.06 Aligned_cols=251 Identities=20% Similarity=0.252 Sum_probs=203.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.++|...+.| |+|+||.||++.. .++..|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus 18 ~~~~~~~~~l-g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEe-cCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 3678888888 9999999999998 5667899999865544556778899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++.. ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999864 35788999999999999999999 99999999999999999999999999998875543
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ......+++.|+|||.+.+..++.++|+||||+++|++++|..||....... .... ........
T Consensus 168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---------~~~~-~~~~~~~~- 234 (293)
T cd06647 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---------ALYL-IATNGTPE- 234 (293)
T ss_pred ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---------heee-hhcCCCCC-
Confidence 322 1223348889999999988889999999999999999999999997543210 0000 00000000
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.. .....+..+.+++.+||..+|++||++.+++..
T Consensus 235 ---~~------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 ---LQ------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---CC------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011345678999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=292.56 Aligned_cols=298 Identities=17% Similarity=0.203 Sum_probs=222.9
Q ss_pred hhcchhHHHHHHhhcCCCCCCcccccHHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHH
Q 018816 26 LRNGQIFLEKLIASFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCF 105 (350)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~ 105 (350)
..+|+..+.+++.....+++..- +.+=--.+..+.....+.| |+|.||+||+|.+.+. .||||.|...+ ...+.
T Consensus 178 ~~~~~stl~Dll~~~~tSGSGSG-lplLVQRTiarqI~L~e~I-GkGRyGEVwrG~wrGe-~VAVKiF~srd---E~SWf 251 (513)
T KOG2052|consen 178 TLAGDSTLKDLLDDLETSGSGSG-LPLLVQRTIARQIVLQEII-GKGRFGEVWRGRWRGE-DVAVKIFSSRD---ERSWF 251 (513)
T ss_pred cccCCccHHHHHHhhccCCCCCC-chhHhHHhhhheeEEEEEe-cCccccceeeccccCC-ceEEEEecccc---hhhhh
Confidence 45566667777766544433321 2222223445667777777 9999999999999887 99999998764 45577
Q ss_pred HHHHHHH--hcCCCCccceeeeeecCC----cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 018816 106 NNIVFAS--QMNHKSILKLIGCCLEAE----MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLR 179 (350)
Q Consensus 106 ~E~~~l~--~l~h~niv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH 179 (350)
+|.+|.. .|+|+||+.+++.-..++ .++||++|.+.|||+|+|.. .+++....++++..+|.||+|||
T Consensus 252 rEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH 325 (513)
T KOG2052|consen 252 RETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLH 325 (513)
T ss_pred hHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHH
Confidence 8888876 459999999998755443 78999999999999999976 57999999999999999999999
Q ss_pred c-----cCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc--ccccccccCCCCCCccccccCC----CC--c
Q 018816 180 F-----GFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH--IKASTAIGSLEFAAPEYLTTGY----YN--E 246 (350)
Q Consensus 180 ~-----~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~~--~ 246 (350)
. +....|.|||||+.|||+.+++.+-|+|+|+|......... ...+..+||.+|||||++...- |. .
T Consensus 326 ~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk 405 (513)
T KOG2052|consen 326 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYK 405 (513)
T ss_pred HHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhh
Confidence 4 23567999999999999999999999999999777554322 2356678999999999986532 22 4
Q ss_pred cchhHHHHHHHHHHHhC----------CCCCCCCcccCCCCcchHHHHHHHHH-HhcCCCccCccccCCCCccchHHHHH
Q 018816 247 KTDVYSFGKLLLVLLTG----------RTIGHLSRLATGGSNFFITDRVEKFI-RSNGYMNIDPVIVGDRSCFRKEEKLQ 315 (350)
Q Consensus 247 ~~DiwslG~il~el~tg----------~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (350)
.+||||||.++||+... +.||...-+.+ ... +.+++.+ .+...+.+++.+... +...
T Consensus 406 ~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D----Ps~-eeMrkVVCv~~~RP~ipnrW~s~-------~~l~ 473 (513)
T KOG2052|consen 406 RADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD----PSF-EEMRKVVCVQKLRPNIPNRWKSD-------PALR 473 (513)
T ss_pred HHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC----CCH-HHHhcceeecccCCCCCcccccC-------HHHH
Confidence 68999999999999862 46666543321 111 1112211 111133444444433 7788
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 316 AYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 316 ~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.+.+++..||..+|..|-|+--+-+.|.++.+
T Consensus 474 ~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 474 VMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=316.19 Aligned_cols=271 Identities=14% Similarity=0.156 Sum_probs=192.4
Q ss_pred HHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCC------CCccceeeee
Q 018816 54 DLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNH------KSILKLIGCC 126 (350)
Q Consensus 54 ~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~ 126 (350)
++...+++|...+.| |+|+||.||+|.+ ..+..||||++.... .....+..|+.++..++| .+++.+++++
T Consensus 123 ~~~~~~~~y~i~~~l-G~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 123 DIDVSTQRFKILSLL-GEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccccCCCcEEEEEEE-EeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556889999998 9999999999998 556689999986532 223445667777777754 4588888888
Q ss_pred ecC-CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCC--
Q 018816 127 LEA-EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEY-- 202 (350)
Q Consensus 127 ~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~-- 202 (350)
... ...++|||++ +++|.+++... ..+++..+..++.||+.||.||| . .+|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcc
Confidence 754 4788999988 67888888643 46899999999999999999999 7 5999999999999998765
Q ss_pred --------------ceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 018816 203 --------------AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGH 268 (350)
Q Consensus 203 --------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 268 (350)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 499999998764322 1234569999999999999999999999999999999999999997
Q ss_pred CCcccC---------CCCcchHHH-----HHHHHHHhcC--CCccCccccC---CCCccchHHHHHHHHHHHHHccccCC
Q 018816 269 LSRLAT---------GGSNFFITD-----RVEKFIRSNG--YMNIDPVIVG---DRSCFRKEEKLQAYVELAFKCLSHSA 329 (350)
Q Consensus 269 ~~~~~~---------~~~~~~~~~-----~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~~P 329 (350)
...... +..+..+.. .....+.... ....++.... .............+.+|+.+||++||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 543210 000000000 0000110000 0000000000 00000000123567899999999999
Q ss_pred CCCCCHHHHHH
Q 018816 330 EDRPTMIDVAK 340 (350)
Q Consensus 330 ~~RPt~~evl~ 340 (350)
++|||+.|+++
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999997
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=286.66 Aligned_cols=248 Identities=19% Similarity=0.228 Sum_probs=199.4
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|...+.| |+|++|.||++.. .++..+|+|.+.... ....+.+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~l-g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVV-GRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEe-cccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 46677788 9999999999998 566789999986542 2345678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-CceeEcccCCCccCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKLFDFSLSKSIP 216 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 216 (350)
|+++++|.+++..... ..+++..+..++.+++.||.||| +++++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 80 YAPGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred cCCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 9999999999965321 45889999999999999999999 9999999999999999865 467999999998764
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ ......
T Consensus 154 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---------~~~~~~~~-~~~~~~ 220 (256)
T cd08220 154 SKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---------PALVLKIM-SGTFAP 220 (256)
T ss_pred CCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---------HHHHHHHH-hcCCCC
Confidence 4322 2234478899999999988899999999999999999999999864321 11111111 111111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+. ...+..+.+++.+||+.+|++|||+.+++.
T Consensus 221 ~~------------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 IS------------DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CC------------CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.00 Aligned_cols=246 Identities=21% Similarity=0.243 Sum_probs=198.8
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
|...+.| |+|+||.||+|.. .++..||+|.+.... ......+.+|+.++.+++||||+++++++.+++..++||||+
T Consensus 6 ~~~~~~i-g~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhheeE-eecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4556677 9999999999998 566789999875432 234467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++.. ..+++..+..++.+++.|+.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999998854 45889999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
. ......++..|+|||.+.+..++.++|+|||||++|+|++|..|+..... ......+.......+.
T Consensus 156 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----------~~~~~~~~~~~~~~~~- 222 (277)
T cd06641 156 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----------MKVLFLIPKNNPPTLE- 222 (277)
T ss_pred h--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----------HHHHHHHhcCCCCCCC-
Confidence 1 12233478899999999888899999999999999999999999864321 1111111111111111
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...+..+.+++.+||+.+|++||++.+++..
T Consensus 223 -----------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 -----------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -----------cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1345678899999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=292.20 Aligned_cols=247 Identities=20% Similarity=0.244 Sum_probs=197.9
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcC---CCCccceeeeeecCCcCeEE
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMN---HKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 135 (350)
.|+..+.| |+|+||.||+|.+ .++..|++|.+.... .....++.+|+.++++++ |||++++++++.++...++|
T Consensus 2 ~y~~~~~l-~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELI-GRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhhe-eccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 46666777 9999999999998 667799999886542 344567889999999996 99999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++.. ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 81 MEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999998854 36889999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..... ......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||...... ... ......
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---------~~~-~~~~~~-- 217 (277)
T cd06917 152 NQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF---------RAM-MLIPKS-- 217 (277)
T ss_pred CCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---------hhh-hccccC--
Confidence 54332 12333588999999988754 4789999999999999999999998743221 000 000000
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..+.+... ..+.++.+++.+||+.||++||++.+++.
T Consensus 218 --~~~~~~~~-------~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 --KPPRLEDN-------GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --CCCCCCcc-------cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 01111111 24567899999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.41 Aligned_cols=253 Identities=15% Similarity=0.200 Sum_probs=205.7
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |+|++|.||+++. .++..|++|++..... .....+.+|+..+.+++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~i-~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVL-GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred Ccceeeeee-eecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 367777888 9999999999999 4577999999876543 445778999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|+++++|.+++... ..++...+..++.|++.|+.||| + .+++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 80 YMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999654 56899999999999999999999 8 999999999999999999999999999987664
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........... ......
T Consensus 152 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~------~~~~~~~~~~~-~~~~~~ 222 (264)
T cd06623 152 NTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ------PSFFELMQAIC-DGPPPS 222 (264)
T ss_pred cCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc------cCHHHHHHHHh-cCCCCC
Confidence 43321 1233478899999999988899999999999999999999999875431 01111111111 111111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
... . ..+..+.+++.+||+.+|++|||+.++++.
T Consensus 223 ~~~----~-------~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPA----E-------EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCc----c-------cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 0 145789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=283.86 Aligned_cols=255 Identities=19% Similarity=0.216 Sum_probs=215.2
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeec----CC
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLE----AE 130 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~ 130 (350)
..|++|++...++|-|-.|.|-.+.. ..+..+|+|.+.+. ....+|+++.-+. .|||||++++++.+ ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 35788888776669999999999998 66678899988654 4567888887776 59999999999874 34
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCceeEc
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKLF 207 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~ 207 (350)
.+.+|||.++||.|+..+..... ..+++.++-.|+.||+.|+.||| +.+|.||||||+|+|... |..+||+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence 77899999999999999977543 57999999999999999999999 999999999999999964 5678999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|||+|+...... ...+.+.||.|.|||++....|....|+||+||++|-|++|.+||++.+. .-+...+..
T Consensus 207 DfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg------~aispgMk~ 277 (400)
T KOG0604|consen 207 DFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKR 277 (400)
T ss_pred ccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC------ccCChhHHh
Confidence 999998765422 34566789999999999999999999999999999999999999997654 233444566
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
-+..+.+...+|.+ +..++...++++.+|..+|.+|.|+.+++.
T Consensus 278 rI~~gqy~FP~pEW---------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 278 RIRTGQYEFPEPEW---------SCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HhhccCccCCChhH---------hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 66777777777766 477889999999999999999999999875
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=299.24 Aligned_cols=253 Identities=18% Similarity=0.177 Sum_probs=201.1
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|++|.||++.. .++..||+|.+..... ...+.+.+|+.++..++||||+++++.+.+....++|
T Consensus 1 ~~y~~~~~i-g~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLL-GKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeee-cCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 367778888 9999999999999 4577999999876432 2456688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+.+++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 80 MDYCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 999999999999864322 46889999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCcc---------------------------ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 018816 216 PEGKTH---------------------------IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGH 268 (350)
Q Consensus 216 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 268 (350)
...... .......|+..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 322110 01112357889999999998889999999999999999999999987
Q ss_pred CCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 018816 269 LSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT----MIDVAK 340 (350)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt----~~evl~ 340 (350)
.... .......... ... .... ...+..+.+++.+||+.+|++||| +++++.
T Consensus 234 ~~~~---------~~~~~~~~~~-~~~-----~~~~------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 234 GSNR---------DETFSNILKK-EVT-----FPGS------PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCch---------HHHHHHHhcC-Ccc-----CCCc------cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 4321 0111111111 000 0000 124578999999999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=291.25 Aligned_cols=247 Identities=18% Similarity=0.219 Sum_probs=199.0
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCC
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAG 140 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 140 (350)
|...+.| |+|++|.||++.. .++..|++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 21 ~~~~~~l-g~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEe-ccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3334567 9999999999998 5677899999866554556678899999999999999999999999999999999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCc
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 220 (350)
+++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 100 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 100 GGALTDIVTH------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 9999999865 35789999999999999999999 99999999999999999999999999998765533221
Q ss_pred cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... ..... .+.
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---------~~~~~~-~~~~~----~~~ 234 (285)
T cd06648 171 --RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---------LQAMKR-IRDNL----PPK 234 (285)
T ss_pred --ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---------HHHHHH-HHhcC----CCC
Confidence 12234588999999999888899999999999999999999999864321 111111 11111 111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+... ...+..+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 235 LKNL------HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred Cccc------ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1100 124467999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.15 Aligned_cols=261 Identities=17% Similarity=0.148 Sum_probs=200.7
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecC--CcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEA--EMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 135 (350)
++|...+.| |.|++|.||++.+ .++..+|+|.+..... .....+.+|+.++++++||||+++++++.+. +.+++|
T Consensus 1 ~~~~~~~~l-g~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRL-GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEe-ccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 367778888 9999999999999 5667889998865432 3456789999999999999999999988653 468999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++..... ....++......++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999987653211 1146888999999999999999999 999999999999999999999999999998755
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ....++..|+|||.+.+..++.++|+|||||++|+|++|..||...... ...... ...........
T Consensus 156 ~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~ 226 (287)
T cd06621 156 VNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIE----LLSYIVNMPNP 226 (287)
T ss_pred ccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHH----HHHHHhcCCch
Confidence 33221 1234788999999999889999999999999999999999998754321 011111 11222211111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+....... ...++.+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 227 ELKDEPGNG------IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhccCCCCC------CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111111100 134567999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=286.57 Aligned_cols=254 Identities=16% Similarity=0.161 Sum_probs=201.4
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeec--CCcCeEE
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLE--AEMPALV 135 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 135 (350)
+|+..+.| |+|+||.||++.. .++..|++|.+... .....+.+.+|+.++++++||||+++++++.. +...+++
T Consensus 1 ~y~~~~~l-g~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETI-GKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred Cceeeeee-ccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 46677788 9999999999998 56678999988643 23445678899999999999999999998764 4467899
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC--CCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF--PQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
|||+++++|.+++..... ....+++..++.++.+|+.||.|||..+ +.+++|+||+|+||+++.++.+||+|||++.
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred ehhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999999864321 1257899999999999999999999543 6789999999999999999999999999988
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
........ .....+++.|+|||++.+..++.++|+||||+++++|++|..||..... ......+....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~ 226 (265)
T cd08217 159 ILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----------LQLASKIKEGK 226 (265)
T ss_pred cccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----------HHHHHHHhcCC
Confidence 76543321 2233589999999999988899999999999999999999999874321 11122222221
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+. ...+..+.+++.+||+.+|++|||+.+|++
T Consensus 227 ~~~~~------------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 FRRIP------------YRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCCCc------------cccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11111 144567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.03 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=214.6
Q ss_pred ccccccCCCceEEEEEEE-CCCc----eEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 65 RNITIDEIEGYILYMGFL-RDRG----PILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~-~~~~----~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
..+| |+|+||+||+|.+ ..+. +||||.+.... .....++..|+-+|.+|+|||+++++|+|.... +.||++|
T Consensus 701 ~kvL-GsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 701 DKVL-GSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hcee-ccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 4567 9999999999999 3333 89999987654 345678999999999999999999999998766 8899999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
++.|+|.++++... .++.....+.|+.|||+|+.||| .++++||||..+|||+.+-.++|+.|||+++.....
T Consensus 779 mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred cccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999997654 57889999999999999999999 999999999999999999999999999999998877
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
..........-.+.|||-|.+....|+.++|||||||++||++| |..|++... ...+.++++.+.. .-
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~----------~~eI~dlle~geR-Ls 920 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP----------AEEIPDLLEKGER-LS 920 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC----------HHHhhHHHhcccc-CC
Confidence 66555444445778999999999999999999999999999998 889887543 2334444544332 11
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
.| ..++-++.-++.+||..|+..||+++++..++.++.+.+
T Consensus 921 qP-----------piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 921 QP-----------PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CC-----------CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 11 156778999999999999999999999999999987654
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=292.09 Aligned_cols=244 Identities=17% Similarity=0.146 Sum_probs=199.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|.....| |+|++|.||++.+ .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~i-g~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTL-GTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEe-ecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 467788888 9999999999999 566799999886542 23346688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 80 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 80 MEYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999998654 56899999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||..... ............
T Consensus 152 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~~- 215 (290)
T cd05580 152 KGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----------IQIYEKILEGKV- 215 (290)
T ss_pred CCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----------HHHHHHHhcCCc-
Confidence 443 2233488999999999888889999999999999999999999874321 111111111111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
.+.+ ..+..+.+++.+||+.||.+|| ++.+++.
T Consensus 216 ~~~~------------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 RFPS------------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCc------------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111 2346788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=309.49 Aligned_cols=241 Identities=19% Similarity=0.234 Sum_probs=192.5
Q ss_pred ccccCCCceEEEEEEE-CCCceEEE--EEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc--CeEEeecC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILV--MKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM--PALVYEPA 139 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vai--k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~~ 139 (350)
+| |+|+|.+||+|.+ ..|-.||= .++.+- .+...++|..|+.+|+.|+||||++++.+|.+... +-+|+|.+
T Consensus 47 vL-GrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 47 VL-GRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hc-ccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 45 9999999999999 55555552 222222 23445889999999999999999999999997665 78899999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-CceeEcccCCCccCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 218 (350)
..|+|..|+.+. +.++......|++||+.||.|||+. ..+|+|||||.+||+|+.+ |.|||+|+|+|......
T Consensus 126 TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 126 TSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999765 5788899999999999999999976 6799999999999999864 89999999999876544
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ...+|||.|||||.+. ..|+...||||||+.++||+|+..||..+.. .+....+.........+.
T Consensus 200 ~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--------~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 200 HA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--------PAQIYKKVTSGIKPAALS 266 (632)
T ss_pred cc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--------HHHHHHHHHcCCCHHHhh
Confidence 32 2356999999999886 7799999999999999999999999986643 122222322221221111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. -..+++.+||.+||.. .++|||+.|+|.
T Consensus 267 k------------V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 K------------VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred c------------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1 1124789999999999 999999999986
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=285.44 Aligned_cols=252 Identities=18% Similarity=0.187 Sum_probs=200.2
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|...+.| |+|++|.||+|.. .++..|++|.+..... ...+.+.+|+.++++++|+||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~l-g~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKI-GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEe-ecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 36667778 9999999999998 5677999999866543 356788999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 80 YCSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred cCCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 99999999998653 35788999999999999999999 99999999999999999999999999999877654
Q ss_pred CCcccc--ccccccCCCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 218 GKTHIK--ASTAIGSLEFAAPEYLTTGY---YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 218 ~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...... .....+++.|+|||++.+.. ++.++||||||+++|++++|..||..... . ...... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~-~~~~~~-~~~~ 222 (264)
T cd06626 152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------E-FQIMFH-VGAG 222 (264)
T ss_pred CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------h-HHHHHH-HhcC
Confidence 332111 11234788999999998766 88999999999999999999999874321 0 001111 1111
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....+.+ . ...+..+.+++.+||+.+|++|||+.+++.
T Consensus 223 ~~~~~~~----~------~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPD----S------LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCc----c------cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111 0 123567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=293.21 Aligned_cols=252 Identities=17% Similarity=0.239 Sum_probs=193.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHH-HHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVF-ASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|+....| |+|+||.||++.+ .++..||+|++..... ....++..|+.+ ++.++||||+++++++..++..+++|
T Consensus 1 ~~~~~~~~i-g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEEL-GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEe-cccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 467888888 9999999999999 5677999999865432 234456667665 56668999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ-PVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
||++ ++|.+++....... ..+++..++.++.||+.||.||| ++ +++|+||||+||+++.++.+||+|||.+...
T Consensus 80 e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9996 68888775432221 46899999999999999999999 76 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCCCCCCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTT----GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... ..........
T Consensus 155 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~ 223 (283)
T cd06617 155 VDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--------FQQLKQVVEE 223 (283)
T ss_pred ccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--------HHHHHHHHhc
Confidence 33211 122347889999998865 34689999999999999999999998632110 0111111111
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. +... ....+..+.+++.+||..+|++|||+.++++
T Consensus 224 -~~----~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -PS----PQLP-------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CC----CCCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1110 0134567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=290.95 Aligned_cols=263 Identities=17% Similarity=0.152 Sum_probs=199.2
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|...+.| |+|++|.||+|.+ .++..|++|++.... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 1 ~y~~~~~l-~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRI-GEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeec-ccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 36667788 9999999999998 567799999987543 2335678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+ +++|.+++.... ..+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 80 YM-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred cc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 99 999999986532 46899999999999999999999 99999999999999999999999999999877654
Q ss_pred CCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC---
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG--- 293 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 293 (350)
... .......++..|+|||++.+. .++.++||||||+++++|++|.+||..... ..........+....
T Consensus 152 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07832 152 EEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND------IEQLAIVFRTLGTPNEET 224 (286)
T ss_pred CCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH------HHHHHHHHHHcCCCChHH
Confidence 322 112234588999999998754 468999999999999999999877754321 111111111100000
Q ss_pred ---------C-CccCccccCC-CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 ---------Y-MNIDPVIVGD-RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ---------~-~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ....+..... ..... ...+..+.+++.+||+.+|++|||+++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 225 WPGLTSLPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HhhccCcchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 0000000000 00000 123578999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.28 Aligned_cols=246 Identities=20% Similarity=0.255 Sum_probs=195.0
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
+.|...+.| |+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++||||+++.++|.+.+..++|
T Consensus 15 ~~y~~~~~l-g~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheee-cCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 346667778 9999999999998 567799999885432 23345688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||++ |++.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 94 ~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 94 MEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred HHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99997 57777664322 46899999999999999999999 999999999999999999999999999998755
Q ss_pred CCCCccccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
... ....+++.|+|||++. ...++.++||||||+++|+|++|.+||...... .... .....
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---------~~~~-~~~~~ 229 (307)
T cd06607 166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---------SALY-HIAQN 229 (307)
T ss_pred CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---------HHHH-HHhcC
Confidence 322 2334788999999874 356889999999999999999999998643221 0011 11111
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...... ....+..+.+++.+||+.+|++||++.+|+..
T Consensus 230 ~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 DSPTLS-----------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCC-----------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111100 12455679999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=293.80 Aligned_cols=264 Identities=14% Similarity=0.107 Sum_probs=194.7
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|...+.| |+|++|.||+|.+ .++..|++|.+..... .....+.+|+.++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~l-~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEe-cccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 36667778 9999999999999 5677899998864321 223567789999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|++ ++|.+++.... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 80 YCD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred cCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 997 57877765432 46899999999999999999999 99999999999999999999999999999876543
Q ss_pred CCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH----------
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE---------- 286 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------- 286 (350)
... ......+++.|+|||++.+. .++.++|||||||++|+|++|..|+...... ........
T Consensus 152 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07839 152 PVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKRIFRLLGTPTEES 224 (284)
T ss_pred CCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-----HHHHHHHHHHhCCCChHH
Confidence 221 12233478899999998765 4789999999999999999999886543221 00000000
Q ss_pred -HHHHhcCCCccCccccCCCC-ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 287 -KFIRSNGYMNIDPVIVGDRS-CFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 287 -~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...........-+....... .......+..+.+++.+||+.||.+|||+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000000000000000 0000134567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=293.21 Aligned_cols=264 Identities=19% Similarity=0.213 Sum_probs=197.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|+..+.| |+|++|.||+|.+ .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~l-g~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLV-GEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeee-ccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 367777888 9999999999999 4577899998765432 23456889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|..+.... ..+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 80 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 80 EFVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred ecCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 999999998876543 35899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH-----
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR----- 290 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 290 (350)
.... ......++..|+|||++.+. .++.++||||||+++|+|++|.+||...... ...........
T Consensus 152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~ 223 (286)
T cd07846 152 APGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI------DQLYHIIKCLGNLIPR 223 (286)
T ss_pred CCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH------HHHHHHHHHhCCCchh
Confidence 3321 12233478899999998753 4788999999999999999999988643211 00000000000
Q ss_pred ------hcC--CCccCccccCCCCc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 ------SNG--YMNIDPVIVGDRSC-FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ------~~~--~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... .....+........ ......+..+.+|+.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 00000000000000 000134567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.89 Aligned_cols=256 Identities=21% Similarity=0.252 Sum_probs=200.1
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCC----
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAE---- 130 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~---- 130 (350)
..+++|.....| |+|++|.||+|.. .++..+++|.+..... ..+.+.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l-~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVI-GEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred Cchhheeheeee-cCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 356889999998 9999999999999 4566889988765543 346788999999999 6999999999997644
Q ss_pred --cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 131 --MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 131 --~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
..++||||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECC
Confidence 489999999999999988643211 146899999999999999999999 99999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-----GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
||.+........ ......++..|+|||++.. ..++.++|||||||++|+|++|..||...... .
T Consensus 157 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------~ 225 (275)
T cd06608 157 FGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---------R 225 (275)
T ss_pred Cccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---------H
Confidence 999876543221 2233458899999998754 24678999999999999999999998643210 1
Q ss_pred HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..... ..... +.+. .....+..+.+|+.+||..||++|||+.+|++
T Consensus 226 ~~~~~-~~~~~----~~~~------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 ALFKI-PRNPP----PTLK------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHh-hccCC----CCCC------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 11111 1111 01235568999999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=294.24 Aligned_cols=274 Identities=18% Similarity=0.194 Sum_probs=196.7
Q ss_pred cccccccccCCCceEEEEEEEC---CCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecC--CcCe
Q 018816 62 YSMRNITIDEIEGYILYMGFLR---DRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEA--EMPA 133 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~---~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 133 (350)
|.....| |+|++|.||+|... ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 2 y~~~~~i-g~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCI-GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEe-ccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5667777 99999999999993 46799999987632 23346678899999999999999999999988 7899
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC----CCceeEccc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE----EYAAKLFDF 209 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~Df 209 (350)
+||||+++ +|.+.+..........++...+..++.||+.||.||| +.+++|+||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999974 6776664332222236889999999999999999999 999999999999999999 999999999
Q ss_pred CCCccCCCCCc-cccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 210 SLSKSIPEGKT-HIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 210 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|++........ ........+++.|+|||++.+. .++.++|+|||||++++|++|.+||.................+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886643322 1122334578899999988764 588999999999999999999999975543210000000001111
Q ss_pred HHHhcC---------------CCc-cCccccCCCC-ccchH------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNG---------------YMN-IDPVIVGDRS-CFRKE------EKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~---------------~~~-~~~~~~~~~~-~~~~~------~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+..-. ... .+........ ..... ..+..+.+++.+||+.||++|||+.+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 110000 000 0000000000 00000 23457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=284.91 Aligned_cols=250 Identities=20% Similarity=0.243 Sum_probs=199.4
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|...+.| |+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+.++...++|+|
T Consensus 1 ~~~~~~~l-~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKI-GEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEe-cCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 46677788 9999999999999 556788999886532 1334567899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-ceeEcccCCCccCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLSKSIP 216 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 216 (350)
|+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++ .++|+|||.+....
T Consensus 80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 80 YCDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred cCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 9999999999865321 35789999999999999999999 89999999999999999885 46999999987664
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ......|++.|+|||++.+..++.++|+||||+++++|++|..||..... ......... .....
T Consensus 154 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~-~~~~~ 221 (257)
T cd08225 154 DSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---------HQLVLKICQ-GYFAP 221 (257)
T ss_pred CCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHHHHhc-ccCCC
Confidence 3322 12233488999999999888899999999999999999999999863321 112222111 11111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
..+ ..+..+.+++.+||..+|++|||+.+|++.
T Consensus 222 ~~~------------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ISP------------NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCC------------CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111 234579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=280.99 Aligned_cols=249 Identities=23% Similarity=0.295 Sum_probs=203.5
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
+|+..+.| |+|++|.||++.. .++..+++|++..........+.+|+..+++++|+|++++++++..+...++++||+
T Consensus 1 ~y~~~~~l-~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKI-GKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred Cceeeeee-ccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 46667788 9999999999999 467789999997765455678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++.... ..+++..+..++.+++.||.+|| ..+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 80 SGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999986542 46899999999999999999999 8999999999999999999999999999987765443
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
. .....++..|+|||.+....++.++|+||||+++++|++|..||..... ...... ...........
T Consensus 153 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~~~~~~-~~~~~~~~~~~ 219 (253)
T cd05122 153 A---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---------MKALFK-IATNGPPGLRN 219 (253)
T ss_pred c---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---------HHHHHH-HHhcCCCCcCc
Confidence 2 2334488899999999888899999999999999999999999874321 011111 11111111110
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ...+..+.+++.+||+.||++|||+.++++
T Consensus 220 ----~------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 ----P------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----c------cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 022467999999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=292.10 Aligned_cols=264 Identities=17% Similarity=0.140 Sum_probs=197.4
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh-----hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY-----ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
+|...+.| |+|++|.||+|.. .++..|++|++...... ....+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~y~~~~~l-g~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKL-GEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred Cceeeeee-eeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 36667777 9999999999998 56779999998765322 23456789999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+ +++|.+++.... ..+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 v~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeee
Confidence 99999 899999986542 36899999999999999999999 99999999999999999999999999999977
Q ss_pred CCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...... ..............
T Consensus 152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~------~~~~~~~~~~~~~~ 223 (298)
T cd07841 152 FGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI------DQLGKIFEALGTPT 223 (298)
T ss_pred ccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH------HHHHHHHHHcCCCc
Confidence 654322 1222336788999998865 45789999999999999999998777643221 10000000000000
Q ss_pred C------Ccc-CccccCCCCcc----chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 294 Y------MNI-DPVIVGDRSCF----RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 294 ~------~~~-~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
. ... +.......... .....+..+.+++.+||+.+|++|||+.+++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 000 00000000000 001345788999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.04 Aligned_cols=271 Identities=16% Similarity=0.148 Sum_probs=188.5
Q ss_pred HhcCcccccccccCCCceEEEEEEECC--CceEEEE------------------EecccchhhHHHHHHHHHHHHhcCCC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRD--RGPILVM------------------KYRKSVRYASERCFNNIVFASQMNHK 117 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~--~~~vaik------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ 117 (350)
..++|.....| |+|+||.||++..+. +..++.| ++. ........+.+|+.++.+++||
T Consensus 146 ~~~~Y~ii~~L-G~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 146 FLAHFRVIDDL-PAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhccEEEeEe-cCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 45789999999 999999999987632 1111111 111 1112345678999999999999
Q ss_pred CccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceE
Q 018816 118 SILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197 (350)
Q Consensus 118 niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 197 (350)
||+++++++.+.+..++|+|++. ++|.+++...............+..++.||+.||.||| +++|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 99999999999999999999995 57777765432211123446678889999999999999 999999999999999
Q ss_pred eCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCC
Q 018816 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGS 277 (350)
Q Consensus 198 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 277 (350)
++.++.+||+|||++..+...... ......||+.|+|||++.+..++.++|||||||++|||++|..++...... ..
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~--~~ 376 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG--KP 376 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC--CH
Confidence 999999999999999876443221 122345899999999999999999999999999999999987543321110 00
Q ss_pred cchHHH-----------------HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 278 NFFITD-----------------RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 278 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.. ....++...........+ .........+..+.+++.+||+.||++|||+.|++.
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSV---PPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccch---hhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 111111110000000000 000000122356788899999999999999999986
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=288.27 Aligned_cols=260 Identities=19% Similarity=0.189 Sum_probs=195.9
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|+..+.| |.|++|.||+|+. .++..|++|++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l-~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKI-GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred Cceeeeee-cCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 47777888 9999999999998 5677899998864422 233568899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+. ++|.+++..... ..+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 80 FLH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred ccc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 995 688888865322 46889999999999999999999 99999999999999999999999999999876543
Q ss_pred CCccccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC--C
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG--Y 294 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 294 (350)
... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|+.||...... ....+...... .
T Consensus 153 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---------~~~~~~~~~~~~~~ 221 (284)
T cd07860 153 PVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---------DQLFRIFRTLGTPD 221 (284)
T ss_pred Ccc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---------HHHHHHHHHhCCCC
Confidence 221 122233688999999887654 688999999999999999999998643221 01111111000 0
Q ss_pred Ccc-------------CccccC-CCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 MNI-------------DPVIVG-DRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~~~-------------~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... .+.... ..... ....+..+.+++.+||+.||++|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 222 EVVWPGVTSLPDYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhhhhHHHHHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 000000 00000 0023456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=288.27 Aligned_cols=252 Identities=20% Similarity=0.266 Sum_probs=203.4
Q ss_pred HhcCcccccccccCCCceEEEEEEEC-CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.+++|.....+ |+|++|.||+|.+. ++..|++|.+..... ..+.+.+|+.++++++|+||+++++++......++|+
T Consensus 17 ~~~~~~~~~~l-~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKI-GEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhc-cCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45567777777 99999999999994 677999999876544 4567889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 95 e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 95 EYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred eccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999997642 37899999999999999999999 9999999999999999999999999999886554
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ......++..|+|||++.+..++.++|+||||+++|+|++|..||...... ....... ......
T Consensus 168 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---------~~~~~~~-~~~~~~ 235 (286)
T cd06614 168 KEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---------RALFLIT-TKGIPP 235 (286)
T ss_pred cchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHH-hcCCCC
Confidence 3221 122334788999999998888999999999999999999999998643221 1111111 111110
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. . ....+..+.+++.+||+.+|.+|||+.+++.
T Consensus 236 ~~----~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 LK----N------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred Cc----c------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00 0 0124567999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=290.14 Aligned_cols=265 Identities=18% Similarity=0.212 Sum_probs=199.7
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|+..+.| |+|++|.||+|.+ .++..|++|.+.... ....+.+.+|+.++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~i-~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVV-GEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEe-cccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 367778888 9999999999999 456689999886542 233467889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||++++.+..+.... ..+++..+..++.+|+.||.||| +.+++|+||+|+||+++.++.+||+|||++....
T Consensus 80 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 80 EYVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred ecCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 999987776655432 45899999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC--
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG-- 293 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (350)
..... ......++..|+|||++.+. .++.++|+||||+++|+|++|.+||...... ..............
T Consensus 152 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~ 224 (288)
T cd07833 152 ARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI------DQLYLIQKCLGPLPPS 224 (288)
T ss_pred CCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCCHH
Confidence 43321 12234578899999999888 7899999999999999999999998743221 00000000000000
Q ss_pred ---CCccCccccC-----CCCc-----cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 ---YMNIDPVIVG-----DRSC-----FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ---~~~~~~~~~~-----~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....++...+ .... ..+...+..+.+|+.+||..+|++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000 0000 001123678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=286.33 Aligned_cols=247 Identities=16% Similarity=0.137 Sum_probs=200.4
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
+|...+.| |.|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.++...++|+
T Consensus 1 ~y~~~~~i-~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVI-GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEe-ccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 46777888 9999999999999 4577999999875432 34567889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++... .+++...+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||.+....
T Consensus 80 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 80 DLLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred eCCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 999999999998653 47889999999999999999999 9999999999999999999999999999987664
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... .....++..|+|||++.+..++.++|+||||+++|+|++|..||...... ........... ....
T Consensus 152 ~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~ 220 (258)
T cd05578 152 PDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-------IRDQIRAKQET-ADVL 220 (258)
T ss_pred CCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-------HHHHHHHHhcc-cccc
Confidence 4321 22334788999999998888999999999999999999999998754321 11111111111 0111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM--IDVA 339 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~--~evl 339 (350)
.. ...+..+.+++.+||+.||.+||++ .+++
T Consensus 221 ~~------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YP------------ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred Cc------------ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11 1344788999999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=290.91 Aligned_cols=262 Identities=17% Similarity=0.178 Sum_probs=194.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|.....| |+|++|.||+|.. .++..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~l-g~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKL-GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEE-eecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 578888888 9999999999999 4667999999865432 223456789999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|++ ++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 84 ~~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 997 48998886532 46789999999999999999999 99999999999999999999999999999865432
Q ss_pred CCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC--
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY-- 294 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 294 (350)
... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...... ................
T Consensus 156 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 156 PSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-----EDQLHKIFRVLGTPTEET 228 (291)
T ss_pred CCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-----HHHHHHHHHhcCCCChhh
Confidence 211 1122236888999998875 45889999999999999999999998644311 0000000000000000
Q ss_pred ----------C-----ccC-ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 ----------M-----NID-PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ----------~-----~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ... ..+...... ......+.+++.+||+.+|++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPR---LDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcC---CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000 000000000 011257789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=305.47 Aligned_cols=246 Identities=18% Similarity=0.209 Sum_probs=202.7
Q ss_pred ccccccCCCceEEEEEEECCCceE-EEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCc
Q 018816 65 RNITIDEIEGYILYMGFLRDRGPI-LVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCT 143 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~~~~~~v-aik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s 143 (350)
...| |.|+||.||++..++.+.+ |.|.+........++++-||.||...+||+||.+++.|...+.++++.|||+||.
T Consensus 37 iGEL-GDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 37 IGEL-GDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGA 115 (1187)
T ss_pred Hhhh-cCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCch
Confidence 3456 9999999999999766555 4566766666778899999999999999999999999999999999999999999
Q ss_pred hhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcccc
Q 018816 144 LADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK 223 (350)
Q Consensus 144 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 223 (350)
+...+..-. ..++..++..++.|++.||.||| +++|||||||..|||+.-+|.++|+|||.+.... .....
T Consensus 116 VDaimlEL~----r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qk 186 (1187)
T KOG0579|consen 116 VDAIMLELG----RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQK 186 (1187)
T ss_pred HhHHHHHhc----cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhh
Confidence 988775421 67999999999999999999999 9999999999999999999999999999876543 23334
Q ss_pred ccccccCCCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 224 ASTAIGSLEFAAPEYLTT-----GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.....|||.|||||+... .+|..++||||||++|.||..+.+|-....+ -..+.+.........+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---------MRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---------MRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---------HHHHHHHhhcCCCcccC
Confidence 556779999999998763 5799999999999999999999999765443 12222222222233333
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
| ...+..+.+++..||..||..||++.++++
T Consensus 258 P-----------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 P-----------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred c-----------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 3 356678999999999999999999999986
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=291.90 Aligned_cols=264 Identities=17% Similarity=0.150 Sum_probs=195.8
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++++|...+.| |+|+||.||+|.. .++..|++|.+..... .....+.+|+.+++.++|+||+++.+++.+++..++|
T Consensus 3 ~~~~y~~~~~i-g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 3 AATSYLNLEKL-GEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ccceeEEEEEE-EecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 35788888888 9999999999998 5677999999865432 2234577899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||++ ++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++...
T Consensus 82 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 82 FEYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred Eeccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence 99996 67777664432 35778889999999999999999 899999999999999999999999999998754
Q ss_pred CCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC-
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG- 293 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 293 (350)
..... ......+++.|+|||++.+. .++.++|+|||||++|+|++|..||...... .......+...+
T Consensus 154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--------~~~~~~~~~~~~~ 223 (291)
T cd07870 154 SIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--------FEQLEKIWTVLGV 223 (291)
T ss_pred CCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--------HHHHHHHHHHcCC
Confidence 33221 12233478899999998764 5789999999999999999999998744321 011111110000
Q ss_pred ---------------CCccCccccC-CCCc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 ---------------YMNIDPVIVG-DRSC-FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ---------------~~~~~~~~~~-~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....+.... .... ......+..+.+++.+|+..||++|||+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0000 000012457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=292.59 Aligned_cols=256 Identities=18% Similarity=0.233 Sum_probs=192.7
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|.....| |+|+||.||++.. .++..||+|.+.... ......+.+|+.++.++. ||||+++++++..+...+++||
T Consensus 5 ~~~~~~~l-g~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEI-GRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHh-CCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 34445667 9999999999999 566799999986543 234567889999999996 9999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|++ +++.++...........+++..+..++.+++.||.||| + .+++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 45554332100011146899999999999999999999 5 499999999999999999999999999987654
Q ss_pred CCCccccccccccCCCCCCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTG---YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||..... .......... ..
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~-~~ 227 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--------VFDQLTQVVK-GD 227 (288)
T ss_pred cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--------HHHHHhhhcC-CC
Confidence 3221 1223478899999998876 689999999999999999999999864321 1111111110 01
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.+.+..... ...+..+.+|+.+||+.+|++|||+.+|++.
T Consensus 228 ----~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 ----PPILSNSEE----REFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ----CCcCCCcCC----CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111110 1356789999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=293.12 Aligned_cols=246 Identities=21% Similarity=0.257 Sum_probs=194.7
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
|...+.| |+|+||.||++.. .++..||+|.+.... ......+.+|+.++++++|||++++++++.+++..++|||
T Consensus 27 f~~~~~l-g~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhee-ccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 5666778 9999999999998 566789999886432 2334568899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|++ |+|.+.+.... .++++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 997 57777764322 46899999999999999999999 99999999999999999999999999998865432
Q ss_pred CCccccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
. ....+++.|+|||++. .+.++.++|+|||||++|+|++|..||..... ...... +.....
T Consensus 178 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---------~~~~~~-~~~~~~ 241 (317)
T cd06635 178 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------MSALYH-IAQNES 241 (317)
T ss_pred c------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---------HHHHHH-HHhccC
Confidence 2 2334888999999874 45688999999999999999999999864321 111111 111111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
.... ....++.+.+++.+||+.+|.+||++.++++.+.
T Consensus 242 ~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 PTLQ-----------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCC-----------CccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 1000 0134567899999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=288.96 Aligned_cols=261 Identities=15% Similarity=0.125 Sum_probs=196.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecC--CcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEA--EMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 134 (350)
++|...+.| |+|++|.||+|.+ .++..+++|.+..... .....+.+|+.++.+++||||+++++++... ...++
T Consensus 5 ~~y~~~~~l-g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRI-EEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhh-cCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 567778888 9999999999999 4567899999865432 2233567899999999999999999998877 89999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||++ ++|.+++.... ..+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 84 v~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~ 155 (293)
T cd07843 84 VMEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLARE 155 (293)
T ss_pred EehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceee
Confidence 999997 58988886532 36899999999999999999999 99999999999999999999999999999887
Q ss_pred CCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHH--------
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV-------- 285 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-------- 285 (350)
...... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...... ......
T Consensus 156 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~------~~~~~~~~~~~~~~ 227 (293)
T cd07843 156 YGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI------DQLNKIFKLLGTPT 227 (293)
T ss_pred ccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCc
Confidence 654321 12233478899999988765 4689999999999999999999998754321 000000
Q ss_pred ---HHHHHhcC-------CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 286 ---EKFIRSNG-------YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 286 ---~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+..+..-. .......+....+. ...++.+.+++.+||+.+|++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA---LSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccc---cCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000 00000001111110 013567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=282.41 Aligned_cols=242 Identities=21% Similarity=0.161 Sum_probs=195.0
Q ss_pred ccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 69 IDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 69 ig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
||.|++|.||+++. .++..|++|.+.... ....+.+.+|+.++++++||||+++++++.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 49999999999999 456799999986542 23446788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 224 (350)
.+++... ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~ 149 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KT 149 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cc
Confidence 9999654 45889999999999999999999 9999999999999999999999999999988765432 12
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ......... .........|
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~-~~~~~~~~~~----- 216 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-------DPMEIYNDI-LKGNGKLEFP----- 216 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-------CHHHHHHHH-hccCCCCCCC-----
Confidence 233578899999999888899999999999999999999999875431 011111111 1111000000
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAK 340 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 340 (350)
...+..+.+++.+||+.+|++||+ +.|+++
T Consensus 217 ------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 ------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ------cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 122567999999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.56 Aligned_cols=253 Identities=17% Similarity=0.180 Sum_probs=200.2
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEeccc--chhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKS--VRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 135 (350)
...|++...| |+||.+.||++...+.+-+|+|++... +.....-|.+|+..|.+|+ |.+||++++|-..++.+|+|
T Consensus 360 g~~Yeilk~i-G~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQI-GSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhh-cCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3457777788 999999999999987778999987543 3455678999999999995 99999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||- ..+|..+|.... ..++...+..+..||+.++.++| +.||||.||||+|+|+- .|.+||+|||.|..+
T Consensus 439 mE~G-d~DL~kiL~k~~----~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK----SIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred eecc-cccHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 9976 579999997643 23443478889999999999999 99999999999999984 568999999999999
Q ss_pred CCCCccccccccccCCCCCCccccccCC-----------CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHH
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGY-----------YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 284 (350)
....+......-+||+.||+||.+.... .+.++||||||||+|+|+.|++||.... ..
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----------n~ 578 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----------NQ 578 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----------HH
Confidence 8877766666777999999999886432 5689999999999999999999987321 11
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..++ ..+.+|...=.++.. ....++.+++..||..||.+|||+.+||+
T Consensus 579 ~aKl-----~aI~~P~~~Iefp~~---~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 IAKL-----HAITDPNHEIEFPDI---PENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHH-----HhhcCCCccccccCC---CCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1111 122333211111111 11123889999999999999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=287.78 Aligned_cols=243 Identities=19% Similarity=0.227 Sum_probs=195.9
Q ss_pred cccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 66 NITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
..| |+|+||.||++.. .++..||+|++........+.+.+|+.+++.++|+||+++++++..++..++||||+++++|
T Consensus 26 ~~l-g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKI-GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHc-CCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 345 9999999999999 56779999998655445566788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 224 (350)
.+++.. ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 105 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~ 173 (292)
T cd06657 105 TDIVTH------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RR 173 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cc
Confidence 998743 35789999999999999999999 89999999999999999999999999998876543221 12
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ... . ........ +.+...
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~------~~~---~-~~~~~~~~----~~~~~~ 239 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKA---M-KMIRDNLP----PKLKNL 239 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH---H-HHHHhhCC----cccCCc
Confidence 234588999999999888899999999999999999999999864321 111 1 11111111 111000
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+..+.+++.+||+.+|.+||++.+++.
T Consensus 240 ------~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 ------HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ------ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 123456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=276.47 Aligned_cols=267 Identities=21% Similarity=0.236 Sum_probs=218.7
Q ss_pred cHHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeec
Q 018816 51 SSEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLE 128 (350)
Q Consensus 51 ~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 128 (350)
+++|+.+.|+. +| |+|+|+.|--++. .++.++|||.+.+...-.+.++.+|++++.+.+ |+||++++++|++
T Consensus 74 ~F~d~YkLt~e-----~L-GeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTSE-----LL-GEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHHH-----Hh-cCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 46677666643 46 9999999999988 788899999999887677889999999999996 9999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC---cee
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY---AAK 205 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~k 205 (350)
+..+|||||-|.||+|...|+.. .-+++.++.++..+|+.||.||| .+||.||||||+|||..... -+|
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cceEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCcee
Confidence 99999999999999999999765 56899999999999999999999 99999999999999997654 479
Q ss_pred EcccCCCccCCCCCc-----cccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCC
Q 018816 206 LFDFSLSKSIPEGKT-----HIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG 275 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 275 (350)
|+||.+...+..... .....+.+|+..|||||+.. ...|..+.|.||||||+|-|++|.+||...-..+.
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 999988754432221 12234667999999999764 23588999999999999999999999986544321
Q ss_pred C----Cc-chHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 276 G----SN-FFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 276 ~----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+ .. -.=+..+...+..+.++..|..+ ...+.+..+++...|..||..|.++..++.
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdW---------ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDW---------AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhh---------HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 11 12334455666666777777766 367788999999999999999999998876
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=280.08 Aligned_cols=251 Identities=20% Similarity=0.203 Sum_probs=203.3
Q ss_pred CcccccccccCCCceEEEEEEEC-CCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecC--CcCeEE
Q 018816 61 NYSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEA--EMPALV 135 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 135 (350)
+|...+.| |+|++|.||+|... ++..|++|.+..... ...+.+.+|+.++++++||||+++++.+.+. ...+++
T Consensus 1 ~~~~~~~i-~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELL-GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEe-eecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 36667778 99999999999994 677999999866542 4567788999999999999999999999988 889999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
+||+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 80 LEYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL 151 (260)
T ss_pred EEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence 9999999999998654 37899999999999999999999 899999999999999999999999999998877
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.............++..|+|||.+.+..++.++|+||||+++++|++|..||..... ..............
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~- 222 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--------PMAALYKIGSSGEP- 222 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHHHHhccccCCC-
Confidence 554321112334588899999999888899999999999999999999999875431 11111111100001
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+ +...+..+.+++.+||+.+|++||++.+++.
T Consensus 223 ---~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 ---PEI--------PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---cCC--------CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111 1133578999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=288.25 Aligned_cols=264 Identities=16% Similarity=0.100 Sum_probs=195.1
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcC-CCCccceeeeeecCCc----
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMN-HKSILKLIGCCLEAEM---- 131 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~---- 131 (350)
++|+..+.| |+|+||.||+|.+ .++..||+|.+..... .....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~l-g~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKI-GEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEe-cccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 467888888 9999999999999 5677999998755422 22356888999999995 6999999999887665
Q ss_pred -CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-CCceeEccc
Q 018816 132 -PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-EYAAKLFDF 209 (350)
Q Consensus 132 -~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Df 209 (350)
.++||||+++ +|.+++..........+++..+..++.||+.||.||| +.+++|+||+|+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999985 8888876533221246899999999999999999999 999999999999999998 899999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
|.+........ ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...... ......
T Consensus 156 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~ 224 (295)
T cd07837 156 GLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---------QQLLHI 224 (295)
T ss_pred ccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHH
Confidence 99876533211 1122246888999998865 45789999999999999999999998753321 111111
Q ss_pred HHh---cCCCcc-----------CccccCC-CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRS---NGYMNI-----------DPVIVGD-RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~---~~~~~~-----------~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... ...... .+..... ..... ...+..+.+++.+||+.||++|||+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 225 FKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHhCCCChhhCcchhhccchhhcCcccchhHHHhc-cccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 110 000000 0000000 00000 134567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=285.71 Aligned_cols=260 Identities=19% Similarity=0.197 Sum_probs=191.7
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcC-CCCccceeeeeecC--CcCeEEe
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMN-HKSILKLIGCCLEA--EMPALVY 136 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~ 136 (350)
|...+.| |+|+||.||+|.. .++..||+|++..... .......+|+.++.++. |+||+++++++.+. +..++||
T Consensus 1 y~~~~~l-g~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKI-GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeec-cccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 4455677 9999999999998 5677899998865422 22334557899999885 99999999999987 8899999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||++ ++|.+.+.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++. +.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9997 58877775432 46899999999999999999999 999999999999999999 999999999987664
Q ss_pred CCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH---------
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE--------- 286 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------- 286 (350)
.... .....++..|+|||++.. ..++.++|+|||||++|||++|.+||...... .......
T Consensus 151 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~ 221 (282)
T cd07831 151 SKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL------DQIAKIHDVLGTPDAE 221 (282)
T ss_pred cCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH------HHHHHHHHHcCCCCHH
Confidence 3322 122347889999997654 45789999999999999999999999754321 1111110
Q ss_pred --HHHHhcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 287 --KFIRSNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 287 --~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....... .....+...+..........+..+.+++.+||+.+|++|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0111000 00000100000000000134678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=295.50 Aligned_cols=266 Identities=14% Similarity=0.151 Sum_probs=195.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----c
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAE-----M 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~ 131 (350)
+++|...+.| |+|++|.||+|.+ .++..||+|.+.... ......+.+|+.++++++||||+++++++.... .
T Consensus 4 ~~~y~i~~~l-g~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYI-GEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEE-EecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4789988998 9999999999998 567799999986432 234466788999999999999999999876443 5
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++|+||++ ++|.+.+.. ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccc
Confidence 799999996 588777743 46899999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCccc-cccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 212 SKSIPEGKTHI-KASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 212 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
+.......... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|++||...... ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~------~~~~~~~~~~ 226 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL------HQLNLILGVL 226 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHc
Confidence 87654322211 1223458899999998755 46899999999999999999999998643210 0000000000
Q ss_pred HhcCCCccC----c-------cccCCCC-cc--chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 290 RSNGYMNID----P-------VIVGDRS-CF--RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 290 ~~~~~~~~~----~-------~~~~~~~-~~--~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
........+ . ....... .. .....+.++.+++.+||+.+|++|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0 0000000 00 000234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=293.55 Aligned_cols=246 Identities=18% Similarity=0.187 Sum_probs=202.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
+.|+.-++| |+||||.||-++. ..|+.+|.|++.+... ....-..+|-.+|.+++.+.||.+-..|++.+.+|+|
T Consensus 185 n~F~~~Rvl-GkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVL-GKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEE-ecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 567878888 9999999999998 6677889988866532 3344577899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
+..|.||+|.-+|.+... ..+++..++.++.+|+.||.+|| ..+||+|||||+|||+|++|++.|+|+|+|..+
T Consensus 264 LtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999876422 57999999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..+... ...+||.+|||||++.+..|+...|.|||||++|||+.|+.||.....- ...+
T Consensus 338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------------------vk~e 396 (591)
T KOG0986|consen 338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------------------VKRE 396 (591)
T ss_pred CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh------------------hhHH
Confidence 766542 3346999999999999999999999999999999999999998743220 0011
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT 334 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt 334 (350)
.+|.......... ++.+++++.+|+...|+.||++|.-
T Consensus 397 Evdrr~~~~~~ey-~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 397 EVDRRTLEDPEEY-SDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHHHHHhcchhhc-ccccCHHHHHHHHHHHccCHHHhcc
Confidence 1222221111111 1367789999999999999999964
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=279.48 Aligned_cols=250 Identities=17% Similarity=0.165 Sum_probs=196.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc-----chhhHHHHHHHHHHHHhcCCCCccceeeeeecC--Cc
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS-----VRYASERCFNNIVFASQMNHKSILKLIGCCLEA--EM 131 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 131 (350)
.+|...+.| |+|++|.||+|.+ .++..|++|.+... .......+.+|+.++++++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l-g~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLL-GRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeE-ccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 467888888 9999999999998 56779999987432 123345788999999999999999999998764 45
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
+++++||+++++|.+++... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 152 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGA 152 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccc
Confidence 78999999999999998643 45789999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCcc-ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 212 SKSIPEGKTH-IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 212 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+......... .......++..|+|||++.+..++.++|+|||||++|+|++|+.||..... .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~ 223 (264)
T cd06653 153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---------MAAIFKIAT 223 (264)
T ss_pred ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---------HHHHHHHHc
Confidence 8765322111 111234488999999999888899999999999999999999999874321 111111111
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......+ +...++.+.+++.+||+ +|..|||+.+++.
T Consensus 224 ~~~~~~~------------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 224 QPTKPML------------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCC------------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111111 12455779999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=284.01 Aligned_cols=241 Identities=16% Similarity=0.146 Sum_probs=185.5
Q ss_pred ccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHH---hcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 69 IDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFAS---QMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 69 ig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
||+|+||.||++.. .++..+|+|.+..... .....+.+|..++. ..+||||+.+++++...+..++||||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 39999999999999 5677899998865421 11223444544333 34799999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 82 GDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999988653 46899999999999999999999 9999999999999999999999999999987553322
Q ss_pred ccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 222 IKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...... .......... .....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~-----~~~~~ 217 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-------DKHEIDRMTL-----TVNVE 217 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-------CHHHHHHHhh-----cCCcC
Confidence 123358999999999864 45899999999999999999999998743221 0011111100 00111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAKK 341 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 341 (350)
+ +...+..+.+++.+||+.||++|| |+.++++.
T Consensus 218 ~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 L--------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred C--------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 113456889999999999999999 59888773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.63 Aligned_cols=249 Identities=18% Similarity=0.188 Sum_probs=201.8
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|+..+.| |.|++|.||++.. .++..+++|.+.... ......+.+|+.++++++|+||+++++++.+....++|||
T Consensus 1 ~y~~~~~i-~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKL-GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeee-cCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 46777788 9999999999988 566789999986532 2345677899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++...... ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 80 YAPFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hcCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 99999999988653211 146889999999999999999999 99999999999999999999999999999877654
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..............+
T Consensus 156 ~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----------~~~~~~~~~~~~~~~ 221 (256)
T cd08530 156 NM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----------QDLRYKVQRGKYPPI 221 (256)
T ss_pred CC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------HHHHHHHhcCCCCCC
Confidence 41 2223478899999999988899999999999999999999999864321 111111111111111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ...+.++.+++.+||+.+|++|||+.++++
T Consensus 222 ~------------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 P------------PIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred c------------hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1 145577999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=298.44 Aligned_cols=251 Identities=20% Similarity=0.166 Sum_probs=210.5
Q ss_pred HHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
......|.....| |+|.|+.|.++++ ..+..||||.+.+..- .....+.+|+.+|..|+|||||+++++......+
T Consensus 52 ~~~vg~y~i~~ti-g~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTI-GKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeee-ccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 3456788888888 9999999999999 6677999999877643 3335588999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
|+||||+.+|.+++++.+. +.+....+..++.|+++|++||| +++|||||||++||||+.+.++||+|||++
T Consensus 131 ylV~eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred EEEEEeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccc
Confidence 9999999999999999765 56677889999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..+.... ...+.+|++.|.|||++.+..| .+.+|+||+|+++|.|+.|..||+....
T Consensus 203 ~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------------- 260 (596)
T KOG0586|consen 203 TFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------------- 260 (596)
T ss_pred eeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------------
Confidence 9886544 3556779999999999998875 5899999999999999999999985432
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...-++.+.+.+... ...+.++.+|++++|..+|.+|++++++.+.
T Consensus 261 --k~Lr~rvl~gk~rIp--~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 261 --KELRPRVLRGKYRIP--FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred --ccccchheeeeeccc--ceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111112222222111 1445678999999999999999999998763
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=292.40 Aligned_cols=268 Identities=17% Similarity=0.226 Sum_probs=197.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecC-----
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEA----- 129 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 129 (350)
..+.|...+.| |+|+||.||+|.. .++..||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~l-g~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPI-GSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEe-ccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45789988888 9999999999999 56779999998543 223445678899999999999999999987643
Q ss_pred -CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 130 -EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
...++||||++ ++|.+.+.. .++...+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence 35699999996 588887743 3788889999999999999999 89999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccC---------CCCcc
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT---------GGSNF 279 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~~~~ 279 (350)
||++........ .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... +....
T Consensus 162 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 162 FGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred CccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999986543221 223347889999999999999999999999999999999999987432110 00000
Q ss_pred hHHHH----HHHHHHhcC-C--Ccc----CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 280 FITDR----VEKFIRSNG-Y--MNI----DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 280 ~~~~~----~~~~~~~~~-~--~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..... ......... . ..+ ................++.+.+++.+||+.||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 000111100 0 000 0000000000001134567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.57 Aligned_cols=244 Identities=15% Similarity=0.157 Sum_probs=192.0
Q ss_pred ccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 69 IDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 69 ig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
||+|+||+||++.. .++..|++|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 49999999999998 5667899998865321 2344567899999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 224 (350)
.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 151 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KI 151 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cc
Confidence 999865422 36899999999999999999999 9999999999999999999999999999987654321 12
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
....++..|+|||++.+..++.++|+||||+++|+|++|+.||...... . ... .+...... .....
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~-~~~----~~~~~~~~-~~~~~--- 217 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-----V-EKE----ELKRRTLE-MAVEY--- 217 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-----c-cHH----HHHhcccc-ccccC---
Confidence 2334788999999998888999999999999999999999998643321 0 000 01111000 00000
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
+...++.+.+++.+||+.+|++|| ++.+++.
T Consensus 218 -----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 -----PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -----CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 013356789999999999999999 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=278.21 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=203.4
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|...+.| |.|++|.||++.+ +++..|++|++..... .....+.+|+.+++.++|||++++.+.+......++|+|
T Consensus 1 ~y~~~~~l-~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQI-GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeee-ccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 46677788 9999999999999 5677999999865432 456678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++...... ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 80 YADGGDLSQKIKKQKKE-GKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred ecCCCcHHHHHHHhhcc-CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 99999999998754211 157899999999999999999999 89999999999999999999999999999876654
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ......+++.|+|||...+..++.++|+||+|+++++|++|..||..... ....... .......+
T Consensus 156 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---------~~~~~~~-~~~~~~~~ 223 (258)
T cd08215 156 TVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---------LELALKI-LKGQYPPI 223 (258)
T ss_pred Ccc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---------HHHHHHH-hcCCCCCC
Confidence 331 22334588899999999888899999999999999999999999864321 1111111 11111111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ...+..+.+++.+||..+|++|||+.++++
T Consensus 224 ~------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 P------------SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C------------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 133467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=292.31 Aligned_cols=266 Identities=20% Similarity=0.262 Sum_probs=196.4
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhc-CCCCccceeeeeecC--Cc
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQM-NHKSILKLIGCCLEA--EM 131 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~ 131 (350)
..++|.....| |+|+||.||+|.+ .++..||+|++... .......+.+|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~l-g~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKL-GKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhh-cCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45678888888 9999999999998 45678999988542 223445677899999999 999999999988643 36
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||++ ++|.+++.. ..+++..+..++.||+.||.||| +.+|+|+||+|+||+++.++.+||+|||.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 899999997 599888854 25788899999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCcc---ccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 212 SKSIPEGKTH---IKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 212 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
+......... .......++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~------~~~~~~~~ 227 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL------NQLEKIIE 227 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHH
Confidence 8766443221 12223458899999998765 45789999999999999999999998643321 00000000
Q ss_pred H-----------HHhc-CCCccCccccCC---CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 288 F-----------IRSN-GYMNIDPVIVGD---RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 288 ~-----------~~~~-~~~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
. +... ....++...... ..... ...+..+.+++.+||+.+|++|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 0000 000000000000 00000 0235678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=286.66 Aligned_cols=267 Identities=16% Similarity=0.152 Sum_probs=193.8
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCc---
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEM--- 131 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 131 (350)
..++|.....| |+|+||.||+|.. .++..||+|.+..... .....+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~l-g~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEe-ecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34578888888 9999999999999 5677999998854321 223456789999999999999999999876543
Q ss_pred -----CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeE
Q 018816 132 -----PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206 (350)
Q Consensus 132 -----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 206 (350)
.++||||+. ++|.+.+.... ..+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKL 160 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEE
Confidence 499999996 58887775432 36899999999999999999999 899999999999999999999999
Q ss_pred cccCCCccCCCCCcc--ccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 207 FDFSLSKSIPEGKTH--IKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
+|||++......... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|.+||..... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~------~~~~~ 234 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE------QHQLT 234 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence 999998766432221 1122334788899999887654 78999999999999999999999864322 11111
Q ss_pred HHHHHHHhcCCCccCcc-----------ccCCCCc-----cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 284 RVEKFIRSNGYMNIDPV-----------IVGDRSC-----FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~-----------~~~~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
............ ..+. ....... .........+.+|+.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 235 LISQLCGSITPE-VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHhCCCChh-hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 111111000000 0000 0000000 000012346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=284.56 Aligned_cols=245 Identities=20% Similarity=0.147 Sum_probs=194.2
Q ss_pred ccCCCceEEEEEEEC-CCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 69 IDEIEGYILYMGFLR-DRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 69 ig~G~~g~V~~~~~~-~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
+|+|+||.||++.+. ++..+++|.+..... ...+.+.+|+.++.+++||||+++++.+.+....++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 399999999999994 577999999865433 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCc----
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT---- 220 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 220 (350)
.+++... ..+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9998653 46899999999999999999999 99999999999999999999999999999876543321
Q ss_pred --cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 221 --HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 221 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
........++..|+|||.......+.++|+||||+++|+|++|..||..... .... ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---------~~~~-~~~~~~~~~~-- 220 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---------EEIF-QNILNGKIEW-- 220 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---------HHHH-HHHhcCCcCC--
Confidence 0112234478899999999888899999999999999999999999874321 1111 1111111100
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
+. . ...+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 221 ~~---~------~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 221 PE---D------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred Cc---c------ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 00 0 01256789999999999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=276.95 Aligned_cols=247 Identities=19% Similarity=0.255 Sum_probs=201.6
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|+....| |+|++|.||++.. .++..|++|.+..... ...+.+.+|++++.+++|||++++++++.+.+..+++||
T Consensus 1 ~y~~~~~l-~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLI-GRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEE-cccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 36667778 9999999999998 4666899999876643 455678999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 80 YAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred cCCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 99999999998654 46899999999999999999999 99999999999999999999999999999887654
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.... .....++..|+|||...+..++.++|+||||+++++|++|..|+..... ........ ......+
T Consensus 152 ~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---------~~~~~~~~-~~~~~~~ 219 (254)
T cd06627 152 VSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---------MAALFRIV-QDDHPPL 219 (254)
T ss_pred Cccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---------HHHHHHHh-ccCCCCC
Confidence 3321 2233478899999998887889999999999999999999999864321 01111111 1111111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ...+..+.+++.+||+.+|++|||+.+++.
T Consensus 220 ~------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 P------------EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C------------CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 133467889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=284.13 Aligned_cols=260 Identities=18% Similarity=0.180 Sum_probs=194.7
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
|+..+.| |.|++|.||+|.+ .++..|++|++..... .....+.+|+.++++++||||+++++++.+++..+++|||
T Consensus 1 y~~~~~l-~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKI-GEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEe-cCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 4556677 9999999999998 5777999998865432 2235688999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
++ ++|.+++..... ..+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 80 LD-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred cC-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 95 689998865421 36899999999999999999999 899999999999999999999999999998765332
Q ss_pred CccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC--C-
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG--Y- 294 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~- 294 (350)
.. ......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||...... ........... .
T Consensus 153 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~~~~~~~~~ 221 (283)
T cd07835 153 VR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI---------DQLFRIFRTLGTPDE 221 (283)
T ss_pred cc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHHhCCCCh
Confidence 21 11222468899999988764 5789999999999999999999998643221 00111111000 0
Q ss_pred ------------CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 ------------MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...-+..............+..+.+++.+||+.+|++|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000000000123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=287.33 Aligned_cols=265 Identities=16% Similarity=0.155 Sum_probs=195.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecC--CcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEA--EMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 133 (350)
.++|...+.| |.|+||.||+|.+ .++..||+|.+..... .....+.+|+.++.+++|+||+++++++.+. +..+
T Consensus 6 ~~~y~~~~~i-g~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeee-eecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4678888888 9999999999999 5677999999864422 1123466899999999999999999998755 4689
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||++ ++|.+++.... ..+++..+..++.||+.||.||| +.+++|+||+|+||+++.++.+||+|||.+.
T Consensus 85 lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~ 156 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156 (309)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceee
Confidence 9999996 58888876432 46899999999999999999999 9999999999999999999999999999988
Q ss_pred cCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||..... ..............
T Consensus 157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~------~~~~~~~~~~~~~~ 228 (309)
T cd07845 157 TYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE------IEQLDLIIQLLGTP 228 (309)
T ss_pred ecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCC
Confidence 7654321 1122235788999999865 4588999999999999999999999874332 11111111100000
Q ss_pred CCCc---c------Cc-cccCCC-Cccc--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYMN---I------DP-VIVGDR-SCFR--KEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~~---~------~~-~~~~~~-~~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... . .. ...... .... ....++.+.+++.+||+.||++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0 00 000000 0000 0023567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=285.28 Aligned_cols=268 Identities=18% Similarity=0.156 Sum_probs=197.1
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCC---
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAE--- 130 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 130 (350)
...++|+..+.| |+|+||.||+|.. .++..||+|.+..... .....+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~l-g~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQI-GEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeee-cccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456788888998 9999999999999 5567899999865432 23356778999999999999999999987654
Q ss_pred -------cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 131 -------MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 131 -------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||.||| +.+|+|+||+|+||++++++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCc
Confidence 78999999975 6767665431 46899999999999999999999 999999999999999999999
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
+||+|||.+......... ......++..|+|||.+.+. .++.++|||||||++++|++|++||..... ....
T Consensus 155 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~------~~~~ 227 (302)
T cd07864 155 IKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE------LAQL 227 (302)
T ss_pred EEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh------HHHH
Confidence 999999998766443221 11222367889999988654 578999999999999999999999874322 1111
Q ss_pred HHHHHHHHhcCCC------------ccCccccCCCCc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 283 DRVEKFIRSNGYM------------NIDPVIVGDRSC-FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 283 ~~~~~~~~~~~~~------------~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..+.......... ..++........ ......+..+.+++.+||+.+|++|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111110000 000000000000 000123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=286.38 Aligned_cols=253 Identities=18% Similarity=0.181 Sum_probs=188.5
Q ss_pred CceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCchhhhhh
Q 018816 73 EGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY 149 (350)
Q Consensus 73 ~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~ 149 (350)
++|.||.++. .++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 3444555554 35669999998654 33455779999999999999999999999999999999999999999999987
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc-----ccc
Q 018816 150 GPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH-----IKA 224 (350)
Q Consensus 150 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-----~~~ 224 (350)
.... ..+++.....++.|++.||.||| +.+|+|+||||+||+++.++.+|++|||.+......... ...
T Consensus 92 ~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 92 THFP---EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred Hhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 5322 35788999999999999999999 999999999999999999999999999988655322111 112
Q ss_pred cccccCCCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC-------
Q 018816 225 STAIGSLEFAAPEYLTTG--YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM------- 295 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 295 (350)
....++..|+|||++... .++.++|+|||||++|||++|..||...... .... .........
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-----~~~~----~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-----QMLL----EKVRGTVPCLLDKSTY 236 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH----HHHhccCccccccCch
Confidence 233467889999998763 5889999999999999999999999754321 0000 001000000
Q ss_pred -------------ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 -------------NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 -------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..++................++.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 011111111111112345678999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=292.72 Aligned_cols=266 Identities=17% Similarity=0.216 Sum_probs=197.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeec----CCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLE----AEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~ 131 (350)
.++|+..+.| |+|++|.||+|.. .++..||+|++.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~l-g~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENI-GSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeee-ecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 3688888888 9999999999998 567799999986542 2335667889999999999999999998763 346
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+. ++|.+++... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred EEEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccccc
Confidence 899999995 6898888643 45899999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCccc--cccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccC---------CCCcc
Q 018816 212 SKSIPEGKTHI--KASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT---------GGSNF 279 (350)
Q Consensus 212 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~~~~ 279 (350)
+.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... +....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 87654322211 1123458889999998865 458999999999999999999999997543210 00000
Q ss_pred hHH-----HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 280 FIT-----DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 280 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... ........... ...+ ...... ....+..+.+++.+||+.+|++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLP--RKQP---VPWSKI-FPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HhhhhhchhhHHHHHhhcc--cCCC---CCHHHH-cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 00000110000 0000 000000 0134578999999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=285.64 Aligned_cols=258 Identities=11% Similarity=0.047 Sum_probs=182.2
Q ss_pred cCcccccccccCCCceEEEEEEECCC----ceEEEEEecccchhh-----------HHHHHHHHHHHHhcCCCCccceee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDR----GPILVMKYRKSVRYA-----------SERCFNNIVFASQMNHKSILKLIG 124 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~----~~vaik~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~ 124 (350)
+.|...+.| |+|+||.||+|.+.++ ..+++|......... ......+...+..++|+||+++++
T Consensus 12 ~~y~i~~~L-G~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 12 KEWKIDKLI-GCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CceEEeeEE-ecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 578888888 9999999999998443 345555432221110 011223344556678999999999
Q ss_pred eeecCC----cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC
Q 018816 125 CCLEAE----MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE 200 (350)
Q Consensus 125 ~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 200 (350)
++.... ..++++|++. .++.+.+... ...++..+..++.|++.||.||| +.+|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcC
Confidence 766543 3367777763 4566655432 34578888999999999999999 999999999999999999
Q ss_pred CCceeEcccCCCccCCCCCcc-----ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCC
Q 018816 201 EYAAKLFDFSLSKSIPEGKTH-----IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG 275 (350)
Q Consensus 201 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 275 (350)
++.++|+|||+|+........ .......||+.|+|||+..+..++.++|||||||++|||++|..||......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~-- 239 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN-- 239 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--
Confidence 999999999999766432211 1122345999999999999999999999999999999999999999754221
Q ss_pred CCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
..........++..-....... ...++.+.+++..||+.+|++||++.++++.|
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 240 --GNLIHAAKCDFIKRLHEGKIKI-----------KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred --hHHHHHhHHHHHHHhhhhhhcc-----------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0111111111111111000000 02346799999999999999999999999876
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=282.28 Aligned_cols=263 Identities=16% Similarity=0.153 Sum_probs=196.9
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
+|+..+.| |.|++|.||+|+. .++..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l-~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKL-GEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeee-ccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 47777888 9999999999999 5677899999865432 2345677899999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++ +|.+++..... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++......
T Consensus 80 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MDK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CCc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 974 88888754321 135899999999999999999999 899999999999999999999999999998755332
Q ss_pred CccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH-----------
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE----------- 286 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------- 286 (350)
.. ......++..|++||++.+. .++.++|+|||||++|+|++|..||...... .......
T Consensus 154 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 154 VN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE------DQLLKIFRIMGTPTESTW 225 (284)
T ss_pred cc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHHHhCCCChhhH
Confidence 21 12233478899999988664 5789999999999999999999998754321 0000000
Q ss_pred HHHHhcCCCccCccccCCCC---ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 287 KFIRSNGYMNIDPVIVGDRS---CFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+... ............ .......+..+.+++.+||+.||.+||++.++++
T Consensus 226 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 226 PGISQL--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhcC--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001100 000000000000 0000133567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=291.04 Aligned_cols=269 Identities=17% Similarity=0.216 Sum_probs=198.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecC-----C
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEA-----E 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 130 (350)
.+.|.....| |+|+||+||+|.. .++..||+|.+... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~l-g~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPI-GRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEe-ccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3568888888 9999999999998 56779999998653 223345677899999999999999999988654 3
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++|+||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCc
Confidence 5799999995 6888887543 56899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCC---------C-Cc-
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG---------G-SN- 278 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---------~-~~- 278 (350)
++........ ......++..|+|||.+.. ..++.++|+|||||++|+|++|++||........ . ..
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 154 LARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred cccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 9876643321 1223347889999998865 4689999999999999999999999864321000 0 00
Q ss_pred ---chHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHh
Q 018816 279 ---FFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK--LRQM 345 (350)
Q Consensus 279 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L~~~ 345 (350)
............... ...++..... ....+..+.+++.+||+.+|++|||+.++++. +..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 232 DLGFIRNEKARRYIRSLP-YTPRQSFARL-----FPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HhhhcCchhhhHHHHhcC-cccccCHHHH-----cccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000000000 0000000000 01345678999999999999999999999975 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=278.19 Aligned_cols=241 Identities=19% Similarity=0.093 Sum_probs=186.6
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHH-HhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFA-SQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|++|.||+|.. .++..||+|.+..... .....+..|..++ ...+|+||+++++++.+++..++|+||+++
T Consensus 3 ~l-~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 3 PI-SKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred cC-CcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 45 9999999999999 5667999999865432 1223344555444 455899999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999998643 46889999999999999999999 89999999999999999999999999998875432
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||..... . ............ ..+..
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---------~-~~~~~~~~~~~~-~~~~~ 216 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---------D-AVFDNILSRRIN-WPEEV 216 (260)
T ss_pred --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---------H-HHHHHHHhcccC-CCCcc
Confidence 1233478899999999888899999999999999999999999864321 1 111111111110 01100
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...+++.+.+++.+||+.+|++||++.++.+.
T Consensus 217 --------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 217 --------KEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred --------cccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 01345679999999999999999977554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=286.91 Aligned_cols=246 Identities=21% Similarity=0.244 Sum_probs=193.2
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS---VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
|+..+.| |+|++|.||+|+. .++..|++|.+... ......++.+|+.+++.++|+|++++++++......++|||
T Consensus 17 ~~~~~~l-g~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 17 FSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHhe-eeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 5555667 9999999999998 56668999987542 22334568899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+. +++.+.+.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 996 68877764332 45889999999999999999999 99999999999999999999999999999876533
Q ss_pred CCccccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
. ....+++.|+|||++. ...++.++|||||||++|+|++|..||..... ..... .......
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~-~~~~~~~ 231 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------MSALY-HIAQNES 231 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH---------HHHHH-HHhhcCC
Confidence 2 2334788999999874 34678899999999999999999999764321 00111 1111111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
+... ....+..+.+|+.+||+.+|++||++.+++....
T Consensus 232 ----~~~~-------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 ----PALQ-------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ----CCcC-------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1000 0144567899999999999999999999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=280.81 Aligned_cols=263 Identities=17% Similarity=0.177 Sum_probs=195.2
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecC--CcCeEEe
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEA--EMPALVY 136 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 136 (350)
|.....| |+|++|.||+|.. .++..+|+|.+.... ......+.+|+.++++++|||++++++++.+. +..++|+
T Consensus 1 y~~~~~l-~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQI-GEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEe-ccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 4455677 9999999999999 456799999987653 23345688999999999999999999999988 7999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||++ ++|.+++.... ..+++..+..++.||+.||.||| +.+++|+||+|+||++++++.++|+|||.+....
T Consensus 80 e~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~ 151 (287)
T cd07840 80 EYMD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT 151 (287)
T ss_pred cccc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeecc
Confidence 9997 48888875532 46899999999999999999999 8999999999999999999999999999987665
Q ss_pred CCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC--
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG-- 293 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (350)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... ..............
T Consensus 152 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~------~~~~~~~~~~~~~~~~ 224 (287)
T cd07840 152 KRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL------EQLEKIFELCGSPTDE 224 (287)
T ss_pred CCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCchh
Confidence 43321 1122346788999998765 45889999999999999999999998743321 00111111000000
Q ss_pred -CCccCc-----cccCCCC------ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 -YMNIDP-----VIVGDRS------CFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 -~~~~~~-----~~~~~~~------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...... ....... ......++..+.+++.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 0000000 0000012578899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=282.67 Aligned_cols=243 Identities=20% Similarity=0.247 Sum_probs=191.2
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
|.....| |+|+||.||+|+. .++..|++|.+.... ......+.+|+.+++.++|||++++++++.+.+..++|||
T Consensus 23 ~~~~~~l-g~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceee-ccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 4444567 9999999999998 566789999886432 2334568899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+. +++.+++.... .++++..+..++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 ~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 102 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred cCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 996 57777775432 46889999999999999999999 99999999999999999999999999998864322
Q ss_pred CCccccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.....|+..|+|||++. ...++.++|+|||||++|+|++|..||..... .............
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---------~~~~~~~~~~~~~ 238 (313)
T cd06633 174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------MSALYHIAQNDSP 238 (313)
T ss_pred ------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHhcCCC
Confidence 22345889999999984 35688999999999999999999999864322 1111111111111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... ...+..+.+|+.+||+.+|++||++.+++.
T Consensus 239 ~~~~------------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 239 TLQS------------NEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCCc------------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 123456889999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=284.43 Aligned_cols=263 Identities=16% Similarity=0.136 Sum_probs=192.7
Q ss_pred cCC--CceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 70 DEI--EGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 70 g~G--~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
|+| +||+||++.+ .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 7 g~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l 86 (328)
T cd08226 7 GRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSA 86 (328)
T ss_pred CCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCH
Confidence 666 8899999999 577799999986432 23346788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc---
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH--- 221 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 221 (350)
.+++..... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++||+.+.........
T Consensus 87 ~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 87 NSLLKTYFP---EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred HHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 998865321 35889999999999999999999 999999999999999999999999999754322111100
Q ss_pred --ccccccccCCCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC---
Q 018816 222 --IKASTAIGSLEFAAPEYLTTG--YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY--- 294 (350)
Q Consensus 222 --~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 294 (350)
.......++..|+|||++.+. .++.++|||||||++|+|++|..||...... ............
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~---------~~~~~~~~~~~~~~~ 231 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT---------QMLLQKLKGPPYSPL 231 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH---------HHHHHHhcCCCCCCc
Confidence 001112256679999999764 4789999999999999999999998753210 000000000000
Q ss_pred -------------------------CccCc----ccc-CCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HH
Q 018816 295 -------------------------MNIDP----VIV-GDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK--KL 342 (350)
Q Consensus 295 -------------------------~~~~~----~~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L 342 (350)
..... ... ..........++..+.+|+.+||+.||++|||+.++++ .+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 00000 000 00001111256778999999999999999999999985 45
Q ss_pred HHhhh
Q 018816 343 RQMYR 347 (350)
Q Consensus 343 ~~~~~ 347 (350)
..+++
T Consensus 312 ~~~~~ 316 (328)
T cd08226 312 KQVKE 316 (328)
T ss_pred HHHHH
Confidence 55544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=282.79 Aligned_cols=266 Identities=19% Similarity=0.228 Sum_probs=206.5
Q ss_pred ccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHH--hcCCCCccceeeeeecCC----cCeEEeec
Q 018816 65 RNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFAS--QMNHKSILKLIGCCLEAE----MPALVYEP 138 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~~~~~~~~~~----~~~lv~e~ 138 (350)
..++ |+|.||.||+|.+.+. .||||++... ....|.+|-.|.+ .++|+||+++++.-.... .++||+||
T Consensus 215 ~eli-~~Grfg~V~KaqL~~~-~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 215 LELI-GRGRFGCVWKAQLDNR-LVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred HHHh-hcCccceeehhhccCc-eeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 3455 9999999999999886 9999999764 3456777776665 458999999999866544 89999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcc------CCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFG------FPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
.+.|+|.++|.. ..++|....+++..+++||+|||+. +..+|+|||||..|||+.+++++-|+|||+|
T Consensus 290 h~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 290 HPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred ccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 999999999976 5799999999999999999999963 4568999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCC-CC-----ccchhHHHHHHHHHHHhCCCCCCCCcccCCCCc-------c
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGY-YN-----EKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN-------F 279 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~-------~ 279 (350)
..+..+.........+||.+|||||++.+.. +. .+.||||+|.++|||++.-.-.+...+.+.+.+ .
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 8887655544444567999999999997642 32 468999999999999996554432211111111 1
Q ss_pred hHHHHHHHHHHh-cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 280 FITDRVEKFIRS-NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 280 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
...+.++..+-. ..++.+...+..+ .-...+.+.+..||..||+.|.|+.=|-+++.++...
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~h-------~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRKH-------AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhcC-------ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 122334444433 3355555555544 4456789999999999999999999999998887543
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.65 Aligned_cols=249 Identities=17% Similarity=0.121 Sum_probs=187.7
Q ss_pred HHHHHhcCccccccc-ccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCC
Q 018816 54 DLKTAINNYSMRNIT-IDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAE 130 (350)
Q Consensus 54 ~l~~~~~~f~~~~~l-ig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 130 (350)
++....++|...+.+ +|+|+||.||++.. .++..+|+|.+....... .|+.....+ +||||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334444555544432 39999999999998 556677888775432111 122222222 6999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-ceeEccc
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDF 209 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Df 209 (350)
..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 999999999999999998653 37899999999999999999999 99999999999999999998 9999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
|.+...... ....++..|+|||++.+..++.++|+||||+++|+|++|..||...... ......+. ...
T Consensus 155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~ 223 (267)
T PHA03390 155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE----ELDLESLL-KRQ 223 (267)
T ss_pred ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc----hhhHHHHH-Hhh
Confidence 998765432 1234889999999999888999999999999999999999998743211 11111111 110
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-MIDVAK 340 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~evl~ 340 (350)
.... +.. ...+..+.+++.+||+.+|.+||+ ++++++
T Consensus 224 ---~~~~--~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ---QKKL--PFI---------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---cccC--Ccc---------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 000 134567899999999999999996 588874
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=280.51 Aligned_cols=249 Identities=18% Similarity=0.196 Sum_probs=200.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 134 (350)
++|.....| |+|++|.||+|.. .++..|++|.+.... ......+.+|+.++.+++ ||||+++++++.+++..++
T Consensus 1 ~~y~~~~~l-g~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKII-GEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeee-cCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 367778888 9999999999999 567799999886532 233466889999999998 9999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 80 VLEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccc
Confidence 99999999999998654 47999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCcc------------------ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCC
Q 018816 215 IPEGKTH------------------IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG 276 (350)
Q Consensus 215 ~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 276 (350)
....... .......++..|+|||++....++.++|+||||++++++++|..||.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---- 227 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---- 227 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----
Confidence 6443221 112234478899999999888899999999999999999999999874321
Q ss_pred CcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 018816 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM----IDVAK 340 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~----~evl~ 340 (350)
........ ..... +. ...++.+.+++.+||+.+|++|||+ .+++.
T Consensus 228 -----~~~~~~~~-~~~~~-~~------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 -----YLTFQKIL-KLEYS-FP------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -----HHHHHHHH-hcCCC-CC------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 01111111 11110 00 1335678999999999999999999 76654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=280.24 Aligned_cols=262 Identities=16% Similarity=0.116 Sum_probs=197.0
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
|...+.| |+|++|.||++.. .++..+++|.+..... .....+.+|+.++++++|+||+++++++.+++..++|+||
T Consensus 1 y~~~~~i-~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKI-GEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred Cccceee-ecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 3445667 9999999999999 5677899998865432 2456788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++ +|.+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 80 MDT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred cCC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 975 8888776532 47899999999999999999999 999999999999999999999999999998766543
Q ss_pred CccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC----
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG---- 293 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 293 (350)
.. ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... .........+....
T Consensus 152 ~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 223 (283)
T cd05118 152 VR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI------DQLFKIFRTLGTPDPEVW 223 (283)
T ss_pred cc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHcCCCchHhc
Confidence 31 11223478889999998876 7899999999999999999999998654321 00000000000000
Q ss_pred CCccC------ccccCCCC---ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNID------PVIVGDRS---CFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~------~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....+ ........ .......+..+.+++.+||+.||.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 00000000 0001245678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=281.70 Aligned_cols=251 Identities=19% Similarity=0.264 Sum_probs=192.5
Q ss_pred cCcccccccccCCCceEEEEEEEC-CCceEEEEEecccch-hhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSVR-YASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|...+.| |+|++|.||+|.++ ++..||+|.+..... .....+..|+.++.+.. ||||+++++++.+....+++|
T Consensus 15 ~~~~~~~~l-g~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEI-GSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEe-eccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 567778888 99999999999995 477999999865432 33455677887777774 999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
||++ +++.+++.... ..+++..+..++.+++.||.||| + .+|+|+||+|+||++++++.+||+|||++...
T Consensus 94 e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9985 56776664422 46889999999999999999999 6 58999999999999999999999999998765
Q ss_pred CCCCccccccccccCCCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGY----YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
...... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... ...........
T Consensus 166 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~ 234 (296)
T cd06618 166 VDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--------EFEVLTKILQE 234 (296)
T ss_pred cCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--------HHHHHHHHhcC
Confidence 432221 2224788999999987553 78999999999999999999999864211 01111111111
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.. ..... . ...+.++.+|+.+||+.||++|||+.+++..
T Consensus 235 ~~-~~~~~----~------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 235 EP-PSLPP----N------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-CCCCC----C------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 11100 0 0234678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=278.00 Aligned_cols=240 Identities=16% Similarity=0.159 Sum_probs=186.1
Q ss_pred ccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHH---HHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 69 IDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIV---FASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 69 ig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
||+|+||.||++.. .++..||+|.+..... .....+..|.. .+....||||+.+++++.+.+..++||||+++
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 39999999999998 5567999999865421 11222334433 44455799999999999999999999999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 82 GDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999988543 46899999999999999999999 8999999999999999999999999999987553322
Q ss_pred ccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 222 IKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
.....|+..|+|||++.++ .++.++||||+|+++|+|++|..||....... .......... ..+.
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-----~~~~ 217 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------KHEIDRMTLT-----MAVE 217 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-------hHHHHHHhhc-----cCCC
Confidence 2234589999999998755 58999999999999999999999997542210 0001111100 0111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
+. ...+..+.+++.+||..+|++|| ++.++++
T Consensus 218 ~~--------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LP--------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CC--------CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 12346799999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.44 Aligned_cols=272 Identities=19% Similarity=0.178 Sum_probs=208.1
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecC------CcCe
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEA------EMPA 133 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 133 (350)
+...+.| |+|+||.||+|+. ..|..||||.++... ....+...+|+++|++++|||||+++++-.+. ....
T Consensus 15 W~~~e~L-G~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERL-GKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhh-cCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3445677 9999999999997 788899999998753 35577889999999999999999999986543 3678
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC--C--CCceeEccc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ--E--EYAAKLFDF 209 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~--~~~~kl~Df 209 (350)
+|||||.+|||...+...... ..+++.+.+.++.+++.||.||| .++|+||||||.||++- . .-.-||+||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred EEEeecCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 999999999999999775432 46999999999999999999999 99999999999999993 2 234699999
Q ss_pred CCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
|.|+....+. .....+||..|++||.+.. ..|+..+|.|||||++|+.+||..||-..... ......++..
T Consensus 169 G~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p-----k~~~~~~~~~ 240 (732)
T KOG4250|consen 169 GAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP-----KNNKEIMWHI 240 (732)
T ss_pred cccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc-----cccchhhhhh
Confidence 9999887655 3556679999999999985 78999999999999999999999999754321 1112222333
Q ss_pred HHhcCCC---ccCcccc------CCC--CccchHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHhhh
Q 018816 289 IRSNGYM---NIDPVIV------GDR--SCFRKEEKLQAYVELAFKCLSHSAEDRP--TMIDVAKKLRQMYR 347 (350)
Q Consensus 289 ~~~~~~~---~~~~~~~------~~~--~~~~~~~~~~~l~~l~~~cl~~~P~~RP--t~~evl~~L~~~~~ 347 (350)
..+.... ..++..+ ... ++.........+..++..+|..+|.+|- ...+....+..|.+
T Consensus 241 ~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 241 ITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 3222211 1111111 111 1111124556788899999999999998 77777777776654
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=282.06 Aligned_cols=262 Identities=19% Similarity=0.170 Sum_probs=193.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|.....| |+|++|.||+|.+ .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 2 ~~y~~~~~l-~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKI-GEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEe-cCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 468888888 9999999999999 4667899998854322 22356889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-CCceeEcccCCCccC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-EYAAKLFDFSLSKSI 215 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 215 (350)
||++ ++|.+++..... ..+++..+..++.||+.||.||| +++++|+||+|+||+++. ++.+||+|||++...
T Consensus 81 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred eccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 9996 578777754321 34678888999999999999999 999999999999999985 567899999998765
Q ss_pred CCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC-
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG- 293 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 293 (350)
..... ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||...... +..........
T Consensus 154 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---------~~~~~~~~~~~~ 222 (294)
T PLN00009 154 GIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---------DELFKIFRILGT 222 (294)
T ss_pred CCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHHHhCC
Confidence 43221 11223478899999988764 5789999999999999999999998753221 11111111000
Q ss_pred --CCc------------cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 --YMN------------IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 --~~~------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... ..+..............+..+.+++.+||+.+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00000000000000123467889999999999999999999986
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=286.62 Aligned_cols=264 Identities=16% Similarity=0.156 Sum_probs=194.1
Q ss_pred cCccc-ccccccCCCceEEEEEEE-CCCceEEEEEecccchhh--------------HHHHHHHHHHHHhcCCCCcccee
Q 018816 60 NNYSM-RNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYA--------------SERCFNNIVFASQMNHKSILKLI 123 (350)
Q Consensus 60 ~~f~~-~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~ 123 (350)
+.|.. .+.| |+|+||.||+|.+ .++..||+|.+....... ...+.+|+.++++++||||++++
T Consensus 8 ~ry~~~~~~i-g~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHL-GEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred cchhhhhhcc-cCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 44543 3456 9999999999998 567799999986542211 12477899999999999999999
Q ss_pred eeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 124 GCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
+++...+..++||||++ ++|.+++... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCC
Confidence 99999999999999996 6899888543 46889999999999999999999 999999999999999999999
Q ss_pred eeEcccCCCccCCCCCc------------cccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 018816 204 AKLFDFSLSKSIPEGKT------------HIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLS 270 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~ 270 (350)
++|+|||.+........ ........+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999876541110 0111223367889999998764 4789999999999999999999998754
Q ss_pred cccCCCCcchHHHHHHHHHHhcCCC------------ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 018816 271 RLATGGSNFFITDRVEKFIRSNGYM------------NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev 338 (350)
.. ................. ...+......... ....+..+.+++.+||+.+|++|||+.++
T Consensus 238 ~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 310 (335)
T PTZ00024 238 NE------IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEA 310 (335)
T ss_pred CH------HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence 32 11111111111111000 0000000000000 01235678899999999999999999999
Q ss_pred HH
Q 018816 339 AK 340 (350)
Q Consensus 339 l~ 340 (350)
+.
T Consensus 311 l~ 312 (335)
T PTZ00024 311 LK 312 (335)
T ss_pred hc
Confidence 86
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.38 Aligned_cols=256 Identities=18% Similarity=0.217 Sum_probs=192.3
Q ss_pred HHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecC----
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEA---- 129 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 129 (350)
.+...+|.+..+| |+||||.||+++. -||..+|||++.-.. ......+.+|+++|++|+|||||+++..|.+.
T Consensus 475 SRY~~DFEEL~lL-GkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELL-GKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHh-cCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 4667889999999 9999999999999 678899999986553 34456688999999999999999999876531
Q ss_pred --------------------------------------------------------------------------------
Q 018816 130 -------------------------------------------------------------------------------- 129 (350)
Q Consensus 130 -------------------------------------------------------------------------------- 129 (350)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHH
Q 018816 130 -----------------------------------EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANA 174 (350)
Q Consensus 130 -----------------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~ 174 (350)
..+||-||||+..++.+++..+... -.....++++++|+.|
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~----~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN----SQRDEAWRLFREILEG 709 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc----hhhHHHHHHHHHHHHH
Confidence 0137889999988888888664211 1366789999999999
Q ss_pred HHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC----------------CCCccccccccccCCCCCCccc
Q 018816 175 VAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP----------------EGKTHIKASTAIGSLEFAAPEY 238 (350)
Q Consensus 175 l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~ 238 (350)
|.|+| ++|||||||||.||++++++.|||+|||+|+... .+......+..+||..|+|||+
T Consensus 710 LaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 99999 9999999999999999999999999999998721 0011112345679999999999
Q ss_pred cccC---CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHH
Q 018816 239 LTTG---YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQ 315 (350)
Q Consensus 239 ~~~~---~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (350)
+.+. .|+.|+|+||||+++|||+. ||...- .-+.. ...++++.-+. ++.+. .+..+
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--------ERa~i-L~~LR~g~iP~-~~~f~--------~~~~~ 845 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--------ERASI-LTNLRKGSIPE-PADFF--------DPEHP 845 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchH--------HHHHH-HHhcccCCCCC-Ccccc--------cccch
Confidence 9865 49999999999999999997 344321 11111 11111111110 11110 13334
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHH
Q 018816 316 AYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 316 ~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.-.+++.+|++.||++||||.|+|.
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhh
Confidence 5678999999999999999999986
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=288.86 Aligned_cols=260 Identities=18% Similarity=0.253 Sum_probs=193.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC------
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAE------ 130 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 130 (350)
++|.....| |+|+||.||+|+. .++..||+|++.... ......+.+|+.++++++||||+++++++....
T Consensus 15 ~~y~~~~~i-g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQV-GSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEe-eecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 788888888 9999999999998 567799999986532 222356789999999999999999999987543
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++|+||+. .+|..+.. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 4589999996 46766542 35889999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
++...... .....++..|+|||++.+ ..++.++|+|||||++|||++|+.||...... ..+....
T Consensus 163 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---------~~~~~~~ 228 (342)
T cd07879 163 LARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---------DQLTQIL 228 (342)
T ss_pred CCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHH
Confidence 98764322 122347888999999876 46889999999999999999999999753211 0111111
Q ss_pred HhcC---------------CCcc--Cccc-cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhh
Q 018816 290 RSNG---------------YMNI--DPVI-VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK--LRQMY 346 (350)
Q Consensus 290 ~~~~---------------~~~~--~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L~~~~ 346 (350)
...+ .... .+.. ........ ...+..+.+|+.+||+.||++||++.+++.. ++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 1000 0000 0000 00000000 0234568899999999999999999999953 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=280.01 Aligned_cols=256 Identities=17% Similarity=0.144 Sum_probs=198.2
Q ss_pred CcccccccccCCCceEEEEEEE----CCCceEEEEEecccch----hhHHHHHHHHHHHHhc-CCCCccceeeeeecCCc
Q 018816 61 NYSMRNITIDEIEGYILYMGFL----RDRGPILVMKYRKSVR----YASERCFNNIVFASQM-NHKSILKLIGCCLEAEM 131 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~----~~~~~vaik~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 131 (350)
+|...+.| |+|++|.||+++. .++..||+|.+..... ...+.+.+|+.++.++ +||||+.+++.+..+..
T Consensus 1 ~~~~~~~i-g~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVL-GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEe-ccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 36667778 9999999999986 3456899999865321 2345678999999999 59999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred EEEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcc
Confidence 99999999999999988643 46889999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY--YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
+......... ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...... ....... ...
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~~~-~~~ 224 (288)
T cd05583 152 SKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-----NSQSEIS-RRI 224 (288)
T ss_pred cccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-----chHHHHH-HHH
Confidence 8765433221 122334789999999987665 788999999999999999999998642210 1111111 111
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
.... +.. +...+..+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 225 ~~~~-----~~~--------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 225 LKSK-----PPF--------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HccC-----CCC--------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1110 000 013345788999999999999999988887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=276.54 Aligned_cols=258 Identities=19% Similarity=0.221 Sum_probs=193.2
Q ss_pred cccccccccCCCceEEEEEEEC-CCceEEEEEecccch--hhHHHHHHHHHHHHhc---CCCCccceeeeeecCCc----
Q 018816 62 YSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSVR--YASERCFNNIVFASQM---NHKSILKLIGCCLEAEM---- 131 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~---- 131 (350)
|+....| |+|+||.||+|... ++..||+|.+..... .....+.+|+.++.++ +||||+++++++.+.+.
T Consensus 1 y~~~~~l-~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEe-cccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 4556777 99999999999994 477999999864322 2234566788877766 59999999999988776
Q ss_pred -CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 132 -PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 132 -~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
.+++|||++ ++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccC
Confidence 999999997 588888865322 35899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
.+........ .....++..|+|||++.+..++.++|+|||||++|+|++|.+||...... ........
T Consensus 153 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---------~~~~~~~~ 220 (287)
T cd07838 153 LARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---------DQLDKIFD 220 (287)
T ss_pred cceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---------HHHHHHHH
Confidence 9877643321 12223788899999999889999999999999999999999988743321 11111111
Q ss_pred hcCC------C--------ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 SNGY------M--------NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ~~~~------~--------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... . ........... ......+..+.+++.+||+.||++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFK-SFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HcCCCChHhcCCCcccchhhcccccccchh-hhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1000 0 00000000000 000144577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=278.58 Aligned_cols=251 Identities=17% Similarity=0.139 Sum_probs=194.8
Q ss_pred CcccccccccCCCceEEEEEEE----CCCceEEEEEecccch----hhHHHHHHHHHHHHhc-CCCCccceeeeeecCCc
Q 018816 61 NYSMRNITIDEIEGYILYMGFL----RDRGPILVMKYRKSVR----YASERCFNNIVFASQM-NHKSILKLIGCCLEAEM 131 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~----~~~~~vaik~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 131 (350)
+|+..+.| |+|+||.||++.. .++..||+|.+..... ...+.+.+|+.++.++ +|+||+.+++++..+..
T Consensus 1 ~y~~~~~l-g~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVL-GTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred Cceeeeee-ccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 46667788 9999999999987 3567899999865322 2345678899999999 59999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+|||++.++.++|+|||+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 80 LHLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred EEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcc
Confidence 99999999999999998653 46888999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTG--YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
+......... ......|+..|+|||.+... .++.++||||||+++|+|++|..||...... ....... ...
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~-~~~ 224 (290)
T cd05613 152 SKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-----NSQAEIS-RRI 224 (290)
T ss_pred ceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-----ccHHHHH-HHh
Confidence 8765432211 12234488999999998753 4788999999999999999999998643211 1111111 111
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
...... .. ...+..+.+++.+||+.+|++|| ++.+++.
T Consensus 225 ~~~~~~-~~------------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 225 LKSEPP-YP------------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hccCCC-CC------------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111100 00 13446788999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=277.79 Aligned_cols=267 Identities=16% Similarity=0.159 Sum_probs=193.7
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEeec
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
|...+.| |+|++|.||+|+. .++..|++|++..... .......+|+..+.+++ ||||+++++++.+++..++||||
T Consensus 1 y~~~~~i-g~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQL-GDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred Ceeheee-ccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 4456677 9999999999999 4566899999865432 22334567999999999 99999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+ +++|.+++..... ..+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 7899988865421 46899999999999999999999 999999999999999999999999999998765433
Q ss_pred CccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCC-------CcchHHHHHHHHHH
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------SNFFITDRVEKFIR 290 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~ 290 (350)
.. .....++..|+|||++.. ..++.++|+||||+++++|++|.+||......... .......+......
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 153 PP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred CC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 22 123347889999998854 45789999999999999999999998654321000 00000000000000
Q ss_pred hcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 SNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... ...+............+ ..+..+.+++.+||+.+|++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000 00000000000000000 12467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=285.94 Aligned_cols=266 Identities=18% Similarity=0.212 Sum_probs=202.0
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----cC
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAE-----MP 132 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 132 (350)
+|.....| |.|++|.||+|+. ..+..|++|++.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 1 ~y~i~~~i-g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPI-GSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred Cceeeeee-cCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 36667777 9999999999999 457799999987643 344567889999999999999999999988765 78
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
+++|||++ ++|.+++... ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||.+
T Consensus 80 ~lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 99999997 5888888653 47899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCcc-ccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 213 KSIPEGKTH-IKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 213 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
......... .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||...... ........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---------~~~~~i~~ 221 (330)
T cd07834 151 RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---------DQLNLIVE 221 (330)
T ss_pred EeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---------HHHHHHHH
Confidence 876543211 112233478899999999887 7899999999999999999999998754321 00000000
Q ss_pred hcCC---------------Ccc---CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhh
Q 018816 291 SNGY---------------MNI---DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK--KLRQMY 346 (350)
Q Consensus 291 ~~~~---------------~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~~ 346 (350)
..+. ..+ ........... ....+..+.+++.+||+.+|++|||+.+++. .|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 222 VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hcCCCChhHhhhccccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000 000 00000000000 0124567899999999999999999999998 355544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=282.21 Aligned_cols=267 Identities=16% Similarity=0.123 Sum_probs=193.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh--hHHHHHHHHHHHHhcCCCCccceeeeeecCC-----
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY--ASERCFNNIVFASQMNHKSILKLIGCCLEAE----- 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 130 (350)
.++|...+.| |+|++|.||+|.. .++..||+|++...... ....+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~l-g~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKL-GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEe-ccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 5789999998 9999999999998 56679999988654321 2345678999999999999999999876543
Q ss_pred ---cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 131 ---MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 131 ---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
..++|+||++ ++|...+.... ..+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENPS----VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEC
Confidence 4699999996 46777665432 46899999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccCCCCCccc---------cccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCC
Q 018816 208 DFSLSKSIPEGKTHI---------KASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGS 277 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 277 (350)
|||++.......... ......+++.|+|||.+.+. .++.++|||||||++|+|++|.+||......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~---- 233 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI---- 233 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 999987654322111 11223467889999987654 5889999999999999999999998754321
Q ss_pred cchHHHHHHHHHHhcC----------CCccCccccCCCCccch---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 278 NFFITDRVEKFIRSNG----------YMNIDPVIVGDRSCFRK---EEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.............. ....+............ ......+.+++.+||+.||++|||+.+++.
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 --DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred --HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00011110000000 00000000000000000 123357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=286.89 Aligned_cols=270 Identities=17% Similarity=0.195 Sum_probs=199.9
Q ss_pred ccccHHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceee
Q 018816 48 RSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIG 124 (350)
Q Consensus 48 ~~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~ 124 (350)
+.....++...+++|.....| |+|+||.||+|.. .++..||+|++.... ....+.+.+|+.++.+++||||+++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~l-g~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPV-GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred hhhHHHHHhhccCceEEEEEe-eecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 334556677788999999998 9999999999998 667799999986532 223456788999999999999999999
Q ss_pred eeecC------CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe
Q 018816 125 CCLEA------EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 125 ~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 198 (350)
++... ...+++++++ +++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll 153 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV 153 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEE
Confidence 87643 3467888887 7899887753 35889999999999999999999 9999999999999999
Q ss_pred CCCCceeEcccCCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCC
Q 018816 199 QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGS 277 (350)
Q Consensus 199 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 277 (350)
+.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......
T Consensus 154 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---- 224 (345)
T cd07877 154 NEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---- 224 (345)
T ss_pred cCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 99999999999998764322 123347889999998866 46889999999999999999999998643221
Q ss_pred cchHHHHHHHHHHhcCCC---------------ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 278 NFFITDRVEKFIRSNGYM---------------NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
................ .+.......... .....++.+.+++.+||+.||.+|||+.+++.
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 225 --DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred --HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000000000000 000000000000 00012457889999999999999999999886
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=285.56 Aligned_cols=265 Identities=16% Similarity=0.175 Sum_probs=197.7
Q ss_pred HHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeec-C
Q 018816 54 DLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLE-A 129 (350)
Q Consensus 54 ~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~ 129 (350)
++...+++|+....| |.|+||.||++.. .++..||+|++... .....+.+.+|+.++.+++||||+++.+++.. .
T Consensus 4 ~~~~~~~~y~~~~~i-g~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 4 TVFEITNRYVDLQPV-GMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred ceeccccceEEEEee-cccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 344577899999998 9999999999998 57779999987543 22334668899999999999999999998865 5
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
...++++||+ +++|.+++.. .+++......++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcc
Confidence 5789999998 5689888753 35788888899999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
|.+...... .....++..|+|||++.+ ..++.++|+||||+++|+|++|.+||...... .........
T Consensus 153 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~------~~~~~~~~~ 221 (328)
T cd07856 153 GLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV------NQFSIITDL 221 (328)
T ss_pred ccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHH
Confidence 998754321 122347889999998866 46899999999999999999999998643220 000000000
Q ss_pred HH------------hcCCCccCccccCCCCccch---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 289 IR------------SNGYMNIDPVIVGDRSCFRK---EEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 289 ~~------------~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.. ......+. ........... ...+..+.+++.+||+.+|++|||+.+++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 222 LGTPPDDVINTICSENTLRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hCCCCHHHHHhccchhhHHHHh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000000 00000000000 0234679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=286.30 Aligned_cols=268 Identities=15% Similarity=0.162 Sum_probs=195.7
Q ss_pred HHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC--
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAE-- 130 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 130 (350)
....++|...+.| |+|+||.||++.. .++..||+|++.... ......+.+|+.++++++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 11 WEVPDRYRDLKQV-GSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hccccceEEEEEe-eecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3456789888888 9999999999998 567799999985432 233456889999999999999999999987654
Q ss_pred ----cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeE
Q 018816 131 ----MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206 (350)
Q Consensus 131 ----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 206 (350)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEE
Confidence 348999999 6789888753 46889999999999999999999 999999999999999999999999
Q ss_pred cccCCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCc-----ch
Q 018816 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN-----FF 280 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~-----~~ 280 (350)
+|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||........... ..
T Consensus 160 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 160 LDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred eecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999987653321 22347889999999876 3588999999999999999999999875422100000 00
Q ss_pred HHHHHHHHHHhcC-CCcc--CccccC-CCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 281 ITDRVEKFIRSNG-YMNI--DPVIVG-DRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 281 ~~~~~~~~~~~~~-~~~~--~~~~~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....+...+.... .... -+.... ..... ....+..+.+++.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSL-LPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHh-ccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 0000 000000 00000 0123456889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.27 Aligned_cols=255 Identities=16% Similarity=0.126 Sum_probs=201.2
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
..+-+......| |.|.||.||.|.. ++|...|+|-+.-. .......+.+|.+++..|+|||+|+++|+-.+.+..+
T Consensus 1232 nV~~rWqrg~~I-g~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFI-GGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred cceeeecccccc-CCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 334556667777 9999999999999 66656677776433 3334456789999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
|.||||++|+|.+.+... ...++.....+..|++.|+.||| +.|||||||||+||+++.+|.+|++|||.|.
T Consensus 1311 IFMEyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeeccccee
Confidence 999999999999998654 34667777788999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCcc--ccccccccCCCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 214 SIPEGKTH--IKASTAIGSLEFAAPEYLTTGY---YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 214 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
.+...... .......||+.|||||++.+.. ...+.|||||||++.||+||+.||..... +|...+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----------e~aIMy 1452 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----------EWAIMY 1452 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----------hhHHHh
Confidence 77554211 1123456999999999998643 56789999999999999999999875432 121111
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
--..++. +. .|+..+.+-++++..||..||++|.++.++++.
T Consensus 1453 ~V~~gh~----------Pq-~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 HVAAGHK----------PQ-IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHhccCC----------CC-CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111111 11 122567788999999999999999999888763
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=285.99 Aligned_cols=270 Identities=14% Similarity=0.142 Sum_probs=192.7
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecC---------
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEA--------- 129 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------- 129 (350)
++|...+.| |.|+||.||+|.. .++..||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~L-g~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPL-GCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEe-cCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 678888888 9999999999999 56779999998665555567788999999999999999999876543
Q ss_pred -----CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-CCc
Q 018816 130 -----EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-EYA 203 (350)
Q Consensus 130 -----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~ 203 (350)
...++||||++ ++|.+++.. ..+++..+..++.||+.||.||| +.+++|+||||+||+++. ++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCce
Confidence 35789999997 588887753 35889999999999999999999 999999999999999974 567
Q ss_pred eeEcccCCCccCCCCCccc-cccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCC------
Q 018816 204 AKLFDFSLSKSIPEGKTHI-KASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG------ 275 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------ 275 (350)
++++|||.+.......... ......++..|+|||++.. ..++.++|||||||++|+|++|+.||........
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 8999999987653321111 1122347889999998754 4588999999999999999999999975432100
Q ss_pred CCcchHHHHHHHHHHhcCCCccCccccCCCCc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSC-FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..+...........................+. ......+.++.+|+.+||+.||++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000000000000000000000000000 000023467889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=272.54 Aligned_cols=249 Identities=16% Similarity=0.181 Sum_probs=191.6
Q ss_pred cccccccccCCCceEEEEEEEC-CCceEEEEEeccc-----chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 62 YSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKS-----VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
|...+.| |+|+||.||++.+. .+..+++|.+... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 2 y~i~~~i-g~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRL-GKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeee-cCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5666777 99999999999983 3334555554321 112334567899999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++...... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++. +.++|+|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999988642111 156899999999999999999999 999999999999999975 56999999998765
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ ....
T Consensus 156 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---------~~~~~~~~-~~~~- 222 (260)
T cd08222 156 MGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---------LSVVLRIV-EGPT- 222 (260)
T ss_pred CCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHHHHH-cCCC-
Confidence 43322 12233478899999999888889999999999999999999999863221 11111111 1111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.. +...+.++.+++.+||+.+|++||++.++++
T Consensus 223 ---~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 ---PSL--------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCC--------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 1245578899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=299.87 Aligned_cols=265 Identities=22% Similarity=0.280 Sum_probs=210.6
Q ss_pred HHhcCcccccccccCCCceEEEEEEEC----C----CceEEEEEecccch-hhHHHHHHHHHHHHhc-CCCCccceeeee
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFLR----D----RGPILVMKYRKSVR-YASERCFNNIVFASQM-NHKSILKLIGCC 126 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~~----~----~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 126 (350)
...++......+ |+|.||.|++|... . ...||||.+..... ...+.+..|+++|..+ .|+||+.++|+|
T Consensus 293 ~~~~~l~~~~~l-g~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 293 IPRENLKLGKYL-GEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred echhhcccccee-ecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 334444555577 99999999999862 1 44899999876533 4567899999999999 599999999999
Q ss_pred ecCCcCeEEeecCCCCchhhhhhCCC---CCCC--------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCc
Q 018816 127 LEAEMPALVYEPAGYCTLADRLYGPL---QTHL--------EPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWN 195 (350)
Q Consensus 127 ~~~~~~~lv~e~~~~~sL~~~l~~~~---~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N 195 (350)
...+..++|+||+..|+|.+++.... .... ..++..+.+.++.|||.|++||+ +.+++||||..+|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhh
Confidence 99999999999999999999997754 1011 13889999999999999999999 9999999999999
Q ss_pred eEeCCCCceeEcccCCCccCCCCCcccccccc-ccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCccc
Q 018816 196 ILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA-IGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLA 273 (350)
Q Consensus 196 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~ 273 (350)
||+..+..+||+|||+|+.............. .-+..|||||.+....|+.+|||||||+++||++| |..||....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 99999999999999999976655544322211 13556999999999999999999999999999999 778876421
Q ss_pred CCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 274 TGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
....+.+.++.+.... . +..+..++.+++..||+.+|++||++.++.+.|..++
T Consensus 527 -------~~~~l~~~l~~G~r~~-~-----------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 -------PTEELLEFLKEGNRME-Q-----------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -------cHHHHHHHHhcCCCCC-C-----------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1112233444433211 1 1255788999999999999999999999999999864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=307.24 Aligned_cols=257 Identities=18% Similarity=0.141 Sum_probs=204.5
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeec
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLE 128 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 128 (350)
.++....++|.+..+| |+|+||.|.++++ ..+.-+|+|++++.. .....-|..|-.+|.--+.+.|+.+...|.+
T Consensus 68 ~~lrl~~~DfeilKvI-GrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVI-GRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHhCCHHhhHHHHHh-cccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3445556899999998 9999999999999 455567888887632 2334558888999999999999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
.+++|+||||++||+|-.++.+. ..+++..+..++..|+.||.-|| +.|+|||||||+|||||..|++||+|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeecc
Confidence 99999999999999999999664 47999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-----GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
||.|-.+...+.. ...+.+|||.|.+||++.. +.|++.+|+||+||++|||+.|..||+.... ..
T Consensus 219 FGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl---------ve 288 (1317)
T KOG0612|consen 219 FGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL---------VE 288 (1317)
T ss_pred chhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH---------HH
Confidence 9999877654433 3456679999999999863 5699999999999999999999999985432 22
Q ss_pred HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 018816 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT---MIDVA 339 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~evl 339 (350)
...+...-.. ..--|. ....++...+||++.+.. |+.|.. ++++-
T Consensus 289 TY~KIm~hk~-~l~FP~---------~~~VSeeakdLI~~ll~~-~e~RLgrngiedik 336 (1317)
T KOG0612|consen 289 TYGKIMNHKE-SLSFPD---------ETDVSEEAKDLIEALLCD-REVRLGRNGIEDIK 336 (1317)
T ss_pred HHHHHhchhh-hcCCCc---------ccccCHHHHHHHHHHhcC-hhhhcccccHHHHH
Confidence 2222221111 110110 014667888999988765 788877 66654
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=273.56 Aligned_cols=261 Identities=18% Similarity=0.182 Sum_probs=196.5
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
|+....| |+|++|.||+|+. .++..|++|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 y~~~~~i-g~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKL-GEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred Ceeehcc-cccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 3445667 9999999999999 557799999987653 23346678899999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
++ ++|.+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 80 CD-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred cC-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 97 59999986532 36899999999999999999999 899999999999999999999999999998766443
Q ss_pred CccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH----------
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK---------- 287 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------- 287 (350)
.. ......++..|+|||.+.+. .++.++|+|||||+++|+++|.+||...... ........
T Consensus 152 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07829 152 LR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI------DQLFKIFQILGTPTEESW 223 (282)
T ss_pred cc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHHHhCCCcHHHH
Confidence 22 11222357789999998776 7899999999999999999999988643211 00000000
Q ss_pred -HHHhcC-CCccCccccCCCC-ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 -FIRSNG-YMNIDPVIVGDRS-CFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 -~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+.... ....-+....... ... ...+..+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 224 PGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000 0000000000000 000 023567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=264.43 Aligned_cols=246 Identities=19% Similarity=0.253 Sum_probs=192.7
Q ss_pred ccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCC
Q 018816 65 RNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
..-| |+|..|.|++.+. ..+..+|||.+.... ....+++...+.++..- +.|.||+++|+|..+...++.||.|.
T Consensus 97 l~dl-GsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 97 LGDL-GSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred HHhh-cCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3456 9999999999999 556688999997653 34556777888877655 48999999999999999999999983
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
..++.++..-. +++++...-++...+++||.||.. .++|+|||+||+|||+|..|++|++|||.+-.+.....
T Consensus 175 ~C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 175 TCAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred HHHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence 34455544332 578999999999999999999996 67999999999999999999999999999977655443
Q ss_pred ccccccccCCCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 222 IKASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.+...|.+.|||||.+.- ..|...+||||||++++||.||+.||...... +.. +.+.+. ...
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~---ltkvln-~eP---- 312 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEV---LTKVLN-EEP---- 312 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHH---HHHHHh-cCC----
Confidence 233348999999998864 35889999999999999999999999875431 211 122222 112
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
|.+.+. ..++..+.+++..||+.|+.+||.-.++++
T Consensus 313 P~L~~~------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 PLLPGH------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCcc------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 222222 135678999999999999999999998876
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=279.98 Aligned_cols=269 Identities=15% Similarity=0.167 Sum_probs=190.4
Q ss_pred CcccccccccCCCceEEEEEEEC-C--CceEEEEEecccc--hhhHHHHHHHHHHHHhc-CCCCccceeeeeecC----C
Q 018816 61 NYSMRNITIDEIEGYILYMGFLR-D--RGPILVMKYRKSV--RYASERCFNNIVFASQM-NHKSILKLIGCCLEA----E 130 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~-~--~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~ 130 (350)
+|.....| |+|+||.||++... . +..||+|++.... ......+.+|+.++.++ +||||+++++.+... .
T Consensus 1 ~y~~~~~l-g~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKEL-GQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEc-cccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 36667778 99999999999993 3 6689999886432 22345678899999999 599999999875432 4
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++++||++ ++|.+++... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg 150 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFG 150 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCC
Confidence 5788899885 6898888543 56899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccc--cccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCC------cchH
Q 018816 211 LSKSIPEGKTHI--KASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGS------NFFI 281 (350)
Q Consensus 211 ~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~------~~~~ 281 (350)
.+.......... ......|+..|+|||++.+ ..++.++|+|||||++|+|++|.+||.......... ....
T Consensus 151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd07857 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230 (332)
T ss_pred CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence 997654322211 1223458899999998765 468999999999999999999999987533110000 0000
Q ss_pred HHHHHHHHHhcCC---CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 282 TDRVEKFIRSNGY---MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 282 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
............. ............... ...+..+.+++.+||+.||++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIF-PNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhC-CCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000 000000000000000 012467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=268.76 Aligned_cols=276 Identities=17% Similarity=0.177 Sum_probs=201.8
Q ss_pred cCcccccccccCCCceEEEEEEE---CC--CceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeec-CCc
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL---RD--RGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLE-AEM 131 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~---~~--~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 131 (350)
..|.....| |+|.||.||++.. ++ +..+|||++..... .-.....+|+.+++.++|||++.+..++.+ +..
T Consensus 24 ~~ye~ig~I-g~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKI-GRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhcccee-cccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 456666777 9999999999976 22 23789999876532 223457799999999999999999999887 778
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC----CceeEc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE----YAAKLF 207 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~ 207 (350)
.++++||.+ .+|.+.|+.........++...+..|+.||+.|+.||| ++=|+||||||+|||+..+ |.|||+
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence 999999996 69999886543333367899999999999999999999 9999999999999999877 999999
Q ss_pred ccCCCccCCCCCccc-cccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHH
Q 018816 208 DFSLSKSIPEGKTHI-KASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
|||+++.+...-... .....+-|+.|.|||.+.+.. ||++.|+||+|||+.||++-.+.|.....-......+..+.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999886543322 334455799999999999865 999999999999999999999888754332222212222222
Q ss_pred HHHHHhcCC--CccCccccCCCCc------c---------ch------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 286 EKFIRSNGY--MNIDPVIVGDRSC------F---------RK------EEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 286 ~~~~~~~~~--~~~~~~~~~~~~~------~---------~~------~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.--+. ...-|.+..-... + .+ ..-++...+|+.++|..||-+|.|+++.++
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 222221110 0000111000000 0 00 001234789999999999999999999876
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=267.21 Aligned_cols=236 Identities=22% Similarity=0.188 Sum_probs=191.6
Q ss_pred ccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 69 IDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 69 ig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
+|.|++|.||++.. .++..+++|.+..... .....+..|+.++++++||||+++++.+.+++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 49999999999999 4577999999866432 2456788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 224 (350)
.+++... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~ 150 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RT 150 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cc
Confidence 9998654 36899999999999999999999 89999999999999999999999999999876644321 12
Q ss_pred cccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
....++..|+|||...+...+.++|+||||+++|++++|..||..... ....... .... ..+.
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---------~~~~~~~-~~~~-~~~~------ 213 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---------KEIYEKI-LKDP-LRFP------ 213 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---------HHHHHHH-hcCC-CCCC------
Confidence 334478899999999888889999999999999999999999864321 1111111 1111 0011
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCCHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMID 337 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 337 (350)
...+..+.+++.+||..||++|||+.+
T Consensus 214 ------~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 ------EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ------CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 123467889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=268.65 Aligned_cols=241 Identities=16% Similarity=0.117 Sum_probs=199.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|+..++| |+|.||.|-+++- ..++.+|+|.+.+..- .....-..|-.+|...+||.+..+-..|+..+.+|+
T Consensus 167 m~dFdfLKvL-GkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVL-GKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHh-cCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3688888999 9999999999998 5667889999877643 233344567889999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||..||.|.-++... ..+++.....+-..|+.||.||| +++||+||||.+|.|+|.+|++||+|||+++.
T Consensus 246 VMeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchh
Confidence 99999999999888664 57899999999999999999999 99999999999999999999999999999986
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
-... .....+.+|||.|+|||++....|..+.|.|.+||++|||++|+.||..... ..+..++-...
T Consensus 318 ~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----------~kLFeLIl~ed- 384 (516)
T KOG0690|consen 318 EIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----------EKLFELILMED- 384 (516)
T ss_pred cccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----------hHHHHHHHhhh-
Confidence 4332 2346778899999999999999999999999999999999999999986532 11111211111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP 333 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 333 (350)
..- +...+++...|+...|..||.+|.
T Consensus 385 -~kF-----------Pr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 385 -LKF-----------PRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -ccC-----------CccCCHHHHHHHHHHhhcChHhhc
Confidence 000 114456788999999999999995
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=282.26 Aligned_cols=258 Identities=18% Similarity=0.236 Sum_probs=195.8
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc--
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM-- 131 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 131 (350)
...++|.....| |+|++|.||+|.. .++..||+|++... .......+.+|+.++++++||||+++.+++...+.
T Consensus 12 ~~~~~y~~~~~i-g~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPV-GSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEe-ccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 346788888888 9999999999999 55678999988643 22334567789999999999999999998876554
Q ss_pred ----CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 132 ----PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 132 ----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEc
Confidence 89999999 6799998854 46899999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
|||++...... .....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...... ..+.
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---------~~~~ 226 (343)
T cd07851 161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---------DQLK 226 (343)
T ss_pred ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Confidence 99998765432 2233478899999988653 6789999999999999999999998643221 0111
Q ss_pred HHHHhcC--C---------C----ccC---ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 287 KFIRSNG--Y---------M----NID---PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 287 ~~~~~~~--~---------~----~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....... . . ... .......... ....+..+.+++.+||+.+|++|||+.+|+.
T Consensus 227 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 227 RIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV-FSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHH-hccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 1100000 0 0 000 0000000000 0023567999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=264.67 Aligned_cols=220 Identities=19% Similarity=0.113 Sum_probs=176.5
Q ss_pred CCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCchhhhhhC
Q 018816 72 IEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYG 150 (350)
Q Consensus 72 G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 150 (350)
|.+|.||++.+ .++..||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999999 667789999986643 233455555566799999999999999999999999999999998865
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccC
Q 018816 151 PLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230 (350)
Q Consensus 151 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 230 (350)
. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||.+....... ....++
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~ 145 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVE 145 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcC
Confidence 3 45899999999999999999999 9999999999999999999999999999876554321 122357
Q ss_pred CCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccch
Q 018816 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRK 310 (350)
Q Consensus 231 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (350)
..|+|||...+..++.++|+||+|+++|||++|..|+...... ... ...+ .+ +
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~--~~~~--~~--------~ 198 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INT--HTTL--NI--------P 198 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------ccc--cccc--CC--------c
Confidence 7899999998888999999999999999999999886532110 000 0000 00 0
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 018816 311 EEKLQAYVELAFKCLSHSAEDRPTMI 336 (350)
Q Consensus 311 ~~~~~~l~~l~~~cl~~~P~~RPt~~ 336 (350)
...+..+.+++.+||+.||++||++.
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 13346789999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=280.14 Aligned_cols=253 Identities=18% Similarity=0.192 Sum_probs=203.4
Q ss_pred HHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 55 LKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 55 l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
+....+-|. +++| |+|.||+||-|++ ++|+.||||.+.+.. ......+.+|+.||.++.||.||.+-.-|++.+.
T Consensus 560 ~stvYQif~-devL-GSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 560 ISTVYQIFA-DEVL-GSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER 637 (888)
T ss_pred HHHHHHhhh-Hhhc-cCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence 333333343 4567 9999999999999 888899999997642 2445778999999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC---CceeEcc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE---YAAKLFD 208 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~D 208 (350)
.+.|||-+. |+..+.|..... +.+++.....++.||+.||.||| .++|+|+||||+|||+.+. .++||+|
T Consensus 638 vFVVMEKl~-GDMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 638 VFVVMEKLH-GDMLEMILSSEK---GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred EEEEehhhc-chHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecc
Confidence 999999995 565555544332 67999999999999999999999 9999999999999999754 5689999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
||+|+.++.... ....+|||.|+|||++.+..|+..-|+||.|||+|--++|..||....+. ...
T Consensus 711 FGfARiIgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI------------ndQ 775 (888)
T KOG4236|consen 711 FGFARIIGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI------------NDQ 775 (888)
T ss_pred ccceeecchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch------------hHH
Confidence 999999987665 34566999999999999999999999999999999999999999865442 122
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+........-+ .+.+....+||...|+..-.+|-|.+.-+.
T Consensus 776 IQNAaFMyPp~PW---------~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 776 IQNAAFMYPPNPW---------SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhccccccCCCch---------hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2221111100001 266677889999999999999998877654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=295.39 Aligned_cols=146 Identities=21% Similarity=0.112 Sum_probs=130.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|.....| |+|+||.||+|.+ .++..||+|.+.... ......+..|+.++..++||||+++++++......++
T Consensus 3 ~~~y~i~~~L-G~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPI-SRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEE-ecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 3678888888 9999999999999 467799999986542 2234668899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
||||+++++|.+++... ..+++..++.++.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999998653 45788999999999999999999 8999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=287.58 Aligned_cols=259 Identities=18% Similarity=0.209 Sum_probs=210.6
Q ss_pred HHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeee--
Q 018816 52 SEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCL-- 127 (350)
Q Consensus 52 ~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-- 127 (350)
++.+..-++-|.+..++ |.|.+|.||+++. ++++..|+|++.... +..+++..|..+++.+ .|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evi-g~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVI-GNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEE-eeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 33344456778888888 9999999999999 667677888876654 4456677889999988 5999999999986
Q ss_pred ---cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCce
Q 018816 128 ---EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA 204 (350)
Q Consensus 128 ---~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 204 (350)
.++.+|||||||.+||..|++.+..+ ..+.|..+..|++.++.|+.+|| ...++|||||-.|||++.++.|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcE
Confidence 35689999999999999999977552 68999999999999999999999 9999999999999999999999
Q ss_pred eEcccCCCccCCCCCccccccccccCCCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcc
Q 018816 205 KLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-----YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF 279 (350)
Q Consensus 205 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~ 279 (350)
||.|||.+....... ....+.+||+.|||||++... .|+..+|+||||++..||.-|.+|+...++.
T Consensus 163 KLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------ 234 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------ 234 (953)
T ss_pred EEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------
Confidence 999999998775433 345677799999999999754 4778999999999999999999999877763
Q ss_pred hHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 280 FITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.++.- .....|.+. .+...++++.++|..||..|-..||++.++++
T Consensus 235 ------raLF~I--pRNPPPkLk------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 ------RALFLI--PRNPPPKLK------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------hhhccC--CCCCCcccc------chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111110 011111111 12467889999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=280.49 Aligned_cols=239 Identities=23% Similarity=0.211 Sum_probs=193.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++.|.....+ |.|+|+.|-.+.+ ..+...++|.+.+.. .+..+|+.++... +||||+++.+.+.++.+.++||
T Consensus 321 ~~~y~~~~~~-~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREEL-GEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhcccccc-CCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4566666677 9999999999999 566688999987662 2234577666655 7999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe-CCCCceeEcccCCCccC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF-QEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~~ 215 (350)
|.+.++-+.+.+... +.....+..|+.+|+.|+.||| .+|++||||||+|||+ ++.++++|+|||.++..
T Consensus 396 e~l~g~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK------PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred hhccccHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999888887653 2233777889999999999999 9999999999999999 68999999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... ..+.+-|..|.|||++....|++++|+||||++||+|++|+.||...... ......+.. .
T Consensus 467 ~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---------~ei~~~i~~---~ 529 (612)
T KOG0603|consen 467 ERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---------IEIHTRIQM---P 529 (612)
T ss_pred chh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---------HHHHHhhcC---C
Confidence 544 23445788999999999889999999999999999999999998755321 111111111 1
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... ...+...++|+.+||+.||.+||++.++..
T Consensus 530 ~~s------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 530 KFS------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccc------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111 256678999999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=265.73 Aligned_cols=241 Identities=15% Similarity=0.147 Sum_probs=197.1
Q ss_pred hcCcccccccccCCCceEEEEEEECC-CceEEEEEecccch---hhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRD-RGPILVMKYRKSVR---YASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~-~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 133 (350)
..+|....+| |+|+||.|.++..++ ...+|||.+.++.- ++.+--+.|-.+|+.. +-|.++++..++++-+.+|
T Consensus 348 ~tDFnFl~Vl-GKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVL-GKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEe-ccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3578888888 999999999999844 45789998876532 3334455677777766 5788999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+.||+|.-.++.- +.+.+..+..++..||-||-+|| +++|++||||.+||++|.+|++||+|||+++
T Consensus 427 FVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccc
Confidence 999999999999888653 68999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
..-... ..+.+.+|||.|+|||++...+|+.++|+||+||+||||+.|++||+.... +.+...+....
T Consensus 499 Eni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----------~elF~aI~ehn 566 (683)
T KOG0696|consen 499 ENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----------DELFQAIMEHN 566 (683)
T ss_pred ccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----------HHHHHHHHHcc
Confidence 654332 235677899999999999999999999999999999999999999985432 11222222211
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP 333 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 333 (350)
.. .+...+.+..+++...|...|.+|.
T Consensus 567 vs-------------yPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 VS-------------YPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred Cc-------------CcccccHHHHHHHHHHhhcCCcccc
Confidence 10 0125677888999999999999995
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=252.58 Aligned_cols=238 Identities=24% Similarity=0.237 Sum_probs=193.1
Q ss_pred CceEEEEEEEC-CCceEEEEEecccchhh-HHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCchhhhhhC
Q 018816 73 EGYILYMGFLR-DRGPILVMKYRKSVRYA-SERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYG 150 (350)
Q Consensus 73 ~~g~V~~~~~~-~~~~vaik~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 150 (350)
+||.||+|... ++..+++|.+....... .+.+.+|+..+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999994 47799999987765443 67899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccC
Q 018816 151 PLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230 (350)
Q Consensus 151 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 230 (350)
. ..+++..+..++.+++.++.+|| +.+++|+||+|.||+++.++.++|+|||.+....... ......++
T Consensus 81 ~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~ 149 (244)
T smart00220 81 R-----GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGT 149 (244)
T ss_pred c-----cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCC
Confidence 3 23889999999999999999999 8999999999999999999999999999988765432 12234478
Q ss_pred CCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccch
Q 018816 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRK 310 (350)
Q Consensus 231 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (350)
..|++||.+....++.++|+||||++++++++|..||..... ...................
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~---------- 210 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ---------LLELFKKIGKPKPPFPPPE---------- 210 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHhccCCCCcccc----------
Confidence 899999999888899999999999999999999999864211 1111122221111110000
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 311 EEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 311 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+..+.+++.+||..+|++||++.++++
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 014567999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=268.36 Aligned_cols=256 Identities=20% Similarity=0.225 Sum_probs=195.3
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEe--cccchhhH-----HHHHHHHHHHHhcCCCCccceeeeee-cC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKY--RKSVRYAS-----ERCFNNIVFASQMNHKSILKLIGCCL-EA 129 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~--~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~-~~ 129 (350)
.+.|-..+.| |+|||+.||++.+ ...+-||+|.- ++...... +...+|..|.+.|+||.||++|+++. +.
T Consensus 462 n~RYLlLhLL-GrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRYLLLHLL-GRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHHh-ccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3456666777 9999999999999 55557777773 44433322 34668999999999999999999987 56
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCceeE
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKL 206 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl 206 (350)
+.+|-|+|||+|-+|..+|... ..+++.++..|+.||+.||.||..- ..+|||.||||.|||+.+ .|.+||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 6899999999999999998654 5789999999999999999999854 679999999999999954 478999
Q ss_pred cccCCCccCCCCCcc-----ccccccccCCCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCC
Q 018816 207 FDFSLSKSIPEGKTH-----IKASTAIGSLEFAAPEYLTTG----YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGS 277 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 277 (350)
+|||+++.+...... ..+....||..|++||.+.-+ ..+.++||||+|||+|..+.|+.||.....
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs----- 689 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS----- 689 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-----
Confidence 999999988654432 224556699999999988644 478999999999999999999999974321
Q ss_pred cchHHHHHHHHHHhcCCCccC-ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018816 278 NFFITDRVEKFIRSNGYMNID-PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVA 339 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 339 (350)
..+ .+..+. ++. ..+.... ....+.+...+|++||++.-++|....++.
T Consensus 690 ---QQd----ILqeNT--IlkAtEVqFP~----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 690 ---QQD----ILQENT--ILKATEVQFPP----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---HHH----HHhhhc--hhcceeccCCC----CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111 111111 000 0000000 014567788999999999999998877664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=232.04 Aligned_cols=260 Identities=16% Similarity=0.173 Sum_probs=195.0
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+|...+.| |+|.||+||+|+. .....||+|+..-++. .--....+|+-+++.++|.|||++++....+..+.+|+|
T Consensus 3 ~ydkmeki-gegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKI-GEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhh-cCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 45555677 9999999999999 5566788898765432 223567899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
||+ .+|..+...-. +.++......++.|++.||.|+| ++++.||||||.|.||+.+|.+|++|||+++.++-
T Consensus 82 ~cd-qdlkkyfdsln----g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred Hhh-HHHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 995 68888775433 67899999999999999999999 99999999999999999999999999999998765
Q ss_pred CCccccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcC--
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNG-- 293 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (350)
+... .+..+-|..|.+|.++.+.. |++..|+||.||++.|+.. |++.|..... .+.+...+..-+
T Consensus 154 pvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv---------ddqlkrif~~lg~p 222 (292)
T KOG0662|consen 154 PVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---------DDQLKRIFRLLGTP 222 (292)
T ss_pred ceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH---------HHHHHHHHHHhCCC
Confidence 4432 33344689999999998865 8999999999999999987 5555553322 112222221111
Q ss_pred CCccCccc--------cCCCCccch-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVI--------VGDRSCFRK-----EEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~--------~~~~~~~~~-----~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+.--|.+ ...++.... ......-.+|+...|.-+|..|.++++.++
T Consensus 223 ~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 223 TEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 00000110 011110000 122334578999999999999999998775
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=256.30 Aligned_cols=252 Identities=17% Similarity=0.154 Sum_probs=191.2
Q ss_pred cccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 66 NITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
..| |.|+||+|++-.+ ..+...|||++..... .+..++..|.+...+- +.||||+++|.+...+..|+.||.|+ .
T Consensus 70 g~i-G~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 70 GEI-GNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHh-cCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 456 9999999999999 6677899999976543 5667888888866555 68999999999999999999999995 5
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
||..+...........+++...-+|....+.||.||-. ...|+|||+||+|||++..|.+||+|||.+-.+...-
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--- 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--- 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHH---
Confidence 66554321111111468888888899999999999986 6789999999999999999999999999986553322
Q ss_pred cccccccCCCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 223 KASTAIGSLEFAAPEYLTTG--YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
..+...|...|||||.+... .|..+||+||||++|+|+.||..|+..... +-+.+...+.. ..+.+...
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--------vfeql~~Vv~g-dpp~l~~~ 293 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--------VFEQLCQVVIG-DPPILLFD 293 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--------HHHHHHHHHcC-CCCeecCc
Confidence 23344588999999998653 489999999999999999999999874321 12222222222 12222221
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... -+.+..+..++..||..|-+.||+..++++
T Consensus 294 ~~~-------~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 KEC-------VHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccc-------cccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 145678999999999999999999998875
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=258.03 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=211.7
Q ss_pred HhcCcccccccccCCCceEEEEEEE------CCCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeec-C
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLE-A 129 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~ 129 (350)
...++.....+ -+|.||.||.|.+ .+.+.|.+|.+... ++-....+..|.-.+..+.|||+..+.+++.+ .
T Consensus 282 ~r~Rv~l~~ll-qEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 282 QRCRVRLSCLL-QEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhheechhhh-hcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 34567777778 9999999999966 34446777776543 33455678899999999999999999999875 4
Q ss_pred CcCeEEeecCCCCchhhhhhCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeE
Q 018816 130 EMPALVYEPAGYCTLADRLYGP---LQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 206 (350)
..++.++.++..|+|..++... .......++..+...++.|++.|+.||| .+++||.||..+|++||+...+||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEe
Confidence 5788999999999999999721 1122356888899999999999999999 999999999999999999999999
Q ss_pred cccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHH
Q 018816 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
+|=.+++...+....-.......+..||+||.+.+..|+.++|+|||||++|||+| |+.|+-.-.+ . .+
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------f----Em 507 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------F----EM 507 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------H----HH
Confidence 99999988766655444333446889999999999999999999999999999998 8888764322 1 22
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
...+.+ ++..-.| .++++++..++..||...|++||+++++...|.++..+
T Consensus 508 ~~ylkd-GyRlaQP-----------~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 508 EHYLKD-GYRLAQP-----------FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHHhc-cceecCC-----------CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 223332 2222222 26789999999999999999999999999999987543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=254.63 Aligned_cols=267 Identities=16% Similarity=0.179 Sum_probs=195.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecC-------
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEA------- 129 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 129 (350)
+.|.....+ |+|.||.||+++. +.++.||+|+...... .--....+|+++|..|.|+|++.++..|...
T Consensus 17 ~~yek~~ki-gqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKI-GQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhc-CCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 344555667 9999999999999 6666788887644221 1224567999999999999999999988642
Q ss_pred -CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 130 -EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 130 -~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
..+++||.+|+ .+|...+.+.. ..++..++.+++.++..||.|+| ...|+|||+||+|+||+.+|.+||+|
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeec
Confidence 25899999996 58888886653 47899999999999999999999 89999999999999999999999999
Q ss_pred cCCCccCCCCCccc--cccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHH
Q 018816 209 FSLSKSIPEGKTHI--KASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 209 fg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
||+++.+....... ..+..+-|..|.+||.+.+. .|+++.|||+.||++.||+++.+.+..... .......
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte------qqql~~I 241 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE------QQQLHLI 241 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH------HHHHHHH
Confidence 99997665433322 22344468999999999876 599999999999999999999998875432 2222222
Q ss_pred HHHHHhcCC---Ccc-----------CccccCCCCccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 286 EKFIRSNGY---MNI-----------DPVIVGDRSCFR----KEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 286 ~~~~~~~~~---~~~-----------~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
..+...... +.. .|...+...... +..-.++..+|+.+++..||.+|+++.+++..
T Consensus 242 s~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 242 SQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 222211110 001 111111111000 00112367899999999999999999998753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=256.78 Aligned_cols=265 Identities=19% Similarity=0.219 Sum_probs=201.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC--CCC----ccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN--HKS----ILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~~~~~~~~~~~ 131 (350)
++.|.+...+ |+|.||.|-.+.+ ..+..||+|.+..-. ...+..+-|+.+|.++. .|+ +|++.+||.-.++
T Consensus 88 ~~Ry~i~~~l-GeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLL-GEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhh-cCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 6788888888 9999999999999 445688888886543 34566778999999994 233 7889999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-----------
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE----------- 200 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~----------- 200 (350)
.|+|+|.+ |.|+.+++..+. ..+++..++..++.|++.+++||| +.+++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred eEEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCC
Confidence 99999998 679999997643 368999999999999999999999 999999999999999932
Q ss_pred ---------CCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 018816 201 ---------EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSR 271 (350)
Q Consensus 201 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 271 (350)
+..++|+|||.|....... .+.+.|..|.|||++.+-.++.++||||+||||+|+.+|...|....
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 3458999999998754433 45568999999999999999999999999999999999999988654
Q ss_pred ccC---------CCCcchHHHH--HHHHHHhcCCCccC-ccc--cC-------CCCc-----cchHHHHHHHHHHHHHcc
Q 018816 272 LAT---------GGSNFFITDR--VEKFIRSNGYMNID-PVI--VG-------DRSC-----FRKEEKLQAYVELAFKCL 325 (350)
Q Consensus 272 ~~~---------~~~~~~~~~~--~~~~~~~~~~~~~~-~~~--~~-------~~~~-----~~~~~~~~~l~~l~~~cl 325 (350)
..+ +..+...... ..+....+. +| +.. .+ ...+ ...+....++.+|+..||
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~r---ldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGR---LDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhccc---ccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 211 1111111111 122222221 11 000 00 0000 001355667999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 018816 326 SHSAEDRPTMIDVAK 340 (350)
Q Consensus 326 ~~~P~~RPt~~evl~ 340 (350)
..||.+|+|+.|++.
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=272.67 Aligned_cols=241 Identities=17% Similarity=0.125 Sum_probs=199.1
Q ss_pred CcccccccccCCCceEEEEEEECCCc-eEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 61 NYSMRNITIDEIEGYILYMGFLRDRG-PILVMKYRKS---VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~~~~-~vaik~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++.....| |-|+||.|=++..+... .+|+|.+++. +....+.+..|-.+|...+.|.||++|-.|.+....|++|
T Consensus 421 dl~~iaTL-GvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 421 DLKRIATL-GVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhc-ccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34445567 99999999999985443 4787777654 2345667889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|-|-||.|...+.+. +.+.......++..++.|++||| .++||+|||||+|.+++.+|-+||.|||+|+.+.
T Consensus 500 EaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 500 EACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999775 67899999999999999999999 9999999999999999999999999999999987
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.+. .+.+.+|||.|.|||++.+.....++|.||||+++|||++|.+||....+. . .-+.+-++-...
T Consensus 572 ~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm------k----tYn~ILkGid~i 638 (732)
T KOG0614|consen 572 SGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM------K----TYNLILKGIDKI 638 (732)
T ss_pred cCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH------H----HHHHHHhhhhhh
Confidence 655 466788999999999999999999999999999999999999999865542 1 111121211111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT 334 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt 334 (350)
--| ...++...+|+.+....+|.+|.-
T Consensus 639 ~~P-----------r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 EFP-----------RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hcc-----------cccchhHHHHHHHHHhcCcHhhhc
Confidence 111 144566788999999999999964
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=266.63 Aligned_cols=205 Identities=16% Similarity=0.106 Sum_probs=174.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh---hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY---ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
..-|...+.| |-|+||.|.++.. +....+|.|.+.+.+-. ....+..|-.||..-+.+.||+||..|.+.+.+|+
T Consensus 628 KSmFvkik~i-GvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 628 KSMFVKIKTI-GVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred ccceEEEeee-cccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 3567777788 9999999999998 45557888888776432 33446689999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||+|++||++..+|... +-+.+..+..++.++..|+++.| ..|+|||||||+|||||.+|++||+|||+|.-
T Consensus 707 VMdYIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EEeccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecccccc
Confidence 99999999999988653 56888889999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCc----------------------------------------cccccccccCCCCCCccccccCCCCccchhHHHH
Q 018816 215 IPEGKT----------------------------------------HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFG 254 (350)
Q Consensus 215 ~~~~~~----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 254 (350)
+..... .......+||+.|+|||++....|+..+|+||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 532110 0001125699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCcc
Q 018816 255 KLLLVLLTGRTIGHLSRL 272 (350)
Q Consensus 255 ~il~el~tg~~p~~~~~~ 272 (350)
||||||+.|++||....+
T Consensus 859 vil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHHHHhhCCCCccCCCC
Confidence 999999999999986654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=278.67 Aligned_cols=261 Identities=16% Similarity=0.124 Sum_probs=168.7
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CC----CceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeee------e
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RD----RGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGC------C 126 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~----~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~ 126 (350)
..++|...+.| |+|+||.||+|++ .+ +..||+|++..... .+...+| .+....+.++..+... +
T Consensus 130 ~~~~y~l~~~L-G~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKL-GEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEE-eeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 56789999999 9999999999999 44 57999999765321 1111111 1222223333322222 2
Q ss_pred ecCCcCeEEeecCCCCchhhhhhCCCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeecc
Q 018816 127 LEAEMPALVYEPAGYCTLADRLYGPLQTH---------------LEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI 191 (350)
Q Consensus 127 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 191 (350)
.+....++|+||+++++|.+++....... ........+..++.||+.||.||| +.+|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence 45668999999999999999886432100 001123345679999999999999 999999999
Q ss_pred ccCceEeCC-CCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCC----------------------CCccc
Q 018816 192 EPWNILFQE-EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY----------------------YNEKT 248 (350)
Q Consensus 192 kp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~ 248 (350)
||+|||++. ++.+||+|||+++........ ......+++.|+|||.+.... ++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 588999999999765433222 233455899999999664321 33456
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC----------CCccCccccCCCCccchHHHHHHHH
Q 018816 249 DVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG----------YMNIDPVIVGDRSCFRKEEKLQAYV 318 (350)
Q Consensus 249 DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~ 318 (350)
|||||||++|||+++..+++... .. ....+.... .....+.+....... +.......
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~----------~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--d~~~~~~~ 427 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNL----------IQ-FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVL--DLDGGAGW 427 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHH----------HH-HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhc--cccchHHH
Confidence 99999999999999766543210 00 001111100 000000000000000 01123456
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 018816 319 ELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 319 ~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+|+.+||+.||++|||+.++++
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhC
Confidence 8999999999999999999987
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=278.80 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=190.0
Q ss_pred cccccccccCCCce-EEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecC
Q 018816 62 YSMRNITIDEIEGY-ILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 62 f~~~~~lig~G~~g-~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
|...+++ |.|+.| .||+|...+. .||||++.... .....+|+..|..- +|||||++++.-.+..+.||..|.|
T Consensus 511 ~~~~eil-G~Gs~Gt~Vf~G~ye~R-~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEIL-GYGSNGTVVFRGVYEGR-EVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHc-ccCCCCcEEEEEeeCCc-eehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 5556667 999876 7999999887 99999986643 34567999999888 5999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---C--CceeEcccCCCcc
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---E--YAAKLFDFSLSKS 214 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~--~~~kl~Dfg~~~~ 214 (350)
..+|.+++... ........-...+.+..|++.||++|| +.+||||||||.||||+. + ..++|+|||+|+.
T Consensus 586 -~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 586 -ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred -hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 58999999764 111111222456788999999999999 899999999999999976 2 5689999999998
Q ss_pred CCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 215 IPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG-RTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 215 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...+.... ......||-+|+|||++....-+.++||||+||++|+.++| ..||...-.. -.+ +-.+
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-----------~~N-Il~~ 728 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-----------QAN-ILTG 728 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-----------hhh-hhcC
Confidence 87665433 24566699999999999998888999999999999999986 8888743210 000 1111
Q ss_pred CCC--ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYM--NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... .+.+. .++ +..+||.+|++.+|..||++.+|+.
T Consensus 729 ~~~L~~L~~~----------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 729 NYTLVHLEPL----------PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ccceeeeccC----------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 11110 022 7889999999999999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=267.06 Aligned_cols=268 Identities=16% Similarity=0.163 Sum_probs=181.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-----------------CCCceEEEEEecccchhhHHH--------------HHH
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-----------------RDRGPILVMKYRKSVRYASER--------------CFN 106 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-----------------~~~~~vaik~~~~~~~~~~~~--------------~~~ 106 (350)
..++|...++| |+|+||.||+|.+ .++..||||++........++ ...
T Consensus 143 ~~d~F~i~~~L-G~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKL-GGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEe-ecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 46789999999 9999999999975 234579999986543322222 334
Q ss_pred HHHHHHhcCCCCc-----cceeeeeec--------CCcCeEEeecCCCCchhhhhhCCCCC-------------------
Q 018816 107 NIVFASQMNHKSI-----LKLIGCCLE--------AEMPALVYEPAGYCTLADRLYGPLQT------------------- 154 (350)
Q Consensus 107 E~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~------------------- 154 (350)
|+..+.+++|.++ ++++++|.. ....+|||||+++++|.++++.....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6677777766554 677777753 34689999999999999998643210
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCC
Q 018816 155 HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFA 234 (350)
Q Consensus 155 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 234 (350)
....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......... ......+++.|+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 0023567788999999999999999 899999999999999999999999999998765432221 112223578999
Q ss_pred CccccccCCC----------------------CccchhHHHHHHHHHHHhCCC-CCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 235 APEYLTTGYY----------------------NEKTDVYSFGKLLLVLLTGRT-IGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 235 aPE~~~~~~~----------------------~~~~DiwslG~il~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
|||.+..... ..+.|+||+||++++|++|.. |+....... ............+..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~--~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN--TELRQYDNDLNRWRM 455 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh--hHHhhccchHHHHHh
Confidence 9998764321 134799999999999999875 554221100 000000000011111
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSA---EDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~RPt~~evl~ 340 (350)
......+-.. .+..+....+|+.+||..+| .+|+|+.++++
T Consensus 456 ~~~~~~~~~~--------~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 YKGQKYDFSL--------LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hcccCCCccc--------ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000011000 01345678899999999866 68999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=245.20 Aligned_cols=249 Identities=16% Similarity=0.169 Sum_probs=198.9
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 133 (350)
-++|....+| |+|+|+.|..+++ +..+.+|+|.+.+.- .....-...|-.+..+- +||.+|-+..+|.+...++
T Consensus 249 l~df~ll~vi-grgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 249 LQDFDLLRVI-GRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred cccceeeeee-cCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4688989998 9999999999999 556677888876532 23334455666666666 6999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+|.||++||+|...++.. ..++++.+..+...|+.||.||| +.||+.||||.+|+|+|..|++||+|+|.++
T Consensus 328 fvieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhh
Confidence 999999999998877654 57999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... ..+++.+|||.|.|||.+.+..|....|+|+|||+++||+.|+.||+-.... .......+++.+.+-..+
T Consensus 400 e~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~--n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 400 EGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD--NPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred cCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC--CcccchhHHHHHHHhhhc
Confidence 654332 2467888999999999999999999999999999999999999999865421 222334444444443322
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP 333 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 333 (350)
-.+ | ...+-....++..-|..||.+|.
T Consensus 476 iri--p-----------rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IRI--P-----------RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ccc--c-----------ceeehhhHHHHHHhhcCCcHHhc
Confidence 111 1 13334566788888999999885
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=243.12 Aligned_cols=268 Identities=17% Similarity=0.208 Sum_probs=197.2
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----cC
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAE-----MP 132 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 132 (350)
+...++-| |-|+||.||.+++ .+++.|+.|++..--. .+.+++.+|++.|.-++|.|++..++...-.. ++
T Consensus 54 Di~PDRPI-GYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPI-GYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcc-cccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 44566777 9999999999999 8888999999865432 45678999999999999999999999876443 56
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
|.++|.+. .+|...|-.. ..++...+.-++.||++||+||| +.+|.||||||.|.|+++|..+||+|||++
T Consensus 133 YV~TELmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccc
Confidence 88888884 5777776544 57888899999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccC---------CCCcchHH
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT---------GGSNFFIT 282 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~~~~~~~ 282 (350)
+.-....... .+..+-|..|.|||.+.+.. |+.+.||||.||++.||+..+-.|....+.. +....+--
T Consensus 204 Rvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 204 RTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred cccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 8765433322 33344688999999999864 9999999999999999999888887554420 00000000
Q ss_pred H----HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 283 D----RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 283 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
. -+...+-++. ...|...--+....+.....+...++.+++..||.+|.+.++.+..
T Consensus 283 r~ACEGAk~H~LR~~--~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAG--LRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHhhhhHHHhhccC--CCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 0 0111111111 1112221111111122334567788999999999999998887653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=231.63 Aligned_cols=259 Identities=16% Similarity=0.228 Sum_probs=200.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCC--cCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAE--MPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~l 134 (350)
.++|+..+.+ |+|.+++||.|.. .++..++||.+.+-. .+.+.+|++||..|+ ||||+.+++...++. .+.|
T Consensus 37 ~ddYeivrk~-GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKV-GRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHH-cCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 4678888888 9999999999998 666789999987643 567889999999997 999999999988754 7889
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-CceeEcccCCCc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKLFDFSLSK 213 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~ 213 (350)
|+||+.+.+...+. ..++...+...+.+++.||.|+| ++||+|||+||.|++||.. -.++|+|+|+|-
T Consensus 113 iFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred HhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHh
Confidence 99999998887766 67889999999999999999999 9999999999999999964 569999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH--------HH
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT--------DR 284 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~--------~~ 284 (350)
+..++.. .+..+.+..|-.||.+..- .|.-+-|+|||||++..|+..+.||.-.++-. -++. +.
T Consensus 182 FYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~----DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 182 FYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY----DQLVKIAKVLGTDE 254 (338)
T ss_pred hcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH----HHHHHHHHHhChHH
Confidence 8765543 3455578889999988764 58899999999999999999999987654321 1111 11
Q ss_pred HHHHHHhcCCCccCccccC---C---------CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 285 VEKFIRSNGYMNIDPVIVG---D---------RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~---~---------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+...+.+= .-.+||...+ . .+..+..-.+++..+|+...|..|..+|||+.|.+.
T Consensus 255 l~~Yl~KY-~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 255 LYAYLNKY-QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHH-ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11111111 1112332211 0 000011123478899999999999999999999875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=256.32 Aligned_cols=198 Identities=18% Similarity=0.187 Sum_probs=170.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHH-----HHHHHHHHHHhcC---CCCccceeeee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASE-----RCFNNIVFASQMN---HKSILKLIGCC 126 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~-----~~~~E~~~l~~l~---h~niv~~~~~~ 126 (350)
..+|+..+.+ |.|+||.|+++.+ .+...|+||.+.+..- ...+ .+-.|+.||..|+ |+||++++++|
T Consensus 560 ~s~yttlq~l-G~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 560 FSDYTTLQPL-GEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred cccceeeeec-cccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4568888899 9999999999999 5556888888766431 1111 1447999999997 99999999999
Q ss_pred ecCCcCeEEeecC-CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCcee
Q 018816 127 LEAEMPALVYEPA-GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 127 ~~~~~~~lv~e~~-~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 205 (350)
++++.+||+||-. ++.+|+++|... ..+++..+..|+.||+.|+++|| +.+|||||||-+||+++.+|.+|
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEE
Confidence 9999999999975 677999999765 67999999999999999999999 99999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCC
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHL 269 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~ 269 (350)
|+|||.+....++. ..+.+||..|.|||++.+.+| ....|||++|+++|.++....||++
T Consensus 711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999998765544 345679999999999999886 5778999999999999999999863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=225.27 Aligned_cols=207 Identities=16% Similarity=0.158 Sum_probs=168.4
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCe
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 133 (350)
...++......| |+|++|.|-+-++ .+|.-.|+|++...- .+..++..+|+.+..+- ..|.+|+++|........+
T Consensus 43 V~ad~L~~i~el-GrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 43 VPADDLVGIEEL-GRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred cchhhhhhhhhh-cCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 334444555667 9999999999998 677788999987653 35567788899877665 6999999999998888999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+.||.|+ .||..+........ ..+++...-+|+..+..||.|||+ ...++|||+||+||||+.+|++|++|||.+-
T Consensus 122 IcME~M~-tSldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999995 57776654433222 678999999999999999999996 6689999999999999999999999999987
Q ss_pred cCCCCCccccccccccCCCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTG----YYNEKTDVYSFGKLLLVLLTGRTIGHLSR 271 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~el~tg~~p~~~~~ 271 (350)
.+...-. .+...|...|+|||.+... .|+.+|||||||+++.||.+++.||+...
T Consensus 198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 6644322 2223488899999988643 58999999999999999999999998654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-31 Score=224.06 Aligned_cols=211 Identities=27% Similarity=0.376 Sum_probs=182.2
Q ss_pred ccCCCceEEEEEEEC-CCceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCchhh
Q 018816 69 IDEIEGYILYMGFLR-DRGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD 146 (350)
Q Consensus 69 ig~G~~g~V~~~~~~-~~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~ 146 (350)
||+|++|.||++... ++..+++|.+...... ....+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 499999999999995 4679999998776432 35678999999999999999999999999899999999999999999
Q ss_pred hhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-CCceeEcccCCCccCCCCCcccccc
Q 018816 147 RLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-EYAAKLFDFSLSKSIPEGKTHIKAS 225 (350)
Q Consensus 147 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 225 (350)
++.... ..+++..+..++.+++.++.+|| ..+++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLK 151 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhh
Confidence 986532 36889999999999999999999 899999999999999999 89999999999876644321 122
Q ss_pred ccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCC
Q 018816 226 TAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304 (350)
Q Consensus 226 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (350)
...+...|++||.+... .++.++|+|++|++++++
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 23478889999999877 788999999999999998
Q ss_pred CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 305 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1467999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-33 Score=256.72 Aligned_cols=252 Identities=21% Similarity=0.214 Sum_probs=205.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
++|....++ |+|.||.|||+++ ..+...|+|.++-.......-+.+|+-+++..+|||||.++|.+...+.+++.|||
T Consensus 15 ddyellqrv-gsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 15 DDYELLQRV-GSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred cchhheeee-cCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 577778888 9999999999999 66668888888766556667788999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
|.+|+|.+..+.. +++++.++...++..++||+||| +.+=+|||||-.||+++..|.+|+.|||.+..++..
T Consensus 94 cgggslQdiy~~T-----gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred cCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999976554 78999999999999999999999 999999999999999999999999999998766443
Q ss_pred CccccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
- .......||+.|||||+.. .+.|...+|||++|+...|+---++|....++. .+.....+..
T Consensus 166 i--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm----------r~l~LmTkS~-- 231 (829)
T KOG0576|consen 166 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM----------RALFLMTKSG-- 231 (829)
T ss_pred h--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH----------HHHHHhhccC--
Confidence 2 2344556999999999774 457999999999999999999988886654431 2222222222
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+|.-..+. ....+.+.+|+..|+..+|.+|||++.++.
T Consensus 232 -~qpp~lkDk-----~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 -FQPPTLKDK-----TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -CCCCcccCC-----ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 222111111 144567899999999999999999998765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=231.54 Aligned_cols=263 Identities=17% Similarity=0.215 Sum_probs=195.0
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecC------C
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEA------E 130 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 130 (350)
..|....-+ |.|.. .|-.+.+ -.+.+||+|+....- ....++..+|..++..++|+||++++.++.-. .
T Consensus 17 ~Ry~nL~p~-~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPI-GSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeccc-CCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 445555566 88888 7777777 566699999975432 24567888999999999999999999998743 3
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..|+|||+|. ++|.+.+. ..++-.....++.|++.|++||| +.+|+||||||+||++..++.+||.|||
T Consensus 95 e~y~v~e~m~-~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL-------MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccch
Confidence 6799999995 78988876 24667778899999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccC---------CC----C
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT---------GG----S 277 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~----~ 277 (350)
+|+.-... ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|...|.+....+ +. .
T Consensus 164 ~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 164 LARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred hhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 99865433 23445568899999999999889999999999999999999998876432210 00 1
Q ss_pred cchHHHHHHHHHHhcC-CC-------ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 278 NFFITDRVEKFIRSNG-YM-------NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+...++.++.... +. ..|..+...... . ......+.+++.+||..||++|.|+.++|.
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~-~-~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEG-S-KLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccC-C-ccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 1112223333333221 11 011111111100 0 123456889999999999999999999986
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=228.41 Aligned_cols=131 Identities=12% Similarity=0.184 Sum_probs=109.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-----C---CCccceeeeeec--
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-----H---KSILKLIGCCLE-- 128 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~-- 128 (350)
..|...++| |-|.|++||++.+ .+.+-||+|+..... --.+..+.||++|++++ | .+||++++.|..
T Consensus 78 gRY~v~rKL-GWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKL-GWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEec-cccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 567778889 9999999999999 666677888775543 33566789999999984 3 359999999874
Q ss_pred --CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe
Q 018816 129 --AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 129 --~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 198 (350)
+.++|+|+|++ |.+|..+|....- ..++...+.+|+.||+.||.|||..| +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 55899999999 7788888865432 57999999999999999999999844 99999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=220.19 Aligned_cols=199 Identities=25% Similarity=0.239 Sum_probs=170.5
Q ss_pred cccccccccCCCceEEEEEEECC-CceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 62 YSMRNITIDEIEGYILYMGFLRD-RGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~~-~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
|.....| |+|++|.||++...+ +..+++|.+...... ..+.+.+|+..+.+++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i-~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKL-GEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEe-ecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 3455667 999999999999954 779999999876544 5678899999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++++|.+++.... ..+++.....++.+++.++.+|| +.+++|+||+|.||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999999986542 11789999999999999999999 8899999999999999999999999999988765442
Q ss_pred ccccccccccCCCCCCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 018816 220 THIKASTAIGSLEFAAPEYL-TTGYYNEKTDVYSFGKLLLVLLTGRTIGHL 269 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~~ 269 (350)
.. ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 153 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11 12233477889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=217.06 Aligned_cols=254 Identities=17% Similarity=0.176 Sum_probs=187.2
Q ss_pred cCcccccccccCCCceEEEEEEEC-CCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeee-eecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGC-CLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~~~~~~lv~ 136 (350)
+.|.+.+.+ |+|.||.+-++.++ ..+.+++|-+... .....+|.+|...--.|. |.||+.-|+. |++.+...+++
T Consensus 24 d~y~I~k~l-geG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 24 DVYTINKQL-GEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhHHHHh-cccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 567777888 99999999999994 4446666666443 355688999988777775 8999998875 66777888999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC--CCCceeEcccCCCcc
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ--EEYAAKLFDFSLSKS 214 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~ 214 (350)
||++.|+|..-+.. ..+.+....+++.|+++||.||| ++++||||||.+||||- +...+||+|||.+..
T Consensus 102 E~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred ccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999988755 35778888999999999999999 99999999999999993 345799999999876
Q ss_pred CCCCCccccccccccCCCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTG-----YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
.+...... ..+-.|.+||.+... ...+.+|+|.||+++|.++||.+|+.-... .....+-+..+
T Consensus 173 ~g~tV~~~-----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~------~d~~Y~~~~~w 241 (378)
T KOG1345|consen 173 VGTTVKYL-----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI------MDKPYWEWEQW 241 (378)
T ss_pred cCceehhh-----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc------cCchHHHHHHH
Confidence 65433211 145568899976542 256889999999999999999999983322 11122222233
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
..+.. +.+...+. .+++.+..+..+-|..+|++|=...++.+....
T Consensus 242 ~~rk~----~~~P~~F~-----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 242 LKRKN----PALPKKFN-----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred hcccC----ccCchhhc-----ccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 33221 12222222 345678899999999999999555555444433
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=234.82 Aligned_cols=199 Identities=20% Similarity=0.173 Sum_probs=164.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC------CCCccceeeeeecCCcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN------HKSILKLIGCCLEAEMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~ 132 (350)
+.|...... |+|-|++|-+|.+ ..+..||||++..... ..+.=..|+.+|++|+ --|+++++-.|...+++
T Consensus 432 ~RY~V~~~~-GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 432 SRYEVQGYT-GKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred ceeEEEecc-ccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 466666777 9999999999999 5556999999987632 2344458999999996 34799999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-CceeEcccCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKLFDFSL 211 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~ 211 (350)
|||+|.+ ..+|.+.|.....+ -.+....+..++.|+..||..|- .-+|+|.||||+|||++.. ..+||||||.
T Consensus 510 ClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 510 CLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred EEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcc
Confidence 9999988 46899988653221 35778889999999999999999 8899999999999999865 6689999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLS 270 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 270 (350)
|........ +...-+..|.|||++.+-+|+...|+||+||+||||.||+..|.+.
T Consensus 584 A~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 584 ASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 987654432 1112456799999999999999999999999999999999888754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=226.91 Aligned_cols=270 Identities=22% Similarity=0.240 Sum_probs=197.0
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-C---CCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCc
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-R---DRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEM 131 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~---~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 131 (350)
...+.|...+.| |.|.|++||++++ . ....||+|.+.... ...++.+|++.|..+. +.||+.+.+++...+.
T Consensus 33 ~~~~~~~~v~ki-geGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 33 FISNAYKVVNKI-GEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhccc-cccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 344677788888 9999999999998 3 56699999987663 3456889999999995 8999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-CceeEcccC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKLFDFS 210 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg 210 (350)
..+|+||++.....+++ ..++...+..++..+..||.++| .+|||||||||.|+|.+.. +.-.|.|||
T Consensus 110 v~ivlp~~~H~~f~~l~--------~~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLY--------RSLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eEEEecccCccCHHHHH--------hcCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEech
Confidence 99999999998888887 46789999999999999999999 9999999999999999864 667999999
Q ss_pred CCccCC-----------------C--CC---------------c--------cccccccccCCCCCCccccccC-CCCcc
Q 018816 211 LSKSIP-----------------E--GK---------------T--------HIKASTAIGSLEFAAPEYLTTG-YYNEK 247 (350)
Q Consensus 211 ~~~~~~-----------------~--~~---------------~--------~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 247 (350)
+|.... . +. . ........||++|.|||++..- .-+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 986110 0 00 0 0001124599999999998764 57899
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCcccCCCCcch----HHHHHHHHHHhcC-------------------CCccC-ccccC
Q 018816 248 TDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF----ITDRVEKFIRSNG-------------------YMNID-PVIVG 303 (350)
Q Consensus 248 ~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~-------------------~~~~~-~~~~~ 303 (350)
+||||.|||++.+++++.||....+..+..... -...+++...-.+ ...++ ..+..
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 999999999999999999997654321100000 0001111100000 11111 11111
Q ss_pred CC-----CccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 304 DR-----SCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 304 ~~-----~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. .....+..+..+.+|+.+|+..||.+|.|+++.|+
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00 00111234457899999999999999999999886
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=253.60 Aligned_cols=196 Identities=18% Similarity=0.194 Sum_probs=139.5
Q ss_pred hcCC-CCccceeeee-------ecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 018816 113 QMNH-KSILKLIGCC-------LEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ 184 (350)
Q Consensus 113 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 184 (350)
.++| +||.+++++| .....+++++|++ +++|.+++.... ..+++.+++.++.||+.||.||| ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAH---SQ 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHH---hC
Confidence 4455 5788888887 2334677888987 569999996432 46899999999999999999999 99
Q ss_pred CeEeeccccCceEeCC-------------------CCceeEcccCCCccCCCCCc--------------cccccccccCC
Q 018816 185 PVVFRNIEPWNILFQE-------------------EYAAKLFDFSLSKSIPEGKT--------------HIKASTAIGSL 231 (350)
Q Consensus 185 ~ivH~dlkp~Nill~~-------------------~~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~ 231 (350)
+|+||||||+||||+. ++.+|++|||+++....... ........||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999965 34556666666653211000 00011235788
Q ss_pred CCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchH
Q 018816 232 EFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKE 311 (350)
Q Consensus 232 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (350)
.|+|||++.+..++.++|||||||++|||++|.+|+..... ... .+.. ....+...
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----------~~~-~~~~---~~~~~~~~--------- 235 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----------TMS-SLRH---RVLPPQIL--------- 235 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----------HHH-HHHH---hhcChhhh---------
Confidence 99999999999999999999999999999998887542110 000 1110 01111110
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 312 EKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 312 ~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
........++.+||+.+|.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 236 LNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 11234568889999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=201.38 Aligned_cols=170 Identities=22% Similarity=0.181 Sum_probs=128.5
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
|+|.+++.... ..+++..++.++.||+.||.||| +.+ ||+|||++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc--
Confidence 68888886532 46999999999999999999999 666 999999999999999 99987654321
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
..||+.|+|||++.+..++.++|||||||++|||++|..||..... .............. .++..
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--------~~~~~~~~~~~~~~--~~~~~ 128 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--------LSAILEILLNGMPA--DDPRD 128 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--------hcHHHHHHHHHhcc--CCccc
Confidence 2489999999999999999999999999999999999999864321 11111122111111 11100
Q ss_pred cCCCCccchHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 302 VGDRSCFRKEEKLQ--AYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 302 ~~~~~~~~~~~~~~--~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.. ....... .+.+++.+||..+|++|||+.++++.+..+...
T Consensus 129 ~~-----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 129 RS-----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cc-----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 00 0113333 699999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=206.18 Aligned_cols=168 Identities=13% Similarity=0.054 Sum_probs=129.6
Q ss_pred HHHHhcCcccccccccCCCceEEEEEEEC--CCceEEEEEeccc-----chhhHHHHHHHHHHHHhcCCCCccceeeeee
Q 018816 55 LKTAINNYSMRNITIDEIEGYILYMGFLR--DRGPILVMKYRKS-----VRYASERCFNNIVFASQMNHKSILKLIGCCL 127 (350)
Q Consensus 55 l~~~~~~f~~~~~lig~G~~g~V~~~~~~--~~~~vaik~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 127 (350)
.....++|.....| |+|+||.||+|.+. ++..||||++... .....+.+.+|+.+|.+++|+|++..+..
T Consensus 13 ~~~~~~~Y~~~~~I-G~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 13 IPALSARFVETAVL-KRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred cccccCCceEccEE-eecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 34456789999998 99999999999883 5556799886533 12235668999999999999999853322
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeecc-ccCceEeCCCCceeE
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI-EPWNILFQEEYAAKL 206 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl 206 (350)
.+..++||||++|++|.. +. ... ...++.+++.||.||| +.+|+|||| ||+|||++.++.+||
T Consensus 90 -~~~~~LVmE~~~G~~L~~-~~--------~~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 90 -TGKDGLVRGWTEGVPLHL-AR--------PHG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred -cCCcEEEEEccCCCCHHH-hC--------ccc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEE
Confidence 245799999999999963 21 111 1467899999999999 999999999 999999999999999
Q ss_pred cccCCCccCCCCCcccc------ccccccCCCCCCcccccc
Q 018816 207 FDFSLSKSIPEGKTHIK------ASTAIGSLEFAAPEYLTT 241 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 241 (350)
+|||+|+.......... -....+++.|+|||.+..
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999987755432221 124457888999998864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-24 Score=193.88 Aligned_cols=262 Identities=16% Similarity=0.150 Sum_probs=195.2
Q ss_pred CcccccccccCCCceEEEEEEECCC--ceEEEEEecccchhhHHHHHHHHHHHHhcCC----CCccceeeee-ecCCcCe
Q 018816 61 NYSMRNITIDEIEGYILYMGFLRDR--GPILVMKYRKSVRYASERCFNNIVFASQMNH----KSILKLIGCC-LEAEMPA 133 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~~~--~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~ 133 (350)
.|.....| |+|+||.||++..... ..+|+|.-..........+..|+.++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~i-G~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKI-GEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeec-cccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 78888998 9999999999999553 3677777655432222367889999998873 6888888888 4777889
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-----CceeEcc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-----YAAKLFD 208 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~D 208 (350)
+||+.+ |.+|.++..... .+.++..+.+.++.|++.+|.+|| +.|++||||||+|+.+... ..+.|.|
T Consensus 98 iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 999988 789999775443 267999999999999999999999 9999999999999999865 4689999
Q ss_pred cCCCc--cCCCCCc----cc-c-ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcch
Q 018816 209 FSLSK--SIPEGKT----HI-K-ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF 280 (350)
Q Consensus 209 fg~~~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~ 280 (350)
||+++ ....... .. . .....||..|+++....+...+.+.|+||++.++.+++.|..|+....... .
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~-----~ 245 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD-----L 245 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc-----h
Confidence 99998 3222111 11 1 223459999999999999999999999999999999999999986543210 0
Q ss_pred HHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 281 ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
. .............. . . ...+..+.++...+-..+..++|....+...|++....
T Consensus 246 -~---~~~~~~~~~~~~~~-~----~----~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 246 -K---SKFEKDPRKLLTDR-F----G----DLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred -H---HHHHHHhhhhcccc-c----c----CCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 1 11111111111111 0 0 02345667777777778999999999999998877543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=190.67 Aligned_cols=244 Identities=17% Similarity=0.153 Sum_probs=187.6
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCch
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
+| .....|+.|+|+++++ .+++|.+... +.....+|..|.-.|+-+.||||+.++|.|..+.++.++..||+.|||
T Consensus 197 kl-~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 197 KL-AESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hh-ccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 45 8888999999999877 7788877543 334456788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc--ccCCCccCCCCCccc
Q 018816 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF--DFSLSKSIPEGKTHI 222 (350)
Q Consensus 145 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~~~ 222 (350)
+..++.... -..+-.++.+++.+|+.|+.|||+. ..-|-..-|....+++|++.+++|+ |--++..
T Consensus 275 ynvlhe~t~---vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq-------- 342 (448)
T KOG0195|consen 275 YNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-------- 342 (448)
T ss_pred HHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee--------
Confidence 999987532 3577889999999999999999964 2234444688999999999887775 3222211
Q ss_pred cccccccCCCCCCccccccCCC---CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 223 KASTAIGSLEFAAPEYLTTGYY---NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.......|.|++||.++..+- -.++|+|||.+++|||.|...||....+.+.+ .+..-.+-...+.|
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------mkialeglrv~ipp 412 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------MKIALEGLRVHIPP 412 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------hhhhhccccccCCC
Confidence 112225789999999987642 36899999999999999999999876653211 11111111222333
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
..+..+..|+.-|+..||.+||.+..|+-.|+++.
T Consensus 413 ------------gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 413 ------------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ------------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 34566889999999999999999999999999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-23 Score=187.75 Aligned_cols=262 Identities=24% Similarity=0.270 Sum_probs=198.1
Q ss_pred cccccccccCCCceEEEEEEECCCceEEEEEecccchh---hHHHHHHHHHHHHhcCCC-CccceeeeeecCCcCeEEee
Q 018816 62 YSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRY---ASERCFNNIVFASQMNHK-SILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e 137 (350)
|.....| |.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +|+++.+.+......+++++
T Consensus 2 ~~~~~~l-~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKL-GEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEee-cCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 4555677 99999999999998 58899998765432 367799999999999988 79999999977777899999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-ceeEcccCCCccCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLSKSIP 216 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 216 (350)
++.++++.+++...... ..+.......+..|++.++.|+| ..+++|||+||+||+++..+ .++++|||.+....
T Consensus 79 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred cCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999776543211 26889999999999999999999 89999999999999999998 79999999988554
Q ss_pred CCCccc----cccccccCCCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 217 EGKTHI----KASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 217 ~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
...... ......|+..|++||.+.+ ..++...|+||+|++++++++|..|+...... .........+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~------~~~~~~~~~~ 227 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS------SATSQTLKII 227 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc------ccHHHHHHHH
Confidence 433221 2355669999999999987 57899999999999999999999996543210 1112222222
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
................. ......+.+++..|+..+|..|.++.+....
T Consensus 228 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 228 LELPTPSLASPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HhcCCcccccccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 22221101111100000 1234578899999999999999998876653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=217.10 Aligned_cols=247 Identities=18% Similarity=0.127 Sum_probs=184.4
Q ss_pred CcccccccccCCCceEEEEEEECCCceEEEEEecccch-hhHHHHH---HHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 61 NYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR-YASERCF---NNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~-~~~~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++...+.| |++.|=.|.+++++.| .|+||.+.+..+ .+.+.+. .|++ ...++|||.+.+.-+...+...|+|-
T Consensus 24 e~~~~~~L-GstRFlKv~r~k~~eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENL-GSTRFLKVARAKDREG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeeccc-CchhhhhhhhccCCCc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 67777888 9999999999999988 799999876653 3344444 4444 45568999999998888888889999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
+|. ..+|.|.+..+ .-+...+..-|+.|++.||..+| ..||+|+|||.+||||.+-+.+.|+||...+...
T Consensus 101 qyv-khnLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred HHH-hhhhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCcc
Confidence 998 56999998654 34667778889999999999999 9999999999999999999999999999876543
Q ss_pred CCCcccc-----ccccccCCCCCCccccccC----------C-CCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcc
Q 018816 217 EGKTHIK-----ASTAIGSLEFAAPEYLTTG----------Y-YNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNF 279 (350)
Q Consensus 217 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~ 279 (350)
-+..... -.+...-.+|+|||.+... . .+++-||||+||+++||++ |++||..+.
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------- 243 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------- 243 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--------
Confidence 2222111 1122245689999988541 2 5788999999999999988 677776332
Q ss_pred hHHHHHHHHHHhcCCCccCc--cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 280 FITDRVEKFIRSNGYMNIDP--VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
++.-......++ .+.+ -....+++|+..|++.||+.|.++++.|+.-+
T Consensus 244 --------L~aYr~~~~~~~e~~Le~--------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 244 --------LLAYRSGNADDPEQLLEK--------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred --------HHhHhccCccCHHHHHHh--------CcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 111111111111 0100 11236889999999999999999999998744
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-25 Score=213.05 Aligned_cols=257 Identities=17% Similarity=0.164 Sum_probs=188.2
Q ss_pred ccccccCCCceEEEEEEE-CCCceEEEEEec----ccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 65 RNITIDEIEGYILYMGFL-RDRGPILVMKYR----KSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~-~~~~~vaik~~~----~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
..++ |.|++|.|+.... ......+.|.+. .... .....+..|+-+-..+.|||++..+..+.+.....-+||
T Consensus 323 ~~~~-g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVL-GSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccee-eecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3455 9999998888777 444445555443 1111 111225677778888999999998888877766666699
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
||++ +|..++... ..++...+-.++.|++.|+.||| ..||.|||+|++|+++..+|.+||+|||.+..+..
T Consensus 402 ~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 999998654 36888889999999999999999 99999999999999999999999999999876654
Q ss_pred CCcc--ccccccccCCCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 218 GKTH--IKASTAIGSLEFAAPEYLTTGYYN-EKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 218 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
+... ......+|+..|+|||++.+..|. ...||||.|+++..|.+|+.||......... + ........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~---~------~~~~~~~~ 543 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS---F------KTNNYSDQ 543 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc---h------hhhccccc
Confidence 4332 334556699999999999998886 5689999999999999999998755432110 0 00000000
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHh
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK--KLRQM 345 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~ 345 (350)
.. ....... .-...+.....++..||+.+|.+|.|+++|++ +++.+
T Consensus 544 ~~----~~~~~~~-~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 544 RN----IFEGPNR-LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred cc----cccChHH-HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 00 0000000 11366778899999999999999999999986 44443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-24 Score=178.41 Aligned_cols=262 Identities=15% Similarity=0.122 Sum_probs=197.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCC-CCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNH-KSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 136 (350)
.+.|...+.| |+|+||.+|.|.. .++..||||.-.... ....+.-|.++...|++ ..|..+..+..+...-.+||
T Consensus 14 ~gky~lvrki-GsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKI-GSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEee-cCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4678888888 9999999999999 888899999865542 23457789999999985 67888888888889999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCceeEcccCCCc
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKLFDFSLSK 213 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~ 213 (350)
+.+ |.||++++.-.. ..++..+++-++.|++.-++|+| .++++||||||+|+|..- ...+.++|||+|+
T Consensus 91 dLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchh
Confidence 998 789999875432 57899999999999999999999 999999999999999964 3568999999998
Q ss_pred cCCCCCcc-----ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 214 SIPEGKTH-----IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 214 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
......+. .......||.+|.+--...+..-+...|+=|+|.++.++--|..||...... .-.....+.
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~------tk~QKyEkI 236 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA------TKKQKYEKI 236 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh------hHHHHHHHH
Confidence 77544322 1233456899999887776677788999999999999999999999865432 111122222
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
.+......+.. .+...+.++.-.+.-|-..--++-|.-.-+-+.++-+.
T Consensus 237 ~EkK~s~~ie~---------LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 237 SEKKMSTPIEV---------LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHhhcCCCHHH---------HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 22111111111 11234567888888888888888888776666555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=175.53 Aligned_cols=263 Identities=13% Similarity=0.130 Sum_probs=197.8
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 135 (350)
..-+|.....| |.|.||.++.|+. -++.+||||.-... ....++..|....+.|. .++|..++.+-.++-+-.||
T Consensus 26 VG~hyrVGkKI-GeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 26 VGPHYRVGKKI-GEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ecccceecccc-ccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 34578999998 9999999999998 56669999885333 22445777888888874 69999999998888899999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-----CceeEcccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-----YAAKLFDFS 210 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~Dfg 210 (350)
+|.+ |.||+|+..-.. ..++..++..+|.|++.-++|+| .+.+|.|||||+|+||... ..+-++|||
T Consensus 103 idLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 9998 789988774322 57999999999999999999999 9999999999999999753 457999999
Q ss_pred CCccCCCCCccc-----cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHH
Q 018816 211 LSKSIPEGKTHI-----KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 211 ~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
+|+......+.. ......||.+||+-....+..-+...|+=|||-++++.+-|..||....-.. .....
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t------nK~kY 248 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT------NKEKY 248 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc------hHHHH
Confidence 999886654322 2345569999999998888889999999999999999999999998764321 11111
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
.+.-.......+.. .++.++.++..-+.-.-..+-.+-|.-+-+..-+.+++
T Consensus 249 eKIGe~Kr~T~i~~---------Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 249 EKIGETKRSTPIEV---------LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred HHhccccccCCHHH---------HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11111111111111 12245567777777777777778888776666665554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=173.91 Aligned_cols=138 Identities=14% Similarity=0.093 Sum_probs=107.4
Q ss_pred cccccCCCceEEEEEEECCCceEEEEEecccchh--h-------H-----------------HHHHHHHHHHHhcCCCCc
Q 018816 66 NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRY--A-------S-----------------ERCFNNIVFASQMNHKSI 119 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni 119 (350)
..| |+|++|.||+|...++..||+|.+...... . . ....+|+.++.++.++++
T Consensus 3 ~~i-g~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCI-STGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred Ccc-ccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 345 999999999999987889999998764211 0 0 122359999999988777
Q ss_pred cceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HccCCCCeEeeccccCceEe
Q 018816 120 LKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYL-RFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 120 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlkp~Nill 198 (350)
.....+.. ...++||||++++++....... ..++......++.|++.+|.++ | ..+|+||||||+|||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 44333222 2348999999987776543222 4688999999999999999999 7 8899999999999999
Q ss_pred CCCCceeEcccCCCccC
Q 018816 199 QEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 199 ~~~~~~kl~Dfg~~~~~ 215 (350)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=177.81 Aligned_cols=170 Identities=15% Similarity=0.136 Sum_probs=132.0
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHH---H------HHHHHHHHHhcCCCCccceeeeeecC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASE---R------CFNNIVFASQMNHKSILKLIGCCLEA 129 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~~~~~~~~~ 129 (350)
.++|...+++ |.|+||.||+... +++.+|+|.+.+....... . +.+|+..+.+++||+|..+.+++...
T Consensus 30 ~~~y~~~~~l-~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVF-RNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEe-cCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 5789999999 9999999999666 4558999999765432222 2 57899999999999999999886643
Q ss_pred --------CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC
Q 018816 130 --------EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201 (350)
Q Consensus 130 --------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 201 (350)
...++||||++|.+|.++.. ++. ....+++.++..+| ..|++|+|++|+||+++.+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCC
Confidence 35789999999999988631 222 34669999999999 9999999999999999998
Q ss_pred CceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHH
Q 018816 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLL 261 (350)
Q Consensus 202 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 261 (350)
+ ++|+|||........... ..++....|..++|+||||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999987654321111 01333445678999999999877544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=187.64 Aligned_cols=218 Identities=22% Similarity=0.311 Sum_probs=166.3
Q ss_pred HHhcCCCCccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCe-Eee
Q 018816 111 ASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPV-VFR 189 (350)
Q Consensus 111 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~ 189 (350)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..+++.-...+.++|+.||.||| ..+| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLH---NSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHh---cCcceeee
Confidence 357899999999999999999999999999999999997633 56888889999999999999999 4444 999
Q ss_pred ccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccC---C----CCccchhHHHHHHHHHHHh
Q 018816 190 NIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG---Y----YNEKTDVYSFGKLLLVLLT 262 (350)
Q Consensus 190 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~----~~~~~DiwslG~il~el~t 262 (350)
.+++.|+++|....+|++|||+.................-..-|.|||.+... . .+.+.|+||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999998766431111111111134568999998763 1 4678999999999999999
Q ss_pred CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 018816 263 GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKL 342 (350)
Q Consensus 263 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L 342 (350)
...||+....... . ......+.+.....+.|.+.... +..+.+..++.+||..+|++||++..|-..+
T Consensus 154 r~~~~~~~~~~~~--~----~eii~~~~~~~~~~~rP~i~~~~------e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 154 RSGPFDLRNLVED--P----DEIILRVKKGGSNPFRPSIELLN------ELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred ccCccccccccCC--h----HHHHHHHHhcCCCCcCcchhhhh------hcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 9999986543211 1 22222233333444444443221 3344789999999999999999999999988
Q ss_pred HHhhh
Q 018816 343 RQMYR 347 (350)
Q Consensus 343 ~~~~~ 347 (350)
+.+..
T Consensus 222 ~~~~~ 226 (484)
T KOG1023|consen 222 LTINK 226 (484)
T ss_pred hhhcc
Confidence 87754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=167.02 Aligned_cols=140 Identities=14% Similarity=0.074 Sum_probs=110.1
Q ss_pred cccccCCCceEEEEEEECCCceEEEEEecccchh--------------------------hHHHHHHHHHHHHhcCCCCc
Q 018816 66 NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRY--------------------------ASERCFNNIVFASQMNHKSI 119 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 119 (350)
..| |+|++|.||+|.+.++..||||.+...... ....+.+|...+.++.|+++
T Consensus 3 ~~i-g~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 3 GCI-STGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred cee-ecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 345 999999999999887889999998765211 01223578999999999987
Q ss_pred cceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEe
Q 018816 120 LKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILF 198 (350)
Q Consensus 120 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill 198 (350)
.....+... ..++||||++++++....... ..++......++.+++.++.++| . .||+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEE
Confidence 554444333 248999999988654432221 35778889999999999999999 7 999999999999999
Q ss_pred CCCCceeEcccCCCccCCC
Q 018816 199 QEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 199 ~~~~~~kl~Dfg~~~~~~~ 217 (350)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=159.99 Aligned_cols=187 Identities=11% Similarity=-0.017 Sum_probs=138.8
Q ss_pred ccccccccCCCceEEEEEEECCCceEEEEEecccchh----hHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEee
Q 018816 63 SMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRY----ASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 63 ~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 137 (350)
.....| ++|+||+||.+.. ++..++.+.+...... ....+.+|+.+|++|+ |++|++++++ +..+++||
T Consensus 5 ~~~~~l-~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPL-KSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceee-cCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 344567 9999999997776 4458888777655331 1235789999999995 5889999886 34699999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeecc-ccCceEeCCCCceeEcccCCCccCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI-EPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|++|.+|...+.. ....++.+++.+|.++| ..||+|||| ||+|||++.++.++|+|||++....
T Consensus 79 yI~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 79 YLAGAAMYQRPPR------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred eecCccHHhhhhh------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999888654311 11357889999999999 999999999 7999999999999999999998655
Q ss_pred CCCcc----c-c------ccccccCCCCCCccccccC-CCC-ccchhHHHHHHHHHHHhCCCCCCCC
Q 018816 217 EGKTH----I-K------ASTAIGSLEFAAPEYLTTG-YYN-EKTDVYSFGKLLLVLLTGRTIGHLS 270 (350)
Q Consensus 217 ~~~~~----~-~------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~el~tg~~p~~~~ 270 (350)
..... . . ......++.|++|+.-.-. ..+ ...+.++-|+-+|.++|+..+.-..
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 43311 0 0 1112257778888744332 334 5678889999999999999876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=163.02 Aligned_cols=136 Identities=12% Similarity=0.026 Sum_probs=105.7
Q ss_pred ccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhc-----CCCCccceeeeeecCC---c-Ce
Q 018816 63 SMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQM-----NHKSILKLIGCCLEAE---M-PA 133 (350)
Q Consensus 63 ~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~~ 133 (350)
+....| |+|+||.||. +......+||++........+.+.+|+.+++.+ +||||++++|++.++. . ..
T Consensus 5 ~~~~~L-G~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPL-GTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCccee-cCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 344566 9999999996 533335579988765444567799999999999 5799999999998874 3 33
Q ss_pred EEeec--CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHccCCCCeEeeccccCceEeCC----CCceeE
Q 018816 134 LVYEP--AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAV-AYLRFGFPQPVVFRNIEPWNILFQE----EYAAKL 206 (350)
Q Consensus 134 lv~e~--~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl 206 (350)
+|+|| +++++|.+++... .+++. ..++.+++.++ .||| +++|+||||||+|||++. ++.++|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 5579999999542 34444 35678888777 9999 999999999999999974 347999
Q ss_pred cccCCC
Q 018816 207 FDFSLS 212 (350)
Q Consensus 207 ~Dfg~~ 212 (350)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-22 Score=187.51 Aligned_cols=223 Identities=19% Similarity=0.105 Sum_probs=177.2
Q ss_pred cCCCceEEEEEEE----CCCceEEEEEecccchh--hHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEeecCCCC
Q 018816 70 DEIEGYILYMGFL----RDRGPILVMKYRKSVRY--ASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 70 g~G~~g~V~~~~~----~~~~~vaik~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
|+|+||.|+++.. +.+..+|.|...+.+.. .......|..++...+ ||.+|++...++.+...+++++|..+|
T Consensus 3 g~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg 82 (612)
T KOG0603|consen 3 GQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGG 82 (612)
T ss_pred CcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccc
Confidence 9999999998765 44557777777654321 1124556788888886 999999999999999999999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
.|...+... ..+.......+...++.+++++| +.+++|||+|++||+++.+|++++.|||+++..-....
T Consensus 83 ~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 83 DLFTRLSKE-----VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred hhhhccccC-----CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 998887654 46778888889999999999999 99999999999999999999999999999987643322
Q ss_pred cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcccc
Q 018816 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIV 302 (350)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (350)
.+||..|||||++. ....++|.||||++++||+||..||.. +.+..... .. ..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------------~~~~~Il~-~~--~~----- 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------------DTMKRILK-AE--LE----- 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------HHHHHHhh-hc--cC-----
Confidence 16999999999987 567899999999999999999999874 11111111 00 00
Q ss_pred CCCCccchHHHHHHHHHHHHHccccCCCCCCCH
Q 018816 303 GDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335 (350)
Q Consensus 303 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 335 (350)
.+......+.+++.+++..+|..|.-.
T Consensus 206 ------~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 ------MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ------CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 113667778899999999999998644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=165.39 Aligned_cols=233 Identities=20% Similarity=0.137 Sum_probs=146.7
Q ss_pred cccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCC----------CCccceeeeee
Q 018816 62 YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNH----------KSILKLIGCCL 127 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~ 127 (350)
......| |.|+++.||.+++ ..+..+|+|.+..... ...+.+.+|.-....+.+ -.++-.++...
T Consensus 14 l~~~~~i-~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 14 LVRGRII-GKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEE-EEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEcccc-ccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3445667 9999999999999 5677999999754432 334556666544444322 12222222221
Q ss_pred ---------cCC--------cCeEEeecCCCCchhhhhh---CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeE
Q 018816 128 ---------EAE--------MPALVYEPAGYCTLADRLY---GPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVV 187 (350)
Q Consensus 128 ---------~~~--------~~~lv~e~~~~~sL~~~l~---~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv 187 (350)
... +.+++|+-+ .++|.+++. ..... ...+....++.+..|+++.+++|| ..|++
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlV 167 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLH---SYGLV 167 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHh---hcceE
Confidence 111 336677776 578887753 22111 123455566778899999999999 99999
Q ss_pred eeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccC--------CCCccchhHHHHHHHHH
Q 018816 188 FRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG--------YYNEKTDVYSFGKLLLV 259 (350)
Q Consensus 188 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwslG~il~e 259 (350)
|+||+|+|++++.+|.+.|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999876654332211 2245779999976442 47899999999999999
Q ss_pred HHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCC
Q 018816 260 LLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDR 332 (350)
Q Consensus 260 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 332 (350)
|++|..||........... .+. .| .+.++.+..||..+|+.||++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~---------------------~f~---~C---~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW---------------------DFS---RC---RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG---------------------GGT---TS---S---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc---------------------cch---hc---CCcCHHHHHHHHHHccCCcccC
Confidence 9999999986544211110 111 11 1667889999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=186.60 Aligned_cols=254 Identities=13% Similarity=0.131 Sum_probs=182.8
Q ss_pred HHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC---CCCccceeeeeecCC
Q 018816 54 DLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN---HKSILKLIGCCLEAE 130 (350)
Q Consensus 54 ~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 130 (350)
+++.....|.+...+ |+|+||.||+|...++..||+|.-.+..... |.--.+++.+|+ -+.|..+...+.-.+
T Consensus 692 ~~~~~~~~~~I~~e~-G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEI-GEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeee-ccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 344455678888888 9999999999999878899999876654321 222233444444 345566666666677
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-------CCc
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-------EYA 203 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------~~~ 203 (350)
..+||+||.+.|+|.+++... +.+++..++.++.|++..+++|| ..+|||+||||+|+||.. +..
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred cceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccc
Confidence 889999999999999999633 67999999999999999999999 999999999999999943 456
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
++|+|||.+..+..-.....-...++|-.+-.+|...+.+++-..|.|.|+-+++-|+.|+..=
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q---------------- 903 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME---------------- 903 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------------
Confidence 8999999986553322222334455788899999999999999999999999999999998631
Q ss_pred HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
..++....++..+... -.-+.+.+++..+|..|-..=|...++...|++.+.
T Consensus 904 -----~~~g~~~~~~~~~~Ry-------~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 904 -----VKNGSSWMVKTNFPRY-------WKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -----hcCCcceeccccchhh-------hhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1111111111111000 112235566666666555555777777777777654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=157.38 Aligned_cols=143 Identities=13% Similarity=0.038 Sum_probs=110.5
Q ss_pred hcCcccccccccCCCceEEEEEE--ECCCceEEEEEecccchh------------------------hHHHHHHHHHHHH
Q 018816 59 INNYSMRNITIDEIEGYILYMGF--LRDRGPILVMKYRKSVRY------------------------ASERCFNNIVFAS 112 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~--~~~~~~vaik~~~~~~~~------------------------~~~~~~~E~~~l~ 112 (350)
.-.|...+.| |+|++|.||+|. ..++..||+|.+...... ....+.+|+.++.
T Consensus 27 ~~~~~i~~~L-g~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 27 GILSAIGGCI-STGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred CchHHhCCee-ccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 3357777888 999999999999 367889999998654210 1123568999999
Q ss_pred hcCCCC--ccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-eEee
Q 018816 113 QMNHKS--ILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP-VVFR 189 (350)
Q Consensus 113 ~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~ 189 (350)
++.+.+ +..++++ ...++||||+++.+|....... ..+.......++.|++.++.+|| ..+ ++|+
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~ 173 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLY---KEGELVHG 173 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeC
Confidence 997532 3444442 2358999999998887654222 34556667899999999999999 999 9999
Q ss_pred ccccCceEeCCCCceeEcccCCCccC
Q 018816 190 NIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 190 dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
||||+||+++ ++.++|+|||.+...
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999 889999999988754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-20 Score=161.26 Aligned_cols=195 Identities=17% Similarity=0.137 Sum_probs=138.4
Q ss_pred CCCCccceeeeeecC---------------------------CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHH
Q 018816 115 NHKSILKLIGCCLEA---------------------------EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKV 167 (350)
Q Consensus 115 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i 167 (350)
+|||||++.++|.+. ..+|+||--.+ .+|.+++.. ...+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 599999999987652 25688988774 699999865 35677788889
Q ss_pred HHHHHHHHHHHHccCCCCeEeeccccCceEeC--CC--CceeEcccCCCccCCCC---Cccc-cccccccCCCCCCcccc
Q 018816 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQ--EE--YAAKLFDFSLSKSIPEG---KTHI-KASTAIGSLEFAAPEYL 239 (350)
Q Consensus 168 ~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~--~~~kl~Dfg~~~~~~~~---~~~~-~~~~~~gt~~y~aPE~~ 239 (350)
+.|++.|+.||| .++|.|||+|.+|||+. .+ ..+.|+|||++-.-..- .... -.....|....||||+.
T Consensus 347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999999 99999999999999994 33 35689999987433221 0111 11223377889999988
Q ss_pred ccCC------CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHH
Q 018816 240 TTGY------YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEK 313 (350)
Q Consensus 240 ~~~~------~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (350)
...+ --.++|.|+.|.+.||+++...||+..... ...... +.+... |. .++.+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L~~r~-----Yqe~qL----Pa--------lp~~v 482 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LLDTRT-----YQESQL----PA--------LPSRV 482 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh----eechhh-----hhhhhC----CC--------CcccC
Confidence 7532 126899999999999999999999853211 111111 111111 11 11356
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 314 LQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 314 ~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+..+.+|+...|+.||++|++..=...
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCccHHHh
Confidence 678899999999999999998654333
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=153.66 Aligned_cols=133 Identities=14% Similarity=0.104 Sum_probs=112.1
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKSVR--------YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.| |+|++|.||+|...+ ..|++|....... .....+.+|+.++..++|++|.....++.+....+++|||
T Consensus 3 ~l-~~G~~~~vy~~~~~~-~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 3 LI-KRGAEAEIYLGDFLG-IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cc-ccCceEEEEEEeeCC-CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 45 999999999999844 4899998654321 1234577899999999999998888887778889999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
++|++|.+++... .. ....++.+++.+|.+|| +.+++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988532 12 78899999999999999 99999999999999999 78899999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-20 Score=170.45 Aligned_cols=175 Identities=27% Similarity=0.323 Sum_probs=133.3
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
.+++.|++|...+|.+|+.+.... ...++...+.++.|++.|+.| ++.+|+|+||.||+...+..+||+|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 588999999999999999754322 467888999999999999998 689999999999999999999999999
Q ss_pred CCccCCCCC----ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHH
Q 018816 211 LSKSIPEGK----THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 211 ~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
+........ .....+..+||..||+||.+.+..|+.++||||||++++||+. -...+..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---------------- 465 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---------------- 465 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------------
Confidence 987665444 2223455669999999999999999999999999999999998 3332221
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev 338 (350)
...........++|....+. +.-..|+.++++..|.+||++.++
T Consensus 466 ~~t~~d~r~g~ip~~~~~d~---------p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFLQDY---------PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHhhhhhhcCCCChHHhhcC---------cHHHHHHHHhcCCCcccCchHHHH
Confidence 11111112333333332222 234589999999999999955443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=150.68 Aligned_cols=130 Identities=18% Similarity=0.164 Sum_probs=106.7
Q ss_pred ccCCCceEEEEEEECCCceEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCC
Q 018816 69 IDEIEGYILYMGFLRDRGPILVMKYRKSVR--------YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAG 140 (350)
Q Consensus 69 ig~G~~g~V~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 140 (350)
||+|++|.||+|.+.+ ..|++|....... ...+++.+|+.++..++|+++.....++...+..++||||++
T Consensus 2 ig~G~~~~vy~~~~~~-~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLG-LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeecCC-ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 4999999999999654 5899998654211 123567799999999998877666666666777899999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|++|.+.+... .. .++.+++.+|.+|| +.+++|+|++|.||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEG-----ND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhc-----HH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999887432 11 78999999999999 99999999999999999 889999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=170.94 Aligned_cols=137 Identities=17% Similarity=0.132 Sum_probs=112.1
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEeccc-c-------hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKS-V-------RYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~-~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
...|...+.| |+|+||.||+|.+.+. .+++|+.... . ....+++.+|+.++..++|++++....++.+..
T Consensus 332 ~~~~~~~~~i-G~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLI-GKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCcccee-ccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445566777 9999999999998665 4454443221 1 112356889999999999999998888887777
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+|||+ .++.++|+|||
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 8899999999999998873 34678999999999999 9999999999999999 67889999999
Q ss_pred CCcc
Q 018816 211 LSKS 214 (350)
Q Consensus 211 ~~~~ 214 (350)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=146.97 Aligned_cols=146 Identities=14% Similarity=0.067 Sum_probs=111.7
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccch----------------------hhHHHHHHHHHH
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR----------------------YASERCFNNIVF 110 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~----------------------~~~~~~~~E~~~ 110 (350)
.++......|...+.| |+|+||.||++...++..||||.+..... .....+.+|..+
T Consensus 8 ~~~~~~~~~~~~~~~i-~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 86 (198)
T cd05144 8 HTLVKRGVVESLGNQI-GVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA 86 (198)
T ss_pred HHHHHcCchhhcCCcc-ccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence 4444444446667777 99999999999998888999998754321 011235678899
Q ss_pred HHhcCCCC--ccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEe
Q 018816 111 ASQMNHKS--ILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVF 188 (350)
Q Consensus 111 l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 188 (350)
+..+.|++ ++..++ ....++||||+++++|...... .....++.+++.++.++| ..+++|
T Consensus 87 l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H 148 (198)
T cd05144 87 LKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIH 148 (198)
T ss_pred HHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCc
Confidence 99998774 444443 2456899999999998765320 234678899999999999 899999
Q ss_pred eccccCceEeCCCCceeEcccCCCccCCC
Q 018816 189 RNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 189 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
+||+|+||+++.++.++|+|||.+.....
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-19 Score=174.76 Aligned_cols=208 Identities=20% Similarity=0.205 Sum_probs=143.0
Q ss_pred hcCcccccccccCCCceEEEEEEEC-CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
-.+|+..+.+ ..|+||.||.++++ ..+++|+ ++++..- +.+. ++.....|.+|
T Consensus 82 e~df~~Ikli-sngAygavylvrh~~trqrfa~-kiNkq~l-----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLI-SNGAYGAVYLVRHKETRQRFAM-KINKQNL-----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEee-ccCCCCceeeeeccccccchhh-cccccch-----hhhc--cccccCCccee-----------------
Confidence 3688888888 99999999999995 4447777 6655421 1111 22222223222
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+=...+... ++++... +.+++||| +.+|+|||+||+|.+|..-|++|++|||+++....
T Consensus 136 ----gDc~tllk~~-----g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ----GDCATLLKNI-----GPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ----chhhhhcccC-----CCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 2222222211 3444332 78999999 99999999999999999999999999999875532
Q ss_pred CCc-------------cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHH
Q 018816 218 GKT-------------HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 218 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 284 (350)
... .......+||+.|.|||++....|...+|+|++|+|+||.+-|..||+...+. ..
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe---------el 266 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---------EL 266 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH---------HH
Confidence 211 11233457999999999999999999999999999999999999999865331 11
Q ss_pred HHHHHHhcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC
Q 018816 285 VEKFIRSNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP 333 (350)
Q Consensus 285 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 333 (350)
+..++.... ...-| +..+.+..+++.+.|+.+|..|-
T Consensus 267 fg~visd~i~wpE~d------------ea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 267 FGQVISDDIEWPEED------------EALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HhhhhhhhccccccC------------cCCCHHHHHHHHHHHHhChHhhc
Confidence 111221111 11101 14456889999999999999994
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=139.18 Aligned_cols=135 Identities=14% Similarity=0.129 Sum_probs=104.7
Q ss_pred ccccc-CCCceEEEEEEECCCceEEEEEecccc-------------hhhHHHHHHHHHHHHhcCCCCc--cceeeeeecC
Q 018816 66 NITID-EIEGYILYMGFLRDRGPILVMKYRKSV-------------RYASERCFNNIVFASQMNHKSI--LKLIGCCLEA 129 (350)
Q Consensus 66 ~~lig-~G~~g~V~~~~~~~~~~vaik~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~ 129 (350)
.+| | .||.|+||.+...++ .+++|.+.... ......+.+|+.++.+|+|++| +..+++....
T Consensus 37 ~~l-g~~~g~gtv~~v~~~~~-~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVV-GSAKGRGTTWFVQTPGV-NWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred cee-ecCCCCccEEEEEeCCc-eEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 345 8 899999999988754 89999885321 1223567889999999998775 6777765433
Q ss_pred C----cCeEEeecCCC-CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCce
Q 018816 130 E----MPALVYEPAGY-CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA 204 (350)
Q Consensus 130 ~----~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 204 (350)
. ..++|||++++ .+|.+++.. .+++.. .+.+++.+|.+|| +.||+|+||||+|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCE
Confidence 2 23599999997 689888754 234433 3678999999999 9999999999999999999999
Q ss_pred eEcccCCCccC
Q 018816 205 KLFDFSLSKSI 215 (350)
Q Consensus 205 kl~Dfg~~~~~ 215 (350)
+|+|||.+...
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999988653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-16 Score=127.80 Aligned_cols=133 Identities=12% Similarity=0.048 Sum_probs=111.8
Q ss_pred cccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCC--CCccceeeeeecCCcCeEEeecCCCCc
Q 018816 66 NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNH--KSILKLIGCCLEAEMPALVYEPAGYCT 143 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~s 143 (350)
+.+ |+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..+++|||++++.
T Consensus 4 ~~i-~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 4 KLL-KGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred eec-ccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 456 999999999999966 5899999866533 4678899999999976 589999998888888999999998876
Q ss_pred hhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 144 LADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 144 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
+..+ +......++.+++.++.+||.....+++|+|++|.||+++..+.++++|||.+..
T Consensus 80 ~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6532 4566678899999999999944335799999999999999999999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.6e-17 Score=134.62 Aligned_cols=134 Identities=17% Similarity=0.155 Sum_probs=96.6
Q ss_pred cccccCCCceEEEEEEECCCceEEEEEecccchh--hHHH----------------------HHHHHHHHHhcCCCC--c
Q 018816 66 NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRY--ASER----------------------CFNNIVFASQMNHKS--I 119 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 119 (350)
+.| |+|+||.||+|.+.++..||||.+...... .... ...|...+.++.+.. +
T Consensus 3 ~~l-g~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 3 GPI-GTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred ccc-ccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 456 999999999999987789999998654221 1111 134566666664332 4
Q ss_pred cceeeeeecCCcCeEEeecCCCCchhhh-hhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceE
Q 018816 120 LKLIGCCLEAEMPALVYEPAGYCTLADR-LYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNIL 197 (350)
Q Consensus 120 v~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nil 197 (350)
...+++ ...++||||++++++... +... .. ......++.+++.++.++| . .+|+|+||||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RL-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh------hh-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEE
Confidence 444433 246899999998654321 2110 01 1567889999999999999 7 99999999999999
Q ss_pred eCCCCceeEcccCCCccC
Q 018816 198 FQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 198 l~~~~~~kl~Dfg~~~~~ 215 (350)
++ ++.++++|||.+...
T Consensus 148 i~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EE-CCcEEEEECcccccc
Confidence 99 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6e-18 Score=164.12 Aligned_cols=255 Identities=16% Similarity=0.169 Sum_probs=188.4
Q ss_pred cCcccccccccCCCceEEEEEEEC--CCceEEEEEecccc--hhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR--DRGPILVMKYRKSV--RYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~--~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 134 (350)
..|....-| |+|+|+.|-..... ....+|.|.+.... ....+....|..+-..+. |+|++.+++...+.+..++
T Consensus 20 ~~~~~~~~i-g~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSI-GKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccc-cccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 344455557 99999999988883 33345555554432 233344556888888886 9999999999999999999
Q ss_pred EeecCCCCchhhhh-hCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-ceeEcccCCC
Q 018816 135 VYEPAGYCTLADRL-YGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLS 212 (350)
Q Consensus 135 v~e~~~~~sL~~~l-~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~ 212 (350)
+++|.+++++.+.+ .... ...+....-..+.|+..++.|+|. ..++.|+|+||+|.+++.++ ..++.|||+|
T Consensus 99 ~~~~s~g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred ccCcccccccccccccCCc----cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhh
Confidence 99999999999887 3321 246667778899999999999996 67899999999999999999 9999999999
Q ss_pred ccCCC-CCcccccccccc-CCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 213 KSIPE-GKTHIKASTAIG-SLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 213 ~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
..+.. ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+.......+. ...+.
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--------~~~~~ 244 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--------YSSWK 244 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--------ceeec
Confidence 88776 444444455568 9999999998874 5678999999999999999999998765432100 00000
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVA 339 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 339 (350)
....... ...+ ........+++.+++..+|+.|.+.+++-
T Consensus 245 ~~~~~~~-~~~~---------~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 245 SNKGRFT-QLPW---------NSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccccc-cCcc---------ccCChhhhhcccccccCCchhcccccccc
Confidence 0000000 0000 13445678899999999999999988764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.3e-16 Score=132.74 Aligned_cols=205 Identities=20% Similarity=0.168 Sum_probs=144.3
Q ss_pred HHHHhcCCCCccceeeeeecCC-----cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC
Q 018816 109 VFASQMNHKSILKLIGCCLEAE-----MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP 183 (350)
Q Consensus 109 ~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~ 183 (350)
.-|-++-|.|||++..||.+.. ...+++||+..|++..+|.+..... ..+....-.+|+.||.+||.|||++ +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 4455667999999999987643 5788999999999999997643332 4577777789999999999999976 7
Q ss_pred CCeEeeccccCceEeCCCCceeEcccCCCccCCCC--CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHH
Q 018816 184 QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG--KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLL 261 (350)
Q Consensus 184 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 261 (350)
.+|+|+++-.+.|++..+|-+|++--........- ..........+.++|.+||.-.....+.++|||+||+...+|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 89999999999999999998888754332222111 1111233444788999999877777889999999999999998
Q ss_pred hCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 262 TGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 262 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+..-...+.. .... ...+...+.+..+. .-+.++..|++..|+.||+|.+++.
T Consensus 277 ilEiq~tnseS-----~~~~------------ee~ia~~i~~len~--------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSES-----KVEV------------EENIANVIIGLENG--------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcc-----eeeh------------hhhhhhheeeccCc--------cccCcCcccccCCCCCCcchhhhhc
Confidence 87643221110 0000 01111111111111 1236778999999999999998875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-14 Score=136.15 Aligned_cols=141 Identities=14% Similarity=0.043 Sum_probs=99.4
Q ss_pred cccccCCCceEEEEEEECCCceEEEEEecccchhhH----------------------------------------HHHH
Q 018816 66 NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYAS----------------------------------------ERCF 105 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~----------------------------------------~~~~ 105 (350)
+-| |+|++|.||+|++++|..||||...+...... -++.
T Consensus 123 ~pl-asaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPL-AAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cce-eeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 446 99999999999998889999999876521100 0244
Q ss_pred HHHHHHHhcC----CCCccceeeeee-cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 018816 106 NNIVFASQMN----HKSILKLIGCCL-EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETAN-AVAYLR 179 (350)
Q Consensus 106 ~E~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~-~l~~LH 179 (350)
+|+..+.+++ |.+-+.+-..+. .....+|||||++|++|.+...... ... ....++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCC---CHHHHHHHHHHHHHHHHH
Confidence 5555555542 333333333332 2345789999999999988764321 112 23456666665 477888
Q ss_pred ccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 180 FGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 180 ~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
..|++|+|++|.||+++.++.++++|||++.....
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 89999999999999999999999999999877643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.9e-14 Score=133.07 Aligned_cols=249 Identities=16% Similarity=0.165 Sum_probs=179.8
Q ss_pred cCcccccccccC--CCceEEEEEEE---CCCceEEEEEecccc--hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCc
Q 018816 60 NNYSMRNITIDE--IEGYILYMGFL---RDRGPILVMKYRKSV--RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEM 131 (350)
Q Consensus 60 ~~f~~~~~lig~--G~~g~V~~~~~---~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 131 (350)
+.|.....+ |. |.+|.||.+.. .+...+|+|+-.... +.....=.+|+.....+ .|+|.++.+..+...+.
T Consensus 114 ~~~~~~~~~-g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRT-GSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhccccccc-ccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345566677 99 99999999988 455588888843322 23334445677777777 49999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHccCCCCeEeeccccCceEeCCC-CceeE
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETAN----AVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKL 206 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl 206 (350)
.++-+|.+. .+|..+.+... ..++....+....+..+ ||.++| +.+++|.|+||+||++..+ ...++
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred ceeeecccc-chhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeec
Confidence 999999994 78888776542 33666677777777777 999999 9999999999999999999 88999
Q ss_pred cccCCCccCCCCCcccc---ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 207 FDFSLSKSIPEGKTHIK---ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
+|||+...+........ .....|...|++||... +.++..+|+||+|.+..+..++..+........
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--------- 334 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--------- 334 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC---------
Confidence 99999887766543221 11223777899999764 678899999999999999999877654331100
Q ss_pred HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+....+..+-+... +.-..++...+.+|+..+|-.|++...+..
T Consensus 335 ----W~~~r~~~ip~e~~---------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 ----WSQLRQGYIPLEFC---------EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----ccccccccCchhhh---------cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000100111111 122345666999999999999999887654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.6e-12 Score=121.43 Aligned_cols=169 Identities=21% Similarity=0.188 Sum_probs=125.2
Q ss_pred EEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCC
Q 018816 80 GFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEP 158 (350)
Q Consensus 80 ~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 158 (350)
|.. .++.+|.|...............+-++.|+.++||||+++++.+......|||+|-+. .|..++. .
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk--------~ 100 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK--------E 100 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH--------H
Confidence 444 6667888888876654334556788899999999999999999999999999999873 5555552 3
Q ss_pred CCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccc
Q 018816 159 LLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEY 238 (350)
Q Consensus 159 ~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 238 (350)
+.....-..+.||+.||.|||. ..+++|++|.-+.|+++..|..||++|.++........ ......--..|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 4455666778999999999985 66899999999999999999999999988754432111 0111111223555554
Q ss_pred cccCCCCccchhHHHHHHHHHHHhCC
Q 018816 239 LTTGYYNEKTDVYSFGKLLLVLLTGR 264 (350)
Q Consensus 239 ~~~~~~~~~~DiwslG~il~el~tg~ 264 (350)
+... .-..|.|-|||+++|++.|.
T Consensus 177 ~~~s--~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 177 IDPS--EWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cCcc--ccchhhhhHHHHHHHHhCcc
Confidence 3221 14569999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.3e-13 Score=109.11 Aligned_cols=126 Identities=14% Similarity=-0.002 Sum_probs=93.7
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCc-cceeeeeecCCcCeEEeecCCCCchh
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSI-LKLIGCCLEAEMPALVYEPAGYCTLA 145 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL~ 145 (350)
.+ ++|.++.||++...+ ..|++|....... ....+..|+.++..+.+.++ .+++.+. ....++||||++|.++.
T Consensus 5 ~l-~~G~~~~vy~~~~~~-~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 5 PL-KGGMTNKNYRVEVAN-KKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred ec-CCcccCceEEEEECC-eEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 45 899999999999874 4899998765432 22346789999998865554 4455443 33458999999998875
Q ss_pred hhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-----eEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 146 DRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP-----VVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 146 ~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
+.- . ....++.+++.+|..|| ..+ ++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~----------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED----------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 0 11345789999999999 665 59999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.6e-13 Score=127.31 Aligned_cols=146 Identities=12% Similarity=0.089 Sum_probs=91.8
Q ss_pred cCcccccccccCCCceEEEEEEECC-CceEEEEEecccchh----------------------------------hHH--
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD-RGPILVMKYRKSVRY----------------------------------ASE-- 102 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~-~~~vaik~~~~~~~~----------------------------------~~~-- 102 (350)
.+|+. .-+ |+|++|.||+|++++ |..||||...+.-.. -.+
T Consensus 120 ~~fd~-~Pl-asaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 120 DDFDI-KPL-ASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HhcCh-hhh-cCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 34665 556 999999999999966 889999999765211 011
Q ss_pred ----HHHHHHHHHHhcC----CCCccceeeeeec-CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHH
Q 018816 103 ----RCFNNIVFASQMN----HKSILKLIGCCLE-AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETAN 173 (350)
Q Consensus 103 ----~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~ 173 (350)
++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.-.-.. ...+. ..++...+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~----~g~d~---~~la~~~v~ 270 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA----AGTDM---KLLAERGVE 270 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh----cCCCH---HHHHHHHHH
Confidence 1334444444442 3333333333322 345679999999999987421110 11111 112222221
Q ss_pred -HHHHHHccCCCCeEeeccccCceEeCCCC----ceeEcccCCCccCCC
Q 018816 174 -AVAYLRFGFPQPVVFRNIEPWNILFQEEY----AAKLFDFSLSKSIPE 217 (350)
Q Consensus 174 -~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~ 217 (350)
-+..+. ..|++|+|++|.||+++.++ .++++|||++.....
T Consensus 271 ~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 123334 67999999999999999888 999999999877654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=9e-12 Score=103.85 Aligned_cols=135 Identities=10% Similarity=0.053 Sum_probs=98.3
Q ss_pred ccccCCCceEEEEEEECC-------CceEEEEEecccch----------------------hhHHHH----HHHHHHHHh
Q 018816 67 ITIDEIEGYILYMGFLRD-------RGPILVMKYRKSVR----------------------YASERC----FNNIVFASQ 113 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~-------~~~vaik~~~~~~~----------------------~~~~~~----~~E~~~l~~ 113 (350)
.| |.|--+.||.|...+ +..+|+|....... ...+.+ .+|+..|.+
T Consensus 4 ~i-~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 4 CI-STGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred cc-ccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 45 999999999998743 46999998764321 001222 289999999
Q ss_pred cC--CCCccceeeeeecCCcCeEEeecCCCCchhh-hhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HccCCCCeEee
Q 018816 114 MN--HKSILKLIGCCLEAEMPALVYEPAGYCTLAD-RLYGPLQTHLEPLLLTHRLKVAMETANAVAYL-RFGFPQPVVFR 189 (350)
Q Consensus 114 l~--h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~ 189 (350)
+. .-++...+++ ...++||||+.+..+.. .+.+ ..++......+..+++.+|..| | ..+++|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 85 3566777764 45689999997654422 2211 2344556677889999999998 8 8899999
Q ss_pred ccccCceEeCCCCceeEcccCCCccCC
Q 018816 190 NIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 190 dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||++.||+++ ++.+.|+|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4679999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.7e-13 Score=125.04 Aligned_cols=259 Identities=13% Similarity=0.113 Sum_probs=183.7
Q ss_pred CCcccccHHH-HHHHhcCcccccccccCCCceEEEEEEE--CCCceEEEEEecccchhhHHH--HHHHHHHHHhc-CCCC
Q 018816 45 NPIRSFSSED-LKTAINNYSMRNITIDEIEGYILYMGFL--RDRGPILVMKYRKSVRYASER--CFNNIVFASQM-NHKS 118 (350)
Q Consensus 45 ~~~~~~~~~~-l~~~~~~f~~~~~lig~G~~g~V~~~~~--~~~~~vaik~~~~~~~~~~~~--~~~E~~~l~~l-~h~n 118 (350)
.+.+.|...+ ......+|.....| |.|.|+.|+.... .++..+++|...........+ -..|+-+...+ .|.+
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i-~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKI-SDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred chhheecccccceeecCCcceeEEc-cCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccc
Confidence 4455555555 44556788888888 9999999998776 456688888876654332222 34677777766 5999
Q ss_pred ccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe
Q 018816 119 ILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 119 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 198 (350)
++.++..|...+..++-.|||+++++...+.-. ..+.....+.+..|++.++.++| ++.++|+|++|+||++
T Consensus 328 ~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i 399 (524)
T KOG0601|consen 328 SVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILI 399 (524)
T ss_pred cCCCCCCccccccccCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceee
Confidence 999999998888889999999999887766221 45778888999999999999999 9999999999999999
Q ss_pred CCC-CceeEcccCCCccCCCCCccccccccccCCCCC--CccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCC
Q 018816 199 QEE-YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFA--APEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG 275 (350)
Q Consensus 199 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 275 (350)
.++ +..+++|||+...+.-. .....+.-++. +|.......+..+.|++|||..+.+.+++.+........
T Consensus 400 ~~~~~~~~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-- 472 (524)
T KOG0601|consen 400 SNDGFFSKLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-- 472 (524)
T ss_pred ccchhhhhcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc--
Confidence 987 77899999987642211 11111333344 444444557889999999999999999987643321110
Q ss_pred CCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
..+. ...-+... ....++..+..-++..++..||.+.++.....
T Consensus 473 -----------~~i~----~~~~p~~~---------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 473 -----------LTIR----SGDTPNLP---------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -----------eeee----cccccCCC---------chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 0000 00001110 22256778889999999999999988776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.9e-11 Score=103.94 Aligned_cols=141 Identities=16% Similarity=0.143 Sum_probs=108.4
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEecccch-hhHHHHHHHHHHHHhcCC--CCccceeeeeecCC---cCeEEeecCC
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKSVR-YASERCFNNIVFASQMNH--KSILKLIGCCLEAE---MPALVYEPAG 140 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~~ 140 (350)
.+ +.|..+.||++...++..+++|....... .....+.+|+.++..+++ .++.+++.+..... ..++||||++
T Consensus 5 ~l-~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 5 QL-SGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred ec-CCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 35 99999999999987756899998765432 134568899999999975 45677777776542 5689999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC--------------------------------------
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF-------------------------------------- 182 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 182 (350)
|.++.+.+.. ..++......++.+++.+|..||...
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888775531 24667777788888888888888421
Q ss_pred ---------------CCCeEeeccccCceEeCC--CCceeEcccCCCcc
Q 018816 183 ---------------PQPVVFRNIEPWNILFQE--EYAAKLFDFSLSKS 214 (350)
Q Consensus 183 ---------------~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~ 214 (350)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.2e-12 Score=126.95 Aligned_cols=250 Identities=14% Similarity=0.050 Sum_probs=166.6
Q ss_pred HhcCcccccccccCCCceEEEEEEECCCc-eEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRDRG-PILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~~~-~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
..++|....-+ -+|.++.++.+.-...+ ..+++...... ....+....+-.++-...+|-+++....+......+
T Consensus 802 S~d~~~i~~p~-qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 802 SPDGFEITKPS-QSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCccceecccc-cCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45666666666 89999999887763322 22333322111 111222233333333334566666665555667889
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
|+++|..+++|...++.. +..+..-.......+.+++++|| ...+.|+|++|.|.++..+++.++.|||...
T Consensus 881 L~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccc
Confidence 999999999999988765 34555555667788889999999 7779999999999999999999999998332
Q ss_pred cCCCC------------------------Cc-----cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCC
Q 018816 214 SIPEG------------------------KT-----HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264 (350)
Q Consensus 214 ~~~~~------------------------~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 264 (350)
..+-. .. ........+|+.|.+||...+......+|+|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 11100 00 01122345899999999999999999999999999999999999
Q ss_pred CCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHH
Q 018816 265 TIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI 336 (350)
Q Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 336 (350)
+||....+. +.+++-. ..+..+... +...+....+++...+..+|..|..+.
T Consensus 1033 pp~na~tpq-------------~~f~ni~--~~~~~~p~g-----~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQ-------------QIFENIL--NRDIPWPEG-----PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchh-------------hhhhccc--cCCCCCCCC-----ccccChhhhhhhhhhhccCchhccCcc
Confidence 999865431 1111100 011111111 124455677889999999999997765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.3e-11 Score=94.79 Aligned_cols=129 Identities=18% Similarity=0.163 Sum_probs=100.0
Q ss_pred ccCCCceEEEEEEECCCceEEEEEecccc--------hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCC
Q 018816 69 IDEIEGYILYMGFLRDRGPILVMKYRKSV--------RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAG 140 (350)
Q Consensus 69 ig~G~~g~V~~~~~~~~~~vaik~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 140 (350)
+++|+-+.+|.+.+.+. ++++|.=.+.. .-..++-.+|+.++.++.--.|....-+..+.+...|+|||++
T Consensus 4 i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 4 IKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 38999999999988665 55665532221 1123456789999999875555555555567788899999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
|..|.+.+... ...++..+-.-+.-|| ..+|+|+||.++||+++... +.++|||++..
T Consensus 83 G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999888542 2567888888899999 99999999999999998776 99999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.4e-10 Score=100.68 Aligned_cols=268 Identities=16% Similarity=0.049 Sum_probs=168.4
Q ss_pred cccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeee------cC-CcCeE
Q 018816 64 MRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCL------EA-EMPAL 134 (350)
Q Consensus 64 ~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~------~~-~~~~l 134 (350)
...-| |+|+-+.+|-.-. .+ -+.|.++........+... .|... .||-+-.-+.|=. +. ...-+
T Consensus 15 ~gr~L-gqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPL-GQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccc-cCCccceeeecchhhc---hhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 34556 9999999996544 33 3678877665443333222 22222 4554332122110 11 12556
Q ss_pred EeecCCCCc-hhhhhhC-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 135 VYEPAGYCT-LADRLYG-PLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 135 v~e~~~~~s-L~~~l~~-~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
+|+.+++.. +.+++.. ...++.....|.-.++.++.++.+.+-|| ..|.+-+|+.++|+|+++++.+.|.|-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccce
Confidence 777766542 2233221 22345567889999999999999999999 999999999999999999999999986654
Q ss_pred ccCCCCCccccccccccCCCCCCccccccC-----CCCccchhHHHHHHHHHHHhC-CCCCCCCcccCCCCcchHHHHHH
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTG-----YYNEKTDVYSFGKLLLVLLTG-RTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
....++.. ....+|...|.+||.-.-+ .-+...|.|.||+++|+++.| ++||..-................
T Consensus 165 qi~~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QINANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eeccCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 44333222 2344588999999976522 346789999999999999886 89997654332222221111111
Q ss_pred HH---HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHhhhcC
Q 018816 287 KF---IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHS--AEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 287 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~--P~~RPt~~evl~~L~~~~~~~ 349 (350)
-. ..+.+.... |..... .-+..++.+..|..+|+..- +.-|||++..+..|..+.++.
T Consensus 242 g~f~ya~~~~~g~~-p~P~~~----P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 242 GRFAYASDQRRGLK-PPPRSI----PLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred ceeeechhccCCCC-CCCCCC----ChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11 111111111 111111 11356678889999999874 678999999999998887654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-10 Score=93.07 Aligned_cols=143 Identities=12% Similarity=0.114 Sum_probs=104.8
Q ss_pred ccccccCCCceEEEEEEECCCceEEEEE-ecccc-------hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 65 RNITIDEIEGYILYMGFLRDRGPILVMK-YRKSV-------RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~~~~~~vaik~-~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
...+ -+|+-+.|+++.+.+. ..+||. +.+.- .-...+..+|+++|.++.--.|.-..-++.+...-.|+|
T Consensus 12 l~li-kQGAEArv~~~~~~Ge-~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 12 LELI-KQGAEARVPRGSFSGE-AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred ceee-eccceeeEeeeccCCc-eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3455 9999999999999776 444443 33221 123566789999999987556655555667777889999
Q ss_pred ecCCC-CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc---eeEcccCCC
Q 018816 137 EPAGY-CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA---AKLFDFSLS 212 (350)
Q Consensus 137 e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~ 212 (350)
||++| .++.+++..... ..........++..|-..+.-|| ..+|||+||-.+||++..++. +.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecch
Confidence 99987 478888765322 12222233788999999999999 999999999999999976543 589999998
Q ss_pred ccC
Q 018816 213 KSI 215 (350)
Q Consensus 213 ~~~ 215 (350)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=5.7e-10 Score=92.71 Aligned_cols=126 Identities=16% Similarity=0.142 Sum_probs=83.8
Q ss_pred EEEEEEECCCceEEEEEecccch--------------------------hhHHHHHHHHHHHHhcCCC--Cccceeeeee
Q 018816 76 ILYMGFLRDRGPILVMKYRKSVR--------------------------YASERCFNNIVFASQMNHK--SILKLIGCCL 127 (350)
Q Consensus 76 ~V~~~~~~~~~~vaik~~~~~~~--------------------------~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 127 (350)
.||.|...++..+|+|....... .......+|...|.++... ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998888999999765321 0123456899999999754 567776552
Q ss_pred cCCcCeEEeecCC--CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHccCCCCeEeeccccCceEeCCCCce
Q 018816 128 EAEMPALVYEPAG--YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAY-LRFGFPQPVVFRNIEPWNILFQEEYAA 204 (350)
Q Consensus 128 ~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlkp~Nill~~~~~~ 204 (350)
...|||||++ |..+..+... .++......++.+++..+.. +| ..||+|+||.+.||+++.+ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eE
Confidence 3479999998 6555544322 12234456677888875544 58 8999999999999999888 89
Q ss_pred eEcccCCCccCC
Q 018816 205 KLFDFSLSKSIP 216 (350)
Q Consensus 205 kl~Dfg~~~~~~ 216 (350)
.++|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-09 Score=95.36 Aligned_cols=138 Identities=10% Similarity=0.007 Sum_probs=99.8
Q ss_pred cCCCceEEEEEEECCCceEEEEEecccchh-----------hHHHHHHHHHHHHhcCCCC--ccceeeeeec-----CCc
Q 018816 70 DEIEGYILYMGFLRDRGPILVMKYRKSVRY-----------ASERCFNNIVFASQMNHKS--ILKLIGCCLE-----AEM 131 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~~~vaik~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~-----~~~ 131 (350)
-......|.++...+. .+.||+....... ....+.+|...+.++...+ .+..+++... ...
T Consensus 31 ~~~~~rrvvr~~~~g~-~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 31 RELEGRRTLRFELAGK-SYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred ecCCCceEEEEEECCE-EEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 5555566778776554 8999987543311 1113778999888885333 3444555443 224
Q ss_pred CeEEeecCCCC-chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-------CCc
Q 018816 132 PALVYEPAGYC-TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-------EYA 203 (350)
Q Consensus 132 ~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-------~~~ 203 (350)
.+||||++++. +|.+++..... .+.+......++.+++..+.-|| ..||+|+|+++.|||++. +..
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 68999999876 79888743211 34566777899999999999999 999999999999999975 467
Q ss_pred eeEcccCCCcc
Q 018816 204 AKLFDFSLSKS 214 (350)
Q Consensus 204 ~kl~Dfg~~~~ 214 (350)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-08 Score=94.36 Aligned_cols=171 Identities=15% Similarity=0.127 Sum_probs=128.3
Q ss_pred CceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeec----CCcCeEEeecCCC-Cchhh
Q 018816 73 EGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLE----AEMPALVYEPAGY-CTLAD 146 (350)
Q Consensus 73 ~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-~sL~~ 146 (350)
.-.+.|++.. -||..|++|+++-...........-++..+++.|+|+|.+.+++.. +..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3458899998 6777999999944333333344456788899999999999998873 4578999999875 46877
Q ss_pred hhhCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 147 RLYGPLQT----------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 147 ~l~~~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
+....... .....++...+.++.|+..||.++| +.|+..+-|.|.+||++.+..++|+..|..-...
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65432111 1134678889999999999999999 8999999999999999999999998888765443
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 265 (350)
.... |.+. -..+-|.=.||.+++.|.||..
T Consensus 445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 2220 0111 1356899999999999999865
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.1e-08 Score=87.75 Aligned_cols=134 Identities=13% Similarity=0.054 Sum_probs=98.4
Q ss_pred ccccccccCCCceEEEEEEECCCceEEEEEecccch----------------------hhHHHHHHHHHHHHhcCCC--C
Q 018816 63 SMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR----------------------YASERCFNNIVFASQMNHK--S 118 (350)
Q Consensus 63 ~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 118 (350)
.....| |-|.-+.||.|....+.++|+|.=.-... -+.....+|.++|.+|... .
T Consensus 94 ~iG~~I-GvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKI-GVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhcccc-ccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 344566 99999999999998888999987432211 1223466899999999644 6
Q ss_pred ccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe
Q 018816 119 ILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 119 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 198 (350)
+...+++ +.-.+|||+++|..|... +++....-.++..|+.-+.-+- ..|+||+|+++-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~----------r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL----------RLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc----------cCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEE
Confidence 7777664 455799999988666442 1234444556666666666665 6789999999999999
Q ss_pred CCCCceeEcccCCCcc
Q 018816 199 QEEYAAKLFDFSLSKS 214 (350)
Q Consensus 199 ~~~~~~kl~Dfg~~~~ 214 (350)
+.+|.+.++||-.+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999976654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=4.4e-10 Score=106.96 Aligned_cols=151 Identities=23% Similarity=0.195 Sum_probs=102.5
Q ss_pred HHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc-------cccccccCCCCCCcccccc
Q 018816 169 METANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI-------KASTAIGSLEFAAPEYLTT 241 (350)
Q Consensus 169 ~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 241 (350)
.+++.|+.|+|. +.++||++|.|++|.++.++..||+.|+.+.....+.... ..........|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 344599999996 6789999999999999999999999999876554422111 1112224567999999998
Q ss_pred CCCCccchhHHHHHHHHHHHhCC-CCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHH
Q 018816 242 GYYNEKTDVYSFGKLLLVLLTGR-TIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVEL 320 (350)
Q Consensus 242 ~~~~~~~DiwslG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 320 (350)
...+.++|+||+||++|.+..|. ..+...... +... .. ....+-.. ...+ ...++++.+=
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-------~~~~----~~---~~~~~~~~-~~~s----~~~p~el~~~ 244 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-------LSYS----FS---RNLLNAGA-FGYS----NNLPSELRES 244 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-------chhh----hh---hccccccc-cccc----ccCcHHHHHH
Confidence 88899999999999999999544 433322110 0000 00 00000000 0000 1566788899
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 018816 321 AFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 321 ~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+++..++..||++..+..
T Consensus 245 l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 245 LKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHhcCCcccCcchhhhhc
Confidence 99999999999997776653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.5e-08 Score=84.82 Aligned_cols=107 Identities=17% Similarity=0.096 Sum_probs=84.5
Q ss_pred HHHHHHHHHHHHhcC--CCCccceeeeeecCC----cCeEEeecCCCC-chhhhhhCCCCCCCCCCCHHHHHHHHHHHHH
Q 018816 101 SERCFNNIVFASQMN--HKSILKLIGCCLEAE----MPALVYEPAGYC-TLADRLYGPLQTHLEPLLLTHRLKVAMETAN 173 (350)
Q Consensus 101 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~----~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~ 173 (350)
.....+|...+.+|. .-.+...+++..... ..++|+|++++. +|.+++... ...+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHH
Confidence 346778888888875 334566666665533 348999999874 799988653 22566678899999999
Q ss_pred HHHHHHccCCCCeEeeccccCceEeCCCC---ceeEcccCCCccC
Q 018816 174 AVAYLRFGFPQPVVFRNIEPWNILFQEEY---AAKLFDFSLSKSI 215 (350)
Q Consensus 174 ~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~ 215 (350)
.+.-|| ..||+|+|+++.|||++.+. .+.++||+.+...
T Consensus 130 ~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 99999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-07 Score=79.67 Aligned_cols=137 Identities=12% Similarity=0.043 Sum_probs=104.0
Q ss_pred cCCCceEEEEEEECCCceEEEEEecccc------hhhHHHHHHHHHHHHhcCC--CCccceeeeee-cC----CcCeEEe
Q 018816 70 DEIEGYILYMGFLRDRGPILVMKYRKSV------RYASERCFNNIVFASQMNH--KSILKLIGCCL-EA----EMPALVY 136 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~~~vaik~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~-~~----~~~~lv~ 136 (350)
|+||-+.|++....+. .+.+|+-.... +.....|.+|+..+.+|.. -.+.+.. ++. .. -..+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 8899999999887666 78899865211 2356789999999999853 3355555 332 11 1467999
Q ss_pred ecCC-CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc--eeEcccCCCc
Q 018816 137 EPAG-YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA--AKLFDFSLSK 213 (350)
Q Consensus 137 e~~~-~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~ 213 (350)
|-++ ..+|.+++..... .+.+...+..+..+++..+.-|| +.|+.|+|+-+.||+++.++. +.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9764 3588888754321 45677888899999999999999 999999999999999987777 9999998765
Q ss_pred c
Q 018816 214 S 214 (350)
Q Consensus 214 ~ 214 (350)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.7e-08 Score=91.37 Aligned_cols=138 Identities=14% Similarity=0.031 Sum_probs=92.6
Q ss_pred cCCCceEEEEEEECCCceEEEEEecccchhh----------------------------------------HHHHHHHHH
Q 018816 70 DEIEGYILYMGFLRDRGPILVMKYRKSVRYA----------------------------------------SERCFNNIV 109 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~~~vaik~~~~~~~~~----------------------------------------~~~~~~E~~ 109 (350)
+.++-|.||+|++++|..||||..+++-... .=++.+|..
T Consensus 134 AsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~ 213 (517)
T COG0661 134 ASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAA 213 (517)
T ss_pred hhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHH
Confidence 9999999999999989999999998764210 001334555
Q ss_pred HHHhcC-----CCCccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHH-HHHHHccCC
Q 018816 110 FASQMN-----HKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANA-VAYLRFGFP 183 (350)
Q Consensus 110 ~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~-l~~LH~~~~ 183 (350)
-+.+++ .+++.-.-=++.-.....|+|||++|..+.+...-.. ...+ ...++..++.+ +..+- .
T Consensus 214 n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d---~k~ia~~~~~~f~~q~~---~ 283 (517)
T COG0661 214 NAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGID---RKELAELLVRAFLRQLL---R 283 (517)
T ss_pred HHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCC---HHHHHHHHHHHHHHHHH---h
Confidence 554442 3333222222333456689999999999988753221 2233 23344444433 33333 5
Q ss_pred CCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 184 QPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 184 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
.|+.|.|.+|.||+++.+|.+-+.|||+......
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 6999999999999999999999999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.2e-07 Score=78.31 Aligned_cols=141 Identities=11% Similarity=0.033 Sum_probs=84.5
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCC--CccceeeeeecCCcCeEEeecCCCCc-
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHK--SILKLIGCCLEAEMPALVYEPAGYCT- 143 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lv~e~~~~~s- 143 (350)
.| |+|..+.||+. . +..+++|...... ......+|.+++..+..- .+.+.+++..+.+...+|||+++|.+
T Consensus 8 ~i-~~G~t~~~y~~--~-~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 8 QT-GEGGNGESYTH--K-TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred ee-cCCCCcceeEe--c-CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 34 99999999984 2 3367788876543 334578899999988643 35777888877777889999998863
Q ss_pred hhhhhhCC-----------------C-CCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHc-cCCCCeEeeccc
Q 018816 144 LADRLYGP-----------------L-QTHLEPLLLTHRLK-VAM----------ETAN-AVAYLRF-GFPQPVVFRNIE 192 (350)
Q Consensus 144 L~~~l~~~-----------------~-~~~~~~~~~~~~~~-i~~----------~i~~-~l~~LH~-~~~~~ivH~dlk 192 (350)
+...+... . .............. +.. .+.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111100 0 00000111111100 000 0111 1122221 113467999999
Q ss_pred cCceEeCCCCceeEcccCCCcc
Q 018816 193 PWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 193 p~Nill~~~~~~kl~Dfg~~~~ 214 (350)
|.||+++.++ +.++||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=7.6e-07 Score=75.85 Aligned_cols=154 Identities=18% Similarity=0.140 Sum_probs=103.3
Q ss_pred ccHHHHHHHhcCccccccc--ccCCCceEEEEEEECCCceEEEEEecccchhhH------------------------HH
Q 018816 50 FSSEDLKTAINNYSMRNIT--IDEIEGYILYMGFLRDRGPILVMKYRKSVRYAS------------------------ER 103 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~~~~l--ig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~------------------------~~ 103 (350)
.+.+.|............. |++|.-+.||+|...++..+|+|++........ .-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 5556666655555554443 266667799999998888999999876532111 11
Q ss_pred HHHHHHHHHhcC--CCCccceeeeeecCCcCeEEeecCCCCchh-hhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 018816 104 CFNNIVFASQMN--HKSILKLIGCCLEAEMPALVYEPAGYCTLA-DRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRF 180 (350)
Q Consensus 104 ~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~sL~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~ 180 (350)
...|+.-|.++. +-.+.+.+++. .-.|||||+...... -.|.+ -++.......+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH
Confidence 336777777773 44555555543 346999998543111 11111 223333677788888888888872
Q ss_pred cCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 181 GFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 181 ~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
..++||+||+.-|||+. ++.+.++|||.|....
T Consensus 185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 37999999999999999 8899999999886554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.8e-06 Score=70.05 Aligned_cols=104 Identities=20% Similarity=0.211 Sum_probs=82.3
Q ss_pred HHHHHHHhcCC-CCccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC
Q 018816 106 NNIVFASQMNH-KSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ 184 (350)
Q Consensus 106 ~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ 184 (350)
+|.-++..+++ +++++++|+|-. ++|.||.+.+++...- ... ...-..+|..+.+||.+++..+.+|++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~-~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIY-RPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccc-ccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 57888888876 699999999933 6899999877664320 000 0113578999999999999999999976656
Q ss_pred CeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 185 PVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 185 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
.+.-+|++|+|+-+++++.+|++|.+.....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 7889999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.55 E-value=7e-07 Score=75.19 Aligned_cols=137 Identities=13% Similarity=0.068 Sum_probs=90.5
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHH---------HHHHHHHhcCCC---Cccceeeee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCF---------NNIVFASQMNHK---SILKLIGCC 126 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~---------~E~~~l~~l~h~---niv~~~~~~ 126 (350)
.++|...+++ -.....-|.+-..+++ .+++|..........+.|. +++..+.+++.. ....++.+.
T Consensus 30 ~~~~~~~kv~-k~~~r~~ValIei~~~-kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVF-KNTKRNYVALIEIDGK-KYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEee-cCCCccEEEEEEECCc-EEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4667777777 6766667777666665 8999988765543333322 344444444322 222222222
Q ss_pred e-----cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC
Q 018816 127 L-----EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201 (350)
Q Consensus 127 ~-----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~ 201 (350)
. -....+++|||++|..|.+... ++. .++..+++++.-|| ..|+.|+|..|.|++++.+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC
Confidence 2 1234568999999988876531 222 35567788899999 9999999999999999865
Q ss_pred CceeEcccCCCcc
Q 018816 202 YAAKLFDFSLSKS 214 (350)
Q Consensus 202 ~~~kl~Dfg~~~~ 214 (350)
+ ++++||+..+.
T Consensus 172 ~-i~iID~~~k~~ 183 (229)
T PF06176_consen 172 G-IRIIDTQGKRM 183 (229)
T ss_pred c-EEEEECccccc
Confidence 5 89999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.9e-08 Score=95.25 Aligned_cols=183 Identities=15% Similarity=0.016 Sum_probs=133.6
Q ss_pred cccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCC-ccceeeeeecCCcCeEEeecCCCC-c
Q 018816 66 NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKS-ILKLIGCCLEAEMPALVYEPAGYC-T 143 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~~-s 143 (350)
+.+ ++|+++.++|.+....+....+.+... ....-++++|.+++||| .+..++-+......+++++++.++ +
T Consensus 248 h~f-vK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 248 HNF-VKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHH-HHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 445 899999999998744444444444322 34556889999999999 777777777778899999999877 3
Q ss_pred hhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcccc
Q 018816 144 LADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIK 223 (350)
Q Consensus 144 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 223 (350)
......... ..+...+...+.+.-..++++|| +..=+|+| ||+..+ +..+.+||+....+.... .
T Consensus 322 ~~~~~~~se----~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~ 386 (829)
T KOG0576|consen 322 SALEMTVSE----IALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K 386 (829)
T ss_pred ccccCChhh----Hhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc---c
Confidence 222211110 23344445566777788999999 55568888 776655 678999999887665443 3
Q ss_pred ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 018816 224 ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHL 269 (350)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 269 (350)
..+..+++.++|||+...+.+..+.|.|++|+-..++.-|-+|-..
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 4556699999999999999999999999999887788888777543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.49 E-value=3e-06 Score=71.06 Aligned_cols=132 Identities=18% Similarity=0.148 Sum_probs=92.3
Q ss_pred cccccCCCceEEEEEEECCCceEEEEEecccc----------------hhhHHHHHHHHHHHHhcC------CCCcccee
Q 018816 66 NITIDEIEGYILYMGFLRDRGPILVMKYRKSV----------------RYASERCFNNIVFASQMN------HKSILKLI 123 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~~ 123 (350)
..| |+|+.-.||. +.+.....||...... ....++..+|+.-...+. +.+|.+++
T Consensus 7 ~~i-~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLI-AQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred ccc-ccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 445 9999999987 5444567888887665 122355667776666555 88999999
Q ss_pred eeeecCCcCeEEeecCC------CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceE
Q 018816 124 GCCLEAEMPALVYEPAG------YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197 (350)
Q Consensus 124 ~~~~~~~~~~lv~e~~~------~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 197 (350)
|+..++..+-+|+|.+. ..+|.+++.. ..++. ...+.+. .-..||- ..+|+.+|++|.||+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~~~~~L~---~f~~~l~---~~~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE------GGLTE-ELRQALD---EFKRYLL---DHHIVIRDLNPHNIV 150 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc------CCccH-HHHHHHH---HHHHHHH---HcCCeecCCCcccEE
Confidence 99999999999999753 2367777744 23444 3333333 4445555 778999999999999
Q ss_pred eCCCC----ceeEcc-cCCCc
Q 018816 198 FQEEY----AAKLFD-FSLSK 213 (350)
Q Consensus 198 l~~~~----~~kl~D-fg~~~ 213 (350)
+..+. .+.|+| ||...
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EEecCCCceEEEEEeCCCCcc
Confidence 96432 578888 56543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-06 Score=83.14 Aligned_cols=158 Identities=13% Similarity=0.028 Sum_probs=97.8
Q ss_pred cccccHHHHHHH------------hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhh--------------
Q 018816 47 IRSFSSEDLKTA------------INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYA-------------- 100 (350)
Q Consensus 47 ~~~~~~~~l~~~------------~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~-------------- 100 (350)
..+++++|+... ...|+.. -| |..+.|.||+|++++|..||||.-++.-...
T Consensus 137 ~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~-pi-aaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~ 214 (538)
T KOG1235|consen 137 APPFPWEEAFKIFEEELGAPIEDIFSEFDEE-PI-AAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKV 214 (538)
T ss_pred CCCCCHHHHHHHHHHHhCCCHHHHHHhcCcc-hh-hhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHH
Confidence 345777776433 2344433 34 9999999999999999999999987753210
Q ss_pred -----------------HH------HHHHHHHHHH----hcCCCC------ccceeeeeecCCcCeEEeecCCCCchhhh
Q 018816 101 -----------------SE------RCFNNIVFAS----QMNHKS------ILKLIGCCLEAEMPALVYEPAGYCTLADR 147 (350)
Q Consensus 101 -----------------~~------~~~~E~~~l~----~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~ 147 (350)
.+ +|.+|++-.. .+.|-+ |.+++-.+ .....|+||||+|.-+.|.
T Consensus 215 l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl 292 (538)
T KOG1235|consen 215 LQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDL 292 (538)
T ss_pred HHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCH
Confidence 11 1334433222 223444 33333332 2356899999999988775
Q ss_pred hhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC----CCceeEcccCCCccCCC
Q 018816 148 LYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE----EYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 148 l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~~~~~~ 217 (350)
-.-.. ..++... ++..+.++...+= ...|++|+|=+|.||++.. ++.+.+.|||+...+..
T Consensus 293 ~~i~~----~gi~~~~---i~~~l~~~~~~qI--f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 293 DAIDK----RGISPHD---ILNKLVEAYLEQI--FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHH----cCCCHHH---HHHHHHHHHHHHH--HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 32211 2344443 3333333322211 1458999999999999984 67899999999876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.8e-06 Score=74.27 Aligned_cols=136 Identities=12% Similarity=-0.038 Sum_probs=83.0
Q ss_pred CceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEeecCCCCchhhhhh--
Q 018816 73 EGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY-- 149 (350)
Q Consensus 73 ~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-- 149 (350)
....||+....+ ..+++|...... ...+.+|+.++..+. +--+.+++++....+..++|||+++|.++.....
T Consensus 11 ~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~ 86 (244)
T cd05150 11 SGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWEEL 86 (244)
T ss_pred CcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhccc
Confidence 347999998754 578888875542 345678988888884 4456677887776667899999999887764321
Q ss_pred -----------------CCCCCCCCCCC--HHHHHHHHHH--------------------HHHHHHHHHc----cCCCCe
Q 018816 150 -----------------GPLQTHLEPLL--LTHRLKVAME--------------------TANAVAYLRF----GFPQPV 186 (350)
Q Consensus 150 -----------------~~~~~~~~~~~--~~~~~~i~~~--------------------i~~~l~~LH~----~~~~~i 186 (350)
.-.... .++. .......... +...+..|-. .....+
T Consensus 87 ~~~~~~~~l~~~l~~lH~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 165 (244)
T cd05150 87 EPERLVDALAEALRRLHALPVAD-CPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDLVV 165 (244)
T ss_pred CHHHHHHHHHHHHHHHhcCCccc-CCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCceEE
Confidence 100000 0111 0000100000 1111122210 113569
Q ss_pred EeeccccCceEeCCCCceeEcccCCCc
Q 018816 187 VFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 187 vH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+|+|+.|.|||++++..+.|+||+.+.
T Consensus 166 ~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 166 THGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ECCCCCCccEEEeCCcEEEEEEccccc
Confidence 999999999999998778999998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.1e-06 Score=71.68 Aligned_cols=142 Identities=17% Similarity=0.123 Sum_probs=83.4
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCC--Cccceeeeeec---CCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHK--SILKLIGCCLE---AEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~~ 141 (350)
.+ +.|..+.||+....++ .+++|..... .....+.+|..++..+... .+.+++.+... ....+++|+++++
T Consensus 4 ~l-~~G~~n~~~~v~~~~~-~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 4 PL-SGGFSNRVYRVTTDDG-RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EE-EESSSSEEEEEEETTS-EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred cC-CCCCeeeEEEEEECCc-EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 45 8899999999999885 9999997665 4456778899998888532 35666664433 2346899999998
Q ss_pred Cchhh----------------hhh---CCCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHc
Q 018816 142 CTLAD----------------RLY---GPLQTHLEPLLLTH---------RLKV------------AMETAN-AVAYLRF 180 (350)
Q Consensus 142 ~sL~~----------------~l~---~~~~~~~~~~~~~~---------~~~i------------~~~i~~-~l~~LH~ 180 (350)
.++.. .+. ...... .+..... .... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPF-SPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTC-CCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccc-cccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 88777 110 110000 0111110 0000 111222 2333331
Q ss_pred ----cCCCCeEeeccccCceEeC-CCCceeEcccCCCc
Q 018816 181 ----GFPQPVVFRNIEPWNILFQ-EEYAAKLFDFSLSK 213 (350)
Q Consensus 181 ----~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~ 213 (350)
.....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1256799999999999999 56666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=6.7e-06 Score=66.44 Aligned_cols=127 Identities=9% Similarity=0.063 Sum_probs=87.5
Q ss_pred ccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccc-eeeeeecCCcCeEEeecCCCCc
Q 018816 65 RNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILK-LIGCCLEAEMPALVYEPAGYCT 143 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~~~s 143 (350)
...| ++|.+|.||+|.+.++ .+|+|.-..++ ....+..|+++|..++..++.. ++.|-. ..+.|||++|-.
T Consensus 27 ~~~L-~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 27 EKEL-AKGTTSVVYLGEWRGG-EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhh-hcccccEEEEeeccCc-eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 3456 9999999999999887 89999876653 4577889999999998766543 443322 235599999888
Q ss_pred hhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeecccc-CceEeCCCCceeEcccCCCcc
Q 018816 144 LADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEP-WNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 144 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp-~Nill~~~~~~kl~Dfg~~~~ 214 (350)
|.+.-.. .+-.+ ...++..---|- ..||-|..|.- ...++-+++.+.|+||..|+.
T Consensus 99 L~~~~~~--------~~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG--------GDRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc--------ccHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8776532 12222 333344433344 67888998864 444444555899999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.9e-05 Score=80.90 Aligned_cols=78 Identities=8% Similarity=0.004 Sum_probs=56.5
Q ss_pred cccccCCCceEEEEEEECCC---ceEEEEEecccc-hhhHHHHHHHHHHHHhcC-CCCc--cceeeeeecC---CcCeEE
Q 018816 66 NITIDEIEGYILYMGFLRDR---GPILVMKYRKSV-RYASERCFNNIVFASQMN-HKSI--LKLIGCCLEA---EMPALV 135 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~---~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv 135 (350)
..+ +.|.+..+|+....++ ..+++|+..... ......+.+|+.+++.+. |+++ .+++.+|.+. +..++|
T Consensus 44 ~~l-~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 44 SQF-GHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEe-CCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 445 8999999999887553 367777754432 123456889999999995 6664 7888888764 467899
Q ss_pred eecCCCCch
Q 018816 136 YEPAGYCTL 144 (350)
Q Consensus 136 ~e~~~~~sL 144 (350)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.7e-05 Score=68.95 Aligned_cols=70 Identities=10% Similarity=-0.080 Sum_probs=44.3
Q ss_pred cCCCce-EEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCC---CccceeeeeecC---CcCeEEeecCCCC
Q 018816 70 DEIEGY-ILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHK---SILKLIGCCLEA---EMPALVYEPAGYC 142 (350)
Q Consensus 70 g~G~~g-~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~~~ 142 (350)
+.|+.. .||+.. ..+++|..... .....+.+|..++..+... .+..+++..... ...+++|++++|.
T Consensus 6 ~~gG~~n~vy~~~----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~ 79 (235)
T cd05155 6 DSGGTDNATFRLG----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGE 79 (235)
T ss_pred cCCCcccceEEcC----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCC
Confidence 666665 588752 25677765442 2345788999999888532 345555544332 2458899999987
Q ss_pred chh
Q 018816 143 TLA 145 (350)
Q Consensus 143 sL~ 145 (350)
++.
T Consensus 80 ~l~ 82 (235)
T cd05155 80 TAT 82 (235)
T ss_pred CCC
Confidence 764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.8e-05 Score=79.03 Aligned_cols=195 Identities=18% Similarity=0.190 Sum_probs=132.3
Q ss_pred HHHHHHHHHhcCCCCccceeeeeecCCcC----eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 018816 104 CFNNIVFASQMNHKSILKLIGCCLEAEMP----ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLR 179 (350)
Q Consensus 104 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH 179 (350)
..-|+..+..++|+|++.++.|-...... .+..+++..-++...+... ...+....+.+..+...||.|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHHHH
Confidence 33566777888999999999987654432 3445678777887777543 67889999999999999999999
Q ss_pred ccCCCCeEeeccccC---ceEeCCCCceeEc--ccCCCccCCCCCccccccccccCCCCCCccccccCCCC--ccchhHH
Q 018816 180 FGFPQPVVFRNIEPW---NILFQEEYAAKLF--DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN--EKTDVYS 252 (350)
Q Consensus 180 ~~~~~~ivH~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Diws 252 (350)
.....|.-+... +--.+..+.+..+ ||+.+...+..... .....+..+.+||........ ...|+|.
T Consensus 304 ---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 ---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred ---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHH
Confidence 555555544444 3334455666666 88887766543321 122245567788877665544 4479999
Q ss_pred HHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCC
Q 018816 253 FGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDR 332 (350)
Q Consensus 253 lG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 332 (350)
+|.....+..|..+....... ...++. .......+...+|+..++++|
T Consensus 378 lgll~~~~~~~~~i~~~~~~~--------------------~~~l~~------------~~~~~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAVP--------------------VSLLDV------------LSTSELLDALPKCLDEDSEER 425 (1351)
T ss_pred HHHHHhhhhhcCcccccccch--------------------hhhhcc------------ccchhhhhhhhhhcchhhhhc
Confidence 999999999988763321110 001110 111156788899999999999
Q ss_pred CCHHHHHHH
Q 018816 333 PTMIDVAKK 341 (350)
Q Consensus 333 Pt~~evl~~ 341 (350)
+++.+++..
T Consensus 426 l~~~~ll~~ 434 (1351)
T KOG1035|consen 426 LSALELLTH 434 (1351)
T ss_pred cchhhhhhc
Confidence 999998864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00011 Score=66.19 Aligned_cols=75 Identities=9% Similarity=-0.021 Sum_probs=55.5
Q ss_pred cccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCC---CCccceeeeeecC---CcCeEEeecC
Q 018816 66 NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNH---KSILKLIGCCLEA---EMPALVYEPA 139 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---~~~~lv~e~~ 139 (350)
.-| |+|..+.||.....++ .+++|..... .....+..|...|+.|.- ..+.+++++|.+. +..+||||++
T Consensus 20 ~~i-~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 20 ECI-SEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eec-CCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 345 9999999999987666 5666664331 123578899999998853 4688888887543 5689999999
Q ss_pred CCCch
Q 018816 140 GYCTL 144 (350)
Q Consensus 140 ~~~sL 144 (350)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00011 Score=63.61 Aligned_cols=73 Identities=15% Similarity=0.011 Sum_probs=47.4
Q ss_pred ccccCCCceEEEEEEECC--CceEEEEEecccchhhHHHHHHHHHHHHhcCC-CCccceeeeeecCCcCeEEeecCCCCc
Q 018816 67 ITIDEIEGYILYMGFLRD--RGPILVMKYRKSVRYASERCFNNIVFASQMNH-KSILKLIGCCLEAEMPALVYEPAGYCT 143 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~--~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~~s 143 (350)
.| ..|-...+|+....+ +..|++|........ .-...+|+.++..+.. .-.+++++.+. -.++|||++|.+
T Consensus 5 ~l-~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 5 RF-TGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred Ec-CCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 35 788888999998764 558888876543221 1223478888888853 33444544332 248999999876
Q ss_pred hh
Q 018816 144 LA 145 (350)
Q Consensus 144 L~ 145 (350)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00013 Score=67.91 Aligned_cols=74 Identities=8% Similarity=-0.043 Sum_probs=53.6
Q ss_pred ccccCCCceEEEEEEECCC-ceEEEEEeccc-------chhhHHHHHHHHHHHHhcC---CCCccceeeeeecCCcCeEE
Q 018816 67 ITIDEIEGYILYMGFLRDR-GPILVMKYRKS-------VRYASERCFNNIVFASQMN---HKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~-~~vaik~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv 135 (350)
.| |.|....||++...++ +.|+||.-.+. .+...++...|...|..+. ..++++++.+ +....++|
T Consensus 33 el-ggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 33 EI-GDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred Ec-CCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 45 9999999999999766 48999985421 1234566777888888763 3457777776 44567899
Q ss_pred eecCCCCc
Q 018816 136 YEPAGYCT 143 (350)
Q Consensus 136 ~e~~~~~s 143 (350)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.90 E-value=8.2e-05 Score=65.49 Aligned_cols=138 Identities=11% Similarity=-0.025 Sum_probs=77.4
Q ss_pred cCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCc-cceeeeeecCCcCeEEeecCCCCchhhh-
Q 018816 70 DEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSI-LKLIGCCLEAEMPALVYEPAGYCTLADR- 147 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL~~~- 147 (350)
..|-.+.+|+.... +..+++|........-.-...+|..+++.+....+ .+++.... .++||||++|..+...
T Consensus 5 ~~G~tn~~y~~~~~-~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~ 79 (256)
T TIGR02721 5 SGGLTNRSWRIEHP-GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQ 79 (256)
T ss_pred CCcCcCCeEEEEeC-CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccccc
Confidence 67778899988754 44788877544322211235678888888854323 34444332 3699999998765421
Q ss_pred ----------------hhCCCCCCCCCCCHHHH-HHHHHHH---------HHHHHHHHc-----cCCCCeEeeccccCce
Q 018816 148 ----------------LYGPLQTHLEPLLLTHR-LKVAMET---------ANAVAYLRF-----GFPQPVVFRNIEPWNI 196 (350)
Q Consensus 148 ----------------l~~~~~~~~~~~~~~~~-~~i~~~i---------~~~l~~LH~-----~~~~~ivH~dlkp~Ni 196 (350)
++... ....+++.... ..+..++ ...+..+-. .....++|+|+.|.||
T Consensus 80 ~~~~~~~~~la~~l~~lH~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 80 FVALDLLLELAALLHQLHSQP-RFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred ccCchhHHHHHHHHHHHhCCC-CCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11110 00012222211 1111111 111222211 1134689999999999
Q ss_pred EeCCCCceeEcccCCCcc
Q 018816 197 LFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~ 214 (350)
+++.++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999877 78999997754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00012 Score=65.85 Aligned_cols=141 Identities=16% Similarity=0.124 Sum_probs=82.7
Q ss_pred cCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCC--Cccceeee------eecCCcCeEEeecCCC
Q 018816 70 DEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHK--SILKLIGC------CLEAEMPALVYEPAGY 141 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e~~~~ 141 (350)
..|....+|+....++ .+++|.... .....+..|+.++..+.+. .+.+++.. ....+..++|++|++|
T Consensus 23 ~~G~~n~~y~v~~~~~-~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G 98 (296)
T cd05153 23 SAGIENTNYFVTTDSG-RYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAG 98 (296)
T ss_pred cCccccceEEEEeCCC-cEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCC
Confidence 7777789999877665 788888764 2245567788888887432 24444432 1223456899999988
Q ss_pred Cchhh-----------h---hhCCCCCC------CCCCCHHHHH----------HHHHHHHHHHHHHHc----cCCCCeE
Q 018816 142 CTLAD-----------R---LYGPLQTH------LEPLLLTHRL----------KVAMETANAVAYLRF----GFPQPVV 187 (350)
Q Consensus 142 ~sL~~-----------~---l~~~~~~~------~~~~~~~~~~----------~i~~~i~~~l~~LH~----~~~~~iv 187 (350)
..+.. . ++...... .....|.... .....+..++.++.. ....++|
T Consensus 99 ~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 178 (296)
T cd05153 99 EHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVI 178 (296)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCC
Confidence 76532 0 11100000 0011111110 011112333444442 1235799
Q ss_pred eeccccCceEeCCCCceeEcccCCCcc
Q 018816 188 FRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 188 H~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
|+|+.|.||+++.++.+.|+||+.+..
T Consensus 179 HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 179 HADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred ccCcCcccEEEeCCceEEEeehhhhcC
Confidence 999999999999987789999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00027 Score=59.01 Aligned_cols=136 Identities=15% Similarity=0.149 Sum_probs=94.4
Q ss_pred CCCcccccHHHHHHHhcCcccccccccCCCc-eEEEEEEECCCceEEEEEecc---cch------------------hhH
Q 018816 44 RNPIRSFSSEDLKTAINNYSMRNITIDEIEG-YILYMGFLRDRGPILVMKYRK---SVR------------------YAS 101 (350)
Q Consensus 44 ~~~~~~~~~~~l~~~~~~f~~~~~lig~G~~-g~V~~~~~~~~~~vaik~~~~---~~~------------------~~~ 101 (350)
.+...+|+. -+.+++..+.| |.|.. |.||++...+. .+|+|.+.. ... ...
T Consensus 26 gPKL~~F~~-----h~~~I~flefL-g~g~~~~~V~kv~I~g~-~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~ 98 (207)
T PF13095_consen 26 GPKLEPFTH-----HGDDIEFLEFL-GHGSHDGYVFKVEIDGR-IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA 98 (207)
T ss_pred CCCcCCcCC-----CCCcEeeeeec-CCCCceeEEEEEEECCe-EEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence 345566776 23788888899 99999 99999999887 999999322 110 011
Q ss_pred HHHHHHHHHHHhcC---CCCc--cceeeeeecC------------------CcCeEEeecCCCCchhhhhhCCCCCCCCC
Q 018816 102 ERCFNNIVFASQMN---HKSI--LKLIGCCLEA------------------EMPALVYEPAGYCTLADRLYGPLQTHLEP 158 (350)
Q Consensus 102 ~~~~~E~~~l~~l~---h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~ 158 (350)
.-|..|.....+|+ +.++ |+++||..-. ....||.||++... .
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~ 164 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------P 164 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------c
Confidence 24778888888885 4455 9999986321 02245666654321 1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 159 LLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 159 ~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
+. ..-+.+|.+-+..+| ..+|+-+|+++.|.. .-+|+|||.+
T Consensus 165 ~~----~~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 165 LQ----IRDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cc----hhHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 22 334566777788899 999999999999986 3489999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00031 Score=63.40 Aligned_cols=72 Identities=19% Similarity=0.087 Sum_probs=47.3
Q ss_pred cCCCceEEEEEEECC-------CceEEEEEecccchhhHHHHHHHHHHHHhcCCCC-ccceeeeeecCCcCeEEeecCCC
Q 018816 70 DEIEGYILYMGFLRD-------RGPILVMKYRKSVRYASERCFNNIVFASQMNHKS-ILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 70 g~G~~g~V~~~~~~~-------~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
..|-...+|+....+ +..+++|...... .......+|..++..+.... ..++++++.. .+|+||++|
T Consensus 7 ~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~G 81 (302)
T cd05156 7 SGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIPS 81 (302)
T ss_pred cCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeCC
Confidence 667777999998754 4588888865543 22244568888888885322 3455555532 368999988
Q ss_pred Cchhh
Q 018816 142 CTLAD 146 (350)
Q Consensus 142 ~sL~~ 146 (350)
.++..
T Consensus 82 ~~l~~ 86 (302)
T cd05156 82 RTLTT 86 (302)
T ss_pred CcCCH
Confidence 76643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00093 Score=60.48 Aligned_cols=142 Identities=16% Similarity=0.131 Sum_probs=81.4
Q ss_pred cCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCC--Cccceeeee------ecCCcCeEEeecCCC
Q 018816 70 DEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHK--SILKLIGCC------LEAEMPALVYEPAGY 141 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~------~~~~~~~lv~e~~~~ 141 (350)
+.|....+|+....++ .+++|...... ..+.+..|+.++..|... .+.+++... ...+..++++||++|
T Consensus 31 ~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G 107 (307)
T TIGR00938 31 AEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQG 107 (307)
T ss_pred CCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeCCC
Confidence 7777789999877665 68888765431 234455677777777422 244444321 123456899999988
Q ss_pred Cchhh-----------h---hhCCCCCCCC-------CCCHHHHH------------HHHHHHHHHHHHHHc----cCCC
Q 018816 142 CTLAD-----------R---LYGPLQTHLE-------PLLLTHRL------------KVAMETANAVAYLRF----GFPQ 184 (350)
Q Consensus 142 ~sL~~-----------~---l~~~~~~~~~-------~~~~~~~~------------~i~~~i~~~l~~LH~----~~~~ 184 (350)
..+.. . ++........ .-.|.... .....+...+.++.. ....
T Consensus 108 ~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~ 187 (307)
T TIGR00938 108 LSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPR 187 (307)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 54321 0 1111100000 01111100 011223334555532 1247
Q ss_pred CeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 185 PVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 185 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
++||+|+.+.||+++.++.+.|+||+.+..
T Consensus 188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 188 GVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred ccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 899999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0016 Score=59.22 Aligned_cols=160 Identities=13% Similarity=0.092 Sum_probs=85.4
Q ss_pred ccHHHHHHHhcCccc-----ccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCC--Cccce
Q 018816 50 FSSEDLKTAINNYSM-----RNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHK--SILKL 122 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~-----~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~ 122 (350)
++.+++...-..|.. .+.+ +.|....+|+....++ .+++|.+... ..+.+..|+.++..|... .+.+.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l-~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGI-AEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchh-ccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 555555554455543 1234 6777779999987766 7888887521 223444566666665321 23333
Q ss_pred eee------eecCCcCeEEeecCCCCchh-----------hhh---hCCCCCC------CCCCCH-HHHHH---------
Q 018816 123 IGC------CLEAEMPALVYEPAGYCTLA-----------DRL---YGPLQTH------LEPLLL-THRLK--------- 166 (350)
Q Consensus 123 ~~~------~~~~~~~~lv~e~~~~~sL~-----------~~l---~~~~~~~------~~~~~~-~~~~~--------- 166 (350)
+.. ....+..++++||++|..+. ..+ +...... ...+.+ .....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 321 12244578999999886432 111 1111000 001111 11111
Q ss_pred ---HHHH-HHHHHHHHHcc----CCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 167 ---VAME-TANAVAYLRFG----FPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 167 ---i~~~-i~~~l~~LH~~----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
...+ +...+..+... ...++||+|+.|.||+++.+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 11122222210 245899999999999999776668999998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00029 Score=62.63 Aligned_cols=133 Identities=12% Similarity=0.088 Sum_probs=90.5
Q ss_pred CcccccccccCCCceEEEEEEECCCceEEEEEecccch----------------------hhHHHHHHHHHHHHhcC-CC
Q 018816 61 NYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR----------------------YASERCFNNIVFASQMN-HK 117 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~----------------------~~~~~~~~E~~~l~~l~-h~ 117 (350)
-++..+.| |-|.-+.||.+-+.+|.+.++|.-.-... .++-...+|+..|+.|. |.
T Consensus 93 v~svGnqI-GVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQI-GVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhcccc-ccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 35667788 99999999999998887888775321110 01122457888888874 22
Q ss_pred -CccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCce
Q 018816 118 -SILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196 (350)
Q Consensus 118 -niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 196 (350)
-+...++ .+..++|||++.+..|...-+ -... ..+...+..-+.-|- .+|+||+|..-=||
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~--------v~d~---~~ly~~lm~~Iv~la---~~GlIHgDFNEFNi 233 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH--------VEDP---PTLYDDLMGLIVRLA---NHGLIHGDFNEFNI 233 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeee--------cCCh---HHHHHHHHHHHHHHH---HcCceecccchhee
Confidence 2344443 345689999998877765321 1222 234444444455555 88999999999999
Q ss_pred EeCCCCceeEcccCCC
Q 018816 197 LFQEEYAAKLFDFSLS 212 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~ 212 (350)
+++.++.++++||-..
T Consensus 234 mv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 234 MVKDDDKIVVIDFPQM 249 (465)
T ss_pred EEecCCCEEEeechHh
Confidence 9999999999999754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0024 Score=56.84 Aligned_cols=31 Identities=26% Similarity=0.439 Sum_probs=25.8
Q ss_pred CCeEeeccccCceEeCCCCc-eeEcccCCCcc
Q 018816 184 QPVVFRNIEPWNILFQEEYA-AKLFDFSLSKS 214 (350)
Q Consensus 184 ~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~ 214 (350)
..++|+|+.|.||+++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997554 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.36 E-value=4.2e-05 Score=79.73 Aligned_cols=162 Identities=9% Similarity=-0.121 Sum_probs=114.6
Q ss_pred HHHHHHHHHhcCCCCccceeeeee--cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcc
Q 018816 104 CFNNIVFASQMNHKSILKLIGCCL--EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFG 181 (350)
Q Consensus 104 ~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~ 181 (350)
...|...++...|+++...+.=.. +....+..++|+.+|.+.+.|.++.... ..+...-+.....+.+....-+|..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-PDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-CcchhchHHHHHHHHHhccchhhhc
Confidence 344555566678999877665443 2346788999999999999997765432 2232222222233335566665543
Q ss_pred C--CCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHH
Q 018816 182 F--PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLV 259 (350)
Q Consensus 182 ~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 259 (350)
. ..--+|++||+.|.+|..+..+|++++|+.+...+... ......+++-|++|+....-.++.++|+|..|+.+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 2 34578999999999999999999999999983322211 2334457888999999888889999999999999999
Q ss_pred HHhCCCCCC
Q 018816 260 LLTGRTIGH 268 (350)
Q Consensus 260 l~tg~~p~~ 268 (350)
..-|..+|-
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 888877653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0025 Score=58.59 Aligned_cols=140 Identities=15% Similarity=0.056 Sum_probs=79.3
Q ss_pred cCCCceEEEEEEECC-----CceEEEEEecccchhhHHHHHHHHHHHHhcCCCC-ccceeeeeecCCcCeEEeecCCCCc
Q 018816 70 DEIEGYILYMGFLRD-----RGPILVMKYRKSVRYASERCFNNIVFASQMNHKS-ILKLIGCCLEAEMPALVYEPAGYCT 143 (350)
Q Consensus 70 g~G~~g~V~~~~~~~-----~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~~s 143 (350)
-.|-...+|+....+ +..|+++..........+ -.+|..++..+...+ -.++++.+..+ .|++|+++.+
T Consensus 45 ~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~ 119 (344)
T PLN02236 45 KGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHART 119 (344)
T ss_pred CCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCC
Confidence 567788999987632 247888877654332222 257888888885333 34555655332 5899998766
Q ss_pred hhhh-----------------hhCCCCCCCC-CCCHHHHHHHHHHH-----------------HHHHHHH----Hc-cCC
Q 018816 144 LADR-----------------LYGPLQTHLE-PLLLTHRLKVAMET-----------------ANAVAYL----RF-GFP 183 (350)
Q Consensus 144 L~~~-----------------l~~~~~~~~~-~~~~~~~~~i~~~i-----------------~~~l~~L----H~-~~~ 183 (350)
+... ++...-.... ...+.....+..++ ...+..| .. ...
T Consensus 120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~ 199 (344)
T PLN02236 120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE 199 (344)
T ss_pred CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence 6421 1111000000 11122222332111 1112122 11 224
Q ss_pred CCeEeeccccCceEeCC-CCceeEcccCCCcc
Q 018816 184 QPVVFRNIEPWNILFQE-EYAAKLFDFSLSKS 214 (350)
Q Consensus 184 ~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~ 214 (350)
..++|+|+++.||++++ ++.+.++||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 57999999999999986 46899999987754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0038 Score=57.10 Aligned_cols=77 Identities=9% Similarity=0.024 Sum_probs=50.9
Q ss_pred cCCCceEEEEEEECCC-ceEEEEEeccc-------chhhHHHHHHHHHHHHhcC--CC-CccceeeeeecCCcCeEEeec
Q 018816 70 DEIEGYILYMGFLRDR-GPILVMKYRKS-------VRYASERCFNNIVFASQMN--HK-SILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~-~~vaik~~~~~-------~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~e~ 138 (350)
|.|....||++...++ +.|+||.-.+. .+...++..-|...|.... -| .+++++.+ +.....+|||+
T Consensus 4 gdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vMEd 81 (370)
T TIGR01767 4 GDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVMED 81 (370)
T ss_pred CCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehHhh
Confidence 9999999999998654 58999985432 2334456667878877663 24 45555554 55566799999
Q ss_pred CCCC-chhhhh
Q 018816 139 AGYC-TLADRL 148 (350)
Q Consensus 139 ~~~~-sL~~~l 148 (350)
++.. .|...+
T Consensus 82 L~~~~ilR~~L 92 (370)
T TIGR01767 82 LSHHKIARKGL 92 (370)
T ss_pred CccchHHHHHH
Confidence 8543 343433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.002 Score=54.34 Aligned_cols=151 Identities=17% Similarity=0.116 Sum_probs=90.7
Q ss_pred CCceEEEEEEECCCceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCchhhhhhC
Q 018816 72 IEGYILYMGFLRDRGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYG 150 (350)
Q Consensus 72 G~~g~V~~~~~~~~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 150 (350)
++.++.-.+..+-| +..+|++....-. ...-|.++..+++++. .|+++..= +.-..-++.|.|-..
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-------- 139 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc--------
Confidence 34445555555444 7788887665433 4455778888888774 45665521 233456788877321
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccC
Q 018816 151 PLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230 (350)
Q Consensus 151 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt 230 (350)
.....-.+..+ +.+|.-.|+. +.+.+|+|..|+||+-|+.|.+||.|=+.--. .+
T Consensus 140 ---------~i~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~ 194 (308)
T PF07387_consen 140 ---------KINFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQ 194 (308)
T ss_pred ---------ccchhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------he
Confidence 11111112222 3567778865 67899999999999999999999999663210 11
Q ss_pred CCCCCccccccCCCCccchhHHHHHHHHHHHhC
Q 018816 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263 (350)
Q Consensus 231 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 263 (350)
.-|.--| ....|+++.+-+|-.-++++...
T Consensus 195 V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 195 VNMVNIE---YESLTQEAEVKVFVKSCLKLVEK 224 (308)
T ss_pred eeEEeee---ccccChHHHHHHHHHHHHHHHHH
Confidence 1122211 12346677777777666766653
|
The function of this family is unknown. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.01 Score=53.47 Aligned_cols=129 Identities=14% Similarity=0.035 Sum_probs=78.1
Q ss_pred EEEEEEECCCceEEEEEecc--cchhhHHHHHHHHHHHHhcC--CCCccceeeeeecCC--cCeEEeecCCCCchhhhhh
Q 018816 76 ILYMGFLRDRGPILVMKYRK--SVRYASERCFNNIVFASQMN--HKSILKLIGCCLEAE--MPALVYEPAGYCTLADRLY 149 (350)
Q Consensus 76 ~V~~~~~~~~~~vaik~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~ 149 (350)
.+|..... +..+++. ... ..........+|..+++.+. -.-+...+++|.++. ..+.||+|++|..+.+.+.
T Consensus 40 ~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 44444334 4466666 221 12234456678888888774 344566677777766 7899999998854433221
Q ss_pred CCCCCCCCCCCHHHHHHHH-HHHHHHHHHHH-------------------------------------------------
Q 018816 150 GPLQTHLEPLLLTHRLKVA-METANAVAYLR------------------------------------------------- 179 (350)
Q Consensus 150 ~~~~~~~~~~~~~~~~~i~-~~i~~~l~~LH------------------------------------------------- 179 (350)
.. +.. .+++ ..++..|.-||
T Consensus 118 ~~--------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 118 PE--------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cc--------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 10 000 1111 23333333333
Q ss_pred -cc-----CCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 180 -FG-----FPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 180 -~~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
.. ....++|+|+.+.|++++...-+=|+||+.+..-.
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 11 13469999999999999999889999999987643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0096 Score=55.47 Aligned_cols=78 Identities=9% Similarity=0.046 Sum_probs=52.5
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEecccc-------hhhHHHHHHHHHHHHhcC---CCCccceeeeeecCCcCeEEe
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKSV-------RYASERCFNNIVFASQMN---HKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 136 (350)
.+ |.|....||+....+ +.++||.-.... +-...+...|...|..+. ..++.+++.++.+ ..+++|
T Consensus 39 ei-ggGn~N~VyrV~~~~-~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 39 EV-GDGNLNFVYIVVSSS-GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred Ec-CCCceeeEEEEEcCC-ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 45 999999999988754 479999865221 113444555677776553 3578888888774 457899
Q ss_pred ecCCC--Cchhhhh
Q 018816 137 EPAGY--CTLADRL 148 (350)
Q Consensus 137 e~~~~--~sL~~~l 148 (350)
|++++ ..+.+-+
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99976 3444433
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0087 Score=54.40 Aligned_cols=137 Identities=15% Similarity=0.110 Sum_probs=91.0
Q ss_pred cCCCceEEEEEEECCCceEEEEEecccch----------------------hhH----HHHHHHHHHHHhcCCCCcccee
Q 018816 70 DEIEGYILYMGFLRDRGPILVMKYRKSVR----------------------YAS----ERCFNNIVFASQMNHKSILKLI 123 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~~~vaik~~~~~~~----------------------~~~----~~~~~E~~~l~~l~h~niv~~~ 123 (350)
..|--+.||.+.-.+|..+|||.+..+-- ..+ --...|+.-|.+|....|...-
T Consensus 153 STGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~Pe 232 (520)
T KOG2270|consen 153 STGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPE 232 (520)
T ss_pred ccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence 88888999999998888999998764310 001 1134677778887655542211
Q ss_pred eeeecCCcCeEEeecCCCCchhh-hhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC
Q 018816 124 GCCLEAEMPALVYEPAGYCTLAD-RLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY 202 (350)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 202 (350)
-... ....|||+|+....-.. .|.+ ..++...+..+-.+++.-+.-|.. .-++||.||+--|+|+ .+|
T Consensus 233 PIlL--k~hVLVM~FlGrdgw~aPkLKd------~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 233 PILL--KNHVLVMEFLGRDGWAAPKLKD------ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY-HDG 301 (520)
T ss_pred ceee--ecceEeeeeccCCCCcCccccc------ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE-ECC
Confidence 1111 13369999995322111 1111 356677777788888888877775 3479999999999998 567
Q ss_pred ceeEcccCCCccCCC
Q 018816 203 AAKLFDFSLSKSIPE 217 (350)
Q Consensus 203 ~~kl~Dfg~~~~~~~ 217 (350)
.+.++|.+.+.....
T Consensus 302 ~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 302 KLYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEEccccccCCC
Confidence 899999988765543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0099 Score=53.78 Aligned_cols=30 Identities=17% Similarity=0.293 Sum_probs=26.0
Q ss_pred CCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 183 PQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 183 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 468999999999999988 668999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0044 Score=57.39 Aligned_cols=72 Identities=8% Similarity=-0.016 Sum_probs=50.3
Q ss_pred ccccCCCceEEEEEEEC-CCceEEEEEeccc------chhhHHHHHHHHHHHHhcC--CC-CccceeeeeecCCcCeEEe
Q 018816 67 ITIDEIEGYILYMGFLR-DRGPILVMKYRKS------VRYASERCFNNIVFASQMN--HK-SILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~-~~~~vaik~~~~~------~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~ 136 (350)
.| |.|.-.-||++.+. +++.|+||.-.+. .+...++..-|...|+.+. -| .+++++.+ +.....+||
T Consensus 36 ei-gdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 36 EI-GDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred Ec-CCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 45 99999999999984 3558999985332 2344567777888887663 24 45666655 555667899
Q ss_pred ecCCC
Q 018816 137 EPAGY 141 (350)
Q Consensus 137 e~~~~ 141 (350)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 98854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.01 Score=54.35 Aligned_cols=141 Identities=13% Similarity=0.084 Sum_probs=76.9
Q ss_pred cCCCceEEEEEEECC----CceEEEEEecccchhhHHHHHHHHHHHHhcCCCCc-cceeeeeecCCcCeEEeecCCCCch
Q 018816 70 DEIEGYILYMGFLRD----RGPILVMKYRKSVRYASERCFNNIVFASQMNHKSI-LKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 70 g~G~~g~V~~~~~~~----~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
..|-...+|+....+ +..|+++........ .-.-.+|..+++.+..-++ .++++++..+ +|.+|+++.+|
T Consensus 23 ~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~l 97 (330)
T PLN02421 23 SGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINARTL 97 (330)
T ss_pred CCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCCC
Confidence 557777899887633 237888877654322 1223478888888864443 4556555322 58899877655
Q ss_pred hhh-----------------hhCCCCCCCCCC-CHHHHHHHHHHH----------------------HHHHHHHHc----
Q 018816 145 ADR-----------------LYGPLQTHLEPL-LLTHRLKVAMET----------------------ANAVAYLRF---- 180 (350)
Q Consensus 145 ~~~-----------------l~~~~~~~~~~~-~~~~~~~i~~~i----------------------~~~l~~LH~---- 180 (350)
..- ++...-...... .+....++..++ ..-+..+..
T Consensus 98 ~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~ 177 (330)
T PLN02421 98 TPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITDS 177 (330)
T ss_pred ChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhcc
Confidence 321 111100000001 122222222221 111111111
Q ss_pred -cCCCCeEeeccccCceEeCC-CCceeEcccCCCccC
Q 018816 181 -GFPQPVVFRNIEPWNILFQE-EYAAKLFDFSLSKSI 215 (350)
Q Consensus 181 -~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~ 215 (350)
....-++|+|+.+.|||++. ++.++++||..|...
T Consensus 178 ~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 178 LKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred CCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11234899999999999974 578999999987543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.016 Score=52.54 Aligned_cols=32 Identities=13% Similarity=0.221 Sum_probs=28.6
Q ss_pred CCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 183 PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 183 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
..++||+|+.+.|+|++.++.+-++||..++.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45899999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.024 Score=50.57 Aligned_cols=72 Identities=11% Similarity=-0.081 Sum_probs=46.1
Q ss_pred cccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC---CCCccceeeeeecCCcCeEEeecCCCC
Q 018816 66 NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN---HKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
..+ +.|....+|+.. .+++.+.+|.-.. .....|..|..-|+.|. .-.+.+++++....+..+|||||++.+
T Consensus 23 ~~v-~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPV-SGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE---SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred Eec-CCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 345 889999999987 5555899998763 23455778888888773 455778888887777789999998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.015 Score=49.53 Aligned_cols=31 Identities=26% Similarity=0.411 Sum_probs=22.1
Q ss_pred CCeEeeccccCceEe-CCCCceeEcccCCCcc
Q 018816 184 QPVVFRNIEPWNILF-QEEYAAKLFDFSLSKS 214 (350)
Q Consensus 184 ~~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~ 214 (350)
..++|+|+.|.|||+ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 568999999999999 8899999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.0082 Score=55.25 Aligned_cols=61 Identities=18% Similarity=0.026 Sum_probs=44.0
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE 200 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 200 (350)
..++-+|.+|.++..++... ..++.-..+++.-.++|+.-+-- -.+++|.|+.|.||++--
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~------~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK------SQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcc------cChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence 34666788888998888542 34445666777777777655442 568999999999999953
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.32 Score=44.39 Aligned_cols=97 Identities=11% Similarity=0.185 Sum_probs=56.6
Q ss_pred CCcccccHHHHHHHhcCcccc---c-ccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCC--C
Q 018816 45 NPIRSFSSEDLKTAINNYSMR---N-ITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHK--S 118 (350)
Q Consensus 45 ~~~~~~~~~~l~~~~~~f~~~---~-~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~--n 118 (350)
.+...++.+.+..+...+... . .. -.+.-..||+....++..+++|...... .....+..|+..+..|... .
T Consensus 6 ~~~~~l~p~~~~~a~~~~g~~~~~~~~~-l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gip 83 (325)
T PRK11768 6 FPFQTLTPDLILDALESLGLRVDGRLLA-LNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIP 83 (325)
T ss_pred CCCCCCChHHHHHHHHHcCCCCccceEe-eccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCC
Confidence 345567777777666555321 1 11 2334568999988777688888875432 2345666788777776321 1
Q ss_pred cccee---e--eeecCCcCeEEeecCCCCc
Q 018816 119 ILKLI---G--CCLEAEMPALVYEPAGYCT 143 (350)
Q Consensus 119 iv~~~---~--~~~~~~~~~lv~e~~~~~s 143 (350)
++... | ....++..+.++++++|..
T Consensus 84 v~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 84 VVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 22221 1 1122345678889887754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.011 Score=56.01 Aligned_cols=50 Identities=16% Similarity=0.186 Sum_probs=38.4
Q ss_pred HHHHHHHHHHHHhcCCCCccceeeeeecC-CcCeEEeecCCCCchhhhhhCC
Q 018816 101 SERCFNNIVFASQMNHKSILKLIGCCLEA-EMPALVYEPAGYCTLADRLYGP 151 (350)
Q Consensus 101 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~ 151 (350)
...+..-...++.++|+|...++++-... ....+|+|++ +.||++.+...
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence 34566677888999999999998876543 3578899999 67999987543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.075 Score=48.41 Aligned_cols=139 Identities=16% Similarity=0.160 Sum_probs=80.2
Q ss_pred CceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCC------ccceeee----eecCCcCeEEeecCCCC
Q 018816 73 EGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKS------ILKLIGC----CLEAEMPALVYEPAGYC 142 (350)
Q Consensus 73 ~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~----~~~~~~~~lv~e~~~~~ 142 (350)
.-..+|+....++ .+++|..... ....++..|+..+..|.-.. +...=|- ...+...+-+++|++|.
T Consensus 37 ~eN~~f~~~~~~g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDG-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCC-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 4558899999887 4577777665 34566777888888773211 2222121 11123667889999988
Q ss_pred chhh-h--------------hhCCCCCC-------CCCCCHH----H---------HHHHHHHHHHHHHHHHcc-----C
Q 018816 143 TLAD-R--------------LYGPLQTH-------LEPLLLT----H---------RLKVAMETANAVAYLRFG-----F 182 (350)
Q Consensus 143 sL~~-~--------------l~~~~~~~-------~~~~~~~----~---------~~~i~~~i~~~l~~LH~~-----~ 182 (350)
.+.. . ++...... .....|. . ......++...+..+... .
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 7773 1 11000000 0112222 0 111233444444444421 1
Q ss_pred CCC--eEeeccccCceEeCCCCc-eeEcccCCCcc
Q 018816 183 PQP--VVFRNIEPWNILFQEEYA-AKLFDFSLSKS 214 (350)
Q Consensus 183 ~~~--ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~ 214 (350)
..+ +||+|+.|.||+++.+.. +.++||+.+..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 233 999999999999998874 89999997753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.079 Score=49.41 Aligned_cols=71 Identities=14% Similarity=-0.011 Sum_probs=42.3
Q ss_pred cCCCceEEEEEEECCC--ce-----EEEEEecccchhhHHHHHHHHHHHHhcCCCC-ccceeeeeecCCcCeEEeecCCC
Q 018816 70 DEIEGYILYMGFLRDR--GP-----ILVMKYRKSVRYASERCFNNIVFASQMNHKS-ILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~--~~-----vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
..|-...+|++...++ .. |++...-...... -+-.+|+.+++.+...+ -.++++.+.. .+|.||++|
T Consensus 59 ~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeG 133 (383)
T PTZ00384 59 NNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEG 133 (383)
T ss_pred CCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEecc
Confidence 5677889999986432 12 3333322211111 12246888999986444 4556665543 599999998
Q ss_pred Cchh
Q 018816 142 CTLA 145 (350)
Q Consensus 142 ~sL~ 145 (350)
-+|.
T Consensus 134 r~l~ 137 (383)
T PTZ00384 134 NTMG 137 (383)
T ss_pred ccCC
Confidence 7764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.016 Score=52.59 Aligned_cols=56 Identities=25% Similarity=0.221 Sum_probs=48.1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 157 EPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 157 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
..-.+.+...++.+.+..+.-+.. ...+-|||+.-.||||+ +|++.|+||-+++.-
T Consensus 316 k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 316 KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 345688899999998888888874 56889999999999999 999999999999843
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.16 Score=53.56 Aligned_cols=162 Identities=14% Similarity=0.129 Sum_probs=84.4
Q ss_pred ccccHHHHHHH-hcCcccc---cccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC-------C
Q 018816 48 RSFSSEDLKTA-INNYSMR---NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN-------H 116 (350)
Q Consensus 48 ~~~~~~~l~~~-~~~f~~~---~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-------h 116 (350)
..++.+++... .+.|... ..| ++ ..-.+|+....++..+++|..+... .......|...|..|. -
T Consensus 9 p~~s~~~~~~~~~~~ygl~~~~~~L-~s-~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpv 84 (1013)
T PRK06148 9 PEFTTKDAEALLAQHFGISATATPL-DG-ERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPV 84 (1013)
T ss_pred CCCCHHHHHHHHHHHcCCceEEeec-CC-cCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCc
Confidence 34555555332 2334322 234 43 4577899888777789999987653 2333444556665552 2
Q ss_pred CCcccee-e----eeec-CC--cCeEEeecCCCCchhhhh-----------------hCCCCC--C---CCCCCHH----
Q 018816 117 KSILKLI-G----CCLE-AE--MPALVYEPAGYCTLADRL-----------------YGPLQT--H---LEPLLLT---- 162 (350)
Q Consensus 117 ~niv~~~-~----~~~~-~~--~~~lv~e~~~~~sL~~~l-----------------~~~~~~--~---~~~~~~~---- 162 (350)
|.++.-. | .... ++ ..+-+++|++|..+.+.. +..... + ...+.|.
T Consensus 85 P~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~ 164 (1013)
T PRK06148 85 PRLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHA 164 (1013)
T ss_pred CeeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccc
Confidence 2323221 1 1111 12 356789999987765411 000000 0 0111121
Q ss_pred -------------HHHHHHHHHHHHHH-----HHHccCCCCeEeeccccCceEeCCCC--ce-eEcccCCCcc
Q 018816 163 -------------HRLKVAMETANAVA-----YLRFGFPQPVVFRNIEPWNILFQEEY--AA-KLFDFSLSKS 214 (350)
Q Consensus 163 -------------~~~~i~~~i~~~l~-----~LH~~~~~~ivH~dlkp~Nill~~~~--~~-kl~Dfg~~~~ 214 (350)
....++.++..... .+.. ...++||+|+.+.|||++.++ .+ -|+|||.+..
T Consensus 165 ~~l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 165 GRARDRLHFIDDPEDRALVERFLARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred hhhhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 11222223332221 1221 246799999999999999875 45 4999998764
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.15 Score=44.51 Aligned_cols=72 Identities=14% Similarity=0.016 Sum_probs=52.1
Q ss_pred cCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHH---HHHHhcCCCCccceeeeeecCCcCeEEeecC-CCCchh
Q 018816 70 DEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNI---VFASQMNHKSILKLIGCCLEAEMPALVYEPA-GYCTLA 145 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~~sL~ 145 (350)
..|..+.|+.++..+|.+.++|...+... ...|. ..|+..+-...|++++.- .....+++|.+ ++.+|.
T Consensus 11 ~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 11 AHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCCchh
Confidence 67889999999998888999998875432 12233 457777777888999874 34557888988 555776
Q ss_pred hhh
Q 018816 146 DRL 148 (350)
Q Consensus 146 ~~l 148 (350)
+..
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 350 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-26 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-25 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-21 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-06 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-05 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-05 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-05 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-04 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 6e-51
Identities = 89/303 (29%), Positives = 134/303 (44%), Gaps = 27/303 (8%)
Query: 48 RSFSSEDLKTAINNYSMRNITIDEIEGY-ILYMGFLRDRGPILVMKYRKSVRYASERCFN 106
DL+ A NN+ + + I + +Y G LRD + + K R F
Sbjct: 27 YRVPLVDLEEATNNFDHKFL-IGH-GVFGKVYKGVLRDGAKVAL-KRRTPESSQGIEEFE 83
Query: 107 N-IVFASQMNHKSILKLIGCCLEAEMPALVYE--PAGYCTLADRLYGPLQTHLEPLLLTH 163
I S H ++ LIG C E L+Y+ G L LYG +
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG--NLKRHLYGS-DLPTMSMSWEQ 140
Query: 164 RLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG-KTHI 222
RL++ + A + YL ++ R+++ NIL E + K+ DF +SK E +TH+
Sbjct: 141 RLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 223 KASTAI-GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT-IGHLSRLATGGSNFF 280
ST + G+L + PEY G EK+DVYSFG +L +L R+ I L N
Sbjct: 198 --STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ--SLPREMVN-- 251
Query: 281 ITDRVEKFIRSNGYMNI-DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVA 339
+ + + + I DP + R E L+ + + A KCL+ S+EDRP+M DV
Sbjct: 252 LAEWAVESHNNGQLEQIVDPNLADK---IRPES-LRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 340 KKL 342
KL
Sbjct: 308 WKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-51
Identities = 90/302 (29%), Positives = 156/302 (51%), Gaps = 18/302 (5%)
Query: 47 IRSFSSEDLKTAINNYSMRNITIDEIEGY-ILYMGFLRDRGPILVMKYRKSVRYASERCF 105
++ FS +L+ A +N+S +NI + G+ +Y G L D + V + ++ E F
Sbjct: 17 LKRFSLRELQVASDNFSNKNI-LGR-GGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 106 NNIVFA-SQMNHKSILKLIGCCLEAEMPALVYE--PAGYCTLADRLYGPLQTHLEPLLLT 162
V S H+++L+L G C+ LVY G ++A L ++ PL
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG--SVASCLRERPESQP-PLDWP 131
Query: 163 HRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222
R ++A+ +A +AYL ++ R+++ NIL EE+ A + DF L+K + TH+
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191
Query: 223 KASTAI-GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFI 281
+TA+ G++ APEYL+TG +EKTDV+ +G +LL L+TG+ L+RLA + +
Sbjct: 192 --TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA-NDDDVML 248
Query: 282 TDRVEKFIRSNGYMNI-DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340
D V+ ++ + D + G+ ++ EE Q +++A C S +RP M +V +
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGN---YKDEEVEQL-IQVALLCTQSSPMERPKMSEVVR 304
Query: 341 KL 342
L
Sbjct: 305 ML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-43
Identities = 80/322 (24%), Positives = 136/322 (42%), Gaps = 42/322 (13%)
Query: 39 SFDGKRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYIL--------YMGFLRDRGPILV 90
S + SFS +LK NN+ R I++ G + Y G++ + + V
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISV---GGNKMGEGGFGVVYKGYVNNT-TVAV 59
Query: 91 MKYRKSVRYAS---ERCFNN-IVFASQMNHKSILKLIGCCLEAEMPALVYE--PAGYCTL 144
K V + ++ F+ I ++ H+++++L+G + + LVY P G +L
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG--SL 117
Query: 145 ADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA 204
DRL T PL R K+A AN + +L + R+I+ NIL E + A
Sbjct: 118 LDRLSCLDGT--PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTA 172
Query: 205 KLFDFSLSKSIPEG-KTHIKASTAI-GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
K+ DF L+++ + +T + ++ I G+ + APE L G K+D+YSFG +LL ++T
Sbjct: 173 KISDFGLARASEKFAQTVM--TSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIIT 229
Query: 263 GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN--IDPVIVGDRSCFRKEEKLQAYVEL 320
G R + D E+ + ID + +
Sbjct: 230 GLPAVDEHR-----EPQLLLDIKEEIEDEEKTIEDYIDKKMND----ADSTSVEAM-YSV 279
Query: 321 AFKCLSHSAEDRPTMIDVAKKL 342
A +CL RP + V + L
Sbjct: 280 ASQCLHEKKNKRPDIKKVQQLL 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 54/272 (19%), Positives = 94/272 (34%), Gaps = 32/272 (11%)
Query: 99 YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA----LVYEPAGYCTLADRLYGPLQT 154
S + + M H++IL+ IG L+ + G L
Sbjct: 60 KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA---FHEK-----GSLSD 111
Query: 155 HL--EPLLLTHRLKVAMETANAVAYL-------RFGFPQPVVFRNIEPWNILFQEEYAAK 205
L + +A A +AYL + G + R+I+ N+L + A
Sbjct: 112 FLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171
Query: 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY-----YNEKTDVYSFGKLLLVL 260
+ DF L+ GK+ +G+ + APE L + D+Y+ G +L L
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231
Query: 261 LTGRTI--GHLSRLATGGSNFFITDR-VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAY 317
+ T G + +E + PV+ R ++K +
Sbjct: 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVL---RDYWQKHAGMAML 288
Query: 318 VELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349
E +C H AE R + V +++ QM R +
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERITQMQRLT 320
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 32/239 (13%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
S++NH +I+KL G CL LV E A +L + L+G L H + ++
Sbjct: 56 SRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQC 111
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLSKSIPEGKTHIKASTAIGS 230
+ VAYL P+ ++ R+++P N+L K+ DF + I T GS
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGS 166
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT-IGHLSRLATGGSNFFITDRVEKFI 289
+ APE Y+EK DV+S+G +L ++T R + A F I V
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FRIMWAVHNGT 221
Query: 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348
R P + ++ + L +C S RP+M ++ K + + R
Sbjct: 222 R--------PPL--IKNL------PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-23
Identities = 59/240 (24%), Positives = 103/240 (42%), Gaps = 28/240 (11%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
++ H +I+ +G + ++V E +L L+ E L RL +A +
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDV 146
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
A + YL P+V RN++ N+L ++Y K+ DF LS+ + T + + +A G+
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTP 203
Query: 232 EFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT-IGHLSRLATGGSNFFITDRVEKFIR 290
E+ APE L NEK+DVYSFG +L L T + G+L+ + V
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-------VVAAV----- 251
Query: 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTSV 350
G+ I R+ + C ++ RP+ + LR + +++V
Sbjct: 252 --GFKCKRLEI--PRNL------NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 7e-23
Identities = 47/289 (16%), Positives = 87/289 (30%), Gaps = 46/289 (15%)
Query: 95 KSVRYASERCFNN---IVFASQMNHKSILKLIGCCLEAEMPA-----LVYEPAGYC---T 143
K +A+ + F N I M H +I + I LV E Y +
Sbjct: 42 KVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME---YYPNGS 98
Query: 144 LADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ------PVVFRNIEPWNIL 197
L L L ++A +AYL P+ + R++ N+L
Sbjct: 99 LXKYL------SLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152
Query: 198 FQEEYAAKLFDFSLSK------SIPEGKTHIKASTAIGSLEFAAPEYL-------TTGYY 244
+ + + DF LS + G+ A + +G++ + APE L
Sbjct: 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212
Query: 245 NEKTDVYSFGKLLLVLLTGRTIGHLSRLATG-----GSNFFITDRVEKFIRSNGYMNIDP 299
++ D+Y+ G + + T + E P
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRP 272
Query: 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348
+ +++ E C AE R T +++ ++
Sbjct: 273 KF--PEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 50/250 (20%), Positives = 93/250 (37%), Gaps = 55/250 (22%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL--EPLLLTHRLKVAM 169
+ + H +I+ L G CL+ LV E + GPL L + + + A+
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVME---FAR-----GGPLNRVLSGKRIPPDILVNWAV 112
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA--------AKLFDFSLSKSIPEGKTH 221
+ A + YL P++ R+++ NIL ++ K+ DF L++
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHR 168
Query: 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFI 281
+A G+ + APE + +++ +DV+S+G LL LLTG
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV---------------- 212
Query: 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRK------EEKLQAYVELAFKCLSHSAEDRPTM 335
+ ID + V K + + +L C + RP+
Sbjct: 213 -----------PFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF 261
Query: 336 IDVAKKLRQM 345
++ +L +
Sbjct: 262 TNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 58/242 (23%), Positives = 93/242 (38%), Gaps = 40/242 (16%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
S +NH +I+KL G P +V E + D LY L P+ + +L++ ++
Sbjct: 78 SNLNHPNIVKLYGLMHNP--PRMVME---FVPCGD-LYHRLLDKAHPIKWSVKLRLMLDI 131
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQE-----EYAAKLFDFSLSKSIPEGKTHIKAST 226
A + Y++ P+V R++ NI Q AK+ DF LS+ +
Sbjct: 132 ALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS-----G 185
Query: 227 AIGSLEFAAPEYLTT--GYYNEKTDVYSFGKLLLVLLTGRT-IGHLSRLATGGSNFFITD 283
+G+ ++ APE + Y EK D YSF +L +LTG S
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--------- 236
Query: 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343
KFI + P I C + C S + RP + K+L
Sbjct: 237 ---KFINMIREEGLRPTI--PEDC------PPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
Query: 344 QM 345
++
Sbjct: 286 EL 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 48/259 (18%), Positives = 90/259 (34%), Gaps = 34/259 (13%)
Query: 112 SQMNHKSILKLIGCCLEAEMP----ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKV 167
M H++IL I ++ L+ + Y LY L++ L LK+
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITD---YHENGS-LYDYLKST--TLDAKSMLKL 139
Query: 168 AMETANAVAYL-----RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH- 221
A + + + +L + R+++ NIL ++ + D L+
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 222 -IKASTAIGSLEFAAPEYLTTGY------YNEKTDVYSFGKLLLVL---LTGRTIGHLSR 271
I +T +G+ + PE L D+YSFG L+L G +
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG---LILWEVARRCVSGGIVE 256
Query: 272 LATGGSNFFITDR--VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSA 329
+ + E + P + + +E L+ +L +C +H+
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF---PNRWSSDECLRQMGKLMTECWAHNP 313
Query: 330 EDRPTMIDVAKKLRQMYRT 348
R T + V K L +M +
Sbjct: 314 ASRLTALRVKKTLAKMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-20
Identities = 48/262 (18%), Positives = 96/262 (36%), Gaps = 40/262 (15%)
Query: 112 SQMNHKSILKLIGCCLEAEMPA----LVYEPAGYCTLADRLYGPLQTHL--EPLLLTHRL 165
+ H++IL I + LV + Y G L +L + + +
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSD---YHEH-----GSLFDYLNRYTVTVEGMI 142
Query: 166 KVAMETANAVAYLRFGFPQ-----PVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220
K+A+ TA+ +A+L + R+++ NIL ++ + D L+
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 221 H--IKASTAIGSLEFAAPEYL------TTGYYNEKTDVYSFGKLLLVL---LTGRTIGHL 269
I + +G+ + APE L ++ D+Y+ G LV +IG +
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG---LVFWEIARRCSIGGI 259
Query: 270 S---RLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLS 326
+L VE+ + + P I + ++ E L+ ++ +C
Sbjct: 260 HEDYQLPYYDLVPSDPS-VEEMRKVVCEQKLRPNI---PNRWQSCEALRVMAKIMRECWY 315
Query: 327 HSAEDRPTMIDVAKKLRQMYRT 348
+ R T + + K L Q+ +
Sbjct: 316 ANGAARLTALRIKKTLSQLSQQ 337
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 56/286 (19%), Positives = 106/286 (37%), Gaps = 44/286 (15%)
Query: 77 LYMGFLRDRGPILVMKYRKSVRYASERCFNN-IVFASQMNHKSILKLIGCCLEAEMPALV 135
R+ G ++VMK ++R F + + H ++LK IG + + +
Sbjct: 26 AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85
Query: 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWN 195
E Y L G +++ + R+ A + A+ +AYL ++ R++ N
Sbjct: 86 TE---YIKGGT-LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHN 138
Query: 196 ILFQEEYAAKLFDFSLSKSIPEG------------KTHIKASTAIGSLEFAAPEYLTTGY 243
L +E + DF L++ + + K T +G+ + APE +
Sbjct: 139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS 198
Query: 244 YNEKTDVYSFGKLLLVLLTGRTI--GHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301
Y+EK DV+SFG +L ++ +L R G N V F+
Sbjct: 199 YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN------VRGFLD--------RYC 244
Query: 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347
+ C ++ + +C E RP+ + + L +
Sbjct: 245 PPN--C------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 48/240 (20%), Positives = 99/240 (41%), Gaps = 30/240 (12%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
+ H +IL +G ++ A+V + +C + LY L + + +A +T
Sbjct: 75 RKTRHVNILLFMGYSTAPQL-AIVTQ---WCEGSS-LYHHLHASETKFEMKKLIDIARQT 129
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
A + YL + ++ R+++ NI E+ K+ DF L+ + GS+
Sbjct: 130 ARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 232 EFAAPE---YLTTGYYNEKTDVYSFGKLLLVLLTGRT-IGHLSRLATGGSNFFITDRVEK 287
+ APE + Y+ ++DVY+FG +L L+TG+ +++ I + V +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGR 240
Query: 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347
S + +C + L +CL ++RP+ + ++ ++ R
Sbjct: 241 GSLSPDLSKVRS------NC------PKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 42/259 (16%), Positives = 89/259 (34%), Gaps = 40/259 (15%)
Query: 112 SQMNHKSILKLIGCCLEAEMPA----LV--YEPAGYCTLADRLYGPLQTHLEPLLLTHRL 165
+ H++IL I + + + L+ Y G +L D L L L L
Sbjct: 57 VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMG--SLYDYL------QLTTLDTVSCL 108
Query: 166 KVAMETANAVAYLRFGFPQ-----PVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220
++ + A+ +A+L + R+++ NIL ++ + D L+ +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 221 HIKAS--TAIGSLEFAAPE------YLTTGYYNEKTDVYSFGKLLLVL---LTGRTIGHL 269
+ +G+ + APE + ++ D+++FG LVL +
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG---LVLWEVARRMVSNGI 225
Query: 270 S---RLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLS 326
+ E + P I + + + L + +L +C
Sbjct: 226 VEDYKPPFYDVVPNDPS-FEDMRKVVCVDQQRPNI---PNRWFSDPTLTSLAKLMKECWY 281
Query: 327 HSAEDRPTMIDVAKKLRQM 345
+ R T + + K L ++
Sbjct: 282 QNPSARLTALRIKKTLTKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 37/247 (14%), Positives = 85/247 (34%), Gaps = 43/247 (17%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
Q H++++ +G C+ A++ C LY ++ L + ++A E
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITS---LCKGRT-LYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK---SIPEGKTHIKASTAI 228
+ YL + ++ ++++ N+ + + + DF L + G+ K
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 229 GSLEFAAPEYLTTGY---------YNEKTDVYSFGKLLLVLLTGRT-IGHLSRLATGGSN 278
G L APE + +++ +DV++ G + L A
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----- 250
Query: 279 FFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
I ++ ++ P + + ++ C + E+RPT +
Sbjct: 251 --IIWQMGTGMK--------PNLS-QIGM------GKEISDILLFCWAFEQEERPTFTKL 293
Query: 339 AKKLRQM 345
L ++
Sbjct: 294 MDMLEKL 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 41/242 (16%), Positives = 79/242 (32%), Gaps = 43/242 (17%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALV----YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKV 167
+H ++L ++G C P + P G +L + L+ ++ + +K
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG--SLYNVLHEGTNFVVDQ---SQAVKF 116
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
A++ A +A+L + + +++ E+ A++ + S
Sbjct: 117 ALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGR 168
Query: 228 IGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRT-IGHLSRLATGGSNFFITD 283
+ + + APE L D++SF LL L+T LS + G
Sbjct: 169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228
Query: 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343
R I I P +L C++ RP + L
Sbjct: 229 RPT--IPP----GISP----------------HVSKLMKICMNEDPAKRPKFDMIVPILE 266
Query: 344 QM 345
+M
Sbjct: 267 KM 268
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 24/163 (14%), Positives = 47/163 (28%), Gaps = 14/163 (8%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
+K L LV E Y TL + + T + + + AM
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA-----------KLFDFSLSKSIPEGKTH 221
+ + ++ +I+P N + + L D S +
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ + F E L+ +N + D + + +L G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 51/247 (20%), Positives = 94/247 (38%), Gaps = 52/247 (21%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
Q +H +I++LIG C + + +V E D L+T L + L++ + A
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVME---LVQGGD-FLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
+ YL + + R++ N L E+ K+ DF +S+ +G ++
Sbjct: 224 AGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 233 FAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------SNFFITDRV 285
+ APE L G Y+ ++DV+SFG +LL + G SN + V
Sbjct: 281 WTAPEALNYGRYSSESDVWSFG----ILLW--------ETFSLGASPYPNLSNQQTREFV 328
Query: 286 EKFIRSNGY-----MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340
EK G + L +C ++ RP+ + +
Sbjct: 329 EK-----GGRLPCPELCPDAV----------------FRLMEQCWAYEPGQRPSFSTIYQ 367
Query: 341 KLRQMYR 347
+L+ + +
Sbjct: 368 ELQSIRK 374
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 23/168 (13%), Positives = 52/168 (30%), Gaps = 27/168 (16%)
Query: 114 MNHKSILKLIGCCLEAEMPALVY-EPAGYCTLADRLYGPLQTHL---EPLLLTHRLKVAM 169
K ++++ + + + + P L L +H + L+ RL++ +
Sbjct: 155 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT-FGEVLLSHSSTHKSLVHHARLQLTL 213
Query: 170 ETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
+ +A L +G +V + P +I+ + L F +G +
Sbjct: 214 QVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGARV----VSS 263
Query: 229 GSLEFAAPEYLTT-----------GYYNEKTDVYSFGKLLLVLLTGRT 265
S F PE D ++ G ++ +
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 17/136 (12%), Positives = 37/136 (27%), Gaps = 15/136 (11%)
Query: 134 LVYEPAGYCTLAD--RLYGPLQTHLEPLLLTHRLKVAMETANAVAYL-RFGFPQPVVFRN 190
L+ A L + + + + A L G +V +
Sbjct: 165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG----LVHGH 219
Query: 191 IEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT--TGYYNEKT 248
P N+ + L D S + + + + +A E+L T +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHAL 274
Query: 249 DVYSFGKLLLVLLTGR 264
+ + G + +
Sbjct: 275 NAWQLGLSIYRVWCLF 290
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 40/174 (22%), Positives = 71/174 (40%), Gaps = 21/174 (12%)
Query: 102 ERCFNNIVFASQMNHKSILKLI------GCCLEAEMPALVYEPAGYCTLADRLYGPLQTH 155
ER I ++NH +++ ++P L E YC D L L
Sbjct: 57 ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME---YCEGGD-LRKYLNQF 112
Query: 156 LEPLLLTHR--LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFS 210
L + + ++A+ YL ++ R+++P NI+ Q + K+ D
Sbjct: 113 ENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169
Query: 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+K + +G+ + +G+L++ APE L Y D +SFG L +TG
Sbjct: 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 53/257 (20%), Positives = 99/257 (38%), Gaps = 46/257 (17%)
Query: 95 KSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY----- 149
K V+Y +E+ + ++++H +I+ GC + + L+
Sbjct: 42 KRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEF 101
Query: 150 ---GPLQTHLE---PLLLTHR--LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201
G L+ +E L L++ + V Y+ + ++ R+++P NI +
Sbjct: 102 CDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT 158
Query: 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLL 261
K+ DF L S+ K K + + G+L + +PE +++ Y ++ D+Y+ G L+L
Sbjct: 159 KQVKIGDFGLVTSL---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALG---LILA 212
Query: 262 TGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELA 321
L F T + +R F K+EK L
Sbjct: 213 E---------LLHVCDTAFETSKFFTDLRDGII----S------DIFDKKEK-----TLL 248
Query: 322 FKCLSHSAEDRPTMIDV 338
K LS EDRP ++
Sbjct: 249 QKLLSKKPEDRPNTSEI 265
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 55/244 (22%), Positives = 101/244 (41%), Gaps = 42/244 (17%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL-----EPLLLTHRLKV 167
++ H ++++L+G C ++ E Y G L +L + + L +
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTY--------GNLLDYLRECNRQEVSAVVLLYM 323
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
A + ++A+ YL + + RN+ N L E + K+ DF LS+ + G T+ + A
Sbjct: 324 ATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGA 379
Query: 228 IGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVE 286
+++ APE L ++ K+DV++FG LL + T G G + + +E
Sbjct: 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQVYELLE 433
Query: 287 KFIRSNGY-MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
K Y M P C + EL C + DRP+ ++ + M
Sbjct: 434 K-----DYRMER-P-----EGC------PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
Query: 346 YRTS 349
++ S
Sbjct: 477 FQES 480
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 20/144 (13%), Positives = 39/144 (27%), Gaps = 15/144 (10%)
Query: 131 MPALVYEPAGYCTLADRLYGPLQTHL---EPLLLTHRLKVAMETANAVAYL-RFGFPQPV 186
+ P L L +H + L+ RL++ ++ +A L +G +
Sbjct: 178 LSRFFLYPRMQSNLQTFG-EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----L 232
Query: 187 VFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT-----T 241
V + P +I+ + L F E A L
Sbjct: 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-AVSPIGRGFAPPETTAERMLPFGQHHP 291
Query: 242 GYYNEKTDVYSFGKLLLVLLTGRT 265
D ++ G + +
Sbjct: 292 TLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 58/250 (23%), Positives = 102/250 (40%), Gaps = 49/250 (19%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
+H ++L L+G CL +E LV P Y D L ++ + + ++
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLP--YMKHGD-LRNFIRNETHNPTVKDLIGFGLQV 137
Query: 172 ANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
A + YL +F V R++ N + E++ K+ DF L++ + + + + +
Sbjct: 138 AKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191
Query: 229 GSL--EFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------SNF 279
L ++ A E L T + K+DV+SFG VLL L T G + F
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFG----VLLW--------ELMTRGAPPYPDVNTF 239
Query: 280 FITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVA 339
IT + + G + P C + L Y E+ KC AE RP+ ++
Sbjct: 240 DITVYLLQ-----GRRLLQP-----EYC---PDPL--Y-EVMLKCWHPKAEMRPSFSELV 283
Query: 340 KKLRQMYRTS 349
++ ++ T
Sbjct: 284 SRISAIFSTF 293
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 27/97 (27%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 170 ETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
E A+A+ Y V+ R+I+P N+L + K+ DF S P + T
Sbjct: 122 ELADALHYCHERK----VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR----TMC 173
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265
G+L++ PE + ++EK D++ G L L G
Sbjct: 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 25/98 (25%), Positives = 43/98 (43%), Gaps = 12/98 (12%)
Query: 172 ANAVAYL--RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
N+ +Y+ + R+++P NIL + KL DF S+ + + K + G
Sbjct: 161 LNSFSYIHNEKN----ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK----GSRG 212
Query: 230 SLEFAAPEYLTT--GYYNEKTDVYSFGKLLLVLLTGRT 265
+ EF PE+ + Y K D++S G L V+
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 43/193 (22%), Positives = 76/193 (39%), Gaps = 24/193 (12%)
Query: 86 GPILVMK---YRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL--VYEPAG 140
G ILV K Y + + + ++ H +I++ ++ L V E
Sbjct: 31 GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME--- 87
Query: 141 YCTLADRLYGPLQTHLEPLLLTHR-------LKVAMETANAVAYL--RFGFPQPVVFRNI 191
YC D L + + + L+V + A+ R V+ R++
Sbjct: 88 YCEGGD-----LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 192 EPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVY 251
+P N+ + KL DF L++ + A T +G+ + +PE + YNEK+D++
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIW 200
Query: 252 SFGKLLLVLLTGR 264
S G LL L
Sbjct: 201 SLGCLLYELCALM 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 36/171 (21%), Positives = 62/171 (36%), Gaps = 32/171 (18%)
Query: 113 QMNHKSILKLIGC--CLEAEMPALVYEPAGYCT---LADRLYGPLQTHLEPLLLTHR--L 165
++NHK+I+KL L+ E +C L L + L L
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIME---FCPCGSLYTVL----EEPSNAYGLPESEFL 115
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ----EEYAAKLFDFSLSKSIPEGKTH 221
V + + +LR +V RNI+P NI+ + KL DF ++ + + +
Sbjct: 116 IVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-- 170
Query: 222 IKASTAIGSLEFAAPEYLTTG--------YYNEKTDVYSFGKLLLVLLTGR 264
+ + G+ E+ P+ Y D++S G TG
Sbjct: 171 -QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 4e-11
Identities = 47/252 (18%), Positives = 90/252 (35%), Gaps = 59/252 (23%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
+++ + +L+G CL L+ + + L D Y ++ H + + + L ++ A
Sbjct: 73 SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD--Y--VREHKDNIGSQYLLNWCVQIA 127
Query: 173 NAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ YL R V R++ N+L + K+ DF L+K + + A
Sbjct: 128 KGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------SNFFIT 282
+++ A E + Y ++DV+S+G V + L T G I+
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYG----VTVW--------ELMTFGSKPYDGIPASEIS 229
Query: 283 DRVEKFIRSNGY-----MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMID 337
+EK G + Y + KC A+ RP +
Sbjct: 230 SILEK-----GERLPQPPICTIDV---------------Y-MIMRKCWMIDADSRPKFRE 268
Query: 338 VAKKLRQMYRTS 349
+ + +M R
Sbjct: 269 LIIEFSKMARDP 280
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 64/274 (23%), Positives = 110/274 (40%), Gaps = 34/274 (12%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137
+MG + + K K + E ++ H+ +++L E + +V E
Sbjct: 284 WMGTWNGTTRVAI-KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 341
Query: 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
+L D L G +L L + +A + A+ +AY+ V R++ NIL
Sbjct: 342 YMSKGSLLDFLKGETGKYLRLPQL---VDMAAQIASGMAYVE---RMNYVHRDLRAANIL 395
Query: 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
E K+ DF L++ I + + + +++ APE G + K+DV+SFG LL
Sbjct: 396 VGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILL 454
Query: 258 LVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGY-MNIDPVIVGDRSCFRKEEKLQ 315
L T GR G N + D+VE+ GY M P C +
Sbjct: 455 TELTTKGR------VPYPGMVNREVLDQVER-----GYRMPC-P-----PEC------PE 491
Query: 316 AYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349
+ +L +C E+RPT + L + ++
Sbjct: 492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 55/255 (21%), Positives = 91/255 (35%), Gaps = 47/255 (18%)
Query: 112 SQMNHKSILKLIGCCLEAEMPA--LVYEPAGYCTLADRLYGPLQTHL--EPLLLTHRLKV 167
+ H+ I+K GCC +A + LV E Y G L+ +L + L L
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVME---YVP-----LGSLRDYLPRHSIGLAQLLLF 139
Query: 168 AMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224
A + +AYL + + R++ N+L + K+ DF L+K++PEG + +
Sbjct: 140 AQQICEGMAYLHAQHY------IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 193
Query: 225 STAIGSLEFA--APEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282
G APE L + +DV+SFG V L L T +
Sbjct: 194 RED-GDSPVFWYAPECLKEYKFYYASDVWSFG----VTLY--------ELLTHCDSSQSP 240
Query: 283 DRVEKFIRSNGY--MNIDPVIVGDRSCFRKE------EKLQAYVELAFKCLSHSAEDRPT 334
+ M + + R ++ Y L C A RPT
Sbjct: 241 PTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEV--Y-HLMKNCWETEASFRPT 297
Query: 335 MIDVAKKLRQMYRTS 349
++ L+ ++
Sbjct: 298 FENLIPILKTVHEKY 312
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 64/274 (23%), Positives = 110/274 (40%), Gaps = 34/274 (12%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137
+MG + + K K + E ++ H+ +++L E + +V E
Sbjct: 201 WMGTWNGTTRVAI-KTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTE 258
Query: 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
+L D L G +L L + +A + A+ +AY+ V R++ NIL
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQL---VDMAAQIASGMAYVE---RMNYVHRDLRAANIL 312
Query: 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
E K+ DF L++ I + + + +++ APE G + K+DV+SFG LL
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 258 LVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGY-MNIDPVIVGDRSCFRKEEKLQ 315
L T GR G N + D+VE+ GY M P C +
Sbjct: 372 TELTTKGR------VPYPGMVNREVLDQVER-----GYRMPC-P-----PEC------PE 408
Query: 316 AYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349
+ +L +C E+RPT + L + ++
Sbjct: 409 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 36/171 (21%), Positives = 62/171 (36%), Gaps = 32/171 (18%)
Query: 113 QMNHKSILKLIGC--CLEAEMPALVYEPAGYCT---LADRLYGPLQTHLEPLLLTHR--L 165
++NHK+I+KL L+ E +C L L + L L
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIME---FCPCGSLYTVL----EEPSNAYGLPESEFL 115
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ----EEYAAKLFDFSLSKSIPEGKTH 221
V + + +LR +V RNI+P NI+ + KL DF ++ + + +
Sbjct: 116 IVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-- 170
Query: 222 IKASTAIGSLEFAAPEYLTTG--------YYNEKTDVYSFGKLLLVLLTGR 264
+ + G+ E+ P+ Y D++S G TG
Sbjct: 171 -QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 9e-11
Identities = 50/259 (19%), Positives = 95/259 (36%), Gaps = 58/259 (22%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAG----------YC---TLADRLYGPLQTHLEP 158
+ +NH+ +++ LE YC TL D + + +
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQR 115
Query: 159 LLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI--- 215
++ + A++Y+ Q ++ R+++P NI E K+ DF L+K++
Sbjct: 116 ---DEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 216 ---------PEGKTHIKASTAIGSLEFAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGRT 265
+ ++AIG+ + A E L TG+YNEK D+YS G + ++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-- 227
Query: 266 IGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCL 325
+ G + K +R + + P ++ K EK ++ +
Sbjct: 228 -------FSTGME---RVNILKKLR-SVSIEFPPDFDDNKM---KVEK-----KIIRLLI 268
Query: 326 SHSAEDRPTMIDVAKKLRQ 344
H RP A+ L
Sbjct: 269 DHDPNKRPG----ARTLLN 283
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 37/151 (24%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
+H ++L L+G CL +E LV P Y D L ++ + + ++
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLP--YMKHGD-LRNFIRNETHNPTVKDLIGFGLQV 201
Query: 172 ANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
A + +L +F V R++ N + E++ K+ DF L++ + + + +
Sbjct: 202 AKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 229 GSL--EFAAPEYLTTGYYNEKTDVYSFGKLL 257
L ++ A E L T + K+DV+SFG LL
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 31/158 (19%), Positives = 62/158 (39%), Gaps = 17/158 (10%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANA 174
H ++++ + + + E TL + + HL + + +T +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL----EPITLLQQTTSG 130
Query: 175 VAYLRFGFPQPVVFRNIEPWNILFQEEYA-----AKLFDFSLSKSIPEGKTHI-KASTAI 228
+A+L +V R+++P NIL A A + DF L K + G+ + S
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 229 GSLEFAAPEYL---TTGYYNEKTDVYSFGKLLLVLLTG 263
G+ + APE L D++S G + +++
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 29/169 (17%), Positives = 62/169 (36%), Gaps = 27/169 (15%)
Query: 112 SQMNHKS--ILKLIGCCLEAEMPALVYEPAGYCTLADRL--YGPLQTHLEPLLLTHRLKV 167
+++ S I++L + + +V E L L + ++
Sbjct: 81 NKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSID---PWERKSY---- 132
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
AV + +V +++P N L + KL DF ++ + T + +
Sbjct: 133 WKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 228 IGSLEFAAPEYLT-----------TGYYNEKTDVYSFGKLLLVLLTGRT 265
+G++ + PE + + K+DV+S G +L + G+T
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 41/200 (20%), Positives = 69/200 (34%), Gaps = 29/200 (14%)
Query: 78 YMGFLRDRGPILVMK---YRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA- 133
Y G + + RK + +R + H +I++
Sbjct: 43 YKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102
Query: 134 ---LVYEPAGYCT---LADRL--YGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP 185
LV E T L L + ++ +L + + +L P P
Sbjct: 103 CIVLVTE---LMTSGTLKTYLKRFKVMK---IKVLR----SWCRQILKGLQFLHTRTP-P 151
Query: 186 VVFRNIEPWNILFQEEY-AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
++ R+++ NI + K+ D L+ K A IG+ EF APE Y
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMYEEKY- 206
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
+E DVY+FG +L + T
Sbjct: 207 DESVDVYAFGMCMLEMATSE 226
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 30/123 (24%), Positives = 47/123 (38%), Gaps = 20/123 (16%)
Query: 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEE 201
+L L + + +E A++YL G +V+ +++P NI+ EE
Sbjct: 170 SLKRSKGQKLP-------VAEAIAYLLEILPALSYLHSIG----LVYNDLKPENIMLTEE 218
Query: 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLL 261
KL D I G+ F APE + TG TD+Y+ G+ L L
Sbjct: 219 -QLKLIDLGAVSRI----NS--FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALT 270
Query: 262 TGR 264
Sbjct: 271 LDL 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 29/169 (17%), Positives = 63/169 (37%), Gaps = 27/169 (15%)
Query: 112 SQMNHKS--ILKLIGCCLEAEMPALVYEPAGYCTLADRL--YGPLQTHLEPLLLTHRLKV 167
+++ S I++L + + +V E L L + ++
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSID---PWERKSY---- 160
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
AV + +V +++P N L + KL DF ++ + T + +
Sbjct: 161 WKNMLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 228 IGSLEFAAPEYL-----------TTGYYNEKTDVYSFGKLLLVLLTGRT 265
+G++ + PE + + + K+DV+S G +L + G+T
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 24/160 (15%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRL------ 165
S + H +IL+L G +A L+ E Y G + L+ +
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILE---YAP-----LGTVYRELQK---LSKFDEQRTA 112
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
E ANA++Y + V+ R+I+P N+L K+ DF S P +
Sbjct: 113 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---- 165
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265
G+L++ PE + ++EK D++S G L L G+
Sbjct: 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 10/95 (10%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ + YL +V R+I+P NIL + K+ DF LS + K +G
Sbjct: 157 SGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLG 210
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ + APE L YNEK DV+S G ++ +LL G
Sbjct: 211 TAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY 244
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 50/250 (20%), Positives = 98/250 (39%), Gaps = 39/250 (15%)
Query: 112 SQMNHKSILKLIGCCLEAEMPA--LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAM 169
+ H++I+K G C E L+ E +L + Y L + + L +LK A+
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE--Y--LPKNKNKINLKQQLKYAV 133
Query: 170 ETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
+ + YL ++ V R++ N+L + E+ K+ DF L+K+I K +
Sbjct: 134 QICKGMDYLGSRQY------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 227 AIGS-LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV 285
S + + APE L + +DV+SFG V L L T + +
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFG----VTLH--------ELLTYCDSDSSPMAL 235
Query: 286 EKFIRSNGY--MNIDPVIVGDRSCFRKE------EKLQAYVELAFKCLSHSAEDRPTMID 337
+ + M + ++ + R +++ Y +L KC +R + +
Sbjct: 236 FLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEV--Y-QLMRKCWEFQPSNRTSFQN 292
Query: 338 VAKKLRQMYR 347
+ + + +
Sbjct: 293 LIEGFEALLK 302
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 33/160 (20%), Positives = 61/160 (38%), Gaps = 26/160 (16%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCT---LADRLYGPLQTHLEPLLLTHRLKVAM 169
+ H +++ L + ++YE + + L +++ E A+
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYE---FMSGGELFEKVADEHNKMSE--------DEAV 258
Query: 170 ETA----NAVAYLRFGFPQPVVFRNIEPWNILFQ--EEYAAKLFDFSLSKSIPEGKTHIK 223
E + ++ V +++P NI+F KL DF L+ + +
Sbjct: 259 EYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---S 312
Query: 224 ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
G+ EFAAPE TD++S G L +LL+G
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 33/158 (20%), Positives = 62/158 (39%), Gaps = 20/158 (12%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL---------EPLLLT 162
+ +H + KL+G L + + P L +G L L L L
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIP--MVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 163 HRLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219
++ ++ A + YL F + R++ N + E+ + DF LS+ I G
Sbjct: 138 TLVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ + + +++ A E L Y +DV++FG +
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 44/250 (17%), Positives = 82/250 (32%), Gaps = 49/250 (19%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHR--LKVAMETA 172
+H ++++ + E L D + + L + + + A
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILF-------------QEEYAAKLFDFSLSKSIPEGK 219
+ VA+L ++ R+++P NIL E + DF L K + G+
Sbjct: 126 SGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 220 T--HIKASTAIGSLEFAAPEYL-------TTGYYNEKTDVYSFGKLLLVLLTGRTIGHLS 270
+ + G+ + APE L T D++S G + +L
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL--------- 233
Query: 271 RLATGGSNFF--ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHS 328
+ G + F R IR G ++D + E +L + + H
Sbjct: 234 ---SKGKHPFGDKYSRESNIIR--GIFSLDEMKCLHDRSLIAEAT-----DLISQMIDHD 283
Query: 329 AEDRPTMIDV 338
RPT + V
Sbjct: 284 PLKRPTAMKV 293
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 31/179 (17%), Positives = 67/179 (37%), Gaps = 27/179 (15%)
Query: 102 ERCFNNIVFASQMNHKS--ILKLIGCCLEAEMPALVYEPAGYCTLADRL--YGPLQTHLE 157
+ N I + +++ S I++L + + +V E L L +
Sbjct: 52 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSID---P 107
Query: 158 PLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217
++ AV + +V +++P N L + KL DF ++ +
Sbjct: 108 WERKSY----WKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 159
Query: 218 GKTHIKASTAIGSLEFAAPEYL-----------TTGYYNEKTDVYSFGKLLLVLLTGRT 265
T + + +G++ + PE + + + K+DV+S G +L + G+T
Sbjct: 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 14/151 (9%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
+NH ++L LIG L E V P Y D L +++ + + ++
Sbjct: 77 RGLNHPNVLALIGIMLPPEGLPHVLLP--YMCHGD-LLQFIRSPQRNPTVKDLISFGLQV 133
Query: 172 ANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
A + YL +F V R++ N + E + K+ DF L++ I + + +
Sbjct: 134 ARGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 229 GSL--EFAAPEYLTTGYYNEKTDVYSFGKLL 257
L ++ A E L T + K+DV+SFG LL
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLL 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 53/253 (20%), Positives = 106/253 (41%), Gaps = 49/253 (19%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD--------RLYGPLQTHLEPLLLTH 163
+ N +++L+G + + ++ E T D R L P L+
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIME---LMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 164 RLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220
+++A E A+ +AYL +F V R++ N + E++ K+ DF +++ I E
Sbjct: 140 MIQMAGEIADGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT----GG 276
+ K + + + +PE L G + +DV+SFG +L + T LA G
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------LAEQPYQGL 244
Query: 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI 336
SN ++V +F+ G ++ P +C + EL C ++ + RP+ +
Sbjct: 245 SN----EQVLRFVMEGGLLDK-P-----DNC-----PDMLF-ELMRMCWQYNPKMRPSFL 288
Query: 337 DVAKKLRQMYRTS 349
++ +++
Sbjct: 289 EIISSIKEEMEPG 301
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 25/181 (13%)
Query: 92 KYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCT---LADRL 148
K + + E + Q++H +I+KL + LV E T L D +
Sbjct: 61 KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE---VYTGGELFDEI 117
Query: 149 YGPLQTHLEPLLLTHRL--KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYA 203
+ + ++ + + + Y+ +V R+++P N+L + ++
Sbjct: 118 -------ISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDAN 167
Query: 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
++ DF LS K K IG+ + APE L G Y+EK DV+S G +L +LL+G
Sbjct: 168 IRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223
Query: 264 R 264
Sbjct: 224 C 224
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 7e-10
Identities = 30/128 (23%), Positives = 52/128 (40%), Gaps = 17/128 (13%)
Query: 142 CTLADRL--YGPLQTHLEPLLLTHRLKVAMETANAVAYL-RFGFPQPVVFRNIEPWNILF 198
LA L GPL + + + +A+ G R+++P NIL
Sbjct: 119 VDLAAMLRRQGPLAPP-------RAVAIVRQIGSALDAAHAAG----ATHRDVKPENILV 167
Query: 199 QEEYAAKLFDFSLSKSIPEGK-THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ A L DF ++ + + K T +G+L + APE + + + D+Y+ +L
Sbjct: 168 SADDFAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMAPERFSESHATYRADIYALTCVL 225
Query: 258 LVLLTGRT 265
LTG
Sbjct: 226 YECLTGSP 233
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 35/98 (35%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ--EEYAAKLFDFSLSKSIPEGKTH--IKASTAI 228
+A+ YL Q + R+I+P N LF + + KL DF LSK + +T
Sbjct: 179 SALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 229 GSLEFAAPEYLTTGY--YNEKTDVYSFGKLLLVLLTGR 264
G+ F APE L T Y K D +S G LL +LL G
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ V YL +V R+++P N+L + ++ K+ DF LS K K +G
Sbjct: 147 SGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLG 200
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ + APE L Y+EK DV+S G +L +LL G
Sbjct: 201 TAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-10
Identities = 23/97 (23%), Positives = 44/97 (45%), Gaps = 10/97 (10%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
A+ +L + R+++P N+L+ ++ KL DF +K + T
Sbjct: 138 GTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPC 190
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265
+ + APE L Y++ D++S G ++ +LL G
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 22/93 (23%), Positives = 44/93 (47%), Gaps = 8/93 (8%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ--EEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
+ ++ ++ +++P NIL + K+ DF L++ + K G+
Sbjct: 198 EGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGT 251
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
EF APE + + + TD++S G + +LL+G
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 31/148 (20%), Positives = 65/148 (43%), Gaps = 14/148 (9%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
+++ + +L+G CL L+ + + L D Y ++ H + + + L ++ A
Sbjct: 73 SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD--Y--VREHKDNIGSQYLLNWCVQIA 127
Query: 173 NAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ YL R V R++ N+L + K+ DF L+K + + A
Sbjct: 128 KGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+++ A E + Y ++DV+S+G +
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTV 209
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
+AV+++ VV R+++P N+LF + K+ DF ++ P +K T
Sbjct: 116 VSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--TPC 170
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265
+L +AAPE L Y+E D++S G +L +L+G+
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 34/248 (13%)
Query: 112 SQMNHKSILKLIGCCLEAEMPA--LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAM 169
+ H +I+K G C A L+ E Y +L D Y LQ H E + L+
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD--Y--LQKHKERIDHIKLLQYTS 121
Query: 170 ETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
+ + YL R+ + R++ NIL + E K+ DF L+K +P+ K K
Sbjct: 122 QICKGMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 227 AIGSLEF--AAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284
G APE LT ++ +DV+SFG +L L T ++ + + + F
Sbjct: 176 P-GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-----YIEKSKSPPAEFMRMIG 229
Query: 285 VEKFIRSNGYMNIDPVIVGDR-----SCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVA 339
+K + + I+ + R C + Y + +C +++ RP+ D+A
Sbjct: 230 NDKQGQMIVFHLIELLKNNGRLPRPDGC-----PDEIY-MIMTECWNNNVNQRPSFRDLA 283
Query: 340 KKLRQMYR 347
++ Q+
Sbjct: 284 LRVDQIRD 291
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
NA+AY Q VV ++++P NILFQ K+ DF L++ + + A G
Sbjct: 135 NALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAG 188
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+ + APE K D++S G ++ LLTG
Sbjct: 189 TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 14/154 (9%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD--RLYGPLQTHLEPLLLTHRLKVAM 169
S+ NH++I++ IG L++ ++ E L R P + L + L VA
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 170 ETANAVAYL---RFGFPQPVVFRNIEPWNIL---FQEEYAAKLFDFSLSKSIPEGKTHIK 223
+ A YL F + R+I N L AK+ DF +++ I + K
Sbjct: 148 DIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 224 ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
A+ +++ PE G + KTD +SFG LL
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 53/249 (21%), Positives = 90/249 (36%), Gaps = 35/249 (14%)
Query: 113 QMNHKSILKLIGCCLEAEMPA--LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAME 170
++ I+K G + LV E L D + LQ H L + L + +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD--F--LQRHRARLDASRLLLYSSQ 135
Query: 171 TANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
+ YL R V R++ NIL + E K+ DF L+K +P K +
Sbjct: 136 ICKGMEYLGSRRC------VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP 189
Query: 228 IGSLEFA--APEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDR 284
G APE L+ ++ ++DV+SFG +L L T S +
Sbjct: 190 -GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK-----------SCSPSAEF 237
Query: 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEE----KLQAYVELAFKCLSHSAEDRPTMIDVAK 340
+ + ++ R + + EL C + S +DRP+ +
Sbjct: 238 LRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH-ELMKLCWAPSPQDRPSFSALGP 296
Query: 341 KLRQMYRTS 349
+L ++ S
Sbjct: 297 QLDMLWSGS 305
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 51/252 (20%), Positives = 90/252 (35%), Gaps = 59/252 (23%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
++H I++L+G C LV + +L D + ++ H L L ++ A
Sbjct: 71 SLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLD--H--VRQHRGALGPQLLLNWGVQIA 125
Query: 173 NAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ YL V RN+ N+L + ++ DF ++ +P + S A
Sbjct: 126 KGMYYLEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------SNFFIT 282
+++ A E + G Y ++DV+S+G V + L T G +
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYG----VTVW--------ELMTFGAEPYAGLRLAEVP 227
Query: 283 DRVEKFIRSNGYMNIDPVIVGDR-----SCFRKEEKLQAYVELAFKCLSHSAEDRPTMID 337
D +EK G+R C + KC RPT +
Sbjct: 228 DLLEK---------------GERLAQPQIC------TIDVYMVMVKCWMIDENIRPTFKE 266
Query: 338 VAKKLRQMYRTS 349
+A + +M R
Sbjct: 267 LANEFTRMARDP 278
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 59/250 (23%), Positives = 104/250 (41%), Gaps = 34/250 (13%)
Query: 112 SQMNHKSILKLIGCCLEAEMPA--LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAM 169
+ H +I+K G C A L+ E Y +L D Y LQ H E + L+
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD--Y--LQKHKERIDHIKLLQYTS 152
Query: 170 ETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
+ + YL R+ + R++ NIL + E K+ DF L+K +P+ K + K
Sbjct: 153 QICKGMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE 206
Query: 227 AIGSLEF--AAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284
G APE LT ++ +DV+SFG +L L T ++ + + + F
Sbjct: 207 P-GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-----YIEKSKSPPAEFMRMIG 260
Query: 285 VEKFIRSNGYMNIDPVIVGDR-----SCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVA 339
+K + + I+ + R C + Y + +C +++ RP+ D+A
Sbjct: 261 NDKQGQMIVFHLIELLKNNGRLPRPDGC-----PDEIY-MIMTECWNNNVNQRPSFRDLA 314
Query: 340 KKLRQMYRTS 349
++ Q+
Sbjct: 315 LRVDQIRDQM 324
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 9/97 (9%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
A+ YL + R+++P N+L+ KL DF +K + +T
Sbjct: 171 GEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TTPC 224
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265
+ + APE L Y++ D++S G ++ +LL G
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 41/154 (26%), Positives = 66/154 (42%), Gaps = 14/154 (9%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD--RLYGPLQTHLEPLLLTHRLKVAM 169
S+ NH++I++ IG L++ ++ E L R P + L + L VA
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 170 ETANAVAYL---RFGFPQPVVFRNIEPWNIL---FQEEYAAKLFDFSLSKSIPEGKTHIK 223
+ A YL F + R+I N L AK+ DF +++ I + K
Sbjct: 189 DIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 224 ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
A+ +++ PE G + KTD +SFG LL
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 35/182 (19%), Positives = 67/182 (36%), Gaps = 26/182 (14%)
Query: 102 ERCFNNIVFASQMNHKSILKLIGCCLEAEMPA----LVYEPAGYC---TLADRLYGPLQT 154
E NH +IL+L+ CL L+ + TL + +
Sbjct: 71 EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP---FFKRGTLWNEIERLKDK 127
Query: 155 HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF-SLSK 213
L L + + + + + R+++P NIL +E L D S+++
Sbjct: 128 G-NFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
Query: 214 SIPEGKTHIKAS------TAIGSLEFAAPEYLTTGY----YNEKTDVYSFGKLLLVLLTG 263
+ + +A ++ + APE L + +E+TDV+S G +L ++ G
Sbjct: 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
Query: 264 RT 265
Sbjct: 243 EG 244
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 37/163 (22%), Positives = 70/163 (42%), Gaps = 31/163 (19%)
Query: 112 SQMNHKSILKLIGCCLEAE-----MPALVYEPAGYCTLADRLYGPLQTHL---------E 157
+H ++++L+G C+E P ++ + YG L T+L +
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILP---FMK-----YGDLHTYLLYSRLETGPK 142
Query: 158 PLLLTHRLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214
+ L LK ++ A + YL F + R++ N + +++ + DF LSK
Sbjct: 143 HIPLQTLLKFMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
I G + + A +++ A E L Y K+DV++FG +
Sbjct: 197 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 23/93 (24%), Positives = 43/93 (46%), Gaps = 8/93 (8%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ--EEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
+ ++ +V +I+P NI+ + + + K+ DF L+ + + +
Sbjct: 160 EGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTAT 213
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
EFAAPE + TD+++ G L VLL+G
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-09
Identities = 30/127 (23%), Positives = 62/127 (48%), Gaps = 15/127 (11%)
Query: 142 CTLADRL--YGPLQTHLEPLLLTHRLKVAMETANAVAYL-RFGFPQPVVFRNIEPWNILF 198
TL D + GP+ ++V + A+ + + G ++ R+++P NI+
Sbjct: 101 VTLRDIVHTEGPMTPK-------RAIEVIADACQALNFSHQNG----IIHRDVKPANIMI 149
Query: 199 QEEYAAKLFDFSLSKSIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
A K+ DF ++++I + + + + IG+ ++ +PE + ++DVYS G +L
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 258 LVLLTGR 264
+LTG
Sbjct: 210 YEVLTGE 216
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 10/95 (10%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ + Y+ +V R+++P NIL + ++ K+ DF LS + K IG
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIG 185
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ + APE L G Y+EK DV+S G +L +LL+G
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 20/150 (13%)
Query: 113 QMNHKSILKLIGCCLEAEMPA-LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
Q+ H ++++L+G +E + +V E +L D L ++ L L LK +++
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDV 298
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI----PEGKTHIKASTA 227
A+ YL V R++ N+L E+ AK+ DF L+K GK +K
Sbjct: 299 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---- 351
Query: 228 IGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ APE L ++ K+DV+SFG LL
Sbjct: 352 -----WTAPEALREKKFSTKSDVWSFGILL 376
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 7e-09
Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 10/94 (10%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+AVAY V R+++P N LF + KL DF L+ GK T +G
Sbjct: 117 SAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVG 170
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+ + +P+ L G Y + D +S G ++ VLL G
Sbjct: 171 TPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 26/93 (27%), Positives = 41/93 (44%), Gaps = 9/93 (9%)
Query: 174 AVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
AV Y + +V R+++ N+L + K+ DF S G K G+
Sbjct: 126 AVQYCHQKR----IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPP 178
Query: 233 FAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGR 264
+AAPE Y + DV+S G +L L++G
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 33/157 (21%), Positives = 67/157 (42%), Gaps = 16/157 (10%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYC---TLADRLYGPLQTHL-EPLLLTHRLKV 167
+ M H +I++ E +V + YC L R+ E +L
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMD---YCEGGDLFKRINAQKGVLFQEDQIL----DW 130
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTA 227
++ A+ ++ + ++ R+I+ NI ++ +L DF +++ + T A
Sbjct: 131 FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARAC 185
Query: 228 IGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
IG+ + +PE YN K+D+++ G +L L T +
Sbjct: 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 40/160 (25%), Positives = 78/160 (48%), Gaps = 21/160 (13%)
Query: 111 ASQMNHKSILKLIGCCLEAEMPALVYEPAGY---CTLADRL--YGPLQTHLEPLLLTHRL 165
+SQ++H++I+ +I E + LV E Y TL++ + +GPL +
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVME---YIEGPTLSEYIESHGPLSVD-------TAI 114
Query: 166 KVAMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224
+ + + + +V R+I+P NIL K+FDF ++K++ E + +
Sbjct: 115 NFTNQILDGIKHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQT 169
Query: 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ +G++++ +PE +E TD+YS G +L +L G
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
V YL +V +++P NIL K+ DF +S+ I + +G
Sbjct: 142 EGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMG 195
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+ E+ APE L TD+++ G + +LLT
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 10/95 (10%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA----KLFDFSLSKSIPEGKTHIKASTAI 228
N V YL + +++P NI+ + K+ DF L+ I G
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIF 178
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
G+ EF APE + + D++S G + +LL+G
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 23/93 (24%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ--EEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
A+ +L + +I P NI++Q K+ +F ++ + G +
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTA 166
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
E+ APE + TD++S G L+ VLL+G
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 51/255 (20%), Positives = 89/255 (34%), Gaps = 48/255 (18%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTL----------ADRLYGPLQTHLEPLLL 161
+ + H+ I++ G C E +V+E + L A L G PL L
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 162 THRLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218
L VA + A + YL F V R++ N L + K+ DF +S+ I
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLA----T 274
+ + + + PE + + ++DV+SFG +L + T
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT---------YGKQPWY 262
Query: 275 GGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT 334
SN I + P R+C + Y + C + R +
Sbjct: 263 QLSN----TEAIDCITQGRELER-P-----RAC-----PPEVY-AIMRGCWQREPQQRHS 306
Query: 335 MIDVAKKLRQMYRTS 349
+ DV +L+ + +
Sbjct: 307 IKDVHARLQALAQAP 321
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
+AV YL +V R+++P N+L+ +E + DF LSK G STA
Sbjct: 116 LSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STAC 168
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
G+ + APE L Y++ D +S G + +LL G
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 10/95 (10%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ----EEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
+ V YL + + +++P NI+ KL DF L+ I +G +
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIF 179
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
G+ EF APE + + D++S G + +LL+G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 10/95 (10%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA----KLFDFSLSKSIPEGKTHIKASTAI 228
+ V YL + + +++P NI+ ++ KL DF ++ I G +
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIF 172
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
G+ EF APE + + D++S G + +LL+G
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 51/245 (20%), Positives = 96/245 (39%), Gaps = 45/245 (18%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
+ H ++KL + + ++ E +L D L + L + + + A
Sbjct: 239 TLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIA 294
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
+A++ + + R++ NIL K+ DF L++ I + + + ++
Sbjct: 295 EGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIK 350
Query: 233 FAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------SNFFITDRV 285
+ APE + G + K+DV+SFG +LL + T G SN + +
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFG----ILLM--------EIVTYGRIPYPGMSNPEVIRAL 398
Query: 286 EKFIRSNGY-MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344
E+ GY M P +C E+L Y + +C + E+RPT + L
Sbjct: 399 ER-----GYRMPR-P-----ENC---PEEL--Y-NIMMRCWKNRPEERPTFEYIQSVLDD 441
Query: 345 MYRTS 349
Y +
Sbjct: 442 FYTAT 446
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 25/97 (25%), Positives = 43/97 (44%), Gaps = 12/97 (12%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
+ L +V R+++P NIL ++ KL DF S + G+ K G+
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 188
Query: 233 FAAPEYLTTGY------YNEKTDVYSFGKLLLVLLTG 263
+ APE + Y ++ D++S G ++ LL G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+AV YLR + ++ R+I+ NI+ E++ KL DF + + GK T G++
Sbjct: 140 VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTI 193
Query: 232 EFAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGR 264
E+ APE L Y + +++S G L L+
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 55/253 (21%), Positives = 96/253 (37%), Gaps = 62/253 (24%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
Q+++ I++LIG C E LV E AG L L E + +++ ++ + +
Sbjct: 392 QLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVS 446
Query: 173 NAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ YL F V RN+ N+L + AK+ DF LSK++ ++ A +A G
Sbjct: 447 MGMKYLEEKNF------VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA-G 499
Query: 230 SLEFA--APEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------SNFF 280
APE + ++ ++DV+S+G V + + G
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYG----VTMW--------EALSYGQKPYKKMKGPE 547
Query: 281 ITDRVEKFIRSNGYMNIDPVIVGDR-----SCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335
+ +E+ G R C L C + EDRP
Sbjct: 548 VMAFIEQ---------------GKRMECPPEC------PPELYALMSDCWIYKWEDRPDF 586
Query: 336 IDVAKKLRQMYRT 348
+ V +++R Y +
Sbjct: 587 LTVEQRMRACYYS 599
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 2e-08
Identities = 25/94 (26%), Positives = 46/94 (48%), Gaps = 9/94 (9%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
++AY +V RN++P N+L + A KL DF L+ + + + G
Sbjct: 116 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAG 169
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+ + +PE L Y++ D+++ G +L +LL G
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 10/95 (10%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ----EEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
+ V YL + + +++P NI+ KL DF L+ I +G +
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIF 179
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
G+ EF APE + + D++S G + +LL+G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 2e-08
Identities = 50/258 (19%), Positives = 95/258 (36%), Gaps = 71/258 (27%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
+++H +++L G CLE LV E + L+D Y L+T L + ++
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD--Y--LRTQRGLFAAETLLGMCLDV 113
Query: 172 ANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE--------GKTHI 222
+AYL + R++ N L E K+ DF +++ + + K +
Sbjct: 114 CEGMAYLEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG------ 276
K +A+PE + Y+ K+DV+SFG VL+ + + G
Sbjct: 170 K---------WASPEVFSFSRYSSKSDVWSFG----VLMW--------EVFSEGKIPYEN 208
Query: 277 -SNFFITDRVEKFIRSNGY-----MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAE 330
SN + + + G+ + Y ++ C E
Sbjct: 209 RSNSEVVEDIST-----GFRLYKPRLASTHV---------------Y-QIMNHCWRERPE 247
Query: 331 DRPTMIDVAKKLRQMYRT 348
DRP + ++L ++ +
Sbjct: 248 DRPAFSRLLRQLAEIAES 265
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 9/95 (9%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
AVAYL +V R+++P N+L+ + K+ DF LSK + T
Sbjct: 158 LEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVC 211
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
G+ + APE L Y + D++S G + +LL G
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 12/97 (12%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
AV YL ++ R+++P N+L E+ K+ DF SK + E T G
Sbjct: 250 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCG 303
Query: 230 SLEFAAPEYLTTGY---YNEKTDVYSFGKLLLVLLTG 263
+ + APE L + YN D +S G +L + L+G
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 37/193 (19%), Positives = 62/193 (32%), Gaps = 20/193 (10%)
Query: 78 YMGFLRDRGPILVMKY-RKSVRYASER--CFNNI-VFASQMNHKSILKLIGCCLEAEMPA 133
+ ++ G + +K R +R + H ++L E +
Sbjct: 74 FKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133
Query: 134 LVYEPAGYC--TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI 191
L E C +L + E + +T A+A+L Q +V ++
Sbjct: 134 LQTE---LCGPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLH---SQGLVHLDV 183
Query: 192 EPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVY 251
+P NI KL DF L + G + APE L Y DV+
Sbjct: 184 KPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQGSY-GTAADVF 239
Query: 252 SFGKLLLVLLTGR 264
S G +L +
Sbjct: 240 SLGLTILEVACNM 252
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 30/94 (31%), Positives = 49/94 (52%), Gaps = 10/94 (10%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ + Y+ +V R+++P NIL + ++ K+ DF LS + IG
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIG 185
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+ + APE L G Y+EK DV+S G +L +LL+G
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 5e-08
Identities = 57/255 (22%), Positives = 98/255 (38%), Gaps = 61/255 (23%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
++H+++++L G L +V E A +L DRL + H LL + A++ A
Sbjct: 77 SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVA 131
Query: 173 NAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
+ YL RF + R++ N+L K+ DF L +++P+ H
Sbjct: 132 EGMGYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH-R 184
Query: 230 SLEFA--APEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------SNFF 280
+ FA APE L T ++ +D + FG V L + T G +
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFG----VTLW--------EMFTYGQEPWIGLNGSQ 232
Query: 281 ITDRVEKFIRSNGY-----MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335
I +++K G + I Y + +C +H EDRPT
Sbjct: 233 ILHKIDK----EGERLPRPEDCPQDI---------------Y-NVMVQCWAHKPEDRPTF 272
Query: 336 IDVAKKLRQMYRTSV 350
+ + L + T +
Sbjct: 273 VALRDFLLEAQPTDM 287
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 35/182 (19%), Positives = 72/182 (39%), Gaps = 8/182 (4%)
Query: 81 FLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAG 140
+LR + V K R+ + + + L + +
Sbjct: 117 YLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRR-----LDSITSSQSSASSGFVEEK 171
Query: 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE 200
+ + P + + L L H + + + A + +L + + R++ NIL E
Sbjct: 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 228
Query: 201 EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVL 260
+ K+ DF L++ I + +++ A L++ APE + Y ++DV+SFG LL +
Sbjct: 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288
Query: 261 LT 262
+
Sbjct: 289 FS 290
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 5e-08
Identities = 49/259 (18%), Positives = 93/259 (35%), Gaps = 55/259 (21%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRL-----------YGPLQTHLEPLL 160
+ + H+ I+K G C + + +V+E + L L G + L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 161 LTHRLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217
L+ L +A + A+ + YL F V R++ N L K+ DF +S+ +
Sbjct: 132 LSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG- 276
+ + + + PE + + ++DV+SFG V+L + T G
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG----VILW--------EIFTYGK 233
Query: 277 ------SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAE 330
SN V + I + P R C + Y ++ C +
Sbjct: 234 QPWFQLSN----TEVIECITQGRVLER-P-----RVC-----PKEVY-DVMLGCWQREPQ 277
Query: 331 DRPTMIDVAKKLRQMYRTS 349
R + ++ K L + + +
Sbjct: 278 QRLNIKEIYKILHALGKAT 296
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 44/149 (29%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
Q +H I+KLIG E ++ E L + LQ L L + A +
Sbjct: 446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS--F--LQVRKFSLDLASLILYAYQL 500
Query: 172 ANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
+ A+AYL RF V R+I N+L KL DF LS+ + E T+ KAS
Sbjct: 501 STALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGK 553
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+++ APE + + +DV+ FG +
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCM 582
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 25/94 (26%), Positives = 46/94 (48%), Gaps = 9/94 (9%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
++AY +V RN++P N+L + A KL DF L+ + + + G
Sbjct: 139 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAG 192
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+ + +PE L Y++ D+++ G +L +LL G
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 29/159 (18%), Positives = 61/159 (38%), Gaps = 19/159 (11%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCT---LADRLYGPLQTHLEPLLLTHRL--KV 167
+ H I++L+ M +V+E + L + ++ + + +
Sbjct: 82 MLKHPHIVELLETYSSDGMLYMVFE---FMDGADLCFEI---VKRADAGFVYSEAVASHY 135
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKA 224
+ A+ Y ++ R+++P +L KL F ++ + E
Sbjct: 136 MRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG- 191
Query: 225 STAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+G+ F APE + Y + DV+ G +L +LL+G
Sbjct: 192 -GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 9/98 (9%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEE----YAAKLFDFSLSKSIPEGKTHIKASTA 227
V YL Q VV R+++P NIL+ +E + ++ DF +K + + T
Sbjct: 126 TKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM--TP 180
Query: 228 IGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT 265
+ F APE L Y+ D++S G LL +LTG T
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 7e-08
Identities = 30/155 (19%), Positives = 64/155 (41%), Gaps = 26/155 (16%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
++H+ +++L G C + ++ E Y L L+ L++ +
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITE---YMANGC-LLNYLREMRHRFQTQQLLEMCKDV 129
Query: 172 ANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE--------GKTHI 222
A+ YL F + R++ N L ++ K+ DF LS+ + + K +
Sbjct: 130 CEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 185
Query: 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ ++ PE L ++ K+D+++FG L+
Sbjct: 186 R---------WSPPEVLMYSKFSSKSDIWAFGVLM 211
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 20/157 (12%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTL-----------ADRLYGPLQTHLEPLLLTH 163
HK+I+ L+G C + ++ E A L + Y P E L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 164 RLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220
+ A + A + YL + + R++ N+L E+ K+ DF L++ I
Sbjct: 193 LVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246
Query: 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ K + +++ APE L Y ++DV+SFG LL
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 37/158 (23%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 115 NHKSILKLIGCCLEAEMPALV---YEPAG----Y-----CTLADRLYGPLQTHLEPLLLT 162
+H +++ L+G C + P +V + G Y P + + L L
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 163 HRLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219
H + + + A + +L + + R++ NIL E+ K+ DF L++ I +
Sbjct: 149 HLICYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+++ A L++ APE + Y ++DV+SFG LL
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 27/97 (27%), Positives = 45/97 (46%), Gaps = 12/97 (12%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
AV++L +V R+++P NIL + +L DF S + G+ K G+
Sbjct: 211 EAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPG 264
Query: 233 FAAPEYLTTGY------YNEKTDVYSFGKLLLVLLTG 263
+ APE L Y ++ D+++ G +L LL G
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 8e-08
Identities = 33/156 (21%), Positives = 62/156 (39%), Gaps = 16/156 (10%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGY-------------CTLADRLYGPLQTHLEPLLL 161
NH +I+ L+G C ++ E Y + ++ L L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 162 THRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221
L + + A +A+L + + R++ NIL K+ DF L++ I +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ A +++ APE + Y ++DV+S+G L
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-08
Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 11/94 (11%)
Query: 174 AVAYL-RFGFPQPVVFRNIEPWNILFQEEYA-AKLFDFSLSKSIPEGKTHIKASTAIGSL 231
AV + G V+ R+I+ NIL KL DF + + G+
Sbjct: 161 AVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTR 212
Query: 232 EFAAPEYLTTGYYN-EKTDVYSFGKLLLVLLTGR 264
++ PE++ Y+ V+S G LL ++ G
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 9e-08
Identities = 32/147 (21%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
+++H ++K G C + +V E L + Y L++H + L + L++ +
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN--Y--LRSHGKGLEPSQLLEMCYDV 113
Query: 172 ANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
+A+L F + R++ N L + K+ DF +++ + + + T
Sbjct: 114 CEGMAFLESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF-P 168
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLL 257
++++APE Y+ K+DV++FG L+
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILM 195
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 59/258 (22%), Positives = 99/258 (38%), Gaps = 69/258 (26%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL---EPLLLTHRLKVAM 169
Q+++ I+++IG C E LV E A GPL +L + + +++
Sbjct: 74 QLDNPYIVRMIGICEA-ESWMLVMEMAEL--------GPLNKYLQQNRHVKDKNIIELVH 124
Query: 170 ETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
+ + + YL F V R++ N+L ++ AK+ DF LSK++ + + KA T
Sbjct: 125 QVSMGMKYLEESNF------VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178
Query: 227 AIGSLEF--AAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------S 277
G APE + ++ K+DV+SFG VL+ + G
Sbjct: 179 H-GKWPVKWYAPECINYYKFSSKSDVWSFG----VLMW--------EAFSYGQKPYRGMK 225
Query: 278 NFFITDRVEKFIRSNGY-----MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDR 332
+T +EK G + Y +L C ++ E+R
Sbjct: 226 GSEVTAMLEK-----GERMGCPAGCPREM---------------Y-DLMNLCWTYDVENR 264
Query: 333 PTMIDVAKKLRQMYRTSV 350
P V +LR Y V
Sbjct: 265 PGFAAVELRLRNYYYDVV 282
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 37/163 (22%), Positives = 64/163 (39%), Gaps = 34/163 (20%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL-----------------E 157
H++I+ L+G C ++ E YC YG L L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITE---YCC-----YGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 158 PLLLTHRLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214
L + + A +A+L + R++ N+L + AK+ DF L++
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
I +I A +++ APE + Y ++DV+S+G LL
Sbjct: 214 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 39/151 (25%), Positives = 75/151 (49%), Gaps = 19/151 (12%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHL-----EPLLLTHRLKV 167
++ H ++++L+G C ++ E + T YG L +L + + L +
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITE---FMT-----YGNLLDYLRECNRQEVSAVVLLYM 116
Query: 168 AMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
A + ++A+ YL + F + R++ N L E + K+ DF LS+ + G T+ +
Sbjct: 117 ATQISSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAG 171
Query: 227 AIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
A +++ APE L ++ K+DV++FG LL
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 202
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 54/254 (21%), Positives = 97/254 (38%), Gaps = 62/254 (24%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
Q+++ I++LIG C E LV E AG L + L E + +++ ++ +
Sbjct: 65 HQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHK--F--LVGKREEIPVSNVAELLHQV 119
Query: 172 ANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
+ + YL F V R++ N+L + AK+ DF LSK++ ++ A +A
Sbjct: 120 SMGMKYLEEKNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA- 172
Query: 229 GSLEFA--APEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------SNF 279
G APE + ++ ++DV+S+G V + + G
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYG----VTMW--------EALSYGQKPYKKMKGP 220
Query: 280 FITDRVEKFIRSNGYMNIDPVIVGDR-----SCFRKEEKLQAYVELAFKCLSHSAEDRPT 334
+ +E+ G R C L C + EDRP
Sbjct: 221 EVMAFIEQ---------------GKRMECPPEC------PPELYALMSDCWIYKWEDRPD 259
Query: 335 MIDVAKKLRQMYRT 348
+ V +++R Y +
Sbjct: 260 FLTVEQRMRACYYS 273
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 24/94 (25%), Positives = 40/94 (42%), Gaps = 11/94 (11%)
Query: 174 AVAYL-RFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
A+ + G VV R+I+ NIL AKL DF + + G+
Sbjct: 151 AIQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT----DFDGTR 202
Query: 232 EFAAPEYLTTGYYN-EKTDVYSFGKLLLVLLTGR 264
++ PE+++ Y+ V+S G LL ++ G
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 48/252 (19%), Positives = 92/252 (36%), Gaps = 47/252 (18%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTL-----------ADRLYGPLQTHLEPLLLTH 163
HK+I+ L+G C + ++ E A L + Y + E +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 164 RLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220
+ + A + YL + + R++ N+L E K+ DF L++ I
Sbjct: 205 LVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDY 258
Query: 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN-- 278
+ K + +++ APE L Y ++DV+SFG VL+ + T G +
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG----VLMW--------EIFTLGGSPY 306
Query: 279 -FFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMID 337
+ + K ++ M+ P +C + Y + C RPT
Sbjct: 307 PGIPVEELFKLLKEGHRMDK-P-----ANC-----TNELY-MMMRDCWHAVPSQRPTFKQ 354
Query: 338 VAKKLRQMYRTS 349
+ + L ++ +
Sbjct: 355 LVEDLDRILTLT 366
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 48/253 (18%), Positives = 92/253 (36%), Gaps = 47/253 (18%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTL-----------ADRLYGPLQTHLEPLLLTH 163
HK+I+ L+G C + ++ E A L + Y + E +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 164 RLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220
+ + A + YL + + R++ N+L E K+ DF L++ I
Sbjct: 159 LVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212
Query: 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN-- 278
+ K + +++ APE L Y ++DV+SFG VL+ + T G +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG----VLMW--------EIFTLGGSPY 260
Query: 279 -FFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMID 337
+ + K ++ M+ P +C + Y + C RPT
Sbjct: 261 PGIPVEELFKLLKEGHRMDK-P-----ANC-----TNELY-MMMRDCWHAVPSQRPTFKQ 308
Query: 338 VAKKLRQMYRTSV 350
+ + L ++ +
Sbjct: 309 LVEDLDRILTLTT 321
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 32/156 (20%)
Query: 113 QMNHKSILKLIGCCLEAEMPA-LVYEPAGYCTLADRLYGPLQTHL-----EPLLLTHRLK 166
Q+ H ++++L+G +E + +V E Y G L +L L LK
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTE---YMA-----KGSLVDYLRSRGRSVLGGDCLLK 121
Query: 167 VAMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE----GKTH 221
+++ A+ YL F V R++ N+L E+ AK+ DF L+K GK
Sbjct: 122 FSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177
Query: 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+K + APE L ++ K+DV+SFG LL
Sbjct: 178 VK---------WTAPEALREKKFSTKSDVWSFGILL 204
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 8/94 (8%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
AV + VV RN++P N+L + A KL DF L+ + + G
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFAG 175
Query: 230 SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263
+ + +PE L Y + D+++ G +L +LL G
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 12/97 (12%)
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
AV YL ++ R+++P N+L E+ K+ DF SK + E T G
Sbjct: 125 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCG 178
Query: 230 SLEFAAPEYLTTGY---YNEKTDVYSFGKLLLVLLTG 263
+ + APE L + YN D +S G +L + L+G
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 28/94 (29%), Positives = 42/94 (44%), Gaps = 6/94 (6%)
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
V YL G + R+I+P N+L E K+ DF L+ + G+L
Sbjct: 116 AGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 232 EFAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGR 264
+ APE L ++ E DV+S G +L +L G
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 34/132 (25%), Positives = 58/132 (43%), Gaps = 19/132 (14%)
Query: 146 DRLY--------GPLQTHL--EPLLLTHRLKV-AMETANAVAYLRFGFPQPVVFRNIEPW 194
D+L G L HL + ++ A E + ++ + VV+R+++P
Sbjct: 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPA 321
Query: 195 NILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSF 253
NIL E ++ D L+ + K H ++G+ + APE L G Y+ D +S
Sbjct: 322 NILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 254 GKLLLVLLTGRT 265
G +L LL G +
Sbjct: 378 GCMLFKLLRGHS 389
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
A+ Y R +V R+++P N+L + K+ DF LS + +G T+ GS
Sbjct: 119 CAIEYCHRHK----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSP 171
Query: 232 EFAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGR 264
+AAPE + Y + DV+S G +L V+L GR
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 2e-07
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 11/96 (11%)
Query: 172 ANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI--PEGKTHIKASTAI 228
+ YL G ++ R++ N+L K+ DF L+ + P K + T
Sbjct: 122 ITGMLYLHSHG----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY----TLC 173
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
G+ + +PE T + ++DV+S G + LL GR
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 33/149 (22%), Positives = 64/149 (42%), Gaps = 14/149 (9%)
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
Q +H +I++L G + +V E +L + L+TH + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT--F--LRTHDGQFTIMQLVGMLRGVG 161
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS- 230
+ YL G+ V R++ N+L K+ DF LS+ + + +T G
Sbjct: 162 AGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGK 215
Query: 231 --LEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ + APE + ++ +DV+SFG ++
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVM 244
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 33/186 (17%), Positives = 64/186 (34%), Gaps = 26/186 (13%)
Query: 102 ERCFNNIVFASQM-NHKSILKLIGCCLEA--EMPALVYEPAGYCTLADRLYGPLQTHLEP 158
+ F ++ H +I++ E E + L + G L L+
Sbjct: 70 RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE---FLLLTELCKGQLVEFLKK 126
Query: 159 LLLTHRL------KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF--- 209
+ L K+ +T AV ++ P++ R+++ N+L + KL DF
Sbjct: 127 MESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
Query: 210 -------SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFGKLLLV 259
S S + T + + PE + EK D+++ G +L +
Sbjct: 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
Query: 260 LLTGRT 265
L +
Sbjct: 246 LCFRQH 251
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 37/197 (18%), Positives = 76/197 (38%), Gaps = 22/197 (11%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASER----CFNNIVFASQMNHKSILKLIGCCLEAEMPA 133
Y G + +K + + C I Q+NH +++K +E
Sbjct: 49 YRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108
Query: 134 LVYEPAGYC---TLADRL--YGPLQTHL-EPLLLTHRLKVAMETANAVAYLRFGFPQPVV 187
+V E L+ + + + + E + K ++ +A+ ++ + V+
Sbjct: 109 IVLE---LADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSALEHMH---SRRVM 158
Query: 188 FRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEK 247
R+I+P N+ KL D L + A + +G+ + +PE + YN K
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYNFK 216
Query: 248 TDVYSFGKLLLVLLTGR 264
+D++S G LL + +
Sbjct: 217 SDIWSLGCLLYEMAALQ 233
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+AV Y R VV R+++P N+L AK+ DF LS + +G+ T+ GS
Sbjct: 122 SAVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSP 174
Query: 232 EFAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGR 264
+AAPE ++ Y + D++S G +L LL G
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 3e-07
Identities = 59/371 (15%), Positives = 113/371 (30%), Gaps = 108/371 (29%)
Query: 30 QIFLEKLIASFDGKRNP--IRS-FSSEDLKTAIN-----NYSMRNITIDEIEGYILYMGF 81
+F + + +FD K +S S E++ I + ++R + + F
Sbjct: 23 SVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF 82
Query: 82 ----LRDRGPILVMKYRK--------SVRYASER--CFNNIVFASQMN---HKSILKLIG 124
LR L+ + + Y +R +N+ ++ N + LKL
Sbjct: 83 VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ 142
Query: 125 CCLEAEMPA---LVYEPAGYC---TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYL 178
LE PA L+ G +A L L+++++ M+ + +L
Sbjct: 143 ALLELR-PAKNVLIDGVLG-SGKTWVA------LDV-----CLSYKVQCKMD--FKIFWL 187
Query: 179 RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEY 238
P +L + D + + S + ++IK I S++
Sbjct: 188 NLK-------NCNSPETVLEMLQKLLYQIDPNWT-SRSDHSSNIKLR--IHSIQAELRRL 237
Query: 239 LTTGYYNEK----TDVYS------FG---KLLLVLLTGRTIGHLSRLATGGSNFFITDRV 285
L + Y +V + F K +LLT R +TD +
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCK---ILLTTRFKQ-------------VTDFL 281
Query: 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----------T 334
+ + +E L K L +D P +
Sbjct: 282 ------SAATTTHISLDHHSMTLTPDEVK----SLLLKYLDCRPQDLPREVLTTNPRRLS 331
Query: 335 MIDVAKKLRQM 345
+I A+ +R
Sbjct: 332 II--AESIRDG 340
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 28/94 (29%), Positives = 42/94 (44%), Gaps = 6/94 (6%)
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
V YL G + R+I+P N+L E K+ DF L+ + G+L
Sbjct: 116 AGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 232 EFAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGR 264
+ APE L ++ E DV+S G +L +L G
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 38/161 (23%), Positives = 68/161 (42%), Gaps = 21/161 (13%)
Query: 115 NHKSILKLIGCCLEAEMPALVYE----------------PAGYCTLADRLYGPLQTHLEP 158
+H++I+ L+G C + L++E + L+ +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 159 LLLTHR--LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216
+LT L A + A + +L F + V R++ N+L K+ DF L++ I
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
++ A +++ APE L G Y K+DV+S+G LL
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 23/96 (23%), Positives = 42/96 (43%), Gaps = 10/96 (10%)
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+ YL ++ R+I+P N+L E+ K+ DF +S + +G+
Sbjct: 148 KGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS--NTVGTP 201
Query: 232 EFAAPEYLTT---GYYNEKTDVYSFGKLLLVLLTGR 264
F APE L+ + + DV++ G L + G+
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 31/150 (20%), Positives = 62/150 (41%), Gaps = 14/150 (9%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
Q +H +I++L G + + ++ E Y L L+ + + +
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITE---YMENGA-LDKFLREKDGEFSVLQLVGMLRGI 156
Query: 172 ANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
A + YL + V R++ NIL K+ DF LS+ + + ++ G
Sbjct: 157 AAGMKYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GG 210
Query: 231 ---LEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ + APE ++ + +DV+SFG ++
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVM 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 50/264 (18%), Positives = 99/264 (37%), Gaps = 57/264 (21%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYE-----------------PAGYCTLADRLYGPLQT 154
++ ++ +I+KL+G C + L++E + +D +
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 155 HLEPLLLTHR--LKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209
P L+ L +A + A +AYL +F V R++ N L E K+ DF
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADF 218
Query: 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHL 269
LS++I + + + PE + Y ++DV+++G +L + +
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS------- 271
Query: 270 SRLA----TGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCL 325
G ++ + V ++R + P +C L+ Y L C
Sbjct: 272 --YGLQPYYGMAH----EEVIYYVRDGNILAC-P-----ENC-----PLELY-NLMRLCW 313
Query: 326 SHSAEDRPTMIDVAKKLRQMYRTS 349
S DRP+ + + L++M +
Sbjct: 314 SKLPADRPSFCSIHRILQRMCERA 337
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSKSIPEGKTHIKAS--- 225
A+A+ +L + + R+++P NIL + + K+ DF L I S
Sbjct: 121 ASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 226 --TAIGSLEFAAPEYLTTGY-----YNEKTDVYSFGKLLLVLLTG 263
T GS E+ APE + Y+++ D++S G +L +LL+G
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 22/95 (23%), Positives = 40/95 (42%), Gaps = 7/95 (7%)
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+ + YL G +V ++I+P N+L K+ +++++ T+ GS
Sbjct: 120 DGLEYLHSQG----IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 232 EFAAPEYL--TTGYYNEKTDVYSFGKLLLVLLTGR 264
F PE + K D++S G L + TG
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 22/79 (27%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+V+R+++P NIL + ++ D L+ +PEG+T +G++ + APE + Y
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYT 363
Query: 246 EKTDVYSFGKLLLVLLTGR 264
D ++ G LL ++ G+
Sbjct: 364 FSPDWWALGCLLYEMIAGQ 382
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 6e-07
Identities = 56/253 (22%), Positives = 93/253 (36%), Gaps = 60/253 (23%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
++H I+KLIG E E ++ E Y L Y L+ + L + + +++
Sbjct: 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGH--Y--LERNKNSLKVLTLVLYSLQI 122
Query: 172 ANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
A+AYL V R+I NIL KL DF LS+ I E + + KAS
Sbjct: 123 CKAMAYLESINC------VHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTR 175
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG-------SNFFI 281
+++ +PE + + +DV+ F V + + + G N +
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFA----VCMW--------EILSFGKQPFFWLENKDV 223
Query: 282 TDRVEKFIRSNGY-----MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI 336
+EK G PV+ Y L +C + DRP
Sbjct: 224 IGVLEK-----GDRLPKPDLCPPVL---------------Y-TLMTRCWDYDPSDRPRFT 262
Query: 337 DVAKKLRQMYRTS 349
++ L +Y+
Sbjct: 263 ELVCSLSDVYQME 275
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 31/150 (20%), Positives = 64/150 (42%), Gaps = 14/150 (9%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
Q +H +I++L G +++ +V E +L + L+ H + + +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--F--LRKHDAQFTVIQLVGMLRGI 156
Query: 172 ANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
A+ + YL G+ V R++ NIL K+ DF L + + + + G
Sbjct: 157 ASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GG 210
Query: 231 ---LEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ + +PE + + +DV+S+G +L
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 9e-07
Identities = 36/146 (24%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 113 QMNHKSILKLIGCCLEAEMPAL-VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
Q+ H+ +++L + P + E +L D L P L L L +A +
Sbjct: 64 QLQHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKL---LDMAAQI 118
Query: 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
A +A++ + + R++ NIL + + K+ DF L++ I + + + +
Sbjct: 119 AEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PI 174
Query: 232 EFAAPEYLTTGYYNEKTDVYSFGKLL 257
++ APE + G + K+DV+SFG LL
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILL 200
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 44/264 (16%), Positives = 86/264 (32%), Gaps = 77/264 (29%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
S+++HK ++ G C+ + LV E + +L Y L+ + + + +L+VA +
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT--Y--LKKNKNCINILWKLEVAKQL 122
Query: 172 ANAVAYL---RFGFPQPVVFRNIEPWNIL--------FQEEYAAKLFDFSLSKSIPE--- 217
A A+ +L + N+ NIL KL D +S ++
Sbjct: 123 AAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 218 GKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG 276
+ I + PE + N TD +SFG L + +GG
Sbjct: 177 LQERIP---------WVPPECIENPKNLNLATDKWSFG----TTLW--------EICSGG 215
Query: 277 -------SNFFITDRVEKFIRSNGYM---NIDPVIVGDRSCFRKEEKLQAYVELAFKCLS 326
+ R +F + + L C+
Sbjct: 216 DKPLSALDS----QRKLQFYEDRHQLPAPKAAEL----------------A-NLINNCMD 254
Query: 327 HSAEDRPTMIDVAKKLRQMYRTSV 350
+ + RP+ + + L ++ +
Sbjct: 255 YEPDHRPSFRAIIRDLNSLFTPDL 278
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 30/162 (18%), Positives = 59/162 (36%), Gaps = 22/162 (13%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYC---TLADRL--YGPLQTHLEPLLLTHRLK 166
+ ++ I+ L G E + E +L + G L E L
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFME---LLEGGSLGQLIKQMGCLP---EDRALY---- 154
Query: 167 VAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKLFDFSLSKSIPE---GKTHI 222
+ + YL + ++ +++ N+L + A L DF + + GK+ +
Sbjct: 155 YLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
Query: 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
G+ APE + + K D++S ++L +L G
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 38/152 (25%), Positives = 64/152 (42%), Gaps = 15/152 (9%)
Query: 106 NNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC---TLADRLYGPLQTHLEPLLLT 162
I Q + ++K G + +V E YC +++D + + + L
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVME---YCGAGSVSDII----RLRNKTLTED 125
Query: 163 HRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222
+ T + YL F + R+I+ NIL E AKL DF ++ + + T
Sbjct: 126 EIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--TMA 180
Query: 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFG 254
K +T IG+ + APE + YN D++S G
Sbjct: 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 28/168 (16%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYE-----------------PAGYCTLADRLYGPLQT 154
Q+NH ++KL G C + L+ E GY
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 155 HLEPLLLTHR--LKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209
H + LT + A + + + YL + V R++ NIL E K+ DF
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDF 194
Query: 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
LS+ + E +++K S +++ A E L Y ++DV+SFG LL
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 24/94 (25%), Positives = 43/94 (45%), Gaps = 7/94 (7%)
Query: 172 ANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
YL R V+ R+++ N+ E+ K+ DF L+ + K G+
Sbjct: 151 VLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK--VLCGT 204
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ APE L+ ++ + DV+S G ++ LL G+
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSL 231
+ V Y R VV R+++P N+L AK+ DF LS + +G+ T+ GS
Sbjct: 127 SGVDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSP 179
Query: 232 EFAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGR 264
+AAPE ++ Y + D++S G +L LL G
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 36/152 (23%), Positives = 62/152 (40%), Gaps = 15/152 (9%)
Query: 105 FNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLT-- 162
FN +V H +++++ L E ++ E + G L + + L
Sbjct: 90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME---FLQG-----GALTDIVSQVRLNEE 141
Query: 163 HRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222
V A+AYL Q V+ R+I+ +IL + KL DF I K
Sbjct: 142 QIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVP 196
Query: 223 KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFG 254
K + +G+ + APE ++ Y + D++S G
Sbjct: 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLG 228
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 1e-06
Identities = 24/94 (25%), Positives = 43/94 (45%), Gaps = 7/94 (7%)
Query: 172 ANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGS 230
YL R V+ R+++ N+ E+ K+ DF L+ + K G+
Sbjct: 125 VLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK--VLCGT 178
Query: 231 LEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+ APE L+ ++ + DV+S G ++ LL G+
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 30/119 (25%), Positives = 57/119 (47%), Gaps = 10/119 (8%)
Query: 146 DRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205
D++ E +L KV++ + YLR ++ R+++P NIL K
Sbjct: 119 DQVLKKAGRIPEQILG----KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIK 172
Query: 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
L DF +S + A++ +G+ + +PE L +Y+ ++D++S G L+ + GR
Sbjct: 173 LCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 38/154 (24%), Positives = 63/154 (40%), Gaps = 19/154 (12%)
Query: 105 FNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC---TLADRL-YGPLQTHLEPLL 160
N I+ + + +I+ + L + +V E Y +L D + + E +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVME---YLAGGSLTDVVTETCMD---EGQI 118
Query: 161 LTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220
V E A+ +L V+ R+I+ NIL + + KL DF I
Sbjct: 119 AA----VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI--TPE 169
Query: 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFG 254
K ST +G+ + APE +T Y K D++S G
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 40/265 (15%), Positives = 81/265 (30%), Gaps = 40/265 (15%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKV 167
+ + NH +I+ + +V Y + D + + L + + L+
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ- 135
Query: 168 AMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT-----HI 222
A+ Y+ V R+++ +IL + L + S+ H
Sbjct: 136 --GVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 223 KASTAIGSLEFAAPEYLT--TGYYNEKTDVYSFG-------------------KLLLVLL 261
++ L + +PE L Y+ K+D+YS G ++LL L
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
Query: 262 TGRT---IGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKL-QAY 317
G + + A + + + + GD +
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310
Query: 318 VELAFKCLSHSAEDRPTMIDVAKKL 342
+CL + + RP+ A L
Sbjct: 311 HHFVEQCLQRNPDARPS----ASTL 331
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 19/80 (23%), Positives = 45/80 (56%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
++ R+++P NIL E+ ++ DF +K + +A++ +G+ ++ +PE LT
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 210
Query: 246 EKTDVYSFGKLLLVLLTGRT 265
+ +D+++ G ++ L+ G
Sbjct: 211 KSSDLWALGCIIYQLVAGLP 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 37/131 (28%), Positives = 59/131 (45%), Gaps = 17/131 (12%)
Query: 146 DRLY--------GPLQTHL--EPLLLTHRLKV-AMETANAVAYLRFGFPQPVVFRNIEPW 194
DRL G L HL E + R + E +A+ YL + VV+R+++
Sbjct: 221 DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLE 278
Query: 195 NILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSF 253
N++ ++ K+ DF L K I +G T T G+ E+ APE L Y D +
Sbjct: 279 NLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 335
Query: 254 GKLLLVLLTGR 264
G ++ ++ GR
Sbjct: 336 GVVMYEMMCGR 346
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 38/149 (25%), Positives = 62/149 (41%), Gaps = 15/149 (10%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRL-- 165
I SQ + + K G L+ ++ E Y G LEP L
Sbjct: 71 ITVLSQCDSPYVTKYYGSYLKDTKLWIIME---YLGG-----GSALDLLEPGPLDETQIA 122
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
+ E + YL + + R+I+ N+L E KL DF ++ + + T IK +
Sbjct: 123 TILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRN 177
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFG 254
T +G+ + APE + Y+ K D++S G
Sbjct: 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLG 206
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 41/211 (19%), Positives = 79/211 (37%), Gaps = 42/211 (19%)
Query: 141 YC---TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
C L D + + LE L + ++ A AV +L + ++ R+++P NI
Sbjct: 142 LCRKENLKDWMNR--RCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIF 196
Query: 198 FQEEYAAKLFDFSLSKSI----------PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEK 247
F + K+ DF L ++ + + +G+ + +PE + Y+ K
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 248 TDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSC 307
D++S G L+L L S R+ +R+ + P++ +
Sbjct: 257 VDIFSLG---LILFE---------LLYSFSTQMERVRIITDVRNLKF----PLLFTQKY- 299
Query: 308 FRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
+E + LS S +RP D+
Sbjct: 300 --PQEH-----MMVQDMLSPSPTERPEATDI 323
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 44/149 (29%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171
Q +H I+KLIG E ++ E L + LQ L L + A +
Sbjct: 71 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRS--F--LQVRKYSLDLASLILYAYQL 125
Query: 172 ANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI 228
+ A+AYL RF V R+I N+L KL DF LS+ + E T+ KAS
Sbjct: 126 STALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGK 178
Query: 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+++ APE + + +DV+ FG +
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCM 207
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 170 ETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIG 229
E A+ YL+ Q ++ R+++P NIL E + DF+++ +P +T G
Sbjct: 123 ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAG 176
Query: 230 SLEFAAPEYLTTGY---YNEKTDVYSFGKLLLVLLTGRT 265
+ + APE ++ Y+ D +S G LL GR
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 20/79 (25%), Positives = 40/79 (50%), Gaps = 2/79 (2%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+++R+++P N+L ++ ++ D L+ + G+T K G+ F APE L Y+
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYD 367
Query: 246 EKTDVYSFGKLLLVLLTGR 264
D ++ G L ++ R
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 28/104 (26%), Positives = 47/104 (45%), Gaps = 11/104 (10%)
Query: 168 AMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
E A+ + + V R+I+P NIL +L DF + E T +++S
Sbjct: 181 LAEMVIAIDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSV 235
Query: 227 AIGSLEFAAPEYLTT-----GYYNEKTDVYSFGKLLLVLLTGRT 265
A+G+ ++ +PE L G Y + D +S G + +L G T
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 11/96 (11%)
Query: 173 NAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAA--KLFDFSLSKSIPEGKTHIKASTAIG 229
+ V+Y + R+++ N L A K+ DF SKS + + +G
Sbjct: 127 SGVSYCHSMQ----ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVG 179
Query: 230 SLEFAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGR 264
+ + APE L Y + DV+S G L V+L G
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 34/173 (19%), Positives = 71/173 (41%), Gaps = 27/173 (15%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAG---------YC---TLADRLYGPLQTHLEPL 159
+++ H I++ LE + + C L D + G + +E
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEER 115
Query: 160 LLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI---- 215
+ L + ++ A AV +L + ++ R+++P NI F + K+ DF L ++
Sbjct: 116 ERSVCLHIFLQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 216 ------PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT 262
+ + + +G+ + +PE + Y+ K D++S G +L LL
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 23/80 (28%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
+++R+++ N++ E K+ DF + K +I +G T T G+ ++ APE + Y
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQPY 519
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
+ D ++FG LL +L G+
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQ 539
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 1e-05
Identities = 31/80 (38%), Positives = 47/80 (58%), Gaps = 4/80 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
+++R+++P NIL EE KL DF LSK SI K A + G++E+ APE + +
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGH 203
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
+ D +SFG L+ +LTG
Sbjct: 204 TQSADWWSFGVLMFEMLTGT 223
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 25/163 (15%), Positives = 66/163 (40%), Gaps = 26/163 (15%)
Query: 112 SQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD--------------RLYGPLQTHLE 157
+++ H +++ L+G + + ++++ YC+ D +T
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFS---YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 158 PLLLTHRLKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214
L + + + A + YL V +++ N+L ++ K+ D L +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ + ++ + + APE + G ++ +D++S+G +L
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 2e-05
Identities = 28/80 (35%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
+++R+++P NI+ + KL DF L K SI +G T G++E+ APE L +
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGTIEYMAPEILMRSGH 198
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
N D +S G L+ +LTG
Sbjct: 199 NRAVDWWSLGALMYDMLTGA 218
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 23/80 (28%), Positives = 44/80 (55%), Gaps = 4/80 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
+++R+++ N++ E K+ DF + K +I +G T T G+ ++ APE + Y
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQPY 198
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
+ D ++FG LL +L G+
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQ 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 23/80 (28%), Positives = 40/80 (50%), Gaps = 4/80 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
+++R+++ N+L E KL D+ + K + G T ST G+ + APE L Y
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDY 230
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
D ++ G L+ ++ GR
Sbjct: 231 GFSVDWWALGVLMFEMMAGR 250
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 10/103 (9%)
Query: 168 AMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAST 226
E A+ + GF + R+++P N+L + KL DF + + ++ T
Sbjct: 174 TAEVVLALDAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDT 228
Query: 227 AIGSLEFAAPEYLTT----GYYNEKTDVYSFGKLLLVLLTGRT 265
A+G+ ++ +PE L + GYY + D +S G L +L G T
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 25/80 (31%), Positives = 41/80 (51%), Gaps = 4/80 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
VV+R+I+ N++ ++ K+ DF L K I +G T T G+ E+ APE L Y
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDNDY 182
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
D + G ++ ++ GR
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 3e-05
Identities = 23/80 (28%), Positives = 40/80 (50%), Gaps = 4/80 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
+++R+++ N+L E KL D+ + K + G T ST G+ + APE L Y
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDY 187
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
D ++ G L+ ++ GR
Sbjct: 188 GFSVDWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 3e-05
Identities = 25/80 (31%), Positives = 43/80 (53%), Gaps = 4/80 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
+V+R+++ NIL ++ K+ DF + K ++ +T G+ ++ APE L Y
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEILLGQKY 195
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
N D +SFG LL +L G+
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQ 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 4/80 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
+++R+++ N+L E KL DF + K I G T +T G+ ++ APE L Y
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPEILQEMLY 201
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
D ++ G LL +L G
Sbjct: 202 GPAVDWWAMGVLLYEMLCGH 221
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 42/200 (21%), Positives = 77/200 (38%), Gaps = 29/200 (14%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNN----IVFASQMNHKSILKLIGCCLEAEMPA 133
Y G + +K + R I + HK+I++ +G E
Sbjct: 39 YAGRDLSNQVRIAIK---EIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95
Query: 134 LVYEPAGYC---TLADRL---YGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVV 187
+ E +L+ L +GPL+ + E + + + YL +V
Sbjct: 96 IFME---QVPGGSLSALLRSKWGPLKDN-EQTIG----FYTKQILEGLKYLH---DNQIV 144
Query: 188 FRNIEPWNILFQEEY-AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY--Y 244
R+I+ N+L K+ DF SK + + T G+L++ APE + G Y
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE--TFTGTLQYMAPEIIDKGPRGY 202
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
+ D++S G ++ + TG+
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 41/163 (25%), Positives = 64/163 (39%), Gaps = 35/163 (21%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRL---------YGPLQTHLEPLLLTHR- 164
+H +I+ L+G C L E A + L D L + L+ +
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 165 -LKVAMETANAVAYL---RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE--- 217
L A + A + YL +F + R++ NIL E Y AK+ DF LS+
Sbjct: 144 LLHFAADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 197
Query: 218 ---GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
G+ ++ + A E L Y +DV+S+G LL
Sbjct: 198 KTMGRLPVR---------WMAIESLNYSVYTTNSDVWSYGVLL 231
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 27/80 (33%), Positives = 40/80 (50%), Gaps = 4/80 (5%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSK-SIPEGKTHIKASTAIGSLEFAAPEYLTTGYY 244
+V+R+++P NIL + L DF L K +I T ST G+ E+ APE L Y
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPY 216
Query: 245 NEKTDVYSFGKLLLVLLTGR 264
+ D + G +L +L G
Sbjct: 217 DRTVDWWCLGAVLYEMLYGL 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 4e-04
Identities = 40/152 (26%), Positives = 66/152 (43%), Gaps = 21/152 (13%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC--TLADRLYGPLQTHLEPLLLTHRL 165
+ F ++ H + ++ GC L LV E YC + +D L + H +PL
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVME---YCLGSASDLL----EVHKKPLQEVEIA 157
Query: 166 KVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKAS 225
V +AYL ++ R+++ NIL E KL DF + + A+
Sbjct: 158 AVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APAN 208
Query: 226 TAIGSLEFAAPE---YLTTGYYNEKTDVYSFG 254
+ +G+ + APE + G Y+ K DV+S G
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 240
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 4e-04
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 20/155 (12%)
Query: 108 IVFASQMNHKSILKLIGCCLEAEMPALVYE--PAGYCT-LADRLYGPLQTHLEPLLLTHR 164
I + +H I+KL+G ++ E P G + L L EP +
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQV-- 121
Query: 165 LKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKA 224
V + A+ +L + ++ R+++ N+L E +L DF +S + T K
Sbjct: 122 --VCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKR 174
Query: 225 STAIGSLEFAAPE-----YLTTGYYNEKTDVYSFG 254
+ IG+ + APE + Y+ K D++S G
Sbjct: 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG 209
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 5e-04
Identities = 19/80 (23%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 186 VVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN 245
+++R+++P N+L ++ ++ DF +K + + T G+ E APE + + YN
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYN 216
Query: 246 EKTDVYSFGKLLLVLLTGRT 265
+ D ++ G L+ + G
Sbjct: 217 KAVDWWALGVLIYEMAAGYP 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.96 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.73 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.62 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.55 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.5 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.22 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.0 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.84 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.8 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.8 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.63 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.53 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.49 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.35 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.19 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.33 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.46 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.08 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.04 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.79 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-61 Score=433.09 Aligned_cols=264 Identities=19% Similarity=0.246 Sum_probs=217.9
Q ss_pred cCcccccccccCCCceEEEEEEEC------CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++|...+.| |+|+||.||+|++. ++..||||++........++|.+|+.+|++++|||||+++|+|.+++.++
T Consensus 13 ~~~~l~~~l-G~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKREL-GEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEE-EC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEE-eeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 567778888 99999999999873 35689999998776677788999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCcee
Q 018816 134 LVYEPAGYCTLADRLYGPL--------QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~--------~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 205 (350)
||||||++|+|.+++.... ......+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence 9999999999999996431 111247999999999999999999999 89999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHH
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 284 (350)
|+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||..... ..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~----------~~ 238 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----------NE 238 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----------HH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH----------HH
Confidence 999999987654443333444568999999999999999999999999999999999 8999975432 12
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
+...+..+...... ..+++++.+|+.+||+.||++|||+.+|++.|+++.+++
T Consensus 239 ~~~~i~~~~~~~~p------------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 239 VIECITQGRVLQRP------------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHHHHTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHcCCCCCCC------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 22233333211111 144578999999999999999999999999999997754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-61 Score=434.01 Aligned_cols=264 Identities=18% Similarity=0.225 Sum_probs=211.5
Q ss_pred cCcccccccccCCCceEEEEEEEC------CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++|...+.| |+|+||.||+|++. ++..||||++........++|.+|+.+|++++|||||+++|+|.+++.++
T Consensus 41 ~d~~l~~~L-G~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWEL-GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEE-EECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEE-ccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 567777888 99999999999874 45689999998777677788999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQ----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
||||||++|+|.+++..... ....++++.+++.++.||+.||.||| +++|+||||||+||||+.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence 99999999999999975321 11246999999999999999999999 899999999999999999999
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 282 (350)
+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---------- 266 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---------- 266 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH----------
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH----------
Confidence 99999999987655443333445569999999999999999999999999999999999 8999975432
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
..+...+..+...... ..+++++.+|+.+||+.||++|||+.+|++.|+.+.+.+
T Consensus 267 ~~~~~~i~~g~~~~~p------------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 267 TEAIDCITQGRELERP------------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHHHHHHHTCCCCCC------------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHcCCCCCCc------------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 1122233332211111 144568999999999999999999999999999998765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-60 Score=425.22 Aligned_cols=261 Identities=16% Similarity=0.231 Sum_probs=212.5
Q ss_pred CcccccccccCCCceEEEEEEEC------CCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 61 NYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++...+.| |+|+||.||+|.+. ++..||||++..... ...++|.+|+.++++++|||||+++|+|.+++.++
T Consensus 27 ~~~~~~~l-G~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 27 AVRFMEEL-GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GEEEEEEE-EECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HCeEeeEe-ccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45556778 99999999999972 456899999975432 34578999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY 202 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 202 (350)
||||||++|+|.++|..... .....+++..++.++.|||.||.||| +++||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence 99999999999999965321 11146899999999999999999999 89999999999999999999
Q ss_pred ceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchH
Q 018816 203 AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFI 281 (350)
Q Consensus 203 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~ 281 (350)
.+||+|||+|+...............||+.|+|||++.++.|+.++|||||||++|||+| |..||.....
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--------- 253 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------- 253 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---------
Confidence 999999999987654433333445669999999999999999999999999999999998 8999875432
Q ss_pred HHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
..+...+..+..... +..++..+.+|+.+||+.||++|||+.+|++.|+.+.+
T Consensus 254 -~~~~~~i~~~~~~~~------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 254 -QDVVEMIRNRQVLPC------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp -HHHHHHHHTTCCCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred -HHHHHHHHcCCCCCC------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 122233333221111 11456789999999999999999999999999987643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-59 Score=416.71 Aligned_cols=262 Identities=18% Similarity=0.236 Sum_probs=206.5
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.+++...+.| |+|+||+||+|++++ .||||.+... .....+.|.+|+.++++++|||||+++|+|.+ +.++|||
T Consensus 35 ~~~l~l~~~i-G~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRI-GSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEEC-CCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEE-eeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3567777888 999999999998754 6999998643 33456789999999999999999999998865 5689999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|||++|+|.+++.... ..+++.+++.++.|||.||.||| +++||||||||+||||+.++.+||+|||+|+...
T Consensus 111 Ey~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp ECCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EcCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 9999999999997543 57999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...........+||+.|||||++.+ +.|+.++|||||||++|||+||+.||..... ...+...+..+.
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~---------~~~~~~~~~~~~ 254 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN---------RDQIIFMVGRGY 254 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---------HHHHHHHHHTTC
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh---------HHHHHHHHhcCC
Confidence 4433333455679999999999864 4699999999999999999999999975432 112222232221
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..|.+.... ..+++.+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 255 ---~~p~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 255 ---ASPDLSKLY-----KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp ---CCCCSTTSC-----TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ---CCCCccccc-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 111111111 14557899999999999999999999999999887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=419.70 Aligned_cols=249 Identities=18% Similarity=0.207 Sum_probs=209.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
..|...+.| |+|+||.||+|++ .++..||||++........+.+.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus 74 ~~y~~~~~i-G~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEe-ecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 458888888 9999999999999 56779999999766555566789999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
|++|+|.+++.. ..+++..+..++.||+.||.||| +++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 153 ~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 153 LEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999864 46899999999999999999999 999999999999999999999999999999876543
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ...+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||..... . .....+.......+.
T Consensus 224 ~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---------~-~~~~~i~~~~~~~~~ 291 (346)
T 4fih_A 224 VP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---------L-KAMKMIRDNLPPRLK 291 (346)
T ss_dssp SC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------H-HHHHHHHHSSCCCCS
T ss_pred CC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---------H-HHHHHHHcCCCCCCC
Confidence 22 23456799999999999999999999999999999999999999975332 1 112222222111110
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ....++++.+|+.+||+.||++|||+.|+++
T Consensus 292 ~----------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 N----------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp C----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c----------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0144578999999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=419.87 Aligned_cols=250 Identities=17% Similarity=0.181 Sum_probs=203.3
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|...+.| |+|+||.||+|++ .++..||||++... .....+.+.+|+.+|++|+|||||++++++.+++.+||||
T Consensus 24 e~Y~~~~~l-G~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKI-GEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC-------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEE-ecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 578888998 9999999999999 66779999999754 2344677999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|||+||+|.+++..... ..+++..+..++.||+.||.||| +++|+||||||+||||+.++.+||+|||+|+...
T Consensus 103 Ey~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp ECCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred eCCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 99999999999964321 46789999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||..... ...+.... ......
T Consensus 177 ~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---------~~~~~~i~-~~~~~~ 244 (350)
T 4b9d_A 177 STV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM---------KNLVLKII-SGSFPP 244 (350)
T ss_dssp HHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHHHH-HTCCCC
T ss_pred CCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---------HHHHHHHH-cCCCCC
Confidence 321 123445699999999999999999999999999999999999999975322 12222222 222111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+. ...++++.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VS------------LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC------------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 134567999999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=412.75 Aligned_cols=249 Identities=17% Similarity=0.154 Sum_probs=210.7
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|++ .++..||+|.+.+.. ....+.+.+|+.+|++++|||||++++++.+.+.+|+
T Consensus 31 ~~dy~i~~~l-G~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKIL-GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEE-ecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3679999999 9999999999999 677799999997542 2345678999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
|||||+||+|.+++... +.+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 110 vmEy~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp EECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 99999999999999653 57999999999999999999999 99999999999999999999999999999998
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...........+.+||+.|+|||++.+..|+.++|||||||++|||++|++||..... .. +...+.+...
T Consensus 182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---------~~-~~~~i~~~~~ 251 (311)
T 4aw0_A 182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------GL-IFAKIIKLEY 251 (311)
T ss_dssp CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HH-HHHHHHHTCC
T ss_pred cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---------HH-HHHHHHcCCC
Confidence 7654444445567799999999999999999999999999999999999999974322 11 1222222221
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVA 339 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 339 (350)
.. . ...++++.+|+.+||+.||++|||+.|++
T Consensus 252 ~~-p------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DF-P------------EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CC-C------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CC-C------------cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11 1 12346789999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=419.00 Aligned_cols=275 Identities=16% Similarity=0.266 Sum_probs=223.0
Q ss_pred ccHHHHHHHhcCcccccccccCCCceEEEEEEECC------CceEEEEEecccch-hhHHHHHHHHHHHHhcCC-CCccc
Q 018816 50 FSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRD------RGPILVMKYRKSVR-YASERCFNNIVFASQMNH-KSILK 121 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~------~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~ 121 (350)
++.++++...++|...+.| |+|+||.||+|.+.+ .+.||||++..... ...+.+.+|+.+|.+++| ||||+
T Consensus 54 ~~~~~wEi~~~~~~l~~~L-G~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPL-GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEE-EECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccEecHHHeEEeeEE-ecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 4445555566889999998 999999999999732 24799999976533 445679999999999976 99999
Q ss_pred eeeeeecC-CcCeEEeecCCCCchhhhhhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEee
Q 018816 122 LIGCCLEA-EMPALVYEPAGYCTLADRLYGPLQT-----------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFR 189 (350)
Q Consensus 122 ~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 189 (350)
++|+|.+. +.+++|||||++|+|.++|...... ....+++.+++.++.|||.||.||| +++||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecC
Confidence 99998764 5789999999999999999653211 1145899999999999999999999 9999999
Q ss_pred ccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 018816 190 NIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGH 268 (350)
Q Consensus 190 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 268 (350)
||||+|||++.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |..||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987765544444555669999999999999999999999999999999998 899997
Q ss_pred CCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 269 LSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.... ...+...+..+...... ..+++++.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus 290 ~~~~---------~~~~~~~i~~g~~~~~p------------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 290 GVKI---------DEEFCRRLKEGTRMRAP------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp TCCC---------SHHHHHHHHHTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCH---------HHHHHHHHHcCCCCCCC------------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 5432 11223333333211111 13456789999999999999999999999999999876
Q ss_pred C
Q 018816 349 S 349 (350)
Q Consensus 349 ~ 349 (350)
+
T Consensus 349 ~ 349 (353)
T 4ase_A 349 N 349 (353)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=405.42 Aligned_cols=244 Identities=16% Similarity=0.192 Sum_probs=196.8
Q ss_pred ccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeec----CCcCeEE
Q 018816 63 SMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLE----AEMPALV 135 (350)
Q Consensus 63 ~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 135 (350)
.....| |+|+||.||+|.+ .++..||+|++... .....+.+.+|+.+|++++|||||+++++|.+ .+.++||
T Consensus 29 ~~~~~i-G~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEI-GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEE-ecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 445567 9999999999999 56679999998654 23446779999999999999999999999875 3468999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEeeccccCceEeCC-CCceeEcccCCC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP--VVFRNIEPWNILFQE-EYAAKLFDFSLS 212 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~Nill~~-~~~~kl~Dfg~~ 212 (350)
||||++|+|.+++... ..+++..+..++.||+.||.||| +++ |+||||||+||||+. ++.+||+|||+|
T Consensus 108 mEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla 179 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence 9999999999999653 57999999999999999999999 777 999999999999985 799999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
+..... ...+.+||+.|+|||++.+ .|+.++|||||||++|||+||++||..... ...+...+...
T Consensus 180 ~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~---------~~~~~~~i~~~ 245 (290)
T 3fpq_A 180 TLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---------AAQIYRRVTSG 245 (290)
T ss_dssp GGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---------HHHHHHHHTTT
T ss_pred EeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc---------HHHHHHHHHcC
Confidence 864332 2345579999999998864 699999999999999999999999974322 11122222221
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... +.+. ...++++.+|+.+||+.||++|||+.++++
T Consensus 246 ~~~---~~~~--------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 246 VKP---ASFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCC---GGGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC---CCCC--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1110 123357899999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-58 Score=414.19 Aligned_cols=256 Identities=14% Similarity=0.081 Sum_probs=207.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.+.|...+.| |+|+||.||+|++ .++..||||++..... ..+|+.++++++|||||++++++.+++.+|||||
T Consensus 57 ~~~~~~~~~l-G~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRV-GRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTEEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhheEeCcEe-ccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3567777788 9999999999999 6677999999975421 2479999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-ceeEcccCCCccCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLSKSIP 216 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 216 (350)
||+||+|.+++... +.+++..+..++.||+.||.||| +++|+||||||+||||+.++ .+||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999653 57999999999999999999999 99999999999999999987 69999999998765
Q ss_pred CCCcc---ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 217 EGKTH---IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 217 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
..... ......+||+.|||||++.+..|+.++|||||||++|||++|++||...... .+. .... ...
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~---~~i~-~~~ 272 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG------PLC---LKIA-SEP 272 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS------CCH---HHHH-HSC
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHH---HHHH-cCC
Confidence 43221 1233456999999999999999999999999999999999999999754321 111 1111 111
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
... . .+ +..+++.+.+|+.+||+.||++|||+.||++.|......
T Consensus 273 ~~~-~-~~--------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 273 PPI-R-EI--------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp CGG-G-GS--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCc-h-hc--------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 110 0 00 014457899999999999999999999999999887653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=420.99 Aligned_cols=249 Identities=18% Similarity=0.204 Sum_probs=210.1
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
+.|...+.| |+|+||.||+|++ .++..||||++........+.+.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus 151 ~~y~~~~~i-G~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEe-ccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 468888888 9999999999999 66779999999766555567789999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
|+||+|.+++.. ..+++.++..++.||+.||.||| +++||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 230 ~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 230 LEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp CTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 999999999864 46899999999999999999999 999999999999999999999999999999876543
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ...+.+||+.|||||++.+..|+.++|||||||++|||++|.+||..... . .+...+.......
T Consensus 301 ~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---------~-~~~~~i~~~~~~~-- 366 (423)
T 4fie_A 301 VP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---------L-KAMKMIRDNLPPR-- 366 (423)
T ss_dssp CC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------H-HHHHHHHHSCCCC--
T ss_pred Cc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---------H-HHHHHHHcCCCCC--
Confidence 22 23456799999999999999999999999999999999999999975332 1 1122222222111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+... ..+++++.+|+.+||+.||++|||+.|+++
T Consensus 367 --~~~~------~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 367 --LKNL------HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --CSCT------TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --Cccc------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1000 134567899999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-57 Score=405.36 Aligned_cols=274 Identities=18% Similarity=0.193 Sum_probs=203.8
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCC----cCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE----MPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv 135 (350)
++|...+.| |+|+||+||+|++. +..||||++...... ...+..|+..+.+++|||||+++++|.+++ .++||
T Consensus 3 r~i~L~~~i-G~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESI-GKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEE-EECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEE-eeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 456777788 99999999999986 459999999764321 222345666667899999999999998654 47999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFG-----FPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
||||++|+|.+++.. .++++..+.+++.|++.||.|||+. +..+|+||||||+|||++.++.+||+|||
T Consensus 80 ~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 999999999999965 4689999999999999999999932 12399999999999999999999999999
Q ss_pred CCccCCCCCccc--cccccccCCCCCCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCC-----
Q 018816 211 LSKSIPEGKTHI--KASTAIGSLEFAAPEYLTTG------YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGS----- 277 (350)
Q Consensus 211 ~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~----- 277 (350)
+|+......... .....+||+.|+|||++.+. .++.++|||||||++|||+||.+|+..........
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 998765433221 22345699999999998754 46789999999999999999998875433211000
Q ss_pred cchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 278 NFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
...........+... ..+|.+..... ..+.+..+.+|+.+||+.||++||||.+|++.|+++.++
T Consensus 234 ~~~~~~~~~~~~~~~---~~rp~~p~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQ---KLRPNIPNRWQ---SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHTTS---CCCCCCCGGGG---SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHhcc---cCCCCCCcccc---chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 001112222222221 12222211111 116678899999999999999999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=395.36 Aligned_cols=246 Identities=22% Similarity=0.259 Sum_probs=192.7
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|++ .++..||+|.+.+.. ....+.+.+|+.++++++|||||++++++.+.+.+++
T Consensus 12 ig~Y~i~~~l-G~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTL-GEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp --CCEEEEEE-EC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eeCeEEEEEE-ecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3689999998 9999999999999 667899999987542 2335678999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+ +|+|.+++... +.+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 91 vmEy~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI 161 (275)
T ss_dssp EEECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred EEeCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence 99999 68999998654 57999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
..... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... . .+...+.+..
T Consensus 162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---------~-~~~~~i~~~~ 228 (275)
T 3hyh_A 162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---------P-VLFKNISNGV 228 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------H-HHHHHHHHTC
T ss_pred cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---------H-HHHHHHHcCC
Confidence 64332 2345569999999999998876 5899999999999999999999974321 1 1222222222
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... . ...++++.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~-p------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 YTL-P------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCC-C------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC-C------------CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 1 123467899999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-56 Score=398.75 Aligned_cols=247 Identities=20% Similarity=0.163 Sum_probs=197.3
Q ss_pred cCcccccccccCCCceEEEEEEEC----CCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR----DRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~----~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++|...+.| |+|+||.||+|+.. .+..||+|.+.... ......+.+|+.+|++++|||||++++++.+++.+|
T Consensus 24 ~~Y~i~~~l-G~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVL-GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEE-ECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEE-ecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 579999999 99999999999872 35589999986542 223446889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+|||||+||+|.+++... +.+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+
T Consensus 103 ivmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccce
Confidence 999999999999999653 57999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... ...+.+||+.|+|||++.+..|+.++|||||||++|||++|++||..... .... ..+.+..
T Consensus 175 ~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---------~~~~-~~i~~~~ 242 (304)
T 3ubd_A 175 ESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---------KETM-TMILKAK 242 (304)
T ss_dssp C-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHH-HHHHHCC
T ss_pred eccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---------HHHH-HHHHcCC
Confidence 6543222 23456799999999999999999999999999999999999999975332 1111 2222222
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM-----IDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~ 340 (350)
... | ...++++.+|+.+||+.||++|||+ +|+++
T Consensus 243 ~~~--p-----------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 LGM--P-----------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCC--C-----------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCC--C-----------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111 0 1345678999999999999999984 67764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=388.99 Aligned_cols=252 Identities=18% Similarity=0.271 Sum_probs=190.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC------
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAE------ 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 130 (350)
.++|+..+.| |+|+||.||+|++ .++..||||++.... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~l-G~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCL-GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEE-EECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEE-ecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 3578888998 9999999999999 667799999986543 344567899999999999999999999987654
Q ss_pred ------cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCce
Q 018816 131 ------MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA 204 (350)
Q Consensus 131 ------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 204 (350)
.+|+|||||++|+|.+++..... .....+..++.++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcE
Confidence 36899999999999999976421 234567778999999999999999 9999999999999999999999
Q ss_pred eEcccCCCccCCCCCccc----------cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccC
Q 018816 205 KLFDFSLSKSIPEGKTHI----------KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT 274 (350)
Q Consensus 205 kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 274 (350)
||+|||+|+......... .....+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--- 231 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--- 231 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---
Confidence 999999998765432211 1234569999999999999999999999999999999996 654211
Q ss_pred CCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 275 GGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... ....+..... .+. ....++.+.+|+.+||+.||++|||+.++++
T Consensus 232 -----~~~~-~~~~~~~~~~---p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -----ERVR-TLTDVRNLKF---PPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -----HHHH-HHHHHHTTCC---CHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHH-HHHHHhcCCC---CCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 1111111111 111 1244456789999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=386.20 Aligned_cols=265 Identities=13% Similarity=0.169 Sum_probs=201.4
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeec------CC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLE------AE 130 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 130 (350)
++|...+.| |+|+||.||+|++ .++..||||++.... ....+.+.+|+.+|++++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~l-G~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETI-GNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEE-ecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 568888998 9999999999999 677799999996542 2445678899999999999999999998764 35
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
.+|||||||+ |+|.+++... +.+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecc
Confidence 7899999995 7899998654 57999999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCc--cccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 211 LSKSIPEGKT--HIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 211 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
+|+.+..... .....+.+||+.|+|||++.+. .++.++||||+||++|||++|++||..... .........
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~------~~~l~~I~~ 277 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY------VHQLQLIMM 277 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH------HHHHHHHHH
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH------HHHHHHHHH
Confidence 9987644321 1224456799999999998875 479999999999999999999999975432 111111111
Q ss_pred HHHhcCCCccCc-----------cccCCCCccch---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNIDP-----------VIVGDRSCFRK---EEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~~~-----------~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
............ .+....+.... ...++++.+|+.+||+.||++|||+.|+++
T Consensus 278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 110000000000 00000000000 023467899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=381.33 Aligned_cols=201 Identities=17% Similarity=0.223 Sum_probs=171.7
Q ss_pred HHhcCcccccccccCCCceEEEEEEEC----CCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCc
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFLR----DRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEM 131 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~~----~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 131 (350)
...+.|...+.| |+|+||+||+|+++ .+..||+|++.... ...++.+|+.+|..+ +||||+++++++.+.+.
T Consensus 18 ~l~~~Y~i~~~l-G~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKI-GEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGTCEEEEEE-EECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CccCcEEEEEEE-ecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345789999999 99999999999872 45689999986653 345688999999998 69999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-CceeEcccC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKLFDFS 210 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg 210 (350)
+++||||+++|+|.+++ ..+++.++..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||
T Consensus 95 ~~lvmE~~~g~~L~~~~--------~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL--------NSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEECCCCCCHHHHH--------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeCCCcccHHHHH--------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999998 45899999999999999999999 9999999999999999877 799999999
Q ss_pred CCccCCCCCcc--------------------------ccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhC
Q 018816 211 LSKSIPEGKTH--------------------------IKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTG 263 (350)
Q Consensus 211 ~~~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg 263 (350)
+|+........ ......+||+.|+|||++.+. .|+.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99765432211 112345699999999999876 489999999999999999999
Q ss_pred CCCCCCCc
Q 018816 264 RTIGHLSR 271 (350)
Q Consensus 264 ~~p~~~~~ 271 (350)
+.||....
T Consensus 244 ~~Pf~~~~ 251 (361)
T 4f9c_A 244 RYPFYKAS 251 (361)
T ss_dssp CSSSSCCS
T ss_pred CCCCCCCC
Confidence 99997543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=373.38 Aligned_cols=289 Identities=27% Similarity=0.382 Sum_probs=234.7
Q ss_pred ccccHHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeee
Q 018816 48 RSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCL 127 (350)
Q Consensus 48 ~~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 127 (350)
..+++.++...+++|...+.| |+|+||.||+|.+.++..||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 105 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLI-GHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCS-CBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred eeecHHHHHHHHhccCcccee-ecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 445666677788999999999 9999999999999878899999988766666788999999999999999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
+.+..++||||+++++|.+++...... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 106 ERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CTTCCEEEEECCTTCBTGGGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEEC
T ss_pred CCCeEEEEEEcCCCCcHHHHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEe
Confidence 999999999999999999998654221 136899999999999999999999 8999999999999999999999999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|||++................||+.|+|||++.+..++.++|||||||++|+|++|+.||....+. .......+...
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~---~~~~~~~~~~~ 258 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR---EMVNLAEWAVE 258 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS---SCCCHHHHTHH
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH---HHHHHHHHhhh
Confidence 999998654333222233445899999999999899999999999999999999999999765432 12223333333
Q ss_pred HHHhcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 288 FIRSNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 288 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
...... ...+++...... ....+..+.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 259 SHNNGQLEQIVDPNLADKI----RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHTTTCCCSSSSSSCTTCS----CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccccHHHhcChhhcccc----CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 322222 333344333222 237888999999999999999999999999999998653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=397.15 Aligned_cols=252 Identities=16% Similarity=0.157 Sum_probs=211.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.++|...+.| |+|+||.||+|++ .++..||+|.+........+.+.+|+.+|+.++|||||++++++.+.+.+++|||
T Consensus 156 l~~Y~i~~~l-G~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEEL-GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEE-eeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3689999998 9999999999999 6677999999977665667789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC--CceeEcccCCCccC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE--YAAKLFDFSLSKSI 215 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~ 215 (350)
||+||+|.+++.... ..+++.++..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 235 ~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 235 FMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp CCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred ecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999999986532 46899999999999999999999 9999999999999999854 89999999999887
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||..... . .....+......
T Consensus 308 ~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---------~-~~~~~i~~~~~~ 374 (573)
T 3uto_A 308 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---------D-ETLRNVKSCDWN 374 (573)
T ss_dssp CTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---------H-HHHHHHHTTCCC
T ss_pred cCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---------H-HHHHHHHhCCCC
Confidence 54432 3345699999999999999999999999999999999999999975432 1 112222222222
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..++.+ ...++.+.+|+.+||+.||++|||+.|+++
T Consensus 375 ~~~~~~---------~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 MDDSAF---------SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCSGGG---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcccc---------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 134567899999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=392.64 Aligned_cols=249 Identities=16% Similarity=0.141 Sum_probs=200.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHH---HHHHHHhcCCCCccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFN---NIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
.++|...++| |+|+||.||+|+. .++..||+|.+.+..- .....+.+ ++.+++.++|||||++++++.+.+.
T Consensus 188 lddf~i~k~L-G~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRII-GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEE-ecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 3689999998 9999999999999 6677999999975421 12223333 4667777899999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
+|+|||||+||+|.++|... +.+++..+..++.||+.||.||| +++||||||||+||||+.+|++||+|||+
T Consensus 267 lylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccce
Confidence 99999999999999999653 57999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
|+...... ..+.+||+.|+|||++.. ..|+.++|||||||++|||++|.+||...... ... .+.....
T Consensus 339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~------~~~-~i~~~i~ 407 (689)
T 3v5w_A 339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK------DKH-EIDRMTL 407 (689)
T ss_dssp CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC------CHH-HHHHHHH
T ss_pred eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHH-HHHHhhc
Confidence 98765432 345679999999999975 47999999999999999999999999753321 111 1111221
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 340 (350)
...... . ...++++.+|+.+||+.||++|++ +.||++
T Consensus 408 ~~~~~~-p------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 408 TMAVEL-P------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HCCCCC-C------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCCC-C------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111111 0 134567899999999999999998 677764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=367.44 Aligned_cols=290 Identities=28% Similarity=0.457 Sum_probs=233.5
Q ss_pred CCcccccHHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCcccee
Q 018816 45 NPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLI 123 (350)
Q Consensus 45 ~~~~~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~ 123 (350)
...+.++..++...+++|...+.| |+|+||.||+|...++..||+|++..... .....+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNIL-GRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEE-ECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeE-ecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 346779999999999999999999 99999999999987788999999876532 2234688999999999999999999
Q ss_pred eeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC---CeEeeccccCceEeCC
Q 018816 124 GCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ---PVVFRNIEPWNILFQE 200 (350)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---~ivH~dlkp~Nill~~ 200 (350)
+++.+....++||||+++++|.+++...... ...+++..+..++.|++.||.||| +. +|+||||||+|||++.
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECT
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECC
Confidence 9999999999999999999999999765322 246999999999999999999999 66 9999999999999999
Q ss_pred CCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcch
Q 018816 201 EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF 280 (350)
Q Consensus 201 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~ 280 (350)
++.+||+|||++.......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....... .....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~ 247 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN-DDDVM 247 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT-TSCSB
T ss_pred CCCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc-ccchh
Confidence 9999999999998765433222 233459999999999998899999999999999999999999996332211 12223
Q ss_pred HHHHHHHHHHhcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 281 ITDRVEKFIRSNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 281 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
...+......... ....+..+.... ....+..+.+++.+||+.||++|||+.+|++.|++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 248 LLDWVKGLLKEKKLEALVDVDLQGNY----KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHHTTTTSSCCSTTSSCTTCTTSC----CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHhhchhhhhhcChhhcccc----CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 3333333322222 223333333322 247788999999999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=354.25 Aligned_cols=285 Identities=26% Similarity=0.368 Sum_probs=227.8
Q ss_pred CCcccccHHHHHHHhcCcccc------cccccCCCceEEEEEEECCCceEEEEEecccc----hhhHHHHHHHHHHHHhc
Q 018816 45 NPIRSFSSEDLKTAINNYSMR------NITIDEIEGYILYMGFLRDRGPILVMKYRKSV----RYASERCFNNIVFASQM 114 (350)
Q Consensus 45 ~~~~~~~~~~l~~~~~~f~~~------~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~----~~~~~~~~~E~~~l~~l 114 (350)
.+...|++.++..++++|+.. +.| |+|+||.||+|... +..||+|++.... ....+.+.+|+.+++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~l-g~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l 87 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKM-GEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC 87 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEE-EECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCcc-ccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence 356789999999999999988 778 99999999999985 4599999986532 23457789999999999
Q ss_pred CCCCccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccC
Q 018816 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPW 194 (350)
Q Consensus 115 ~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 194 (350)
+||||+++++++.+.+..++||||+++++|.+++..... ..++++..+..++.||+.||.||| +.+|+|+||||+
T Consensus 88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~ 162 (307)
T 2nru_A 88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSA 162 (307)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHH
Confidence 999999999999999999999999999999999865321 146899999999999999999999 899999999999
Q ss_pred ceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccC
Q 018816 195 NILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT 274 (350)
Q Consensus 195 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 274 (350)
||+++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|.+||......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~- 240 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP- 240 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-
Confidence 99999999999999999987654433333344568999999998764 5899999999999999999999999765431
Q ss_pred CCCcchHHHHHHHHHHhcC---CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 275 GGSNFFITDRVEKFIRSNG---YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....... ....... ...+++.+.. .+...+..+.+++.+||+.||++|||+.+|++.|+++..+
T Consensus 241 ----~~~~~~~-~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 241 ----QLLLDIK-EEIEDEEKTIEDYIDKKMND-----ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp ----SBTTHHH-HHHHTTSCCHHHHSCSSCSC-----CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred ----HHHHHHH-HHhhhhhhhhhhhccccccc-----cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 1111111 1111111 1112222211 1236778899999999999999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=356.77 Aligned_cols=261 Identities=17% Similarity=0.221 Sum_probs=214.1
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|++........+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 9 ~~~~~~~~~l-G~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVL-GKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEE-ECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeecccee-cCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 3678888888 9999999999999 5677999999877666777889999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 88 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 88 YIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp CCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 999999999997532 56899999999999999999999 89999999999999999999999999999987644
Q ss_pred CCccc------------cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHH
Q 018816 218 GKTHI------------KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 218 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+..................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 32211 111456999999999999999999999999999999999999998754432212111211111
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.... .+ .+++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 241 ----~~~~----~~------------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 241 ----DRYC----PP------------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ----HHTC----CT------------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cccC----CC------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1100 00 223468899999999999999999999999998865
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=357.22 Aligned_cols=271 Identities=18% Similarity=0.164 Sum_probs=212.4
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc----CeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM----PAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~l 134 (350)
.++|...+.| |+|+||.||+|++.+ ..||+|++.... .......+|+.++.+++||||+++++++.+... .++
T Consensus 23 ~~~y~~~~~l-g~G~~g~Vy~~~~~~-~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVK-ARGRFGCVWKAQLLN-EYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEE-ECSTTCEEEEEEETT-EEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhhee-cccCceEEEEEEECC-CEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4688999998 999999999999874 599999996553 334456679999999999999999999987554 699
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC----------CeEeeccccCceEeCCCCce
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ----------PVVFRNIEPWNILFQEEYAA 204 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~dlkp~Nill~~~~~~ 204 (350)
||||+++|+|.+++.. ..+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+
T Consensus 100 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 9999999999999965 35899999999999999999999 88 99999999999999999999
Q ss_pred eEcccCCCccCCCCCccccccccccCCCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCc-
Q 018816 205 KLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-----YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN- 278 (350)
Q Consensus 205 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~- 278 (350)
||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||...........
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999999876554433334445699999999999863 466789999999999999999999976433210000
Q ss_pred -----chHHHHHHHHHHhcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 279 -----FFITDRVEKFIRSNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 279 -----~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
............... ...+...+.. ...++.+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK-------HAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGS-------SHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccc-------cchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 001111111111111 2222221111 25677899999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=349.41 Aligned_cols=250 Identities=18% Similarity=0.230 Sum_probs=209.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 19 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEE-EEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeee-ccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 4678888998 9999999999998 6777999999976655566778999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp CCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999865 35899999999999999999999 89999999999999999999999999999887654
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ................
T Consensus 169 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~~~~~~~~~~~ 237 (297)
T 3fxz_A 169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---------LRALYLIATNGTPELQ 237 (297)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------HHHHHHHHHHCSCCCS
T ss_pred ccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHhCCCCCCC
Confidence 332 23345699999999999999999999999999999999999999975432 1111122222111111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+ ...+..+.+|+.+||+.||++|||+.++++
T Consensus 238 ~~-----------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 238 NP-----------EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CG-----------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cc-----------cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11 134567899999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=351.18 Aligned_cols=270 Identities=20% Similarity=0.242 Sum_probs=206.1
Q ss_pred ccHHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeee
Q 018816 50 FSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCL 127 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 127 (350)
++..++....++|...+.| |+|+||.||+|.+.+ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~i~~~~y~i~~~l-G~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 27 MDGDDMDIPWCDLNIKEKI-GAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp -----CBCCGGGEEEEEEE-EECSSEEEEEEEETT-EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCcccccCChhHceeeeEe-ecCCCeEEEEEEECC-CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3334444456788989998 999999999998854 489999986543 344567899999999999999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEeeccccCceEeCCCCcee
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP--VVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~k 205 (350)
+.+..++||||+++++|.+++...... ..+++..++.++.||+.||.||| +.+ |+||||||+||+++.++.+|
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~k 179 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVK 179 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHH--HHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEE
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEE
Confidence 999999999999999999999764211 24899999999999999999999 888 99999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHH
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 180 L~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---------~~~~ 248 (309)
T 3p86_A 180 VCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---------AQVV 248 (309)
T ss_dssp ECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---------HHHH
T ss_pred ECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHH
Confidence 999999976543221 22344589999999999999999999999999999999999999975432 1111
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
...........+. ...+..+.+|+.+||+.||++|||+.+|++.|+.+.++.
T Consensus 249 ~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 249 AAVGFKCKRLEIP------------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHSCCCCCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHhcCCCCCCC------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1111111111111 134467899999999999999999999999999997753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=358.74 Aligned_cols=264 Identities=18% Similarity=0.240 Sum_probs=213.6
Q ss_pred hcCcccccccccCCCceEEEEEEEC--------CCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR--------DRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLE 128 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~--------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 128 (350)
.++|...+.| |+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++++ +||||++++++|.+
T Consensus 80 ~~~~~~~~~L-G~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPL-GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEE-SCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEE-eeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3678888888 99999999999872 33469999987653 34457799999999999 89999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceE
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQT-----------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 197 (350)
.+..++||||+++|+|.+++...... ....+++..++.++.||+.||.||| +++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEE
Confidence 99999999999999999999753210 1135889999999999999999999 899999999999999
Q ss_pred eCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCC
Q 018816 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGG 276 (350)
Q Consensus 198 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~ 276 (350)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---- 311 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 311 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence 99999999999999987654433333344457889999999999999999999999999999999 9999875332
Q ss_pred CcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.. +...+......... ..++..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus 312 --~~----~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 312 --EE----LFKLLKEGHRMDKP------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp --GG----HHHHHHTTCCCCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HH----HHHHHhcCCCCCCC------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11 11222222111111 13456799999999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=349.98 Aligned_cols=261 Identities=18% Similarity=0.217 Sum_probs=215.5
Q ss_pred ccccHHHHHHHhcC----------cccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCC
Q 018816 48 RSFSSEDLKTAINN----------YSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNH 116 (350)
Q Consensus 48 ~~~~~~~l~~~~~~----------f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h 116 (350)
..++.+++..+++. |.....| |+|+||.||+|++ .++..||||.+........+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-g~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKI-GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEe-ccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 45889999888865 6666777 9999999999999 4778999999977655566789999999999999
Q ss_pred CCccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCce
Q 018816 117 KSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196 (350)
Q Consensus 117 ~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 196 (350)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI 172 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSI 172 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHE
Confidence 9999999999999999999999999999999854 46899999999999999999999 89999999999999
Q ss_pred EeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCC
Q 018816 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG 276 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 276 (350)
+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---- 246 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---- 246 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----
T ss_pred EECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 999999999999999887654322 12344699999999999999999999999999999999999999874322
Q ss_pred CcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. ....+.......... ....+..+.+++.+||+.||++|||+.++++
T Consensus 247 -----~~-~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 247 -----VQ-AMKRLRDSPPPKLKN----------SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -----HH-HHHHHHHSSCCCCTT----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----HH-HHHHHhcCCCCCcCc----------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 112222221111110 0134467899999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=351.96 Aligned_cols=260 Identities=17% Similarity=0.250 Sum_probs=210.1
Q ss_pred cCcccccccccCCCceEEEEEEEC----CCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR----DRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~----~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
++|...+.| |+|+||.||+|.+. .+..||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 49 ~~y~i~~~l-G~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 49 SRIHIEKII-GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGEEEEEEE-EETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hHeEEeeEE-EeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 567777888 99999999999993 2335999999765 33456779999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 128 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999996542 46899999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 215 IPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 215 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ......+...
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----------~~~~~~~~~~ 270 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----------RDVISSVEEG 270 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----------HHHHHHHHTT
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----------HHHHHHHHcC
Confidence 65432211 1223346788999999998899999999999999999999 9999875432 1112222222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
...... ..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.+
T Consensus 271 ~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 271 YRLPAP------------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCCC------------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 111111 134567999999999999999999999999999997654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=344.19 Aligned_cols=259 Identities=19% Similarity=0.310 Sum_probs=213.5
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...+.| |+|+||.||+|.+.++..||+|++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEI-GSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEE-EECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeehee-cCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 3678888888 9999999999999777799999997653 2346789999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999996543 46899999999999999999999 999999999999999999999999999999866443
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... . .....+...... .
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---------~-~~~~~~~~~~~~-~ 227 (269)
T 4hcu_A 160 QYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---------S-EVVEDISTGFRL-Y 227 (269)
T ss_dssp HHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------H-HHHHHHHTTCCC-C
T ss_pred ccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---------H-HHHHHHhcCccC-C
Confidence 221 1223346788999999998999999999999999999999 8999874322 1 112222221111 1
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
.+ ...+..+.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 228 ~~-----------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 228 KP-----------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp CC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CC-----------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 11 123467899999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=363.58 Aligned_cols=261 Identities=20% Similarity=0.286 Sum_probs=213.1
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 112 ~~~~~~~~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 112 NHEDLVLGEQI-GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CGGGEEEEEEE-EEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred chHHeEEeeEe-ccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 45678888888 9999999999999 467799999987543 23345688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 191 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999986432 46899999999999999999999 899999999999999999999999999999865
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.............+++.|+|||++.++.++.++|||||||++|||++ |..||..... ......+..+..
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----------~~~~~~~~~~~~ 333 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----------QQTREFVEKGGR 333 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----------HHHHHHHHTTCC
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHHcCCC
Confidence 43322212222335778999999998999999999999999999998 9999875432 122233333221
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.... ..+++.+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 334 ~~~~------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 334 LPCP------------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1111 13446789999999999999999999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=350.66 Aligned_cols=248 Identities=19% Similarity=0.228 Sum_probs=207.3
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~l-G~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTI-GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEE-eeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 34689999999 9999999999999 67779999998654 23445678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 92 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp EECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred EEECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 99999999999998653 56899999999999999999999 89999999999999999999999999999986
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYN-EKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||..... . .....+....
T Consensus 164 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~-~~~~~i~~~~ 230 (328)
T 3fe3_A 164 FTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL---------K-ELRERVLRGK 230 (328)
T ss_dssp GSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH---------H-HHHHHHHHCC
T ss_pred cCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH---------H-HHHHHHHhCC
Confidence 654332 3445699999999999888765 899999999999999999999975432 1 1222222222
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... | ...+..+.+|+.+||+.||++|||+.++++
T Consensus 231 ~~~--p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 231 YRI--P-----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCC--C-----------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCC--C-----------CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 0 023457889999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=356.43 Aligned_cols=275 Identities=16% Similarity=0.268 Sum_probs=220.8
Q ss_pred cccHHHHHHHhcCcccccccccCCCceEEEEEEE------CCCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCcc
Q 018816 49 SFSSEDLKTAINNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSIL 120 (350)
Q Consensus 49 ~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv 120 (350)
.+...++....++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++.++ +||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPL-GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEE-EECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCcccccccccceeeceee-cCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 46666777778999999999 9999999999984 344689999997643 34456799999999999 789999
Q ss_pred ceeeeeecCC-cCeEEeecCCCCchhhhhhCCCCCC--------------------------------------------
Q 018816 121 KLIGCCLEAE-MPALVYEPAGYCTLADRLYGPLQTH-------------------------------------------- 155 (350)
Q Consensus 121 ~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~-------------------------------------------- 155 (350)
++++++.+.+ ..++||||+++|+|.+++.......
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999988755 4899999999999999997643210
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 156 -----------------LEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 156 -----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
...+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 112889999999999999999999 899999999999999999999999999999876544
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
..........||+.|+|||++.+..++.++|||||||++|||++ |..||...... ......+........
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------~~~~~~~~~~~~~~~ 317 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---------EEFCRRLKEGTRMRA 317 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---------HHHHHHHHHTCCCCC
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---------HHHHHHHHcCCCCCC
Confidence 43333445568999999999999999999999999999999998 99998754321 112222222221111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.. ..++.+.+++.+||+.||++|||+.+|++.|+++.++
T Consensus 318 ~~------------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 318 PD------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC------------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 11 2345789999999999999999999999999999765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=345.83 Aligned_cols=270 Identities=20% Similarity=0.256 Sum_probs=210.2
Q ss_pred hcCcccccccccCCCceEEEEEEE-----CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeec--CCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-----RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLE--AEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 131 (350)
.++|...+.| |+|+||.||+|++ .++..||+|++........+.+.+|+.++.+++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~l-g~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQL-GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhhee-eccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 3678888888 9999999999984 4667999999987766667889999999999999999999999864 456
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred eEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 899999999999999996542 45899999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCcc-ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCccc------CCCCcchHHHH
Q 018816 212 SKSIPEGKTH-IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLA------TGGSNFFITDR 284 (350)
Q Consensus 212 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~~~~~~~ 284 (350)
+......... .......++..|+|||++.+..++.++||||||+++|+|++|..|+...... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 9876543322 1223334777899999999999999999999999999999999987643210 00000111111
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....+........ +..+++.+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 241 ~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 241 LIELLKNNGRLPR------------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHTTCCCCC------------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhccCcCCC------------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 2222222111111 114457899999999999999999999999999999765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=340.26 Aligned_cols=257 Identities=16% Similarity=0.256 Sum_probs=212.3
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...+.| |+|+||.||+|.+.++..||+|.+.... ...+++.+|+.++.+++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKEL-GSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEE-EEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeee-ccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4678888888 9999999999999888789999997653 2346789999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp CTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred cCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999986532 45899999999999999999999 899999999999999999999999999999876554
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... .... ....... ...
T Consensus 158 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~-~~~~~~~-~~~ 225 (268)
T 3sxs_A 158 QYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---------SEVV-LKVSQGH-RLY 225 (268)
T ss_dssp CEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---------HHHH-HHHHTTC-CCC
T ss_pred hhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---------HHHH-HHHHcCC-CCC
Confidence 3322 223336778999999998899999999999999999999 9999874432 1111 1111111 111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.+ ...++.+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 226 ~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 226 RP-----------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CC-----------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CC-----------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11 1234578999999999999999999999999999865
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=340.22 Aligned_cols=259 Identities=14% Similarity=0.249 Sum_probs=210.6
Q ss_pred HhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
..++|...+.| |+|+||.||+|.+.++..||+|.+.... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 22 DPKDLTFLKEL-GTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CGGGEEEEEEC-C---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CHHHHHhHhhc-CCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 45688888998 9999999999999888899999997653 234678999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 100 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999997532 46899999999999999999999 89999999999999999999999999999986644
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... . .....+.......
T Consensus 173 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---------~-~~~~~~~~~~~~~ 241 (283)
T 3gen_A 173 DEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---------S-ETAEHIAQGLRLY 241 (283)
T ss_dssp HHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---------H-HHHHHHHTTCCCC
T ss_pred cccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---------h-HHHHHHhcccCCC
Confidence 3221 1223336788999999998899999999999999999998 9999875332 1 1122222221111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.+ ...++.+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 242 -~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 242 -RP-----------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -CC-----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC-----------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11 12345789999999999999999999999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=354.59 Aligned_cols=260 Identities=17% Similarity=0.234 Sum_probs=200.2
Q ss_pred hcCcccccccccCCCceEEEEEEEC----CCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR----DRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~----~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.++|...+.| |+|+||.||+|++. ++..||||.+... .....+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~~l-G~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVV-GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEE-EECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEE-eeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3578888888 99999999999874 4568999998754 3345677999999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 123 lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999997542 46899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 214 SIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 214 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||..... ......+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----------~~~~~~i~~ 265 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----------QDVIKAVDE 265 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----------HHHHHHHHT
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHHc
Confidence 765432211 1122235778999999999999999999999999999998 9999864321 111222222
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....... ..++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 266 ~~~~~~~------------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 266 GYRLPPP------------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TEECCCC------------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCC------------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1110000 13456799999999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=349.57 Aligned_cols=252 Identities=19% Similarity=0.183 Sum_probs=207.0
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh------hHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY------ASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
..+.|...+.| |+|+||.||+|.. .++..||+|.+...... ..+.+.+|+.++.+++||||+++++++.+..
T Consensus 10 ~~~~y~~~~~L-G~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 10 VEDFYDIGEEL-GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp GGGTEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred hhhceEEeeEE-eeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 34678888998 9999999999999 56779999998765321 3467899999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC----ceeE
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY----AAKL 206 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl 206 (350)
..++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 999999999999999999653 57899999999999999999999 89999999999999998877 7999
Q ss_pred cccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH
Q 018816 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
+|||++........ ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..... .. ..
T Consensus 161 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---------~~-~~ 227 (361)
T 2yab_A 161 IDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---------QE-TL 227 (361)
T ss_dssp CCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---------HH-HH
T ss_pred EecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---------HH-HH
Confidence 99999987654322 2345599999999999988999999999999999999999999975322 11 11
Q ss_pred HHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..+....... ++... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~i~~~~~~~-~~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 228 ANITAVSYDF-DEEFF--------SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHTTCCCC-CHHHH--------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhcCCCC-Cchhc--------cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222221111 11100 133467899999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=351.93 Aligned_cols=265 Identities=18% Similarity=0.249 Sum_probs=215.6
Q ss_pred HhcCcccccccccCCCceEEEEEEEC--------CCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeee
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLR--------DRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCL 127 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~--------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 127 (350)
..++|...+.| |+|+||.||+|.+. .+..||+|++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 67 ~~~~y~i~~~L-G~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 67 PRDRLVLGKPL-GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CGGGEEEEEEE-EECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred chhheEeeeEE-ecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34678888888 99999999999972 22479999987653 34457789999999999 8999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCce
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQT-----------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 196 (350)
+.+..++||||+++|+|.+++...... ....+++..++.++.||+.||.||| +.+|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 999999999999999999999654211 1135899999999999999999999 89999999999999
Q ss_pred EeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCC
Q 018816 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATG 275 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~ 275 (350)
|++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999987755443333444457889999999999999999999999999999999 9999874321
Q ss_pred CCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
......+.......... .++..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 300 -------~~~~~~~~~~~~~~~~~------------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 300 -------EELFKLLKEGHRMDKPS------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp -------HHHHHHHHTTCCCCCCS------------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHHHHHcCCCCCCCc------------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 12223333222111111 3346789999999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=367.01 Aligned_cols=265 Identities=19% Similarity=0.272 Sum_probs=215.5
Q ss_pred HHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 52 SEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 52 ~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
..++....++|...+.| |+|+||.||+|.++++..||||.+.... ...+.+.+|+.++++++||||+++++++. .+.
T Consensus 180 ~~~~~i~~~~~~~~~~l-G~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKL-GAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp TTCSBCCGGGEEEEEEE-ECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred ccceeechHHeEEEEEc-ccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 33445556788888888 9999999999999877899999997653 34678999999999999999999999986 667
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred cEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 8999999999999999975321 35889999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
++........ ......+|+.|+|||++....++.++|||||||++|||++ |..||..... . .+...+.
T Consensus 331 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---------~-~~~~~i~ 399 (454)
T 1qcf_A 331 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---------P-EVIRALE 399 (454)
T ss_dssp GGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------H-HHHHHHH
T ss_pred ceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---------H-HHHHHHH
Confidence 9876432211 1222336788999999998999999999999999999999 9999874321 1 1222222
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.+.... .+ ..+++.+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus 400 ~~~~~~-~~-----------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 400 RGYRMP-RP-----------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HTCCCC-CC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred cCCCCC-CC-----------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 221111 11 13456799999999999999999999999999998654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=344.28 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=215.4
Q ss_pred HhcCcccccccccCCCceEEEEEEE------CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 21 PRKNLVLGKTL-GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CGGGEEEEEEE-EECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred chhheeeeeee-cccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 35788888888 9999999999987 233689999987543 344577899999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeecc
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQT-------------------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI 191 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 191 (350)
..++||||+++++|.+++...... ....+++..++.++.||+.||.||| +.+|+|+||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence 999999999999999999754210 0134889999999999999999999 899999999
Q ss_pred ccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 018816 192 EPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLS 270 (350)
Q Consensus 192 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~ 270 (350)
||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987755444333444557889999999998899999999999999999999 99998754
Q ss_pred cccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 271 RLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.. .. ....+......... ...++.+.+++.+||+.||++|||+.+|++.|+++...
T Consensus 257 ~~------~~----~~~~~~~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PP------ER----LFNLLKTGHRMERP------------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CG------GG----HHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CH------HH----HHHHhhcCCcCCCC------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 32 11 12222222211111 13446799999999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=355.58 Aligned_cols=264 Identities=21% Similarity=0.260 Sum_probs=210.5
Q ss_pred hcCcccccccccCCCceEEEEEEEC------CCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
.++|...+.| |+|+||.||+|.+. ++..||+|++... .......+.+|+.++++++||||+++++++.+...
T Consensus 70 ~~~~~~~~~L-G~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGL-GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEEC-CCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEe-eeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3678888888 99999999999952 4458999998654 33445678899999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC---ceeE
Q 018816 132 PALVYEPAGYCTLADRLYGPLQ--THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY---AAKL 206 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl 206 (350)
.++||||+++|+|.+++..... .....+++..++.++.||+.||.||| +.+|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999865321 11245899999999999999999999 89999999999999999554 5999
Q ss_pred cccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHH
Q 018816 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ...
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----------~~~ 295 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------QEV 295 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------HHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----------HHH
Confidence 99999975432222222334457899999999999999999999999999999998 9999874322 112
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
...+......... ..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 296 ~~~i~~~~~~~~~------------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 296 LEFVTSGGRMDPP------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHcCCCCCCC------------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 2222222211111 13346789999999999999999999999999988653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=339.72 Aligned_cols=262 Identities=18% Similarity=0.241 Sum_probs=208.1
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 10 ~~~y~i~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKL-GGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEE-EEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEE-ccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3578888998 9999999999998 567799999985432 2445678999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++... .++++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 89 v~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 99999999999998653 46899999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ........... .
T Consensus 161 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---------~~~~~~~~~~~-~ 229 (294)
T 4eqm_A 161 LSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA---------VSIAIKHIQDS-V 229 (294)
T ss_dssp C--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---------HHHHHHHHSSC-C
T ss_pred ccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHhhcc-C
Confidence 6433221 22334589999999999999999999999999999999999999975432 11111121111 1
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhhc
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-TMIDVAKKLRQMYRT 348 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~~~~ 348 (350)
....+... ...++.+.+++.+||+.||++|| ++.++.+.|+++...
T Consensus 230 ~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 230 PNVTTDVR--------KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp CCHHHHSC--------TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred CCcchhcc--------cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11101110 13456799999999999999998 899999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=349.29 Aligned_cols=267 Identities=19% Similarity=0.259 Sum_probs=214.4
Q ss_pred HHHhcCcccccccccCCCceEEEEEEECC------CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeec
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFLRD------RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLE 128 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~~~------~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 128 (350)
....++|...+.| |+|+||.||+|.+.+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 43 ~~~~~~~~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDI-GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEE-EECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EecHHHCeeeeee-eecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3456889999998 999999999999843 3689999987653 3445678999999999999999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEee
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQT-------------------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFR 189 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 189 (350)
.+..++||||+++++|.+++...... ....+++..++.++.||+.||.||| +.+|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 99999999999999999998653211 0146899999999999999999999 8999999
Q ss_pred ccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 018816 190 NIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGH 268 (350)
Q Consensus 190 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 268 (350)
||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999976543332222334458899999999998899999999999999999999 999987
Q ss_pred CCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 269 LSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.... ......+......... ..++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 279 ~~~~----------~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 279 GMAH----------EEVIYYVRDGNILACP------------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TSCH----------HHHHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCh----------HHHHHHHhCCCcCCCC------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 4321 1122222222211111 13446799999999999999999999999999998654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=344.68 Aligned_cols=248 Identities=17% Similarity=0.143 Sum_probs=205.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+++. .++..||+|.+.+.. ......+.+|+.++..++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~l-G~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLL-GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEE-ecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 4688889998 9999999999999 567799999997642 2345678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 83 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 99999999999998653 46899999999999999999999 89999999999999999999999999999986
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...... .....+||+.|+|||++.+..++.++|+|||||++|||++|..||..... . .....+.....
T Consensus 155 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------~-~~~~~i~~~~~ 222 (337)
T 1o6l_A 155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------E-RLFELILMEEI 222 (337)
T ss_dssp SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---------H-HHHHHHHHCCC
T ss_pred cccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---------H-HHHHHHHcCCC
Confidence 433221 23445699999999999999999999999999999999999999974321 1 11122222111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
. +. ...+..+.+|+.+||+.||++|| ++.+|++
T Consensus 223 ~-~p------------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 R-FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C-CC------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C-CC------------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1 00 13346789999999999999999 8999876
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=343.88 Aligned_cols=251 Identities=16% Similarity=0.171 Sum_probs=206.2
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDL-GRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEE-ecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4678888998 9999999999999 566688999886543 445678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC--CCceeEcccCCCccC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE--EYAAKLFDFSLSKSI 215 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~ 215 (350)
|+++++|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||++...
T Consensus 82 ~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 82 FISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred eCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 999999999996532 46899999999999999999999 899999999999999987 789999999999877
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .... ..+......
T Consensus 155 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~-~~i~~~~~~ 221 (321)
T 1tki_A 155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---------QQII-ENIMNAEYT 221 (321)
T ss_dssp CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHH-HHHHHTCCC
T ss_pred CCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---------HHHH-HHHHcCCCC
Confidence 54332 2334589999999999988899999999999999999999999974322 1111 222222211
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.+ ...+.++.+|+.+||+.||++|||+.++++
T Consensus 222 ~~~~~~---------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAF---------KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHH---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhh---------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111000 133567899999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=341.57 Aligned_cols=267 Identities=19% Similarity=0.248 Sum_probs=216.8
Q ss_pred HhcCcccccccccCCCceEEEEEEE------CCCceEEEEEecccch-hhHHHHHHHHHHHHhc-CCCCccceeeeeecC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSVR-YASERCFNNIVFASQM-NHKSILKLIGCCLEA 129 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 129 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++.++ +||||+++++++.+.
T Consensus 21 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 21 PRNRLSFGKTL-GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CGGGEEEEEEE-EECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChhhhhHHHhh-CccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 34688888888 9999999999985 3456899999976533 4457789999999999 899999999999999
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCce
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQT-------------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 196 (350)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||.||| +.+|+|+||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence 9999999999999999998754211 0125899999999999999999999 89999999999999
Q ss_pred EeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCC
Q 018816 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATG 275 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~ 275 (350)
+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 254 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--
Confidence 999999999999999987765443333344457889999999999999999999999999999999 99998754321
Q ss_pred CCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
................ ...+..+.+++.+||+.||++|||+.++++.|+++..++
T Consensus 255 -------~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 255 -------SKFYKMIKEGFRMLSP------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp -------HHHHHHHHHTCCCCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -------hHHHHHhccCCCCCCc------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1122222222111111 133467899999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=347.54 Aligned_cols=254 Identities=17% Similarity=0.195 Sum_probs=208.5
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
...++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 26 ~~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEEL-GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEE-ecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 345789999999 9999999999999 567799999986542 344567889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC---CceeEcccC
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE---YAAKLFDFS 210 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg 210 (350)
+||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||
T Consensus 105 lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp EEECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence 999999999999998654 56899999999999999999999 8999999999999999865 459999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ......+.
T Consensus 177 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~----------~~~~~~i~ 243 (362)
T 2bdw_A 177 LAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----------HRLYAQIK 243 (362)
T ss_dssp TCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHH
T ss_pred cceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----------HHHHHHHH
Confidence 9987654322 2344699999999999988999999999999999999999999874321 11222233
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
........+.+ ...+..+.+|+.+||+.||++|||+.++++.
T Consensus 244 ~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 244 AGAYDYPSPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HTCCCCCTTGG---------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hCCCCCCcccc---------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 32222211111 1345678999999999999999999999863
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=337.39 Aligned_cols=264 Identities=16% Similarity=0.192 Sum_probs=203.6
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHh--cCCCCccceeeeeecC----CcC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQ--MNHKSILKLIGCCLEA----EMP 132 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~ 132 (350)
.++|...+.| |+|+||.||+|.+. +..||+|.+.... ...+..|.+++.. ++||||+++++++.+. ...
T Consensus 7 ~~~y~~~~~l-g~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECV-GKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEE-EECSSEEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEee-ccCCCcEEEEEEEC-CEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 4788999999 99999999999985 5599999986542 3456667777766 7899999999987643 458
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC-----CCCeEeeccccCceEeCCCCceeEc
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF-----PQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
++||||+++|+|.+++.. ..+++..++.++.||+.||.|||... +.+|+||||||+|||++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999954 46899999999999999999999422 5789999999999999999999999
Q ss_pred ccCCCccCCCCCccc--cccccccCCCCCCccccccC------CCCccchhHHHHHHHHHHHhC----------CCCCCC
Q 018816 208 DFSLSKSIPEGKTHI--KASTAIGSLEFAAPEYLTTG------YYNEKTDVYSFGKLLLVLLTG----------RTIGHL 269 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tg----------~~p~~~ 269 (350)
|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997654433221 12334699999999999876 456799999999999999999 777654
Q ss_pred CcccCCCCcchHHHHHHHHHHhcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 270 SRLATGGSNFFITDRVEKFIRSNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
.... ............... ...+.+.. .....+..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus 236 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPN-----DPSFEDMRKVVCVDQQRPNIPNRW-------FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCS-----SCCHHHHHHHHTTSCCCCCCCGGG-------GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC-----CcchhhhhHHHhccCCCCCCChhh-------ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3221 111112222221111 11111111 1126778999999999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=334.85 Aligned_cols=259 Identities=19% Similarity=0.301 Sum_probs=212.6
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...+.| |+|+||.||+|.+.++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEI-GSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEE-EEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEe-cCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 3678888888 99999999999997777999999976542 346789999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999996542 46899999999999999999999 899999999999999999999999999999866432
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. .......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... .. ....+.......
T Consensus 158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~-~~~~i~~~~~~~- 225 (267)
T 3t9t_A 158 QY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---------SE-VVEDISTGFRLY- 225 (267)
T ss_dssp HH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------HH-HHHHHHTTCCCC-
T ss_pred cc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---------HH-HHHHHhcCCcCC-
Confidence 21 11223347788999999998899999999999999999999 8999874321 11 112222221111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
.+ ...+..+.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 226 ~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 226 KP-----------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp CC-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CC-----------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11 123467899999999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=349.03 Aligned_cols=258 Identities=17% Similarity=0.268 Sum_probs=203.2
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCc----eEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRG----PILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~----~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
.++|...+.| |+|+||.||+|++ .++. .||+|.+.... ....+.+.+|+.++++++||||++++++|.++. .
T Consensus 14 ~~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEE-EEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEE-eeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 3678888898 9999999999998 3333 35888875432 244577999999999999999999999998754 7
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++|+||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcce
Confidence 89999999999999986542 56899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
+...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...... . ....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~----~~~~~~~ 234 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E----ISSILEK 234 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------G----HHHHHHT
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH------H----HHHHHHc
Confidence 87655443333334447889999999999999999999999999999999 99998754321 1 1222222
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
....... ..++..+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 235 ~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 235 GERLPQP------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TCCCCCC------------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCCC------------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2211111 1334678999999999999999999999999998865
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=342.46 Aligned_cols=251 Identities=17% Similarity=0.171 Sum_probs=205.7
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh------hHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY------ASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
.+.|...+.| |+|+||.||++.+ .++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 10 DDYYDTGEEL-GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHEEEEEEE-ECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccceEeceEE-eeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3568888888 9999999999999 56779999998754321 35778999999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC----ceeEc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY----AAKLF 207 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~ 207 (350)
.++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 99999999999999999653 56899999999999999999999 89999999999999999887 79999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .... .
T Consensus 161 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~-~ 227 (326)
T 2y0a_A 161 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---------QETL-A 227 (326)
T ss_dssp CCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---------HHHH-H
T ss_pred ECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---------HHHH-H
Confidence 9999987654322 2344599999999999988999999999999999999999999874321 1111 1
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+.........+.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 228 NVSAVNYEFEDEYF---------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHTCCCCCHHHH---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCcCcccc---------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12221111111100 123467899999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=346.97 Aligned_cols=266 Identities=19% Similarity=0.254 Sum_probs=211.2
Q ss_pred HhcCcccccccccCCCceEEEEEEE------CCCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEA 129 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 129 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 43 ~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVL-GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEE-EECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeee-cCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 45788888998 9999999999997 234479999987543 23457789999999999 899999999999999
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeecc
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQT------------------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI 191 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 191 (350)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||.||| +.+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence 9999999999999999999764321 0134789999999999999999999 899999999
Q ss_pred ccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 018816 192 EPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLS 270 (350)
Q Consensus 192 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~ 270 (350)
||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999986654433333344457889999999998999999999999999999998 99998754
Q ss_pred cccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 271 RLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
... ................ ...++.+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 279 ~~~---------~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PVD---------ANFYKLIQNGFKMDQP------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCS---------HHHHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcH---------HHHHHHHhcCCCCCCC------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 321 1122222222111111 12346799999999999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=355.41 Aligned_cols=254 Identities=18% Similarity=0.161 Sum_probs=207.9
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
...++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 8 ~~~~~Y~i~~~L-G~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEEL-GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEE-EEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEe-ccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 345789999998 9999999999998 677799999986543 234567889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC---CCCceeEcccC
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFS 210 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg 210 (350)
+||||+++|+|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||
T Consensus 87 lv~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 999999999999988754 56899999999999999999999 89999999999999998 46789999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ......+.
T Consensus 159 ~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~----------~~~~~~i~ 226 (444)
T 3soa_A 159 LAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ----------HRLYQQIK 226 (444)
T ss_dssp SCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH----------HHHHHHHH
T ss_pred eeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH----------HHHHHHHH
Confidence 9977654322 22345699999999999998999999999999999999999999974321 12223333
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+......+.+. ..++.+.+|+.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~---------~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 227 AGAYDFPSPEWD---------TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HTCCCCCTTTTT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCCCccccc---------cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 333222222211 33467899999999999999999999987
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=347.51 Aligned_cols=253 Identities=20% Similarity=0.227 Sum_probs=203.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~i~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTL-GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEE-ecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3688889999 9999999999999 5777999999865432 33456889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 85 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 999999999998653 46899999999999999999999 8999999999999999999999999999998664
Q ss_pred CCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
............||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .. ........ . .
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~----~~~~~~~~-~-~ 226 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS----CQ----EYSDWKEK-K-T 226 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT----SH----HHHHHHTT-C-T
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH----HH----HHHHHhcc-c-c
Confidence 3333333345569999999999987775 78999999999999999999999754321 00 11111111 1 1
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+ . ...+..+.+|+.+||+.||++|||+.++++
T Consensus 227 ~~~~-~---------~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 227 YLNP-W---------KKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TSTT-G---------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCc-c---------ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111 0 134567889999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=345.33 Aligned_cols=267 Identities=16% Similarity=0.249 Sum_probs=197.5
Q ss_pred HHhcCcccccccccCCCceEEEEEEECCCc----eEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFLRDRG----PILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~~~~~----~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
...++|...+.| |+|+||.||+|.+..+. .||+|.+... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 20 i~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRML-GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEE-EEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred cChhHeEEecee-cccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 345789999998 99999999999984432 7999998654 3345678999999999999999999999998776
Q ss_pred cC------eEEeecCCCCchhhhhhCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 131 MP------ALVYEPAGYCTLADRLYGPLQ-THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 131 ~~------~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
.. ++||||+++++|.+++..... .....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence 55 999999999999999854211 11136899999999999999999999 899999999999999999999
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 282 (350)
+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~-- 247 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------E-- 247 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------G--
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH------H--
Confidence 99999999987654443333334447889999999999999999999999999999999 89998754321 1
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
....+......... ...+..+.+|+.+||+.||++|||+.++++.|+++...+
T Consensus 248 --~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 248 --IYNYLIGGNRLKQP------------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp --HHHHHHTTCCCCCC------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred --HHHHHhcCCCCCCC------------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11112211111111 133467999999999999999999999999999997653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=333.97 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=203.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhh-------HHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYA-------SERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 18 DNEIEYEKQI-GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp STTEEEEEEC-CCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hccceehhcc-ccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 3678888888 9999999999999 677799999986543211 167889999999999999999999986654
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEeeccccCceEeCCCCc-----
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP--VVFRNIEPWNILFQEEYA----- 203 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~----- 203 (350)
++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+ |+|+||||+||+++.++.
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred --eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCcee
Confidence 79999999999999886543 57899999999999999999999 888 999999999999988776
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT--TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFI 281 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~ 281 (350)
+||+|||++...... .....||+.|+|||++. ...++.++|||||||++|+|++|..||...... .
T Consensus 168 ~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~ 235 (287)
T 4f0f_A 168 AKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-------K 235 (287)
T ss_dssp EEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-------H
T ss_pred EEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-------H
Confidence 999999999754332 23345899999999984 456889999999999999999999999754321 1
Q ss_pred HHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
...............+. ..+++.+.+++.+||+.||++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 236 IKFINMIREEGLRPTIP------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHHSCCCCCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHhccCCCCCCC------------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111111111111111 13456799999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=365.30 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=213.5
Q ss_pred HhcCcccccccccCCCceEEEEEEEC-CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
...+|...+.| |+|+||.||+|.+. .+..||||.+.... ...+.+.+|+.++++++||||++++++|.+....++||
T Consensus 218 ~~~~~~~~~~l-G~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 218 ERTDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CGGGEEEEEES-GGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred CHHHceeeeEe-cCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 45678888888 99999999999994 46689999987653 34678999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999999975322 46899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ......+++.|+|||++.+..++.++|||||||++|||++ |..||..... .. +...+......
T Consensus 370 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~------~~----~~~~~~~~~~~ 438 (495)
T 1opk_A 370 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQ----VYELLEKDYRM 438 (495)
T ss_dssp TCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GG----HHHHHHTTCCC
T ss_pred CCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH------HH----HHHHHHcCCCC
Confidence 43221 2223336788999999999999999999999999999999 9999875432 11 12222222111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
... ..+++.+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 439 ~~~------------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 439 ERP------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCC------------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 100 13456799999999999999999999999999998654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=336.22 Aligned_cols=264 Identities=11% Similarity=0.064 Sum_probs=211.2
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+.... ..+.+.+|+.++.++ +|+|++++++++.+....++||
T Consensus 9 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRI-GEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEE-EECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEE-eecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 4678888998 9999999999998 677799999986542 334578899999999 7999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc-----eeEcccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA-----AKLFDFSL 211 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~ 211 (350)
||+ +++|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++. +||+|||+
T Consensus 86 e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred Eec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 999 999999997532 46899999999999999999999 999999999999999987766 99999999
Q ss_pred CccCCCCCcc-----ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH
Q 018816 212 SKSIPEGKTH-----IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 212 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
+......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~~ 231 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA------TNKQKYE 231 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC------CHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc------ccHHHHH
Confidence 9876543321 1233456999999999999999999999999999999999999999864321 1111111
Q ss_pred HHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.......... .+... ..+++.+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 232 ~~~~~~~~~~-~~~~~--------~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 232 RIGEKKQSTP-LRELC--------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHHHHHHSC-HHHHT--------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHhhccCcc-HHHHH--------hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 1111100000 00000 02346799999999999999999999999999998754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=348.30 Aligned_cols=268 Identities=18% Similarity=0.236 Sum_probs=213.5
Q ss_pred HHHhcCcccccccccCCCceEEEEEEECC-C-----ceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeee
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFLRD-R-----GPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCL 127 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~~~-~-----~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 127 (350)
....++|...+.| |+|+||.||+|.+.. + ..||+|.+.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 42 ~~~~~~~~~~~~l-G~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 42 EFPRNNLQFGKTL-GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp BCCTTSEEEEEEE-EECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHceeeeEe-ccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3445788889998 999999999999833 2 269999987653 34456789999999999 8999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQ---------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 198 (350)
+.+..++||||+++|+|.+++..... .....+++..++.++.||+.||.||| +.+|+|+||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence 99999999999999999999864210 00145799999999999999999999 8999999999999999
Q ss_pred CCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCC
Q 018816 199 QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGS 277 (350)
Q Consensus 199 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~ 277 (350)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----- 272 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV----- 272 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS-----
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch-----
Confidence 9999999999999986644333323334457889999999998899999999999999999998 8999875322
Q ss_pred cchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 278 NFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
............... .+ ...+..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 273 ----~~~~~~~~~~~~~~~-~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 273 ----NSKFYKLVKDGYQMA-QP-----------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ----SHHHHHHHHHTCCCC-CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----hHHHHHHHhcCCCCC-CC-----------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 111222222221111 11 02346789999999999999999999999999988653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=360.49 Aligned_cols=261 Identities=22% Similarity=0.259 Sum_probs=207.8
Q ss_pred HHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
....++|...+.| |+|+||.||+|.+.++..||||.+.... ...+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 180 ~i~~~~~~~~~~l-G~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 180 EIPRESLRLEVKL-GQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp BCCGGGEEEEEEE-EECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccChhHceeeeee-cCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 3445678888888 9999999999999877789999997653 335679999999999999999999999876 678999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 257 ~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp ECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred ehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 999999999999964211 35899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||..... ......+..+..
T Consensus 331 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----------~~~~~~i~~~~~ 399 (452)
T 1fmk_A 331 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQVERGYR 399 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------HHHHHHHHTTCC
T ss_pred CCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHHcCCC
Confidence 433221 1222336789999999999999999999999999999999 9999874321 112222222211
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.... ..+++.+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus 400 ~~~~------------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 400 MPCP------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCC------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 1111 13456789999999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=356.36 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=208.4
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-cCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE-MPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e 137 (350)
.++|...+.| |+|+||.||+|.+.+. .||||.+.... ..+.+.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 192 ~~~~~~~~~l-G~G~fg~V~~~~~~~~-~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTI-GKGEFGDVMLGDYRGN-KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEETTE-EEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeee-cCcCCeeEEEEEecCC-eEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 4678888888 9999999999999754 99999997653 4577999999999999999999999987665 7899999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++....
T Consensus 268 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999975321 34789999999999999999999 89999999999999999999999999999985432
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. ....+++.|+|||++.+..++.++|||||||++|||++ |..||...... . +...+..+....
T Consensus 342 ~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~----~~~~i~~~~~~~ 406 (450)
T 1k9a_A 342 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------D----VVPRVEKGYKMD 406 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT------T----HHHHHHTTCCCC
T ss_pred cc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------H----HHHHHHcCCCCC
Confidence 21 12247889999999999999999999999999999998 99998754321 1 112222221111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
.. ..+++.+.+|+.+||+.||++|||+.+|++.|+++....
T Consensus 407 ~p------------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 407 AP------------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CC------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 10 134578999999999999999999999999999997653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=336.56 Aligned_cols=259 Identities=19% Similarity=0.224 Sum_probs=198.8
Q ss_pred HhcCcccccccccCCCceEEEEEEECC----CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRD----RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~----~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
..++|...+.| |+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus 13 ~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 13 QRERIELGRCI-GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CGGGEEEEEEE-EECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred ehHHeEEEeEe-eecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34678888888 999999999999832 3368999986543 344567899999999999999999999984 5678
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccc
Confidence 99999999999999996532 46899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... .. ...+..
T Consensus 164 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~------~~----~~~i~~ 232 (281)
T 1mp8_A 164 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DV----IGRIEN 232 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GH----HHHHHT
T ss_pred cccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH------HH----HHHHHc
Confidence 876543221 1223346789999999998899999999999999999997 99998754321 11 111222
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....... ...++.+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 233 ~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 233 GERLPMP------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 13456789999999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.17 Aligned_cols=273 Identities=17% Similarity=0.151 Sum_probs=213.3
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC--cCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAE--MPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 134 (350)
.+.|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.. ..++
T Consensus 8 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDIL-GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEe-cCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 3678888888 9999999999999 557799999987643 234567889999999999999999999988655 7799
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe----CCCCceeEcccC
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF----QEEYAAKLFDFS 210 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg 210 (350)
||||+++++|.+++...... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 99999999999999764221 24899999999999999999999 8999999999999999 888889999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccc--------cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLT--------TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
++........ .....||+.|+|||++. +..++.++|||||||++|||++|..||...... ....
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~ 233 (319)
T 4euu_A 162 AARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP-----RRNK 233 (319)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG-----GGCH
T ss_pred CceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-----chhH
Confidence 9987654332 23345899999999886 467899999999999999999999999754321 1222
Q ss_pred HHHHHHHHhcCCCccCc---------cccC--CCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 283 DRVEKFIRSNGYMNIDP---------VIVG--DRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~---------~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
..+...........+.. .+.. ..........+..+.+|+.+||+.||++|||+.++++...+.
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 23333333222111000 0000 011112247888999999999999999999999999988764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=333.43 Aligned_cols=262 Identities=19% Similarity=0.275 Sum_probs=199.5
Q ss_pred HhcCcccccccccCCCceEEEEEEECCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
..++|...+.| |+|+||.||+|.+.+ .||+|.+.... ....+.+.+|+.++++++||||+++++++ .....++|
T Consensus 22 ~~~~y~~~~~l-G~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRI-GSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEE-EECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEe-cCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34678888998 999999999998754 59999986543 34457789999999999999999999965 55678999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 98 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999996542 56899999999999999999999 899999999999999999999999999999765
Q ss_pred CCCCccccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
.............||+.|+|||++. +..++.++||||||+++|+|++|..||..... ...........
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~~~~~ 241 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---------RDQIIEMVGRG 241 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC---------HHHHHHHHHHT
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch---------HHHHHHHhccc
Confidence 4333222333455899999999986 56789999999999999999999999975432 12222233322
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
... +.+.... ..+++.+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus 242 ~~~---~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 242 SLS---PDLSKVR-----SNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCC---CCTTSSC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccC---cchhhcc-----ccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 211 1111100 1345789999999999999999999999999999865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=341.13 Aligned_cols=264 Identities=18% Similarity=0.260 Sum_probs=213.5
Q ss_pred HhcCcccccccccCCCceEEEEEEEC--------CCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeee
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLR--------DRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCL 127 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~--------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 127 (350)
..++|...+.| |+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++.++ +||||+++++++.
T Consensus 33 ~~~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 33 PRDKLTLGKPL-GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CGGGEEEEEEE-EECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHhHeEEeeEE-eecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34788888998 99999999999973 34579999987543 34457789999999999 8999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCce
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQT-----------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 196 (350)
+.+..++||||+++++|.+++...... ....+++..++.++.||+.||.||| +.+|+|+||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence 999999999999999999999764311 0124889999999999999999999 89999999999999
Q ss_pred EeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCC
Q 018816 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATG 275 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~ 275 (350)
+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 999999999999999987655443333344457889999999988889999999999999999999 9999874321
Q ss_pred CCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
......+......... ..++..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 266 -------~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 -------EELFKLLKEGHRMDKP------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp -------HHHHHHHHHTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHHHHHhcCCCCCCC------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122222222211111 1334678999999999999999999999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=342.69 Aligned_cols=258 Identities=19% Similarity=0.258 Sum_probs=205.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCce----EEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGP----ILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~----vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++|...+.| |+|+||.||+|.+ .++.. ||+|.+.... ......+.+|+.++.+++||||+++++++. ++..+
T Consensus 13 ~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVL-GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEE-ECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeee-eecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 577888888 9999999999998 44433 7778775432 233356778999999999999999999986 55689
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 9999999999999997542 47889999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... .....+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----------~~~~~~~~~ 233 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----------EVPDLLEKG 233 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----------HHHHHHHTT
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----------HHHHHHHcC
Confidence 8765544333444558889999999999999999999999999999999 99999754321 112222222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....... .++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 234 ~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 234 ERLAQPQ------------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CBCCCCT------------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCCCCC------------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 2111111 1223577999999999999999999999999998653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=349.14 Aligned_cols=252 Identities=16% Similarity=0.156 Sum_probs=201.1
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 133 (350)
.++|...+.| |+|+||.||+|+. .++..||+|.+.+... ...+.+.+|..++.++ +||||+++++++.+.+.++
T Consensus 51 ~~~y~~~~~L-G~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVI-GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred hhHcEEEEEE-eeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4689999999 9999999999999 5566899999876532 2334578899999887 8999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 130 lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence 999999999999998653 56999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..........+....
T Consensus 202 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~-~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 202 EGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-QNTEDYLFQVILEKQ 278 (396)
T ss_dssp CCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------CCHHHHHHHHHHCC
T ss_pred ecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc-hhhHHHHHHHHhccc
Confidence 6432221 2445669999999999999999999999999999999999999997543211111 111122222222222
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 335 (350)
... . ...+..+.+|+.+||+.||++||++
T Consensus 279 ~~~-p------------~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 IRI-P------------RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCC-C------------TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cCC-C------------CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111 1 1234678999999999999999995
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=342.43 Aligned_cols=262 Identities=13% Similarity=0.108 Sum_probs=209.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||.||+|.. .++..||+|.+.... ..+.+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 8 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKI-GCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEEC-CC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEe-eccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 4678888998 9999999999998 677799999986543 234588999999999 8999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc-----eeEcccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA-----AKLFDFSL 211 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~ 211 (350)
||+ +++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 85 e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 999 899999987532 57999999999999999999999 899999999999999998887 99999999
Q ss_pred CccCCCCCccc-----cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH
Q 018816 212 SKSIPEGKTHI-----KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 212 ~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
++......... ......||+.|+|||++.+..++.++|||||||++|||++|..||..... ........
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~------~~~~~~~~ 230 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA------DTLKERYQ 230 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------SSHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc------ccHHHHHH
Confidence 98764432211 12355699999999999999999999999999999999999999985432 11111111
Q ss_pred HHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.......... .+.+. ...+ .+.+++..||+.||.+||++.+|++.|+++.+
T Consensus 231 ~i~~~~~~~~-~~~~~--------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 231 KIGDTKRATP-IEVLC--------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHHHHHSC-HHHHT--------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhhhccCC-HHHHh--------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 1111100000 00000 0123 89999999999999999999999999998865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=336.38 Aligned_cols=266 Identities=16% Similarity=0.154 Sum_probs=202.8
Q ss_pred HhcCcccccccccCCCceEEEEEEECCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
..++|...+.| |+|+||+||+|.+.++..||+|++..... .....+.+|+.++++++||||+++++++.+....++|
T Consensus 19 l~~~y~~~~~l-G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKV-GEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEE-EECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhc-cCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 34788888998 99999999999997788999999865432 2346788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||++ ++|.+.+.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 98 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 98 FEFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EcCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 99997 58888876542 46899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...............
T Consensus 170 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~~~~ 241 (311)
T 3niz_A 170 GIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD------DQLPKIFSILGTPNP 241 (311)
T ss_dssp TSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT------THHHHHHHHHCCCCT
T ss_pred CCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHHCCCCh
Confidence 43322 2233458999999999876 46899999999999999999999999754321 111111111111110
Q ss_pred CccC-------------ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 MNID-------------PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~~~~-------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... ...............++++.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 000000000000123467899999999999999999999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=347.28 Aligned_cols=252 Identities=15% Similarity=0.146 Sum_probs=207.3
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+..........+.+|+.++.+++||||+++++++.+....++|||
T Consensus 50 ~~~y~i~~~L-G~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEEL-GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEE-ecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4678999998 9999999999999 5667889999877655556778999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC--CCceeEcccCCCccC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE--EYAAKLFDFSLSKSI 215 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~ 215 (350)
|+++++|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 129 FLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp CCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 999999999986532 46899999999999999999999 899999999999999974 577999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .... ..+......
T Consensus 202 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---------~~~~-~~i~~~~~~ 268 (387)
T 1kob_A 202 NPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---------LETL-QNVKRCDWE 268 (387)
T ss_dssp CTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---------HHHH-HHHHHCCCC
T ss_pred CCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH---------HHHH-HHHHhCCCC
Confidence 54332 2233599999999999998999999999999999999999999975322 1111 112222211
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ++... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 269 ~-~~~~~--------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 F-DEDAF--------SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp C-CSSTT--------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred C-Ccccc--------ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1 11110 134567899999999999999999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=354.04 Aligned_cols=263 Identities=16% Similarity=0.112 Sum_probs=209.7
Q ss_pred cHHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeee
Q 018816 51 SSEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCC 126 (350)
Q Consensus 51 ~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~ 126 (350)
...++...+++|...+.| |+|+||.||+|++ .++..||+|.+.+... .....+.+|+.++..++||||++++++|
T Consensus 65 ~~~~~~~~~~~y~~~~~L-G~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVI-GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHSCCGGGEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhcccCChhheEEEEEE-EeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 445566667899999999 9999999999999 4566899999875422 1223488999999999999999999999
Q ss_pred ecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeE
Q 018816 127 LEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206 (350)
Q Consensus 127 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl 206 (350)
.+.+.+++||||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL 216 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRL 216 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEE
Confidence 99999999999999999999997632 56899999999999999999999 899999999999999999999999
Q ss_pred cccCCCccCCCCCccccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchH
Q 018816 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFI 281 (350)
Q Consensus 207 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~ 281 (350)
+|||+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|++||.....
T Consensus 217 ~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~--------- 286 (437)
T 4aw2_A 217 ADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------- 286 (437)
T ss_dssp CCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---------
T ss_pred cchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---------
Confidence 999999776543322 233456999999999987 45799999999999999999999999975332
Q ss_pred HHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 018816 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAED--RPTMIDVAK 340 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~ 340 (350)
...............+.+.. . ..++.+.+|+.+||..+|++ ||+++++++
T Consensus 287 ~~~~~~i~~~~~~~~~p~~~-~--------~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 287 VETYGKIMNHKERFQFPTQV-T--------DVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHHHHHTHHHHCCCCSSC-C--------CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hHHHHhhhhccccccCCccc-c--------cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11112221111100111100 0 23467899999999988888 999999876
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=344.76 Aligned_cols=250 Identities=18% Similarity=0.190 Sum_probs=204.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||++.. .++..||+|.+.... ....+.+.+|+.++..++||||+++++++.+....++
T Consensus 14 ~~~y~i~~~L-G~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 14 FDHFEILRAI-GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp GGGEEEEEEE-ECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEE-eeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3678888998 9999999999999 556689999986543 2335678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 93 v~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp EECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 99999999999999764 57999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
..... .....+||+.|+|||++.. ..++.++|||||||++|+|++|..||..... ..... ....+..
T Consensus 165 ~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~------~~~~~-~~~~~~~ 234 (384)
T 4fr4_A 165 LPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS------TSSKE-IVHTFET 234 (384)
T ss_dssp CCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT------SCHHH-HHHHHHH
T ss_pred ccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC------ccHHH-HHHHHhh
Confidence 65432 2345569999999999874 4589999999999999999999999974322 11111 1112221
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-MIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~evl~ 340 (350)
.... .. ...+..+.+|+.+||+.||++||+ +.+|+.
T Consensus 235 ~~~~-~p------------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 235 TVVT-YP------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCC-CC------------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cccC-CC------------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1111 01 133467899999999999999998 666654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=331.61 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=194.7
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccch----hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR----YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|.+. +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~l-g~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEII-GIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEE-EEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeee-ccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3678888898 99999999999987 45999999865432 224678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC---eEeeccccCceEeCC--------CCc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP---VVFRNIEPWNILFQE--------EYA 203 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~dlkp~Nill~~--------~~~ 203 (350)
||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+ |+|+||||+||+++. ++.
T Consensus 84 v~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp EEECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred EEEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcc
Confidence 9999999999999853 46899999999999999999999 777 999999999999986 778
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
+||+|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ..
T Consensus 155 ~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~ 221 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---------LA 221 (271)
T ss_dssp EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---------HH
T ss_pred eEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HH
Confidence 99999999976543321 233589999999999988999999999999999999999999975432 11
Q ss_pred HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
.... ....... .... ...++.+.+++.+||+.||++|||+.++++.|+++
T Consensus 222 ~~~~-~~~~~~~---~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 222 VAYG-VAMNKLA---LPIP--------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHH-HHTSCCC---CCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHHh-hhcCCCC---CCCC--------cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111 1111111 0010 13446799999999999999999999999999865
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=338.50 Aligned_cols=253 Identities=18% Similarity=0.247 Sum_probs=200.1
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc----
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEM---- 131 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 131 (350)
..++|...+.| |+|+||.||+|++ .++..||||++.... ....+.+.+|+.++++++||||++++++|.+...
T Consensus 4 ~~~~y~~~~~l-G~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCM-GRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEE-ECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEe-cCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 35678889998 9999999999999 477799999986543 3456779999999999999999999999865442
Q ss_pred -----------------------------------------------------CeEEeecCCCCchhhhhhCCCCCCCCC
Q 018816 132 -----------------------------------------------------PALVYEPAGYCTLADRLYGPLQTHLEP 158 (350)
Q Consensus 132 -----------------------------------------------------~~lv~e~~~~~sL~~~l~~~~~~~~~~ 158 (350)
.++||||+++++|.+++..... ...
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~ 160 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LED 160 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccc
Confidence 7999999999999999976432 245
Q ss_pred CCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc----------ccccccc
Q 018816 159 LLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH----------IKASTAI 228 (350)
Q Consensus 159 ~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~ 228 (350)
.++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++......... .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 677789999999999999999 899999999999999999999999999999877544211 1123345
Q ss_pred cCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCcc
Q 018816 229 GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCF 308 (350)
Q Consensus 229 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (350)
||+.|+|||++.+..++.++|||||||++|+|++|..|+.. ...............
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~------------~~~~~~~~~~~~~~~------------ 293 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME------------RVRIITDVRNLKFPL------------ 293 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH------------HHHHHHHHHTTCCCH------------
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH------------HHHHHHHhhccCCCc------------
Confidence 99999999999999999999999999999999998776321 111111111111110
Q ss_pred chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 309 RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 309 ~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....++.+.+|+.+||+.||++|||+.++++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 11245567899999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=336.77 Aligned_cols=260 Identities=20% Similarity=0.286 Sum_probs=214.3
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||
T Consensus 11 ~~~~~~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 11 ERTDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CGGGEEEEEES-GGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccceeEEeec-CCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 56788888998 9999999999999 456689999987543 44677899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++....
T Consensus 89 e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp ECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999965322 46899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... .. ....+......
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~------~~----~~~~~~~~~~~ 231 (288)
T 3kfa_A 163 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQ----VYELLEKDYRM 231 (288)
T ss_dssp SSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GG----HHHHHHTTCCC
T ss_pred CCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH----HHHHHhccCCC
Confidence 44322 2233347889999999998999999999999999999999 9999875432 11 11122221111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
... ...++.+.+|+.+||+.||++|||+.++++.|+++...
T Consensus 232 ~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 232 ERP------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC------------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 13446799999999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=347.74 Aligned_cols=270 Identities=12% Similarity=0.077 Sum_probs=206.4
Q ss_pred HhcCcccccccccCCCceEEEEEEECC------CceEEEEEecccchhh-----------HHHHHHHHHHHHhcCCCCcc
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRD------RGPILVMKYRKSVRYA-----------SERCFNNIVFASQMNHKSIL 120 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~------~~~vaik~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv 120 (350)
..++|...+.| |+|+||.||+|.+.. +..||+|.+....... ...+..|+..+..++||||+
T Consensus 33 ~~~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPI-GQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TCCEEEEEEEC-CCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred CCCeEEEEEEE-ecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 45689999998 999999999999854 3689999986653211 12234566677888999999
Q ss_pred ceeeeeecC----CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCce
Q 018816 121 KLIGCCLEA----EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196 (350)
Q Consensus 121 ~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 196 (350)
++++++.+. ...++||||+ +++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Ni 183 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNL 183 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHE
Confidence 999998865 4589999999 999999986532 56999999999999999999999 89999999999999
Q ss_pred EeC--CCCceeEcccCCCccCCCCCccc-----cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 018816 197 LFQ--EEYAAKLFDFSLSKSIPEGKTHI-----KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHL 269 (350)
Q Consensus 197 ll~--~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 269 (350)
|++ .++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999 88999999999997664322111 12334599999999999999999999999999999999999999984
Q ss_pred CcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 270 SRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
... ...................+++.+... ..+.++.+++..||+.||++||++.+|++.|+++.+.
T Consensus 264 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 264 NLK-----DPKYVRDSKIRYRENIASLMDKCFPAA-------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp GTT-----CHHHHHHHHHHHHHCHHHHHHHHSCTT-------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccc-----CHHHHHHHHHHhhhhHHHHHHHhcccc-------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 321 111111111111111111222221111 2356799999999999999999999999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=343.30 Aligned_cols=246 Identities=20% Similarity=0.244 Sum_probs=202.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+..... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 8 i~~Y~i~~~l-G~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETL-GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEE-ecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3678888998 9999999999999 6777999999865422 224578899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+ +|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 87 v~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp EECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred EEECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence 99999 68998888653 56899999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... .
T Consensus 158 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------------~ 216 (336)
T 3h4j_B 158 MTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------------L 216 (336)
T ss_dssp TTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------------C
T ss_pred ccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------------H
Confidence 654332 334569999999999988776 789999999999999999999997543210 0
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.. +... .+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 217 ~~~i~~---~~~~--~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 217 FKKVNS---CVYV--MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp BCCCCS---SCCC--CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHHHc---CCCC--CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000000 0000 01134567899999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=344.90 Aligned_cols=255 Identities=16% Similarity=0.153 Sum_probs=204.7
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-----hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-----YASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
.+.|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 23 ~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 23 EDVYELCEVI-GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccceEEeeEE-eeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3578888998 9999999999999 5677999999864321 1357789999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc---eeEccc
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA---AKLFDF 209 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Df 209 (350)
++||||+++++|.+.+...... ...+++..+..++.||+.||.||| +++|+||||||+|||++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999998887542211 135899999999999999999999 899999999999999987654 999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
|++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+
T Consensus 178 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------~~~~~i 244 (351)
T 3c0i_A 178 GVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----------RLFEGI 244 (351)
T ss_dssp TTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----------HHHHHH
T ss_pred cceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----------HHHHHH
Confidence 99987654322 23344699999999999998999999999999999999999999974311 111222
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.........+.+ ...+..+.+|+.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 245 IKGKYKMNPRQW---------SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHTCCCCCHHHH---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HcCCCCCCcccc---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 222211111100 123567899999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=334.48 Aligned_cols=257 Identities=21% Similarity=0.285 Sum_probs=200.0
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...+.| |+|+||.||+|.+.+ ..||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 7 ~~~~~~~~~l-g~G~~g~V~~~~~~~-~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVV-GRGAFGVVCKAKWRA-KDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEE-ECCSSSEEEEEEETT-EEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEe-ecCCCceEEEEEECC-eeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 3578888888 999999999999875 48999998654 345778999999999999999999999874 48999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc-eeEcccCCCccCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA-AKLFDFSLSKSIPE 217 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~ 217 (350)
+++++|.+++..... ...+++..++.++.|++.||.|||..+.++|+||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999976421 135789999999999999999999322289999999999999998886 79999999876533
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ...... ..........
T Consensus 159 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~-~~~~~~~~~~ 225 (307)
T 2eva_A 159 HM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-------AFRIMW-AVHNGTRPPL 225 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-------HHHHHH-HHHTTCCCCC
T ss_pred cc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-------HHHHHH-HHhcCCCCCc
Confidence 21 2334899999999999989999999999999999999999999743221 111111 1111111111
Q ss_pred CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 298 DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
. ...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 226 ~------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 226 I------------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp B------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred c------------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1 13346789999999999999999999999999998653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=330.07 Aligned_cols=253 Identities=17% Similarity=0.179 Sum_probs=206.0
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecC--CcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEA--EMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 134 (350)
.++|...+.| |+|+||.||+|++. +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~l-g~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKL-NENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEE-EEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHh-cCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 3678888888 99999999999997 4589999987543 34456799999999999999999999999887 78899
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEeeccccCceEeCCCCceeEcccCCC
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP--VVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
||||+++++|.+++..... ..+++..+..++.||+.||.||| +.+ ++|+||||+||+++.++.++|+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp EEECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred eecccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 9999999999999976432 35899999999999999999999 888 999999999999999999999988876
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCc---cchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNE---KTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
..... ....||+.|+|||++.+..++. ++||||||+++|+|++|..||..... ........
T Consensus 161 ~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~~ 224 (271)
T 3kmu_A 161 FSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---------MEIGMKVA 224 (271)
T ss_dssp CTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---------HHHHHHHH
T ss_pred eeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---------HHHHHHHH
Confidence 54322 2234899999999998765444 89999999999999999999874432 11122222
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.......+.+ ..+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 225 ~~~~~~~~~~------------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 225 LEGLRPTIPP------------GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HSCCCCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred hcCCCCCCCC------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 2221111111 334679999999999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=334.88 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=210.9
Q ss_pred HhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
..++|...+.| |+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 11 ~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERL-GAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEE-EEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred CHHhhhheeee-cCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 44678888998 9999999999999887799999987543 34567899999999999999999999986 456899999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 88 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 9999999999864311 26899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... . .....+.......
T Consensus 162 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---------~-~~~~~~~~~~~~~ 230 (279)
T 1qpc_A 162 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---------P-EVIQNLERGYRMV 230 (279)
T ss_dssp SCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---------H-HHHHHHHTTCCCC
T ss_pred cccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---------H-HHHHHHhcccCCC
Confidence 3322 1223346889999999998889999999999999999999 8999874321 1 1122222221111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.. ...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 231 ~~------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 RP------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Cc------------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 10 13346799999999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=339.34 Aligned_cols=274 Identities=16% Similarity=0.268 Sum_probs=219.3
Q ss_pred ccHHHHHHHhcCcccccccccCCCceEEEEEEE------CCCceEEEEEecccch-hhHHHHHHHHHHHHhc-CCCCccc
Q 018816 50 FSSEDLKTAINNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSVR-YASERCFNNIVFASQM-NHKSILK 121 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~ 121 (350)
++..++....++|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++.++ +||||++
T Consensus 17 ~~~~~~~~~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPL-GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEE-EECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccceecchhheeeeeEE-cCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 5566666677899999999 9999999999985 3456899999876533 3456789999999999 6999999
Q ss_pred eeeeeecCC-cCeEEeecCCCCchhhhhhCCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEee
Q 018816 122 LIGCCLEAE-MPALVYEPAGYCTLADRLYGPLQTH-----------LEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFR 189 (350)
Q Consensus 122 ~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 189 (350)
+++++.+.+ ..++||||+++++|.+++....... ...+++..+..++.||+.||.||| +.+|+|+
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 999987655 5899999999999999997643210 122889999999999999999999 8999999
Q ss_pred ccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCC
Q 018816 190 NIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGH 268 (350)
Q Consensus 190 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~ 268 (350)
||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654443333344557899999999999999999999999999999998 999987
Q ss_pred CCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 269 LSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..... ......+.......... ..+..+.+++.+||+.||++|||+.+|++.|+++.++
T Consensus 253 ~~~~~---------~~~~~~~~~~~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 253 GVKID---------EEFCRRLKEGTRMRAPD------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp TCCCS---------HHHHHHHHHTCCCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchh---------HHHHHHhccCccCCCCC------------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 54321 11222222222111111 2345789999999999999999999999999999765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=333.85 Aligned_cols=274 Identities=18% Similarity=0.240 Sum_probs=206.8
Q ss_pred cHHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhc--CCCCccceeeeeec
Q 018816 51 SSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQM--NHKSILKLIGCCLE 128 (350)
Q Consensus 51 ~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~ 128 (350)
....-....++|...+.| |+|+||.||+|++. +..||+|.+.... ...+..|..++..+ +||||+++++++.+
T Consensus 28 ~~~~~~~~~~~y~~~~~l-g~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQI-GKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp CHHHHTTHHHHCEEEEEE-EEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CcccccccccceEEEeEe-ecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 333334556889999999 99999999999987 5599999986542 33445566666554 89999999999987
Q ss_pred C----CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC--------CeEeeccccCce
Q 018816 129 A----EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ--------PVVFRNIEPWNI 196 (350)
Q Consensus 129 ~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~dlkp~Ni 196 (350)
. ...++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +|+||||||+||
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Ni 173 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNI 173 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHE
Confidence 7 678999999999999999964 46899999999999999999999 77 999999999999
Q ss_pred EeCCCCceeEcccCCCccCCCCCccc--cccccccCCCCCCccccccCCCCcc------chhHHHHHHHHHHHhC-----
Q 018816 197 LFQEEYAAKLFDFSLSKSIPEGKTHI--KASTAIGSLEFAAPEYLTTGYYNEK------TDVYSFGKLLLVLLTG----- 263 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~el~tg----- 263 (350)
|++.++.+||+|||++.......... ......||+.|+|||++.+...+.. +|||||||++|||++|
T Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~ 253 (337)
T 3mdy_A 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253 (337)
T ss_dssp EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence 99999999999999997664433221 1234469999999999987766654 9999999999999999
Q ss_pred -----CCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 018816 264 -----RTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338 (350)
Q Consensus 264 -----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ev 338 (350)
..||...... ............... ..+..... .....++..+.+|+.+||+.||++|||+.+|
T Consensus 254 ~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 254 IVEEYQLPYHDLVPS-----DPSYEDMREIVCIKK---LRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp BCCCCCCTTTTTSCS-----SCCHHHHHHHHTTSC---CCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ccccccccHhhhcCC-----CCchhhhHHHHhhhc---cCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 4444432211 111111122221111 11111111 1112778899999999999999999999999
Q ss_pred HHHHHHhhhcC
Q 018816 339 AKKLRQMYRTS 349 (350)
Q Consensus 339 l~~L~~~~~~~ 349 (350)
++.|+++.++.
T Consensus 323 l~~L~~l~~~~ 333 (337)
T 3mdy_A 323 KKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHhhc
Confidence 99999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=345.85 Aligned_cols=249 Identities=18% Similarity=0.184 Sum_probs=200.8
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 132 (350)
..++|...+.| |+|+||.||+|++ .++..||+|.+.... ....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 21 ~~~~y~~~~~l-G~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 21 GIDNFEFIRVL-GKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp --CCEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred chhheEEEEEE-eeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 35789999999 9999999999999 567799999997642 23456688999999988 699999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccce
Confidence 9999999999999998654 56999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... .. ....+...
T Consensus 172 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---------~~-~~~~i~~~ 239 (353)
T 3txo_A 172 KEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---------DD-LFEAILND 239 (353)
T ss_dssp BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HH-HHHHHHHC
T ss_pred eecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---------HH-HHHHHHcC
Confidence 8643222 123455699999999999988999999999999999999999999975432 11 12222222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM------IDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~------~evl~ 340 (350)
.... | ...+..+.+|+.+||+.||++||++ .++++
T Consensus 240 ~~~~--p-----------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 EVVY--P-----------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCC--C-----------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCC--C-----------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1110 1 0234578899999999999999998 66664
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=331.37 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=209.3
Q ss_pred cCccccc-ccccCCCceEEEEEEE---CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRN-ITIDEIEGYILYMGFL---RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~-~lig~G~~g~V~~~~~---~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
++|.... .| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~l-g~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEE-ECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccc-cccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4566665 66 9999999999986 355689999997643 34567799999999999999999999999 5567899
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999999999986432 56899999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 215 IPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 215 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------~~~~~~i~~~ 229 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----------PEVMAFIEQG 229 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----------HHHHHHHHTT
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----------HHHHHHHhcC
Confidence 75433221 2233346889999999988889999999999999999998 9999875432 1122223222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
......+ ..+..+.+++.+||+.||++|||+.++++.|++++.+
T Consensus 230 ~~~~~~~------------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 230 KRMECPP------------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp CCCCCCT------------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcCCCCC------------CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 2111111 3456799999999999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=345.14 Aligned_cols=246 Identities=17% Similarity=0.150 Sum_probs=198.3
Q ss_pred ccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCCc
Q 018816 65 RNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCT 143 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~s 143 (350)
.+.| |+|+||.||+|.. .++..||+|.+........+.+.+|+.++.+++||||+++++++.+.+..++||||+++++
T Consensus 94 ~~~l-G~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEIL-GGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEC-C-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEE-ecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 4567 9999999999998 6677999999987665667789999999999999999999999999999999999999999
Q ss_pred hhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe--CCCCceeEcccCCCccCCCCCcc
Q 018816 144 LADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF--QEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 144 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++........
T Consensus 173 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 173 LFDRIIDES----YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 999886432 46899999999999999999999 8999999999999999 5678999999999987654332
Q ss_pred ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccc
Q 018816 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301 (350)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (350)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... .......... ......+..
T Consensus 245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---------~~~~~~i~~~-~~~~~~~~~ 312 (373)
T 2x4f_A 245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---------AETLNNILAC-RWDLEDEEF 312 (373)
T ss_dssp --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHHHHHHHT-CCCSCSGGG
T ss_pred --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHhc-cCCCChhhh
Confidence 2334599999999999988999999999999999999999999975432 1122222221 111111111
Q ss_pred cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 302 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...++.+.+|+.+||+.||++|||+.++++
T Consensus 313 ---------~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 ---------QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---------ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 134567899999999999999999999997
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=334.41 Aligned_cols=249 Identities=18% Similarity=0.262 Sum_probs=197.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--------------------------hhHHHHHHHHHHH
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--------------------------YASERCFNNIVFA 111 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--------------------------~~~~~~~~E~~~l 111 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++
T Consensus 12 ~~~y~~~~~l-G~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 12 LNQYTLKDEI-GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp ETTEEEEEEE-EC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred ecceEEEeEE-eecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4688889998 9999999999998 5677899999865431 1135688999999
Q ss_pred HhcCCCCccceeeeeec--CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEee
Q 018816 112 SQMNHKSILKLIGCCLE--AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFR 189 (350)
Q Consensus 112 ~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 189 (350)
++++||||+++++++.+ ....++||||+++++|.+++.. ..+++..+..++.||+.||.||| +.+|+||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 161 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLH---YQKIIHR 161 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 99999999999999986 5678999999999999886532 47899999999999999999999 8999999
Q ss_pred ccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCC
Q 018816 190 NIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY---YNEKTDVYSFGKLLLVLLTGRTI 266 (350)
Q Consensus 190 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~~p 266 (350)
||||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999999987654322 123345999999999998765 47889999999999999999999
Q ss_pred CCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 267 GHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
|..... . .....+.......... ...++.+.+|+.+||+.||++|||+.++++
T Consensus 240 f~~~~~---------~-~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDERI---------M-CLHSKIKSQALEFPDQ-----------PDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSSH---------H-HHHHHHHHCCCCCCSS-----------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccH---------H-HHHHHHhcccCCCCCc-----------cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 874321 1 1112222222111100 023467899999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=340.43 Aligned_cols=252 Identities=17% Similarity=0.167 Sum_probs=201.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 133 (350)
.++|...+.| |+|+||.||+|++ .++..||+|.+.... ....+.+.+|..++.++ +||||+++++++.+....+
T Consensus 8 ~~~y~~~~~l-G~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVI-GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEE-EecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 3678888998 9999999999999 567789999987642 23456688999999988 8999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 87 lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158 (345)
T ss_dssp EEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccc
Confidence 999999999999998653 46899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... .....+||+.|+|||++.+..++.++|+|||||++|||++|..||.......... ..........+....
T Consensus 159 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~i~~~~ 235 (345)
T 3a8x_A 159 EGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-QNTEDYLFQVILEKQ 235 (345)
T ss_dssp CSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------CHHHHHHHHHHCC
T ss_pred cccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc-cccHHHHHHHHHcCC
Confidence 6432221 2345569999999999999999999999999999999999999997533211110 111122222222222
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM 335 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 335 (350)
.. +. ...+..+.+|+.+||+.||++||++
T Consensus 236 ~~-~p------------~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 IR-IP------------RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CC-CC------------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CC-CC------------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 11 1334678999999999999999995
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=342.68 Aligned_cols=252 Identities=22% Similarity=0.227 Sum_probs=191.7
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
...+.|...+.| |+|+||.||+|++ .++..||+|.+.... ..+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 50 ~~~~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 50 ALSDFFEVESEL-GRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp CGGGTEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCcEEEeeEE-eeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345678888998 9999999999999 456689999987653 346688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCceeEcccCCC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKLFDFSLS 212 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~ 212 (350)
|||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|||++
T Consensus 127 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp ECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999999998654 46899999999999999999999 899999999999999975 889999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .......+...
T Consensus 199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~~i~~~ 266 (349)
T 2w4o_A 199 KIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG---------DQFMFRRILNC 266 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC---------HHHHHHHHHTT
T ss_pred cccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc---------cHHHHHHHHhC
Confidence 8654322 12344589999999999998999999999999999999999999874332 11112222222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......+.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 267 ~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 267 EYYFISPWW---------DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCCCCTTTT---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCccCCchh---------hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222111111 134567899999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=335.56 Aligned_cols=245 Identities=19% Similarity=0.218 Sum_probs=204.9
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+++. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 5 ~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTL-GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEE-eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 4678888998 9999999999999 5677999999876422 335668899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp EECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCccee
Confidence 99999999999999754 56899999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.... ....+||+.|+|||++.+..++.++|+|||||++|||++|..||..... ......... ...
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~i~~-~~~ 220 (318)
T 1fot_A 156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---------MKTYEKILN-AEL 220 (318)
T ss_dssp CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHHHHHHH-CCC
T ss_pred cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---------HHHHHHHHh-CCC
Confidence 5432 2345699999999999999999999999999999999999999975322 111222222 111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
. +. ...+..+.+|+.+||+.||++|| +++++++
T Consensus 221 ~-~p------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 R-FP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp C-CC------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C-CC------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1 00 02346789999999999999999 8888874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=333.64 Aligned_cols=254 Identities=20% Similarity=0.282 Sum_probs=204.4
Q ss_pred hcCcccccccccCCCceEEEEEEECC-C-------ceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRD-R-------GPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~-~-------~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
.++|...+.| |+|+||.||+|.+.. + ..||+|.+........+.+.+|+.++++++||||+++++++.+++
T Consensus 7 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESL-GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEE-EEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeee-ccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3678888888 999999999999843 2 369999997766666788999999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc-------
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA------- 203 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~------- 203 (350)
..++||||+++++|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccc
Confidence 9999999999999999997542 34899999999999999999999 899999999999999998887
Q ss_pred -eeEcccCCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchH
Q 018816 204 -AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFI 281 (350)
Q Consensus 204 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~ 281 (350)
+||+|||++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|..|+.....
T Consensus 159 ~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--------- 223 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--------- 223 (289)
T ss_dssp EEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---------
T ss_pred eeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc---------
Confidence 999999998754321 22347899999999987 6799999999999999999996555432211
Q ss_pred HHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
............ ...+ ..+..+.+|+.+||+.||++|||+.++++.|+++..+.
T Consensus 224 ~~~~~~~~~~~~--~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 224 SQRKLQFYEDRH--QLPA------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHHHHHHHHTTC--CCCC------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred hHHHHHHhhccC--CCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 011111111111 1111 11235789999999999999999999999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=342.16 Aligned_cols=259 Identities=17% Similarity=0.261 Sum_probs=201.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCce----EEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGP----ILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~----vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
.++|...+.| |+|+||.||+|.+ .++.. |++|.+... .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 14 ~~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEE-EECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEe-eeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 3678888998 9999999999998 44443 577776543 2345678999999999999999999999998765 7
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++|+||+++|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred eEEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 89999999999999986542 56899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... . ....+..
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~----~~~~~~~ 234 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------E----ISSILEK 234 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------G----HHHHHHT
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH------H----HHHHHHc
Confidence 87654433333334447889999999999999999999999999999999 99998754321 1 1122222
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.......+ ..+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 235 ~~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 235 GERLPQPP------------ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TCCCCCCT------------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCCc------------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 22111111 3345789999999999999999999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=334.19 Aligned_cols=262 Identities=19% Similarity=0.261 Sum_probs=209.3
Q ss_pred HHHHhcCccccc-ccccCCCceEEEEEEE---CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeec
Q 018816 55 LKTAINNYSMRN-ITIDEIEGYILYMGFL---RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLE 128 (350)
Q Consensus 55 l~~~~~~f~~~~-~lig~G~~g~V~~~~~---~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 128 (350)
+....++|.... .| |+|+||.||+|.+ ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++ +
T Consensus 11 ~~~~~~~y~~~~~~l-g~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CBCCGGGEEEEEEEE-EECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeecchhhhhccCcc-ccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 333456787777 77 9999999999965 345689999987543 23357799999999999999999999999 5
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEcc
Confidence 67789999999999999999754 46899999999999999999999 89999999999999999999999999
Q ss_pred cCCCccCCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHH
Q 018816 209 FSLSKSIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 209 fg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ....
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----------~~~~ 230 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------SEVT 230 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------HHHH
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----------HHHH
Confidence 99998765443322 1223346788999999988889999999999999999999 9999875322 1122
Q ss_pred HHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..+......... ...+..+.+++.+||+.||++|||+.+|++.|++++.+
T Consensus 231 ~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 231 AMLEKGERMGCP------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp HHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCC------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 222222211111 13456799999999999999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=341.84 Aligned_cols=273 Identities=18% Similarity=0.304 Sum_probs=218.6
Q ss_pred cccHHHHHHHhcCcccccccccCCCceEEEEEEEC------CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccc
Q 018816 49 SFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILK 121 (350)
Q Consensus 49 ~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 121 (350)
.+..+++....++|...+.| |+|+||.||+|.+. ++..||+|.+.... ......+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSREL-GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEE-EECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred ccChhhhcchhhheeeeeEe-ccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 35555666777899999999 99999999999874 35689999987543 244567889999999999999999
Q ss_pred eeeeeecCCcCeEEeecCCCCchhhhhhCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCce
Q 018816 122 LIGCCLEAEMPALVYEPAGYCTLADRLYGPLQ-----THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196 (350)
Q Consensus 122 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Ni 196 (350)
+++++.+.+..++||||+++++|.+++..... .....+++..++.++.||+.||.||| +.+|+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceE
Confidence 99999999999999999999999999864210 11145789999999999999999999 89999999999999
Q ss_pred EeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCC
Q 018816 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATG 275 (350)
Q Consensus 197 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~ 275 (350)
+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 246 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--- 246 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---
Confidence 999999999999999986644333223334457889999999998899999999999999999999 8888864321
Q ss_pred CCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
......+......... ...+..+.+|+.+||+.||++|||+.++++.|+++..
T Consensus 247 -------~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 -------EQVLRFVMEGGLLDKP------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -------HHHHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------HHHHHHHHcCCcCCCC------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1122222222211111 1344678999999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=335.02 Aligned_cols=268 Identities=18% Similarity=0.192 Sum_probs=208.5
Q ss_pred cCcccccccccCCCceEEEEEEE-----CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecC--Cc
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-----RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEA--EM 131 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-----~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~ 131 (350)
+.|...+.| |+|+||.||+|++ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 21 ~~~~~~~~l-g~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEE-EECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhcc-CCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 557888888 9999999999993 466799999987543 23457789999999999999999999999876 67
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccc
Confidence 899999999999999985432 46899999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCcc-ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCccc-----CCCCcchHHHHH
Q 018816 212 SKSIPEGKTH-IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLA-----TGGSNFFITDRV 285 (350)
Q Consensus 212 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~ 285 (350)
+......... .......+|..|+|||++.+..++.++||||||+++|+|++|..|+...... ............
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 9877554322 2233445888899999999999999999999999999999999986432100 000001111112
Q ss_pred HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 286 EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
............. ...++.+.+|+.+||+.||++|||+.++++.|+++.+
T Consensus 253 ~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 253 VNTLKEGKRLPCP------------PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHTTCCCCCC------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHhccCCCCCC------------CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 2222221111111 1345679999999999999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=343.22 Aligned_cols=250 Identities=20% Similarity=0.212 Sum_probs=204.1
Q ss_pred HHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCC
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAE 130 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 130 (350)
....++|...+.| |+|+||.||+|++ .++..||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+
T Consensus 13 ~~~~~~y~~~~~l-G~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 13 KLKIEDFILHKML-GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ---CTTEEEEEEE-EECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCChHHeEEEEEE-eeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 4456899999999 9999999999999 567789999997642 23356678899999877 8999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++||||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeECh
Confidence 999999999999999998653 46899999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+++....... .....+||+.|+|||++.+..++.++|+|||||++|||++|..||..... . .....+.
T Consensus 164 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------~-~~~~~i~ 231 (345)
T 1xjd_A 164 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---------E-ELFHSIR 231 (345)
T ss_dssp TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------H-HHHHHHH
T ss_pred hhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---------H-HHHHHHH
Confidence 9986433221 23455699999999999999999999999999999999999999974322 1 1112222
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI-DVA 339 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl 339 (350)
..... +. ...+..+.+|+.+||+.||++||++. +|+
T Consensus 232 ~~~~~-~p------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 232 MDNPF-YP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HCCCC-CC------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred hCCCC-CC------------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 22111 10 12346789999999999999999987 554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=340.79 Aligned_cols=269 Identities=19% Similarity=0.193 Sum_probs=212.6
Q ss_pred cCcccccccccCCCceEEEEEEE-----CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeee--cCCcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-----RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCL--EAEMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~ 132 (350)
++|...+.| |+|+||.||+|++ .++..||+|++........+.+.+|+.++++++||||+++++++. +....
T Consensus 23 ~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQL-GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEE-EEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhc-cCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 678888888 9999999999994 466789999998776666778999999999999999999999886 45568
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred EEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 99999999999999986532 46899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCccc-----CCCCcchHHHHHH
Q 018816 213 KSIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLA-----TGGSNFFITDRVE 286 (350)
Q Consensus 213 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~ 286 (350)
.......... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||...... .............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 8775443221 233345788899999999889999999999999999999999998643211 0000011111222
Q ss_pred HHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
............ ..+++.+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 255 ~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 255 ELLEEGQRLPAP------------PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHhhcccCCCCC------------CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 222222111111 14456799999999999999999999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=351.76 Aligned_cols=258 Identities=16% Similarity=0.141 Sum_probs=207.1
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeec
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLE 128 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 128 (350)
.++....++|...+.| |+|+||.||+|++ .++..||+|.+.+... ...+.+.+|+.++..++||||+++++++.+
T Consensus 62 ~~~~~~~~~y~~~~~L-G~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVI-GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHSCCGGGEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HhcccCccccEEEEEE-EcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3444556899999999 9999999999999 5567899999865321 223457899999999999999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
...+++||||+++|+|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEec
Confidence 9999999999999999999864 35899999999999999999999 89999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY----YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 284 (350)
||+++........ .....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||..... ...
T Consensus 212 FG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------~~~ 281 (410)
T 3v8s_A 212 FGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---------VGT 281 (410)
T ss_dssp CTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---------HHH
T ss_pred cceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---------hhH
Confidence 9999876543321 233556999999999998655 88999999999999999999999975332 111
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAED--RPTMIDVAK 340 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~evl~ 340 (350)
......... ....|.. ...+..+.+|+.+||+.+|.+ ||++.+|++
T Consensus 282 ~~~i~~~~~-~~~~p~~---------~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 282 YSKIMNHKN-SLTFPDD---------NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHTHHH-HCCCCTT---------CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHHhccc-cccCCCc---------ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 122211110 0000100 023467899999999999988 999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=336.87 Aligned_cols=259 Identities=19% Similarity=0.249 Sum_probs=202.2
Q ss_pred cCcccccccccCCCceEEEEEEECCC-----ceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDR-----GPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~-----~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
++|...+.| |+|+||.||+|.+... ..||+|.+.... ......+.+|+.++.+++||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~l-G~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVI-GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEE-EECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEE-ecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 456667788 9999999999998322 259999987643 344567889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999996532 46899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 214 SIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 214 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ......+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----------~~~~~~~~~ 265 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------HEVMKAIND 265 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------HHHHHHHHT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----------HHHHHHHHC
Confidence 764432211 1222336788999999998899999999999999999999 9999864321 112222222
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....... ..++..+.+++.+||+.||++||++.++++.|+++.+.
T Consensus 266 ~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 266 GFRLPTP------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp TCCCCCC------------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCcCCCc------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 2111111 13446789999999999999999999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=328.10 Aligned_cols=259 Identities=20% Similarity=0.212 Sum_probs=210.6
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|++........+.+.+|+.++++++||||+++++++.+....++||
T Consensus 7 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTI-GRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEE-eecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 45678889998 9999999999999 555689999997765566788999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe---CCCCceeEcccCCCc
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLSK 213 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~ 213 (350)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+|+||||+||++ +.++.+||+|||++.
T Consensus 86 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 86 ELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp ECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999988653 46899999999999999999999 8999999999999999 788999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ......+....
T Consensus 158 ~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------~~~~~~~~~~~ 223 (277)
T 3f3z_A 158 RFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD----------SEVMLKIREGT 223 (277)
T ss_dssp ECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHHCC
T ss_pred eccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH----------HHHHHHHHhCC
Confidence 7654332 234459999999998865 489999999999999999999999875322 11122222222
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhhhc
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK--KLRQMYRT 348 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~~~~ 348 (350)
........ ...++.+.+|+.+||+.||++|||+.++++ .+++...+
T Consensus 224 ~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 224 FTFPEKDW---------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271 (277)
T ss_dssp CCCCHHHH---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred CCCCchhh---------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence 11111100 023467899999999999999999999986 55555443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=334.34 Aligned_cols=267 Identities=21% Similarity=0.285 Sum_probs=201.1
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-C---CCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-R---DRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~---~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
...++|...+.| |+|+||.||+|.+ . .+..||+|.+... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKIL-GEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEE-EC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccce-eecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 345778888888 9999999999988 3 2337999998654 2344567899999999999999999999998755
Q ss_pred -----cCeEEeecCCCCchhhhhhCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCce
Q 018816 131 -----MPALVYEPAGYCTLADRLYGPL-QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA 204 (350)
Q Consensus 131 -----~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 204 (350)
..++||||+++++|.+++.... ......+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcE
Confidence 3499999999999999984321 112256999999999999999999999 9999999999999999999999
Q ss_pred eEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHH
Q 018816 205 KLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 205 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~ 283 (350)
||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~-- 258 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN------HEM-- 258 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGH--
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH------HHH--
Confidence 9999999987654433233334457889999999999999999999999999999999 8888865432 111
Q ss_pred HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
...+......... ...+..+.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 259 --~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 259 --YDYLLHGHRLKQP------------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp --HHHHHTTCCCCCB------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --HHHHHcCCCCCCC------------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1112211111111 134467999999999999999999999999999998653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=329.72 Aligned_cols=259 Identities=19% Similarity=0.238 Sum_probs=204.7
Q ss_pred CcccccccccCCCceEEEEEEE-CCCc---eEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC-eE
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRG---PILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMP-AL 134 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~---~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~l 134 (350)
.|...+.| |+|+||.||+|.+ .++. .||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVI-GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEE-EEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCcee-ccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 34455677 9999999999997 3332 699999875433 4457789999999999999999999999876655 99
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+.+++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 101 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 999999999999997632 56889999999999999999999 89999999999999999999999999999986
Q ss_pred CCCCCcc--ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 215 IPEGKTH--IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 215 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
....... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+..... ... ........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-----~~~----~~~~~~~~ 244 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-----PFD----LTHFLAQG 244 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----GGG----HHHHHHTT
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-----HHH----HHHHhhcC
Confidence 6443211 122334578899999999999999999999999999999996655443221 111 11222222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
...... ...++.+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 245 ~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 245 RRLPQP------------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCC------------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111 13346789999999999999999999999999998765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=330.62 Aligned_cols=259 Identities=22% Similarity=0.265 Sum_probs=205.8
Q ss_pred HhcCcccccccccCCCceEEEEEEECC----CceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRD----RGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~----~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
..++|...+.| |+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 10 ~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 10 AREDVVLNRIL-GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CGGGEEEEEEE-EECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred cccceEEEEEE-EecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 45788888998 999999999999732 225999998765 33456779999999999999999999999865 457
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 160 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLS 160 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred EEEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCC
Confidence 99999999999999996532 46899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..... ... ...+..
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~------~~~----~~~~~~ 229 (281)
T 3cc6_A 161 RYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN------KDV----IGVLEK 229 (281)
T ss_dssp GCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG------GGH----HHHHHH
T ss_pred ccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh------HHH----HHHHhc
Confidence 876543322 1223347889999999998899999999999999999998 9999874332 111 112222
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....... ...++.+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 230 ~~~~~~~------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 230 GDRLPKP------------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC------------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 2111111 12346789999999999999999999999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=330.61 Aligned_cols=265 Identities=14% Similarity=0.107 Sum_probs=200.4
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|...+.| |+|+||+||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEE-EECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEe-cCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 578888888 9999999999999 567789999986543 233467889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++ ++.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp ECCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 99975 5555554322 57999999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCccccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..|+...... .................
T Consensus 153 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-----~~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 153 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp SCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-----HHHHHHHHHHHCCCCTT
T ss_pred Cccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHHhCCCChh
Confidence 3322 233445899999999998765 899999999999999999988886533221 11111111111111100
Q ss_pred ccC---------cc--cc-CCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NID---------PV--IV-GDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~---------~~--~~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... +. .. ...........+..+.+|+.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00 00 00000000134567899999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=349.68 Aligned_cols=263 Identities=16% Similarity=0.091 Sum_probs=208.8
Q ss_pred ccHHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeee
Q 018816 50 FSSEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGC 125 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~ 125 (350)
+.+.++....++|...+.| |+|+||.||+++. .++..||+|++.+... ...+.+.+|..++..++||||++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~l-G~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVI-GRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhccCChhhEEEEEEE-eeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 4455566677899999999 9999999999999 5677999999976422 223457899999999999999999999
Q ss_pred eecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCcee
Q 018816 126 CLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 126 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 205 (350)
+.+.+.+++||||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+|
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEE
Confidence 999999999999999999999996431 36899999999999999999999 89999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCc
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT-------TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN 278 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~ 278 (350)
|+|||+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 203 L~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------ 275 (412)
T 2vd5_A 203 LADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------ 275 (412)
T ss_dssp ECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------
T ss_pred EeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------
Confidence 9999999876543321 223456999999999987 35689999999999999999999999975432
Q ss_pred chHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 018816 279 FFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDR---PTMIDVAK 340 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R---Pt~~evl~ 340 (350)
............ ....|... ...+.++.+|+.+||+ +|.+| |+++++++
T Consensus 276 ---~~~~~~i~~~~~-~~~~p~~~--------~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 276 ---AETYGKIVHYKE-HLSLPLVD--------EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ---HHHHHHHHTHHH-HCCCC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ---HHHHHHHHhccc-CcCCCccc--------cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111111111100 00001100 1345679999999999 99998 58998875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=362.71 Aligned_cols=262 Identities=22% Similarity=0.257 Sum_probs=212.6
Q ss_pred HHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 55 LKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 55 l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
++...++|...+.| |+|+||.||+|.+.++..||||.+.... ...+.+.+|+.+|++++||||+++++++.+ +..++
T Consensus 262 ~~i~~~~~~~~~~l-G~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 262 WEIPRESLRLEVKL-GQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp SBCCGGGEEEEEEE-EECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred eecchhhhhhheec-ccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 33445678888888 9999999999999877789999997654 335679999999999999999999999876 67899
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 339 v~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999964211 35889999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..+...+..+.
T Consensus 413 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----------~~~~~~i~~~~ 481 (535)
T 2h8h_A 413 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQVERGY 481 (535)
T ss_dssp CCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----------HHHHHHHHTTC
T ss_pred cCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHHcCC
Confidence 643211 11222336788999999999999999999999999999999 8999874321 11222222221
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..... ..++..+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus 482 ~~~~~------------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 482 RMPCP------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCC------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11111 13456789999999999999999999999999998654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=339.39 Aligned_cols=245 Identities=16% Similarity=0.109 Sum_probs=205.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||++++ .++..||+|.+..... ...+.+.+|+.++..++||||+++++++.+....++
T Consensus 40 ~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEe-ecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3688999998 9999999999999 5677999999866432 335678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 119 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp EEECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEccccccee
Confidence 99999999999999653 46899999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ... ...+.....
T Consensus 191 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------~~~-~~~i~~~~~ 255 (350)
T 1rdq_E 191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------IQI-YEKIVSGKV 255 (350)
T ss_dssp CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHH-HHHHHHCCC
T ss_pred ccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---------HHH-HHHHHcCCC
Confidence 6432 2344699999999999999999999999999999999999999974322 111 122222211
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 340 (350)
.. . ...+..+.+|+.+||+.||++||+ +.+|++
T Consensus 256 ~~-p------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 RF-P------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CC-C------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CC-C------------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11 0 133467899999999999999998 788765
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=338.53 Aligned_cols=249 Identities=20% Similarity=0.205 Sum_probs=180.5
Q ss_pred cccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEeecCCCCc
Q 018816 66 NITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAGYCT 143 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~s 143 (350)
+.| |+|+||.||+|.+ .++..||+|.+... ....+.+|+.++..++ ||||+++++++.+....++||||+++++
T Consensus 17 ~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPL-GEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCS-EEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred Ccc-ccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 556 9999999999999 56779999998654 3456778999999997 9999999999999999999999999999
Q ss_pred hhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC---ceeEcccCCCccCCCCCc
Q 018816 144 LADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY---AAKLFDFSLSKSIPEGKT 220 (350)
Q Consensus 144 L~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~ 220 (350)
|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++........
T Consensus 93 L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 93 LFERIKKK-----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999754 57999999999999999999999 89999999999999997665 899999999986644322
Q ss_pred cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...........+..+......+.
T Consensus 165 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 165 --PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL---TCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred --cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc---ccccHHHHHHHHHcCCCCCCccc
Confidence 2234458999999999999999999999999999999999999997543210 00111112222222221111111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+ ...++.+.+|+.+||+.||++|||+.++++
T Consensus 240 ~---------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 W---------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp H---------HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred c---------cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0 134578999999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=341.53 Aligned_cols=254 Identities=17% Similarity=0.169 Sum_probs=195.3
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
..++|...+.| |+|+||.||+++. .++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 18 ~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 18 DSDRYDFVKDI-GSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp CTTTEEEEEEE-SSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCcEEEEEEe-ccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 35689999998 9999999999999 577799999987543 23466889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc--eeEcccCCCcc
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA--AKLFDFSLSKS 214 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~ 214 (350)
||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+|||+++.
T Consensus 96 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 96 EYASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999998653 56899999999999999999999 899999999999999987765 99999999875
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCcc-chhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEK-TDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... ............ ..
T Consensus 168 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~~~~~~~~-~~ 238 (361)
T 3uc3_A 168 SVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----RDYRKTIQRILS-VK 238 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-----CCHHHHHHHHHT-TC
T ss_pred ccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-----HHHHHHHHHHhc-CC
Confidence 43222 2234459999999999988887655 89999999999999999999754321 111222222211 11
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
...... ...+..+.+|+.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 YSIPDD-----------IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCTT-----------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCc-----------CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111000 0234678899999999999999999999873
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.70 Aligned_cols=252 Identities=15% Similarity=0.216 Sum_probs=196.6
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCC--CCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKS--VRYASERCFNNIVFASQMNH--KSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~l 134 (350)
.+.|...+.| |+|+||.||++.+.++..||+|++... .....+.+.+|+.++.+++| |||+++++++.++...++
T Consensus 8 ~~~y~i~~~l-G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQI-GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEE-SCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEE-ecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 4678888998 999999999999988889999998654 23445778999999999986 999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||| +.+++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||++..
T Consensus 87 v~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEC-CCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEe-CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 999 5588999999754 57899999999999999999999 89999999999999997 67899999999987
Q ss_pred CCCCCccccccccccCCCCCCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTT-----------GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~ 228 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--------QIS 228 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--------HHH
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--------HHH
Confidence 754443333345569999999999865 6789999999999999999999999974321 111
Q ss_pred HHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 284 RVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
................ ..+..+.+|+.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~------------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 229 KLHAIIDPNHEIEFPD------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHHCTTSCCCCCC------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCCcccCCcc------------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111111111110 223568899999999999999999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=332.55 Aligned_cols=265 Identities=19% Similarity=0.242 Sum_probs=201.9
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS---VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
..++|...+.| |+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKI-GRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEE-ECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEEEEee-cCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34678999998 9999999999998 67779999998752 2345677889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++++|.+++...... ...+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++.
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 999999999999988542111 146899999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..... .... ....+....
T Consensus 185 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~-~~~~~~~~~ 254 (310)
T 2wqm_A 185 FFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-------NLYS-LCKKIEQCD 254 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-------CHHH-HHHHHHTTC
T ss_pred eecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-------hHHH-HHHHhhccc
Confidence 6543322 12234589999999999999999999999999999999999999864321 1111 112222222
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.....+ ...+..+.+|+.+||+.||++|||+.+|++.|+++..+
T Consensus 255 ~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 255 YPPLPS-----------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp SCCCCT-----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcc-----------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 111110 13346799999999999999999999999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=344.41 Aligned_cols=271 Identities=13% Similarity=0.124 Sum_probs=204.4
Q ss_pred HhcCcccccccccCC--CceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 58 AINNYSMRNITIDEI--EGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G--~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
..++|...+.| |+| +||.||+|++ .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 23 ~~~~y~~~~~l-G~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVI-GKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEE-EEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecc-cCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 45789999999 999 9999999999 567799999997553 34456788999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++++|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 999999999999999865422 46899999999999999999999 899999999999999999999999999987
Q ss_pred ccCCCCCc-----cccccccccCCCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHH
Q 018816 213 KSIPEGKT-----HIKASTAIGSLEFAAPEYLTT--GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 213 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~ 250 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT-----QMLLEKL 250 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST-----THHHHC-
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHh
Confidence 65422211 111233458999999999987 57999999999999999999999999754321 0000000
Q ss_pred HHHHH----hcC---------------CCcc-------Ccc--ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHH
Q 018816 286 EKFIR----SNG---------------YMNI-------DPV--IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMID 337 (350)
Q Consensus 286 ~~~~~----~~~---------------~~~~-------~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 337 (350)
..... ... .... .+. .............++.+.+|+.+||+.||++|||+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 00000 000 0000 000 0000000011244577999999999999999999999
Q ss_pred HHH
Q 018816 338 VAK 340 (350)
Q Consensus 338 vl~ 340 (350)
+++
T Consensus 331 ll~ 333 (389)
T 3gni_B 331 LLN 333 (389)
T ss_dssp HTT
T ss_pred Hhc
Confidence 985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=329.84 Aligned_cols=265 Identities=16% Similarity=0.164 Sum_probs=205.0
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeee-ecCCcCeEE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCC-LEAEMPALV 135 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv 135 (350)
..++|...+.| |+|+||.||+|++ .++..||+|.+.... ....+.+|+.++..++|++++..++.+ .+.+..++|
T Consensus 7 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKI-GSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEE-EECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeee-cCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 45789999999 9999999999998 677799999865542 234578899999999988877777666 566788999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe---CCCCceeEcccCCC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLS 212 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~ 212 (350)
|||+ +++|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 9999 899999986432 46899999999999999999999 8999999999999999 78899999999999
Q ss_pred ccCCCCCcc-----ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 213 KSIPEGKTH-----IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 213 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~ 233 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK--RQKYERISEK 233 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS--SSHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh--hhhhhhhhcc
Confidence 876543321 122345689999999999999999999999999999999999999986543211 1111111111
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.... .. +... ...++.+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 234 ~~~~-~~----~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 234 KMST-PI----EVLC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHS-CH----HHHT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccc-hh----hhhh--------ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 1110 00 0000 02346799999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=326.93 Aligned_cols=251 Identities=17% Similarity=0.198 Sum_probs=206.2
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEEL-GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhh-cCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 5788999998 9999999999999 567799999986543 34456788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc---eeEcccCCC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA---AKLFDFSLS 212 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~ 212 (350)
|||+++++|.+.+... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++. +||+|||++
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999888653 46899999999999999999999 899999999999999987655 999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+...
T Consensus 156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----------~~~~~~~~~~ 222 (284)
T 3kk8_A 156 IEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----------HRLYAQIKAG 222 (284)
T ss_dssp EECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHHT
T ss_pred EEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----------hHHHHHHHhc
Confidence 77654332 2334589999999999999999999999999999999999999874322 1122222222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......+.. ...++.+.+|+.+||+.||++|||+.++++
T Consensus 223 ~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 223 AYDYPSPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCCCCTTTT---------TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCchhh---------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 222111111 133467899999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=336.55 Aligned_cols=270 Identities=16% Similarity=0.205 Sum_probs=200.3
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHH--HHhcCCCCccceeeeeec-----CCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVF--ASQMNHKSILKLIGCCLE-----AEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~~ 131 (350)
.++|...+.| |+|+||.||+|+..+ ..||+|.+.... ...+..|..+ +..++||||+++++.+.. ...
T Consensus 12 ~~~y~~~~~l-g~G~~g~Vy~~~~~~-~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELI-GRGRYGAVYKGSLDE-RPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEE-EECSSEEEEEEEETT-EEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeec-ccCCCeEEEEEEECC-eEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 4688888998 999999999998854 599999986543 2334444444 456899999999985542 235
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC---------CeEeeccccCceEeCCCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ---------PVVFRNIEPWNILFQEEY 202 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~dlkp~Nill~~~~ 202 (350)
.++||||+++|+|.+++.. ...++..+..++.||+.||.||| +. +|+||||||+|||++.++
T Consensus 87 ~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred EEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCC
Confidence 6899999999999999965 34589999999999999999999 78 999999999999999999
Q ss_pred ceeEcccCCCccCCCCCc------cccccccccCCCCCCcccccc-------CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 018816 203 AAKLFDFSLSKSIPEGKT------HIKASTAIGSLEFAAPEYLTT-------GYYNEKTDVYSFGKLLLVLLTGRTIGHL 269 (350)
Q Consensus 203 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~ 269 (350)
.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..|+..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999999987643321 111234459999999999986 4567899999999999999999877654
Q ss_pred CcccCCCCcch--------HHHHHHHHHHhcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 270 SRLATGGSNFF--------ITDRVEKFIRSNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 270 ~~~~~~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
........... ............. ...+.+.+... ...++.+.+|+.+||+.||++|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN------SLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCC------SHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccc------cchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 43321111100 0111112222111 11222211111 257778999999999999999999999999
Q ss_pred HHHHhhhc
Q 018816 341 KLRQMYRT 348 (350)
Q Consensus 341 ~L~~~~~~ 348 (350)
.|+++...
T Consensus 312 ~L~~ll~~ 319 (336)
T 3g2f_A 312 RMAELMMI 319 (336)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHHH
Confidence 99998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=348.75 Aligned_cols=247 Identities=21% Similarity=0.223 Sum_probs=205.7
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|++ .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 15 ~~~Y~l~~~L-G~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTL-GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp ETTEEEEEEE-ECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEE-eeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3678888888 9999999999999 5777999999976432 234678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 94 v~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 94 VMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 99999999999999653 57999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .... ..+..+.
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---------~~~~-~~i~~~~ 232 (476)
T 2y94_A 166 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---------PTLF-KKICDGI 232 (476)
T ss_dssp CCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---------HHHH-HHHHTTC
T ss_pred cccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---------HHHH-HHHhcCC
Confidence 654332 334569999999999988765 6899999999999999999999975432 1111 1222211
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... | ...+..+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~--p-----------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 FYT--P-----------QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCC--C-----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCC--C-----------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 110 0 123457899999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=329.61 Aligned_cols=264 Identities=18% Similarity=0.168 Sum_probs=200.3
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |+|+||.||+|.+.++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l-g~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKI-GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEE-EEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhc-ccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 468888888 99999999999998788999999865432 234678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++ +|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CCSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred ecCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 9974 9999886542 46899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC--
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY-- 294 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 294 (350)
... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||..... ................
T Consensus 153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 153 PVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCTTT
T ss_pred ccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHHCCCChhh
Confidence 221 12234589999999998764 589999999999999999999999975432 1111111111111100
Q ss_pred -------CccCccccCCCCc---cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 -------MNIDPVIVGDRSC---FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 -------~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...++......+. ......++.+.+|+.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0111111100000 000134567899999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=332.07 Aligned_cols=260 Identities=20% Similarity=0.296 Sum_probs=203.6
Q ss_pred hcCcccccccccCCCceEEEEEEECCC----ceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeee-cCCcC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDR----GPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCL-EAEMP 132 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~----~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~ 132 (350)
...|...+.| |+|+||.||+|.+.++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..
T Consensus 24 ~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVI-GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEE-EEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhccee-eecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 3567777888 9999999999997322 258899887643 344577899999999999999999999865 45688
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccc
Confidence 99999999999999996532 46899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCcc--ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 213 KSIPEGKTH--IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 213 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||..... ... ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------~~~----~~~~ 245 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDI----TVYL 245 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT------TTH----HHHH
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH------HHH----HHHH
Confidence 866443221 11233447889999999999999999999999999999999 5555543321 111 1111
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....... .+ ...+..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 246 ~~~~~~~-~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 246 LQGRRLL-QP-----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp HTTCCCC-CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCCCC-CC-----------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 11 12346789999999999999999999999999999764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=339.26 Aligned_cols=244 Identities=17% Similarity=0.114 Sum_probs=193.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||+||+|.+ .++..||||++.... .........|+..+.++ +||||++++++|.+++..++|
T Consensus 57 ~~y~~~~~L-G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRL-GHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEE-EEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeehee-ccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 678988999 9999999999999 477899999986542 23344556666666655 899999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+ +++|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 136 ~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 679988876532 46999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ...+...
T Consensus 208 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------------~~~~~~~--- 267 (311)
T 3p1a_A 208 GTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------------WQQLRQG--- 267 (311)
T ss_dssp C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------------HHHHTTT---
T ss_pred ccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------HHHHhcc---
Confidence 44322 234458999999998875 799999999999999999999877653211 1111111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.+. ...++.+.+|+.+||+.||++|||+.++++
T Consensus 268 ~~~~~~~--------~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 268 YLPPEFT--------AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCCHHHH--------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccc--------cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111111 133567999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=338.70 Aligned_cols=247 Identities=20% Similarity=0.225 Sum_probs=200.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.+.|...+.| |+|+||.||+|+. .++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 53 ~~~y~~~~~l-G~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeeEE-ccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 3558888888 9999999999998 677799999986542 2334678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 132 v~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 999997 68888775322 57899999999999999999999 89999999999999999999999999999976
Q ss_pred CCCCCccccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
.... ....||+.|+|||++. ...++.++|||||||++|||++|..||..... ..........
T Consensus 204 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---------~~~~~~~~~~ 268 (348)
T 1u5q_A 204 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------MSALYHIAQN 268 (348)
T ss_dssp SSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------HHHHHHHHHS
T ss_pred cCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHhc
Confidence 5432 2345999999999985 56789999999999999999999999875432 1112222221
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
....... ...++.+.+|+.+||+.||++|||+.++++.
T Consensus 269 ~~~~~~~------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 269 ESPALQS------------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCCCC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCC------------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1111111 1234678899999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=333.78 Aligned_cols=265 Identities=21% Similarity=0.233 Sum_probs=207.6
Q ss_pred cccccccccCCCceEEEEEEE-----CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecC--CcCe
Q 018816 62 YSMRNITIDEIEGYILYMGFL-----RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEA--EMPA 133 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~-----~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 133 (350)
|...+.| |+|+||.||++.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 33 ~~~~~~l-G~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEE-EECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred Hhhhhee-cCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 4777888 9999999999875 356689999997653 34467789999999999999999999999874 5789
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++++|.+++.. ..+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++.
T Consensus 112 lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccc
Confidence 99999999999999965 35899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCcc-ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCccc-----CCCCcchHHHHHHH
Q 018816 214 SIPEGKTH-IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLA-----TGGSNFFITDRVEK 287 (350)
Q Consensus 214 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~ 287 (350)
........ .......+|+.|+|||++.+..++.++||||||+++|+|++|..||...... ..............
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 77554322 1233445788899999999889999999999999999999999998643210 00000001111122
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
........... ..++..+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus 263 ~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 263 LLERGERLPRP------------DKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcccCCCCC------------ccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 22221111111 13456899999999999999999999999999998653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=331.44 Aligned_cols=276 Identities=17% Similarity=0.181 Sum_probs=213.0
Q ss_pred ccHHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHh--cCCCCccceeeeee
Q 018816 50 FSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQ--MNHKSILKLIGCCL 127 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~ 127 (350)
....--....++|...+.| |+|+||.||+|.+. +..||+|.+... ....+.+|+.++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~l-g~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESI-GKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEE-EEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeee-cCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 4444345566899999999 99999999999986 569999998654 24567789998887 78999999999998
Q ss_pred cCC----cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEeeccccCceEe
Q 018816 128 EAE----MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFG-----FPQPVVFRNIEPWNILF 198 (350)
Q Consensus 128 ~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~Nill 198 (350)
... ..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||.. ++.+|+|+||||+|||+
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence 776 78999999999999999964 3689999999999999999999932 14689999999999999
Q ss_pred CCCCceeEcccCCCccCCCCCccc--cccccccCCCCCCccccccC------CCCccchhHHHHHHHHHHHhC-------
Q 018816 199 QEEYAAKLFDFSLSKSIPEGKTHI--KASTAIGSLEFAAPEYLTTG------YYNEKTDVYSFGKLLLVLLTG------- 263 (350)
Q Consensus 199 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tg------- 263 (350)
+.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 999999999999997664433221 22344699999999998765 334789999999999999999
Q ss_pred ---CCCCCCCcccCCCCcchHHHHHHHHHHhcC-CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018816 264 ---RTIGHLSRLATGGSNFFITDRVEKFIRSNG-YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVA 339 (350)
Q Consensus 264 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl 339 (350)
..||...... ... .......+.... ...+..... ....+..+.+|+.+||+.||++|||+.+|+
T Consensus 261 ~~~~~p~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 261 EDYQLPYYDLVPS----DPS-VEEMRKVVCEQKLRPNIPNRWQ-------SCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp CCCCCTTTTTSCS----SCC-HHHHHHHHTTSCCCCCCCGGGG-------TSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cccccCccccCcC----ccc-HHHHHHHHHHHHhCCCCccccc-------chhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 5666543221 011 111222222111 111111111 126778899999999999999999999999
Q ss_pred HHHHHhhhc
Q 018816 340 KKLRQMYRT 348 (350)
Q Consensus 340 ~~L~~~~~~ 348 (350)
+.|+++.++
T Consensus 329 ~~L~~i~~~ 337 (342)
T 1b6c_B 329 KTLSQLSQQ 337 (342)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHH
Confidence 999999765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=332.26 Aligned_cols=262 Identities=16% Similarity=0.156 Sum_probs=201.8
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
...++|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 31 ~~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLV-GRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ---CCEEEEEEE-EECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred cEeccEEEEEEE-cCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 345789999999 9999999999999 5677899999875432 2346788999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIA 181 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred EEEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccC
Confidence 9999999999999998653 46899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
......... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ......+...
T Consensus 182 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~~~~~~~ 250 (309)
T 2h34_A 182 SATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----------SVMGAHINQA 250 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----------HHHHHHHHSC
T ss_pred ccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----------HHHHHHhccC
Confidence 766443221 12234589999999999988999999999999999999999999874321 1222222221
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhhc
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-TMIDVAKKLRQMYRT 348 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~~~~ 348 (350)
... .. ... ...+..+.+++.+||+.||++|| |+.++++.|+++...
T Consensus 251 ~~~-~~-~~~--------~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 251 IPR-PS-TVR--------PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp CCC-GG-GTS--------TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred CCC-cc-ccC--------CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 111 00 000 13345789999999999999999 999999999987654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=334.93 Aligned_cols=270 Identities=20% Similarity=0.257 Sum_probs=212.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-----CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCC--c
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-----RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE--M 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-----~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~ 131 (350)
.++|...+.| |+|+||.||++.+ .++..||+|++........+.+.+|+.++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQL-GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEE-ECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeee-ccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 3567888888 9999999999984 466799999998776666778999999999999999999999987644 7
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||+
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 899999999999999996542 46899999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCccc------CCCCcchHHHH
Q 018816 212 SKSIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLA------TGGSNFFITDR 284 (350)
Q Consensus 212 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~~~~~~~ 284 (350)
+.......... ......++..|+|||++.+..++.++||||||+++|+|++|..|+...... ...........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 98775443221 122334778899999999888999999999999999999999987632100 00000011111
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....+........ +..++..+.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus 272 ~~~~~~~~~~~~~------------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 272 LIELLKNNGRLPR------------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHTTCCCCC------------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCC------------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1222222111110 013456799999999999999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=326.15 Aligned_cols=247 Identities=21% Similarity=0.260 Sum_probs=201.6
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
+.++|...+.| |+|+||.||+|.+ .++..||+|.+..... .....+.+|+.++++++||||+++++++.+....+
T Consensus 7 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPL-GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEE-ecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 34688888998 9999999999999 5566899999865432 22466889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++.
T Consensus 86 lv~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp EEECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred EEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence 999999999999998653 46899999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... . .....+....
T Consensus 158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~-~~~~~~~~~~ 223 (279)
T 3fdn_A 158 HAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---------Q-ETYKRISRVE 223 (279)
T ss_dssp CC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------H-HHHHHHHHTC
T ss_pred cCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---------H-HHHHHHHhCC
Confidence 543322 2334589999999999998999999999999999999999999874321 1 1112222211
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... . ...+..+.+|+.+||+.||++|||+.++++
T Consensus 224 ~~~-~------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 FTF-P------------DFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCC-C------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCC-C------------CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 0 123457889999999999999999999997
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.56 Aligned_cols=268 Identities=21% Similarity=0.207 Sum_probs=205.8
Q ss_pred HHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-----hhhHHHHHHHHHHHHhcCCCCccceeeeeec
Q 018816 55 LKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-----RYASERCFNNIVFASQMNHKSILKLIGCCLE 128 (350)
Q Consensus 55 l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 128 (350)
+....++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 21 LLELQKKYHLKGAI-GQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp HHHHHHHEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhheeeccee-eecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 55667889999999 9999999999999 666689999986542 2445778999999999999999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCC-----------------------------------CCCCCCHHHHHHHHHHHHH
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQT-----------------------------------HLEPLLLTHRLKVAMETAN 173 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~-----------------------------------~~~~~~~~~~~~i~~~i~~ 173 (350)
.+..++||||+++|+|.+++...... ....+++..+..++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988521000 0012456778899999999
Q ss_pred HHHHHHccCCCCeEeeccccCceEeCCCC--ceeEcccCCCccCCCCCc--cccccccccCCCCCCcccccc--CCCCcc
Q 018816 174 AVAYLRFGFPQPVVFRNIEPWNILFQEEY--AAKLFDFSLSKSIPEGKT--HIKASTAIGSLEFAAPEYLTT--GYYNEK 247 (350)
Q Consensus 174 ~l~~LH~~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 247 (350)
||.||| +.+|+|+||||+||+++.++ .+||+|||++........ ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999 89999999999999998776 899999999976532211 112334559999999999875 678999
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHcccc
Q 018816 248 TDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSH 327 (350)
Q Consensus 248 ~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 327 (350)
+|||||||++|+|++|..||..... .......... ......+.. ...++.+.+|+.+||+.
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND---------ADTISQVLNK-KLCFENPNY---------NVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHHHHHC-CCCTTSGGG---------GGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh---------HHHHHHHHhc-ccccCCccc---------ccCCHHHHHHHHHHcCC
Confidence 9999999999999999999975432 1222222222 211111111 13456789999999999
Q ss_pred CCCCCCCHHHHHH--HHHHh
Q 018816 328 SAEDRPTMIDVAK--KLRQM 345 (350)
Q Consensus 328 ~P~~RPt~~evl~--~L~~~ 345 (350)
||++|||+.++++ .++++
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTT
T ss_pred ChhHCCCHHHHhcChhhccC
Confidence 9999999999987 34443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=328.01 Aligned_cols=264 Identities=16% Similarity=0.162 Sum_probs=208.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeee-ecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCC-LEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||.||+|++ .++..||+|.+.... ..+.+.+|+.++..++|++++..+.++ .+....++||
T Consensus 8 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKI-GSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEE-EEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEE-ccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 5789999998 9999999999998 677799999986543 234688999999999998877766665 5667789999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe---CCCCceeEcccCCCc
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLSK 213 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~ 213 (350)
||+ +++|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||++.
T Consensus 85 e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 999 899999996432 46899999999999999999999 8999999999999999 488999999999998
Q ss_pred cCCCCCccc-----cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 214 SIPEGKTHI-----KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 214 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~ 234 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEKK 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS--SHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh--hhhhhhcccc
Confidence 765433211 123456999999999999999999999999999999999999999864432111 1111111111
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.. ... +.+. ...++.+.+++.+||+.||++|||+.+|++.|+++...
T Consensus 235 ~~-~~~----~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 235 MS-TPI----EVLC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HH-SCH----HHHT--------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cC-Cch----HHHH--------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 11 000 0000 02346799999999999999999999999999998754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=338.47 Aligned_cols=249 Identities=15% Similarity=0.154 Sum_probs=203.5
Q ss_pred HhcCcccccccccCCCceEEEEEEEC-CCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLR-DRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 132 (350)
..++|...+.| |+|+||.||+|+.. ++..||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 18 ~~~~y~~~~~l-G~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 18 KLTDFNFLMVL-GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp -CTTEEEEEEE-EEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred chHHcEEEEEE-eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 45789999999 99999999999994 56689999987642 23356688999999988 799999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 9999999999999998653 46899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
+....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..... .... ..+...
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---------~~~~-~~i~~~ 236 (353)
T 2i0e_A 169 KENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------DELF-QSIMEH 236 (353)
T ss_dssp BCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHH-HHHHHC
T ss_pred cccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---------HHHH-HHHHhC
Confidence 86432221 23455699999999999999999999999999999999999999974321 1111 222222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 340 (350)
.... . ...+..+.+|+.+||+.||++||+ +.++++
T Consensus 237 ~~~~-p------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 237 NVAY-P------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCCC-C------------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCC-C------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 0 133467899999999999999995 566654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=332.96 Aligned_cols=263 Identities=21% Similarity=0.227 Sum_probs=200.2
Q ss_pred cCcccc-cccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMR-NITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~-~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 136 (350)
+.|... +.| |+|+||.||+|.+ .++..||+|.+........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 12 ~~y~i~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVL-GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCC-CCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCcee-cCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 566664 566 9999999999998 56779999999776555567899999999985 7999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc---eeEcccCCCc
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA---AKLFDFSLSK 213 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~ 213 (350)
||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999653 46899999999999999999999 899999999999999998776 9999999987
Q ss_pred cCCCCCc-----cccccccccCCCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCc-----
Q 018816 214 SIPEGKT-----HIKASTAIGSLEFAAPEYLTT-----GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN----- 278 (350)
Q Consensus 214 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----- 278 (350)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 6542211 111223458999999999875 4688999999999999999999999976543210000
Q ss_pred chHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 279 FFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..........+.........+.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPDKDW---------AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCHHHH---------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhHHHHHHHHHhccCcccCchhc---------ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00111222222222221111100 023467899999999999999999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=332.38 Aligned_cols=251 Identities=19% Similarity=0.190 Sum_probs=206.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh------hHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY------ASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
.+.|...+.| |+|+||.||+|.+ .++..||+|.+...... ..+.+.+|+.++.+++||||+++++++.+...
T Consensus 11 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 11 EDFYDIGEEL-GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hccEEEeeEe-eecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 4678888998 9999999999999 56779999998764321 35779999999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC----ceeEc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY----AAKLF 207 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~ 207 (350)
.++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 99999999999999999754 56899999999999999999999 89999999999999999887 79999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ... ..
T Consensus 162 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~-~~ 228 (321)
T 2a2a_A 162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---------QET-LA 228 (321)
T ss_dssp CCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---------HHH-HH
T ss_pred cCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---------HHH-HH
Confidence 9999987654322 2334589999999999988999999999999999999999999874321 111 11
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+...... .++... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 229 ~i~~~~~~-~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 229 NITSVSYD-FDEEFF--------SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHTTCCC-CCHHHH--------TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHhcccc-cChhhh--------cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 12211111 111110 123467899999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=341.11 Aligned_cols=250 Identities=16% Similarity=0.229 Sum_probs=196.5
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEeccc--chhhHHHHHHHHHHHHhcC--CCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKS--VRYASERCFNNIVFASQMN--HKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv 135 (350)
.+|...+.| |+|+||.||++...++..||||.+... .....+.+.+|+.++.+++ ||||+++++++...+..++|
T Consensus 56 ~~y~~~~~L-G~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQI-GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEE-ECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEE-ccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 468888998 999999999999977889999998654 2345577899999999997 59999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|| +.+++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||++...
T Consensus 135 ~E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EE-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred Ee-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99 5688999999754 46889999999999999999999 99999999999999995 588999999999876
Q ss_pred CCCCccccccccccCCCCCCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHH
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTT-----------GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 284 (350)
............+||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ....
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~ 276 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--------QISK 276 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--------HHHH
Confidence 54433323345569999999999865 3689999999999999999999999974321 1111
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
............. +. ..+..+.+|+.+||+.||++|||+.+|++
T Consensus 277 ~~~~~~~~~~~~~-~~-----------~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 277 LHAIIDPNHEIEF-PD-----------IPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHHCTTSCCCC-CC-----------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCccccCCC-Cc-----------cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 2222111111111 10 11357889999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=341.05 Aligned_cols=276 Identities=17% Similarity=0.150 Sum_probs=215.1
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCC--cCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAE--MPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 134 (350)
.+.|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.. ..++
T Consensus 8 ~~~y~i~~~L-G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDIL-GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEE-EcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 3678888898 9999999999999 5577999999976432 34567889999999999999999999988655 6799
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe----CCCCceeEcccC
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF----QEEYAAKLFDFS 210 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg 210 (350)
||||+++++|.+++...... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||
T Consensus 87 v~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999999654221 24899999999999999999999 8999999999999999 788889999999
Q ss_pred CCccCCCCCccccccccccCCCCCCcccccc--------CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTT--------GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||...... ....
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~-----~~~~ 233 (396)
T 4eut_A 162 AARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP-----RRNK 233 (396)
T ss_dssp GCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT-----TTCH
T ss_pred CceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc-----cchH
Confidence 9987654322 234459999999999865 56788999999999999999999999754321 1112
Q ss_pred HHHHHHHHhcCCCccC---c------cccC--CCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 283 DRVEKFIRSNGYMNID---P------VIVG--DRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~---~------~~~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..+...........+. . .+.. ...+......+..+.+++.+||+.||++|||+.++++.+++++..
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 2233333322111110 0 0000 011112247888999999999999999999999999999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=343.33 Aligned_cols=253 Identities=17% Similarity=0.197 Sum_probs=193.2
Q ss_pred hcCcccc-cccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHh-cCCCCccceeeeeec----CCc
Q 018816 59 INNYSMR-NITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQ-MNHKSILKLIGCCLE----AEM 131 (350)
Q Consensus 59 ~~~f~~~-~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~ 131 (350)
.++|... +.| |+|+||.||++.+ .++..||+|.+... ..+.+|+.++.+ .+||||+++++++.. ...
T Consensus 60 ~~~y~~~~~~L-G~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVL-GLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGTEEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceecccee-eeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 3556655 566 9999999999999 56778999998643 356788888754 489999999999875 567
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCceeEcc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKLFD 208 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~D 208 (350)
+++||||+++|+|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEe
Confidence 8999999999999999976421 46899999999999999999999 899999999999999998 78999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... .. ....
T Consensus 208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~----~~~~ 278 (400)
T 1nxk_A 208 FGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PG----MKTR 278 (400)
T ss_dssp CTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CS----HHHH
T ss_pred cccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HH----HHHH
Confidence 99998654322 233456899999999999999999999999999999999999999765432100 00 1112
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
+..+......+.+ ...+.++.+|+.+||+.||++|||+.++++.
T Consensus 279 i~~~~~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 279 IRMGQYEFPNPEW---------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHTCCCCCTTTT---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHcCcccCCCccc---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2222222211111 1345678999999999999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=343.61 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=195.7
Q ss_pred CcccccccccCCCceEEEEEEEC--CC--ceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeec-CCcCeE
Q 018816 61 NYSMRNITIDEIEGYILYMGFLR--DR--GPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLE-AEMPAL 134 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~--~~--~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 134 (350)
.|...+.| |+|+||.||+|.+. ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 90 ~~~~~~~L-G~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVI-GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEE-ECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEe-eeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35556777 99999999999982 22 258899886543 3456789999999999999999999998754 558899
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccc
Confidence 999999999999997542 46889999999999999999999 89999999999999999999999999999986
Q ss_pred CCCCCccc--cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 215 IPEGKTHI--KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 215 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||..... .... ..+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~------~~~~----~~~~~ 311 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDIT----VYLLQ 311 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS------SCHH----HHHHT
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH------HHHH----HHHHc
Confidence 64332111 1223347788999999999999999999999999999999 6777764332 1111 11222
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.... ..+ ..++..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 312 ~~~~-~~p-----------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 312 GRRL-LQP-----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp TCCC-CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCC-CCC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 111 13446799999999999999999999999999999765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=360.37 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=201.2
Q ss_pred ccccCCCceEEEEEEEC---CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCCC
Q 018816 67 ITIDEIEGYILYMGFLR---DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~---~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
.| |+|+||.||+|.+. ++..||||.+.... ....+.+.+|+.+|++++||||++++++|.+ +..++||||+++|
T Consensus 343 ~L-G~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 EL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EE-EECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EE-ecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 56 99999999999873 44579999997653 2456789999999999999999999999976 5689999999999
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccc
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHI 222 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 222 (350)
+|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.........
T Consensus 421 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 421 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp BHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 9999996542 56899999999999999999999 8999999999999999999999999999998765432211
Q ss_pred -cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCcc
Q 018816 223 -KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPV 300 (350)
Q Consensus 223 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (350)
......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... . .+...+..+......
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~----~~~~~i~~~~~~~~p-- 561 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------P----EVMAFIEQGKRMECP-- 561 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------H----HHHHHHHTTCCCCCC--
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------H----HHHHHHHcCCCCCCC--
Confidence 1222336789999999999999999999999999999998 9999975432 1 122233332211111
Q ss_pred ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 301 IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 301 ~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..++..+.+|+.+||+.||++|||+.+|++.|+.++.+
T Consensus 562 ----------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 562 ----------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ----------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 13457899999999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=339.54 Aligned_cols=252 Identities=21% Similarity=0.194 Sum_probs=202.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 135 (350)
..++|...+.| |+|+||.||++.+ .++..||+|.+..... ...+|+.++.++ +||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDI-GVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEE-eeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 45678999998 9999999999999 5677899999876532 245688888888 799999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC----CceeEcccCC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE----YAAKLFDFSL 211 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~ 211 (350)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||+... +.+||+|||+
T Consensus 95 ~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp ECCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999998754 56899999999999999999999 8999999999999998543 3599999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
+........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .........+..
T Consensus 167 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~~~~i~~ 237 (342)
T 2qr7_A 167 AKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-------DTPEEILARIGS 237 (342)
T ss_dssp CEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-------SCHHHHHHHHHH
T ss_pred cccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-------CCHHHHHHHHcc
Confidence 987643322 23345689999999999888899999999999999999999999974321 112222333333
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+......+.+ ...++.+.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 238 GKFSLSGGYW---------NSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCCCCCSTTT---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCcccc---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3322211111 134567899999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=334.71 Aligned_cols=260 Identities=19% Similarity=0.255 Sum_probs=198.9
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC--
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP-- 132 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-- 132 (350)
.++|...+.| |+|+||.||++.+ .++..||+|.+.... ......+.+|+.++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEIL-GFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEE-ccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4678888998 9999999999998 677799999987642 23346788999999999999999999998876554
Q ss_pred --eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 133 --ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 133 --~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred ccEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999998653 46899999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCcc-ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 211 LSKSIPEGKTH-IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 211 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ........
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---------~~~~~~~~ 232 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---------VSVAYQHV 232 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHHHH
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHh
Confidence 99866443221 123344589999999999999999999999999999999999999975432 11112222
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHHHHhh
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI-DVAKKLRQMY 346 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl~~L~~~~ 346 (350)
..... .+.... ...+..+.+|+.+||+.||++||++. ++.+.|.++.
T Consensus 233 ~~~~~---~~~~~~-------~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 233 REDPI---PPSARH-------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HCCCC---CHHHHS-------TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCCC---Cccccc-------CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 21110 010000 12456789999999999999999654 4555666554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=333.65 Aligned_cols=248 Identities=19% Similarity=0.175 Sum_probs=194.9
Q ss_pred hcCcccccccccCCCceEEEEEEE----CCCceEEEEEecccc----hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL----RDRGPILVMKYRKSV----RYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~----~~~~~vaik~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
.++|...+.| |+|+||.||+++. .++..||+|.+.... ......+.+|+.++++++||||+++++++.+.+
T Consensus 16 ~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVL-GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEE-EEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred HHHeEEEEEE-EeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 4689999998 9999999999998 467799999987642 123456789999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EEEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence 999999999999999998653 46889999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .........
T Consensus 167 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~i~~ 235 (327)
T 3a62_A 167 LCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---------KKTIDKILK 235 (327)
T ss_dssp CC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHHHHH
T ss_pred cccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---------HHHHHHHHh
Confidence 9875432221 22344699999999999998999999999999999999999999974322 111222221
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
.... +.+ ..+..+.+|+.+||+.||++|| ++.++++
T Consensus 236 -~~~~-~p~------------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 236 -CKLN-LPP------------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -TCCC-CCT------------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -CCCC-CCC------------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111 111 2346789999999999999999 7778775
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=323.75 Aligned_cols=253 Identities=20% Similarity=0.220 Sum_probs=205.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQTL-GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEEEE-EECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEEEe-ecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4678888998 9999999999999 567799999986543 244577899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.+....
T Consensus 85 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 999999999998643 46899999999999999999999 8999999999999999999999999999997654
Q ss_pred CCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
............||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ... ... +.... .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~----~~~-~~~~~-~ 226 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS----CQE----YSD-WKEKK-T 226 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT----SHH----HHH-HHTTC-T
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH----HHH----HHH-hhhcc-c
Confidence 3332222344568999999999987765 78999999999999999999999754321 011 111 11111 1
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+ . ...+..+.+|+.+||+.||++|||+.++++
T Consensus 227 ~~~~-~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 YLNP-W---------KKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TSTT-G---------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCc-h---------hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1110 0 133467889999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=332.82 Aligned_cols=269 Identities=15% Similarity=0.161 Sum_probs=190.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKL-GNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEE-CCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 4678888888 9999999999998 5677999999865432 33467889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 137 EPAGYCTLADRLYGPL-QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
||++ ++|.+++.... ......+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 69998885421 111135899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ................
T Consensus 159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~~~ 230 (317)
T 2pmi_A 159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND------EEQLKLIFDIMGTPNE 230 (317)
T ss_dssp TSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCSCCT
T ss_pred CCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCCh
Confidence 43221 12334589999999998764 689999999999999999999999975432 1111111111111000
Q ss_pred C---------ccCccccCCCCcc--------chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 M---------NIDPVIVGDRSCF--------RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~---------~~~~~~~~~~~~~--------~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ...+.+....... .....+..+.+|+.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000000000000 00123467999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=334.98 Aligned_cols=265 Identities=21% Similarity=0.262 Sum_probs=206.9
Q ss_pred HhcCcccccccccCCCceEEEEEEE------CCCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
..++|...+.| |+|+||.||+|++ .++..||+|.+... .......+.+|+.++++++||||+++++++.+..
T Consensus 28 ~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 28 PRKNITLIRGL-GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CGGGCEEEEEC-C--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhheEEEEEE-cCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34788888998 9999999999984 34558999998654 3345567889999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCcee
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQ--THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAK 205 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~k 205 (350)
..++||||+++++|.+++..... .....+++..++.++.||+.||.||| +.+|+|+||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999975421 11135889999999999999999999 899999999999999984 45699
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHH
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~ 284 (350)
|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------~~ 253 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------QE 253 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----------HH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH----------HH
Confidence 999999875543332222334457899999999998999999999999999999998 8898864321 11
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....+......... ..++..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 254 ~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 254 VLEFVTSGGRMDPP------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcCCCCCCC------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 22222222211111 13346789999999999999999999999999988653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=329.53 Aligned_cols=263 Identities=16% Similarity=0.160 Sum_probs=199.6
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|...+.| |+|+||.||+|.+ .++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 3 ~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKI-GEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEE-eecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 578888898 9999999999999 5577999999865432 33566889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++....
T Consensus 82 e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999999988654 56899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH--------
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK-------- 287 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------- 287 (350)
..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... ........
T Consensus 154 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~ 225 (311)
T 4agu_A 154 GPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV------DQLYLIRKTLGDLIPR 225 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCSCCHH
T ss_pred Ccccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhcccccc
Confidence 33221 233458999999999876 56899999999999999999999999754321 11111111
Q ss_pred ---HHHhcC----CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 ---FIRSNG----YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ---~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+.... ....++.......... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHC-TTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCcCCCccccchhhhhc-ccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 111110 0000110000000000 134567899999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=350.79 Aligned_cols=248 Identities=16% Similarity=0.124 Sum_probs=196.2
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 147 ~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLL-GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEE-eeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4678889998 9999999999999 667799999987542 2334567889999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
||||+++++|.+++... ..+++..+..++.||+.||.||| + .+|+||||||+|||++.++.+||+|||+++
T Consensus 226 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence 99999999999998653 56899999999999999999999 7 899999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..... . .....+....
T Consensus 298 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---------~-~~~~~i~~~~ 365 (446)
T 4ejn_A 298 EGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------E-KLFELILMEE 365 (446)
T ss_dssp TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------H-HHHHHHHHCC
T ss_pred eccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---------H-HHHHHHHhCC
Confidence 6433222 23445699999999999999999999999999999999999999975322 1 1112222211
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
... . ...++.+.+|+.+||+.||++|| |+.++++
T Consensus 366 ~~~-p------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 IRF-P------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCC-C------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCC-C------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 110 0 12346789999999999999999 9999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=345.84 Aligned_cols=282 Identities=11% Similarity=0.095 Sum_probs=207.3
Q ss_pred hhcchhHHHHHHhhcCCCC-CCcccccHHHHHHH---------------------hcCcccccccccCCCceEEEEEEE-
Q 018816 26 LRNGQIFLEKLIASFDGKR-NPIRSFSSEDLKTA---------------------INNYSMRNITIDEIEGYILYMGFL- 82 (350)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~---------------------~~~f~~~~~lig~G~~g~V~~~~~- 82 (350)
...|..++++.+....+.. .+.......++... .++|...+.| |+|+||.||+|++
T Consensus 17 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~l-G~G~~g~V~~a~~~ 95 (377)
T 3byv_A 17 QGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVL-GQEDPYAYLEATDQ 95 (377)
T ss_dssp CCTTHHHHHHHHHHCGGGCCCSTTC-CHHHHHHHHHHHTCC-CCEEEEEESSSCCCEEEEEEEEE-EEETTEEEEEEEC-
T ss_pred CCCchHHHHHHHHhCcccccccccccccchhhhhhHHHhcCCCCcEEEEeecCCCCceEEEccee-ecCCCEEEEEEEEC
Confidence 3456677777777665544 44444444444332 3557777888 9999999999998
Q ss_pred CCCceEEEEEeccc---chhhHHHHHHHHH---HHHhcCCCCcccee-------eeeecCC-----------------cC
Q 018816 83 RDRGPILVMKYRKS---VRYASERCFNNIV---FASQMNHKSILKLI-------GCCLEAE-----------------MP 132 (350)
Q Consensus 83 ~~~~~vaik~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~~~~~~-----------------~~ 132 (350)
.++..||||.+... .....+.+.+|+. ++++++||||++++ +++.+.+ ..
T Consensus 96 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 175 (377)
T 3byv_A 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175 (377)
T ss_dssp CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESE
T ss_pred CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEE
Confidence 66779999998743 3345677889994 55556899999998 5554443 37
Q ss_pred eEEeecCCCCchhhhhhCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQ--THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
++||||+ +|+|.+++..... .....+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 176 ~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG 251 (377)
T 3byv_A 176 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 251 (377)
T ss_dssp EEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGG
T ss_pred EEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEech
Confidence 8999999 6899999864210 00023445888899999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccC-----------CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcc
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-----------YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF 279 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~ 279 (350)
+++.... ......| +.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 252 ~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~------ 319 (377)
T 3byv_A 252 HLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAAL------ 319 (377)
T ss_dssp GCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred hheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccc------
Confidence 9986432 2234457 999999999887 8999999999999999999999998643221
Q ss_pred hHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHh
Q 018816 280 FITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK--KLRQM 345 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~ 345 (350)
.......... . ..++.+.+|+.+||+.||++|||+.++++ .++++
T Consensus 320 ---------------~~~~~~~~~~-~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 320 ---------------GGSEWIFRSC-K-----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp ---------------CCSGGGGSSC-C-----CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred ---------------cchhhhhhhc-c-----CCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 0000000000 0 23467899999999999999999999986 44444
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=329.16 Aligned_cols=250 Identities=20% Similarity=0.221 Sum_probs=203.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.++|...+.| |+|+||.||++.. .++..||+|.+........+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVL-GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeec-cCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4678888898 9999999999999 5677999999986654455678899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe---CCCCceeEcccCCCcc
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLSKS 214 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~ 214 (350)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+|+|+||||+||++ +.++.+||+|||++..
T Consensus 87 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 87 LVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred cCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999988643 46899999999999999999999 8999999999999999 7889999999999876
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+.....
T Consensus 159 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~~~~~i~~~~~ 224 (304)
T 2jam_A 159 EQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----------SKLFEKIKEGYY 224 (304)
T ss_dssp CCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----------HHHHHHHHHCCC
T ss_pred cCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----------HHHHHHHHcCCC
Confidence 43321 2233489999999999999999999999999999999999999874321 112222222222
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....+.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 225 EFESPFW---------DDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCCTTTT---------TTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCcccc---------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 134567899999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=325.82 Aligned_cols=250 Identities=18% Similarity=0.232 Sum_probs=205.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeec--------
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLE-------- 128 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 128 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|.+.... +.+.+|+.++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELI-GSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEE-ECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeee-ccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 45678889998 9999999999999 477799999987653 346789999999999999999998864
Q ss_pred --------CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC
Q 018816 129 --------AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE 200 (350)
Q Consensus 129 --------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~ 200 (350)
....++||||+++++|.+++..... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcC
Confidence 3457999999999999999964321 46899999999999999999999 899999999999999999
Q ss_pred CCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcch
Q 018816 201 EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF 280 (350)
Q Consensus 201 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~ 280 (350)
++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..|+...
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------- 224 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------- 224 (284)
T ss_dssp TTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------
T ss_pred CCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------
Confidence 99999999999987654332 23345899999999999989999999999999999999999875411
Q ss_pred HHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 281 ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
......+.... +.+ ..+..+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 225 --~~~~~~~~~~~---~~~------------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 225 --SKFFTDLRDGI---ISD------------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp --HHHHHHHHTTC---CCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred --HHHHHHhhccc---ccc------------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11111111111 111 2335688999999999999999999999999998765
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=339.37 Aligned_cols=258 Identities=12% Similarity=0.115 Sum_probs=206.3
Q ss_pred HHhcCcccccccccCCCceEEEEEE------ECCCceEEEEEecccchhhHHHHHHHHHHHHhcC---CCCccceeeeee
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGF------LRDRGPILVMKYRKSVRYASERCFNNIVFASQMN---HKSILKLIGCCL 127 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~------~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~ 127 (350)
...++|...+.| |+|+||.||+|. ...+..||+|.+.... ..++.+|+.++.+++ |+||+.+++++.
T Consensus 62 ~~~~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLL-GEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEE-EECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEe-eccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 345778888888 999999999994 3567799999997653 456778888888886 999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-------
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE------- 200 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~------- 200 (350)
..+..++||||+++|+|.+++..........+++..++.++.||+.||.||| +.+|+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999996421111257999999999999999999999 999999999999999998
Q ss_pred ----CCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCC
Q 018816 201 ----EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG 276 (350)
Q Consensus 201 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~ 276 (350)
++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 8999999999997653222223344556999999999999999999999999999999999999998643210
Q ss_pred CcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHhhhc
Q 018816 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDR-PTMIDVAKKLRQMYRT 348 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-Pt~~evl~~L~~~~~~ 348 (350)
...+...+... ...+.+.+++..||+.+|.+| |++.++.+.|+++..+
T Consensus 292 -----------------~~~~~~~~~~~-------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 292 -----------------ECKPEGLFRRL-------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -----------------EEEECSCCTTC-------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----------------ceeechhcccc-------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 00011111111 124567899999999999999 6789999888887653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=325.48 Aligned_cols=250 Identities=18% Similarity=0.217 Sum_probs=184.9
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
..++|...+.| |+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 9 ~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 9 KIEDFKVGNLL-GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SGGGEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred ccccceeeeee-cCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 34678888998 9999999999998 6777999999865432 22467889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 160 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLAT 160 (278)
T ss_dssp EEEECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence 9999999999999997542 56899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 161 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------~~~~~~ 225 (278)
T 3cok_A 161 QLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-------------TLNKVV 225 (278)
T ss_dssp ECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CC
T ss_pred eccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-------------HHHHHh
Confidence 7643222 1223458999999999998889999999999999999999999987543210 000000
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. +... +...+..+.+|+.+||+.||++|||+.++++
T Consensus 226 ~~--~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LA--DYEM--------PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SS--CCCC--------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hc--ccCC--------ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 0000 0133467899999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=334.72 Aligned_cols=260 Identities=20% Similarity=0.253 Sum_probs=205.3
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCce--EEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGP--ILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~--vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 134 (350)
++|...+.| |+|+||.||+|++ .++.. |++|.+.... ....+.+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVI-GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEE-ECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeee-ecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 678888888 9999999999998 44444 4888886532 23456788999999999 89999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 135 VYEPAGYCTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
||||+++++|.+++..... .....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence 9999999999999976420 11146899999999999999999999 899999999999999999999
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~ 282 (350)
+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||..... .
T Consensus 181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---------~ 248 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------A 248 (327)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------H
T ss_pred EEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---------H
Confidence 9999999987432211 1223347889999999988889999999999999999998 9999875432 1
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.....+......... ...+..+.+|+.+||+.||++|||+.++++.|+++...
T Consensus 249 -~~~~~~~~~~~~~~~------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 249 -ELYEKLPQGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp -HHHHHGGGTCCCCCC------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -HHHHHhhcCCCCCCC------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111111111110000 13346799999999999999999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.34 Aligned_cols=261 Identities=16% Similarity=0.197 Sum_probs=195.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE----- 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 130 (350)
.++|...+.| |+|+||.||+|.+ .++..||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~l-G~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPI-GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEE-EECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEe-ecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4678888888 9999999999998 56779999999754 2344667889999999999999999999997654
Q ss_pred -cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 131 -MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEE
Confidence 45999999975 5666663 34889999999999999999999 899999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH------
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD------ 283 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~------ 283 (350)
|+++...... .....+||+.|+|||++.+..++.++|||||||++|||++|++||...... ....
T Consensus 209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~------~~~~~i~~~l 279 (464)
T 3ttj_A 209 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI------DQWNKVIEQL 279 (464)
T ss_dssp CCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHH
T ss_pred EeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhc
Confidence 9998764432 233456999999999999999999999999999999999999999754321 1110
Q ss_pred -------------HHHHHHHhcC-CCccC-----ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 284 -------------RVEKFIRSNG-YMNID-----PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 284 -------------~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.......... ..... +..............+.++.+|+.+||+.||++|||+.|+++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111111110 00000 000000000011133678999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=339.25 Aligned_cols=266 Identities=14% Similarity=0.109 Sum_probs=199.6
Q ss_pred hcCcccccccccCCCceEEEEEEEC----CCceEEEEEecccchh-----------hHHHHHHHHHHHHhcCCCCcccee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR----DRGPILVMKYRKSVRY-----------ASERCFNNIVFASQMNHKSILKLI 123 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~----~~~~vaik~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~ 123 (350)
.++|...+.| |+|+||.||+|.+. .+..||+|.+...... ....+.+|+..+..++||||++++
T Consensus 36 ~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKI-GSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC-------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred CceEEEEeeE-eecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3678888998 99999999999994 5668999998765321 123466888999999999999999
Q ss_pred eeeec----CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC
Q 018816 124 GCCLE----AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ 199 (350)
Q Consensus 124 ~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~ 199 (350)
+++.+ ....++||||+ +++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+|||++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEc
Confidence 99987 67899999999 99999998653 47899999999999999999999 89999999999999999
Q ss_pred CCC--ceeEcccCCCccCCCCCcc-----ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Q 018816 200 EEY--AAKLFDFSLSKSIPEGKTH-----IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRL 272 (350)
Q Consensus 200 ~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 272 (350)
.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 887 9999999999766432211 112344699999999999998999999999999999999999999963211
Q ss_pred cCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 273 ATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
...................+...... ...+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 266 -----~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 266 -----DPVAVQTAKTNLLDELPQSVLKWAPS-------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -----CHHHHHHHHHHHHHTTTHHHHHHSCT-------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -----ccHHHHHHHHhhcccccHHHHhhccc-------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 01111111111111111100000000 023467999999999999999999999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=352.38 Aligned_cols=253 Identities=17% Similarity=0.209 Sum_probs=207.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|.. .++..||+|.+.... ......+.+|+.+|.+++||||+++++++.+.+..++
T Consensus 183 ~~~f~~~~~L-G~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVL-GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGGEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEE-eeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4678888888 9999999999999 567799999996642 2334568899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++|+|.+++..... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++..
T Consensus 262 VmEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 9999999999999875421 35899999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||...... .....+...+.....
T Consensus 336 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~------~~~~~i~~~i~~~~~ 406 (576)
T 2acx_A 336 VPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK------IKREEVERLVKEVPE 406 (576)
T ss_dssp CCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC------CCHHHHHHHHHHCCC
T ss_pred cccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc------hhHHHHHHHhhcccc
Confidence 654332 23346999999999999989999999999999999999999999754321 111222222222211
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
.. . ...+..+.+|+.+||+.||++|| ++.+|++
T Consensus 407 ~~-p------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 EY-S------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CC-C------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cC-C------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11 1 13346789999999999999999 7888875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=338.92 Aligned_cols=212 Identities=18% Similarity=0.193 Sum_probs=183.7
Q ss_pred CCcccccHHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-----CCC
Q 018816 45 NPIRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-----HKS 118 (350)
Q Consensus 45 ~~~~~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-----h~n 118 (350)
.+...+++.+.....++|...+.| |+|+||.||+|++ .++..||+|.+.... .....+..|+.++..++ |||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKM-GDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred ccceeeeeecceEecCEEEEEEEE-cccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCC
Confidence 345557777766778899999999 9999999999999 667789999987532 34566778999999996 999
Q ss_pred ccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe
Q 018816 119 ILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 119 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 198 (350)
|+++++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||+
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 170 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILL 170 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEE
Confidence 999999999999999999999 8999999975422 45899999999999999999999 9999999999999999
Q ss_pred CC-------------------------CCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHH
Q 018816 199 QE-------------------------EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSF 253 (350)
Q Consensus 199 ~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 253 (350)
+. ++.+||+|||++...... .....||+.|+|||++.+..++.++|||||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHH
Confidence 75 788999999999865432 234458999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 018816 254 GKLLLVLLTGRTIGHLS 270 (350)
Q Consensus 254 G~il~el~tg~~p~~~~ 270 (350)
||++|+|++|+.||...
T Consensus 246 G~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHSSCSCCCS
T ss_pred HHHHHHHHHCCCCCCCC
Confidence 99999999999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=328.49 Aligned_cols=266 Identities=15% Similarity=0.134 Sum_probs=199.6
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-----hhHHHHHHHHHHHHhcC---CCCccceeeeeec
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-----YASERCFNNIVFASQMN---HKSILKLIGCCLE 128 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 128 (350)
.+++|...+.| |+|+||+||+|++ .++..||+|.+..... .....+.+|+.++++++ ||||+++++++.+
T Consensus 7 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 7 ATSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ---CCEEEEEE-CCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred cccceEEEEEE-ecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 46789999999 9999999999998 6677999999864321 11345667877777664 9999999999987
Q ss_pred CC-----cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 129 AE-----MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 129 ~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
.. ..++||||++ ++|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCC
Confidence 65 4799999997 699999876432 34899999999999999999999 899999999999999999999
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|.+||..... .....
T Consensus 159 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~ 229 (308)
T 3g33_A 159 VKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE------ADQLG 229 (308)
T ss_dssp EEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH------HHHHH
T ss_pred EEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence 99999999987643322 2344589999999999999999999999999999999999999975432 11111
Q ss_pred HHHHHHHhcCCCccCcc-------ccCCCCcc---chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 284 RVEKFIRSNGYMNIDPV-------IVGDRSCF---RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~-------~~~~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
................. ........ .....++.+.+|+.+||+.||++|||+.++++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 230 KIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11111111110000000 00000000 00134567899999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=339.31 Aligned_cols=265 Identities=16% Similarity=0.122 Sum_probs=206.7
Q ss_pred hcCcccccccccCCCceEEEEEEECC---------CceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccc--------
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRD---------RGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILK-------- 121 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~---------~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------- 121 (350)
.++|...+.| |+|+||.||+|.+.. +..||+|.+... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~l-g~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQ-TRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEE-EEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEe-cCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 4689999998 999999999999953 679999998754 45789999999999999988
Q ss_pred -------eeeeeec-CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeecccc
Q 018816 122 -------LIGCCLE-AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEP 193 (350)
Q Consensus 122 -------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 193 (350)
+++++.. +...++||||+ +++|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp 187 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTA 187 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCH
Confidence 5666665 67889999999 9999999975421 46999999999999999999999 89999999999
Q ss_pred CceEeCCCC--ceeEcccCCCccCCCCCccc-----cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 018816 194 WNILFQEEY--AAKLFDFSLSKSIPEGKTHI-----KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTI 266 (350)
Q Consensus 194 ~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 266 (350)
+|||++.++ .+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 89999999997664322111 12334699999999999998999999999999999999999999
Q ss_pred CCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhh
Q 018816 267 GHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346 (350)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~ 346 (350)
|...... ...... ....+........++.... ...+..+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 268 f~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 268 WTNCLPN----TEDIMK-QKQKFVDKPGPFVGPCGHW-------IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TGGGTTC----HHHHHH-HHHHHHHSCCCEECTTSCE-------ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cccCCcC----HHHHHH-HHHhccCChhhhhhhcccc-------CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 9754311 111111 1111122222221111100 023467999999999999999999999999999987
Q ss_pred hc
Q 018816 347 RT 348 (350)
Q Consensus 347 ~~ 348 (350)
+.
T Consensus 336 ~~ 337 (352)
T 2jii_A 336 QD 337 (352)
T ss_dssp HH
T ss_pred Hh
Confidence 54
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.58 Aligned_cols=267 Identities=16% Similarity=0.134 Sum_probs=207.6
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeee----cCCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCL----EAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~ 132 (350)
..++|...+.| |+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++||||+++++++. .....
T Consensus 27 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKL-GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEE-EC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEe-cCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 34789999998 9999999999999 677799999987766666788999999999999999999999987 34478
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++++|.+++...... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 9999999999999988642111 156899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCccc-------cccccccCCCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 213 KSIPEGKTHI-------KASTAIGSLEFAAPEYLTTGY---YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 213 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...... . ...
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~--~~~- 256 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK--G--DSV- 256 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT--T--SCH-
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc--c--chh-
Confidence 7653211100 012234799999999987553 789999999999999999999998632110 0 000
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
...... .... +.. ...+..+.+++.+||+.||++|||+.+|++.|+.+...+
T Consensus 257 ---~~~~~~-~~~~--~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 257 ---ALAVQN-QLSI--PQS---------PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp ---HHHHHC-C--C--CCC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred ---hHHhhc-cCCC--Ccc---------ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 111111 1000 000 133467999999999999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.34 Aligned_cols=204 Identities=22% Similarity=0.300 Sum_probs=164.7
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcC-CCCccceeeeeecCC--
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMN-HKSILKLIGCCLEAE-- 130 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-- 130 (350)
...++|...+.| |+|+||.||+|.+ .++..||+|++... .......+.+|+.++.++. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKL-GKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC--------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEe-eeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 345789999999 9999999999998 66779999998653 2345567889999999997 999999999997544
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++||||++ ++|.+++.. ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 7899999997 699998864 46889999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCc-------------------cccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 018816 211 LSKSIPEGKT-------------------HIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLS 270 (350)
Q Consensus 211 ~~~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~ 270 (350)
+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9976532110 111234569999999999986 57999999999999999999999999754
Q ss_pred c
Q 018816 271 R 271 (350)
Q Consensus 271 ~ 271 (350)
.
T Consensus 235 ~ 235 (388)
T 3oz6_A 235 S 235 (388)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=326.14 Aligned_cols=253 Identities=19% Similarity=0.187 Sum_probs=198.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||.||++.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKL-GSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeeccee-ccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4678888998 9999999999999 567799999987653 234578899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe---CCCCceeEcccCCCc
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLSK 213 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~ 213 (350)
||+++++|.+++...... ...+++..+..++.|++.||.||| +.+|+|+||||+||++ +.++.+||+|||++.
T Consensus 100 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999988542111 146899999999999999999999 8999999999999999 456889999999997
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... .....||+.|+|||++. ..++.++||||||+++|+|++|..||..... . ..........
T Consensus 176 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---------~-~~~~~~~~~~ 241 (285)
T 3is5_A 176 LFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---------E-EVQQKATYKE 241 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------H-HHHHHHHHCC
T ss_pred ecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---------H-HHHhhhccCC
Confidence 6544322 23445899999999875 5689999999999999999999999975321 1 1111111111
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... .... . ..++.+.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~-~~~~----~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNY-AVEC----R-----PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCC-CC------C-----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccc-cccc----C-----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 110 0000 0 12457889999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=327.77 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=199.9
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecC-CcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEA-EMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 137 (350)
.++|...+.| |+|+||.||++... +..||+|.+.... ..+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~l-g~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTI-GKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEE-EECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEE-ecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 4788888998 99999999999986 4599999987653 456789999999999999999999987654 47899999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999864311 23789999999999999999999 89999999999999999999999999999876543
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. ....+++.|+|||++.+..++.++||||||+++|+|++ |..||...... . ....+.......
T Consensus 170 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~----~~~~~~~~~~~~ 234 (278)
T 1byg_A 170 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------D----VVPRVEKGYKMD 234 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------G----HHHHHTTTCCCC
T ss_pred cc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------H----HHHHHhcCCCCC
Confidence 22 22347889999999998899999999999999999998 99998754321 1 111121111111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.. ...++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 235 ----~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 ----AP--------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ----CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----Cc--------ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 10 13456799999999999999999999999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=360.50 Aligned_cols=250 Identities=20% Similarity=0.261 Sum_probs=200.9
Q ss_pred ccccCCCceEEEEEEE---CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFL---RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~---~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||.||+|.+ ..+..||||.+..... ...+++.+|+.++.+++|||||++++++.+ +..++||||+++
T Consensus 376 ~L-G~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 376 EL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EE-EECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred Ee-ccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 56 9999999999976 3456899999876432 345789999999999999999999999964 568899999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999653 56899999999999999999999 899999999999999999999999999999876543322
Q ss_pred -ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 222 -IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 222 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
.......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+...+.........
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----------~~~~~~i~~~~~~~~p- 594 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------SEVTAMLEKGERMGCP- 594 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------HHHHHHHHTTCCCCCC-
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----------HHHHHHHHcCCCCCCC-
Confidence 12223346789999999999999999999999999999998 9999875432 1222333332211111
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..++..+.+|+.+||+.||++|||+.+|++.|++++..
T Consensus 595 -----------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 595 -----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp -----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 13456899999999999999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=336.48 Aligned_cols=243 Identities=21% Similarity=0.209 Sum_probs=202.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCccceeeeeec
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--------YASERCFNNIVFASQMNHKSILKLIGCCLE 128 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 128 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|.+..... .....+.+|+.++++++||||+++++++.+
T Consensus 22 ~~~~y~~~~~l-G~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPL-GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEEC-SSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccceEEEeEE-EecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45788888998 9999999999998 6677899999876421 123457789999999999999999999999
Q ss_pred CCcCeEEeecCCCC-chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 129 AEMPALVYEPAGYC-TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 129 ~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
.+..++||||+.+| +|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999776 999998764 46999999999999999999999 8999999999999999999999999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
|||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 173 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------- 236 (335)
T 3dls_A 173 DFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------- 236 (335)
T ss_dssp CCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------
T ss_pred ecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------
Confidence 9999987654332 233458999999999988776 88999999999999999999998743211
Q ss_pred HHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
......+ . ...++.+.+|+.+||+.||++|||+.++++.
T Consensus 237 ------~~~~~~~----~------~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ------VEAAIHP----P------YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------TTTCCCC----S------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------HhhccCC----C------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0 0234678999999999999999999999873
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=339.99 Aligned_cols=249 Identities=18% Similarity=0.168 Sum_probs=194.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHH-HHhcCCCCccceeeeeecCCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVF-ASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~ 132 (350)
..++|...+.| |+|+||.||+|+. .++..||+|.+.+... .....+.+|..+ ++.++||||+++++++.+.+..
T Consensus 36 ~~~~y~~~~~l-G~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVI-GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CGGGEEEEEEE-ECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEE-eeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 34789999999 9999999999999 5566899999876532 233456677776 4678999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 115 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a 186 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 186 (373)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred EEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccc
Confidence 9999999999999998653 46889999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
+....... .....+||+.|+|||++.+..++.++|+|||||++|||++|..||..... ........ ..
T Consensus 187 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---------~~~~~~i~-~~ 254 (373)
T 2r5t_A 187 KENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---------AEMYDNIL-NK 254 (373)
T ss_dssp GGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---------HHHHHHHH-HS
T ss_pred cccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---------HHHHHHHH-hc
Confidence 76432211 23455699999999999999999999999999999999999999975322 11122222 21
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... +.+ ..+..+.+|+.+||+.||++||++.+.++
T Consensus 255 ~~~-~~~------------~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 255 PLQ-LKP------------NITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp CCC-CCS------------SSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred ccC-CCC------------CCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 111 111 23457899999999999999999864433
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=325.63 Aligned_cols=249 Identities=20% Similarity=0.232 Sum_probs=206.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.+.|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEE-EECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhh-cccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3568888888 9999999999998 567799999986543 344678999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++.. ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++....
T Consensus 100 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 100 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp ECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999999854 46899999999999999999999 8999999999999999999999999999997764
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+.......
T Consensus 171 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~~~~~~~~~ 238 (303)
T 3a7i_A 171 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----------MKVLFLIPKNNPPT 238 (303)
T ss_dssp TTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----------HHHHHHHHHSCCCC
T ss_pred cccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----------HHHHHHhhcCCCCC
Confidence 3321 22344589999999999999999999999999999999999999874332 11112222222111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
+.. ..+..+.+|+.+||+.||++|||+.++++.
T Consensus 239 ~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 LEG------------NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCS------------SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred Ccc------------ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111 234578999999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=346.62 Aligned_cols=251 Identities=19% Similarity=0.213 Sum_probs=204.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
..++|...+.| |+|+||+||+|.+ .++..||+|.+.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 20 ~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCML-GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEE-ECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEE-eecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 44678999998 9999999999999 567799999986542 2345678999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC---CCCceeEcccCC
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSL 211 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~ 211 (350)
||||+++++|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+
T Consensus 99 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 99999999999988653 56899999999999999999999 89999999999999995 456799999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
+........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... ......+..
T Consensus 171 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------~~~~~~i~~ 236 (486)
T 3mwu_A 171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----------YDILKRVET 236 (486)
T ss_dssp TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHH
T ss_pred CeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----------HHHHHHHHh
Confidence 986644322 234459999999999875 599999999999999999999999975432 112222333
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.......+.+ ...++.+.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 237 GKYAFDLPQW---------RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp TCCCSCSGGG---------GGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCccc---------CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2222211211 134567899999999999999999999997
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=345.76 Aligned_cols=195 Identities=18% Similarity=0.277 Sum_probs=155.2
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecC-----C
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEA-----E 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 130 (350)
.++|...+.| |+|+||.||+|.+ .++..||||++... .....+.+.+|+.+|++++||||+++++++... .
T Consensus 52 ~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLI-GTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC--------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEe-eecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3679999998 9999999999998 56779999998653 234457789999999999999999999998543 5
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
.+++||||+ +++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccc
Confidence 789999998 57999988654 56999999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCcc-------------------------ccccccccCCCCCCcccc-ccCCCCccchhHHHHHHHHHHHhC
Q 018816 211 LSKSIPEGKTH-------------------------IKASTAIGSLEFAAPEYL-TTGYYNEKTDVYSFGKLLLVLLTG 263 (350)
Q Consensus 211 ~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg 263 (350)
+++........ ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 99876432211 112344689999999986 456699999999999999999994
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=334.20 Aligned_cols=260 Identities=17% Similarity=0.195 Sum_probs=190.9
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeee-------
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCL------- 127 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~------- 127 (350)
....+|...+.| |+|+||.||+|.+ .++..||+|++........+.+.+|+.++.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 25 LGELRLRVRRVL-AEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp ETTEEEEEEEEE-ECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred ccCceEEEEEEE-ccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 345688889998 9999999999998 567799999987766666778899999999996 999999999984
Q ss_pred -cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEeeccccCceEeCCCCce
Q 018816 128 -EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP--VVFRNIEPWNILFQEEYAA 204 (350)
Q Consensus 128 -~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~Nill~~~~~~ 204 (350)
.....++||||++ |+|.+++...... ..+++..++.++.||+.||.||| +.+ |+|+||||+|||++.++.+
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCE
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCE
Confidence 3345799999995 7998888542111 46999999999999999999999 888 9999999999999999999
Q ss_pred eEcccCCCccCCCCCccc----------cccccccCCCCCCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 018816 205 KLFDFSLSKSIPEGKTHI----------KASTAIGSLEFAAPEYL---TTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSR 271 (350)
Q Consensus 205 kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 271 (350)
||+|||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||....
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 999999998765432211 11234589999999998 56678999999999999999999999986432
Q ss_pred ccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 272 LATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.. ..... .... .+ .. ..+..+.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 258 ~~-------------~~~~~-~~~~-~~--~~--------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 258 KL-------------RIVNG-KYSI-PP--HD--------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp ----------------------CCC-CT--TC--------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH-------------HhhcC-cccC-Cc--cc--------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 21 00110 0000 00 00 1224578999999999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=343.12 Aligned_cols=253 Identities=22% Similarity=0.225 Sum_probs=194.1
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCccceeeeee
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--------YASERCFNNIVFASQMNHKSILKLIGCCL 127 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 127 (350)
...++|...+.| |+|+||.||+|.+ .++..||+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~L-G~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTL-GSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEE-EECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhccEEEEeEE-eeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456789999998 9999999999999 6667999999875421 11234789999999999999999999975
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC---ce
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY---AA 204 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~---~~ 204 (350)
. +..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCE
T ss_pred c-CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceE
Confidence 4 4579999999999999988654 57899999999999999999999 89999999999999997544 59
Q ss_pred eEcccCCCccCCCCCccccccccccCCCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchH
Q 018816 205 KLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFI 281 (350)
Q Consensus 205 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~ 281 (350)
||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ...
T Consensus 282 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-----~~~ 353 (419)
T 3i6u_A 282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-----VSL 353 (419)
T ss_dssp EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-----CCH
T ss_pred EEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-----HHH
Confidence 999999998765432 2334569999999999863 56889999999999999999999999754321 111
Q ss_pred HHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.........+.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 354 ----~~~i~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 354 ----KDQITSGKYNFIPEVW---------AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ----HHHHHTTCCCCCHHHH---------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHHhcCCCCCCchhh---------cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1122222211111110 123567899999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.82 Aligned_cols=250 Identities=19% Similarity=0.211 Sum_probs=201.1
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
.+.|...+.| |+|+||.||+|++ .++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 36 ~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKL-GSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEE-ECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEE-ecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578888998 9999999999999 566789999987543 23356788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC---CceeEcccCCC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE---YAAKLFDFSLS 212 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~ 212 (350)
|||+++|+|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.. +.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999988653 46899999999999999999999 8999999999999999764 55999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
....... ......||+.|+|||++. ..++.++|||||||++|+|++|.+||..... ......+...
T Consensus 187 ~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------~~~~~~i~~~ 252 (494)
T 3lij_A 187 AVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD----------QEILRKVEKG 252 (494)
T ss_dssp EECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHHT
T ss_pred eECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----------HHHHHHHHhC
Confidence 8765432 233456999999999886 5699999999999999999999999975432 1222233333
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......+.+. ..++.+.+|+.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~---------~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 253 KYTFDSPEWK---------NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCCCCSGGGT---------TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCchhcc---------cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 3222222221 33467899999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=331.29 Aligned_cols=254 Identities=20% Similarity=0.239 Sum_probs=205.6
Q ss_pred HHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--------hhHHHHHHHHHHHHhc-CCCCccceeee
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--------YASERCFNNIVFASQM-NHKSILKLIGC 125 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~ 125 (350)
....++|...+.| |+|+||.||+|.+ .++..||||.+..... ...+.+.+|+.++.++ +||||++++++
T Consensus 90 ~~~~~~y~~~~~l-g~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 90 KEFYQKYDPKDVI-GRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhcccceEE-ecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 4455778888998 9999999999999 4678999999865431 1245678999999999 79999999999
Q ss_pred eecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCcee
Q 018816 126 CLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 126 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 205 (350)
+......++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999998643 46899999999999999999999 89999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcc
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT------GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF 279 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~ 279 (350)
|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 241 l~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------- 310 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------- 310 (365)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred EEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------
Confidence 999999987654332 234569999999998863 3588999999999999999999999874321
Q ss_pred hHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 280 FITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......+.........+.+. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 311 ---~~~~~~i~~~~~~~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 ---ILMLRMIMEGQYQFSSPEWD---------DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHHHHHTCCCCCHHHHS---------SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHHhCCCCCCCcccc---------cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11112222222221111110 23457899999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=321.58 Aligned_cols=246 Identities=20% Similarity=0.186 Sum_probs=203.7
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|.. .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 13 IDDFDIGRPL-GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeehee-cCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 3678888998 9999999999999 4566899999865422 224678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 92 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp EECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 99999999999998653 46899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
..... .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... ... ...+.....
T Consensus 164 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~-~~~~~~~~~ 229 (284)
T 2vgo_A 164 APSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---------TET-HRRIVNVDL 229 (284)
T ss_dssp CSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------HHH-HHHHHTTCC
T ss_pred Ccccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---------hHH-HHHHhcccc
Confidence 54322 2334589999999999998999999999999999999999999874322 111 111111111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. +. ...+..+.+++.+||+.||++|||+.++++
T Consensus 230 ~-~~------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 K-FP------------PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp C-CC------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-CC------------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 00 123467899999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=322.03 Aligned_cols=258 Identities=18% Similarity=0.195 Sum_probs=205.9
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch------hhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR------YASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
.++|...+.| |+|+||.||++.+ .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 4 EDHYEMGEEL-GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhHHhh-cccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3578888898 9999999999999 4677999999865422 135778999999999999999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC----ceeEc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY----AAKLF 207 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~ 207 (350)
.++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++ .+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEE
Confidence 99999999999999998643 46899999999999999999999 89999999999999998877 79999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||..... . ....
T Consensus 155 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~-~~~~ 221 (283)
T 3bhy_A 155 DFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---------Q-ETLT 221 (283)
T ss_dssp CCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---------H-HHHH
T ss_pred ecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---------H-HHHH
Confidence 9999987644322 2234589999999999988999999999999999999999999874321 1 1111
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhhh
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK--KLRQMYR 347 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~~~ 347 (350)
.+...... ..+... ...+..+.+|+.+||+.||++|||+.++++ .++.+..
T Consensus 222 ~~~~~~~~-~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 222 NISAVNYD-FDEEYF--------SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp HHHTTCCC-CCHHHH--------TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred HhHhcccC-Ccchhc--------ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 12211111 111100 123467899999999999999999999997 5665543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=340.05 Aligned_cols=200 Identities=17% Similarity=0.272 Sum_probs=167.7
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecC-----C
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEA-----E 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 130 (350)
.++|...+.| |+|+||.||+|.+ .++..||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 25 ~~~y~~~~~l-G~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLI-GRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEE-EEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEE-eecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4689999998 9999999999999 56678999999653 234457789999999999999999999998766 5
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++||||++ ++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 7899999996 6999999754 46899999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCcc--------------------ccccccccCCCCCCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 018816 211 LSKSIPEGKTH--------------------IKASTAIGSLEFAAPEYL-TTGYYNEKTDVYSFGKLLLVLLTGRTIGH 268 (350)
Q Consensus 211 ~~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~el~tg~~p~~ 268 (350)
+++........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 99876543211 112455699999999986 45669999999999999999998666554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=346.40 Aligned_cols=255 Identities=13% Similarity=0.121 Sum_probs=205.4
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+|++ .++..||+|++..... .....+.+|+.++.+++||||+++++++.+...+++|
T Consensus 185 ~~f~~~~~L-G~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVL-GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGEEEEEEE-EECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEE-eeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 677888888 9999999999999 5677999999976432 2346788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++...... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999999998654221 146899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...... ... ..+...+......
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-----~~~-~~~~~~i~~~~~~ 411 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-----VEN-KELKQRVLEQAVT 411 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-----CCH-HHHHHHHHHCCCC
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-----hhH-HHHHHHHhhcccC
Confidence 54332 123446999999999999999999999999999999999999999754321 111 1122222221111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM-----IDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~ 340 (350)
+. ...+..+.+|+.+||+.||++||++ .+|++
T Consensus 412 -~p------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 412 -YP------------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CC------------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -CC------------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 00 1344678999999999999999975 56653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=336.48 Aligned_cols=263 Identities=15% Similarity=0.180 Sum_probs=202.2
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||.||++.+ .++..||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 32 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISEL-GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeee-cCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3678888998 9999999999999 56678999998765 3344577899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ-PVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
||+++++|.+++... ..+++..+..++.+++.||.||| +. +|+|+||||+||+++.++.+||+|||++...
T Consensus 111 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred ECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999653 46899999999999999999999 75 8999999999999999999999999998654
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH--------
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK-------- 287 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------- 287 (350)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 183 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 183 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK------ELELMFGCQVEGDAAE 252 (360)
T ss_dssp HHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH------HHHHHHC---------
T ss_pred ccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHhcccccccCCC
Confidence 221 123345899999999999999999999999999999999999999753321 00000000
Q ss_pred ----------HHH---hcC------CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 ----------FIR---SNG------YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ----------~~~---~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... ... ...++...............+..+.+|+.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 000 00000000000000001134567999999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=321.86 Aligned_cols=252 Identities=19% Similarity=0.194 Sum_probs=197.9
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
.|....+| |+|+||.||+|.+ .++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 23 ~~~~~~~l-g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVL-GKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEE-EECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEE-eecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34444577 9999999999998 666789999997766556678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-CCceeEcccCCCccCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-EYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 218 (350)
++++|.+++..... ...+++..+..++.|++.||.||| +.+++|+||||+||+++. ++.+||+|||++......
T Consensus 102 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 102 PGGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp SEEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999999865421 135678899999999999999999 899999999999999987 899999999999876432
Q ss_pred CccccccccccCCCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGY--YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.. ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...... .............
T Consensus 177 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~-- 244 (295)
T 2clq_A 177 NP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--------QAAMFKVGMFKVH-- 244 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--------HHHHHHHHHHCCC--
T ss_pred CC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--------hHHHHhhcccccc--
Confidence 21 123445899999999987654 889999999999999999999998643210 0111111111111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.+. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 245 --~~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 --PEIP--------ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --CCCC--------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --cccc--------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 133467899999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=346.42 Aligned_cols=251 Identities=20% Similarity=0.192 Sum_probs=202.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-------------hhHHHHHHHHHHHHhcCCCCcccee
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-------------YASERCFNNIVFASQMNHKSILKLI 123 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~ 123 (350)
..++|...+.| |+|+||+||+|.+ .++..||+|.+..... ...+.+.+|+.++++++||||++++
T Consensus 34 i~~~Y~~~~~l-G~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 34 IGESYFKVRKL-GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp GGGTEEEEEEE-EC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cccceEEEeEe-cccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45789999998 9999999999999 5667899999865421 2246788999999999999999999
Q ss_pred eeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-
Q 018816 124 GCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY- 202 (350)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~- 202 (350)
+++.+....++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCC
Confidence 9999999999999999999999988653 56899999999999999999999 89999999999999998776
Q ss_pred --ceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcch
Q 018816 203 --AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF 280 (350)
Q Consensus 203 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~ 280 (350)
.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|.+||.....
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------- 252 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-------- 252 (504)
T ss_dssp CSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------
T ss_pred CccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------
Confidence 699999999987654322 33445999999999986 5699999999999999999999999975432
Q ss_pred HHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 281 ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......+.........+.+ ...++.+.+|+.+||+.||++|||+.++++
T Consensus 253 --~~~~~~i~~~~~~~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 253 --QDIIKKVEKGKYYFDFNDW---------KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp --HHHHHHHHHCCCCCCHHHH---------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHHcCCCCCCcccc---------CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1122222222211111111 123567999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=325.42 Aligned_cols=256 Identities=17% Similarity=0.159 Sum_probs=203.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeee--cCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCL--EAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~ 133 (350)
.++|...+.| |+|+||.||++.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++. .....+
T Consensus 5 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTI-GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEE-EECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhc-cCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4688888998 9999999999999 567789999986542 344567899999999999999999999875 466889
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-----eEeeccccCceEeCCCCceeEcc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP-----VVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlkp~Nill~~~~~~kl~D 208 (350)
+||||+++++|.+++...... ...+++..++.++.|++.||.||| +.+ |+|+||||+||+++.++.+||+|
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEEeCCCCCCHHHHHHhhccc-CCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 999999999999998643211 135899999999999999999999 777 99999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......
T Consensus 160 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------~~~~~~ 227 (279)
T 2w5a_A 160 FGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----------KELAGK 227 (279)
T ss_dssp CCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHH
T ss_pred Cchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----------HHHHHH
Confidence 999877643322 12233589999999999988999999999999999999999999875321 112222
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLR 343 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~ 343 (350)
+..+....+.. ..+..+.+++.+||+.||++|||+.+|++.+.
T Consensus 228 i~~~~~~~~~~------------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 228 IREGKFRRIPY------------RYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHTCCCCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HhhcccccCCc------------ccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 33322211111 33467899999999999999999999998654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=348.21 Aligned_cols=250 Identities=20% Similarity=0.227 Sum_probs=206.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.+.|...+.| |+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 25 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVL-GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEE-ecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4678888888 9999999999999 577799999986542 2346778999999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe---CCCCceeEcccCC
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSL 211 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~ 211 (350)
||||+.+++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999998764 56899999999999999999999 8999999999999999 5678999999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
+........ .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||..... ......+..
T Consensus 176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------~~~~~~i~~ 241 (484)
T 3nyv_A 176 STHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE----------YDILKKVEK 241 (484)
T ss_dssp HHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHH
T ss_pred eEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH----------HHHHHHHHc
Confidence 987654332 233459999999999865 699999999999999999999999975432 112222333
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.......+.+ ...++.+.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 242 GKYTFELPQW---------KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCCCCSGGG---------GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCccc---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 3322211211 134567899999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=323.51 Aligned_cols=247 Identities=14% Similarity=0.164 Sum_probs=199.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 133 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|.+.... ......+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 9 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKI-GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhh-cCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 45788999998 9999999999999 477799999987542 24456788999999999 8999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC------------
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE------------ 201 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~------------ 201 (350)
+||||+++++|.+++...... ...+++..+..++.||+.||.||| +.+|+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------
T ss_pred EEEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999998643111 145899999999999999999999 8999999999999999844
Q ss_pred -------CceeEcccCCCccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCccc
Q 018816 202 -------YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLA 273 (350)
Q Consensus 202 -------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 273 (350)
..+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 479999999998764422 23489999999999876 567899999999999999999987653211
Q ss_pred CCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 274 TGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.......+.+ ..+..+.+|+.+||+.||++|||+.++++
T Consensus 237 ------------~~~~~~~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ------------WHEIRQGRLPRIPQ------------VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ------------HHHHHTTCCCCCSS------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------HHHHHcCCCCCCCc------------ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 11122222111111 23467899999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=324.58 Aligned_cols=260 Identities=21% Similarity=0.295 Sum_probs=198.9
Q ss_pred hcCcccccccccCCCceEEEEEEE--CCCc--eEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL--RDRG--PILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~--~~~~--~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
.++|...+.| |+|+||.||+|.+ .++. .||+|.+.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEEC-C----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeee-cCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 4678888998 9999999999987 2322 58999886542 244677899999999999999999999998765
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred ceeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccc
Confidence 899999999999999986532 46899999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 212 SKSIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 212 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
+.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... .... ..+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~-~~~ 237 (291)
T 1u46_A 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---------SQIL-HKI 237 (291)
T ss_dssp CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------HHHH-HHH
T ss_pred cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---------HHHH-HHH
Confidence 98765443221 2233447888999999988889999999999999999999 9999874422 1111 122
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.........+ ...+..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 238 ~~~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 238 DKEGERLPRP-----------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HTSCCCCCCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HccCCCCCCC-----------cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 2211111000 13456799999999999999999999999999998654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.39 Aligned_cols=246 Identities=17% Similarity=0.188 Sum_probs=196.5
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeec----CCcCe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLE----AEMPA 133 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 133 (350)
.|.....| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~~~~l-g~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEI-GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eEEeeeec-cCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45666677 9999999999999 566689999986542 3456778999999999999999999998875 34689
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEeeccccCceEeC-CCCceeEcccC
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP--VVFRNIEPWNILFQ-EEYAAKLFDFS 210 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg 210 (350)
+||||+++++|.+++... ..+++..+..++.||+.||.||| +.+ |+|+||||+||+++ .++.+||+|||
T Consensus 106 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 999999999999999653 46899999999999999999999 888 99999999999998 78999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
++....... .....||+.|+|||++. +.++.++||||||+++|+|++|..||...... ........
T Consensus 178 ~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---------~~~~~~~~ 243 (290)
T 1t4h_A 178 LATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA---------AQIYRRVT 243 (290)
T ss_dssp GGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---------HHHHHHHT
T ss_pred Ccccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH---------HHHHHHHh
Confidence 997654332 22345899999999876 56999999999999999999999998753321 11111111
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... ..... ...++.+.+|+.+||+.||++|||+.++++
T Consensus 244 ~~~~---~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 244 SGVK---PASFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTCC---CGGGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCC---ccccC--------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111 11110 122357899999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=322.63 Aligned_cols=248 Identities=18% Similarity=0.180 Sum_probs=204.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||++.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 14 ~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 14 RRRYVRGRFL-GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TEEEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEE-eecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4678888888 9999999999999 456688999886542 2445678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 93 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 99999999999988643 46899999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .... ..+.....
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---------~~~~-~~~~~~~~ 232 (294)
T 2rku_A 165 VEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETY-LRIKKNEY 232 (294)
T ss_dssp CCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHH-HHHHTTCC
T ss_pred cccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHH-HHHhhccC
Confidence 643222 12334589999999999988899999999999999999999999875322 1111 11111111
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. . ...+..+.+++.+||+.||++|||+.++++
T Consensus 233 ~~-~------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 SI-P------------KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CC-C------------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CC-c------------cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 10 0 123457889999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=330.10 Aligned_cols=266 Identities=18% Similarity=0.183 Sum_probs=197.4
Q ss_pred HHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh-----hHHHHHHHHHHHHhcCCCCccceeeeeec
Q 018816 55 LKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY-----ASERCFNNIVFASQMNHKSILKLIGCCLE 128 (350)
Q Consensus 55 l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 128 (350)
+....++|...+.| |+|+||.||+|.+ .++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 5 VKSRAKRYEKLDFL-GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp --------CEEEEE-EEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hHHHhcccEEEeEE-eecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 34456789999999 9999999999999 56779999998654221 12467899999999999999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
.+..++||||+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D 155 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLAD 155 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCceEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEe
Confidence 9999999999975 8888886532 46889999999999999999999 89999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
||++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||..... ......
T Consensus 156 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---------~~~~~~ 224 (346)
T 1ua2_A 156 FGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---------LDQLTR 224 (346)
T ss_dssp CGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHHH
T ss_pred cccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---------HHHHHH
Confidence 999987643322 22344589999999998764 589999999999999999999999875432 112222
Q ss_pred HHHhcCC--CccCccc--------cCCCCccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGY--MNIDPVI--------VGDRSCFR----KEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~--~~~~~~~--------~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....... ...-+.. ....+... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 225 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 2221110 0000000 00000000 0133468999999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=329.09 Aligned_cols=249 Identities=18% Similarity=0.178 Sum_probs=205.3
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
..++|...+.| |+|+||.||++.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 39 ~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFL-GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEE-eeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34678888998 9999999999999 556688999886542 244567889999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++.
T Consensus 118 lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 189 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189 (335)
T ss_dssp EEECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence 999999999999988643 46899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .... ..+....
T Consensus 190 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~-~~~~~~~ 257 (335)
T 2owb_A 190 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETY-LRIKKNE 257 (335)
T ss_dssp ECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHH-HHHHHTC
T ss_pred ecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---------HHHH-HHHhcCC
Confidence 7643222 22344589999999999988999999999999999999999999874321 1111 1122211
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... .. ..+..+.+|+.+||+.||++|||+.++++
T Consensus 258 ~~~-~~------------~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 YSI-PK------------HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCC-CT------------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCC-Cc------------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 00 23357889999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=331.34 Aligned_cols=264 Identities=17% Similarity=0.165 Sum_probs=195.1
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh-hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY-ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |+|+||.||+|.+ .++..||+|.+...... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKL-GEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEE-cCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 568888888 9999999999999 56779999998654322 12245679999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|++ ++|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 997 69988886542 46899999999999999999999 89999999999999999999999999999876543
Q ss_pred CCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ..................
T Consensus 153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 153 PTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV------EEQLHFIFRILGTPTEET 224 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCTTT
T ss_pred Ccc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCChHh
Confidence 221 1233458999999999876 5689999999999999999999999975432 111111111111111111
Q ss_pred cCcccc-------------CCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 297 IDPVIV-------------GDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 297 ~~~~~~-------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...... ...........+..+.+|+.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 100000 00000000123467899999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=328.47 Aligned_cols=261 Identities=16% Similarity=0.137 Sum_probs=204.7
Q ss_pred cHHHHHHHhcCcccc-cccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcC-CCCccceeee
Q 018816 51 SSEDLKTAINNYSMR-NITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMN-HKSILKLIGC 125 (350)
Q Consensus 51 ~~~~l~~~~~~f~~~-~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~ 125 (350)
.+.......+.|... +.| |+|+||.||+|.. .++..||+|.+..... .....+.+|+.++.+++ ||||++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKEL-GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred HHHHHHhhhhEEeecccee-CCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 333344556677776 667 9999999999999 5677999999876432 33567889999999995 6999999999
Q ss_pred eecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CC
Q 018816 126 CLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EY 202 (350)
Q Consensus 126 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~ 202 (350)
+.+.+..++||||+++++|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++. ++
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCC
Confidence 9999999999999999999999865322 56899999999999999999999 899999999999999998 78
Q ss_pred ceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 203 AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 203 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .
T Consensus 172 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~ 239 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---------Q 239 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------H
T ss_pred cEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------h
Confidence 999999999987644322 2334599999999999999999999999999999999999999875332 1
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... .+.........+.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~-~i~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 240 ETYL-NISQVNVDYSEETF---------SSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHH-HHHHTCCCCCTTTT---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHH-HHHhcccccCchhh---------cccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1111 11111111111111 134467899999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=331.59 Aligned_cols=266 Identities=15% Similarity=0.150 Sum_probs=195.3
Q ss_pred HHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 54 DLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 54 ~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
.-....++|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 28 ~~~~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 28 PSATSIDRYRRITKL-GEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp ----CGGGEEEEEEE-EECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred CcccchhhEEEEEEE-EecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 344566899999999 9999999999998 6777999999865432 22456789999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe-----CCCCcee
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF-----QEEYAAK 205 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill-----~~~~~~k 205 (350)
..++||||++ ++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+|
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEE
T ss_pred EEEEEEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEE
Confidence 9999999997 5999998654 46899999999999999999999 8999999999999999 4556699
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHH
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 284 (350)
|+|||++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||..... ...
T Consensus 178 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~ 246 (329)
T 3gbz_A 178 IGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---------IDQ 246 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHH
T ss_pred ECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---------HHH
Confidence 999999976643221 12334589999999999875 489999999999999999999999975432 111
Q ss_pred HHHHHHhcC---CCcc-----CccccCCCCcc--------chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 285 VEKFIRSNG---YMNI-----DPVIVGDRSCF--------RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 285 ~~~~~~~~~---~~~~-----~~~~~~~~~~~--------~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......... .... .+.+....+.. .....++.+.+|+.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 247 LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 122221111 0000 00000000000 00114567899999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=331.93 Aligned_cols=254 Identities=16% Similarity=0.177 Sum_probs=194.9
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE----- 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 130 (350)
.+.|...+.| |+|+||.||+|.+ .++..||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~l-G~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPV-GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC-------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEe-eecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4678888888 9999999999999 66779999998553 2234567889999999999999999999987653
Q ss_pred -cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 131 -MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEee
Confidence 469999999 8899999864 46899999999999999999999 899999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHH---
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV--- 285 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 285 (350)
|+++..... ....++|+.|+|||++.+ ..++.++|||||||++|||++|++||...... ......
T Consensus 173 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~l~~i~~~ 241 (367)
T 1cm8_A 173 GLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL------DQLKEIMKV 241 (367)
T ss_dssp TTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHH
T ss_pred ecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHh
Confidence 999875432 233458999999999887 67999999999999999999999999754321 111110
Q ss_pred -----------------HHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 286 -----------------EKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 286 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
........ ......+.... ...++.+.+|+.+||+.||++|||+.++++
T Consensus 242 ~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 242 TGTPPAEFVQRLQSDEAKNYMKGLP-ELEKKDFASIL-----TNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSC-CCCCCCGGGTC-----TTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCCHHHHHHhhhHHHHHHHHhCC-CCCCCCHHHHC-----CCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 11111100 00000010000 133567899999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=333.31 Aligned_cols=269 Identities=15% Similarity=0.183 Sum_probs=201.1
Q ss_pred ccHHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccch-----------hhHHHHHHHHHHHHhcCCCC
Q 018816 50 FSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR-----------YASERCFNNIVFASQMNHKS 118 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n 118 (350)
....++....++|...+.| |+|+||.||+|.+.++..||+|++..... ...+.+.+|+.++++++|||
T Consensus 12 ~~~~~~~~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFI-SSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEE-EEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHhccceEEeEEe-ccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 4567788889999999999 99999999999997788999999865322 22377899999999999999
Q ss_pred ccceeeeeec-----CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeecccc
Q 018816 119 ILKLIGCCLE-----AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEP 193 (350)
Q Consensus 119 iv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 193 (350)
|+++++++.. ....++||||++ |+|.+++.... ..+++..+..++.||+.||.||| +.+|+|+||||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp 162 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHP 162 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCG
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCCh
Confidence 9999999854 335799999997 68888886532 46899999999999999999999 89999999999
Q ss_pred CceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Q 018816 194 WNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRL 272 (350)
Q Consensus 194 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 272 (350)
+||+++.++.+||+|||++........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp GGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999975433222 233458999999999877 6799999999999999999999999975432
Q ss_pred cCCCCcchHHHHHHHHHHhcCC-------------------CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC
Q 018816 273 ATGGSNFFITDRVEKFIRSNGY-------------------MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP 333 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 333 (350)
. ............ ..... .............++.+.+|+.+||+.||++||
T Consensus 240 ~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 309 (362)
T 3pg1_A 240 Y---------NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSN-VPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309 (362)
T ss_dssp H---------HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCC-CCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred H---------HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhccc-CChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC
Confidence 1 111111110000 00000 000000000012346789999999999999999
Q ss_pred CHHHHHH
Q 018816 334 TMIDVAK 340 (350)
Q Consensus 334 t~~evl~ 340 (350)
|+.++++
T Consensus 310 t~~ell~ 316 (362)
T 3pg1_A 310 STEQALR 316 (362)
T ss_dssp CHHHHHT
T ss_pred CHHHHHc
Confidence 9999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=323.29 Aligned_cols=251 Identities=19% Similarity=0.207 Sum_probs=200.0
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|.+.... ..+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 27 ~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEEC-C----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheee-ccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 35678888998 9999999999999 557799999987642 3467889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 104 e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT 176 (314)
T ss_dssp ECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred ecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence 9999999999986321 56899999999999999999999 8999999999999999999999999999997664
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ..... .........
T Consensus 177 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~-~~~~~~~~~ 244 (314)
T 3com_A 177 DTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---------MRAIF-MIPTNPPPT 244 (314)
T ss_dssp TTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---------HHHHH-HHHHSCCCC
T ss_pred hhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH-HHhcCCCcc
Confidence 3221 22334589999999999998999999999999999999999999874332 11111 111111111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... +...+..+.+|+.+||+.||++|||+.++++
T Consensus 245 ~~~----------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 FRK----------PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CSS----------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCC----------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 100 0133467899999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=329.93 Aligned_cols=265 Identities=18% Similarity=0.243 Sum_probs=200.3
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
.++|.....| |+|+||.||+|.+ .++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 24 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLV-GEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEG-GGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEE-eecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 4678888888 9999999999999 5577999999865432 3356688999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 103 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999999887543 56899999999999999999999 899999999999999999999999999999765
Q ss_pred CCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHH---------
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV--------- 285 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--------- 285 (350)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...... ......
T Consensus 175 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 175 AAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI------DQLYHIMMCLGNLIP 246 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCSCCH
T ss_pred cCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHHHhCCCCh
Confidence 43322 12334589999999999875 6899999999999999999999999754321 100000
Q ss_pred --HHHHHhcC--CCccCccccCCCCc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 286 --EKFIRSNG--YMNIDPVIVGDRSC-FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 286 --~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.... .....+.+...... ......++.+.+|+.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 247 RHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111111 00111111111000 000134578999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=320.28 Aligned_cols=253 Identities=17% Similarity=0.154 Sum_probs=199.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc----hhhHHHHHHHHHHHHhcCCCCccceeeeee--cCC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV----RYASERCFNNIVFASQMNHKSILKLIGCCL--EAE 130 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~ 130 (350)
..++|...+.| |+|+||.||++.+ .++..||+|.+.... ....+.+.+|+.++++++||||+++++++. +..
T Consensus 3 l~~~y~i~~~l-g~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLL-GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEE-EECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred cccceeEeeEE-ecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 34789999999 9999999999999 566799999987643 234577899999999999999999999984 456
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++||||++++ |.+++..... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg 154 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALG 154 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccc
Confidence 889999999866 6666654322 56899999999999999999999 8999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY--YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
++................||+.|+|||++.+.. ++.++||||||+++|+|++|..||..... . .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~-~~~~~ 224 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI---------Y-KLFEN 224 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH---------H-HHHHH
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH---------H-HHHHH
Confidence 998765433333334455899999999987643 47899999999999999999999874321 1 11222
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
+....... . . ..+..+.+|+.+||+.||++|||+.++++.
T Consensus 225 i~~~~~~~-~----~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 225 IGKGSYAI-P----G--------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHCCCCC-C----S--------SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCC-C----C--------ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22222111 0 0 234578899999999999999999999963
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=325.46 Aligned_cols=253 Identities=16% Similarity=0.153 Sum_probs=199.2
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
..+.|...+.| |+|+||.||+|.+ .++..||+|.+........+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 17 ~~~~y~i~~~l-g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGEL-GDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEE-ECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred Cccceeeccee-ccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34678888888 9999999999999 457789999987765566778999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++++|.+++.... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++....
T Consensus 96 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp ECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999886422 46899999999999999999999 8999999999999999999999999999875321
Q ss_pred CCCccccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
.. ........||+.|+|||++. +..++.++||||||+++|+|++|..||..... ..........
T Consensus 169 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---------~~~~~~~~~~ 237 (302)
T 2j7t_A 169 KT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---------MRVLLKIAKS 237 (302)
T ss_dssp HH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---------HHHHHHHHHS
T ss_pred cc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---------HHHHHHHhcc
Confidence 11 01122345899999999983 56789999999999999999999999875432 1112222221
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.......+ ...+..+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 238 DPPTLLTP-----------SKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCCCCSSG-----------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCcccCCc-----------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11111111 134567899999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=320.35 Aligned_cols=253 Identities=19% Similarity=0.216 Sum_probs=205.2
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---------hhhHHHHHHHHHHHHhcC-CCCccceeee
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---------RYASERCFNNIVFASQMN-HKSILKLIGC 125 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~ 125 (350)
...++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++.+++ ||||++++++
T Consensus 14 ~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 14 GFYENYEPKEIL-GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp -CTTTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred chhhccceeeee-cCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 345789999998 9999999999999 567799999986542 123456889999999996 9999999999
Q ss_pred eecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCcee
Q 018816 126 CLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 126 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 205 (350)
+.+....++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+|
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k 164 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIK 164 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred eccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEE
Confidence 99999999999999999999999653 46899999999999999999999 89999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcc
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT------TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF 279 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~ 279 (350)
|+|||++........ .....+++.|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 165 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------- 234 (298)
T 1phk_A 165 LTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------- 234 (298)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred EecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------
Confidence 999999987654332 23345899999999885 45688999999999999999999999864321
Q ss_pred hHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 280 FITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. .....+.........+.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 235 --~-~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 --M-LMLRMIMSGNYQFGSPEW---------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --H-HHHHHHHHTCCCCCTTTG---------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --H-HHHHHHhcCCcccCcccc---------cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 112222222222111111 134567999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=330.37 Aligned_cols=262 Identities=18% Similarity=0.222 Sum_probs=201.2
Q ss_pred ccccHHHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeee
Q 018816 48 RSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGC 125 (350)
Q Consensus 48 ~~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 125 (350)
..+++.++....++|...+.| |+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.++.++ +||||++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELV-GNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred hhccchhccCCCCcEEEEEEe-ccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 335555566678899999999 9999999999999 567799999986543 3456788999999999 79999999999
Q ss_pred eec------CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC
Q 018816 126 CLE------AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ 199 (350)
Q Consensus 126 ~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~ 199 (350)
+.. ....++||||+++++|.+++..... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~ 163 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLT 163 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEc
Confidence 986 4578999999999999999975421 46889999999999999999999 89999999999999999
Q ss_pred CCCceeEcccCCCccCCCCCccccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccC
Q 018816 200 EEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT 274 (350)
Q Consensus 200 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 274 (350)
.++.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-- 239 (326)
T 2x7f_A 164 ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-- 239 (326)
T ss_dssp TTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--
T ss_pred CCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--
Confidence 999999999999876543221 123345899999999987 45689999999999999999999999874332
Q ss_pred CCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 275 GGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..... .+......... . ...+..+.+|+.+||+.||++|||+.++++
T Consensus 240 -------~~~~~-~~~~~~~~~~~----~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 -------MRALF-LIPRNPAPRLK----S-------KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -------HHHHH-HHHHSCCCCCS----C-------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -------HHHHH-HhhcCccccCC----c-------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 11221111110 0 023467899999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=317.91 Aligned_cols=248 Identities=22% Similarity=0.233 Sum_probs=196.9
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 10 ~~~y~i~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTL-GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp ETTEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eccEEEEeee-cCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3678888888 9999999999999 4677999999865432 234678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++++|.+++... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 89 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence 99999999999998653 46899999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
...... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||..... ......+....
T Consensus 161 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------~~~~~~~~~~~ 227 (276)
T 2h6d_A 161 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----------PTLFKKIRGGV 227 (276)
T ss_dssp CCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHHCC
T ss_pred cCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----------HHHHHHhhcCc
Confidence 654322 223458999999999987765 6899999999999999999999874321 11122222221
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
.. +. ...+..+.+++.+||+.||++|||+.++++.
T Consensus 228 ~~-~~------------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 FY-IP------------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CC-CC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cc-Cc------------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 00 1234578899999999999999999999973
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=326.22 Aligned_cols=266 Identities=16% Similarity=0.169 Sum_probs=201.1
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecC------
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEA------ 129 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 129 (350)
.++|...+.| |+|+||.||+|++ .++..||+|++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEEC-SSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEE-ecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4688999998 9999999999999 6777999999865432 2345688999999999999999999998873
Q ss_pred --CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 130 --EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 130 --~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
+..++||||++ ++|.+.+.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred CCceEEEEEeccC-CCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEc
Confidence 46899999997 57777776543 46899999999999999999999 8999999999999999999999999
Q ss_pred ccCCCccCCCCCcc--ccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHH
Q 018816 208 DFSLSKSIPEGKTH--IKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 208 Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 284 (350)
|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..... ......
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~ 240 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE------QHQLAL 240 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHH
Confidence 99999876432221 12334558999999999876 4589999999999999999999999975432 111111
Q ss_pred HHHHHHhcCCCccCccc------------cCCCCccch----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 285 VEKFIRSNGYMNIDPVI------------VGDRSCFRK----EEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~------------~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
........... ..+.. ......... ...++.+.+|+.+||+.||++|||+.++++
T Consensus 241 i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 241 ISQLCGSITPE-VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHCCCCTT-TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCChh-hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11111111111 00000 000000000 011456889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=325.18 Aligned_cols=258 Identities=15% Similarity=0.201 Sum_probs=200.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeec--CCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLE--AEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~l 134 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+.... .+.+.+|+.++.+++ ||||+++++++.+ ....++
T Consensus 35 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKL-GRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEe-cccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 3678888998 9999999999998 677799999987543 467889999999997 9999999999987 567899
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-ceeEcccCCCc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLSK 213 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~ 213 (350)
||||+++++|.+++ ..++...+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++.
T Consensus 111 v~e~~~~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 111 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEECCCCCCHHHHG--------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeccCchhHHHHH--------HhCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999999988 45889999999999999999999 89999999999999999776 89999999998
Q ss_pred cCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH---------
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD--------- 283 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------- 283 (350)
....... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....
T Consensus 180 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-----~~~l~~~~~~~~~~ 251 (330)
T 3nsz_A 180 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-----YDQLVRIAKVLGTE 251 (330)
T ss_dssp ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-----HHHHHHHHHHHCHH
T ss_pred EcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-----HHHHHHHHHhcCCc
Confidence 7654332 234458999999999887 66999999999999999999999998643221 00000
Q ss_pred HHHHHHHhcCCCccCcc------------ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 284 RVEKFIRSNGYMNIDPV------------IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 284 ~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....+.... ...++. +............++.+.+|+.+||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 252 DLYDYIDKYN-IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHTT-CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhHHHHhc-cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111111111 001110 0000000001134678999999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=320.93 Aligned_cols=254 Identities=14% Similarity=0.156 Sum_probs=187.6
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hh-HHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YA-SERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|++..... .. .+.+.++...++.++||||+++++++.+.+..++
T Consensus 5 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 5 KADDLEPIMEL-GRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CGGGEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred cHHhhhhHHhc-CCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 35788899998 9999999999999 6777999999875422 22 2334455556788899999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ-PVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
||||++ ++|.+++...... ...+++..+..++.|++.||.||| +. +|+|+||||+||+++.++.+||+|||++.
T Consensus 84 v~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999997 5887776431111 157999999999999999999999 87 99999999999999999999999999997
Q ss_pred cCCCCCccccccccccCCCCCCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYL----TTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
....... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||..... .........
T Consensus 159 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~ 227 (290)
T 3fme_A 159 YLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--------PFQQLKQVV 227 (290)
T ss_dssp --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--------HHHHHHHHH
T ss_pred ccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--------hHHHHHHHh
Confidence 7644322 2233589999999996 456789999999999999999999999874321 111222222
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 228 EEPSPQLPA------------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HSCCCCCCT------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCCCccc------------ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 221111111 133467899999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=332.62 Aligned_cols=254 Identities=17% Similarity=0.152 Sum_probs=202.5
Q ss_pred hcCcccccccccCCCceEEEEEEE----CCCceEEEEEecccc----hhhHHHHHHHHHHHHhc-CCCCccceeeeeecC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL----RDRGPILVMKYRKSV----RYASERCFNNIVFASQM-NHKSILKLIGCCLEA 129 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~----~~~~~vaik~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 129 (350)
.++|...+.| |+|+||.||+++. .++..||+|.+.... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 53 ~~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 53 IENFELLKVL-GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp GGGEEEEEEE-EETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred ccceEEEEEe-ccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 3689999998 9999999999998 367799999986542 12345677899999999 699999999999999
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
...++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred ceEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeC
Confidence 9999999999999999998653 46899999999999999999999 899999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG--YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|+++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...... .........
T Consensus 204 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~ 277 (355)
T 1vzo_A 204 GLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-----NSQAEISRR 277 (355)
T ss_dssp SEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-----CCHHHHHHH
T ss_pred CCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-----chHHHHHHH
Confidence 999865432222 22344599999999999863 4789999999999999999999999754321 111122222
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAKK 341 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~~ 341 (350)
... .... .. ...+..+.+|+.+||+.||++|| |+.++++.
T Consensus 278 ~~~-~~~~-~~------------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 278 ILK-SEPP-YP------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHH-CCCC-CC------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred Hhc-cCCC-CC------------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 211 1111 10 13346788999999999999999 99999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=326.98 Aligned_cols=267 Identities=16% Similarity=0.205 Sum_probs=193.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE----- 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 130 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPI-GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeee-EecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4678888998 9999999999998 56778999998653 2344567889999999999999999999987655
Q ss_pred -cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 131 -MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
..++||||++ ++|.+.+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEe
Confidence 6799999996 57888874 35889999999999999999999 899999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccC---------CCCcc-
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT---------GGSNF- 279 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~~~~- 279 (350)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... +....
T Consensus 172 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 172 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp CC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHH
T ss_pred eccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9998654322 1233458999999999999899999999999999999999999997543210 00000
Q ss_pred ---hHHHHHHHHHHhcC-CCcc-----CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 280 ---FITDRVEKFIRSNG-YMNI-----DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 280 ---~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+............ .... .+..............+..+.+|+.+||+.||++|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00001111111111 0000 0000000000111234678999999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=352.67 Aligned_cols=259 Identities=20% Similarity=0.241 Sum_probs=205.8
Q ss_pred HhcCcccccccccCCCceEEEEEEECC----CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLRD----RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~~----~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
..++|...+.| |+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus 388 ~~~~y~i~~~L-G~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCI-GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CGGGEEEEEEE-ECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ccccEEEeeEE-eeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 44678888888 999999999999832 3468999886543 344577999999999999999999999985 4578
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 99999999999999996532 46899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... . .....+..
T Consensus 539 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---------~-~~~~~i~~ 607 (656)
T 2j0j_A 539 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---------N-DVIGRIEN 607 (656)
T ss_dssp CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------H-HHHHHHHH
T ss_pred eecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---------H-HHHHHHHc
Confidence 876543322 2223347789999999998899999999999999999997 9999874322 1 11222222
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.......+ .++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 608 ~~~~~~~~------------~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 608 GERLPMPP------------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TCCCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCc------------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 22111111 3446789999999999999999999999999998653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=325.41 Aligned_cols=252 Identities=22% Similarity=0.240 Sum_probs=197.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCccceeeeeec
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--------YASERCFNNIVFASQMNHKSILKLIGCCLE 128 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 128 (350)
..++|...+.| |+|+||.||+|.+ .++..||+|.+..... .....+.+|+.++++++||||+++++++..
T Consensus 8 l~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTL-GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhceeEeeEE-ecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34678999998 9999999999999 5667999999865421 123457899999999999999999999876
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc---ee
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA---AK 205 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~k 205 (350)
.. .++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++. +|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEE
Confidence 54 89999999999999988653 57899999999999999999999 899999999999999987654 99
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
|+|||++........ .....||+.|+|||++. ...++.++|||||||++|+|++|..||...... ..+
T Consensus 158 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~- 228 (322)
T 2ycf_A 158 ITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-----VSL- 228 (322)
T ss_dssp ECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-----SCH-
T ss_pred EccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-----HHH-
Confidence 999999987644321 22345899999999974 467899999999999999999999999754321 111
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+........ +... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 229 ---~~~~~~~~~~~~-~~~~--------~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 229 ---KDQITSGKYNFI-PEVW--------AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HHHHHHTCCCCC-HHHH--------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHhCccccC-chhh--------hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111222221111 1100 123567899999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=338.67 Aligned_cols=263 Identities=16% Similarity=0.188 Sum_probs=206.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCC-CCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNH-KSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||.||+|.+ .++..||||.+..... ...+.+|+.++..++| ++|..+..++.+....++||
T Consensus 6 ~~~y~i~~~L-G~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKI-GSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCC-EECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEE-eeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 4688999998 9999999999998 6677999998765432 3457899999999987 55666666667788889999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe---CCCCceeEcccCCCc
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF---QEEYAAKLFDFSLSK 213 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~ 213 (350)
||+ +++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++
T Consensus 83 e~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred ECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 999 899999996432 56999999999999999999999 8999999999999999 688999999999998
Q ss_pred cCCCCCccc-----cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 214 SIPEGKTHI-----KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 214 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~------~~~~~~~~i 228 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKI 228 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS------SHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch------hHHHHHHHH
Confidence 765433211 123556999999999999999999999999999999999999999864321 111111111
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
........+.. +. ..++.++.+|+..||+.+|++||++.+|++.|+++..
T Consensus 229 ~~~~~~~~~~~-l~--------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 229 SEKKVATSIEA-LC--------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHHHSCHHH-HH--------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred hhccccccHHH-Hh--------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11110111110 00 0234679999999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=352.60 Aligned_cols=249 Identities=15% Similarity=0.147 Sum_probs=204.5
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 132 (350)
..++|...+.| |+|+||.||+|.+ .++..||||.+.+.. ....+.+..|..++..+ +||||+.+++++.+.+.+
T Consensus 339 ~~~~f~~~~~L-G~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVL-GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp -CTTEEEEEES-SBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred cccceEEEEEE-ccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 45789999998 9999999999999 556689999987542 23456688899999988 699999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+||||+.++.+||+|||++
T Consensus 418 ~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence 9999999999999999753 46899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
+....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..... . .....+...
T Consensus 490 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---------~-~~~~~i~~~ 557 (674)
T 3pfq_A 490 KENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---------D-ELFQSIMEH 557 (674)
T ss_dssp EECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---------H-HHHHHHHSS
T ss_pred eccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---------H-HHHHHHHhC
Confidence 86433222 23455699999999999999999999999999999999999999975322 1 112222221
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTM-----IDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~evl~ 340 (350)
.... . ...+.++.+|+.+||+.||++||++ .+|++
T Consensus 558 ~~~~-p------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 NVAY-P------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCCC-C------------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCC-C------------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1110 0 1345678999999999999999997 66654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=325.35 Aligned_cols=264 Identities=15% Similarity=0.208 Sum_probs=200.6
Q ss_pred cccccHHHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEeccc--chhhHHHHHHHHHHHHhcC--CCCccce
Q 018816 47 IRSFSSEDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKS--VRYASERCFNNIVFASQMN--HKSILKL 122 (350)
Q Consensus 47 ~~~~~~~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~ 122 (350)
.+.+.++.+....++|...+.| |+|+||.||++.+.++..||+|.+... .....+.+.+|+.++.+++ ||||+++
T Consensus 15 ~~~~~~~~~~~~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~ 93 (313)
T 3cek_A 15 TENLYFQSMSVKGRIYSILKQI-GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93 (313)
T ss_dssp -----CCEEEETTEEEEEEEEE-ECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred CCCCCeeeeeeccceEEEEEEe-cCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence 3445555555667889999999 999999999999977889999998653 2345677899999999997 5999999
Q ss_pred eeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC
Q 018816 123 IGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY 202 (350)
Q Consensus 123 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~ 202 (350)
++++.+.+..++||| +.+++|.+++... ..+++..+..++.||+.||.||| +.+|+|+||||+||++++ +
T Consensus 94 ~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~ 163 (313)
T 3cek_A 94 YDYEITDQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-G 163 (313)
T ss_dssp EEEEECSSEEEEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-T
T ss_pred EEEeecCCEEEEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-C
Confidence 999999999999999 5688999999754 46899999999999999999999 899999999999999964 8
Q ss_pred ceeEcccCCCccCCCCCccccccccccCCCCCCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 018816 203 AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-----------GYYNEKTDVYSFGKLLLVLLTGRTIGHLSR 271 (350)
Q Consensus 203 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~el~tg~~p~~~~~ 271 (350)
.+||+|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|..||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 999999999987654433222334458999999999875 468899999999999999999999987432
Q ss_pred ccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 272 LATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
. ................... ..+..+.+++.+||+.||++|||+.++++.
T Consensus 244 ~--------~~~~~~~~~~~~~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 244 N--------QISKLHAIIDPNHEIEFPD------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp S--------HHHHHHHHHCTTSCCCCCC------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H--------HHHHHHHHHhcccccCCcc------------cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1 1111112211111111110 123578999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=326.11 Aligned_cols=261 Identities=19% Similarity=0.198 Sum_probs=204.6
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhh-----------------HHHHHHHHHHHHhcCCCCccc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYA-----------------SERCFNNIVFASQMNHKSILK 121 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~ 121 (350)
.++|...+.| |+|+||.||+|.+ ++..||+|.+....... .+.+.+|+.++.+++||||++
T Consensus 30 ~~~y~~~~~l-g~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTL-NQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEE-ECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEE-cCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 4688999998 9999999999999 77799999987653221 178999999999999999999
Q ss_pred eeeeeecCCcCeEEeecCCCCchhhh------hhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEeeccccC
Q 018816 122 LIGCCLEAEMPALVYEPAGYCTLADR------LYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFP-QPVVFRNIEPW 194 (350)
Q Consensus 122 ~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~ 194 (350)
+++++.+.+..++||||+++++|.++ +.... ...+++..+..++.||+.||.||| + .+|+|+||||+
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~ 181 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPS 181 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChH
Confidence 99999999999999999999999998 54321 257999999999999999999999 7 99999999999
Q ss_pred ceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccC-CCCc-cchhHHHHHHHHHHHhCCCCCCCCcc
Q 018816 195 NILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNE-KTDVYSFGKLLLVLLTGRTIGHLSRL 272 (350)
Q Consensus 195 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~el~tg~~p~~~~~~ 272 (350)
||+++.++.+||+|||.+...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||.....
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999876433 23344589999999999887 6666 99999999999999999999975432
Q ss_pred cCCCCcchHHHHHHHHHHhcCCCccCc--cc----cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 273 ATGGSNFFITDRVEKFIRSNGYMNIDP--VI----VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ......+.......... .. ............+..+.+|+.+||+.||++|||+.++++
T Consensus 258 ~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 L---------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp S---------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H---------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 11122222221111000 00 000000000134568999999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=330.03 Aligned_cols=260 Identities=17% Similarity=0.202 Sum_probs=183.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecC------
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEA------ 129 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 129 (350)
.++|...+.| |+|+||.||+|.+ .++..||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~l-G~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPV-GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEEC-C----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEE-eecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4688888898 9999999999998 66779999998653 234456788999999999999999999998654
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
...++|+|++ +++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred CeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeec
Confidence 5689999999 6899988854 46899999999999999999999 899999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||..... ..........
T Consensus 177 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~l~~i~~~ 245 (367)
T 2fst_X 177 GLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQLKLILRL 245 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHH
T ss_pred ccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHH
Confidence 999765432 233458999999999887 6799999999999999999999999975432 1111111111
Q ss_pred HHhcCCCccCc-----------cccCCCCccch---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRSNGYMNIDP-----------VIVGDRSCFRK---EEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~~~~~~~~~-----------~~~~~~~~~~~---~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
........+.. .+......... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 246 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 246 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 11000000000 00000000000 023467899999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.58 Aligned_cols=267 Identities=15% Similarity=0.143 Sum_probs=202.1
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecC-----
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEA----- 129 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 129 (350)
...++|...+.| |+|+||.||+|.+ .++..||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 24 ~~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 24 DVGPRYTNLSYI-GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCTTTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccccEEEEEEe-ecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 445789999999 9999999999999 566789999987543 33457788999999999999999999998754
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
...++||||++ ++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Df 172 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDF 172 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeC
Confidence 36899999996 699998864 46899999999999999999999 899999999999999999999999999
Q ss_pred CCCccCCCCCccc-cccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 210 SLSKSIPEGKTHI-KASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 210 g~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||...... ........
T Consensus 173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~ 246 (364)
T 3qyz_A 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL------DQLNHILG 246 (364)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG------GHHHHHHH
T ss_pred cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHH
Confidence 9998765432211 12344699999999987654 5899999999999999999999999754321 11111111
Q ss_pred HHHhcCCCcc--------------CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNI--------------DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.......... .+..............+..+.+|+.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 247 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1100000000 0000000000000123467899999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=334.51 Aligned_cols=198 Identities=17% Similarity=0.171 Sum_probs=171.3
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc------CCCCccceeeeeecCCc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM------NHKSILKLIGCCLEAEM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~ 131 (350)
..+|...+.| |+|+||.||+|.+ .++..||+|.+.... .....+.+|+.++..+ +|+||+++++++.....
T Consensus 96 ~~ry~~~~~L-G~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVI-GKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEE-EESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEc-ccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4568888998 9999999999999 567799999987643 3346677888888877 57799999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc--eeEccc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA--AKLFDF 209 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Df 209 (350)
.++||||++ ++|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred EEEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999996 699998865422 45899999999999999999999 899999999999999999887 999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLS 270 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 270 (350)
|++...... .....||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 247 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 247 GSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999765432 23445899999999999999999999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=329.81 Aligned_cols=264 Identities=18% Similarity=0.187 Sum_probs=195.3
Q ss_pred HHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecC----
Q 018816 55 LKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEA---- 129 (350)
Q Consensus 55 l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 129 (350)
+....++|...+.| |+|+||.||+|.+ .++..||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~l-G~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTL-GTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEE-ECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEE-EeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 34566889999999 9999999999998 6777999999865432 234799999999999999999998543
Q ss_pred ----------------------------------CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 018816 130 ----------------------------------EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAV 175 (350)
Q Consensus 130 ----------------------------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l 175 (350)
...++||||++ ++|.+.+...... ...+++..+..++.||+.||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHH
Confidence 34789999997 5877766431111 15789999999999999999
Q ss_pred HHHHccCCCCeEeeccccCceEeC-CCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHH
Q 018816 176 AYLRFGFPQPVVFRNIEPWNILFQ-EEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSF 253 (350)
Q Consensus 176 ~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diwsl 253 (350)
.||| +.+|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||
T Consensus 155 ~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 9999 99999999999999997 688999999999987644332 2344589999999998775 48999999999
Q ss_pred HHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC--------------CCccCccccCC-CCccchHHHHHHHH
Q 018816 254 GKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG--------------YMNIDPVIVGD-RSCFRKEEKLQAYV 318 (350)
Q Consensus 254 G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~-~~~~~~~~~~~~l~ 318 (350)
||++|+|++|++||...... +.....+...+ ....-+.+... .....+...+..+.
T Consensus 229 G~il~ell~g~~pf~~~~~~---------~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSI---------DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHH---------HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHH
T ss_pred HHHHHHHHhCCCCCCCCChH---------HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHH
Confidence 99999999999999754321 11111111000 00000111000 00000113456799
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 018816 319 ELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 319 ~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+|+.+||+.||++|||+.++++
T Consensus 300 ~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 300 DLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=324.31 Aligned_cols=267 Identities=16% Similarity=0.217 Sum_probs=187.2
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
...++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 12 i~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVI-GSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp -CCCCCEEEEEC-C---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred cchhhhhhhhee-ccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 345789999998 9999999999998 566799999986543 2345678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 135 VYEPAGYCTLADRLYGP---LQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
||||+++++|.+++... .......+++..+..++.||+.||.||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999988531 0011146899999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCcc---ccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 212 SKSIPEGKTH---IKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 212 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
+......... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...... . ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~---~~~~ 238 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM------K---VLML 238 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG------G---HHHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh------h---HHHH
Confidence 8765433211 11233458999999999876 46899999999999999999999999754321 1 1111
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...... ............ ....+..+.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 TLQNDP-PSLETGVQDKEM---LKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHTSSC-CCTTC-----CC---CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccCC-Cccccccccchh---hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111 111110000000 0123467899999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=334.49 Aligned_cols=254 Identities=9% Similarity=-0.001 Sum_probs=180.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhc--CCCCcccee-------ee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQM--NHKSILKLI-------GC 125 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~-------~~ 125 (350)
..+|...+.| |+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++..| +||||++++ ++
T Consensus 61 ~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPL-RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred ceeeeeeeec-cCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 4458888888 9999999999998 5777999999977532 3455677886555555 699988755 33
Q ss_pred eecC-----------------CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHccC
Q 018816 126 CLEA-----------------EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHR------LKVAMETANAVAYLRFGF 182 (350)
Q Consensus 126 ~~~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~ 182 (350)
+... ...++||||++ ++|.+++.... ..+.+..+ ..++.||+.||.|||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH--- 211 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQ--- 211 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHH---
Confidence 3322 23799999998 89999996531 23455555 778899999999999
Q ss_pred CCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCcccccc--CCCCccchhHHHHHHHHHH
Q 018816 183 PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT--GYYNEKTDVYSFGKLLLVL 260 (350)
Q Consensus 183 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el 260 (350)
+++|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||
T Consensus 212 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 9999999999999999999999999999998664321 13347799999999987 6799999999999999999
Q ss_pred HhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 261 LTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 261 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
++|+.||........... . ....................++.+.+|+.+||+.||++|||+.++++
T Consensus 287 ltg~~Pf~~~~~~~~~~~-----------~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKGSW-----------K---RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHSSCSTTBCCTTCTTCC-----------C---BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HhCCCCCCCcCcccccch-----------h---hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999986532110000 0 00000000000000000134578999999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=331.16 Aligned_cols=268 Identities=13% Similarity=0.127 Sum_probs=200.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC--------CCCccceeeeee--
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN--------HKSILKLIGCCL-- 127 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~-- 127 (350)
.++|...+.| |+|+||.||+|++ .++..||+|.+.... ...+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKL-GWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEe-eecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 4679999998 9999999999998 667789999987543 44567889999999986 788999999987
Q ss_pred --cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEeeccccCceEeCCCC--
Q 018816 128 --EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ-PVVFRNIEPWNILFQEEY-- 202 (350)
Q Consensus 128 --~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~-- 202 (350)
+....++||||+ +++|.+.+..... ..+++..+..++.||+.||.||| ++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchh
Confidence 556899999999 5566665543221 46899999999999999999999 87 999999999999999775
Q ss_pred -----------------------------------------------ceeEcccCCCccCCCCCccccccccccCCCCCC
Q 018816 203 -----------------------------------------------AAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAA 235 (350)
Q Consensus 203 -----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 235 (350)
.+||+|||++...... .....||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence 7999999999876432 233458999999
Q ss_pred ccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh--------cC--CCccCc--ccc-
Q 018816 236 PEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS--------NG--YMNIDP--VIV- 302 (350)
Q Consensus 236 PE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~--~~~~~~--~~~- 302 (350)
||++.+..++.++|||||||++|+|++|..||........................ .. ...... .+.
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 99999999999999999999999999999999754432111011111111111110 00 000000 000
Q ss_pred --CCC----------CccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 303 --GDR----------SCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 303 --~~~----------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... ....+...+..+.+|+.+||+.||++|||+.++++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 00012367788999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=314.19 Aligned_cols=258 Identities=19% Similarity=0.209 Sum_probs=206.7
Q ss_pred HHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 56 KTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 56 ~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
....++|...+.| |+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+....
T Consensus 18 ~~~~~~y~i~~~l-g~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCML-GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEE-cCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3455789999998 9999999999999 467799999986543 23457789999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC---CceeEccc
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE---YAAKLFDF 209 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Df 209 (350)
++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+++|+||||+||+++.+ +.+||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999999988643 46899999999999999999999 8999999999999999764 46999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
|++........ .....+|+.|+|||++.+ .++.++||||||+++|+|++|..||..... ......+
T Consensus 169 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----------~~~~~~~ 234 (287)
T 2wei_A 169 GLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----------YDILKRV 234 (287)
T ss_dssp TGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHH
T ss_pred CcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH----------HHHHHHH
Confidence 99876644322 223348899999998865 589999999999999999999999875322 1122223
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHh
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK--KLRQM 345 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~ 345 (350)
.........+.. ...+..+.+++.+||+.||++|||+.++++ .+++.
T Consensus 235 ~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 235 ETGKYAFDLPQW---------RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHCCCCCCSGGG---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HcCCCCCCchhh---------hhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 332221111111 133467899999999999999999999998 44443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=322.18 Aligned_cols=264 Identities=13% Similarity=0.173 Sum_probs=202.7
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
.+.....++|...+.| |+|+||.||+|.+.+ .||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 26 ~~~~i~~~~~~~~~~l-g~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELI-GKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGSSSCCSCEECCCBC-CCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccCCHHHeEEeeEe-ccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3344456788899998 999999999999864 59999986542 223455778999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..++||||+++++|.+++.... ..+++..+..++.||+.||.||| +.+++|+||||+||+++ ++.+||+|||
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred ceEEEeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecC
Confidence 9999999999999999996532 46899999999999999999999 89999999999999998 6799999999
Q ss_pred CCccCCCCCc---cccccccccCCCCCCcccccc---------CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCc
Q 018816 211 LSKSIPEGKT---HIKASTAIGSLEFAAPEYLTT---------GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN 278 (350)
Q Consensus 211 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~ 278 (350)
++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------ 248 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------ 248 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 9876532211 112233458999999999874 3578999999999999999999999874332
Q ss_pred chHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 279 FFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
. ...............+ . ..+..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 249 ---~-~~~~~~~~~~~~~~~~----~-------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 249 ---E-AIIWQMGTGMKPNLSQ----I-------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ---H-HHHHHHHTTCCCCCCC----S-------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ---H-HHHHHhccCCCCCCCc----C-------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1 1111222221111111 0 1234688999999999999999999999999988653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=312.06 Aligned_cols=253 Identities=18% Similarity=0.235 Sum_probs=193.4
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeec--------
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLE-------- 128 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 128 (350)
..++|...+.| |+|+||.||+|+. .++..||+|.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIAVL-GQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhhee-ccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 45688999998 9999999999998 57779999998654 3445778999999999999999999998865
Q ss_pred -----CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 129 -----AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 129 -----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
....++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCC
Confidence 346799999999999999997532 46788999999999999999999 899999999999999999999
Q ss_pred eeEcccCCCccCCCCCc------------cccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 018816 204 AKLFDFSLSKSIPEGKT------------HIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLS 270 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~ 270 (350)
+||+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 99999999976643211 1112344589999999998764 68999999999999999998 44311
Q ss_pred cccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 271 RLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
. ........+.... ..+.+... ...+..+.+++.+||+.||++|||+.++++
T Consensus 232 ~---------~~~~~~~~~~~~~-~~~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 M---------ERVNILKKLRSVS-IEFPPDFD--------DNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp H---------HHHHHHHHHHSTT-CCCCTTCC--------TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h---------hHHHHHHhccccc-cccCcccc--------ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1 1111112222111 11111111 134467899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=322.00 Aligned_cols=265 Identities=17% Similarity=0.154 Sum_probs=198.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecC-----Cc
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEA-----EM 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 131 (350)
.++|...+.| |+|+||.||+|.+ .++..||||.+.... ......+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLL-GEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEE-cCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4788999998 9999999999999 567789999986543 34456788999999999999999999987754 67
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
.++||||++ ++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 899999996 699998864 46899999999999999999999 89999999999999999999999999999
Q ss_pred CccCCCCCccc--------cccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 212 SKSIPEGKTHI--------KASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 212 ~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
+.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ...
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~ 232 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR------HQL 232 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHH
Confidence 98765322111 1223458999999998765 67899999999999999999999999754321 001
Q ss_pred HHHHHHHHhcCCC-ccC--------------ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 283 DRVEKFIRSNGYM-NID--------------PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 283 ~~~~~~~~~~~~~-~~~--------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
............. ... +..............+..+.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111110000000 000 000000000000134567899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=329.53 Aligned_cols=274 Identities=16% Similarity=0.147 Sum_probs=183.0
Q ss_pred cCcccc-cccccCCCceEEEEEEEC---CCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeee--cCCcCe
Q 018816 60 NNYSMR-NITIDEIEGYILYMGFLR---DRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCL--EAEMPA 133 (350)
Q Consensus 60 ~~f~~~-~~lig~G~~g~V~~~~~~---~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~ 133 (350)
+.|... ++| |+|+||.||+|++. ++..||+|++.... ....+.+|+.++++++||||+++++++. .....+
T Consensus 20 ~~y~~~g~~l-G~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCC-C-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEe-eecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345553 356 99999999999974 46689999987542 2356889999999999999999999995 466899
Q ss_pred EEeecCCCCchhhhhhCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe----CCCCcee
Q 018816 134 LVYEPAGYCTLADRLYGPL----QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF----QEEYAAK 205 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill----~~~~~~k 205 (350)
+||||++ ++|.+++.... ......+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 58887774211 111135899999999999999999999 8999999999999999 7789999
Q ss_pred EcccCCCccCCCCCcc-ccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHH
Q 018816 206 LFDFSLSKSIPEGKTH-IKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITD 283 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 283 (350)
|+|||+++........ ......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||................
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 9999999876543211 123345689999999999874 58999999999999999999999997543321111111112
Q ss_pred HHHHHHHhcCCC--ccCccccCC--------------CCccchH--------HHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018816 284 RVEKFIRSNGYM--NIDPVIVGD--------------RSCFRKE--------EKLQAYVELAFKCLSHSAEDRPTMIDVA 339 (350)
Q Consensus 284 ~~~~~~~~~~~~--~~~~~~~~~--------------~~~~~~~--------~~~~~l~~l~~~cl~~~P~~RPt~~evl 339 (350)
.+...+...+.. ..-+.+... ....... ..+..+.+|+.+||+.||++|||+.+++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 222222211100 000000000 0000000 0145688999999999999999999998
Q ss_pred H
Q 018816 340 K 340 (350)
Q Consensus 340 ~ 340 (350)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=317.92 Aligned_cols=262 Identities=17% Similarity=0.198 Sum_probs=193.7
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeee----------
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCL---------- 127 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~---------- 127 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPL-GCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEEC-C-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEe-ccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3678888888 9999999999999 457799999997766666788999999999999999999999874
Q ss_pred ----cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC-CCC
Q 018816 128 ----EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ-EEY 202 (350)
Q Consensus 128 ----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~ 202 (350)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||.||| +.+|+|+||||+||+++ .++
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTT
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCC
Confidence 3457899999997 699999854 46899999999999999999999 89999999999999997 567
Q ss_pred ceeEcccCCCccCCCCCcc-ccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcch
Q 018816 203 AAKLFDFSLSKSIPEGKTH-IKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF 280 (350)
Q Consensus 203 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~ 280 (350)
.+||+|||++......... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------- 231 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL------- 231 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-------
Confidence 9999999999876432211 11233447899999998866 67899999999999999999999999754321
Q ss_pred HHHHHHHHHHhcCC--------------CccCccccCCCCcc--chHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 281 ITDRVEKFIRSNGY--------------MNIDPVIVGDRSCF--RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 281 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
............ .............. .....+..+.+|+.+||+.||++|||+.++++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 232 --EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp --HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111111111000 00000000000000 00124567999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=322.86 Aligned_cols=255 Identities=16% Similarity=0.228 Sum_probs=195.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC---
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP--- 132 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 132 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~l-G~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHV-GSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEE-ecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4678888888 9999999999999 567799999987542 23456788999999999999999999999877655
Q ss_pred ---eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 133 ---ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 133 ---~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
++||||++ ++|.+.+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999997 68888773 35899999999999999999999 899999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
|++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .......
T Consensus 189 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~i 254 (371)
T 4exu_A 189 GLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---------LDQLTQI 254 (371)
T ss_dssp TCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHHH
T ss_pred CcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHH
Confidence 999765432 233458999999999887 6799999999999999999999999975432 1111111
Q ss_pred HHhcCCC------c------------cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRSNGYM------N------------IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~~~~~------~------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
....+.. . +........... ....++.+.+|+.+||+.||++|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 255 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL-FPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHH-STTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHh-ccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 1100000 0 000000000000 0123568999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=318.45 Aligned_cols=268 Identities=16% Similarity=0.147 Sum_probs=203.8
Q ss_pred hcCcccccccccCCCceEEEEEEE--CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCC------ccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL--RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKS------ILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~--~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~ 130 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.++..++|+| |+++++++.+.+
T Consensus 13 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTL-GEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEE-EEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEE-ecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 3678888998 9999999999998 356689999986543 44567889999999887654 999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC----------
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---------- 200 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---------- 200 (350)
..++||||+ +++|.+++..... .++++..+..++.||+.||.||| +.+|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred cEEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCc
Confidence 999999999 8899999865421 36889999999999999999999 899999999999999987
Q ss_pred ---------CCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 018816 201 ---------EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSR 271 (350)
Q Consensus 201 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 271 (350)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999765432 233458999999999999899999999999999999999999997543
Q ss_pred ccCCCCcchHHHHHHHHHHh--------cC-CCccC---ccccCC---------------CCccchHHHHHHHHHHHHHc
Q 018816 272 LATGGSNFFITDRVEKFIRS--------NG-YMNID---PVIVGD---------------RSCFRKEEKLQAYVELAFKC 324 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~---~~~~~~---------------~~~~~~~~~~~~l~~l~~~c 324 (350)
.. ............ .. ..... ..+... .........++.+.+|+.+|
T Consensus 239 ~~------~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 239 SK------EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp HH------HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred hH------HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 21 111111111100 00 00000 000000 00000125678899999999
Q ss_pred cccCCCCCCCHHHHHHH--HHHhh
Q 018816 325 LSHSAEDRPTMIDVAKK--LRQMY 346 (350)
Q Consensus 325 l~~~P~~RPt~~evl~~--L~~~~ 346 (350)
|+.||++|||+.++++. |+.+.
T Consensus 313 L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 313 LEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp TCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred hCcCcccccCHHHHhcCHHHHHHh
Confidence 99999999999999863 44443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=328.69 Aligned_cols=262 Identities=16% Similarity=0.156 Sum_probs=192.6
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc------Ce
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM------PA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~ 133 (350)
.+|...+.| |+|+||.||+|++..+..||+|++...... ..+|+.+++.++||||+++++++..... .+
T Consensus 40 ~~Y~~~~~l-G~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVI-GNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEE-EEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEE-eeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468888888 999999999999977778999998654321 2369999999999999999999865443 78
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC-CCCceeEcccCCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ-EEYAAKLFDFSLS 212 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~ 212 (350)
+||||++++.+........ ....+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||++
T Consensus 115 lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEECCSEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEeeccCccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 9999998654433321110 0157899999999999999999999 89999999999999999 7999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH--
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI-- 289 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 289 (350)
+....... .....+|+.|+|||++.+. .++.++|||||||++|||++|++||...... ..........
T Consensus 190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~------~~l~~i~~~~g~ 260 (394)
T 4e7w_A 190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI------DQLVEIIKVLGT 260 (394)
T ss_dssp EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCC
T ss_pred ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCC
Confidence 87644332 2344589999999998765 5899999999999999999999999754321 1111111110
Q ss_pred ------HhcC---CCccCccccCCC-CccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 290 ------RSNG---YMNIDPVIVGDR-SCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 290 ------~~~~---~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... ....-+...... ........+.++.+|+.+||+.||++|||+.++++
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000 000001100000 00000124568999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=318.12 Aligned_cols=274 Identities=15% Similarity=0.137 Sum_probs=190.6
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 131 (350)
.+.....++|...+.| |+|+||.||+|.+ .++..||||++.... .......+++..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMA-GQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC-----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEE-ecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 4566778999999999 9999999999999 567799999986543 233456778888999999999999999876443
Q ss_pred -------CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-CCc
Q 018816 132 -------PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-EYA 203 (350)
Q Consensus 132 -------~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~ 203 (350)
.++||||+++ +|.+.+..... ....+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCc
Confidence 7899999976 54443322100 115688999999999999999999943 679999999999999997 899
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
+||+|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ...
T Consensus 171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~~~ 241 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA------GQL 241 (360)
T ss_dssp EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH------HHH
Confidence 99999999987654332 23345899999999987654 899999999999999999999999754321 111
Q ss_pred HHHHHH--------HHhcCCCccCccccCCCCccc-------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 283 DRVEKF--------IRSNGYMNIDPVIVGDRSCFR-------KEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 283 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...... +........+........... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111110 000000000000000000000 0024678999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=320.97 Aligned_cols=257 Identities=16% Similarity=0.181 Sum_probs=178.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHH-HHHhcCCCCccceeeeeecCCcCeEE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIV-FASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+.... ......+..|+. +++.++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEI-GRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEE-EECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehhee-ccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4678888888 9999999999999 567799999987643 233455666666 66778999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ-PVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
|||++ ++|.+++..........+++..+..++.|++.||.||| +. +|+|+||||+||+++.++.+||+|||++..
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99997 48877765211111157899999999999999999999 77 999999999999999999999999999976
Q ss_pred CCCCCccccccccccCCCCCCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYL----TTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
...... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||...... .....
T Consensus 176 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------~~~~~ 240 (327)
T 3aln_A 176 LVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV------------FDQLT 240 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------C
T ss_pred cccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH------------HHHHH
Confidence 643321 2233589999999998 4566899999999999999999999998753211 00000
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. .....+.+..... ...+..+.+|+.+||+.||++|||+.+|++
T Consensus 241 ~~-~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 241 QV-VKGDPPQLSNSEE----REFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC-CCSCCCCCCCCSS----CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HH-hcCCCCCCCCccc----ccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00 0000111111100 134567999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=320.96 Aligned_cols=252 Identities=16% Similarity=0.198 Sum_probs=173.5
Q ss_pred HhcCccccc-ccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHH-HHHHhcCCCCccceeeeeec----CC
Q 018816 58 AINNYSMRN-ITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNI-VFASQMNHKSILKLIGCCLE----AE 130 (350)
Q Consensus 58 ~~~~f~~~~-~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~----~~ 130 (350)
..++|.... +| |+|+||.||+|.+ .++..||+|.+.... ...+|+ ..+..++||||+++++++.. ..
T Consensus 26 ~~~~y~i~~~~l-G~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVL-GLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceee-eeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 457888855 56 9999999999999 567799999986542 122333 34566799999999999876 44
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCceeEc
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKLF 207 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~ 207 (350)
..++||||+++|+|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+||+++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 58999999999999999976432 46899999999999999999999 899999999999999976 4559999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|||++....... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ........
T Consensus 174 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~ 243 (336)
T 3fhr_A 174 DFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ------AISPGMKR 243 (336)
T ss_dssp CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred ccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch------hhhhhHHH
Confidence 999997654322 23345899999999998888999999999999999999999999754321 00000011
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...........+.. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 244 RIRLGQYGFPNPEW---------SEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -------CCCTTTS---------TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhccccccCchhh---------ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111111110 134567899999999999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=316.81 Aligned_cols=253 Identities=17% Similarity=0.196 Sum_probs=195.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc----
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEM---- 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 131 (350)
.++|.....| |+|+||.||+|.+ .++..||||.+.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHV-GSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeE-ecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3678888888 9999999999999 567799999986542 2345678899999999999999999999987654
Q ss_pred --CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 132 --PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 132 --~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
.++||||++ ++|.+++. ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECST
T ss_pred eeEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeec
Confidence 499999997 68888763 35899999999999999999999 899999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH-
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK- 287 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~- 287 (350)
|++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ........
T Consensus 171 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~i~~~ 239 (353)
T 3coi_A 171 GLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKV 239 (353)
T ss_dssp TCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH------HHHHHHHHH
T ss_pred ccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHH
Confidence 999765332 223458999999999887 67899999999999999999999999754321 11111110
Q ss_pred -------------------HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 -------------------FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...... ....+.+.... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 240 TGVPGTEFVQKLNDKAAKSYIQSLP-QTPRKDFTQLF-----PRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HCBCCHHHHTTCSCHHHHHHHHTSC-BCSSCCTTTTC-----TTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hCCCCHHHHHHHhhHHHHHHHHhCc-CCCCccHHHhc-----CCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00000010000 134578999999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=328.67 Aligned_cols=263 Identities=18% Similarity=0.162 Sum_probs=191.9
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecC------CcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEA------EMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 132 (350)
.+|...+.| |+|+||.||+|++ .++..||||++.... ....+|+.++++++||||+++++++... ..+
T Consensus 54 ~~y~~~~~l-G~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVI-GNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEE-eeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 368888888 9999999999999 567799999986542 2234799999999999999999988542 236
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-CceeEcccCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-YAAKLFDFSL 211 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~ 211 (350)
++||||+++ +|.+.+..... ....+++..+..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred Eeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 799999975 66655532110 1157899999999999999999999 9999999999999999965 5689999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH----
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE---- 286 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---- 286 (350)
++....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||...... ..+.....
T Consensus 204 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-----~~l~~i~~~lg~ 275 (420)
T 1j1b_A 204 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-----DQLVEIIKVLGT 275 (420)
T ss_dssp CEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCS
T ss_pred hhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCC
Confidence 987644332 2334589999999998765 7999999999999999999999999754321 01111110
Q ss_pred ---HHHHhcC---CCccCccccCCCCc-cchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 287 ---KFIRSNG---YMNIDPVIVGDRSC-FRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 287 ---~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
..+.... .....+.+...... ..+...+.++.+|+.+||+.||++|||+.++++
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0011000 01111111111000 000123568999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=316.91 Aligned_cols=267 Identities=16% Similarity=0.178 Sum_probs=200.7
Q ss_pred HHhcCcccccccccCCCceEEEEEEE--CCCceEEEEEecccch--hhHHHHHHHHHHHHhc---CCCCccceeeeee--
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL--RDRGPILVMKYRKSVR--YASERCFNNIVFASQM---NHKSILKLIGCCL-- 127 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~--~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-- 127 (350)
...++|...+.| |+|+||.||+|.+ .++..||+|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEE-EEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred Cchhceeeeeee-cccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 356789999999 9999999999998 4566899999865432 1223566788777766 8999999999987
Q ss_pred ---cCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCce
Q 018816 128 ---EAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA 204 (350)
Q Consensus 128 ---~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 204 (350)
.....++||||++ ++|.+++..... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCE
Confidence 4567899999997 699999865422 35899999999999999999999 8999999999999999999999
Q ss_pred eEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHH
Q 018816 205 KLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 205 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 284 (350)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......
T Consensus 160 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~ 230 (326)
T 1blx_A 160 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD------VDQLGK 230 (326)
T ss_dssp EECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH
T ss_pred EEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHH
Confidence 999999997654322 23344589999999999999999999999999999999999999975432 111111
Q ss_pred HHHHHHhcCCCccC-----c--ccc---CCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 285 VEKFIRSNGYMNID-----P--VIV---GDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 285 ~~~~~~~~~~~~~~-----~--~~~---~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.............. + ... ...........+..+.+|+.+||+.||++|||+.++++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111100000000 0 000 00000000134567899999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=319.74 Aligned_cols=203 Identities=19% Similarity=0.195 Sum_probs=171.7
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CC-----CccceeeeeecC
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HK-----SILKLIGCCLEA 129 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~ 129 (350)
...++|...+.| |+|+||.||+|.+ .++..||||.+.... .....+.+|+.++..++ |+ +|+++++++...
T Consensus 51 ~~~~~y~~~~~l-G~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 51 KWMDRYEIDSLI-GKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp EETTTEEEEEEE-EEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred EeeeeEEEEEEE-eecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 346789999998 9999999999999 566789999987543 34566778999988885 55 499999999999
Q ss_pred CcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC--CCCceeEc
Q 018816 130 EMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ--EEYAAKLF 207 (350)
Q Consensus 130 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~ 207 (350)
+..++||||++ ++|.+++..... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999996 599999865422 4589999999999999999999932 36899999999999995 47889999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSR 271 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 271 (350)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999876432 223458999999999999999999999999999999999999998543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=321.77 Aligned_cols=268 Identities=13% Similarity=0.092 Sum_probs=198.5
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-----------CCCccceeeee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-----------HKSILKLIGCC 126 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~ 126 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKL-GWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEee-eecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3678888998 9999999999998 677799999987543 34567889999999886 89999999998
Q ss_pred ecCC----cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEeeccccCceEeC--
Q 018816 127 LEAE----MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ-PVVFRNIEPWNILFQ-- 199 (350)
Q Consensus 127 ~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~Nill~-- 199 (350)
.... ..++||||+ +++|.+++..... ..+++..+..++.||+.||.||| ++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEecc
Confidence 8654 789999999 8999999865322 45899999999999999999999 87 999999999999994
Q ss_pred ----CCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCC
Q 018816 200 ----EEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG 275 (350)
Q Consensus 200 ----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 275 (350)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 4458999999999866432 2234589999999999999999999999999999999999999975432111
Q ss_pred CCcchHHHHHHHHHH--------hcC--------CCccCccccCCC---------CccchHHHHHHHHHHHHHccccCCC
Q 018816 276 GSNFFITDRVEKFIR--------SNG--------YMNIDPVIVGDR---------SCFRKEEKLQAYVELAFKCLSHSAE 330 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~--------~~~--------~~~~~~~~~~~~---------~~~~~~~~~~~l~~l~~~cl~~~P~ 330 (350)
............... ... ............ ....+...+..+.+|+.+||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 111111111111110 000 000000000000 0001236778999999999999999
Q ss_pred CCCCHHHHHH
Q 018816 331 DRPTMIDVAK 340 (350)
Q Consensus 331 ~RPt~~evl~ 340 (350)
+|||+.++++
T Consensus 324 ~Rpt~~ell~ 333 (373)
T 1q8y_A 324 KRADAGGLVN 333 (373)
T ss_dssp TCBCHHHHHT
T ss_pred ccCCHHHHhh
Confidence 9999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=313.39 Aligned_cols=262 Identities=15% Similarity=0.111 Sum_probs=198.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCC-ceEEEEEecccchhhHHHHHHHHHHHHhcCCCC------ccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDR-GPILVMKYRKSVRYASERCFNNIVFASQMNHKS------ILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~-~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~ 130 (350)
.++|...+.| |+|+||.||+|.+ .++ ..||+|.+.... ...+.+.+|+.++++++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNL-GEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEE-EEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEe-eccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4688999998 9999999999998 333 589999986543 44567889999999997766 899999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe------------
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF------------ 198 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill------------ 198 (350)
..++||||+ +++|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eEEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccc
Confidence 999999999 5666666654321 46899999999999999999999 9999999999999999
Q ss_pred -------CCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCc
Q 018816 199 -------QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSR 271 (350)
Q Consensus 199 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 271 (350)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999765432 233458999999999999999999999999999999999999997543
Q ss_pred ccCCCCcchHHHHHHHHHH--------hcCC-Cc-cCc--cccCC---------------CCccchHHHHHHHHHHHHHc
Q 018816 272 LATGGSNFFITDRVEKFIR--------SNGY-MN-IDP--VIVGD---------------RSCFRKEEKLQAYVELAFKC 324 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~--------~~~~-~~-~~~--~~~~~---------------~~~~~~~~~~~~l~~l~~~c 324 (350)
.. .....+..... .... .. ... .+... .........+..+.+|+.+|
T Consensus 244 ~~------~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 244 NR------EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp HH------HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred HH------HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 21 11111111110 0000 00 000 00000 00000114567899999999
Q ss_pred cccCCCCCCCHHHHHH
Q 018816 325 LSHSAEDRPTMIDVAK 340 (350)
Q Consensus 325 l~~~P~~RPt~~evl~ 340 (350)
|+.||++|||+.++++
T Consensus 318 L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 318 LEFDPAQRITLAEALL 333 (355)
T ss_dssp TCSSTTTSCCHHHHTT
T ss_pred hcCChhhCcCHHHHhc
Confidence 9999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=328.12 Aligned_cols=253 Identities=17% Similarity=0.231 Sum_probs=185.6
Q ss_pred cccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEeecCC
Q 018816 62 YSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYEPAG 140 (350)
Q Consensus 62 f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 140 (350)
|...++| |+|+||+||.+...++..||||++.... .+.+.+|+.++.++ +||||+++++++.+.+..++||||++
T Consensus 17 ~~~~~~L-G~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 17 VVSEKIL-GYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEEE-EECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeccCeE-eeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 3345566 9999999987766777899999986542 35678999999887 89999999999999999999999995
Q ss_pred CCchhhhhhCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC-------------Ccee
Q 018816 141 YCTLADRLYGPLQTHL--EPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE-------------YAAK 205 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~-------------~~~k 205 (350)
|+|.+++........ ...++..++.++.||+.||.||| +.+|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 699999976421110 11133346789999999999999 8999999999999999754 4899
Q ss_pred EcccCCCccCCCCCccc--cccccccCCCCCCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCC
Q 018816 206 LFDFSLSKSIPEGKTHI--KASTAIGSLEFAAPEYLTT-------GYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATG 275 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~ 275 (350)
|+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--- 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS--- 245 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT---
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh---
Confidence 99999998775433211 1234469999999999875 568999999999999999999 8999864321
Q ss_pred CCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 276 GSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. ..... ..... . .. ........+.++.+|+.+||+.||++|||+.+|++
T Consensus 246 ----~~----~~i~~-~~~~~-~-~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 ----RE----SNIIR-GIFSL-D-EM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HH----HHHHH-TCCCC-C-CC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----hH----HHHhc-CCCCc-c-cc----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00 11111 11111 0 00 01112367788999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=310.92 Aligned_cols=253 Identities=18% Similarity=0.196 Sum_probs=181.4
Q ss_pred HHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hh-HHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YA-SERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
...++|...+.| |+|+||.||+|.+ .++..||+|.+..... .. .+.+.++..+++.++||||+++++++.+.+..+
T Consensus 22 ~~~~~y~~~~~l-g~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEM-GSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC-------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhcccccccee-eecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 345788888888 9999999999999 5677999999875432 22 233445556778889999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEeeccccCceEeCCCCceeEcccCCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ-PVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
+||||+ ++.+..+..... ..+++..+..++.|++.||.||| +. +++|+||||+||+++.++.+||+|||++
T Consensus 101 lv~e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp EEECCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999 555555543211 46899999999999999999999 75 9999999999999999999999999998
Q ss_pred ccCCCCCccccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
........ .....+|+.|+|||++. ...++.++|||||||++|+|++|..||..... .......
T Consensus 173 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~ 241 (318)
T 2dyl_A 173 GRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--------DFEVLTK 241 (318)
T ss_dssp -----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--------HHHHHHH
T ss_pred hhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--------cHHHHHH
Confidence 76543322 22345899999999984 45688999999999999999999999874321 1112222
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.... ....... . ...+..+.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~-~~~~~~~----~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 242 VLQE-EPPLLPG----H------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHS-CCCCCCS----S------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred Hhcc-CCCCCCc----c------CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2222 1111110 0 023467899999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=314.27 Aligned_cols=244 Identities=18% Similarity=0.215 Sum_probs=191.2
Q ss_pred HHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh------hHHHHHHHHHHHHhc----CCCCcccee
Q 018816 55 LKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY------ASERCFNNIVFASQM----NHKSILKLI 123 (350)
Q Consensus 55 l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~ 123 (350)
.....++|...+.| |+|+||.||+|.+ .++..||+|.+...... ....+.+|+.++.++ +||||++++
T Consensus 26 ~~~~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 26 REAFEAEYRLGPLL-GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp -------CEEEEEE-EEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhhhhceEEeeEE-EcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 44556789999999 9999999999998 56779999998654321 223456799999998 899999999
Q ss_pred eeeecCCcCeEEeec-CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC-CC
Q 018816 124 GCCLEAEMPALVYEP-AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ-EE 201 (350)
Q Consensus 124 ~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~ 201 (350)
+++.+.+..++|||+ +++++|.+++... ..+++..+..++.||+.||.||| +.+|+|+||||+||+++ .+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCC
Confidence 999999999999999 7899999999653 46899999999999999999999 89999999999999999 88
Q ss_pred CceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcch
Q 018816 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYN-EKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF 280 (350)
Q Consensus 202 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~ 280 (350)
+.+||+|||++....... .....||+.|+|||++.+..+. .++||||||+++|+|++|+.||.....
T Consensus 177 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------- 244 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------- 244 (312)
T ss_dssp TEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred CeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------
Confidence 999999999998765432 2334589999999998877664 589999999999999999999863210
Q ss_pred HHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 281 ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... .... +. ...+..+.+|+.+||+.||++|||+.++++
T Consensus 245 -------~~~-~~~~-~~------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -------ILE-AELH-FP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -------HHH-TCCC-CC------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------Hhh-hccC-Cc------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 1110 00 133467899999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=316.75 Aligned_cols=246 Identities=18% Similarity=0.210 Sum_probs=199.7
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchh------hHHHHHHHHHHHHhcC--CCCcccee
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY------ASERCFNNIVFASQMN--HKSILKLI 123 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~ 123 (350)
.+.....++|...+.| |+|+||.||+|.+ .++..||+|.+...... ..+.+.+|+.++.+++ ||||++++
T Consensus 36 ~~~~~~~~~y~~~~~l-g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 36 KEKEPLESQYQVGPLL-GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp ----CCTTTEEEEEEC-SSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred cccCCccCceEEEEEE-eeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 3334456789999998 9999999999998 66779999998665321 2245678999999996 59999999
Q ss_pred eeeecCCcCeEEeecCCC-CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC-CC
Q 018816 124 GCCLEAEMPALVYEPAGY-CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ-EE 201 (350)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~-~~ 201 (350)
+++.+.+..++|||++.+ ++|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ .+
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 115 DWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNR 186 (320)
T ss_dssp EEEECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTT
T ss_pred EEEecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCC
Confidence 999999999999999976 8999998653 56899999999999999999999 89999999999999999 78
Q ss_pred CceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcch
Q 018816 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF 280 (350)
Q Consensus 202 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~ 280 (350)
+.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|..||.....
T Consensus 187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------- 254 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------- 254 (320)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------
Confidence 999999999998765432 223458999999999987765 6889999999999999999999863211
Q ss_pred HHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 281 ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. ... ....+ ..++.+.+|+.+||+.||++|||+.+|++
T Consensus 255 -------~~-~~~-~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 -------II-RGQ-VFFRQ------------RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------HH-HCC-CCCSS------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------hh-ccc-ccccc------------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 111 11111 23467899999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=325.07 Aligned_cols=250 Identities=16% Similarity=0.194 Sum_probs=186.6
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 137 (350)
..+|...+.| |+|+||+|+.....++..||||++..... ..+.+|+.+++++ +||||+++++++.+....++|||
T Consensus 23 ~~~y~~~~~L-G~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVL-GHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEE-EECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCee-ecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 4568888888 99999996655556667999999965432 2356899999999 79999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-----CCceeEcccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-----EYAAKLFDFSLS 212 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~ 212 (350)
|++ |+|.+++.... .......+..++.||+.||.||| +.+|+||||||+|||++. ...+||+|||++
T Consensus 99 ~~~-g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp CCS-EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CCC-CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 996 69999997643 23444556789999999999999 899999999999999953 345789999999
Q ss_pred ccCCCCCcc-ccccccccCCCCCCccccc---cCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHH
Q 018816 213 KSIPEGKTH-IKASTAIGSLEFAAPEYLT---TGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 213 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
+........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||..... .....
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----------~~~~~ 240 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----------RQANI 240 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT----------HHHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH----------HHHHH
Confidence 876543221 1233456999999999997 3567889999999999999999 8888853321 01111
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...........+. ...+..+.+|+.+||+.||++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~----------~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 241 LLGACSLDCLHPE----------KHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HTTCCCCTTSCTT----------CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhccCCccccCcc----------ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111111111110 145667899999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=335.90 Aligned_cols=277 Identities=16% Similarity=0.161 Sum_probs=202.9
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeec------CC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLE------AE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 130 (350)
.++|...+.| |+|+||.||+|.+ .++..||+|.+... .....+.+.+|+.++.+++||||+++++++.. .+
T Consensus 13 ~grY~i~~~L-G~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCC-CBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEE-eeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 4789999999 9999999999999 66779999998654 33456779999999999999999999998765 66
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc---eeEc
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA---AKLF 207 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~---~kl~ 207 (350)
..++||||+++++|.+++...... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++. +||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~--~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENC--CGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCT--TCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 889999999999999999764221 36889999999999999999999 899999999999999997665 8999
Q ss_pred ccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 208 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||............ .......
T Consensus 167 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~-i~~~~~~ 242 (676)
T 3qa8_A 167 DLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK-VREKSNE 242 (676)
T ss_dssp SCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT-CC-----
T ss_pred ccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh-hhcccch
Confidence 9999987654332 23445899999999999999999999999999999999999999753211000000 0000000
Q ss_pred HHHhcCCCccCccc--cCC--CCccchHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHhhh
Q 018816 288 FIRSNGYMNIDPVI--VGD--RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMID-----VAKKLRQMYR 347 (350)
Q Consensus 288 ~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e-----vl~~L~~~~~ 347 (350)
.. .......... ... .+.......+..+.+|+..||+.||++|||+.+ ..+.++++..
T Consensus 243 ~~--~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 243 HI--VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp -C--CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hh--hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00 0000000000 000 000011256788999999999999999999988 4556666544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=334.15 Aligned_cols=240 Identities=20% Similarity=0.265 Sum_probs=195.1
Q ss_pred hcCcccccccccCCCceEEEEEEEC--CCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCc----
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLR--DRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM---- 131 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~--~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 131 (350)
.++|.....| |+|+||.||+|.+. ++..||||.+... .......+.+|+.++.+++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~l-g~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCI-AHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEE-EEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEE-eeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3789999998 99999999999984 5779999998654 33445678899999999999999999999987665
Q ss_pred -CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 132 -PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 132 -~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
.++||||+++++|.+++. ..+++..++.++.||+.||.||| +++|+||||||+|||++.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecc
Confidence 699999999999988764 36899999999999999999999 8999999999999999986 89999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+++..... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+|+......
T Consensus 227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------- 282 (681)
T 2pzi_A 227 AVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------------- 282 (681)
T ss_dssp TCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------
T ss_pred cchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------------
Confidence 99876442 3345999999999987654 89999999999999999999887632110
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhh
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-TMIDVAKKLRQMY 346 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~~ 346 (350)
. +. .. ......++.+.+|+.+||+.||++|| +++++.+.|..+.
T Consensus 283 ----~-~~----~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 283 ----G-LP----ED---DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----S-CC----TT---CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----c-cc----cc---ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 00 00 00113456789999999999999999 5777777777664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=294.03 Aligned_cols=230 Identities=10% Similarity=-0.001 Sum_probs=183.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 31 ~~y~i~~~l-g~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFH-GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEE-EBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEE-cccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 679988898 9999999999999 557799999997653 23347789999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++.. .....++..++.||+.||.||| +.+|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~-------~~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTT-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhc-------CCChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999999843 2355678899999999999999 8999999999999999999999998543
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
|++ .++.++|||||||++|+|++|+.||......... .
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~------------------~ 212 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL------------------A 212 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS------------------E
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh------------------H
Confidence 222 3689999999999999999999999864431100 0
Q ss_pred ccCccccCCCCcc--chHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 296 NIDPVIVGDRSCF--RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 296 ~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.......+..... .....+..+.+|+.+||+.||++| |+.++++.|+++...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 213 PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0000000000000 001345679999999999999999 999999999998653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=294.62 Aligned_cols=229 Identities=16% Similarity=0.196 Sum_probs=178.4
Q ss_pred hcCcccc-cccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHH-HhcCCCCccceeeeeec----CCc
Q 018816 59 INNYSMR-NITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFA-SQMNHKSILKLIGCCLE----AEM 131 (350)
Q Consensus 59 ~~~f~~~-~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~ 131 (350)
.++|... +.| |+|+||.||++.+ .++..||+|.+... ..+.+|+.++ +.++||||+++++++.+ ...
T Consensus 16 ~~~y~~~~~~l-g~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVL-GLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGTEEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccchhhcCccc-ccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 4567766 567 9999999999999 66779999998643 4567888888 55589999999999876 668
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCceeEcc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKLFD 208 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~D 208 (350)
.++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 8999999999999999975422 46899999999999999999999 899999999999999998 78899999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
||++.... +..++.++|||||||++|+|++|..||.......
T Consensus 164 fg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-------------- 205 (299)
T 3m2w_A 164 FGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------------- 205 (299)
T ss_dssp CTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------
T ss_pred cccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh--------------
Confidence 99886432 2446789999999999999999999997543210
Q ss_pred HHhcCCCccCccccCCCCccc--hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFR--KEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
........+ ..+...... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 206 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 206 ISPGMKTRI---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp --CCSCCSS---CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhHHHHHHH---hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000 000000000 0134578999999999999999999999997
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=315.00 Aligned_cols=243 Identities=14% Similarity=0.072 Sum_probs=180.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHHHHHHHHhcCC-CCccceeee---------
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFNNIVFASQMNH-KSILKLIGC--------- 125 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~~~~--------- 125 (350)
.+|...+.| |+|+||.||+|++ .++..||||.+..... ...+.+.+|+.++..++| +|......+
T Consensus 78 ~~~~~~~~L-G~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVL-GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEeccc-ccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 446677788 9999999999998 6677999999874332 235778999999999987 332211111
Q ss_pred ------------eec-----CCcCeEEeecCCCCchhhhhhCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCe
Q 018816 126 ------------CLE-----AEMPALVYEPAGYCTLADRLYGPL--QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPV 186 (350)
Q Consensus 126 ------------~~~-----~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 186 (350)
+.. ....+++|+++ +++|.+++..-. ......+++..++.++.||+.||.||| +++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 111 12356667665 689999884100 001146788899999999999999999 9999
Q ss_pred EeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCcccc----------ccCCCCccchhHHHHHH
Q 018816 187 VFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYL----------TTGYYNEKTDVYSFGKL 256 (350)
Q Consensus 187 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~i 256 (350)
+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998765432 334457 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHH
Q 018816 257 LLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI 336 (350)
Q Consensus 257 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 336 (350)
+|||++|+.||...... ......+.... ..++.+.+|+.+||+.||++|||+.
T Consensus 307 l~elltg~~Pf~~~~~~---------------------~~~~~~~~~~~------~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAAL---------------------GGSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHHHSSCCCCTTGGG---------------------SCSGGGGSSCC------CCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHCCCCCCCcchh---------------------hhHHHHHhhcc------cCCHHHHHHHHHHccCChhhCcCHH
Confidence 99999999999754321 01111111111 2346799999999999999999988
Q ss_pred HHHH
Q 018816 337 DVAK 340 (350)
Q Consensus 337 evl~ 340 (350)
++++
T Consensus 360 ~~l~ 363 (413)
T 3dzo_A 360 QAME 363 (413)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 8764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=299.99 Aligned_cols=243 Identities=11% Similarity=0.040 Sum_probs=182.1
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccc--------hhhHHHHHHHHHHHHhcC---------C-----
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSV--------RYASERCFNNIVFASQMN---------H----- 116 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~--------~~~~~~~~~E~~~l~~l~---------h----- 116 (350)
.++|...+.| |+|+||.||+|++ ++..||+|++.... ....+.+.+|+.+++.++ |
T Consensus 19 ~~~y~~~~~l-G~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKI-GEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEE-EEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeee-cccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4678888998 9999999999998 45699999997642 122377889999998886 4
Q ss_pred ------------CCccceeeeeec-------------CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHH
Q 018816 117 ------------KSILKLIGCCLE-------------AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMET 171 (350)
Q Consensus 117 ------------~niv~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i 171 (350)
|||+++++++.+ ....++||||+++|++.+.+.. ..+++..+..++.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHH
Confidence 555555555544 6789999999999987766643 458999999999999
Q ss_pred HHHHHHHHccCCCCeEeeccccCceEeCCCC--------------------ceeEcccCCCccCCCCCccccccccccCC
Q 018816 172 ANAVAYLRFGFPQPVVFRNIEPWNILFQEEY--------------------AAKLFDFSLSKSIPEGKTHIKASTAIGSL 231 (350)
Q Consensus 172 ~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 231 (350)
+.||.|||+ +.+|+||||||+|||++.++ .+||+|||+|+..... ..+||+
T Consensus 171 ~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 171 TASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 999999993 36899999999999999887 8999999999865432 335999
Q ss_pred CCCCccccccCCCCccchhHHHHHH-HHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccch
Q 018816 232 EFAAPEYLTTGYYNEKTDVYSFGKL-LLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRK 310 (350)
Q Consensus 232 ~y~aPE~~~~~~~~~~~DiwslG~i-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (350)
.|+|||++.+.. +.++|||||+++ .+++++|..||.... .................. ......
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~-------~~~~~~ 305 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--------WLHYLTDKMLKQMTFKTK-------CNTPAM 305 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--------HHHHHHHHHHHTCCCSSC-------CCSHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--------hhhHHHHhhhhhhccCcc-------cchhhh
Confidence 999999998766 899999998777 777888988864210 001111111111111110 011112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 018816 311 EEKLQAYVELAFKCLSHSAEDRPTMIDVA 339 (350)
Q Consensus 311 ~~~~~~l~~l~~~cl~~~P~~RPt~~evl 339 (350)
...++++.+|+.+||+.| |+.+++
T Consensus 306 ~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 367889999999999976 999888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-34 Score=276.61 Aligned_cols=183 Identities=16% Similarity=0.053 Sum_probs=129.4
Q ss_pred cCCCceEEEEEEE-CCCceEEEEEecccc----------hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeEEee
Q 018816 70 DEIEGYILYMGFL-RDRGPILVMKYRKSV----------RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 70 g~G~~g~V~~~~~-~~~~~vaik~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 137 (350)
+.|++|.+..++. -.+..+++|.+.... ....+++.+|+++|+++ .|+||++++++++++...|||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 5555655555444 345689999986531 23456799999999999 69999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|++|++|.++|... ++++.. +|+.||+.||.||| ++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 323 yv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 323 KLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp CCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred cCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999764 456654 58999999999999 99999999999999999999999999999987654
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTI 266 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p 266 (350)
... ...+.+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2344569999999999875 467789999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=246.53 Aligned_cols=185 Identities=11% Similarity=0.048 Sum_probs=146.7
Q ss_pred cccccccCCCceEEEEEEECCCceEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 64 MRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR--------YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 64 ~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
..+.| |+|+||.||+|...+ ..+++|+...... ...+++.+|+.++++++||||+++..++.+.+..++|
T Consensus 340 ~~~~L-G~G~fg~Vy~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLI-GKGAEADIKRDSYLD-FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECSS-CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEE-eeCCCEEEEEEEECC-CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 34566 999999999996555 4899998654321 1235588999999999999999777777788888999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++++|.+++.. +..++.|++.||.||| +++|+||||||+|||++. .+||+|||+++..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999999853 4689999999999999 899999999999999999 9999999999887
Q ss_pred CCCCccc-----cccccccCCCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 018816 216 PEGKTHI-----KASTAIGSLEFAAPEYLTT--GYYNEKTDVYSFGKLLLVLLTGRTIGH 268 (350)
Q Consensus 216 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~ 268 (350)
....... ......||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 5432211 1234569999999999987 568889999999999888888777653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-26 Score=202.76 Aligned_cols=149 Identities=15% Similarity=0.071 Sum_probs=118.8
Q ss_pred HHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccch------------------hhHHHHHHHHHHHHhcCCCC
Q 018816 57 TAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR------------------YASERCFNNIVFASQMNHKS 118 (350)
Q Consensus 57 ~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~------------------~~~~~~~~E~~~l~~l~h~n 118 (350)
.....|...+.| |+|+||.||+|.+.++..||+|.+..... .....+.+|+.++++++ |
T Consensus 87 ~~~~~~~~~~~i-G~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 87 RSGKVDAIGKLM-GEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HTTSCSEEEEEE-EECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred hCCeEEEecCEe-ccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 334455566888 99999999999997778999999864321 13456889999999999 5
Q ss_pred ccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe
Q 018816 119 ILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 119 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 198 (350)
+++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.||| +.+|+||||||+|||+
T Consensus 164 -~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl 226 (282)
T 1zar_A 164 -LAVPKVYA-WEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV 226 (282)
T ss_dssp -SSSCCEEE-EETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred -CCcCeEEe-ccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence 66666554 356799999999999988 421 123469999999999999 9999999999999999
Q ss_pred CCCCceeEcccCCCccCCCCCccccccccccCCCCCCcccccc
Q 018816 199 QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT 241 (350)
Q Consensus 199 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 241 (350)
+ ++.+||+|||+|.. +..+.|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 9 99999999999863 344678887753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-21 Score=169.58 Aligned_cols=138 Identities=13% Similarity=0.069 Sum_probs=105.3
Q ss_pred CcccccccccCCCceEEEEEEE-CCCce--EEEEEecccchh------------------------hHHHHHHHHHHHHh
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGP--ILVMKYRKSVRY------------------------ASERCFNNIVFASQ 113 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~--vaik~~~~~~~~------------------------~~~~~~~E~~~l~~ 113 (350)
-|.....| |+|+||.||+|.+ .++.. ||||.+...... ....+.+|+.++.+
T Consensus 48 ~~~i~~~i-g~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 48 ITAMGGVI-STGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp EEEEEEEE-EECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEE-eecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 35566777 9999999999999 67778 999987543111 12357899999999
Q ss_pred cCCCCc--cceeeeeecCCcCeEEeecCCC-C----chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCe
Q 018816 114 MNHKSI--LKLIGCCLEAEMPALVYEPAGY-C----TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPV 186 (350)
Q Consensus 114 l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i 186 (350)
+.|+++ +.++++ ...++||||+.+ | +|.+... ..++.....++.|++.||.|||. ..+|
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~--~~gi 192 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR--------ELKELDVEGIFNDVVENVKRLYQ--EAEL 192 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG--------GGGGSCHHHHHHHHHHHHHHHHH--TSCE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh--------ccChHHHHHHHHHHHHHHHHHHH--HCCE
Confidence 988764 333332 367899999942 3 6666542 12345678899999999999994 4689
Q ss_pred EeeccccCceEeCCCCceeEcccCCCccC
Q 018816 187 VFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 187 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2e-18 Score=157.74 Aligned_cols=138 Identities=9% Similarity=0.043 Sum_probs=98.8
Q ss_pred CcccccccccCCCceEEEEEEECCCceEEEEEecccch--------------hhHHH--------HHHHHHHHHhcCCCC
Q 018816 61 NYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR--------------YASER--------CFNNIVFASQMNHKS 118 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~n 118 (350)
-|.....| |+|++|.||+|...+|..||||.+..... ..... ..+|...|.++.+.+
T Consensus 96 iY~I~~~I-G~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRI-GVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEE-EECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEe-eeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 47788888 99999999999998888999998753210 00111 234566666664433
Q ss_pred ccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEe
Q 018816 119 ILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF 198 (350)
Q Consensus 119 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill 198 (350)
+.... .+ .....+|||||++|++|..+... .....++.||+.+|.+|| ..|||||||||.|||+
T Consensus 175 v~vp~-p~-~~~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 175 FPVPE-PI-AQSRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILI 238 (397)
T ss_dssp CSCCC-EE-EEETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred CCCCe-ee-eccCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEE
Confidence 32111 11 11234799999999888765321 123568899999999999 8999999999999999
Q ss_pred CCCC----------ceeEcccCCCccC
Q 018816 199 QEEY----------AAKLFDFSLSKSI 215 (350)
Q Consensus 199 ~~~~----------~~kl~Dfg~~~~~ 215 (350)
+.++ .+.|+||+.+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8876 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=7.7e-14 Score=122.06 Aligned_cols=147 Identities=10% Similarity=0.021 Sum_probs=114.2
Q ss_pred HHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCe
Q 018816 55 LKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 55 l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 133 (350)
+.....+|.....+ +.|+++.||++...+ +.+++|............+.+|+.+++.+. +.++.++++++.+.+..+
T Consensus 9 l~~~l~~~~~~~~~-~g~s~~~v~~~~~~~-~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 9 LKKLIEKYRCVKDT-EGMSPAKVYKLVGEN-ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHTTSEEEECC-SCCSSSEEEEEECSS-CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhccceeEeec-cCCCCCeEEEEECCC-CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34455678777777 888889999998664 599999986532223346889999999985 678889999998888899
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC-------------------------------
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF------------------------------- 182 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------- 182 (350)
+||||++|.+|.+.+.. ......++.+++.+|..||...
T Consensus 87 lv~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 99999999999876311 1223478899999999999610
Q ss_pred -------------------------CCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 183 -------------------------PQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 183 -------------------------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
...++|+|++|.||+++.+..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.6e-12 Score=113.28 Aligned_cols=139 Identities=13% Similarity=-0.027 Sum_probs=101.7
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCC--ccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKS--ILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~ 136 (350)
..++....+. +.|..+.||++...++..+++|..... ....+.+|+.+++.+.+.+ +.+++++..+++..++||
T Consensus 19 ~~~~~~~~~~-~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 19 LFGYDWAQQT-IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTCEEEECS-CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred cCCCceEecc-cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 3455544443 566679999998777778999997654 2245778999999886444 566888888777889999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC----------------------------------
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF---------------------------------- 182 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------- 182 (350)
||++|.+|. .. ... ...++.+++..|..||...
T Consensus 95 e~i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 95 GEVPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp ECCSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EecCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 999998884 21 111 1357788888888888421
Q ss_pred ---------------------CCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 183 ---------------------PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 183 ---------------------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
...++|+|++|.||+++.++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=1.8e-11 Score=111.93 Aligned_cols=141 Identities=11% Similarity=0.046 Sum_probs=106.6
Q ss_pred ccccccCCCceEEEEEEECCCceEEEEEec--ccch-hhHHHHHHHHHHHHhcC--CCCccceeeeeecC---CcCeEEe
Q 018816 65 RNITIDEIEGYILYMGFLRDRGPILVMKYR--KSVR-YASERCFNNIVFASQMN--HKSILKLIGCCLEA---EMPALVY 136 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~~~~~~vaik~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~ 136 (350)
...+ +.|.++.||+....++ .+++|+.. .... .....+.+|+.+++.+. +.++++++.++.+. +..++||
T Consensus 43 ~~~l-~~G~sn~~y~v~~~~~-~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQF-KGGQSNPTFKLVTPGQ-TYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEC-CC-CCSCEEEEECSSC-EEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEc-CCcccceEEEEEECCc-eEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3456 9999999999988664 88888876 3321 23456888999999997 45688899988776 3589999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC----------------------------------
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF---------------------------------- 182 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------- 182 (350)
||++|.++.+... ..++......++.+++..|..||...
T Consensus 121 e~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp ECCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999888754221 35678888999999999999999621
Q ss_pred ---------------------CCCeEeeccccCceEeCCCCc--eeEcccCCCcc
Q 018816 183 ---------------------PQPVVFRNIEPWNILFQEEYA--AKLFDFSLSKS 214 (350)
Q Consensus 183 ---------------------~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~ 214 (350)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=6.6e-11 Score=105.68 Aligned_cols=184 Identities=17% Similarity=0.131 Sum_probs=121.6
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCC--ccceeeeeecCC---cCeEEeecCC
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKS--ILKLIGCCLEAE---MPALVYEPAG 140 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~ 140 (350)
.+ +.|....||+.. ..+++|..... .....+.+|..++..+. +.. +.+++....... ..++||++++
T Consensus 27 ~~-~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 27 IS-GEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp EE-EECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred ec-CCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 45 899999999864 47888886543 34567889999998884 333 445555443333 4588999999
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC--------------------------------------
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF-------------------------------------- 182 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 182 (350)
|.+|.+... ..++..++..++.+++..+..||...
T Consensus 100 G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 100 GVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 998876432 34677778888888888888888511
Q ss_pred -----------------CCCeEeeccccCceEeCC--CCceeEcccCCCccCCCCCccccccccccCCCCCCcccccc--
Q 018816 183 -----------------PQPVVFRNIEPWNILFQE--EYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-- 241 (350)
Q Consensus 183 -----------------~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 241 (350)
...++|+|++|.||+++. ...+.|+||+.+............... . .-.+|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~--~-~~~~~~~~~~~l 249 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED--D-EEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT--T-TSCCHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh--c-cccCHHHHHHHH
Confidence 135899999999999998 556789999988654321110000000 0 0012221110
Q ss_pred ---CC---------CCccchhHHHHHHHHHHHhCCCCC
Q 018816 242 ---GY---------YNEKTDVYSFGKLLLVLLTGRTIG 267 (350)
Q Consensus 242 ---~~---------~~~~~DiwslG~il~el~tg~~p~ 267 (350)
+. ...-.+.|+++.++|.+.+|..++
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 112368899999999999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1.4e-07 Score=84.13 Aligned_cols=134 Identities=11% Similarity=0.042 Sum_probs=94.4
Q ss_pred ccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCC---Cccceeeeee-cCCcCeEEeecCCCC
Q 018816 67 ITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHK---SILKLIGCCL-EAEMPALVYEPAGYC 142 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~~ 142 (350)
.+ +.|....||+. ++.+++|.... ......+.+|..+|..+.+. .+.+++.++. ..+..++|||+++|.
T Consensus 26 ~l-~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 26 SL-GEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EE-EECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred ec-CCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45 88888899988 45788888532 23456788999999999742 3566666664 445678999999998
Q ss_pred chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcc-----------------------------------------
Q 018816 143 TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFG----------------------------------------- 181 (350)
Q Consensus 143 sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------------------------------------- 181 (350)
++.+... ..++..+...++.+++..|..||..
T Consensus 99 ~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 99 ILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp ECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 8876432 2344555555666666666666532
Q ss_pred ----------------CCCCeEeeccccCceEeCC---CCc-eeEcccCCCcc
Q 018816 182 ----------------FPQPVVFRNIEPWNILFQE---EYA-AKLFDFSLSKS 214 (350)
Q Consensus 182 ----------------~~~~ivH~dlkp~Nill~~---~~~-~kl~Dfg~~~~ 214 (350)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335799999999999987 355 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=1.8e-07 Score=81.58 Aligned_cols=133 Identities=10% Similarity=-0.034 Sum_probs=94.8
Q ss_pred cCCCc-eEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEeecCCCCchhh
Q 018816 70 DEIEG-YILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAGYCTLAD 146 (350)
Q Consensus 70 g~G~~-g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~ 146 (350)
..|.. +.||+... .++..+++|.-... ....+.+|...|+.+. +-.+.++++++.+++..++|||+++|.++.+
T Consensus 33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 33 NVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp ECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred cCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 44444 47999877 45557888876443 3456888999998884 4457888999998889999999999988877
Q ss_pred hhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC--------------------------------------------
Q 018816 147 RLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF-------------------------------------------- 182 (350)
Q Consensus 147 ~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------- 182 (350)
..... ......+..+++..|..||...
T Consensus 110 ~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 110 VLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 54221 1222345566666666666210
Q ss_pred -----------CCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 183 -----------PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 183 -----------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999887778999997753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=2.5e-07 Score=84.15 Aligned_cols=77 Identities=5% Similarity=-0.095 Sum_probs=53.1
Q ss_pred cCCCceEEEEEEEC-------CCceEEEEEecccc---hhhHHHHHHHHHHHHhcC-C--CCccceeeeeecC---CcCe
Q 018816 70 DEIEGYILYMGFLR-------DRGPILVMKYRKSV---RYASERCFNNIVFASQMN-H--KSILKLIGCCLEA---EMPA 133 (350)
Q Consensus 70 g~G~~g~V~~~~~~-------~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~---~~~~ 133 (350)
+.|....+|+.... ++..+++|...... ......+.+|+.+++.+. + ..+.+++.++.+. ...+
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~ 109 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPF 109 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCE
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCce
Confidence 66777899988764 24578888765432 111245778888888884 3 3577788877665 3568
Q ss_pred EEeecCCCCchhh
Q 018816 134 LVYEPAGYCTLAD 146 (350)
Q Consensus 134 lv~e~~~~~sL~~ 146 (350)
+||||++|.++.+
T Consensus 110 ~v~e~l~G~~l~~ 122 (357)
T 3ats_A 110 FLMDYVEGVVPPD 122 (357)
T ss_dssp EEEECCCCBCCCB
T ss_pred EEEEecCCCChhh
Confidence 9999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=7.2e-06 Score=75.66 Aligned_cols=75 Identities=7% Similarity=0.031 Sum_probs=49.1
Q ss_pred cccccCCCceEEEEEEEC-CCceEEEEEecccch-------hhHHHHHHHHHHHHhcCC--CC-ccceeeeeecCCcCeE
Q 018816 66 NITIDEIEGYILYMGFLR-DRGPILVMKYRKSVR-------YASERCFNNIVFASQMNH--KS-ILKLIGCCLEAEMPAL 134 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~-~~~~vaik~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~~~~~~l 134 (350)
..+ |.|..+.||++... ++..+++|....... ...+++..|..++..+.. |. +.+++.+ +.+..++
T Consensus 36 ~~l-g~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 36 QEI-GDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEC-CSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEC-CCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 345 99999999999763 456899998653221 123456789888888742 33 4455544 4456789
Q ss_pred EeecCCCCc
Q 018816 135 VYEPAGYCT 143 (350)
Q Consensus 135 v~e~~~~~s 143 (350)
|||++++..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.22 E-value=1.6e-05 Score=71.44 Aligned_cols=140 Identities=6% Similarity=-0.030 Sum_probs=78.8
Q ss_pred cCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC--CCCccceee------eeecCCcCeEEeecCCC
Q 018816 70 DEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN--HKSILKLIG------CCLEAEMPALVYEPAGY 141 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~------~~~~~~~~~lv~e~~~~ 141 (350)
+.|..+.||+....++ .+++|...... ..+..|..++..|. .-.+.+++. +....+..+++|+|++|
T Consensus 41 ~gG~~n~~~~v~~~~~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 41 QGNQMALVWKVHTDSG-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp C----CEEEEEEETTE-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred cccccCcEEEEEeCCC-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 6678899999988766 68899887531 33344555555553 112333333 11245567899999998
Q ss_pred Cchh--------------hhhhCCCCCC--C-------CCCCHHHH-------------------------------HHH
Q 018816 142 CTLA--------------DRLYGPLQTH--L-------EPLLLTHR-------------------------------LKV 167 (350)
Q Consensus 142 ~sL~--------------~~l~~~~~~~--~-------~~~~~~~~-------------------------------~~i 167 (350)
.++. ..++...... . ....|... ..+
T Consensus 116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (346)
T 2q83_A 116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF 195 (346)
T ss_dssp BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence 6542 0111100000 0 01122211 011
Q ss_pred HHHHHHHHHHHHc----------cCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 168 AMETANAVAYLRF----------GFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 168 ~~~i~~~l~~LH~----------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
...+..++.+|+. .....++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1223345666652 1257899999999999998888899999997653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.00 E-value=5.4e-05 Score=67.34 Aligned_cols=139 Identities=7% Similarity=-0.074 Sum_probs=90.0
Q ss_pred cccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC---CCCccceeeeeecCCcCeEEeecCCCC
Q 018816 66 NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN---HKSILKLIGCCLEAEMPALVYEPAGYC 142 (350)
Q Consensus 66 ~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~~ 142 (350)
..+ +.|....+|+.... ++.+++|..... ....+..|...|+.|. ...+++++.++...+..++||||+++.
T Consensus 42 ~~l-~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 42 EKL-YSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEE-CCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred EEe-CCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 346 99999999999875 448888887543 2456888999888884 366888888888778899999999987
Q ss_pred chhh-----------hhhCCCC-CCC--------C--------CCCHHHHH---HHH----------------HHHHHH-
Q 018816 143 TLAD-----------RLYGPLQ-THL--------E--------PLLLTHRL---KVA----------------METANA- 174 (350)
Q Consensus 143 sL~~-----------~l~~~~~-~~~--------~--------~~~~~~~~---~i~----------------~~i~~~- 174 (350)
.+.. .++.... ..+ + .-+|.... ++. ..++..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6421 1222111 000 0 11343221 111 112211
Q ss_pred HHHHH-ccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 175 VAYLR-FGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 175 l~~LH-~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
...|. ......++|+|+.+.|++++.++ +.|+|++
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22332 12246799999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.85 E-value=0.00013 Score=67.85 Aligned_cols=79 Identities=14% Similarity=0.034 Sum_probs=46.6
Q ss_pred CCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccC---CCCccchhHHHHHHHHH
Q 018816 183 PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG---YYNEKTDVYSFGKLLLV 259 (350)
Q Consensus 183 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~e 259 (350)
...++|+|++|.|||++.++ +.|+||+.+............ ...-...|++|+..... .-....++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAY-LGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHH-HHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHH-HHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 67899999999999998876 999999988754221110000 00011234555544311 11123455577777777
Q ss_pred HHhC
Q 018816 260 LLTG 263 (350)
Q Consensus 260 l~tg 263 (350)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7664
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00069 Score=60.38 Aligned_cols=165 Identities=15% Similarity=0.150 Sum_probs=92.6
Q ss_pred CCcccccHHHHHHHhcCcccc-----cccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCC--C
Q 018816 45 NPIRSFSSEDLKTAINNYSMR-----NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNH--K 117 (350)
Q Consensus 45 ~~~~~~~~~~l~~~~~~f~~~-----~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h--~ 117 (350)
.+...++.+++......|... ..+ + |....||+....++..+++|...... .....+..|..++..+.. -
T Consensus 6 ~~~~~l~~~~i~~~l~~~g~~~~~~~~~l-~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~ 82 (328)
T 1zyl_A 6 FTFQTLHPDTIMDALFEHGIRVDSGLTPL-N-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEV 82 (328)
T ss_dssp CCCCCCCHHHHHHHHHHTTCCCCSCCEEE-C-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCCHHHHHHHHHHcCCCCCceEEee-c-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCC
Confidence 345567777776665555331 234 6 77789999887666689999986432 123556678888877742 2
Q ss_pred Cccceeee-----eecCCcCeEEeecCCCCchhh-----------h---hhC---CC-CCCCCCCCHHHH----------
Q 018816 118 SILKLIGC-----CLEAEMPALVYEPAGYCTLAD-----------R---LYG---PL-QTHLEPLLLTHR---------- 164 (350)
Q Consensus 118 niv~~~~~-----~~~~~~~~lv~e~~~~~sL~~-----------~---l~~---~~-~~~~~~~~~~~~---------- 164 (350)
.+++++.. ....+..+++|++++|.++.. . ++. .. .......++...
T Consensus 83 ~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 162 (328)
T 1zyl_A 83 PVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFED 162 (328)
T ss_dssp SBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHT
T ss_pred eecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhh
Confidence 24444443 112334578999998765421 0 111 00 000011222111
Q ss_pred ------------HHHHHHHHHHHHHHHc-cCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 165 ------------LKVAMETANAVAYLRF-GFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 165 ------------~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
...+..++..+.-+-. .....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 163 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111122222222110 1245689999999999999 4 899999987754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00012 Score=64.67 Aligned_cols=72 Identities=11% Similarity=-0.004 Sum_probs=44.5
Q ss_pred ccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCc-cceeeeeecCCcCeEEeecC-CCC
Q 018816 65 RNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSI-LKLIGCCLEAEMPALVYEPA-GYC 142 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~~ 142 (350)
...| +.|....+|+. ..+++|........ .....+|+.++..+....+ .+++++. .+.-++++||+ ++.
T Consensus 23 i~~l-~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLER-LGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEE-ESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEc-CCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 3456 88999999998 47888887654221 1123467777777742222 4555543 33457899999 665
Q ss_pred chh
Q 018816 143 TLA 145 (350)
Q Consensus 143 sL~ 145 (350)
++.
T Consensus 94 ~l~ 96 (301)
T 3dxq_A 94 TMS 96 (301)
T ss_dssp ECC
T ss_pred cCC
Confidence 553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00017 Score=63.19 Aligned_cols=79 Identities=11% Similarity=0.013 Sum_probs=56.1
Q ss_pred CcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCC---CCccceeeeeecCCcCeEEee
Q 018816 61 NYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNH---KSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e 137 (350)
.......+ |.|..+.||+.+..+|+.|++|+...........+..|...|+.|.- -.+.+++++. ..++|||
T Consensus 16 ~v~~v~~~-g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAER-GHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEE-EEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEec-CCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34444566 99999999999998888999998755443334567889999998842 2345555442 3479999
Q ss_pred cCCCCch
Q 018816 138 PAGYCTL 144 (350)
Q Consensus 138 ~~~~~sL 144 (350)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9976643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00085 Score=59.62 Aligned_cols=162 Identities=13% Similarity=0.100 Sum_probs=89.5
Q ss_pred cccHHHHHHHhcCcccc-----cccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCC--ccc
Q 018816 49 SFSSEDLKTAINNYSMR-----NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKS--ILK 121 (350)
Q Consensus 49 ~~~~~~l~~~~~~f~~~-----~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 121 (350)
.++.+++......|... ..+ +.|....+|+....++ .+++|..... ...+.+..|+.++..|.... +.+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i-~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGI-AEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEE-CC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeecc-CCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 36667777666666542 234 7788889999988766 7889988653 12234566777777774212 333
Q ss_pred eeee------eecCCcCeEEeecCCCCchhh--------------hhhCCCCCCCC----CC---CHHHHHH--------
Q 018816 122 LIGC------CLEAEMPALVYEPAGYCTLAD--------------RLYGPLQTHLE----PL---LLTHRLK-------- 166 (350)
Q Consensus 122 ~~~~------~~~~~~~~lv~e~~~~~sL~~--------------~l~~~~~~~~~----~~---~~~~~~~-------- 166 (350)
++.. ....+..+++++|++|..+.. .++........ .. .|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 112345689999998765421 01110000000 01 1211100
Q ss_pred ----HHHHHHHHHHHHHcc----CCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 167 ----VAMETANAVAYLRFG----FPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 167 ----i~~~i~~~l~~LH~~----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
+...+...+..+... ...+++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011133445555421 135799999999999999876668999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00036 Score=64.96 Aligned_cols=71 Identities=14% Similarity=0.086 Sum_probs=48.1
Q ss_pred ccccCCCceEEEEEEECC--------CceEEEEEecccchhhHHHHHHHHHHHHhcCCCC-ccceeeeeecCCcCeEEee
Q 018816 67 ITIDEIEGYILYMGFLRD--------RGPILVMKYRKSVRYASERCFNNIVFASQMNHKS-ILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~--------~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 137 (350)
.| +.|....||+....+ +..+++|...... ..+.+.+|..++..|...+ ..++++.+.+ .+|+|
T Consensus 80 ~l-~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 80 RI-KGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EE-CCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred Ee-CCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 45 888889999998753 3578888874321 1145567999888885333 3566766543 38999
Q ss_pred cCCCCch
Q 018816 138 PAGYCTL 144 (350)
Q Consensus 138 ~~~~~sL 144 (350)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00045 Score=61.86 Aligned_cols=141 Identities=12% Similarity=0.006 Sum_probs=72.9
Q ss_pred cCCCceE-EEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCC--CCccceeeeeecCCcCeEEeecCCCCchhh
Q 018816 70 DEIEGYI-LYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNH--KSILKLIGCCLEAEMPALVYEPAGYCTLAD 146 (350)
Q Consensus 70 g~G~~g~-V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~sL~~ 146 (350)
+.|+... +|+....+++.+++|...... ...+..|+.++..+.. -.+.+++.+..+. .+++||++++.++.+
T Consensus 27 ~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~~ 101 (333)
T 3csv_A 27 AGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFTE 101 (333)
T ss_dssp -------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHHH
T ss_pred CCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchHH
Confidence 5554443 677766435577776544321 1234556777776642 2355666653332 378999997766654
Q ss_pred hhhCCC---------------------CCCCCCCCHHHHH-------HH-------------HHHHHHHHHHHH---ccC
Q 018816 147 RLYGPL---------------------QTHLEPLLLTHRL-------KV-------------AMETANAVAYLR---FGF 182 (350)
Q Consensus 147 ~l~~~~---------------------~~~~~~~~~~~~~-------~i-------------~~~i~~~l~~LH---~~~ 182 (350)
++.... ......+...... .+ ...+...+..+. ...
T Consensus 102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~ 181 (333)
T 3csv_A 102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG 181 (333)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence 432110 0001112111100 00 001111222221 112
Q ss_pred CCCeEeeccccCceEeCCC----CceeEcccCCCccC
Q 018816 183 PQPVVFRNIEPWNILFQEE----YAAKLFDFSLSKSI 215 (350)
Q Consensus 183 ~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~ 215 (350)
...++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999874 67899999988654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00057 Score=64.04 Aligned_cols=73 Identities=14% Similarity=-0.031 Sum_probs=46.5
Q ss_pred ccccCCCceEEEEEEECC-CceEEEEEecccchhhHHHHHHHHHHHHhcCCCCc-cceeeeeecCCcCeEEeecCCCCch
Q 018816 67 ITIDEIEGYILYMGFLRD-RGPILVMKYRKSVRYASERCFNNIVFASQMNHKSI-LKLIGCCLEAEMPALVYEPAGYCTL 144 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~-~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~sL 144 (350)
.| +.|-...+|+....+ +..+++|......... -...+|..++..|...++ .++++.+.+ .+||||++|.+|
T Consensus 115 ~l-sgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 II-NGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EE-CC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred Ec-CCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 45 788889999999865 4578888764432111 112478899998864444 567776632 369999987655
Q ss_pred h
Q 018816 145 A 145 (350)
Q Consensus 145 ~ 145 (350)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00074 Score=61.63 Aligned_cols=140 Identities=16% Similarity=0.105 Sum_probs=81.6
Q ss_pred cCCCceEEEEEEECC--------CceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEeecCC
Q 018816 70 DEIEGYILYMGFLRD--------RGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAG 140 (350)
Q Consensus 70 g~G~~g~V~~~~~~~--------~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 140 (350)
..|-...+|+....+ +..+++++.-... .......+|..+++.|. +.-..++++.+.+ .+||||++
T Consensus 59 sGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~ 133 (379)
T 3feg_A 59 SGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIP 133 (379)
T ss_dssp -----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCS
T ss_pred CCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEec
Confidence 778888999998742 3578888863321 23455668999998884 3334667766654 29999999
Q ss_pred CCchhhh-----------------hhCCCCCCCCCCC--HHHHHHHHHHHHH-------------------HHHHHH---
Q 018816 141 YCTLADR-----------------LYGPLQTHLEPLL--LTHRLKVAMETAN-------------------AVAYLR--- 179 (350)
Q Consensus 141 ~~sL~~~-----------------l~~~~~~~~~~~~--~~~~~~i~~~i~~-------------------~l~~LH--- 179 (350)
|.+|..- ++........... +.+..++..++.. .+..|.
T Consensus 134 G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L 213 (379)
T 3feg_A 134 SRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLL 213 (379)
T ss_dssp EEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHH
T ss_pred CccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHH
Confidence 8665421 1111000011222 3445555544322 123332
Q ss_pred -c-cCCCCeEeeccccCceEeCCC----CceeEcccCCCcc
Q 018816 180 -F-GFPQPVVFRNIEPWNILFQEE----YAAKLFDFSLSKS 214 (350)
Q Consensus 180 -~-~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~ 214 (350)
. .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 214 ~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 214 ESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 124579999999999999876 7899999987753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00068 Score=56.18 Aligned_cols=101 Identities=14% Similarity=0.006 Sum_probs=65.5
Q ss_pred CCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCc
Q 018816 141 YCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220 (350)
Q Consensus 141 ~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 220 (350)
..||.+.|.... .++++.+++.++.|.+.+|.-+-.. ..-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 32 ALSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred cccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------
Confidence 347888886543 6899999999999999998877211 1111333457899999999988775 2111
Q ss_pred cccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhC
Q 018816 221 HIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG 263 (350)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 263 (350)
.....+.|||... ...+.+.-|||||+++|.-+-=
T Consensus 98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0223355788653 3456888999999999987763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0019 Score=58.09 Aligned_cols=68 Identities=9% Similarity=-0.072 Sum_probs=43.9
Q ss_pred cCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC---CCCccceeee------eecCCcCeEEeecCC
Q 018816 70 DEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN---HKSILKLIGC------CLEAEMPALVYEPAG 140 (350)
Q Consensus 70 g~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~------~~~~~~~~lv~e~~~ 140 (350)
|.|....||+....++ .+++|....... ..|+.++..|. -|++++.+.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444689999988777 899998765431 34666666553 2224454432 223456789999999
Q ss_pred CCch
Q 018816 141 YCTL 144 (350)
Q Consensus 141 ~~sL 144 (350)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0008 Score=61.18 Aligned_cols=72 Identities=15% Similarity=-0.023 Sum_probs=43.0
Q ss_pred ccccCCCceEEEEEEECC---------CceEEEEEecccchhhHHHHHHHHHHHHhcCCCC-ccceeeeeecCCcCeEEe
Q 018816 67 ITIDEIEGYILYMGFLRD---------RGPILVMKYRKSVRYASERCFNNIVFASQMNHKS-ILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~---------~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 136 (350)
.+ +.|....+|+....+ +..+++|........ ......|..++..+...+ +.++++.. .-++||
T Consensus 40 ~l-~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 40 QI-LSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EC-----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred Ee-CCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 34 788888999998754 247888876543221 112357888888775333 44666543 237899
Q ss_pred ecCCCCch
Q 018816 137 EPAGYCTL 144 (350)
Q Consensus 137 e~~~~~sL 144 (350)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.016 Score=53.60 Aligned_cols=72 Identities=13% Similarity=-0.087 Sum_probs=46.4
Q ss_pred ccccCCCceEEEEEEECC--------CceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEee
Q 018816 67 ITIDEIEGYILYMGFLRD--------RGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~--------~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 137 (350)
.+ ..|-...+|+....+ +..++++..-..... .-...+|..+++.+. +.-..++++.+. -++|||
T Consensus 77 ~l-sGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 77 QI-FSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EE-CCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred Ec-CCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 45 778888999999853 457888886443211 112347888888774 333455555332 378999
Q ss_pred cCCCCch
Q 018816 138 PAGYCTL 144 (350)
Q Consensus 138 ~~~~~sL 144 (350)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.46 E-value=0.14 Score=46.81 Aligned_cols=30 Identities=27% Similarity=0.315 Sum_probs=25.2
Q ss_pred CeEeeccccCceEe------CCCCceeEcccCCCcc
Q 018816 185 PVVFRNIEPWNILF------QEEYAAKLFDFSLSKS 214 (350)
Q Consensus 185 ~ivH~dlkp~Nill------~~~~~~kl~Dfg~~~~ 214 (350)
.++|+|+.+.|||+ +.+..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4567799999998754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.08 E-value=0.3 Score=40.30 Aligned_cols=115 Identities=9% Similarity=0.078 Sum_probs=78.2
Q ss_pred CCCCccceeeeeecCCcCeEEeecCCCC-chhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeecccc
Q 018816 115 NHKSILKLIGCCLEAEMPALVYEPAGYC-TLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEP 193 (350)
Q Consensus 115 ~h~niv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 193 (350)
.||+++.. .+-.+.+.+.+.++.-+.+ ++.. + ...+...+++++..|+....+++ .-+|--|.|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i--------k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P 107 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I--------KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAP 107 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G--------GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H--------HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEec
Confidence 47888766 4555566666666654422 3333 3 56889999999999998886666 347888999
Q ss_pred CceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 018816 194 WNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGH 268 (350)
Q Consensus 194 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 268 (350)
+|++++.++.+++.-.|+...+ +|. .++...=.-.+=+++..+++++..|.
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999988864322 121 11111222357778888999988765
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.04 E-value=0.39 Score=39.75 Aligned_cols=114 Identities=13% Similarity=0.174 Sum_probs=76.1
Q ss_pred CCCCccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHccCCCCeEeecccc
Q 018816 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVA-YLRFGFPQPVVFRNIEP 193 (350)
Q Consensus 115 ~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~dlkp 193 (350)
.||++ -..+-.+.+.+.+.++.-+++.=...+ ..++...+++++..|+.... +++ .-+|--|.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence 47777 334445666666666665444333344 45788999999999988777 555 457888999
Q ss_pred CceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhH-HHHHHHHHHHhCCCCCC
Q 018816 194 WNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVY-SFGKLLLVLLTGRTIGH 268 (350)
Q Consensus 194 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw-slG~il~el~tg~~p~~ 268 (350)
+|++++.++.+++.-.|+-..+ +|.-+ ...|.| .+=+++..++.++..|.
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~l-------------------pP~e~------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESL-------------------PPDEW------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTB-------------------SSCSC------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred ceEEEeCCCcEEEEEcCCcccC-------------------CCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999988864322 22211 112332 46677788888877654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.79 E-value=0.1 Score=48.83 Aligned_cols=54 Identities=7% Similarity=-0.127 Sum_probs=14.4
Q ss_pred ceEEEEEEECC-CceEEE------EEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeee
Q 018816 74 GYILYMGFLRD-RGPILV------MKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCL 127 (350)
Q Consensus 74 ~g~V~~~~~~~-~~~vai------k~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 127 (350)
||.||+|.+.. ..+||+ |....... .....+.+|..++..++|||+++.+++..
T Consensus 152 fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 152 YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 99999999943 358888 76654321 23346788999999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 350 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-30 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-30 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-29 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-29 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-29 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-29 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-28 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-28 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-27 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-27 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-26 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-26 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-25 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-24 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-24 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-24 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-23 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-23 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-23 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-23 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-23 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-22 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-22 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-21 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-20 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-19 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-19 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-19 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-19 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-18 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-17 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-17 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-17 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-17 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-16 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-16 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-16 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-15 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-14 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-14 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-13 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-11 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-10 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-10 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-10 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-36
Identities = 52/274 (18%), Positives = 102/274 (37%), Gaps = 28/274 (10%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137
Y G + ++ + N + + H +IL +G A A+V +
Sbjct: 25 YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 83
Query: 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
+L L+ + + +A +TA + YL + ++ R+++ NI
Sbjct: 84 WCEGSSLYHHLHI----IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIF 136
Query: 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFG 254
E+ K+ DF L+ + GS+ + APE + Y+ ++DVY+FG
Sbjct: 137 LHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG 196
Query: 255 KLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKL 314
+L L+TG+ + + ++ I G + P + RS K
Sbjct: 197 IVLYELMTGQL------------PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA--- 241
Query: 315 QAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348
L +CL ++RP + + + R+
Sbjct: 242 --MKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-33
Identities = 52/268 (19%), Positives = 109/268 (40%), Gaps = 30/268 (11%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137
++G+ ++ + + R+ + E +++H +++L G CLE LV+E
Sbjct: 22 HLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80
Query: 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
+ L+D L L + ++ +AYL V+ R++ N L
Sbjct: 81 FMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEGMAYL---EEACVIHRDLAARNCL 133
Query: 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
E K+ DF +++ + + + T +++A+PE + Y+ K+DV+SFG L+
Sbjct: 134 VGENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVKWASPEVFSFSRYSSKSDVWSFGVLM 192
Query: 258 LVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAY 317
+ + I + +R SN + + + S G+ P +
Sbjct: 193 WEVFSEGKIPYENR-----SNSEVVEDI-----STGFRLYKPRLASTH-----------V 231
Query: 318 VELAFKCLSHSAEDRPTMIDVAKKLRQM 345
++ C EDRP + ++L ++
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (293), Expect = 4e-31
Identities = 54/317 (17%), Positives = 112/317 (35%), Gaps = 44/317 (13%)
Query: 47 IRSFSSEDLKTAINNYS----MRNITIDEIEGY----ILYMGFLRDRG----PILVMKYR 94
I F+ ED A+ ++ + + I+++ G + G L+ G + + +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 95 KSVRYASERCFNN-IVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQ 153
R F + Q +H +++ L G ++ ++ E +L L
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 154 THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213
+ + A + YL V R++ NIL K+ DF LS+
Sbjct: 124 QFTVI----QLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 214 SIPEGKTHIKASTAIG---SLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLS 270
+ + + ++A+G + + APE + + +DV+S+G ++ +++
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----E 231
Query: 271 RLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAE 330
R +N + + +E+ R M+ A +L C
Sbjct: 232 RPYWDMTNQDVINAIEQDYRLPPPMDCPS----------------ALHQLMLDCWQKDRN 275
Query: 331 DRPTMIDVAKKLRQMYR 347
RP + L +M R
Sbjct: 276 HRPKFGQIVNTLDKMIR 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 2e-30
Identities = 63/293 (21%), Positives = 115/293 (39%), Gaps = 39/293 (13%)
Query: 66 NITIDEIE----GY-ILYMGFLRDRG---PILVMKYRKSVRYASERCFNN-IVFASQMNH 116
N+ I +IE + + G R R + + ++ A Q+++
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 117 KSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVA 176
I++LIG C +AE LV E AG L L G E + +++ ++ + + +
Sbjct: 69 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMK 123
Query: 177 YLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI-GSLEFAA 235
YL + V R++ N+L + AK+ DF LSK++ ++ A +A L++ A
Sbjct: 124 YLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 236 PEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295
PE + ++ ++DV+S+G + L+ + V FI M
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYG------QKPYKKMKG---PEVMAFIEQGKRM 231
Query: 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348
P L C + EDRP + V +++R Y +
Sbjct: 232 ECPPEC------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 4e-30
Identities = 51/272 (18%), Positives = 105/272 (38%), Gaps = 30/272 (11%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137
+MG+ + V ++ + + Q+ H+ +++L + E ++ E
Sbjct: 30 WMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87
Query: 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
+L D L P L + L +A + A +A++ + + R++ NIL
Sbjct: 88 YMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANIL 141
Query: 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
+ + K+ DF L++ I + + + A +++ APE + G + K+DV+SFG LL
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 258 LVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAY 317
++ T G + + I++ + R + +
Sbjct: 201 TEIV------------THGRIPYPGMTNPEVIQN---------LERGYRMVRPDNCPEEL 239
Query: 318 VELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349
+L C EDRPT + L + +
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 6e-30
Identities = 40/284 (14%), Positives = 91/284 (32%), Gaps = 34/284 (11%)
Query: 78 YMGFLRDRGPILVMK-YRKSVRYASERCFNN-IVFASQMNHKSILKLIGCCLEAEMPALV 135
+ + G ++ K ++ A + + N I+ G ++
Sbjct: 23 FKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82
Query: 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWN 195
E +L L + KV++ + YLR ++ R+++P N
Sbjct: 83 MEHMDGGSLDQVLK-----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSN 135
Query: 196 ILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGK 255
IL KL DF +S + + + + +G+ + +PE L +Y+ ++D++S G
Sbjct: 136 ILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGL 191
Query: 256 LLLVLLTGR---------------------TIGHLSRLATGGSNFFITDRVEKFIRSNGY 294
L+ + GR + ++ +
Sbjct: 192 SLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIF 251
Query: 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
+D ++ + + KCL + +R + +
Sbjct: 252 ELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 1e-29
Identities = 50/282 (17%), Positives = 103/282 (36%), Gaps = 28/282 (9%)
Query: 83 RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA----LVYEP 138
+ RG + +K S S I + H++IL I + LV +
Sbjct: 23 KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82
Query: 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYL-----RFGFPQPVVFRNIEP 193
+ +L D L + + + +K+A+ TA+ +A+L + R+++
Sbjct: 83 HEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136
Query: 194 WNILFQEEYAAKLFDFSLSKSIPEGK--THIKASTAIGSLEFAAPEYLTT------GYYN 245
NIL ++ + D L+ I + +G+ + APE L
Sbjct: 137 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 196
Query: 246 EKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFI--TDRVEKFIRSNGYMNIDPVIVG 303
++ D+Y+ G + + +IG + + VE+ + + P I
Sbjct: 197 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 256
Query: 304 DRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
++ E L+ ++ +C + R T + + K L Q+
Sbjct: 257 R---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-29
Identities = 37/268 (13%), Positives = 97/268 (36%), Gaps = 30/268 (11%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137
G R + + + ++ + + ++H+ +++L G C + ++ E
Sbjct: 21 KYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79
Query: 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
L + L L++ + A+ YL + + R++ N L
Sbjct: 80 YMANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCL 132
Query: 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
++ K+ DF LS+ + + + + + + ++ PE L ++ K+D+++FG L+
Sbjct: 133 VNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 191
Query: 258 LVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAY 317
+ + +N + + + G P + ++
Sbjct: 192 WEIYSLG-----KMPYERFTNSETAEHIAQ-----GLRLYRPHLASEK-----------V 230
Query: 318 VELAFKCLSHSAEDRPTMIDVAKKLRQM 345
+ + C A++RPT + + +
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (277), Expect = 7e-29
Identities = 52/272 (19%), Positives = 101/272 (37%), Gaps = 28/272 (10%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137
Y G + + +K K E ++ H ++++L+G C ++ E
Sbjct: 34 YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93
Query: 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
Y L D L + + + + L +A + ++A+ YL + + R++ N L
Sbjct: 94 FMTYGNLLDYLR---ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCL 147
Query: 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
E + K+ DF LS+ + A +++ APE L ++ K+DV++FG LL
Sbjct: 148 VGENHLVKVADFGLSRLMTGDTYTAHAGAK-FPIKWTAPESLAYNKFSIKSDVWAFGVLL 206
Query: 258 LVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAY 317
+ T + ++ D R E +
Sbjct: 207 WEIATYG---------------------MSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245
Query: 318 VELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349
EL C + DRP+ ++ + M++ S
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 9e-29
Identities = 54/275 (19%), Positives = 104/275 (37%), Gaps = 36/275 (13%)
Query: 78 YMGFLRDRGP-----ILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132
G+ + + + ++K + + Q+++ I+++IG C EAE
Sbjct: 24 KKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 82
Query: 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIE 192
LV E A L L + + +++ + + + YL V R++
Sbjct: 83 MLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLA 134
Query: 193 PWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI-GSLEFAAPEYLTTGYYNEKTDVY 251
N+L ++ AK+ DF LSK++ + + KA T +++ APE + ++ K+DV+
Sbjct: 135 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 194
Query: 252 SFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKE 311
SFG L+ + + G V + M
Sbjct: 195 SFGVLMWEAFSYG------QKPYRGMKG---SEVTAMLEKGERMGCPAGCP--------- 236
Query: 312 EKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMY 346
+ +L C ++ E+RP V +LR Y
Sbjct: 237 ---REMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 9e-29
Identities = 55/272 (20%), Positives = 99/272 (36%), Gaps = 30/272 (11%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137
+MG + + + + E ++ H+ +++L E +V E
Sbjct: 34 WMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTE 91
Query: 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
Y + L + L L + +A + A+ +AY+ V R++ NIL
Sbjct: 92 ---YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANIL 145
Query: 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
E K+ DF L++ I + + A +++ APE G + K+DV+SFG LL
Sbjct: 146 VGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 204
Query: 258 LVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAY 317
L T G N + D+VE+ R +
Sbjct: 205 TELTTKGR-----VPYPGMVNREVLDQVERGYRMPCPPECPE----------------SL 243
Query: 318 VELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349
+L +C E+RPT + L + ++
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-28
Identities = 45/276 (16%), Positives = 100/276 (36%), Gaps = 35/276 (12%)
Query: 78 YMGFLRDRG-----PILVMKYRKSVRYASERCFNN-IVFASQMNHKSILKLIGCCLEAEM 131
Y G G P+ + + R++ + + + + +++ + +L+G CL + +
Sbjct: 26 YKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV 85
Query: 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI 191
L+ + + L D + + L ++ A + YL + +V R++
Sbjct: 86 Q-LITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGMNYL---EDRRLVHRDL 137
Query: 192 EPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVY 251
N+L + K+ DF L+K + + A +++ A E + Y ++DV+
Sbjct: 138 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 197
Query: 252 SFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKE 311
S+G + L+T G + + + P+ D
Sbjct: 198 SYGVTVWELMTFG------SKPYDGIPA---SEISSILEKGERLPQPPICTID------- 241
Query: 312 EKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347
+ KC A+ RP ++ + +M R
Sbjct: 242 -----VYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-28
Identities = 56/264 (21%), Positives = 106/264 (40%), Gaps = 34/264 (12%)
Query: 83 RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE-MPALVYEPAGY 141
RG + +K K+ ++ +Q+ H ++++L+G +E + +V E
Sbjct: 27 DYRGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85
Query: 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE 201
+L D L ++ L LK +++ A+ YL V R++ N+L E+
Sbjct: 86 GSLVDYLRSRGRSVLGG---DCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSED 139
Query: 202 YAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLL 261
AK+ DF L+K + T +++ APE L ++ K+DV+SFG LL +
Sbjct: 140 NVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 194
Query: 262 TGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELA 321
+ + + + RVEK + + P A E+
Sbjct: 195 SFGRVPY-----PRIPLKDVVPRVEKGYKMDAPDGCPP----------------AVYEVM 233
Query: 322 FKCLSHSAEDRPTMIDVAKKLRQM 345
C A RP+ + + ++L +
Sbjct: 234 KNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-28
Identities = 57/286 (19%), Positives = 102/286 (35%), Gaps = 43/286 (15%)
Query: 61 NYSMRNITIDEIEGY----ILYMGFLRDRGPILVMKYRKSVRYAS----ERCFNNIVFAS 112
+++ + I G +Y+ + IL +K + + + S
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 113 QMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETA 172
+ H +IL+L G +A L+ E A T+ L L E A
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-----KLSKFDEQRTATYITELA 116
Query: 173 NAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLE 232
NA++Y + V+ R+I+P N+L K+ DF S P + T G+L+
Sbjct: 117 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLD 169
Query: 233 FAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292
+ PE + ++EK D++S G L L G+ F E + R
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP------------FEANTYQETYKR-- 215
Query: 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
++ + + +L + L H+ RP + +V
Sbjct: 216 -ISRVEFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREV 252
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-27
Identities = 57/266 (21%), Positives = 90/266 (33%), Gaps = 31/266 (11%)
Query: 78 YMGFLRDRGPILVMKY--RKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135
+ R + +K K E I +NH++++K G E + L
Sbjct: 22 QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81
Query: 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWN 195
E L DR+ + + + V YL + R+I+P N
Sbjct: 82 LEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPEN 133
Query: 196 ILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFG 254
+L E K+ DF L+ + G+L + APE L ++ E DV+S G
Sbjct: 134 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193
Query: 255 KLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKL 314
+L +L G S +D EK N + ID
Sbjct: 194 IVLTAMLAGELPWD----QPSDSCQEYSDWKEKKTYLNPWKKIDS--------------- 234
Query: 315 QAYVELAFKCLSHSAEDRPTMIDVAK 340
A + L K L + R T+ D+ K
Sbjct: 235 -APLALLHKILVENPSARITIPDIKK 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (265), Expect = 4e-27
Identities = 53/276 (19%), Positives = 99/276 (35%), Gaps = 44/276 (15%)
Query: 90 VMKYRKSVRYASERCFNN-IVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRL 148
V ++ + F ++ ++ +I+KL+G C + L++E Y L + L
Sbjct: 48 VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 107
Query: 149 YG-------------------PLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFR 189
PL +L +A + A +AYL + V R
Sbjct: 108 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR 164
Query: 190 NIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTD 249
++ N L E K+ DF LS++I + + + PE + Y ++D
Sbjct: 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224
Query: 250 VYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFR 309
V+++G +L + + G + E+ I V G+
Sbjct: 225 VWAYGVVLWEIF------------SYGLQPYYGMAHEEVIYY--------VRDGNILACP 264
Query: 310 KEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
+ L+ Y L C S DRP+ + + L++M
Sbjct: 265 ENCPLELY-NLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 5e-27
Identities = 53/281 (18%), Positives = 103/281 (36%), Gaps = 36/281 (12%)
Query: 78 YMGFLRDRG----PILVMKYRKSVRYASERCFNN-IVFASQMNHKSILKLIGCCLEAE-M 131
Y G L D V + F + +H ++L L+G CL +E
Sbjct: 44 YHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 103
Query: 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI 191
P +V + L + + + + ++ A ++F + V R++
Sbjct: 104 PLVVLPYMKHGDLRNFIR----NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDL 156
Query: 192 EPWNILFQEEYAAKLFDFSLSKSIP--EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTD 249
N + E++ K+ DF L++ + E + + A +++ A E L T + K+D
Sbjct: 157 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSD 216
Query: 250 VYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFR 309
V+SFG LL L+ T G+ + ++ R +
Sbjct: 217 VWSFGVLLWELM------------TRGAPPYPDVNTFDITVY---------LLQGRRLLQ 255
Query: 310 KEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTSV 350
E E+ KC AE RP+ ++ ++ ++ T +
Sbjct: 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 8e-27
Identities = 47/255 (18%), Positives = 90/255 (35%), Gaps = 41/255 (16%)
Query: 109 VFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLE----------- 157
+ +H++I+ L+G C + L++E Y L + L + E
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 158 -------PLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210
L L A + A + +L F + V R++ N+L K+ DF
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLS 270
L++ I ++ A +++ APE L G Y K+DV+S+G LL + +
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL------- 262
Query: 271 RLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAE 330
G + + F + +I + + + C + +
Sbjct: 263 ----GVNPYPGIPVDANFYK---------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSR 309
Query: 331 DRPTMIDVAKKLRQM 345
RP+ ++ L
Sbjct: 310 KRPSFPNLTSFLGCQ 324
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-26
Identities = 49/270 (18%), Positives = 94/270 (34%), Gaps = 36/270 (13%)
Query: 78 YMGFLRDRGPILVMK---YRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE--MP 132
+ G ILV K Y + + + ++ H +I++ ++
Sbjct: 21 QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80
Query: 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYL--RFGFPQPVVFRN 190
+V E LA + + + L L+V + A+ R V+ R+
Sbjct: 81 YIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139
Query: 191 IEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDV 250
++P N+ + KL DF L++ + + A +G+ + +PE + YNEK+D+
Sbjct: 140 LKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDI 197
Query: 251 YSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE--KFIRSNGYMNIDPVIVGDRSCF 308
+S G LL L F + E IR + I
Sbjct: 198 WSLGCLLYELCALMPP------------FTAFSQKELAGKIREGKFRRIPYRYS------ 239
Query: 309 RKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
E+ + L+ RP++ ++
Sbjct: 240 ------DELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 4e-26
Identities = 53/244 (21%), Positives = 94/244 (38%), Gaps = 29/244 (11%)
Query: 102 ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLL 161
+ + ++H+++++L G L M +V E A +L DRL H LL
Sbjct: 56 DDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRK----HQGHFLL 110
Query: 162 THRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221
+ A++ A + YL + + R++ N+L K+ DF L +++P+ H
Sbjct: 111 GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 222 IKASTAI-GSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFF 280
+ APE L T ++ +D + FG L + T
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ--------------- 212
Query: 281 ITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340
E +I NG + + R E+ Q + +C +H EDRPT + +
Sbjct: 213 -----EPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
Query: 341 KLRQ 344
L +
Sbjct: 268 FLLE 271
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 5e-26
Identities = 56/284 (19%), Positives = 103/284 (36%), Gaps = 43/284 (15%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNI-----VFASQMNHKSILKLIGCCLEAEMP 132
++ G + ++ YAS+ + V +H +I+ L+G C
Sbjct: 27 LKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86
Query: 133 ALVYEPAGYCTLADRLYGPLQTHLEP-----------LLLTHRLKVAMETANAVAYLRFG 181
L E A + L D L +P L L A + A + YL
Sbjct: 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--- 143
Query: 182 FPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT 241
+ + R++ NIL E Y AK+ DF LS+ ++K + + + A E L
Sbjct: 144 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNY 200
Query: 242 GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVI 301
Y +DV+S+G LL +++ + G + + +++ + R +N D +
Sbjct: 201 SVYTTNSDVWSYGVLLWEIVSLGGTPY-----CGMTCAELYEKLPQGYRLEKPLNCDDEV 255
Query: 302 VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
+L +C +RP+ + L +M
Sbjct: 256 ----------------YDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 6e-26
Identities = 47/263 (17%), Positives = 91/263 (34%), Gaps = 34/263 (12%)
Query: 78 YMGFLRDRGPILVMK-YRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136
Y G + ++ + E N I+ + + +I+ + L + +V
Sbjct: 37 YTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96
Query: 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196
E +L D + V E A+ +L V+ R+I+ NI
Sbjct: 97 EYLAGGSLTDVVTETCMD------EGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNI 147
Query: 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKL 256
L + + KL DF I ++ ST +G+ + APE +T Y K D++S G +
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 205
Query: 257 LLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKL-Q 315
+ ++ G ++ N + + + EKL
Sbjct: 206 AIEMIEGEPP---------------------YLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 316 AYVELAFKCLSHSAEDRPTMIDV 338
+ + +CL E R + ++
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 6e-26
Identities = 46/277 (16%), Positives = 87/277 (31%), Gaps = 35/277 (12%)
Query: 78 YMGFLRDRGPILVMKY------RKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131
Y G L+ + Q +H +I++L G + +
Sbjct: 24 YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83
Query: 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI 191
++ E L L + + + A + YL V R++
Sbjct: 84 MMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDL 136
Query: 192 EPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAI-GSLEFAAPEYLTTGYYNEKTDV 250
NIL K+ DF LS+ + + ++ + + APE ++ + +DV
Sbjct: 137 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV 196
Query: 251 YSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRK 310
+SFG ++ ++T R SN + + R M+ I
Sbjct: 197 WSFGIVMWEVMTYG-----ERPYWELSNHEVMKAINDGFRLPTPMDCPSAI--------- 242
Query: 311 EEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347
+L +C RP D+ L ++ R
Sbjct: 243 -------YQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 8e-25
Identities = 44/248 (17%), Positives = 85/248 (34%), Gaps = 36/248 (14%)
Query: 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY-------------GPLQTHLEPLLL 161
NH +I+ L+G C ++ E Y L + L ++ L L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 162 THRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221
L + + A +A+L + + R++ NIL K+ DF L++ I +
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 222 IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFI 281
+ A +++ APE + Y ++DV+S+G L L + + + +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--------PGMPV 253
Query: 282 TDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341
+ K I+ M ++ C RPT + +
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAP------------AEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 342 LRQMYRTS 349
+ + S
Sbjct: 302 IEKQISES 309
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.7 bits (248), Expect = 1e-24
Identities = 44/268 (16%), Positives = 85/268 (31%), Gaps = 37/268 (13%)
Query: 78 YMGFLRDRGPILVMK-YRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136
Y ++ + K E I + +H +I+KL+ ++
Sbjct: 29 YKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88
Query: 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196
E + + PL + V +T +A+ YL ++ R+++ NI
Sbjct: 89 EFCAGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNI 141
Query: 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYL-----TTGYYNEKTDVY 251
LF + KL DF +S + IG+ + APE + Y+ K DV+
Sbjct: 142 LFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVW 199
Query: 252 SFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKE 311
S G L+ + N + + + +
Sbjct: 200 SLGITLIEMAEIEP---------------------PHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 312 EKL-QAYVELAFKCLSHSAEDRPTMIDV 338
+ + + KCL + + R T +
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.9 bits (246), Expect = 2e-24
Identities = 47/268 (17%), Positives = 85/268 (31%), Gaps = 42/268 (15%)
Query: 78 YMGFLRDRGPILVMK-YRKSVRYASE---RCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133
Y ++ +K S + ++E + F ++ H + ++ GC L
Sbjct: 32 YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91
Query: 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEP 193
LV E H +PL V +AYL ++ R+++
Sbjct: 92 LVMEYCLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKA 143
Query: 194 WNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT---GYYNEKTDV 250
NIL E KL DF + + + +G+ + APE + G Y+ K DV
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMAPANSF------VGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 251 YSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRK 310
+S G + L + N + + + +
Sbjct: 198 WSLGITCIELAERKPP---------------------LFNMNAMSALYHIAQNESPALQS 236
Query: 311 EEKLQAYVELAFKCLSHSAEDRPTMIDV 338
+ + CL +DRPT +
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 7e-24
Identities = 60/273 (21%), Positives = 102/273 (37%), Gaps = 35/273 (12%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYAS-----ERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132
+ G + K+ + + E+ + Q +H I+KLIG E
Sbjct: 24 HQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82
Query: 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIE 192
++ E CTL + L LQ L L + A + + A+AYL + V R+I
Sbjct: 83 WIIME---LCTLGE-LRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIA 135
Query: 193 PWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYS 252
N+L KL DF LS+ + + + KAS +++ APE + + +DV+
Sbjct: 136 ARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWM 194
Query: 253 FGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEE 312
FG + +L + G N + R+E R N P +
Sbjct: 195 FGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGERLPMPPNCPPTL----------- 238
Query: 313 KLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
L KC ++ RP ++ +L +
Sbjct: 239 -----YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 1e-23
Identities = 45/272 (16%), Positives = 98/272 (36%), Gaps = 35/272 (12%)
Query: 90 VMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP-ALVYEPAGYCTLADRL 148
++K + + +H +++ L+G C + P ++ E + L+ L
Sbjct: 50 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 109
Query: 149 YG-----------PLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
P + + L L H + + + A + +L + + R++ NIL
Sbjct: 110 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166
Query: 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLL 257
E+ K+ DF L++ I + +++ A L++ APE + Y ++DV+SFG LL
Sbjct: 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226
Query: 258 LVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAY 317
+ + + I + + ++ M
Sbjct: 227 WEIFSLGASPY--------PGVKIDEEFCRRLKEGTRMRAPDYTT------------PEM 266
Query: 318 VELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349
+ C RPT ++ + L + + +
Sbjct: 267 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.5 bits (239), Expect = 2e-23
Identities = 46/249 (18%), Positives = 97/249 (38%), Gaps = 29/249 (11%)
Query: 102 ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY-----GPLQTHL 156
N + N +++L+G + + ++ E L L L
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 157 EPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216
P L+ +++A E A+ +AYL V R++ N + E++ K+ DF +++ I
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184
Query: 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG 276
E + K + + + +PE L G + +DV+SFG +L + T G
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA------EQPYQG 238
Query: 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI 336
+ ++V +F+ G ++ EL C ++ + RP+ +
Sbjct: 239 LS---NEQVLRFVMEGGLLDKPDNC------------PDMLFELMRMCWQYNPKMRPSFL 283
Query: 337 DVAKKLRQM 345
++ +++
Sbjct: 284 EIISSIKEE 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.5 bits (237), Expect = 3e-23
Identities = 33/192 (17%), Positives = 72/192 (37%), Gaps = 12/192 (6%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASE----RCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133
+ +K + E S+++H +KL + E
Sbjct: 25 VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84
Query: 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEP 193
A L + + T E +A+ YL + ++ R+++P
Sbjct: 85 FGLSYAKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKP 136
Query: 194 WNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSF 253
NIL E+ ++ DF +K + +A++ +G+ ++ +PE LT + +D+++
Sbjct: 137 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWAL 196
Query: 254 GKLLLVLLTGRT 265
G ++ L+ G
Sbjct: 197 GCIIYQLVAGLP 208
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 3e-23
Identities = 51/269 (18%), Positives = 96/269 (35%), Gaps = 35/269 (13%)
Query: 88 ILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADR 147
+ ++K + + S+ + HK+I+ L+G C + ++ E A L +
Sbjct: 50 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109
Query: 148 L-----------YGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196
L Y P E L + A + A + YL + + R++ N+
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNV 166
Query: 197 LFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKL 256
L E+ K+ DF L++ I + K + +++ APE L Y ++DV+SFG L
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 257 LLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQA 316
L + T G + + K ++ M+
Sbjct: 227 LWEIFTLG------GSPYPGVPV---EELFKLLKEGHRMDKPSNCT------------NE 265
Query: 317 YVELAFKCLSHSAEDRPTMIDVAKKLRQM 345
+ C RPT + + L ++
Sbjct: 266 LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 96.7 bits (240), Expect = 3e-23
Identities = 45/265 (16%), Positives = 85/265 (32%), Gaps = 34/265 (12%)
Query: 78 YMGFLRDRGPILVMKY-RKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136
+ R G K+ E I S + H +++ L + ++Y
Sbjct: 43 HRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102
Query: 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196
E L +++ + ++ + + ++ V +++P NI
Sbjct: 103 EFMSGGELFEKVA----DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENI 155
Query: 197 LF--QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFG 254
+F + KL DF L+ + ++ G+ EFAAPE TD++S G
Sbjct: 156 MFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVG 212
Query: 255 KLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR-SNGYMNIDPVIVGDRSCFRKEEK 313
L +LL+G + F + E + N+D S
Sbjct: 213 VLSYILLSGLSP------------FGGENDDETLRNVKSCDWNMDDSAFSGIS------- 253
Query: 314 LQAYVELAFKCLSHSAEDRPTMIDV 338
+ + K L R T+
Sbjct: 254 -EDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.4 bits (229), Expect = 3e-22
Identities = 44/269 (16%), Positives = 86/269 (31%), Gaps = 39/269 (14%)
Query: 78 YMGFLRDRGP---ILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEA----E 130
Y G + ++ RK + +R + H +I++ +
Sbjct: 26 YKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85
Query: 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRN 190
LV E TL L + + + + + +L P P++ R+
Sbjct: 86 CIVLVTELMTSGTLKTYLK-----RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRD 139
Query: 191 IEPWNILF-QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTD 249
++ NI + K+ D L+ IG+ EF APE Y+E D
Sbjct: 140 LKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYE-EKYDESVD 194
Query: 250 VYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFR 309
VY+FG +L + T + + I + P +
Sbjct: 195 VYAFGMCMLEMATSEYP-------------YSECQNAAQIYRRVTSGVKPASFDKVA--- 238
Query: 310 KEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
+ E+ C+ + ++R ++ D+
Sbjct: 239 ----IPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.8 bits (230), Expect = 4e-22
Identities = 43/265 (16%), Positives = 86/265 (32%), Gaps = 35/265 (13%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137
+ + K+ K I + H++IL L E +++E
Sbjct: 22 HRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81
Query: 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197
+ +R+ T L + + A+ +L + +I P NI+
Sbjct: 82 FISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENII 134
Query: 198 FQ--EEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGK 255
+Q K+ +F ++ + G + E+ APE + TD++S G
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGT 191
Query: 256 LLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS--NGYMNIDPVIVGDRSCFRKEEK 313
L+ VLL+G F+ + ++ I + N D + S
Sbjct: 192 LVYVLLSGINP-------------FLAETNQQIIENIMNAEYTFDEEAFKEIS------- 231
Query: 314 LQAYVELAFKCLSHSAEDRPTMIDV 338
++ + L + R T +
Sbjct: 232 -IEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 92.0 bits (228), Expect = 1e-21
Identities = 44/264 (16%), Positives = 84/264 (31%), Gaps = 32/264 (12%)
Query: 78 YMGFLRDRGPILVMKY-RKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136
+ + G + V K+ N I +Q++H ++ L + L+
Sbjct: 46 HRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105
Query: 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196
E L DR+ + + + + ++ +V +I+P NI
Sbjct: 106 EFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENI 158
Query: 197 LF--QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFG 254
+ ++ + K+ DF L+ + + + EFAAPE + TD+++ G
Sbjct: 159 MCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVDREPVGFYTDMWAIG 215
Query: 255 KLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKL 314
L VLL+G G + V++ D S
Sbjct: 216 VLGYVLLSGL------SPFAGEDDLETLQNVKR-----CDWEFDEDAFSSVS-------- 256
Query: 315 QAYVELAFKCLSHSAEDRPTMIDV 338
+ L R T+ D
Sbjct: 257 PEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 88.2 bits (218), Expect = 2e-20
Identities = 51/267 (19%), Positives = 89/267 (33%), Gaps = 37/267 (13%)
Query: 78 YMGFLRDRGPILVMK-YRKSVRYASERCFNN-IVFASQMNHKSILKLIGCCLEAEMPALV 135
+ + ++ +K K E N I ++ H +I+ L L+
Sbjct: 26 ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85
Query: 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWN 195
+ L DR+ ++ + +AV YL +V R+++P N
Sbjct: 86 MQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPEN 137
Query: 196 ILF---QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYS 252
+L+ E+ + DF LSK G STA G+ + APE L Y++ D +S
Sbjct: 138 LLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWS 194
Query: 253 FGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR-SNGYMNIDPVIVGDRSCFRKE 311
G + +LL G F+ + + F + D D S
Sbjct: 195 IGVIAYILLCGYPP------------FYDENDAKLFEQILKAEYEFDSPYWDDIS----- 237
Query: 312 EKLQAYVELAFKCLSHSAEDRPTMIDV 338
+ + + E R T
Sbjct: 238 ---DSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 85.7 bits (211), Expect = 1e-19
Identities = 43/281 (15%), Positives = 88/281 (31%), Gaps = 33/281 (11%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIG-CCLEAEMPALVY 136
Y+G G + +K + V+ + M + I C E + +V
Sbjct: 24 YLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82
Query: 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196
E G + L L +A + + + Y+ + + R+++P N
Sbjct: 83 ELLGPSLEDLFNF-----CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNF 134
Query: 197 LFQEEYAAKL---FDFSLSKSIPEGKTH-----IKASTAIGSLEFAAPEYLTTGYYNEKT 248
L L DF L+K + +TH + G+ +A+ + +
Sbjct: 135 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD 194
Query: 249 DVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCF 308
D+ S G +L+ G + +K+ R + P+ V +
Sbjct: 195 DLESLGYVLMYFNLGSLPWQ---------GLKAATKRQKYERISEKKMSTPIEVLCKGY- 244
Query: 309 RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349
+ C S +D+P + + R ++
Sbjct: 245 -----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 85.2 bits (210), Expect = 1e-19
Identities = 45/252 (17%), Positives = 95/252 (37%), Gaps = 33/252 (13%)
Query: 102 ERCFNNIVFASQMNHKSILKLIGCCLE----AEMPALVYEPAGYCTLADRLYGPLQTHLE 157
R A+ +NH +I+ + +P +V E TL D ++
Sbjct: 52 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-----TEG 106
Query: 158 PLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217
P+ ++V + A+ + ++ R+++P NI+ A K+ DF ++++I +
Sbjct: 107 PMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163
Query: 218 GKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGG 276
+ + + IG+ ++ +PE + ++DVYS G +L +LTG
Sbjct: 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---------- 213
Query: 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-TM 335
F D + + P + K L+ + E+R T
Sbjct: 214 ---FTGDSPVSVAYQHVREDPIPPSARHEGLS------ADLDAVVLKALAKNPENRYQTA 264
Query: 336 IDVAKKLRQMYR 347
++ L +++
Sbjct: 265 AEMRADLVRVHN 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.4 bits (208), Expect = 4e-19
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 21/211 (9%)
Query: 62 YSMRNITIDEIEGY----ILYMGFLRDRGPILVMKY---RKSVRYASERCFNN-IVFASQ 113
YS+++ I G +++ R G MK VR N+ + S
Sbjct: 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 114 MNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETAN 173
+ H I+++ G +A+ ++ + L L + A E
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-----LLRKSQRFPNPVAKFYAAEVCL 115
Query: 174 AVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEF 233
A+ YL + +++R+++P NIL + K+ DF +K +P+ T G+ ++
Sbjct: 116 ALEYL---HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDY 167
Query: 234 AAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
APE ++T YN+ D +SFG L+ +L G
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 198
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.2 bits (207), Expect = 5e-19
Identities = 36/276 (13%), Positives = 85/276 (30%), Gaps = 15/276 (5%)
Query: 78 YMGFLRDRGPILVMK---YRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134
+ R G + +K I + H++++ LI C P
Sbjct: 27 FKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86
Query: 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPW 194
+ + Y + L+ ++ + L + ++ R+++
Sbjct: 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAA 146
Query: 195 NILFQEEYAAKLFDFSLSKSIPEGKT--HIKASTAIGSLEFAAPEYLTTG-YYNEKTDVY 251
N+L + KL DF L+++ K + + + +L + PE L Y D++
Sbjct: 147 NVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 206
Query: 252 SFGKLLLVLLTGRT-------IGHLSRLATGGSNF--FITDRVEKFIRSNGYMNIDPVIV 302
G ++ + T L+ ++ + + V+ + +
Sbjct: 207 GAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKR 266
Query: 303 GDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
+ + + ++L K L R D
Sbjct: 267 KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.6 bits (206), Expect = 7e-19
Identities = 38/193 (19%), Positives = 68/193 (35%), Gaps = 15/193 (7%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNI-----VFASQMNHKSILKLIGCCLEAEMP 132
++ + +K K + V + H + + E
Sbjct: 19 FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 78
Query: 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIE 192
V E L + L+ A E + +L + +V+R+++
Sbjct: 79 FFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFYAAEIILGLQFL---HSKGIVYRDLK 130
Query: 193 PWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYS 252
NIL ++ K+ DF + K G +T G+ ++ APE L YN D +S
Sbjct: 131 LDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWS 188
Query: 253 FGKLLLVLLTGRT 265
FG LL +L G++
Sbjct: 189 FGVLLYEMLIGQS 201
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 7e-19
Identities = 45/275 (16%), Positives = 91/275 (33%), Gaps = 26/275 (9%)
Query: 78 YMGFLRDRGPILVMK------YRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEM 131
Y ++ I+ +K ++ + I +++H +I+ L+
Sbjct: 15 YKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 74
Query: 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI 191
+LV++ ++ + L +H + T + YL ++ R++
Sbjct: 75 ISLVFDFMETDLEVI-----IKDNSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDL 126
Query: 192 EPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDV 250
+P N+L E KL DF L+KS G + + + + + APE L Y D+
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM 184
Query: 251 YSFGKLLLVLLTGRT-------IGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVG 303
++ G +L LL + L+R+ T+ + S G
Sbjct: 185 WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP--TEEQWPDMCSLPDYVTFKSFPG 242
Query: 304 DRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
++L + R T
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 2e-18
Identities = 40/262 (15%), Positives = 85/262 (32%), Gaps = 23/262 (8%)
Query: 88 ILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLA-D 146
+ V + + ++ R + H ++++L C + + + D
Sbjct: 41 VRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD 100
Query: 147 RLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206
+ + + + + +L VV R+++P NIL KL
Sbjct: 101 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 157
Query: 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTI 266
DF L++ ++ + +L + APE L Y D++S G + + +
Sbjct: 158 ADFGLARIYSFQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-- 212
Query: 267 GHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKL----------QA 316
L G S+ ++ I G + + R F + +
Sbjct: 213 ----PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 268
Query: 317 YVELAFKCLSHSAEDRPTMIDV 338
+L KCL+ + R +
Sbjct: 269 GKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 1e-17
Identities = 44/257 (17%), Positives = 81/257 (31%), Gaps = 18/257 (7%)
Query: 90 VMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY 149
++ I ++NH +I+KL+ LV+E
Sbjct: 34 KIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD- 92
Query: 150 GPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209
+ L + L + +A+ V+ R+++P N+L E A KL DF
Sbjct: 93 ---ASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADF 146
Query: 210 SLSKSIPEGKTHIKASTAIGSLEFAAPE-YLTTGYYNEKTDVYSFGKLLLVLLTGRT--- 265
L+++ + + +L + APE L YY+ D++S G + ++T R
Sbjct: 147 GLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204
Query: 266 ----IGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELA 321
I L R+ + + D S L
Sbjct: 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG-RSLL 263
Query: 322 FKCLSHSAEDRPTMIDV 338
+ L + R +
Sbjct: 264 SQMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.0 bits (194), Expect = 2e-17
Identities = 42/272 (15%), Positives = 85/272 (31%), Gaps = 41/272 (15%)
Query: 78 YMGFLRDRGPILVMKYRKSVR-------YASERCFNNIVFASQMNHKSILKLIGCCLEAE 130
+ G K+ K R + E + ++ H +++ L
Sbjct: 27 KKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86
Query: 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRN 190
L+ E L D E L + + N + + + +
Sbjct: 87 DVILILELVAGGELFDF-----LAEKESLTEEEATEFLKQILNG---VYYLHSLQIAHFD 138
Query: 191 IEPWNILFQEEYAA----KLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNE 246
++P NI+ + K+ DF L+ I G G+ EF APE +
Sbjct: 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGL 195
Query: 247 KTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRS 306
+ D++S G + +LL+G + F+ D ++ + + +N + +
Sbjct: 196 EADMWSIGVITYILLSGA-------------SPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 307 CFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
+ + L + R T+ D
Sbjct: 243 T------SALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.4 bits (195), Expect = 3e-17
Identities = 39/195 (20%), Positives = 67/195 (34%), Gaps = 20/195 (10%)
Query: 78 YMGFLRDRGPILVMKY---RKSVRYASERCFNNIV----FASQMNHKSILKLIGCCLEAE 130
Y D G + MK ++ E N S + I+ + +
Sbjct: 21 YGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80
Query: 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRN 190
+ + + L L A E + ++ + VV+R+
Sbjct: 81 KLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILGLEHMHN---RFVVYRD 132
Query: 191 IEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTD 249
++P NIL E ++ D L+ + K H +G+ + APE L G Y+ D
Sbjct: 133 LKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSAD 188
Query: 250 VYSFGKLLLVLLTGR 264
+S G +L LL G
Sbjct: 189 WFSLGCMLFKLLRGH 203
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (193), Expect = 5e-17
Identities = 39/276 (14%), Positives = 87/276 (31%), Gaps = 23/276 (8%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYAS--ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135
+ + +K + + +R I + H++I+ +
Sbjct: 25 CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT----- 79
Query: 136 YEPAGYCTLADRLYGPLQTHL---EPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIE 192
E L L G L + L H + + Y+ V+ R+++
Sbjct: 80 IEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLK 136
Query: 193 PWNILFQEEYAAKLFDFSLSKSI-PEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDV 250
P N+L K+ DF L++ P+ + + + + APE + Y + D+
Sbjct: 137 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 196
Query: 251 YSFGKLLLVLLTGR------TIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304
+S G +L +L+ R G + + I + + +
Sbjct: 197 WSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKN 256
Query: 305 RSCFRKEEKL--QAYVELAFKCLSHSAEDRPTMIDV 338
+ + + ++L K L+ + R +
Sbjct: 257 KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 76.3 bits (187), Expect = 1e-16
Identities = 45/254 (17%), Positives = 83/254 (32%), Gaps = 41/254 (16%)
Query: 94 RKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPL 152
+ V+ E + +++ H +I++L LV++ L D L
Sbjct: 46 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK- 104
Query: 153 QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212
L K+ + L +V R+++P NIL ++ KL DF S
Sbjct: 105 ----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 157
Query: 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTG------YYNEKTDVYSFGKLLLVLLTGRTI 266
+ G+ G+ + APE + Y ++ D++S G ++ LL G
Sbjct: 158 CQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
Query: 267 GHLSRLATGGSNFFITDRVEKF--IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKC 324
F+ ++ I S Y P + +L +
Sbjct: 215 ------------FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK---------DLVSRF 253
Query: 325 LSHSAEDRPTMIDV 338
L + R T +
Sbjct: 254 LVVQPQKRYTAEEA 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 76.4 bits (187), Expect = 2e-16
Identities = 30/281 (10%), Positives = 73/281 (25%), Gaps = 35/281 (12%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKS-ILKLIGCCLEAEMPALVY 136
+ G + +K + R + + + + + I + E LV
Sbjct: 22 FEGTNLLNNQQVAIK-FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80
Query: 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNI 196
+ G L + A + V + + +V+R+I+P N
Sbjct: 81 DLLGPSLEDL-----LDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNF 132
Query: 197 LFQEEYA-----AKLFDFSLSKSIPEGKTH-----IKASTAIGSLEFAAPEYLTTGYYNE 246
L + + DF + K + T + G+ + + +
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR 192
Query: 247 KTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRS 306
+ D+ + G + + L G + +
Sbjct: 193 RDDLEALGHVFMYFLRGSL------------PWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 307 CFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347
C E+ Y+ + + + P + ++
Sbjct: 241 CAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (186), Expect = 4e-16
Identities = 39/274 (14%), Positives = 87/274 (31%), Gaps = 23/274 (8%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP----- 132
Y L D G ++ +K V + +++H +I++L +
Sbjct: 37 YQAKLCDSGELVAIK---KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 133 -ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNI 191
LV + + + L + + + ++AY+ + R+I
Sbjct: 94 LNLVLDYVPETVYRVARHYSRAK--QTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDI 148
Query: 192 EP-WNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDV 250
+P +L + KL DF +K + G+ ++ S A Y DV
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFGATDYTSSIDV 206
Query: 251 YSFGKLLLVLLTGR------TIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGD 304
+S G +L LL G+ + +++ + + +
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 305 RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
+ + + L + L ++ R T ++
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 75.3 bits (184), Expect = 5e-16
Identities = 46/259 (17%), Positives = 83/259 (32%), Gaps = 19/259 (7%)
Query: 88 ILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADR 147
+ ++ K I ++ H +I+KL + LV+E
Sbjct: 31 LKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKL- 89
Query: 148 LYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207
L L ++ N +AY + V+ R+++P N+L E K+
Sbjct: 90 ----LDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIA 142
Query: 208 DFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLT-TGYYNEKTDVYSFGKLLLVLLTGR-- 264
DF L+++ G K + I +L + AP+ L + Y+ D++S G + ++ G
Sbjct: 143 DFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
Query: 265 -----TIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVE 319
L R+ + N F K ++
Sbjct: 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESG-ID 259
Query: 320 LAFKCLSHSAEDRPTMIDV 338
L K L R T
Sbjct: 260 LLSKMLKLDPNQRITAKQA 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.3 bits (176), Expect = 5e-15
Identities = 34/272 (12%), Positives = 76/272 (27%), Gaps = 21/272 (7%)
Query: 78 YMGFLRDRGPILVMK---YRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134
+ R+ I+ +K I ++ HK+I++L + L
Sbjct: 19 FKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78
Query: 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPW 194
V+E E + + + + V+ R+++P
Sbjct: 79 VFEFCDQDLKKYFDSCNGDLDPE-----IVKSFLFQLLKGLGFCHS---RNVLHRDLKPQ 130
Query: 195 NILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYL-TTGYYNEKTDVYSF 253
N+L KL +F L+++ S + +L + P+ L Y+ D++S
Sbjct: 131 NLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 188
Query: 254 GKLLLVLLTGR-------TIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRS 306
G + L + + ++ + Y
Sbjct: 189 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSL 248
Query: 307 CFRKEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
+ +L L + R + +
Sbjct: 249 VNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.8 bits (178), Expect = 5e-15
Identities = 44/269 (16%), Positives = 86/269 (31%), Gaps = 36/269 (13%)
Query: 78 YMGFLRDRGPILVMKY-RKSVRYASERCFNNIVFASQMNHKSILKLIGCC----LEAEMP 132
F + +K + + E + I++++ +
Sbjct: 29 LQIFNKRTQEKFALKMLQDCPKARREVE----LHWRASQCPHIVRIVDVYENLYAGRKCL 84
Query: 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIE 192
+V E L R+ + ++ A+ YL + R+++
Sbjct: 85 LIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVK 138
Query: 193 PWNILF---QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTD 249
P N+L+ + KL DF +K + T + + APE L Y++ D
Sbjct: 139 PENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCD 195
Query: 250 VYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFR 309
++S G ++ +LL G I+ ++ IR Y +P + S
Sbjct: 196 MWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPNP----EWSEVS 245
Query: 310 KEEKLQAYVELAFKCLSHSAEDRPTMIDV 338
+E K L L R T+ +
Sbjct: 246 EEVK-----MLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.7 bits (175), Expect = 7e-15
Identities = 29/168 (17%), Positives = 57/168 (33%), Gaps = 15/168 (8%)
Query: 102 ERCFNNIVFASQMN--HKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPL 159
R +V +++ +++L+ + L+ E L+ + L
Sbjct: 52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITER-GAL 107
Query: 160 LLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILF-QEEYAAKLFDFSLSKSIPEG 218
+ AV + V+ R+I+ NIL KL DF + +
Sbjct: 108 QEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164
Query: 219 KTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRT 265
G+ ++ PE++ Y+ V+S G LL ++ G
Sbjct: 165 VYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 2e-14
Identities = 40/192 (20%), Positives = 65/192 (33%), Gaps = 14/192 (7%)
Query: 78 YMGFLRDRGPILVMK-YRKSVRYASE---RCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133
+ + G MK RK V A + H + L +
Sbjct: 22 ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEP 193
V E G L HL + + A V+ L + + VV+R+I+
Sbjct: 82 FVMEY--------ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 194 WNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSF 253
N++ ++ K+ DF L K T G+ E+ APE L Y D +
Sbjct: 134 ENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 191
Query: 254 GKLLLVLLTGRT 265
G ++ ++ GR
Sbjct: 192 GVVMYEMMCGRL 203
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.2 bits (171), Expect = 3e-14
Identities = 39/258 (15%), Positives = 87/258 (33%), Gaps = 18/258 (6%)
Query: 90 VMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY 149
+ ++R + + M H++++ L+ E +
Sbjct: 50 KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL 109
Query: 150 GPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209
G L H E L + + + Y+ ++ R+++P N+ E+ K+ DF
Sbjct: 110 GKLMKH-EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 165
Query: 210 SLSKSIPEGKTHIKASTAIGSLEFAAPE-YLTTGYYNEKTDVYSFGKLLLVLLTGR---- 264
L++ + + + + + APE L Y + D++S G ++ ++TG+
Sbjct: 166 GLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220
Query: 265 --TIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRK--EEKLQAYVEL 320
+ + + V++ + + ++ F V L
Sbjct: 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
Query: 321 AFKCLSHSAEDRPTMIDV 338
K L AE R T +
Sbjct: 281 LEKMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.1 bits (163), Expect = 4e-13
Identities = 35/238 (14%), Positives = 82/238 (34%), Gaps = 29/238 (12%)
Query: 43 KRNPIRSFSSEDLKTAINNYSMRNITIDEIEGYIL------------YMGFLRDRGPILV 90
++ ++ F ++ + + + + +++ + + ++ G
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 91 MKYRKSVRYAS----ERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLAD 146
MK + E N +N ++KL + +V E +
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 147 RLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206
L + H A + YL +++R+++P N+L ++ ++
Sbjct: 131 HLR-----RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
DF +K + T G+ E APE + + YN+ D ++ G L+ + G
Sbjct: 183 TDFGFAKRVKGRTW-----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 61.0 bits (147), Expect = 3e-11
Identities = 42/281 (14%), Positives = 90/281 (32%), Gaps = 36/281 (12%)
Query: 78 YMGFLRDRGPILVMKYRKSVRYASERCFNNI-VFASQMNHKSILKLIGCCLEA--EMPAL 134
+ +V+K K V+ ++ I + + +I+ L + PAL
Sbjct: 52 FEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109
Query: 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPW 194
V+E + + + L E A+ Y ++ R+++P
Sbjct: 110 VFE---HVN-----NTDFKQLYQTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPH 158
Query: 195 NILF-QEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPE-YLTTGYYNEKTDVYS 252
N++ E +L D+ L++ G+ + + + S F PE + Y+ D++S
Sbjct: 159 NVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWS 215
Query: 253 FGKLLLVLLTGRT----------IGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIV 302
G +L ++ + G + + + +I
Sbjct: 216 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 275
Query: 303 GDRSCFRKEEKLQAYV-----ELAFKCLSHSAEDRPTMIDV 338
R + Q V + K L + + R T +
Sbjct: 276 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.9 bits (144), Expect = 1e-10
Identities = 44/260 (16%), Positives = 89/260 (34%), Gaps = 22/260 (8%)
Query: 90 VMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY 149
+ ++R + + M H++++ L+ A E L L
Sbjct: 50 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLM 105
Query: 150 GPLQTHL---EPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKL 206
G ++ + L H + + + Y+ ++ R+++P N+ E+ K+
Sbjct: 106 GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI 162
Query: 207 FDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR-- 264
DF L++ + T A+ A L +YN+ D++S G ++ LLTGR
Sbjct: 163 LDFGLARHTDDEMTGYVATRWY----RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
Query: 265 ----TIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKL--QAYV 318
+L + ++K + I + + F V
Sbjct: 219 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 278
Query: 319 ELAFKCLSHSAEDRPTMIDV 338
+L K L ++ R T
Sbjct: 279 DLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.0 bits (144), Expect = 1e-10
Identities = 24/159 (15%), Positives = 55/159 (34%), Gaps = 3/159 (1%)
Query: 107 NIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLK 166
+ M ILKL+ + + L + + L + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 167 VAMETANAVAYLRFGFPQPVVFRNIEPWNILF-QEEYAAKLFDFSLSKSIPEGKTHIKAS 225
++ + + Y+ ++ +I+P N+L + L ++ +
Sbjct: 130 ISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 226 TAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR 264
+I + E+ +PE L + D++S L+ L+TG
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (139), Expect = 3e-10
Identities = 35/167 (20%), Positives = 59/167 (35%), Gaps = 12/167 (7%)
Query: 102 ERCFNNIVFASQMNHKS-ILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLL 160
E + ++ L L+ + L L E
Sbjct: 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-----QRERFT 127
Query: 161 LTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKT 220
E A+ +L +++R+I+ NIL L DF LSK +T
Sbjct: 128 EHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
Query: 221 HIKASTAIGSLEFAAPEYLTTG--YYNEKTDVYSFGKLLLVLLTGRT 265
A G++E+ AP+ + G +++ D +S G L+ LLTG +
Sbjct: 185 ER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.0 bits (139), Expect = 5e-10
Identities = 36/268 (13%), Positives = 87/268 (32%), Gaps = 27/268 (10%)
Query: 90 VMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLY 149
+ + ++R + +V +NHK+I+ L+ + + L D
Sbjct: 49 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD--A 106
Query: 150 GPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209
Q L + + + +L ++ R+++P NI+ + + K+ DF
Sbjct: 107 NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 163
Query: 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT---- 265
L+++ + + + + APE + Y E D++S G ++ ++ +
Sbjct: 164 GLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 266 ---------IGHLSRLATGGSNFFITDRVEKFIRSNGYM------NIDPVIVGDRSCFRK 310
+ + V ++ + + P +
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 311 EEKLQAYVELAFKCLSHSAEDRPTMIDV 338
+ K +L K L R ++ D
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDA 308
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 350 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.89 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.23 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.5 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.4 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-58 Score=403.20 Aligned_cols=258 Identities=19% Similarity=0.311 Sum_probs=203.4
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
++|...+.| |+|+||+||+|++.++..||||++.... ...+++.+|+.++++++|||||+++|+|.+++..++||||+
T Consensus 5 ~~~~~~~~i-G~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEI-GSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEE-ECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEE-eeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 467788888 9999999999999887799999987643 34577999999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++|+|.+++.... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999987543 56889999999999999999999 8999999999999999999999999999998765433
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
... .....||+.|+|||++.+..++.++|||||||++|||+|+..|+..... . ..+...+..+... ..|
T Consensus 156 ~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--------~-~~~~~~i~~~~~~-~~p 224 (263)
T d1sm2a_ 156 YTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------N-SEVVEDISTGFRL-YKP 224 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--------H-HHHHHHHHHTCCC-CCC
T ss_pred cee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--------H-HHHHHHHHhcCCC-CCc
Confidence 222 2234589999999999999999999999999999999995444432211 1 1122223322211 111
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..+++++.+|+.+||+.||++|||+.+|++.|++|.++
T Consensus 225 -----------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 -----------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 13346789999999999999999999999999999765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-58 Score=410.35 Aligned_cols=271 Identities=17% Similarity=0.240 Sum_probs=206.8
Q ss_pred cccHHHHHHHhcCc---------ccccccccCCCceEEEEEEECC-Cc---eEEEEEeccc-chhhHHHHHHHHHHHHhc
Q 018816 49 SFSSEDLKTAINNY---------SMRNITIDEIEGYILYMGFLRD-RG---PILVMKYRKS-VRYASERCFNNIVFASQM 114 (350)
Q Consensus 49 ~~~~~~l~~~~~~f---------~~~~~lig~G~~g~V~~~~~~~-~~---~vaik~~~~~-~~~~~~~~~~E~~~l~~l 114 (350)
.++++++..++.+| ...+.| |+|+||+||+|.+.. ++ .||||++... .....++|.+|+.+|+++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~l-G~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVI-GAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEE-EECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEE-eeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 35555666555544 445677 999999999999843 22 5888988654 334567899999999999
Q ss_pred CCCCccceeeeeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccC
Q 018816 115 NHKSILKLIGCCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPW 194 (350)
Q Consensus 115 ~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~ 194 (350)
+|||||+++|+|.+++..++|||||++|+|.+++.... ..+++.++..++.||+.||.||| +++|+||||||+
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~ 157 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAAR 157 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGG
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccc
Confidence 99999999999999999999999999999999887543 56899999999999999999999 899999999999
Q ss_pred ceEeCCCCceeEcccCCCccCCCCCcccc---ccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 018816 195 NILFQEEYAAKLFDFSLSKSIPEGKTHIK---ASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLS 270 (350)
Q Consensus 195 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~ 270 (350)
|||++.++.+||+|||+|+.......... .....||+.|+|||++.++.++.++|||||||++|||+| |.+||...
T Consensus 158 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 158 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp GEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 99999999999999999987654332211 122347899999999999999999999999999999998 89998754
Q ss_pred cccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 271 RLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
.. ..+...+..+...... ..+++.+.+|+.+||+.||++|||+.+|++.|+++.+.+
T Consensus 238 ~~----------~~~~~~i~~~~~~~~~------------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 238 TN----------QDVINAIEQDYRLPPP------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp CH----------HHHHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CH----------HHHHHHHHcCCCCCCC------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 32 1122223322211111 144567999999999999999999999999999987653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=401.49 Aligned_cols=263 Identities=19% Similarity=0.242 Sum_probs=207.8
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||+||+|++++ .||||++... .....+.+.+|+.++++++|||||++++++.+ +.+++||
T Consensus 7 ~~~~~~~~~l-G~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRI-GSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEE-EECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEE-eeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 4678888888 999999999998754 6999998644 33556789999999999999999999998754 5689999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++|+|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 Ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp ECCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred ecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999996543 46999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
............||+.|+|||++.+ +.|+.++|||||||++|||+||+.||..... ...+...+..+.
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~---------~~~~~~~~~~~~ 226 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---------RDQIIFMVGRGY 226 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---------HHHHHHHHHHTS
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh---------HHHHHHHHhcCC
Confidence 5443334445669999999999864 3589999999999999999999999975432 112222233222
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
. .|.+.... ..+++.+.+|+.+||+.||++|||+.+|++.|+.+.++.
T Consensus 227 ~---~p~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 227 L---SPDLSKVR-----SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp C---CCCGGGSC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred C---CCcchhcc-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 1 11111110 134578999999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=401.35 Aligned_cols=260 Identities=20% Similarity=0.296 Sum_probs=212.3
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...+.| |+|+||.||+|.++++..||||++.... ...+.+.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 12 ~~~~~~~~~i-G~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERL-GAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEE-EEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEE-ecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 4678888888 9999999999999888799999997643 345679999999999999999999998754 567999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 89 ~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 89 MENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp CTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 999999998754321 35899999999999999999999 899999999999999999999999999999877554
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.... .....||+.|+|||++.++.++.++|||||||++|||+||..|+..... ...+...+..+.....
T Consensus 163 ~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---------~~~~~~~i~~~~~~~~- 231 (272)
T d1qpca_ 163 EYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---------NPEVIQNLERGYRMVR- 231 (272)
T ss_dssp CEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---------HHHHHHHHHTTCCCCC-
T ss_pred cccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---------HHHHHHHHHhcCCCCC-
Confidence 3322 3344589999999999999999999999999999999996655443221 1122223332221111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
| ..+++++.+|+.+||+.||++|||+.+|++.|++++.++
T Consensus 232 p-----------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 232 P-----------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp C-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred c-----------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 1 134567899999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-57 Score=403.77 Aligned_cols=262 Identities=20% Similarity=0.274 Sum_probs=215.6
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
..++|...+.| |+|+||+||+|++ .++..||||++.... ...+++.+|+.+|++++|||||+++++|.+++..++||
T Consensus 15 ~~~~~~~~~~i-G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 15 ERTDITMKHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CGGGEEEEEET-TTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cHHHeEEeeEE-eeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 45678888888 9999999999999 456689999986543 34577999999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++|+|.+++..... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999999865322 57899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
...... .....||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+...+..+....
T Consensus 167 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---------~~~~~~~i~~~~~~~ 236 (287)
T d1opja_ 167 GDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---------LSQVYELLEKDYRME 236 (287)
T ss_dssp SSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---------HHHHHHHHHTTCCCC
T ss_pred CCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---------HHHHHHHHhcCCCCC
Confidence 543322 2233488999999999999999999999999999999997777653321 112223333322111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
.. ..+++.+.+|+.+||+.||++|||+.+|++.|+.+.+++
T Consensus 237 ~~------------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 237 RP------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred CC------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 11 134567999999999999999999999999999986643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=400.28 Aligned_cols=253 Identities=20% Similarity=0.233 Sum_probs=205.6
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|+..+.| |+|+||+||+|++ .++..||||.+..... ...+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~~dy~~~~~l-G~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTL-GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEE-ecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 3578888898 9999999999999 5677999999865432 33466899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 83 Ey~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred eccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999998653 57999999999999999999999 9999999999999999999999999999998775
Q ss_pred CCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
...........+||+.|+|||++.+..+ +.++|||||||++|||++|++||...... . ..... ..... .
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~-----~---~~~~~-~~~~~-~ 224 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----C---QEYSD-WKEKK-T 224 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT-----S---HHHHH-HHTTC-T
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH-----H---HHHHH-HhcCC-C
Confidence 4443333455679999999999988776 57899999999999999999999754321 0 01111 11111 1
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+ . ...++++.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~~~-~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNP-W---------KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTT-G---------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCc-c---------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1110 0 134567889999999999999999999976
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=398.70 Aligned_cols=249 Identities=18% Similarity=0.234 Sum_probs=210.1
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
++|...+.| |+|+||+||+|.+ .++..||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 20 ~~Y~~~~~i-G~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEEC-CCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEE-ecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 468888888 9999999999998 66779999999766555567899999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
|++|+|.+++.. ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 99 ~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp CTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred cCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 999999998764 46899999999999999999999 999999999999999999999999999999876543
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .................
T Consensus 170 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---------~~~~~~~~~~~~~~~~~ 238 (293)
T d1yhwa1 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---------LRALYLIATNGTPELQN 238 (293)
T ss_dssp TC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------HHHHHHHHHHCSCCCSS
T ss_pred cc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---------HHHHHHHHhCCCCCCCC
Confidence 32 23455699999999999999999999999999999999999999974332 12222222222211111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+ ...++.+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~-----------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 P-----------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp G-----------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred c-----------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 144567999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=390.09 Aligned_cols=254 Identities=15% Similarity=0.251 Sum_probs=213.6
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPA 139 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 139 (350)
++|...+.| |+|+||+||+|+++++..||||.+.... ...+++.+|+.++++++||||++++|+|.+++.+++||||+
T Consensus 4 ~~~~~~~~i-G~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKEL-GTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCC-CEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEE-ecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 678888888 9999999999999888899999987654 34578999999999999999999999999999999999999
Q ss_pred CCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCC
Q 018816 140 GYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGK 219 (350)
Q Consensus 140 ~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 219 (350)
++|+|.+++.... ..+++..+.+++.||++||.||| +++|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 82 ANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999976543 56889999999999999999999 8999999999999999999999999999998765443
Q ss_pred ccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 220 THIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
.. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ..+...+.++.. ...
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----------~~~~~~i~~~~~-~~~ 222 (258)
T d1k2pa_ 155 YT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----------SETAEHIAQGLR-LYR 222 (258)
T ss_dssp CC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----------HHHHHHHHTTCC-CCC
T ss_pred ce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----------HHHHHHHHhCCC-CCC
Confidence 32 2334558999999999999999999999999999999998 8989874432 122223333221 111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
| ...++.+.+|+.+||+.||++|||+.+|++.|.+|
T Consensus 223 p-----------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 223 P-----------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp C-----------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred c-----------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1 13346799999999999999999999999999764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=395.27 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=210.3
Q ss_pred cCcccccc-cccCCCceEEEEEEEC---CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNI-TIDEIEGYILYMGFLR---DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~-lig~G~~g~V~~~~~~---~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
++|...++ | |+|+||.||+|.+. ++..||||.+.... ....+++.+|+.+|++++|||||+++|+|.+ +.+++
T Consensus 8 ~~~~~~~~~i-G~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEE-ECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEE-ecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45666664 7 99999999999873 33479999987543 3456789999999999999999999999865 56899
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++|+|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 86 vmE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 999999999999885542 57999999999999999999999 89999999999999999999999999999988
Q ss_pred CCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 215 IPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 215 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
........ ......||+.|+|||++.++.++.++|||||||++|||+| |..||..... . .+...+..+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~------~----~~~~~i~~~ 228 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------P----EVMAFIEQG 228 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------H----HHHHHHHTT
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH------H----HHHHHHHcC
Confidence 76544322 2334558999999999999999999999999999999998 8999975432 1 122333333
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
...... ..+++++.+|+.+||+.||++|||+.+|++.|+.++.
T Consensus 229 ~~~~~p------------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 229 KRMECP------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCCCCC------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC------------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 222111 1345688999999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=392.09 Aligned_cols=245 Identities=21% Similarity=0.267 Sum_probs=206.6
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+|++ .++..||+|.+.+.. ....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 6 ~dy~i~~~i-G~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPL-GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEE-ecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 578888888 9999999999999 567789999986542 23356788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
||||++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|...
T Consensus 85 mEy~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EeecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999998653 57999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.+....
T Consensus 157 ~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------~~~~~~i~~~~~~ 222 (263)
T d2j4za1 157 PSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----------QETYKRISRVEFT 222 (263)
T ss_dssp CCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----------HHHHHHHHTTCCC
T ss_pred CCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH----------HHHHHHHHcCCCC
Confidence 5432 2344699999999999999999999999999999999999999974321 1112222222111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+. ...++++.+|+.+||+.||++|||+.|+++
T Consensus 223 -~p------------~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -FP------------DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CC------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CC------------ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11 134467899999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-56 Score=392.66 Aligned_cols=260 Identities=18% Similarity=0.239 Sum_probs=203.9
Q ss_pred cCcccccccccCCCceEEEEEEECCC-----ceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDR-----GPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~-----~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
+.|+..++| |+|+||.||+|.++++ ..||||++.... .....++.+|+.++++++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~i-G~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVI-GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEE-EECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEE-eeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 568888888 9999999999998432 369999986543 344567899999999999999999999999999999
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||++++++.+.+.... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999999876543 57999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
......... ......||+.|+|||++.++.++.++|||||||++|||++|..|+..... ...+...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---------~~~~~~~i~~~ 229 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------NHEVMKAINDG 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---------HHHHHHHHHTT
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---------HHHHHHHHhcc
Confidence 765432221 22334589999999999999999999999999999999997666543221 11222333332
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
...... ..++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 230 ~~~~~~------------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 FRLPTP------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCC------------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCc------------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 211111 13456799999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=395.30 Aligned_cols=251 Identities=18% Similarity=0.176 Sum_probs=206.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
+.|+..+.| |+|+||.||+|++ .++..||+|++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~i-G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGEL-GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEE-eeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 357888888 9999999999999 56778999999776666677899999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
|++|+|.+++.... .++++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 91 ~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 91 CAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 99999999875432 46999999999999999999999 999999999999999999999999999999764321
Q ss_pred CccccccccccCCCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLT-----TGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
........||+.|+|||++. +..|+.++|||||||++|||++|+.||...... . .+........
T Consensus 164 --~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~------~---~~~~i~~~~~ 232 (288)
T d2jfla1 164 --IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM------R---VLLKIAKSEP 232 (288)
T ss_dssp --HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG------G---HHHHHHHSCC
T ss_pred --cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH------H---HHHHHHcCCC
Confidence 11233556999999999984 456899999999999999999999999754321 1 1122222111
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....+ ...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~-----------~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 PTLAQP-----------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCSSG-----------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCcc-----------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 144568999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-56 Score=390.74 Aligned_cols=249 Identities=20% Similarity=0.261 Sum_probs=201.6
Q ss_pred ccccCCCceEEEEEEEC---CCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeecCCC
Q 018816 67 ITIDEIEGYILYMGFLR---DRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEPAGY 141 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~---~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 141 (350)
.| |+|+||+||+|.+. .+..||||++.... ....+++.+|+.+|++++|||||+++|+|.+ +..++||||+++
T Consensus 14 ~i-G~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 14 EL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EE-EECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred Cc-ccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46 99999999999873 23579999986532 2345679999999999999999999999865 467899999999
Q ss_pred CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCCCcc
Q 018816 142 CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTH 221 (350)
Q Consensus 142 ~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 221 (350)
|+|.+++... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999998754 57999999999999999999999 899999999999999999999999999999876544332
Q ss_pred c-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccCc
Q 018816 222 I-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNIDP 299 (350)
Q Consensus 222 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (350)
. ......||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+...+..+......
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----------~~~~~~i~~~~~~~~p- 232 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------SEVTAMLEKGERMGCP- 232 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------HHHHHHHHTTCCCCCC-
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----------HHHHHHHHcCCCCCCC-
Confidence 2 2334568999999999999999999999999999999998 8999875322 1222333332221111
Q ss_pred cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 300 VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 300 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
..+++++.+|+.+||+.||++|||+.+|++.|+..+.
T Consensus 233 -----------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 233 -----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp -----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 1345679999999999999999999999999988754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=393.83 Aligned_cols=256 Identities=16% Similarity=0.154 Sum_probs=194.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeec--CCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLE--AEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 133 (350)
.++|...+.| |+|+||.||+|++ .++..||+|.+.... ....+.+.+|+.++++++|||||++++++.+ ++.++
T Consensus 3 ~edy~~~~~i-G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTI-GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEE-ecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 3689999998 9999999999999 567789999986543 3445678999999999999999999999865 45689
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC--CCCeEeeccccCceEeCCCCceeEcccCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF--PQPVVFRNIEPWNILFQEEYAAKLFDFSL 211 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 211 (350)
+|||||++|+|.+++...... ...+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+||+|||+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998642111 146999999999999999999999421 23599999999999999999999999999
Q ss_pred CccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 212 SKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 212 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
|+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+..
T Consensus 161 a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----------~~~~~~i~~ 228 (269)
T d2java1 161 ARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----------KELAGKIRE 228 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----------HHHHHHHHH
T ss_pred eeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH----------HHHHHHHHc
Confidence 987654322 23345699999999999999999999999999999999999999974321 112222333
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....+.. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~------------~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKFRRIPY------------RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCCCCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCc------------ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 22221111 34467999999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=398.48 Aligned_cols=260 Identities=20% Similarity=0.268 Sum_probs=208.4
Q ss_pred cCcccccccccCCCceEEEEEEECC-C-----ceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCc
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD-R-----GPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEAEM 131 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~-~-----~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 131 (350)
++|...+.| |+|+||+||+|++.. + ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~l-G~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVL-GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEE-EECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEE-eeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 678888888 999999999999832 2 258999886543 34456789999999998 89999999999999999
Q ss_pred CeEEeecCCCCchhhhhhCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeecccc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQT------------------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEP 193 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp 193 (350)
.++|||||++|+|.+++...... ....+++..++.++.||+.||.||| +++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence 99999999999999999754321 1135899999999999999999999 89999999999
Q ss_pred CceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcc
Q 018816 194 WNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRL 272 (350)
Q Consensus 194 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~ 272 (350)
+|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |.+||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655444333445568999999999999999999999999999999998 8999875432
Q ss_pred cCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 018816 273 ATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQ 344 (350)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~ 344 (350)
. ..+...+..+...... ..+++++.+|+.+||+.||++|||+.+|++.|..
T Consensus 273 ~---------~~~~~~~~~~~~~~~p------------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 D---------ANFYKLIQNGFKMDQP------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp S---------HHHHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H---------HHHHHHHhcCCCCCCC------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1 1122233322211111 1345689999999999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-56 Score=392.94 Aligned_cols=249 Identities=17% Similarity=0.165 Sum_probs=204.3
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+|++ .++..||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~dy~i~~~l-G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKIL-GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEE-eeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 579999998 9999999999999 667799999987542 23456789999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+++|+|.+++... +.+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus 87 mEy~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceec
Confidence 9999999999988654 57999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
............+||+.|+|||++.+..++.++|||||||++|||++|..||..... . .....+......
T Consensus 159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------~-~~~~~i~~~~~~ 228 (288)
T d1uu3a_ 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---------Y-LIFQKIIKLEYD 228 (288)
T ss_dssp C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------H-HHHHHHHTTCCC
T ss_pred ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---------H-HHHHHHHcCCCC
Confidence 554433334456699999999999999999999999999999999999999974322 1 111222221111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+. ...++++.+|+.+||+.||++|||++|++.
T Consensus 229 -~p------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 -FP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CC------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -CC------------ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11 133467899999999999999999998753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=386.44 Aligned_cols=244 Identities=16% Similarity=0.192 Sum_probs=195.9
Q ss_pred ccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeec----CCcCeEE
Q 018816 63 SMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLE----AEMPALV 135 (350)
Q Consensus 63 ~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 135 (350)
.....| |+|+||+||+|++ .++..||+|++... .....+.+.+|+.+|++++|||||++++++.+ ...+++|
T Consensus 12 ~~~~~i-G~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEI-GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEE-ecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 444567 9999999999999 56678999998654 23445678999999999999999999999865 3467999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEeeccccCceEeC-CCCceeEcccCCC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQP--VVFRNIEPWNILFQ-EEYAAKLFDFSLS 212 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~ 212 (350)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +++ |+||||||+|||++ .++.+||+|||+|
T Consensus 91 mE~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EeCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 9999999999999653 57899999999999999999999 877 99999999999996 5789999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
+...... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||..... .......+..+
T Consensus 163 ~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~---------~~~~~~~i~~~ 228 (270)
T d1t4ha_ 163 TLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN---------AAQIYRRVTSG 228 (270)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS---------HHHHHHHHTTT
T ss_pred eeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc---------HHHHHHHHHcC
Confidence 8654322 234569999999999865 699999999999999999999999974322 11122222221
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... +.+. ...++++.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~---~~~~--------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 VKP---ASFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCC---GGGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC---cccC--------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 1111 123456899999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=396.63 Aligned_cols=276 Identities=15% Similarity=0.169 Sum_probs=207.6
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
..++|...+.| |+|+||+||+|++ .++..||+|++... .....+.+.+|+.+|++++|||||+++++|.+.+..++|
T Consensus 4 ~~d~y~~~~~i-G~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISEL-GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEE-ECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEE-ecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35789999998 9999999999999 56778999998654 234456789999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQ-PVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
|||+++|+|.+++... +.+++..+..++.||+.||.||| ++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 83 mEy~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 9999999999999653 56899999999999999999999 64 899999999999999999999999999986
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCC---------CCcchHHHHH
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG---------GSNFFITDRV 285 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---------~~~~~~~~~~ 285 (350)
.... ...+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ +.........
T Consensus 155 ~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 155 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred cCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 5321 23345699999999999999999999999999999999999999975432100 0000000000
Q ss_pred H-------HHHHhcCCC-----ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhh
Q 018816 286 E-------KFIRSNGYM-----NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK--KLRQMY 346 (350)
Q Consensus 286 ~-------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~~ 346 (350)
. ......... ..+.......+.......+.++.+|+.+||+.||++|||+.|+++ .|++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0 000000000 000000000000000123467899999999999999999999998 465543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=387.93 Aligned_cols=259 Identities=22% Similarity=0.274 Sum_probs=206.1
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++|...+.| |+|+||.||+|+++++..||||++.... ...+.|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus 16 ~~~~~i~~~i-G~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKL-GQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEE-EECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEE-eeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 4688999998 9999999999999887899999986543 345779999999999999999999999854 568999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
+++|+|..++..... ..+++.+++.++.||+.||.||| +++|+||||||+||||+.++.+||+|||+++.....
T Consensus 93 ~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999988864321 46899999999999999999999 899999999999999999999999999999876543
Q ss_pred CccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCccC
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNID 298 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (350)
... ......||+.|+|||++.++.++.++|||||||++|||++|..|+..... .......+..+......
T Consensus 167 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---------~~~~~~~i~~~~~~~~~ 236 (285)
T d1fmka3 167 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---------NREVLDQVERGYRMPCP 236 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---------HHHHHHHHHTTCCCCCC
T ss_pred Cce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---------HHHHHHHHHhcCCCCCC
Confidence 322 22334589999999999999999999999999999999997666543221 11122223322211111
Q ss_pred ccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 299 PVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
+ .+++++.+|+.+||+.||++|||+.+|++.|++...+
T Consensus 237 ~------------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 237 P------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp T------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred c------------ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1 3456799999999999999999999999999987754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-55 Score=390.91 Aligned_cols=251 Identities=20% Similarity=0.207 Sum_probs=191.9
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.+.|...+.| |+|+||+||+|++ .++..||||.+..... .....+.+|+.+|++++|||||++++++.+++.+++||
T Consensus 8 ~d~Y~~~~~l-G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVL-GTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEES-BSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEE-eeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3568888888 9999999999999 5677899999876532 33456789999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC---CCCceeEcccCCCc
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ---EEYAAKLFDFSLSK 213 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~ 213 (350)
|||++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||+. .++.+||+|||+|+
T Consensus 87 E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp CCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred eccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999754 57999999999999999999999 99999999999999995 57899999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
....... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||..... . .....+....
T Consensus 159 ~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------~-~~~~~i~~~~ 225 (307)
T d1a06a_ 159 MEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---------A-KLFEQILKAE 225 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------H-HHHHHHHTTC
T ss_pred EccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---------H-HHHHHHhccC
Confidence 7644332 3345699999999999999999999999999999999999999975322 1 1122222222
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.....+.. ...++++.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 226 YEFDSPYW---------DDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCCTTTT---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCccc---------cCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 21111111 134567999999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-55 Score=390.44 Aligned_cols=244 Identities=20% Similarity=0.212 Sum_probs=201.9
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
.|+..+.| |+|+||.||+|++ .++..||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 16 ~y~~l~~l-G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEE-EECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEE-ecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 48888888 9999999999998 667789999986543 234467889999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|||++|+|..++... .++++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|....
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999998766543 57999999999999999999999 9999999999999999999999999999998654
Q ss_pred CCCccccccccccCCCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTT---GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG 293 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (350)
. .....||+.|+|||++.+ +.|+.++|||||||++|||++|..||..... ............
T Consensus 167 ~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~---------~~~~~~i~~~~~ 231 (309)
T d1u5ra_ 167 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---------MSALYHIAQNES 231 (309)
T ss_dssp S------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------HHHHHHHHHSCC
T ss_pred C------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH---------HHHHHHHHhCCC
Confidence 3 234459999999999864 4689999999999999999999999874322 112222222211
Q ss_pred CCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 294 YMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...... ..++.+.+|+.+||+.||++|||+.++++
T Consensus 232 ~~~~~~------------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PALQSG------------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCSCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCC------------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111 33467999999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.2e-54 Score=393.55 Aligned_cols=252 Identities=16% Similarity=0.162 Sum_probs=210.3
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
-++|...+.| |+|+||.||+|++ .++..||||++........+.+.+|+.+|++++|||||++++++.+.+.+++|||
T Consensus 25 l~~Y~i~~~l-G~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEEL-GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEE-EEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEE-ecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3589999998 9999999999999 6677999999987766667789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC--CCceeEcccCCCccC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE--EYAAKLFDFSLSKSI 215 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~ 215 (350)
||++|+|.+++.... +.+++..+..++.||+.||.||| +++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 104 ~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 104 FMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999999999986532 56999999999999999999999 999999999999999964 688999999999877
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...+. .+......
T Consensus 177 ~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---------~~~~~-~i~~~~~~ 243 (350)
T d1koaa2 177 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---------DETLR-NVKSCDWN 243 (350)
T ss_dssp CTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---------HHHHH-HHHHTCCC
T ss_pred ccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---------HHHHH-HHHhCCCC
Confidence 54432 3345699999999999999999999999999999999999999974321 11122 22222211
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.. ...++.+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 244 MDDSAF---------SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp SCCGGG---------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcccc---------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 134567899999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-54 Score=388.81 Aligned_cols=267 Identities=19% Similarity=0.249 Sum_probs=214.4
Q ss_pred HHHHhcCcccccccccCCCceEEEEEEEC------CCceEEEEEecccch-hhHHHHHHHHHHHHhcCCCCccceeeeee
Q 018816 55 LKTAINNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSVR-YASERCFNNIVFASQMNHKSILKLIGCCL 127 (350)
Q Consensus 55 l~~~~~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 127 (350)
++--.++|...+.| |+|+||+||+|++. ++..||||++..... ...+++.+|+.++++++||||++++++|.
T Consensus 8 ~e~p~~~~~~~~~l-G~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 8 LEYPRNNIEYVRDI-GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp TBCCGGGCEEEEEE-EECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHcEEeEEE-eeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 33345789999999 99999999999973 345899999875433 34567999999999999999999999999
Q ss_pred cCCcCeEEeecCCCCchhhhhhCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEe
Q 018816 128 EAEMPALVYEPAGYCTLADRLYGPLQ-------------------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVF 188 (350)
Q Consensus 128 ~~~~~~lv~e~~~~~sL~~~l~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 188 (350)
+.+..++||||+++|+|.+++..... .....+++..++.++.|++.||.||| +++|+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence 99999999999999999999863211 11135889999999999999999999 999999
Q ss_pred eccccCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCC-CCC
Q 018816 189 RNIEPWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR-TIG 267 (350)
Q Consensus 189 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~-~p~ 267 (350)
|||||+|||++.++.+||+|||+|+...............+|+.|+|||.+.+..++.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998665444333444556899999999999999999999999999999999986 566
Q ss_pred CCCcccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 268 HLSRLATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
..... . .+...+..+....+. ..+++++.+|+.+||+.||++||||.+|++.|++|.+
T Consensus 244 ~~~~~---------~-e~~~~v~~~~~~~~p------------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGMAH---------E-EVIYYVRDGNILACP------------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTSCH---------H-HHHHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCH---------H-HHHHHHHcCCCCCCC------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 54322 1 122233333222111 1345679999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-54 Score=391.53 Aligned_cols=252 Identities=15% Similarity=0.140 Sum_probs=210.1
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.++|...+.| |+|+||.||+|++ .++..||||.+........+.+.+|+.+|++++|||||++++++.+++.+++|||
T Consensus 28 ~d~Y~i~~~l-G~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEEL-GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEE-ecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4579999998 9999999999999 6677999999987665666788899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeC--CCCceeEcccCCCccC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQ--EEYAAKLFDFSLSKSI 215 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~ 215 (350)
||++|+|.+++.... .++++.++..++.||+.||.||| +++|+||||||+|||++ .++.+||+|||+|...
T Consensus 107 ~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 107 FLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceec
Confidence 999999998875432 46999999999999999999999 99999999999999998 5789999999999887
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .. ....+......
T Consensus 180 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---------~~-~~~~i~~~~~~ 246 (352)
T d1koba_ 180 NPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---------LE-TLQNVKRCDWE 246 (352)
T ss_dssp CTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---------HH-HHHHHHHCCCC
T ss_pred CCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---------HH-HHHHHHhCCCC
Confidence 65432 3344599999999999999999999999999999999999999975432 11 11222222211
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.. ...++++.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAF---------SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTT---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccc---------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111 134567899999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-55 Score=381.39 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=201.2
Q ss_pred hcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeec-CCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLE-AEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 137 (350)
-++|...+.| |+|+||.||+|++++. .||||++... ...+.+.+|++++++++||||++++|+|.+ .+.+++|||
T Consensus 6 ~~~~~~~~~l-G~G~fg~Vy~~~~~~~-~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTI-GKGEFGDVMLGDYRGN-KVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEE-EECSSCEEEEEEETTE-EEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEE-ecCCCeEEEEEEECCe-EEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 3567788888 9999999999999754 8999999664 345779999999999999999999999865 457899999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
|+++|+|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999999864321 35899999999999999999999 89999999999999999999999999999986543
Q ss_pred CCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
. .....+|+.|+|||++.++.++.++|||||||++|||+| |++||..... ..+ ...+.++....
T Consensus 156 ~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~------~~~----~~~i~~~~~~~ 220 (262)
T d1byga_ 156 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDV----VPRVEKGYKMD 220 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------GGH----HHHHTTTCCCC
T ss_pred C-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH------HHH----HHHHHcCCCCC
Confidence 2 223348899999999999999999999999999999998 6777764322 111 22222222221
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
+.+ ..++++.+|+.+||+.||++|||+.+|++.|++|+...
T Consensus 221 ~~~------------~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~ 261 (262)
T d1byga_ 221 APD------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261 (262)
T ss_dssp CCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCc------------cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCC
Confidence 111 33467899999999999999999999999999998654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=380.38 Aligned_cols=258 Identities=20% Similarity=0.232 Sum_probs=199.6
Q ss_pred hcCcccccccccCCCceEEEEEEECC----CceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRD----RGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~----~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.++|...+.| |+|+||.||+|++.. +..||||.+.... ....+.+.+|+.++++++|||||++++++. .+..+
T Consensus 6 ~~~~~l~~~i-G~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCI-GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEE-EECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEE-eeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 3578888888 999999999999832 2368888886543 344577999999999999999999999986 46789
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+||||+++|+|.+++.... ..+++..++.++.||+.||.||| +++|+||||||+||+++.++.+||+|||+|+
T Consensus 84 iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhe
Confidence 9999999999999875432 57899999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
........ ......||+.|+|||++.+..++.++|||||||++|||++ |.+||..... .. +...+..+
T Consensus 157 ~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~------~~----~~~~i~~~ 225 (273)
T d1mp8a_ 157 YMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------ND----VIGRIENG 225 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GG----HHHHHHTT
T ss_pred eccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH------HH----HHHHHHcC
Confidence 76443222 2334458999999999999999999999999999999998 8888875432 11 12222222
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
....+.+ .+++.+.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus 226 ~~~~~~~------------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 ERLPMPP------------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCCCCCT------------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC------------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2221111 3456799999999999999999999999999998653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=389.28 Aligned_cols=257 Identities=17% Similarity=0.263 Sum_probs=205.1
Q ss_pred cCcccccccccCCCceEEEEEEEC-CCc----eEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-DRG----PILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPA 133 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-~~~----~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 133 (350)
.+|+..+.| |+|+||+||+|.+. ++. .||+|++... .....+++.+|+.++++++|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~l-G~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVL-GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEE-EECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEE-ecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 468888998 99999999999984 333 5899988654 334567899999999999999999999999865 567
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCc
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSK 213 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 213 (350)
+++||+.+++|.+++.... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccce
Confidence 8899999999999876542 57899999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHHhc
Q 018816 214 SIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIRSN 292 (350)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (350)
...............||+.|+|||++.++.++.++|||||||++|||+| |.+||..... .. +...+..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~------~~----~~~~i~~~ 229 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SE----ISSILEKG 229 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG------GG----HHHHHHHT
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH------HH----HHHHHHcC
Confidence 8765444433444568999999999999999999999999999999998 7888764432 11 22233332
Q ss_pred CCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 293 GYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
...... ..+++.+.+|+.+||+.||++|||+.+|++.|..+.+
T Consensus 230 ~~~~~p------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 ERLPQP------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCCCC------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC------------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 221111 1345678999999999999999999999999988754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=381.04 Aligned_cols=250 Identities=17% Similarity=0.164 Sum_probs=206.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch------hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR------YASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
+.|...+.| |+|+||.||+|++ .++..||||.+.+... ...+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 10 d~Y~~~~~l-G~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 10 DYYDTGEEL-GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GTEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCEEEeEEE-ecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 568888998 9999999999999 6677999999865321 2357799999999999999999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC----ceeEcc
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY----AAKLFD 208 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~----~~kl~D 208 (350)
++|||||++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+|++|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecc
Confidence 9999999999999998653 57999999999999999999999 99999999999999998776 499999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
||+|........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .....
T Consensus 161 fG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------~-~~~~~ 227 (293)
T d1jksa_ 161 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---------Q-ETLAN 227 (293)
T ss_dssp CTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------H-HHHHH
T ss_pred hhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---------H-HHHHH
Confidence 999987654332 3345589999999999999999999999999999999999999974322 1 11122
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
+.........+ . ....+..+.+|+.+||+.||++|||+.++++
T Consensus 228 i~~~~~~~~~~-~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 228 VSAVNYEFEDE-Y--------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHTTCCCCCHH-H--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCch-h--------cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222111111 0 0134567899999999999999999999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.1e-53 Score=375.18 Aligned_cols=261 Identities=19% Similarity=0.261 Sum_probs=205.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC----
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAE---- 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 130 (350)
.++|...+.| |+|+||.||+|++ .++..||||.+.... ......+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~drY~i~~~l-G~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEIL-GFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEE-eeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3678888988 9999999999998 677799999996542 234567899999999999999999999988654
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
.+++||||+++++|.+++... +.+++.++..++.||+.||.||| +++|+||||||+|||++.++.++++|||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred eEEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhh
Confidence 378999999999999988654 57999999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCcc-ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 211 LSKSIPEGKTH-IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 211 ~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
.+......... ......+||+.|+|||++.+..++.++|||||||++|||+||++||..... .......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---------~~~~~~~~ 227 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---------VSVAYQHV 227 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHHHH
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH---------HHHHHHHH
Confidence 98765433222 234455699999999999999999999999999999999999999974332 12222333
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhhh
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-TMIDVAKKLRQMYR 347 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~evl~~L~~~~~ 347 (350)
...... +.... ...++++.+|+.+||+.||++|| |++++++.|.++..
T Consensus 228 ~~~~~~---~~~~~-------~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 228 REDPIP---PSARH-------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HCCCCC---GGGTS-------SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred hcCCCC---Cchhc-------cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 222111 10000 13456899999999999999999 89999999998864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=380.51 Aligned_cols=271 Identities=15% Similarity=0.248 Sum_probs=205.8
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEEC------CCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceee
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIG 124 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~ 124 (350)
+.++...++|...+.| |+|+||.||+|++. +++.||||++.... ....+.+.+|+.++.++ +|+||+.+++
T Consensus 6 ~~wei~~~~y~~~~~i-G~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPL-GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHBCCGGGEEEEEEE-EECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccHHHEEEeeEE-eecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3333334688989998 99999999999972 23479999987543 34456788888888887 6899999999
Q ss_pred eeecC-CcCeEEeecCCCCchhhhhhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccc
Q 018816 125 CCLEA-EMPALVYEPAGYCTLADRLYGPLQT-----------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIE 192 (350)
Q Consensus 125 ~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 192 (350)
++.+. ..+++|||||++|+|.+++...... ....+++..++.++.||+.||.||| +++|+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCC
Confidence 87754 4789999999999999998643211 1135899999999999999999999 8999999999
Q ss_pred cCceEeCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCc
Q 018816 193 PWNILFQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR-TIGHLSR 271 (350)
Q Consensus 193 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~-~p~~~~~ 271 (350)
|+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998765554444455567999999999999999999999999999999999975 5665332
Q ss_pred ccCCCCcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 272 LATGGSNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
. ...+...+..+...... ...++++.+|+.+||+.||++|||+.+|++.|+++.++
T Consensus 242 ~---------~~~~~~~~~~~~~~~~~------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 I---------DEEFCRRLKEGTRMRAP------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp C---------SHHHHHHHHHTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---------HHHHHHHHhcCCCCCCC------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1 11222333333221111 13346789999999999999999999999999999765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=382.28 Aligned_cols=248 Identities=17% Similarity=0.140 Sum_probs=208.0
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeE
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 134 (350)
.++|...+.| |+|+||.||+|+. .++..||+|++.+.. ....+.+.+|+.+|++++||||+++++++.+.+.+++
T Consensus 4 l~dy~~~~~l-G~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLL-GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEE-ecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 3689999999 9999999999999 677799999997542 2345678899999999999999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.+|.+||+|||+|+.
T Consensus 83 v~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred ceeccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccc
Confidence 99999999999998754 57899999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||..... ..+.........
T Consensus 155 ~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----------~~~~~~i~~~~~ 222 (337)
T d1o6la_ 155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----------ERLFELILMEEI 222 (337)
T ss_dssp SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHHCCC
T ss_pred cccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH----------HHHHHHHhcCCC
Confidence 644322 23455699999999999999999999999999999999999999975432 112222222221
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 340 (350)
.. . ...++++.+|+.+||+.||++||+ +.++++
T Consensus 223 ~~-p------------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RF-P------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CC-C------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CC-C------------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11 0 133467899999999999999995 788876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-53 Score=377.74 Aligned_cols=265 Identities=18% Similarity=0.250 Sum_probs=212.1
Q ss_pred hcCcccccccccCCCceEEEEEEECC--------CceEEEEEecccch-hhHHHHHHHHHHHHhc-CCCCccceeeeeec
Q 018816 59 INNYSMRNITIDEIEGYILYMGFLRD--------RGPILVMKYRKSVR-YASERCFNNIVFASQM-NHKSILKLIGCCLE 128 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~~~--------~~~vaik~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 128 (350)
.++|...+.| |+|+||.||+|+... +..||||++..... ....++.+|+..+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~i-G~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPL-GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEEC-C-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEE-eecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3577888888 999999999998722 23799999976543 4457788999999888 79999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceE
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQT-----------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~-----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 197 (350)
++..++||||+++|+|.+++...... ....+++.+++.++.||+.||.||| +.+|+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccccee
Confidence 99999999999999999999754311 1246899999999999999999999 999999999999999
Q ss_pred eCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCC
Q 018816 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGG 276 (350)
Q Consensus 198 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~ 276 (350)
++.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||++ |.+||.....
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---- 243 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 243 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence 99999999999999987765544444455668999999999999999999999999999999998 6777764321
Q ss_pred CcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
..+...+..+......+ .+++++.+|+.+||+.||++|||+.||++.|++|...+
T Consensus 244 ------~~~~~~i~~~~~~~~p~------------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~~ 298 (299)
T d1fgka_ 244 ------EELFKLLKEGHRMDKPS------------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298 (299)
T ss_dssp ------HHHHHHHHTTCCCCCCS------------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------HHHHHHHHcCCCCCCCc------------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhcC
Confidence 22333444332221111 23467999999999999999999999999999997654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=374.83 Aligned_cols=256 Identities=20% Similarity=0.289 Sum_probs=197.8
Q ss_pred cCcccccccccCCCceEEEEEEEC-C-C--ceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLR-D-R--GPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~-~-~--~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
++|+..+.| |+|+||.||+|++. + + ..||||++.... ....++|.+|+.+|++++|||||+++|+|.+ +..
T Consensus 8 ~d~~~~~~i-G~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEEC-C----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEE-ecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 578888888 99999999999872 2 2 368999986542 2445679999999999999999999999976 467
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++|++.+++.... ..+++..++.++.||+.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred heeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhh
Confidence 99999999999998876432 56999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCccc-cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 213 KSIPEGKTHI-KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLT-GRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 213 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
+......... ......||..|+|||++.+..++.++|||||||++|||+| |..||..... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---------~~~~~~i~~ 229 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---------SQILHKIDK 229 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------HHHHHHHHT
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---------HHHHHHHHh
Confidence 8875543322 2334457889999999999999999999999999999998 8999874332 112222222
Q ss_pred hcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 018816 291 SNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQM 345 (350)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~ 345 (350)
.+...... ..+++.+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 230 ~~~~~~~~------------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 EGERLPRP------------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp SCCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCc------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 21111111 13446799999999999999999999999998874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=378.74 Aligned_cols=255 Identities=20% Similarity=0.300 Sum_probs=204.2
Q ss_pred ccccccCCCceEEEEEEECCC----ceEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCccceeeeeecC-CcCeEEeec
Q 018816 65 RNITIDEIEGYILYMGFLRDR----GPILVMKYRKS-VRYASERCFNNIVFASQMNHKSILKLIGCCLEA-EMPALVYEP 138 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~~~~----~~vaik~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~ 138 (350)
.++| |+|+||+||+|++.++ ..||||++... .....+++.+|+++|++++|||||+++|+|.+. ...++||||
T Consensus 32 ~~~i-G~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVI-GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEE-EEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEE-eecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3567 9999999999998332 25899998753 345567899999999999999999999998764 578999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
|++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 99999999987643 46788999999999999999999 999999999999999999999999999999876543
Q ss_pred Cccc--cccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 219 KTHI--KASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 219 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
.... ......||+.|+|||.+.++.++.++||||||+++|||++|..||...... .. ....+..+....
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~----~~~~i~~g~~~~ 254 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FD----ITVYLLQGRRLL 254 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------------CHHHHHTTCCCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HH----HHHHHHcCCCCC
Confidence 3221 223345899999999999999999999999999999999988776533211 11 112222222111
Q ss_pred cCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 297 IDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
.| ..+++.+.+|+.+||+.||++|||+.||++.|++++.+
T Consensus 255 -~p-----------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 -QP-----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -Cc-----------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11 13346789999999999999999999999999999765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=377.57 Aligned_cols=266 Identities=19% Similarity=0.226 Sum_probs=215.8
Q ss_pred hcCcccccccccCCCceEEEEEEE------CCCceEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCccceeeeeecCC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL------RDRGPILVMKYRKSV-RYASERCFNNIVFASQM-NHKSILKLIGCCLEAE 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~------~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 130 (350)
.++|...+.| |+|+||.||+|++ ..+..||||++.... ......+.+|+.+++++ +|||||+++++|.+.+
T Consensus 22 ~~~~~l~~~i-G~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTL-GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEE-EECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEE-eecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 4678888888 9999999999986 344589999997643 34456789999999999 6999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceE
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQT-------------HLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNIL 197 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nil 197 (350)
..++|||||++|+|.+++...... ....+++..+..++.||+.||.||| +++++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccc
Confidence 999999999999999998654211 1236899999999999999999999 999999999999999
Q ss_pred eCCCCceeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCcccCCC
Q 018816 198 FQEEYAAKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTG-RTIGHLSRLATGG 276 (350)
Q Consensus 198 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~~p~~~~~~~~~~ 276 (350)
++.++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|+ .+|+.....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~---- 253 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---- 253 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS----
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH----
Confidence 999999999999999887655544445556799999999999999999999999999999999994 555543322
Q ss_pred CcchHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhcC
Q 018816 277 SNFFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRTS 349 (350)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~~ 349 (350)
...+...+..+....... ..++.+.+|+.+||+.||++|||+.+|++.|+++..++
T Consensus 254 -----~~~~~~~i~~~~~~~~~~------------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 254 -----DSKFYKMIKEGFRMLSPE------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp -----SHHHHHHHHHTCCCCCCT------------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -----HHHHHHHHhcCCCCCCcc------------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 122233333322221111 33467999999999999999999999999999876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-52 Score=376.15 Aligned_cols=244 Identities=20% Similarity=0.215 Sum_probs=205.6
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||+||+|++ .++..||||++.... ....+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 4 ~dy~i~~~l-G~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTL-GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEE-ecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 678889998 9999999999999 667799999987542 23456788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||++||+|..++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+..
T Consensus 83 mE~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp ECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eeecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999988764 56889999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..... .+......
T Consensus 155 ~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---------~~~~~-~i~~~~~~ 219 (316)
T d1fota_ 155 PDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---------MKTYE-KILNAELR 219 (316)
T ss_dssp SSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---------HHHHH-HHHHCCCC
T ss_pred ccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH---------HHHHH-HHHcCCCC
Confidence 543 2345699999999999999999999999999999999999999975432 11112 22222111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
+.+ ..++++.+++.+||+.||++|| |++++++
T Consensus 220 -~p~------------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 -FPP------------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCT------------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCC------------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111 2346789999999999999996 8999886
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-53 Score=378.56 Aligned_cols=260 Identities=18% Similarity=0.226 Sum_probs=206.0
Q ss_pred cCcccccccccCCCceEEEEEEECC-Cc--eEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRD-RG--PILVMKYRKS-VRYASERCFNNIVFASQM-NHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~-~~--~vaik~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 134 (350)
++|...+.| |+|+||.||+|++++ +. .||||++... .....+.+.+|+.+|.++ +|||||+++++|.+.+.+++
T Consensus 10 ~~~~~~~~i-G~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVI-GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEE-ECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEE-eeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 678888888 999999999999943 33 5788887544 334556799999999999 79999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc
Q 018816 135 VYEPAGYCTLADRLYGPLQ-----------THLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA 203 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~ 203 (350)
||||+++|+|.+++..... .....+++..++.++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCc
Confidence 9999999999999975421 11257999999999999999999999 899999999999999999999
Q ss_pred eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCC-CCCCCcccCCCCcchHH
Q 018816 204 AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRT-IGHLSRLATGGSNFFIT 282 (350)
Q Consensus 204 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~-p~~~~~~~~~~~~~~~~ 282 (350)
+||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||.....
T Consensus 166 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---------- 232 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------- 232 (309)
T ss_dssp EEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------
T ss_pred eEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH----------
Confidence 9999999997654322 2234458999999999999999999999999999999999765 5543221
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
..+...+..+...... ..+++++.+|+.+||+.||++||||.+|++.|+++.++
T Consensus 233 ~~~~~~i~~~~~~~~~------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 233 AELYEKLPQGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHHGGGTCCCCCC------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHhcCCCCCC------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1122222222111111 13456899999999999999999999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-52 Score=369.34 Aligned_cols=250 Identities=19% Similarity=0.218 Sum_probs=206.3
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---------hhHHHHHHHHHHHHhcC-CCCccceeeeeec
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---------YASERCFNNIVFASQMN-HKSILKLIGCCLE 128 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 128 (350)
++|...+.| |+|+||+||+|++ .++..||||++..... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~y~~~~~i-G~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 3 ENYEPKEIL-GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccCEEceEE-ecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 678888998 9999999999999 6777999999865421 12346889999999997 9999999999999
Q ss_pred CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcc
Q 018816 129 AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFD 208 (350)
Q Consensus 129 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 208 (350)
++..++||||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEcc
Confidence 99999999999999999999653 57999999999999999999999 99999999999999999999999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTT------GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT 282 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~ 282 (350)
||+++....... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.....
T Consensus 154 FG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---------- 220 (277)
T d1phka_ 154 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---------- 220 (277)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------
T ss_pred chheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----------
Confidence 999988755332 334569999999998864 3478899999999999999999999975432
Q ss_pred HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 283 DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......+.........+.. ...++++.+|+.+||+.||++|||+.||++
T Consensus 221 ~~~~~~i~~~~~~~~~~~~---------~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 221 MLMLRMIMSGNYQFGSPEW---------DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHHHHTCCCCCTTTG---------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhCCCCCCCccc---------ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122222222222111111 145578999999999999999999999976
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=372.38 Aligned_cols=274 Identities=18% Similarity=0.191 Sum_probs=203.6
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCC----cCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAE----MPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv 135 (350)
.+|...+.| |+|+||.||+|++++ ..||||++..... .......|+..+.+++|||||+++++|.+.+ .+++|
T Consensus 3 ~~~~l~~~i-G~G~fg~Vy~~~~~g-~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESI-GKGRFGEVWRGKWRG-EEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEE-ECCSSSEEEEEEETT-EEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEE-eeCCCeEEEEEEECC-EEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 456677788 999999999999864 5999999865432 1222334555556789999999999998654 57899
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFG-----FPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
|||+++|+|.+++.. .++++..++.++.|++.||.|||.. ..++|+||||||+|||++.++.+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 999999999999975 4689999999999999999999942 23699999999999999999999999999
Q ss_pred CCccCCCCCccc--cccccccCCCCCCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCc----
Q 018816 211 LSKSIPEGKTHI--KASTAIGSLEFAAPEYLTTG------YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSN---- 278 (350)
Q Consensus 211 ~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---- 278 (350)
+++......... ......||+.|+|||++.+. .++.++|||||||++|||+||.+|+...........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 998765433221 23345699999999998754 267899999999999999999988754332211000
Q ss_pred -chHHHHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhhc
Q 018816 279 -FFITDRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYRT 348 (350)
Q Consensus 279 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~~ 348 (350)
............... .+|.+..... .......+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 234 ~~~~~~~~~~~~~~~~---~~p~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQK---LRPNIPNRWQ---SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHTTSC---CCCCCCGGGG---GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccc---cCCCCCcccC---ChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 011122222222211 2222211111 125667899999999999999999999999999999764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=378.35 Aligned_cols=252 Identities=15% Similarity=0.180 Sum_probs=199.2
Q ss_pred hcCccccc-ccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhc-CCCCccceeeeeec----CCc
Q 018816 59 INNYSMRN-ITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQM-NHKSILKLIGCCLE----AEM 131 (350)
Q Consensus 59 ~~~f~~~~-~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~ 131 (350)
.++|.... +| |+|+||.||+|++ .++..||||++... ..+.+|+.++.++ +|||||++++++.+ ...
T Consensus 10 ~~~y~i~~~~l-G~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVL-GLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEe-eeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 46788765 57 9999999999999 66779999998653 4577899987665 89999999999875 457
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCceeEcc
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKLFD 208 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~D 208 (350)
+|+|||||+||+|.+++..... ..+++.++..++.||+.||.||| +.+|+||||||+|||++. ++.+||+|
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccc
Confidence 8999999999999999975321 46999999999999999999999 999999999999999985 56799999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
||+|+....... .....||+.|+|||++.+..|+.++|||||||++|+|++|++||...... ..... .
T Consensus 158 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~------~~~~~---~ 225 (335)
T d2ozaa1 158 FGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------AISPG---M 225 (335)
T ss_dssp CTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred cceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH------HHHHH---H
Confidence 999987654332 34456999999999999999999999999999999999999999754321 00000 0
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
......... ..+.......++++.+|+.+||+.||++|||+.++++
T Consensus 226 ~~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 226 KTRIRMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --CCCSCSS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhcCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000000000 0011111255678999999999999999999999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=374.09 Aligned_cols=251 Identities=16% Similarity=0.171 Sum_probs=206.1
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
.++|...+.| |+|+||+||+|.+ .++..||+|.+.... .....+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 4 ~~rY~i~~~l-G~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDL-GRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEE-ecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4678888998 9999999999999 567789999997654 334568899999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCC--CceeEcccCCCccC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEE--YAAKLFDFSLSKSI 215 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~ 215 (350)
||++|+|.+++.... ..+++.++..++.||+.||.||| +++|+||||||+|||++.+ ..+||+|||+++..
T Consensus 82 ~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 82 FISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 999999999996542 46899999999999999999999 9999999999999999854 58999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .....+|+.|+|||.+.+..++.++|||||||++|+|++|..||..... .. ....+.+....
T Consensus 155 ~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---------~~-~~~~i~~~~~~ 221 (321)
T d1tkia_ 155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---------QQ-IIENIMNAEYT 221 (321)
T ss_dssp CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---------HH-HHHHHHHTCCC
T ss_pred ccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---------HH-HHHHHHhCCCC
Confidence 54332 3344589999999999999999999999999999999999999975432 11 12222222211
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...+.+ ...++++.+|+.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 FDEEAF---------KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHH---------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhc---------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110 023467899999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.3e-52 Score=379.01 Aligned_cols=248 Identities=17% Similarity=0.146 Sum_probs=198.7
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch---hhHHHHHH---HHHHHHhcCCCCccceeeeeecCCcC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR---YASERCFN---NIVFASQMNHKSILKLIGCCLEAEMP 132 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~---~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 132 (350)
++|...+.| |+|+||.||+|++ .++..||||.+..... .....+.+ |+.+++.++|||||++++++.+.+..
T Consensus 4 ddy~i~~~l-G~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRII-GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEE-ecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 689999998 9999999999999 5677999999865321 12233444 46677778899999999999999999
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
++||||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeecee
Confidence 9999999999999999653 56889999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHh
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRS 291 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (350)
+...... .....||+.|+|||++..+ .++.++|||||||++|||++|+.||...... ... .....
T Consensus 155 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~----~~~~~ 220 (364)
T d1omwa3 155 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK------DKH----EIDRM 220 (364)
T ss_dssp EECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS------CHH----HHHHH
T ss_pred eecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH------HHH----HHHHh
Confidence 8765432 3345699999999999754 6899999999999999999999999754321 111 11111
Q ss_pred cCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 018816 292 NGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPT-----MIDVAK 340 (350)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~evl~ 340 (350)
.... .+... ...++++.+|+.+||+.||++||| ++++++
T Consensus 221 ~~~~--~~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 221 TLTM--AVELP--------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSC--CCCCC--------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cccC--CCCCC--------CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1100 00000 133467899999999999999999 688875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-52 Score=376.46 Aligned_cols=244 Identities=16% Similarity=0.113 Sum_probs=205.5
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 135 (350)
++|...+.| |+|+||.||+|++ .++..||||.+.... ....+.+.+|+.+|++++|||||++++++.+....++|
T Consensus 41 d~y~i~~~l-G~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTL-GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEE-EECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEe-ecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 589999998 9999999999999 677799999986542 23356788999999999999999999999999999999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccC
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSI 215 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 215 (350)
|||+.+|+|.+++... +.+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+..
T Consensus 120 ~e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999998654 57999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 216 PEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+......
T Consensus 192 ~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---------~~-~~~~i~~~~~~ 256 (350)
T d1rdqe_ 192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---------IQ-IYEKIVSGKVR 256 (350)
T ss_dssp SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------HH-HHHHHHHCCCC
T ss_pred ccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---------HH-HHHHHhcCCCC
Confidence 532 2345699999999999999999999999999999999999999974322 11 11222222111
Q ss_pred ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 296 NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
. . ...++++.+|+.+||+.||++|+ |++++++
T Consensus 257 ~-p------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 F-P------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C-C------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C-C------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 0 13346789999999999999994 8999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=372.77 Aligned_cols=264 Identities=18% Similarity=0.286 Sum_probs=213.4
Q ss_pred HhcCcccccccccCCCceEEEEEEEC------CCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFLR------DRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAE 130 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~~------~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 130 (350)
..++|...+.| |+|+||+||+|.+. ++..||||++.... ......+.+|+.++++++||||++++++|...+
T Consensus 18 ~~~~~~l~~~l-G~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 18 AREKITMSREL-GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CGGGEEEEEEE-EECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred cHHHeEEeeEE-eeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 34788888888 99999999999873 24589999997543 344567899999999999999999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCcee
Q 018816 131 MPALVYEPAGYCTLADRLYGPL-----QTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 205 (350)
..++||||+++|+|.+++.... ......+++..+..++.|++.||.||| +++|+||||||+|||++.++++|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~K 173 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK 173 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEE
Confidence 9999999999999999885321 111245789999999999999999999 89999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCcccCCCCcchHHHH
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGR-TIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~-~p~~~~~~~~~~~~~~~~~~ 284 (350)
|+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. +||..... ...
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---------~~~ 244 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---------EQV 244 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---------HHH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH---------HHH
Confidence 99999998765544444445556899999999999999999999999999999999985 66543221 122
Q ss_pred HHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 285 VEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
...+.++...... ..+++.+.+|+.+||+.||++|||+.+|++.|++..+
T Consensus 245 -~~~i~~~~~~~~p------------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 -LRFVMEGGLLDKP------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -HHHHHTTCCCCCC------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHHHhCCCCCCc------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 2223322211111 1344679999999999999999999999999988754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=367.99 Aligned_cols=259 Identities=17% Similarity=0.129 Sum_probs=195.1
Q ss_pred ccccccCCCceEEEEEEE-CCCceEEEEEecccchh-----hHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEeec
Q 018816 65 RNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRY-----ASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYEP 138 (350)
Q Consensus 65 ~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 138 (350)
.++| |+|+||+||+|++ .++..||||++...... ..+.+.+|+.++++++|||||++++++.+.+..++||||
T Consensus 3 l~~l-G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFL-GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEE-EEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred ceEe-ccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3566 9999999999999 56779999998654321 124688999999999999999999999999999999999
Q ss_pred CCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCCC
Q 018816 139 AGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPEG 218 (350)
Q Consensus 139 ~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 218 (350)
++++++..+.... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 82 METDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC
Confidence 9988777665433 56889999999999999999999 999999999999999999999999999999876543
Q ss_pred CccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCcc
Q 018816 219 KTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMNI 297 (350)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (350)
.. .....+||+.|+|||++... .++.++|||||||++|||++|.+||..... ...................
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~------~~~l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 154 NR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRIFETLGTPTEEQW 225 (299)
T ss_dssp CC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCTTTS
T ss_pred cc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH------HHHHHHHHHhcCCCChhhc
Confidence 32 23345699999999998755 589999999999999999999999875432 1111111111111111100
Q ss_pred Cc-------cccCCCCccch----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 298 DP-------VIVGDRSCFRK----EEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 298 ~~-------~~~~~~~~~~~----~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.. ........... ...++++.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 00000000000 123567999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=373.20 Aligned_cols=247 Identities=19% Similarity=0.214 Sum_probs=203.8
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc---hhhHHHHHHHHHHHH-hcCCCCccceeeeeecCCcCeE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV---RYASERCFNNIVFAS-QMNHKSILKLIGCCLEAEMPAL 134 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~l 134 (350)
++|...+.| |+|+||+||+|++ .++..||||.+.+.. ....+.+..|..++. .++|||||++++++.+++..|+
T Consensus 2 ddy~i~~~i-G~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKML-GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEE-EECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEE-ecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 578889998 9999999999999 667799999997542 233456777877765 6899999999999999999999
Q ss_pred EeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 135 VYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 135 v~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
||||+++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 vmEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhh
Confidence 99999999999999654 56899999999999999999999 89999999999999999999999999999986
Q ss_pred CCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCC
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGY 294 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (350)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+...+.....
T Consensus 153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~----------~~~~~~i~~~~~ 220 (320)
T d1xjda_ 153 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----------EELFHSIRMDNP 220 (320)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHHCCC
T ss_pred cccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH----------HHHHHHHHcCCC
Confidence 644322 23445699999999999999999999999999999999999999975332 112222222221
Q ss_pred CccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 018816 295 MNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMI-DVAK 340 (350)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-evl~ 340 (350)
. +. ...++++.+|+.+||+.||++|||+. +|++
T Consensus 221 ~-~p------------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 F-YP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C-CC------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C-CC------------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 11 13346789999999999999999995 6753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=359.88 Aligned_cols=267 Identities=18% Similarity=0.155 Sum_probs=201.7
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch--hhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR--YASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|...+.| |+|+||+||+|++ .++..||+|++..... ...+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 2 d~Y~~~~~l-G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKI-GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEE-EECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEE-ecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 578888998 9999999999999 6677999999865432 23567899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
||+.++.+........ ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||.|+...
T Consensus 81 e~~~~~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp ECCSEEHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred eecCCchhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceecc
Confidence 9997554443333322 56999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcC--
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNG-- 293 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (350)
.... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||..... ............
T Consensus 154 ~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---------~~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 154 VPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---------IDQLFRIFRTLGTP 222 (298)
T ss_dssp CCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---------HHHHHHHHHHHCCC
T ss_pred CCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---------HHHHHHHHHhcCCC
Confidence 4332 233446999999999887765 58999999999999999999999975432 111111111100
Q ss_pred CCccCc------cccCCC----Ccc---chHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHh
Q 018816 294 YMNIDP------VIVGDR----SCF---RKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK--LRQM 345 (350)
Q Consensus 294 ~~~~~~------~~~~~~----~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L~~~ 345 (350)
.....+ ...... ... .....++++.+|+.+||+.||++|||+.|+++. |+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000000 000000 000 001334678999999999999999999999984 5544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=359.86 Aligned_cols=239 Identities=18% Similarity=0.204 Sum_probs=196.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccch------hhHHHHHHHHHHHHhcC--CCCccceeeeeecCC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVR------YASERCFNNIVFASQMN--HKSILKLIGCCLEAE 130 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 130 (350)
++|...+.| |+|+||+||+|++ .++..||||.+..... ....++.+|+.++++++ |||||++++++.+++
T Consensus 4 ~~Y~i~~~l-G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 4 SQYQVGPLL-GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CeEEEeEEE-eeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 578888888 9999999999999 6777999999865421 12234678999999996 899999999999999
Q ss_pred cCeEEeecCCC-CchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-CCceeEcc
Q 018816 131 MPALVYEPAGY-CTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-EYAAKLFD 208 (350)
Q Consensus 131 ~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-~~~~kl~D 208 (350)
..++||||+.+ +++.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECc
Confidence 99999999976 5777777543 57999999999999999999999 999999999999999985 47999999
Q ss_pred cCCCccCCCCCccccccccccCCCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHH
Q 018816 209 FSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYY-NEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEK 287 (350)
Q Consensus 209 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 287 (350)
||+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 155 FG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---------------- 214 (273)
T d1xwsa_ 155 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------------- 214 (273)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------------
T ss_pred cccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------------
Confidence 99998654322 334569999999999987765 577999999999999999999986321
Q ss_pred HHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 288 FIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+.... ..+.+ ..++++.+|+.+||+.||++|||++|+++
T Consensus 215 ~i~~~~-~~~~~------------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 EIIRGQ-VFFRQ------------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHCC-CCCSS------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhhcc-cCCCC------------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111111 11111 23467899999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7e-50 Score=355.27 Aligned_cols=264 Identities=18% Similarity=0.153 Sum_probs=200.8
Q ss_pred cCcccccccccCCCceEEEEEEECCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 137 (350)
++|...+.| |+|+||+||+|+++++..||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..+++||
T Consensus 2 ~~Y~~~~~i-G~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKI-GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEE-EEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEE-ecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 578888888 9999999999999888899999996543 2335789999999999999999999999999999999999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCCC
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIPE 217 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 217 (350)
++.++.+..+.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+|++|||.|.....
T Consensus 81 ~~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp CCSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred eehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 99877776665443 57999999999999999999999 89999999999999999999999999999977644
Q ss_pred CCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCCc
Q 018816 218 GKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYMN 296 (350)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (350)
... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ..................
T Consensus 153 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~------~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 153 PVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCTTT
T ss_pred Ccc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH------HHHHHHHHHhhCCCChhh
Confidence 322 23334589999999998764 579999999999999999999999975432 111111111111100000
Q ss_pred ---------cCccccCCCC---ccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 297 ---------IDPVIVGDRS---CFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 297 ---------~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.+........ .......++.+.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 0001134567899999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=356.89 Aligned_cols=266 Identities=15% Similarity=0.149 Sum_probs=198.3
Q ss_pred HhcCcccccccccCCCceEEEEEEE-CC-CceEEEEEecccch--hhHHHHHHHHHHHHhc---CCCCccceeeeeec--
Q 018816 58 AINNYSMRNITIDEIEGYILYMGFL-RD-RGPILVMKYRKSVR--YASERCFNNIVFASQM---NHKSILKLIGCCLE-- 128 (350)
Q Consensus 58 ~~~~f~~~~~lig~G~~g~V~~~~~-~~-~~~vaik~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-- 128 (350)
..++|...+.| |+|+||+||+|++ ++ +..||||++..... .....+.+|+.+++.| +||||++++++|..
T Consensus 5 ~~~~Y~i~~~L-G~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEE-EEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEE-ecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 34789999999 9999999999998 44 44689999865422 2233566788777766 79999999999863
Q ss_pred ---CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCcee
Q 018816 129 ---AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAK 205 (350)
Q Consensus 129 ---~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~k 205 (350)
....+++|||++++++........ ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred cccCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCee
Confidence 346899999999887765554332 56899999999999999999999 99999999999999999999999
Q ss_pred EcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHH
Q 018816 206 LFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRV 285 (350)
Q Consensus 206 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 285 (350)
|+|||+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|++||..... .......
T Consensus 157 l~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~~~~i 227 (305)
T d1blxa_ 157 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD------VDQLGKI 227 (305)
T ss_dssp ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHH
T ss_pred ecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH------HHHHHHH
Confidence 99999987653322 34456699999999999999999999999999999999999999975432 1111111
Q ss_pred HHHHHhcCCCccCc----------cccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 286 EKFIRSNGYMNIDP----------VIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 286 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
.............. ..............++.+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11111100000000 00000000001134567889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=347.14 Aligned_cols=267 Identities=15% Similarity=0.134 Sum_probs=197.2
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeec-------
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLE------- 128 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------- 128 (350)
.++|...+.| |+|+||+||+|++ .++..||||++.... ......+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~L-G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEE-EECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEE-ecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4788888999 9999999999999 677899999985542 2345678899999999999999999998865
Q ss_pred -CCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEc
Q 018816 129 -AEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLF 207 (350)
Q Consensus 129 -~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 207 (350)
.+..++||||++++.+....... ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred cCceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEee
Confidence 34679999999877766554332 57889999999999999999999 9999999999999999999999999
Q ss_pred ccCCCccCCCCCcc--ccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHH
Q 018816 208 DFSLSKSIPEGKTH--IKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDR 284 (350)
Q Consensus 208 Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 284 (350)
|||++......... ......+||+.|+|||++.+. .++.++|||||||++|||++|++||..... ......
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~------~~~~~~ 233 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE------QHQLAL 233 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH------HHHHHH
Confidence 99999766533221 123345699999999998765 689999999999999999999999975332 111111
Q ss_pred HHHHHHhcCCCc---cC--------ccccCCCCccc----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 285 VEKFIRSNGYMN---ID--------PVIVGDRSCFR----KEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 285 ~~~~~~~~~~~~---~~--------~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
............ .+ ........... .....+.+.+|+.+||+.||++|||+.|+++
T Consensus 234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 222211111000 00 00001111000 0112456789999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-48 Score=353.03 Aligned_cols=267 Identities=15% Similarity=0.120 Sum_probs=196.4
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCccceeeeeecCC----cC
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-RYASERCFNNIVFASQMNHKSILKLIGCCLEAE----MP 132 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 132 (350)
+..|...+.| |+|+||+||+|++ .++..||||++.... ....+.+.+|+.+|++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~L-G~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYI-GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEEC-C---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEE-eeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 3568888898 9999999999998 677799999997543 344567899999999999999999999987653 23
Q ss_pred eEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCC
Q 018816 133 ALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLS 212 (350)
Q Consensus 133 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 212 (350)
+++++|+.+|+|.+++.. ..+++..+..++.||+.||.||| +++|+||||||+|||+++++.+||+|||++
T Consensus 86 ~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCce
Confidence 555666779999999864 46899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCccc-cccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHH
Q 018816 213 KSIPEGKTHI-KASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIR 290 (350)
Q Consensus 213 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 290 (350)
.......... .....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||...... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~------~~~~~~~~~~~ 230 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL------DQLNHILGILG 230 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHC
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH------HHHHHHhhhcc
Confidence 7664432221 2344569999999999855 46789999999999999999999999754321 00000000000
Q ss_pred hcCCC--------------ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 018816 291 SNGYM--------------NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK 341 (350)
Q Consensus 291 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~ 341 (350)
..... ...+..............+.++.+|+.+||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 0000000000000000233578899999999999999999999873
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=355.25 Aligned_cols=265 Identities=16% Similarity=0.185 Sum_probs=195.3
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCccceeeeeecCC-----
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKS--VRYASERCFNNIVFASQMNHKSILKLIGCCLEAE----- 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 130 (350)
.+.|...+.| |+|+||+||+|.+ .++..||||++... .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~l-G~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPV-GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC-------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEE-ecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4678888888 9999999999999 56778999998753 2344567889999999999999999999997654
Q ss_pred -cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEccc
Q 018816 131 -MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDF 209 (350)
Q Consensus 131 -~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 209 (350)
.+++||||+ +.+|..++.. ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+|++||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccc
Confidence 579999999 6678777654 46999999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccC---------CCCcc
Q 018816 210 SLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLAT---------GGSNF 279 (350)
Q Consensus 210 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------~~~~~ 279 (350)
|+|+..... .....||+.|+|||++.+. .++.++||||+||++|+|++|++||....... +....
T Consensus 166 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 166 GLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp TTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 999876442 2345599999999998764 57899999999999999999999997543210 00000
Q ss_pred hHH-----HHHHHHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHh
Q 018816 280 FIT-----DRVEKFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKK--LRQM 345 (350)
Q Consensus 280 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~--L~~~ 345 (350)
... .......... .......+.... ...++.+.+|+.+||+.||++|||+.|+++. |+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGL-PELEKKDFASIL-----TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHTCSCHHHHHHHHHS-CCCCCCCGGGTC-----TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHhhhcchhhhhhhccC-CcccccchHHhc-----cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000 0000000000 000000010000 1334678899999999999999999999973 5443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.1e-48 Score=342.72 Aligned_cols=263 Identities=11% Similarity=0.062 Sum_probs=206.8
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCC-CCccceeeeeecCCcCeEEe
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNH-KSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 136 (350)
.++|...+.| |+|+||+||+|++ .++..||||.+.... ....+.+|+.++..++| +|++.+++++.++...++||
T Consensus 4 g~~Y~i~~~i-G~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRI-GEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEE-EECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEE-ecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 3678888988 9999999999999 567799999875542 23457789999999975 89999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC-----CCceeEcccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE-----EYAAKLFDFSL 211 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~ 211 (350)
||+ +++|.+++.... ..++...+..++.|++.||.||| +++|+||||||+|||++. ++.+||+|||+
T Consensus 81 e~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred Eec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccce
Confidence 999 689999886532 46899999999999999999999 999999999999999974 57899999999
Q ss_pred CccCCCCCcc-----ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH
Q 018816 212 SKSIPEGKTH-----IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE 286 (350)
Q Consensus 212 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 286 (350)
|+........ ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .......
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~------~~~~~~~ 226 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA------TNKQKYE 226 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC------CHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch------hHHHHHH
Confidence 9876433211 1233456999999999999999999999999999999999999999754321 1111111
Q ss_pred HHHHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 287 KFIRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
.......... .+.+.. .+++++.+++..|++.+|++||+...+.+.|+++.+
T Consensus 227 ~i~~~~~~~~-~~~l~~--------~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 227 RIGEKKQSTP-LRELCA--------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHHHHHHSC-HHHHTT--------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHhccCCCC-hHHhcC--------CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 1111100000 000100 234678999999999999999999999999888764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-48 Score=344.97 Aligned_cols=262 Identities=16% Similarity=0.157 Sum_probs=198.6
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccce-eeeeecCCcCeEEee
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKL-IGCCLEAEMPALVYE 137 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e 137 (350)
+.|...+.| |+|+||.||+|++ .++..||||.+.... ..+++.+|+.++++++|+|++.. .++..+.+..++|||
T Consensus 7 ~rY~l~~~i-G~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKI-GSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEE-EECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEE-eeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 568888998 9999999999999 667799999876543 23457899999999987775555 555567778899999
Q ss_pred cCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCC---CCceeEcccCCCcc
Q 018816 138 PAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQE---EYAAKLFDFSLSKS 214 (350)
Q Consensus 138 ~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~ 214 (350)
|++ +++.+.+.... ..+++..+..++.|++.||.||| +++|+||||||+|||++. +..+||+|||+|+.
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 84 LLG-PSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp CCC-CBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EcC-Cchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 994 56666554322 57999999999999999999999 999999999999999864 56799999999987
Q ss_pred CCCCCcc-----ccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 215 IPEGKTH-----IKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 215 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
....... .......||+.|+|||++.+..++.++|||||||++|||++|..||......... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~--~~~~~~~~~~~ 233 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISEKKM 233 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HHHHHHHHH
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH--HHHHHhhcccC
Confidence 6543321 1234556999999999999999999999999999999999999999754331100 11111111100
Q ss_pred HhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhhh
Q 018816 290 RSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAKKLRQMYR 347 (350)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~~L~~~~~ 347 (350)
. .. .+.+. ..+++++.+++..||+.+|++||++.++.+.|+++..
T Consensus 234 ~-~~----~~~~~--------~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 234 S-TP----IEVLC--------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp H-SC----HHHHT--------TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred C-CC----hhHhc--------cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0 00 00000 1344678999999999999999999999998888753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=354.41 Aligned_cols=267 Identities=18% Similarity=0.149 Sum_probs=194.8
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCccceeeeeecC------CcCe
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSILKLIGCCLEA------EMPA 133 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 133 (350)
+|+..++| |+|+||+||+|++ .++..||||++..... ...+|+.+|++++||||+++++++... ..++
T Consensus 21 ~Y~~~k~L-G~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVI-GNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEE-EEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEE-eeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 57778888 9999999999999 5677999999876532 234799999999999999999998543 2478
Q ss_pred EEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-ceeEcccCCC
Q 018816 134 LVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLS 212 (350)
Q Consensus 134 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~ 212 (350)
+||||++++.+........ ....+++..+..++.||+.||.||| +++|+||||||+|||++.++ .+||+|||++
T Consensus 96 lv~Ey~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEECCSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEeccCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccch
Confidence 9999998664444332110 1157999999999999999999999 99999999999999999775 8999999999
Q ss_pred ccCCCCCccccccccccCCCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHH-----
Q 018816 213 KSIPEGKTHIKASTAIGSLEFAAPEYLTT-GYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVE----- 286 (350)
Q Consensus 213 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 286 (350)
........ ....+||+.|+|||.+.+ ..++.++||||+||++|||++|++||...... .......
T Consensus 171 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~------~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 171 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV------DQLVEIIKVLGT 241 (350)
T ss_dssp EECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH------HHHHHHHHHHCC
T ss_pred hhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH------HHHHHHHHHhCC
Confidence 87654332 334569999999998875 46899999999999999999999999754321 1100000
Q ss_pred ---HHHHhcC---CCccCccccCC-CCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHHhh
Q 018816 287 ---KFIRSNG---YMNIDPVIVGD-RSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK--KLRQMY 346 (350)
Q Consensus 287 ---~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~--~L~~~~ 346 (350)
..+.... ....-+..... .........++++.+|+.+||+.||++|||+.|+++ .|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0011111 00000110000 000000134567899999999999999999999996 355543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=346.39 Aligned_cols=262 Identities=15% Similarity=0.185 Sum_probs=199.2
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeec--CCcCeEE
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLE--AEMPALV 135 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv 135 (350)
++|...+.| |+|+||+||+|++ .++..||||++.... .+++.+|+.+|.+++ ||||+++++++.. ....++|
T Consensus 35 d~y~i~~~L-G~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKL-GRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEE-ecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 579999998 9999999999999 677799999986543 467889999999995 9999999999874 4568999
Q ss_pred eecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCC-ceeEcccCCCcc
Q 018816 136 YEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEY-AAKLFDFSLSKS 214 (350)
Q Consensus 136 ~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~ 214 (350)
|||+++++|..+. ..+++..+..++.||+.||.||| +++|+||||||+|||++.++ .+||+|||+|..
T Consensus 111 ~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 111 FEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccccee
Confidence 9999999997764 56899999999999999999999 99999999999999998655 689999999987
Q ss_pred CCCCCccccccccccCCCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHH-----HHHHHH
Q 018816 215 IPEGKTHIKASTAIGSLEFAAPEYLTTG-YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFIT-----DRVEKF 288 (350)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~ 288 (350)
...... .....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||.......... .... ......
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~-~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 180 YHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VRIAKVLGTEDLYDY 255 (328)
T ss_dssp CCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH-HHHHHHHCHHHHHHH
T ss_pred ccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH-HHHHHHHCCchhhhh
Confidence 654432 3445689999999998775 47999999999999999999999987543210000 0000 001111
Q ss_pred HHhcCC---CccCcc--------ccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 289 IRSNGY---MNIDPV--------IVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 289 ~~~~~~---~~~~~~--------~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
...... ...... .............++++.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110 000000 0000011111245577899999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=339.47 Aligned_cols=265 Identities=13% Similarity=0.092 Sum_probs=204.7
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecCCcCeEEe
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEAEMPALVY 136 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 136 (350)
++|...+.| |+|+||+||+|++ .++..||||++.... ....+.+.+|+.++++++||||+++++++.+....++|+
T Consensus 2 ~ry~~i~~L-G~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKI-GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEE-EECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEE-ecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 468888898 9999999999999 677789999985442 244678899999999999999999999999999999999
Q ss_pred ecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccCCCccCC
Q 018816 137 EPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKSIP 216 (350)
Q Consensus 137 e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 216 (350)
|++.+++|..++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||.++...
T Consensus 81 ~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp ECCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eeccccccccccccc-----cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhccc
Confidence 999999998887654 57889999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHHHhcCCC
Q 018816 217 EGKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFIRSNGYM 295 (350)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (350)
..... .....+++.|+|||++.... ++.++|||||||++|||++|+.||...... ......+..........
T Consensus 153 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 153 IPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp SCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-----HHHHHHHHHHHCCCCTT
T ss_pred CCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-----HHHHHHHHhhcCCCChh
Confidence 43322 23334788899999987665 689999999999999999999997643321 11111111111111000
Q ss_pred ccC-----------ccc-cCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 296 NID-----------PVI-VGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 296 ~~~-----------~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
... +.. ............++.+.+|+.+||+.||++|||++||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000 000000011134567899999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-48 Score=346.69 Aligned_cols=252 Identities=17% Similarity=0.140 Sum_probs=201.3
Q ss_pred cCcccccccccCCCceEEEEEEE----CCCceEEEEEecccc----hhhHHHHHHHHHHHHhcCC-CCccceeeeeecCC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL----RDRGPILVMKYRKSV----RYASERCFNNIVFASQMNH-KSILKLIGCCLEAE 130 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~----~~~~~vaik~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~ 130 (350)
++|...+.| |+|+||+||+|+. .++..||||.+.... ....+.+.+|+.++++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~I-G~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 24 ENFELLKVL-GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGEEEEEEE-EETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hceEEEEEE-ecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 679999999 9999999999987 245689999986532 1234568899999999977 89999999999999
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..+++|||+.+|+|.+++... ..++...+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ceeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeecc
Confidence 999999999999999998654 46788999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTG--YYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKF 288 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (350)
+++......... .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||...... .........
T Consensus 175 ~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~------~~~~~i~~~ 247 (322)
T d1vzoa_ 175 LSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK------NSQAEISRR 247 (322)
T ss_dssp EEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC------CCHHHHHHH
T ss_pred chhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHh
Confidence 998765433322 3345599999999999765 4788999999999999999999999754321 111111111
Q ss_pred HHhcCCCccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 018816 289 IRSNGYMNIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRP-----TMIDVAK 340 (350)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~evl~ 340 (350)
....... +. ...++++.+|+.+||+.||++|| |++|+++
T Consensus 248 ~~~~~~~-~~------------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 ILKSEPP-YP------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHCCCC-CC------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cccCCCC-Cc------------ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1111111 00 13456899999999999999999 4888886
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=344.48 Aligned_cols=265 Identities=14% Similarity=0.160 Sum_probs=191.0
Q ss_pred cCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeec------CC
Q 018816 60 NNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLE------AE 130 (350)
Q Consensus 60 ~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 130 (350)
+.|...+.| |+|+||+||+|.+ .++..||||++.... .....++.+|+.++++++||||+++++++.. ..
T Consensus 17 ~~Y~i~~~L-G~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPI-GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEEC-SCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEe-ecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 578888898 9999999999999 567899999996542 3445678899999999999999999999864 35
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
.+|+||||+.++.+. .+. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+|++|||
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eeEEEEeccchHHHH-hhh-------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechh
Confidence 789999999765554 442 46899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCC---------CCc---
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATG---------GSN--- 278 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---------~~~--- 278 (350)
+++...... ......+|+.|+|||++.+..++.++||||+||++++|++|++||........ ...
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp C------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence 987664433 23444589999999999999999999999999999999999999974432100 000
Q ss_pred -chHHHHHHHHHHhcCCC-------ccCccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 279 -FFITDRVEKFIRSNGYM-------NIDPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 279 -~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
................. ......... ........++++.+|+.+||+.||++|||++||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA-DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCC-SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccc-cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000111111111100 000000011 11112356788999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=344.22 Aligned_cols=261 Identities=16% Similarity=0.184 Sum_probs=194.7
Q ss_pred hcCcccccccccCCCceEEEEEEE-CCCceEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCccceeeeeecC-----C
Q 018816 59 INNYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSV--RYASERCFNNIVFASQMNHKSILKLIGCCLEA-----E 130 (350)
Q Consensus 59 ~~~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~ 130 (350)
.++|...+.| |+|+||+||+|++ .++..||||++.... ....+.+.+|+.+|++++|||||++++++... .
T Consensus 17 ~~rY~i~~~L-G~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPV-GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEEC-GGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEE-ecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4678888998 9999999999998 678899999987543 24456788999999999999999999998643 3
Q ss_pred cCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCceeEcccC
Q 018816 131 MPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAAKLFDFS 210 (350)
Q Consensus 131 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 210 (350)
..+++++|+.+|+|.+++.. ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+|++|||
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ceEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccc
Confidence 45677788889999999854 46999999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCccccccccccCCCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcchHHHHHHHHH
Q 018816 211 LSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGY-YNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNFFITDRVEKFI 289 (350)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (350)
.+..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||..... ...........
T Consensus 167 ~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~------~~~~~~i~~~~ 235 (348)
T d2gfsa1 167 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQLKLILRLV 235 (348)
T ss_dssp ---CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHH
T ss_pred hhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHHhc
Confidence 9875432 233455899999999877654 68999999999999999999999975432 11111111110
Q ss_pred HhcCCCcc--------------CccccCCCCccchHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 018816 290 RSNGYMNI--------------DPVIVGDRSCFRKEEKLQAYVELAFKCLSHSAEDRPTMIDVAK 340 (350)
Q Consensus 290 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~evl~ 340 (350)
........ .+..............++++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000 0000000000000123467889999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-40 Score=305.20 Aligned_cols=265 Identities=14% Similarity=0.091 Sum_probs=187.5
Q ss_pred CcccccccccCCCceEEEEEEE-CCCceEEEEEecccchhhHHHHHHHHHHHHhcC-----------CCCccceeeeeec
Q 018816 61 NYSMRNITIDEIEGYILYMGFL-RDRGPILVMKYRKSVRYASERCFNNIVFASQMN-----------HKSILKLIGCCLE 128 (350)
Q Consensus 61 ~f~~~~~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 128 (350)
.|...+.| |+|+||+||+|++ .++..||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~L-G~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKL-GWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEE-EECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEE-eeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 48888998 9999999999999 677899999997653 33466788999888875 5789999988764
Q ss_pred --CCcCeEEeecCCCCchhhh-hhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCc--
Q 018816 129 --AEMPALVYEPAGYCTLADR-LYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYA-- 203 (350)
Q Consensus 129 --~~~~~lv~e~~~~~sL~~~-l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~-- 203 (350)
....+++++++..+..... ..... ...+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTT
T ss_pred ccccceeeeeeeccccccccccccccc---ccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccc
Confidence 3455666766654443322 22211 1578899999999999999999993 289999999999999987653
Q ss_pred ----eeEcccCCCccCCCCCccccccccccCCCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCcccCCCCcc
Q 018816 204 ----AKLFDFSLSKSIPEGKTHIKASTAIGSLEFAAPEYLTTGYYNEKTDVYSFGKLLLVLLTGRTIGHLSRLATGGSNF 279 (350)
Q Consensus 204 ----~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~ 279 (350)
++++|||.+...... ....+||+.|+|||++.+..++.++||||+||++++|++|+.||....... ..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~---~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS---YT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred ccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccc---cc
Confidence 899999998765332 234559999999999999999999999999999999999999987543211 11
Q ss_pred hHHHHHHHHHH-----------hcCC-------CccCccccCCC----------CccchHHHHHHHHHHHHHccccCCCC
Q 018816 280 FITDRVEKFIR-----------SNGY-------MNIDPVIVGDR----------SCFRKEEKLQAYVELAFKCLSHSAED 331 (350)
Q Consensus 280 ~~~~~~~~~~~-----------~~~~-------~~~~~~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~~P~~ 331 (350)
........... .... ......+.... ........++.+.+|+.+||+.||.+
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 11111111111 0000 00000000000 00012367788999999999999999
Q ss_pred CCCHHHHHH
Q 018816 332 RPTMIDVAK 340 (350)
Q Consensus 332 RPt~~evl~ 340 (350)
|||+.|+++
T Consensus 319 Rpta~e~L~ 327 (362)
T d1q8ya_ 319 RADAGGLVN 327 (362)
T ss_dssp CBCHHHHHT
T ss_pred CcCHHHHhc
Confidence 999999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.6e-25 Score=185.57 Aligned_cols=163 Identities=16% Similarity=0.151 Sum_probs=119.2
Q ss_pred ccccccccCCCceEEEEEEECCCceEEEEEecccch------------------hhHHHHHHHHHHHHhcCCCCccceee
Q 018816 63 SMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVR------------------YASERCFNNIVFASQMNHKSILKLIG 124 (350)
Q Consensus 63 ~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~ 124 (350)
...+.| |+|+||+||+|.+.++..||||.+..... ........|...+.++.|++++..++
T Consensus 3 ~vg~~I-G~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLM-GEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEE-EECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEe-eeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 345677 99999999999998888999998653211 11233457888999999999998876
Q ss_pred eeecCCcCeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEeeccccCceEeCCCCce
Q 018816 125 CCLEAEMPALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGFPQPVVFRNIEPWNILFQEEYAA 204 (350)
Q Consensus 125 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~Nill~~~~~~ 204 (350)
+. ..+++|||+++..+.+ ++......++.|++.++.||| ..+|+||||||+|||++++ .+
T Consensus 82 ~~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EE
T ss_pred ec----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CE
Confidence 53 2479999998766543 233445679999999999999 8999999999999999865 48
Q ss_pred eEcccCCCccCCCCCccccccccccCCCCCC------ccccccCCCCccchhHHHHHHH
Q 018816 205 KLFDFSLSKSIPEGKTHIKASTAIGSLEFAA------PEYLTTGYYNEKTDVYSFGKLL 257 (350)
Q Consensus 205 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DiwslG~il 257 (350)
+|+|||.|......... .|+. .+.+ ...|+.++|+||+.--+
T Consensus 142 ~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999998765432211 0111 0111 35678899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.89 E-value=5.3e-09 Score=88.88 Aligned_cols=150 Identities=10% Similarity=0.030 Sum_probs=103.0
Q ss_pred HHHHHHhcCcccccccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCc
Q 018816 53 EDLKTAINNYSMRNITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEM 131 (350)
Q Consensus 53 ~~l~~~~~~f~~~~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 131 (350)
.|+......|...... +.++.+.||+...+++ .+++|+...........+.+|...+..+. +--+.+++.+..+++.
T Consensus 7 ~~l~~~~~~~~~~~~~-~G~s~~~v~rv~~~~~-~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDT-EGMSPAKVYKLVGENE-NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECS-CCCSSSEEEEEECSSC-EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcC-CCCCCCcEEEEEeCCC-eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 3466666677655544 5555679999876555 78888886655444556778888888774 4446788888888888
Q ss_pred CeEEeecCCCCchhhhhhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHccC-----------------------------
Q 018816 132 PALVYEPAGYCTLADRLYGPLQTHLEPLLLTHRLKVAMETANAVAYLRFGF----------------------------- 182 (350)
Q Consensus 132 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------- 182 (350)
.++||++++|.++.+..... . ....++.+++..+..||...
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred eEEEEEeccccccccccccc-------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 99999999998886644221 1 12234445555555555210
Q ss_pred ---------------------------CCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 183 ---------------------------PQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 183 ---------------------------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
...++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999877677999997653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.23 E-value=4.4e-06 Score=69.86 Aligned_cols=74 Identities=9% Similarity=-0.081 Sum_probs=53.5
Q ss_pred cCCC-ceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcC--CCCccceeeeeecCCcCeEEeecCCCCchhh
Q 018816 70 DEIE-GYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMN--HKSILKLIGCCLEAEMPALVYEPAGYCTLAD 146 (350)
Q Consensus 70 g~G~-~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~ 146 (350)
..|. .+.||+...+++..+++|...... ...+..|...++.+. .-.+.+++.+..+++..++||++++|.++.+
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 3443 468999998887778888765442 234677888887774 3346777888888888899999998876643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.17 E-value=6.6e-06 Score=73.65 Aligned_cols=75 Identities=8% Similarity=0.041 Sum_probs=49.0
Q ss_pred ccccCCCceEEEEEEE-CCCceEEEEEecccc-------hhhHHHHHHHHHHHHhcC-C--CCccceeeeeecCCcCeEE
Q 018816 67 ITIDEIEGYILYMGFL-RDRGPILVMKYRKSV-------RYASERCFNNIVFASQMN-H--KSILKLIGCCLEAEMPALV 135 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~-~~~~~vaik~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv 135 (350)
.| |.|....||+... .++..|++|.-.+.. +...++...|...|..+. + ..+.+++.+ +....++|
T Consensus 33 ei-g~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 33 EI-GDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EC-CSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred Ee-CCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 45 9999999999988 445688888754321 122345567888887663 3 345556554 45567899
Q ss_pred eecCCCCch
Q 018816 136 YEPAGYCTL 144 (350)
Q Consensus 136 ~e~~~~~sL 144 (350)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.51 E-value=8.4e-05 Score=63.98 Aligned_cols=162 Identities=14% Similarity=0.134 Sum_probs=86.1
Q ss_pred ccHHHHHHHhcCccccccc----ccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCc--ccee
Q 018816 50 FSSEDLKTAINNYSMRNIT----IDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSI--LKLI 123 (350)
Q Consensus 50 ~~~~~l~~~~~~f~~~~~l----ig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~ 123 (350)
++.+|+.....+|...... |..|---+.|+...+++ .+++|.+.... ..+++..|+.++..|...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 6788898888888775443 14555678899988776 79999886542 23445567777777743222 1111
Q ss_pred ee------eecCCcCeEEeecCCCCchhh--------------hhh---CCCC-CCCCCCCH------------------
Q 018816 124 GC------CLEAEMPALVYEPAGYCTLAD--------------RLY---GPLQ-THLEPLLL------------------ 161 (350)
Q Consensus 124 ~~------~~~~~~~~lv~e~~~~~sL~~--------------~l~---~~~~-~~~~~~~~------------------ 161 (350)
.. ..-......++.+..+..... .++ .... ........
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 11 111233445555555432211 000 0000 00000000
Q ss_pred HHHHHHHHHHHHHHHHHHc-cCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 162 THRLKVAMETANAVAYLRF-GFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 162 ~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
......+..+...+.-.+. ....++||+|+.++||+++.+...-|+||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111222222223333221 2256899999999999999988789999998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.50 E-value=0.0003 Score=60.75 Aligned_cols=165 Identities=16% Similarity=0.165 Sum_probs=87.8
Q ss_pred cccccHHHHHHHhcCcc--cc-cccccCCCceEEEEEEECCCceEEEEEecccchhhHHHHHHHHHHHHhcCCCCc--cc
Q 018816 47 IRSFSSEDLKTAINNYS--MR-NITIDEIEGYILYMGFLRDRGPILVMKYRKSVRYASERCFNNIVFASQMNHKSI--LK 121 (350)
Q Consensus 47 ~~~~~~~~l~~~~~~f~--~~-~~lig~G~~g~V~~~~~~~~~~vaik~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~ 121 (350)
...++.+-+..+...+- .. ..+.-.|---.||++...+|..+++|...+.. .+.+++..|...+..|....+ +.
T Consensus 5 f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~ 83 (325)
T d1zyla1 5 FQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA 83 (325)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred ccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 34466666655543331 11 11101122348999999888889999987652 235667788888888753222 21
Q ss_pred eee-----eeecCCcCeEEeecCCCCchhh-----------h---hh----CCCCCCCCCCCHH----------------
Q 018816 122 LIG-----CCLEAEMPALVYEPAGYCTLAD-----------R---LY----GPLQTHLEPLLLT---------------- 162 (350)
Q Consensus 122 ~~~-----~~~~~~~~~lv~e~~~~~sL~~-----------~---l~----~~~~~~~~~~~~~---------------- 162 (350)
.+. ........+.++++++|..+.. . ++ ..........+..
T Consensus 84 p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~ 163 (325)
T d1zyla1 84 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 163 (325)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred ceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcC
Confidence 111 1223456678899887643321 0 00 0000000111111
Q ss_pred ------HHHHHHHHHHHHHHHH-HccCCCCeEeeccccCceEeCCCCceeEcccCCCcc
Q 018816 163 ------HRLKVAMETANAVAYL-RFGFPQPVVFRNIEPWNILFQEEYAAKLFDFSLSKS 214 (350)
Q Consensus 163 ------~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 214 (350)
.....+..+...+.-. ......++||+|+.+.|||++.+ ..++||+.+..
T Consensus 164 ~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 164 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1122222333222222 11224579999999999999743 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.40 E-value=0.00052 Score=60.88 Aligned_cols=72 Identities=14% Similarity=0.068 Sum_probs=47.5
Q ss_pred ccccCCCceEEEEEEECCC--------ceEEEEEecccchhhHHHHHHHHHHHHhcC-CCCccceeeeeecCCcCeEEee
Q 018816 67 ITIDEIEGYILYMGFLRDR--------GPILVMKYRKSVRYASERCFNNIVFASQMN-HKSILKLIGCCLEAEMPALVYE 137 (350)
Q Consensus 67 ~lig~G~~g~V~~~~~~~~--------~~vaik~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 137 (350)
.| +.|-.-.+|++...++ ..|+++..- ... ......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 49 ~l-~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 49 RI-KGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EE-CCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred Ec-CCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 45 8888899999987543 245555543 222 2334567888888885 4334577777643 68999
Q ss_pred cCCCCchh
Q 018816 138 PAGYCTLA 145 (350)
Q Consensus 138 ~~~~~sL~ 145 (350)
|++|.++.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|